Gene	"Gene synonym"	Ensembl	"Gene description"	Uniprot	Chromosome	Position	"Protein class"	"Biological process"	"Molecular function"	"Disease involvement"	Evidence	"HPA evidence"	"UniProt evidence"	"NeXtProt evidence"	"RNA tissue specificity"	"RNA tissue distribution"	"RNA tissue specificity score"	"RNA tissue specific nTPM"	"RNA single cell type specificity"	"RNA single cell type distribution"	"RNA single cell type specificity score"	"RNA single cell type specific nTPM"	"RNA cancer specificity"	"RNA cancer distribution"	"RNA cancer specificity score"	"RNA cancer specific FPKM"	"RNA brain regional specificity"	"RNA brain regional distribution"	"RNA brain regional specificity score"	"RNA brain regional specific nTPM"	"RNA blood cell specificity"	"RNA blood cell distribution"	"RNA blood cell specificity score"	"RNA blood cell specific nTPM"	"RNA blood lineage specificity"	"RNA blood lineage distribution"	"RNA blood lineage specificity score"	"RNA blood lineage specific nTPM"	"RNA cell line specificity"	"RNA cell line distribution"	"RNA cell line specificity score"	"RNA cell line specific nTPM"	"RNA mouse brain regional specificity"	"RNA mouse brain regional distribution"	"RNA mouse brain regional specificity score"	"RNA mouse brain regional specific nTPM"	"RNA pig brain regional specificity"	"RNA pig brain regional distribution"	"RNA pig brain regional specificity score"	"RNA pig brain regional specific nTPM"	Antibody	"Reliability (IH)"	"Reliability (Mouse Brain)"	"Reliability (IF)"	"Subcellular location"	"Secretome location"	"CCD Protein"	"CCD Transcript"	"Blood concentration - Conc. blood IM [pg/L]"	"Blood concentration - Conc. blood MS [pg/L]"	"Blood expression cluster"	"Tissue expression cluster"	"Cell line expression cluster"	"Single cell expression cluster"	"Subcellular main location"	"Subcellular additional location"	"Antibody RRID"	"Pathology prognostics - Breast cancer"	"Pathology prognostics - Cervical cancer"	"Pathology prognostics - Colorectal cancer"	"Pathology prognostics - Endometrial cancer"	"Pathology prognostics - Glioma"	"Pathology prognostics - Head and neck cancer"	"Pathology prognostics - Liver cancer"	"Pathology prognostics - Lung cancer"	"Pathology prognostics - Melanoma"	"Pathology prognostics - Ovarian cancer"	"Pathology prognostics - Pancreatic cancer"	"Pathology prognostics - Prostate cancer"	"Pathology prognostics - Renal cancer"	"Pathology prognostics - Stomach cancer"	"Pathology prognostics - Testis cancer"	"Pathology prognostics - Thyroid cancer"	"Pathology prognostics - Urothelial cancer"	"Tissue RNA - adipose tissue [nTPM]"	"Tissue RNA - adrenal gland [nTPM]"	"Tissue RNA - amygdala [nTPM]"	"Tissue RNA - appendix [nTPM]"	"Tissue RNA - basal ganglia [nTPM]"	"Tissue RNA - bone marrow [nTPM]"	"Tissue RNA - breast [nTPM]"	"Tissue RNA - cerebellum [nTPM]"	"Tissue RNA - cerebral cortex [nTPM]"	"Tissue RNA - cervix [nTPM]"	"Tissue RNA - choroid plexus [nTPM]"	"Tissue RNA - colon [nTPM]"	"Tissue RNA - duodenum [nTPM]"	"Tissue RNA - endometrium 1 [nTPM]"	"Tissue RNA - epididymis [nTPM]"	"Tissue RNA - esophagus [nTPM]"	"Tissue RNA - fallopian tube [nTPM]"	"Tissue RNA - gallbladder [nTPM]"	"Tissue RNA - heart muscle [nTPM]"	"Tissue RNA - hippocampal formation [nTPM]"	"Tissue RNA - hypothalamus [nTPM]"	"Tissue RNA - kidney [nTPM]"	"Tissue RNA - liver [nTPM]"	"Tissue RNA - lung [nTPM]"	"Tissue RNA - lymph node [nTPM]"	"Tissue RNA - medulla oblongata [nTPM]"	"Tissue RNA - midbrain [nTPM]"	"Tissue RNA - ovary [nTPM]"	"Tissue RNA - pancreas [nTPM]"	"Tissue RNA - parathyroid gland [nTPM]"	"Tissue RNA - pituitary gland [nTPM]"	"Tissue RNA - placenta [nTPM]"	"Tissue RNA - pons [nTPM]"	"Tissue RNA - prostate [nTPM]"	"Tissue RNA - rectum [nTPM]"	"Tissue RNA - retina [nTPM]"	"Tissue RNA - salivary gland [nTPM]"	"Tissue RNA - seminal vesicle [nTPM]"	"Tissue RNA - skeletal muscle [nTPM]"	"Tissue RNA - skin 1 [nTPM]"	"Tissue RNA - small intestine [nTPM]"	"Tissue RNA - smooth muscle [nTPM]"	"Tissue RNA - spinal cord [nTPM]"	"Tissue RNA - spleen [nTPM]"	"Tissue RNA - stomach 1 [nTPM]"	"Tissue RNA - testis [nTPM]"	"Tissue RNA - thalamus [nTPM]"	"Tissue RNA - thymus [nTPM]"	"Tissue RNA - thyroid gland [nTPM]"	"Tissue RNA - tongue [nTPM]"	"Tissue RNA - tonsil [nTPM]"	"Tissue RNA - urinary bladder [nTPM]"	"Tissue RNA - vagina [nTPM]"	"Tissue RNA - white matter [nTPM]"	"Cell RNA - A-431 [nTPM]"	"Cell RNA - A549 [nTPM]"	"Cell RNA - AF22 [nTPM]"	"Cell RNA - AN3-CA [nTPM]"	"Cell RNA - ASC diff [nTPM]"	"Cell RNA - ASC TERT1 [nTPM]"	"Cell RNA - BEWO [nTPM]"	"Cell RNA - BJ [nTPM]"	"Cell RNA - BJ hTERT+ [nTPM]"	"Cell RNA - BJ hTERT+ SV40 Large T+ [nTPM]"	"Cell RNA - BJ hTERT+ SV40 Large T+ RasG12V [nTPM]"	"Cell RNA - CACO-2 [nTPM]"	"Cell RNA - CAPAN-2 [nTPM]"	"Cell RNA - Daudi [nTPM]"	"Cell RNA - EFO-21 [nTPM]"	"Cell RNA - fHDF/TERT166 [nTPM]"	"Cell RNA - GAMG [nTPM]"	"Cell RNA - HaCaT [nTPM]"	"Cell RNA - HAP1 [nTPM]"	"Cell RNA - HBEC3-KT [nTPM]"	"Cell RNA - HBF TERT88 [nTPM]"	"Cell RNA - HDLM-2 [nTPM]"	"Cell RNA - HEK 293 [nTPM]"	"Cell RNA - HEL [nTPM]"	"Cell RNA - HeLa [nTPM]"	"Cell RNA - Hep G2 [nTPM]"	"Cell RNA - HHSteC [nTPM]"	"Cell RNA - HL-60 [nTPM]"	"Cell RNA - HMC-1 [nTPM]"	"Cell RNA - HSkMC [nTPM]"	"Cell RNA - hTCEpi [nTPM]"	"Cell RNA - hTEC/SVTERT24-B [nTPM]"	"Cell RNA - hTERT-HME1 [nTPM]"	"Cell RNA - hTERT-RPE1 [nTPM]"	"Cell RNA - HUVEC TERT2 [nTPM]"	"Cell RNA - JURKAT [nTPM]"	"Cell RNA - K-562 [nTPM]"	"Cell RNA - Karpas-707 [nTPM]"	"Cell RNA - LHCN-M2 [nTPM]"	"Cell RNA - MCF7 [nTPM]"	"Cell RNA - MOLT-4 [nTPM]"	"Cell RNA - NB-4 [nTPM]"	"Cell RNA - NTERA-2 [nTPM]"	"Cell RNA - OE19 [nTPM]"	"Cell RNA - PC-3 [nTPM]"	"Cell RNA - REH [nTPM]"	"Cell RNA - RH-30 [nTPM]"	"Cell RNA - RPMI-8226 [nTPM]"	"Cell RNA - RPTEC TERT1 [nTPM]"	"Cell RNA - RT4 [nTPM]"	"Cell RNA - SCLC-21H [nTPM]"	"Cell RNA - SH-SY5Y [nTPM]"	"Cell RNA - SiHa [nTPM]"	"Cell RNA - SK-BR-3 [nTPM]"	"Cell RNA - SK-MEL-30 [nTPM]"	"Cell RNA - SuSa [nTPM]"	"Cell RNA - T-47d [nTPM]"	"Cell RNA - THP-1 [nTPM]"	"Cell RNA - TIME [nTPM]"	"Cell RNA - U-138 MG [nTPM]"	"Cell RNA - U-2 OS [nTPM]"	"Cell RNA - U-2197 [nTPM]"	"Cell RNA - U-251 MG [nTPM]"	"Cell RNA - U-266/70 [nTPM]"	"Cell RNA - U-266/84 [nTPM]"	"Cell RNA - U-698 [nTPM]"	"Cell RNA - U-87 MG [nTPM]"	"Cell RNA - U-937 [nTPM]"	"Cell RNA - WM-115 [nTPM]"	"Blood RNA - basophil [nTPM]"	"Blood RNA - classical monocyte [nTPM]"	"Blood RNA - eosinophil [nTPM]"	"Blood RNA - gdT-cell [nTPM]"	"Blood RNA - intermediate monocyte [nTPM]"	"Blood RNA - MAIT T-cell [nTPM]"	"Blood RNA - memory B-cell [nTPM]"	"Blood RNA - memory CD4 T-cell [nTPM]"	"Blood RNA - memory CD8 T-cell [nTPM]"	"Blood RNA - myeloid DC [nTPM]"	"Blood RNA - naive B-cell [nTPM]"	"Blood RNA - naive CD4 T-cell [nTPM]"	"Blood RNA - naive CD8 T-cell [nTPM]"	"Blood RNA - neutrophil [nTPM]"	"Blood RNA - NK-cell [nTPM]"	"Blood RNA - non-classical monocyte [nTPM]"	"Blood RNA - plasmacytoid DC [nTPM]"	"Blood RNA - T-reg [nTPM]"	"Blood RNA - total PBMC [nTPM]"	"Brain RNA - amygdala [nTPM]"	"Brain RNA - basal ganglia [nTPM]"	"Brain RNA - cerebellum [nTPM]"	"Brain RNA - cerebral cortex [nTPM]"	"Brain RNA - hippocampal formation [nTPM]"	"Brain RNA - hypothalamus [nTPM]"	"Brain RNA - medulla oblongata [nTPM]"	"Brain RNA - midbrain [nTPM]"	"Brain RNA - pons [nTPM]"	"Brain RNA - spinal cord [nTPM]"	"Brain RNA - thalamus [nTPM]"	"Brain RNA - white matter [nTPM]"	"Single Cell Type RNA - Adipocytes [nTPM]"	"Single Cell Type RNA - Alveolar cells type 1 [nTPM]"	"Single Cell Type RNA - Alveolar cells type 2 [nTPM]"	"Single Cell Type RNA - Astrocytes [nTPM]"	"Single Cell Type RNA - B-cells [nTPM]"	"Single Cell Type RNA - Basal keratinocytes [nTPM]"	"Single Cell Type RNA - Basal prostatic cells [nTPM]"	"Single Cell Type RNA - Basal respiratory cells [nTPM]"	"Single Cell Type RNA - Basal squamous epithelial cells [nTPM]"	"Single Cell Type RNA - Bipolar cells [nTPM]"	"Single Cell Type RNA - Breast glandular cells [nTPM]"	"Single Cell Type RNA - Breast myoepithelial cells [nTPM]"	"Single Cell Type RNA - Cardiomyocytes [nTPM]"	"Single Cell Type RNA - Cholangiocytes [nTPM]"	"Single Cell Type RNA - Club cells [nTPM]"	"Single Cell Type RNA - Collecting duct cells [nTPM]"	"Single Cell Type RNA - Cone photoreceptor cells [nTPM]"	"Single Cell Type RNA - Cytotrophoblasts [nTPM]"	"Single Cell Type RNA - dendritic cells [nTPM]"	"Single Cell Type RNA - Distal enterocytes [nTPM]"	"Single Cell Type RNA - Distal tubular cells [nTPM]"	"Single Cell Type RNA - Ductal cells [nTPM]"	"Single Cell Type RNA - Early spermatids [nTPM]"	"Single Cell Type RNA - Endometrial ciliated cells [nTPM]"	"Single Cell Type RNA - Endometrial stromal cells [nTPM]"	"Single Cell Type RNA - Endothelial cells [nTPM]"	"Single Cell Type RNA - Enteroendocrine cells [nTPM]"	"Single Cell Type RNA - Erythroid cells [nTPM]"	"Single Cell Type RNA - Excitatory neurons [nTPM]"	"Single Cell Type RNA - Exocrine glandular cells [nTPM]"	"Single Cell Type RNA - Extravillous trophoblasts [nTPM]"	"Single Cell Type RNA - Fibroblasts [nTPM]"	"Single Cell Type RNA - Gastric mucus-secreting cells [nTPM]"	"Single Cell Type RNA - Glandular and luminal cells [nTPM]"	"Single Cell Type RNA - granulocytes [nTPM]"	"Single Cell Type RNA - Granulosa cells [nTPM]"	"Single Cell Type RNA - Hepatic stellate cells [nTPM]"	"Single Cell Type RNA - Hepatocytes [nTPM]"	"Single Cell Type RNA - Hofbauer cells [nTPM]"	"Single Cell Type RNA - Horizontal cells [nTPM]"	"Single Cell Type RNA - Inhibitory neurons [nTPM]"	"Single Cell Type RNA - Intestinal goblet cells [nTPM]"	"Single Cell Type RNA - Ionocytes [nTPM]"	"Single Cell Type RNA - Kupffer cells [nTPM]"	"Single Cell Type RNA - Langerhans cells [nTPM]"	"Single Cell Type RNA - Late spermatids [nTPM]"	"Single Cell Type RNA - Leydig cells [nTPM]"	"Single Cell Type RNA - Macrophages [nTPM]"	"Single Cell Type RNA - Melanocytes [nTPM]"	"Single Cell Type RNA - Microglial cells [nTPM]"	"Single Cell Type RNA - monocytes [nTPM]"	"Single Cell Type RNA - Muller glia cells [nTPM]"	"Single Cell Type RNA - NK-cells [nTPM]"	"Single Cell Type RNA - Oligodendrocyte precursor cells [nTPM]"	"Single Cell Type RNA - Oligodendrocytes [nTPM]"	"Single Cell Type RNA - Pancreatic endocrine cells [nTPM]"	"Single Cell Type RNA - Paneth cells [nTPM]"	"Single Cell Type RNA - Peritubular cells [nTPM]"	"Single Cell Type RNA - Plasma cells [nTPM]"	"Single Cell Type RNA - Prostatic glandular cells [nTPM]"	"Single Cell Type RNA - Proximal enterocytes [nTPM]"	"Single Cell Type RNA - Proximal tubular cells [nTPM]"	"Single Cell Type RNA - Respiratory ciliated cells [nTPM]"	"Single Cell Type RNA - Rod photoreceptor cells [nTPM]"	"Single Cell Type RNA - Sertoli cells [nTPM]"	"Single Cell Type RNA - Skeletal myocytes [nTPM]"	"Single Cell Type RNA - Smooth muscle cells [nTPM]"	"Single Cell Type RNA - Spermatocytes [nTPM]"	"Single Cell Type RNA - Spermatogonia [nTPM]"	"Single Cell Type RNA - Squamous epithelial cells [nTPM]"	"Single Cell Type RNA - Suprabasal keratinocytes [nTPM]"	"Single Cell Type RNA - Syncytiotrophoblasts [nTPM]"	"Single Cell Type RNA - T-cells [nTPM]"	"Single Cell Type RNA - Theca cells [nTPM]"	"Single Cell Type RNA - Undifferentiated cells [nTPM]"	"Single Cell Type RNA - Urothelial cells [nTPM]"
AASDH	"ACSF4, LYS2, NRPS998"	ENSG00000157426	"Aminoadipate-semialdehyde dehydrogenase"	Q4L235	4	56338287-56387508	"Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Fatty acid metabolism, Lipid metabolism"	Ligase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA036472, HPA036473"	Approved					NA	NA			"Cluster 39: Non-specific - mRNA processing"	"Cluster 34: Non-specific - Transcription"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 52: Non-specific - Transcription"			"HPA036472: AB_2675142, HPA036473: AB_10673656"	"unprognostic (1.95e-2)"	"unprognostic (2.08e-2)"	"unprognostic (1.46e-2)"	"unprognostic (5.33e-2)"	"unprognostic (1.33e-1)"	"unprognostic (1.73e-1)"	"unprognostic (1.24e-2)"	"unprognostic (1.67e-1)"	"unprognostic (2.47e-2)"	"unprognostic (8.75e-2)"	"unprognostic (1.29e-2)"	"unprognostic (2.46e-1)"	"unprognostic (2.09e-3)"	"unprognostic (1.59e-1)"	"unprognostic (1.73e-1)"	"unprognostic (4.52e-2)"	"unprognostic (1.85e-3)"	4.3	4.9	3.9	4.7	4.6	4.5	8.4	6.1	4.2	5.8	4.0	4.5	4.5	6.4	8.1	4.6	7.0	4.4	3.7	3.6	4.2	6.7	6.5	4.5	6.4	4.5	4.5	8.4	3.8	7.2	4.2	5.0	4.6	6.4	5.8	11.8	5.6	5.4	4.2	7.1	4.2	5.7	4.1	5.9	4.7	5.0	4.3	6.2	7.1	4.2	6.7	4.3	4.3	5.3	5.0	3.3	8.6	6.6	12.8	14.7	5.3	6.2	7.5	6.3	5.4	3.8	10.2	10.9	5.7	6.8	4.8	3.1	6.3	6.3	7.0	4.4	6.3	5.1	6.3	4.9	11.4	9.4	3.7	8.5	10.2	6.7	10.0	9.1	9.8	6.9	11.9	5.4	7.2	4.9	11.1	7.8	4.8	9.1	4.8	8.2	4.2	5.1	9.0	4.2	5.7	5.5	7.1	11.2	7.2	8.1	8.9	6.0	6.7	4.2	5.6	4.4	4.5	4.3	3.6	7.1	6.6	8.4	4.6	0.0	2.0	1.6	2.8	2.5	3.7	2.4	2.8	2.4	2.2	3.0	4.0	3.0	0.4	2.8	1.6	1.9	2.9	1.3	3.9	4.6	6.1	4.2	3.6	4.2	4.5	4.5	4.6	4.1	4.3	5.3	14.1	6.4	16.2	59.4	17.3	10.1	13.9	26.0	13.6	38.7	21.7	21.2	10.1	14.3	17.3	18.4	27.1	40.7	22.8	9.4	25.4	9.9	26.0	22.0	28.6	13.9	12.1	24.0	26.9	7.6	19.4	17.9	14.8	21.0	20.3	26.4	19.6	21.9	15.4	35.3	36.7	14.7	22.4	17.6	8.7	5.2	16.8	12.6	10.6	19.7	21.5	31.3	20.6	36.2	39.1	6.0	13.4	18.0	9.9	14.2	8.0	29.2	11.2	56.4	6.6	22.5	11.9	43.3	35.0	13.6	15.6	23.9	16.5	23.8	15.9	8.1
ABCD1	"adrenoleukodystrophy, ALD, ALDP, AMN"	ENSG00000101986	"ATP binding cassette subfamily D member 1"	P33897	X	153724856-153744755	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted membrane proteins, Transporters"	Transport	Translocase	"Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Extravillous trophoblasts: 19.5;Proximal enterocytes: 39.2;Syncytiotrophoblasts: 27.4"	"Cancer enhanced"	"Detected in all"		"melanoma: 36.0"	"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"EFO-21: 69.7;PC-3: 50.0;SK-BR-3: 49.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA035214	Approved					NA	NA			"Cluster 39: Non-specific - mRNA processing"	"Cluster 72: Non-specific - Transcription"	"Cluster 38: EFO-21 - Unknown function"	"Cluster 45: Enterocytes - Digestion"			"HPA035214: "	"unprognostic (1.90e-2)"	"unprognostic (3.79e-2)"	"unprognostic (2.19e-3)"	"unprognostic (5.57e-3)"	"unprognostic (8.81e-3)"	"unprognostic (1.54e-1)"	"unprognostic (3.37e-3)"	"unprognostic (1.34e-1)"	"unprognostic (6.14e-3)"	"unprognostic (3.40e-2)"	"unprognostic (1.41e-1)"	"unprognostic (6.17e-2)"	"prognostic unfavorable (5.50e-4)"	"unprognostic (4.17e-2)"	"unprognostic (1.17e-1)"	"unprognostic (2.57e-1)"	"unprognostic (4.23e-2)"	14.6	33.3	3.1	5.4	3.9	4.7	12.5	3.4	3.8	7.5	2.2	14.7	10.6	33.2	1.7	3.7	9.3	3.4	11.9	2.9	3.4	7.0	13.3	7.6	3.9	4.4	3.6	5.4	11.9	2.1	10.0	4.7	4.8	9.9	1.8	0.5	6.2	5.6	20.5	4.4	17.4	4.8	3.1	13.8	7.2	19.0	5.5	4.3	6.0	4.6	1.7	11.9	6.1	4.2	13.2	4.0	2.6	11.2	7.4	3.2	34.3	6.3	6.8	4.2	7.4	2.6	7.1	3.5	69.7	8.6	11.3	1.7	1.6	1.4	0.5	11.8	2.1	10.3	42.1	34.1	9.8	6.4	22.4	6.2	1.7	4.8	0.4	4.4	6.7	4.7	6.0	12.4	5.9	4.7	4.5	6.1	3.3	3.2	50.0	7.8	6.2	5.7	3.2	1.4	2.8	11.5	16.4	49.2	26.4	3.0	3.7	10.8	7.9	5.5	7.4	14.3	7.0	12.2	5.7	8.4	6.9	21.7	7.8	0.4	3.2	2.5	0.8	3.0	4.0	1.0	1.0	1.2	2.7	0.7	1.1	0.8	1.7	0.7	2.8	1.7	0.3	2.5	3.1	3.9	3.4	3.8	2.9	3.4	4.4	3.6	4.8	3.1	5.5	4.2	5.0	0.0	1.1	3.6	3.8	3.2	1.6	1.6	0.6	2.2	2.7	2.8	2.4	2.8	2.2	3.7	2.1	12.2	4.8	9.5	0.0	3.8	0.7	2.0	3.5	3.4	6.0	3.6	0.5	6.9	19.5	4.5	3.6	4.0	0.0	6.9	5.7	6.8	12.6	8.4	0.9	5.0	2.0	15.9	8.4	2.7	4.1	12.3	1.8	0.0	5.9	2.4	0.0	0.0	1.2	5.0	2.1	5.7	2.4	0.8	39.2	2.8	1.2	0.7	6.6	2.3	2.8	3.8	4.8	0.8	1.3	27.4	4.0	7.8	5.5	1.4
ABCD3	"PMP70, PXMP1, ZWS2"	ENSG00000117528	"ATP binding cassette subfamily D member 3"	P28288	1	94418389-94518666	"Disease related genes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted membrane proteins, Transporters"	Transport			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 126.6"	"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA032026, HPA032027, CAB032516, CAB075749"	Enhanced		Enhanced	Peroxisomes		NA	NA		12000	"Cluster 39: Non-specific - mRNA processing"	"Cluster 41: Intestine & Liver - Lipid metabolism"	"Cluster 39: CACO-2 - Unknown function"	"Cluster 26: Respiratory epithelial cells - Mucosal defense"	Peroxisomes		"CAB032516: AB_2257637, CAB075749: AB_2665755, HPA032026: AB_2674117, HPA032027: AB_10602103"	"unprognostic (1.41e-2)"	"unprognostic (3.21e-1)"	"prognostic favorable (1.16e-5)"	"unprognostic (1.92e-1)"	"unprognostic (5.42e-2)"	"unprognostic (1.56e-1)"	"unprognostic (1.94e-2)"	"unprognostic (2.54e-2)"	"unprognostic (5.10e-2)"	"unprognostic (3.20e-2)"	"unprognostic (1.01e-1)"	"unprognostic (9.12e-2)"	"prognostic favorable (4.84e-5)"	"unprognostic (5.45e-2)"	"unprognostic (6.20e-2)"	"unprognostic (3.41e-1)"	"unprognostic (1.29e-1)"	16.8	18.7	19.8	16.2	23.2	25.1	32.8	22.7	24.3	22.4	22.6	44.6	44.5	14.7	21.2	26.7	16.7	26.8	26.0	18.7	21.8	59.4	126.6	23.3	13.3	22.1	21.2	10.1	28.6	29.6	13.3	14.4	22.7	21.5	40.2	26.3	17.5	27.0	23.5	35.5	46.1	17.7	23.7	11.0	43.5	16.3	21.4	47.5	27.5	29.8	21.2	22.9	16.2	27.3	81.5	37.6	37.8	36.1	28.3	31.0	55.8	41.4	32.0	46.8	51.5	117.5	25.0	49.8	52.1	52.8	50.0	58.2	43.7	53.7	64.9	40.1	36.9	56.7	52.3	102.5	27.5	51.2	17.0	26.2	29.6	54.2	20.8	30.2	29.0	47.0	25.8	29.2	48.6	11.4	86.4	26.8	43.7	61.7	50.7	48.0	78.4	19.4	45.6	122.2	28.5	46.7	71.5	75.2	55.7	28.4	27.7	41.8	28.9	34.5	49.5	61.3	55.9	16.5	16.5	48.4	27.1	25.6	16.4	0.4	3.8	2.9	4.2	4.3	4.0	1.8	3.8	4.9	5.9	1.8	4.5	4.4	0.9	5.9	3.8	1.5	4.6	3.3	19.8	23.2	22.7	24.3	18.7	21.8	22.1	21.2	22.7	23.7	21.4	27.3	16.9	35.3	48.8	64.3	10.2	23.3	16.2	32.8	14.8	27.5	43.7	21.1	39.1	58.6	43.2	42.3	22.9	25.0	12.3	72.1	23.5	22.8	9.0	37.5	16.8	16.4	39.7	8.4	32.7	44.5	12.0	18.3	37.8	30.6	27.9	19.1	18.2	108.9	11.0	33.7	47.5	37.5	26.4	21.9	7.4	8.2	13.7	15.0	16.0	40.3	15.1	78.4	11.3	67.3	96.5	37.5	33.0	24.5	15.4	20.4	75.7	72.3	49.8	26.3	19.7	19.0	17.7	14.5	23.2	21.0	34.0	15.3	15.4	16.7	39.5	32.5
ABCF1	"ABC50, EST123147"	ENSG00000204574	"ATP binding cassette subfamily F member 1"	Q8NE71	6	30571393-30597179	"Plasma proteins, Predicted intracellular proteins, Transporters"		Activator		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 107.0"	"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA017578	Approved		Enhanced	Cytosol		NA	NA		490000	"Cluster 39: Non-specific - mRNA processing"	"Cluster 59: Non-specific - Translation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 52: Non-specific - Transcription"	Cytosol		"HPA017578: AB_1844438"	"unprognostic (5.85e-2)"	"unprognostic (2.88e-1)"	"unprognostic (1.49e-1)"	"unprognostic (1.41e-3)"	"unprognostic (4.31e-2)"	"unprognostic (7.03e-2)"	"prognostic unfavorable (9.47e-4)"	"unprognostic (5.50e-2)"	"unprognostic (3.45e-2)"	"unprognostic (1.70e-2)"	"unprognostic (2.35e-1)"	"unprognostic (2.77e-1)"	"unprognostic (3.50e-2)"	"unprognostic (1.65e-1)"	"unprognostic (3.65e-1)"	"unprognostic (1.68e-3)"	"unprognostic (7.16e-2)"	31.6	27.5	4.5	6.7	5.0	25.5	28.3	4.4	6.4	29.6	3.5	34.0	2.0	34.3	7.4	32.4	24.6	6.8	35.0	4.3	4.9	28.1	32.6	29.9	7.4	5.1	4.8	26.2	32.7	13.5	24.7	10.5	5.0	28.3	11.4	11.1	30.4	5.4	107.0	39.9	32.3	10.2	4.5	30.7	32.4	35.0	5.3	14.7	29.3	4.1	11.3	32.4	30.0	5.6	46.2	33.5	29.4	39.7	40.0	24.5	4.2	30.1	37.6	49.0	53.6	104.8	16.4	33.8	27.1	34.3	51.9	33.3	61.7	39.5	56.2	34.2	65.2	43.0	47.6	14.5	5.5	9.4	5.6	33.6	33.7	68.6	6.4	4.0	5.6	16.9	77.2	4.5	35.3	8.5	9.3	15.5	7.5	31.2	9.4	64.5	7.5	63.3	32.2	52.4	10.2	42.9	20.1	55.3	6.6	5.0	6.1	24.4	28.2	59.0	6.9	3.8	6.2	35.7	47.5	52.8	1.3	43.3	62.2	1.7	5.5	1.5	10.1	4.7	9.3	6.2	7.2	10.2	4.7	5.1	6.3	6.3	1.8	8.0	4.9	5.4	4.1	6.1	4.5	5.0	4.4	6.4	4.3	4.9	5.1	4.8	5.0	4.5	5.3	5.6	42.5	51.3	84.4	7.2	67.9	86.2	100.3	54.2	49.5	48.9	45.5	30.1	87.3	42.9	65.2	58.8	66.7	100.3	77.5	103.3	60.7	93.9	105.0	67.0	95.4	57.2	50.7	50.9	6.8	87.6	139.4	52.6	53.5	115.2	86.9	27.0	36.0	125.4	49.5	55.5	7.4	80.6	28.5	47.4	43.0	176.4	38.8	52.1	35.6	2.8	63.2	39.3	116.4	2.0	9.2	105.9	73.8	51.9	61.8	92.1	66.2	99.0	44.0	112.9	72.3	58.7	54.3	132.5	104.2	50.2	84.8	166.1	70.5	48.2	72.3	87.1
AC000120.3		ENSG00000285953	"Novel protein"		7	92131774-92245924	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"			"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"		"Alveolar cells type 1: 3.2;Alveolar cells type 2: 1.1;granulocytes: 1.3"					"Low region specificity"	"Detected in some"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in all"											HPA049606	Uncertain		Approved	Vesicles		NA	NA			"Cluster 39: Non-specific - mRNA processing"		"Cluster 1: K-562 - Erythropoiesis"	"Cluster 11: Alveolar cells - Smell perception"	Vesicles		"HPA049606: AB_2680832"																		2.1	1.0	0.5	1.1	1.0	0.4	2.0	1.8	0.9	3.6	0.0	1.0	0.4	1.8	0.0	1.2	2.1	1.6	1.4	0.1	0.9	2.5	2.1	2.1	1.7	0.8	0.7	2.6	1.4	3.2		2.9	0.8	1.5	1.3	2.2	0.9	2.0	3.2	0.2	1.1	1.7	0.5	0.7	0.4	5.9	0.5	1.8	2.5	3.7	2.5	1.2		2.0	3.2	2.7	4.2	2.8	4.3	9.2	4.3	5.2	4.9	7.8	7.8	2.2	4.4	5.7	3.2	4.1	4.4	2.6	6.4	5.0	10.9	3.9	3.1	4.9	4.3	1.3	4.2	6.9	2.9	2.1	3.9	5.7	6.7	2.8	5.4	3.3	12.8	3.7	6.0	1.8	4.4	1.1	3.6	4.3	5.0	2.5	7.0	4.8	1.9	2.3	3.3	2.3	8.0	3.0	3.1	8.4	2.9	2.4	2.0	2.6	3.0	7.1	2.5	2.1	3.9	7.6	2.9	3.0	4.6	0.0	0.1	0.2	0.1	0.1	0.5	0.5	0.2	0.2	0.4	0.2	0.3	0.3	0.0	0.3	0.1	0.2	0.2	0.3	0.5	1.0	1.8	0.9	0.1	0.9	0.8	0.7	0.8	0.5	0.5	2.0	0.0	3.2	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
AC090517.4		ENSG00000285253	"Zinc finger protein 280D"		15	56652488-56918571	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"			"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"		"Adipocytes: 1.5;Alveolar cells type 1: 3.2;Alveolar cells type 2: 1.5;Distal tubular cells: 3.9;Endometrial stromal cells: 2.2"					"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"U-266/84: 6.9"															NA	NA			"Cluster 39: Non-specific - mRNA processing"		"Cluster 2: Karpas-707 - Immune response"	"Cluster 7: Non-specific - Mitochondria"																					1.6	1.2	1.5	1.2	2.9	1.0	1.5	1.6	2.0	1.9	0.0	1.2	1.1	2.1	1.0	1.1	1.6	1.4	1.7	1.3	2.5	1.6	1.2	1.3	1.1	2.1	2.2	2.4	3.7	1.5		1.5	2.2	1.4	1.3	1.8	4.3	1.4	2.0	0.9	1.3	1.9	1.4	1.4	1.4	2.5	2.2	2.6	2.3	2.3	0.8	1.1		4.6	1.5	4.0	1.3	1.1	2.6	1.7	1.1	1.1	1.4	1.3	0.9	0.9	1.8	0.3	2.1	1.5	1.2	1.3	0.5	1.3	1.0	2.4	0.0	2.2	1.6	0.1	1.0	0.4	2.3	1.7	0.7	1.2	1.3	1.0	2.5	0.4	3.3	6.1	1.7	0.4	1.2	0.3	1.1	1.2	0.5	3.3	0.3	0.5	1.8	0.3	1.9	3.3	2.0	1.2	2.0	2.5	2.7	3.5	1.8	0.4	3.1	1.7	0.4	2.7	6.9	0.2	1.8	2.9	2.5	0.0	1.5	0.7	1.2	1.6	1.8	0.8	1.2	1.1	1.2	0.9	0.5	1.1	0.1	1.2	0.7	0.3	0.7	0.8	1.5	2.9	1.6	2.0	1.3	2.5	2.1	2.2	2.2	1.4	2.2	4.6	1.5	3.2	1.5	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.9	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	3.9	0.6	0.0	0.8	2.2	0.4	0.0	0.0	0.0	0.7	0.0	0.4	0.0	0.5	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.6	0.7	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.4	0.6	0.0	0.0
AEN	"FLJ12484, FLJ12562, ISG20L1"	ENSG00000181026	"Apoptosis enhancing nuclease"	Q8WTP8	15	88621337-88632281	"Predicted intracellular proteins"	"Apoptosis, DNA damage"	"Exonuclease, Hydrolase, Nuclease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Late spermatids: 62.7"	"Cancer enhanced"	"Detected in all"		"testis cancer: 38.4"	"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA048599			Supported	"Nucleoplasm,Nuclear membrane,Nucleoli"		NA	NA			"Cluster 39: Non-specific - mRNA processing"	"Cluster 29: Non-specific - Vesicular transport"	"Cluster 5: NTERA-2 - Transcription"	"Cluster 31: Spermatids - Spermatogenesis"	"Nucleoplasm, Nucleoli"	"Nuclear membrane"	"HPA048599: AB_2756313"	"unprognostic (8.64e-2)"	"unprognostic (1.94e-1)"	"unprognostic (2.16e-2)"	"prognostic favorable (1.72e-4)"	"unprognostic (1.52e-2)"	"unprognostic (4.40e-2)"	"unprognostic (4.08e-2)"	"unprognostic (9.42e-2)"	"unprognostic (4.28e-2)"	"unprognostic (1.17e-2)"	"unprognostic (9.00e-2)"	"unprognostic (7.88e-2)"	"unprognostic (8.58e-3)"	"unprognostic (3.39e-2)"	"unprognostic (2.73e-1)"	"unprognostic (8.71e-2)"	"unprognostic (6.10e-2)"	9.1	12.2	6.8	10.7	7.1	17.7	6.0	6.6	6.8	6.8	7.0	8.4	5.1	7.6	9.6	9.6	7.0	12.5	7.3	6.3	11.5	9.0	13.5	10.1	12.8	8.6	7.7	8.0	20.9	4.4	22.4	6.9	7.7	12.1	8.6	1.0	8.3	8.2	15.1	7.2	9.1	10.1	8.1	15.2	13.2	9.8	9.5	10.7	10.3	3.7	11.9	11.5	5.9	7.7	14.9	64.5	39.6	34.2	17.4	20.7	83.7	51.5	46.8	39.1	47.8	53.8	28.2	63.6	16.1	28.3	35.0	20.9	148.0	42.1	32.6	15.7	58.2	34.0	26.4	89.9	42.0	28.5	32.8	25.6	36.4	48.5	39.7	14.0	33.0	20.6	54.6	35.2	48.3	34.4	35.5	24.0	96.0	30.8	36.9	45.4	28.2	46.9	16.5	31.9	31.1	28.5	20.8	23.7	40.1	90.7	19.7	32.0	29.9	39.5	55.1	16.2	70.5	67.0	48.5	54.7	36.0	31.5	79.1	0.0	2.3	0.8	6.2	3.7	12.0	10.9	10.8	8.4	5.2	10.3	11.6	10.6	0.6	3.9	4.9	3.1	19.6	9.2	6.8	7.1	6.6	6.8	6.3	11.5	8.6	7.7	7.7	8.1	9.5	7.7	6.9	6.4	8.1	4.2	21.0	18.6	25.8	6.2	12.0	1.2	21.4	15.4	3.9	8.6	12.9	1.8	0.0	4.7	8.4	5.6	3.9	11.4	23.6	22.5	5.3	7.6	9.0	11.8	20.5	7.6	16.3	9.0	11.7	17.7	2.5	12.3	2.5	6.3	4.5	1.7	16.0	9.9	26.4	4.7	26.4	62.7	4.4	7.8	14.2	3.7	14.2	3.1	9.2	9.0	2.5	11.5	6.2	2.6	26.9	27.8	2.3	5.5	5.4	0.9	13.1	12.0	11.6	10.2	18.2	10.9	28.3	6.2	14.9	6.8	9.7	25.4
AL021546.1		ENSG00000111780	"Novel protein"		12	120438198-120460006	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in some"		"CACO-2: 8.9;HEK 293: 11.5;U-266/84: 10.4"									HPA062394	Uncertain		Approved	Mitochondria		NA	NA			"Cluster 39: Non-specific - mRNA processing"		"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 11: Alveolar cells - Smell perception"	Mitochondria		"HPA062394: AB_2684749"		"unprognostic (3.79e-2)"			"unprognostic (1.74e-1)"	"unprognostic (2.79e-1)"		"unprognostic (2.90e-1)"		"unprognostic (1.71e-1)"		"unprognostic (1.33e-1)"	"unprognostic (9.54e-4)"	"unprognostic (2.04e-1)"				0.0	0.1	0.1	0.0	0.3	0.1	0.0	0.2	0.4	0.1	0.0	0.9	0.0	0.0	0.0	0.1	0.1	0.0	0.2	0.2	0.3	0.1	0.0	0.0	0.0	0.4	0.3	0.4	0.4	0.1	0.0	0.1	0.4	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.2	0.4	0.2	0.0	0.3	0.0	0.2	0.0	0.0	0.1	0.0	0.4	2.0	2.6	0.0	0.6	0.0	0.0	0.0	1.8	0.3	0.5	0.0	8.9	0.0	0.5	3.2	0.0	0.8	0.9	0.0	0.5	0.0	1.6	11.5	0.7	0.0	0.0	0.0	4.1	1.0	0.0	0.3	0.0	0.0	0.0	0.0	0.4	0.9	0.2	0.0	0.0	3.2	0.4	0.2	0.0	4.6	1.8	1.2	1.0	0.0	0.0	4.5	0.3	2.9	0.7	0.0	0.0	0.8	0.4	2.4	1.5	0.4	0.0	1.2	0.9	10.4	3.8	0.6	1.3	0.0	1.6	6.1	5.6	5.0	8.9	5.6	4.9	3.0	5.7	11.0	3.8	3.3	3.1	1.3	2.2	6.9	7.9	5.4	4.2	0.1	0.3	0.2	0.4	0.2	0.3	0.4	0.3	0.4	0.2	0.3	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
AL022318.4		ENSG00000284554	"Novel protein"		22	39014363-39033276	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"			"Tissue enriched"	"Detected in single"	5	"lymphoid tissue: 2.5"	"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in single"		"Karpas-707: 2.7"									HPA055116	Uncertain					NA	NA			"Cluster 39: Non-specific - mRNA processing"	"Cluster 64: Macrophages - Immune response"	"Cluster 2: Karpas-707 - Immune response"				"HPA055116: AB_2682701"																		0.1	0.2	0.2	0.0	0.2	0.0	0.0	0.2	0.4	0.0	0.3	0.2	0.0	0.0	0.1	0.1	0.2	0.0	0.2	0.2	0.2	0.2	0.3	0.1	1.1	0.3	0.3	0.2	0.2	0.0	0.0	0.0	0.4	0.3	0.0	0.1	0.1	0.0	0.2	0.1	0.3	0.0	0.1	2.5	0.4	0.0	0.3	0.1	0.0	0.0	0.1	0.0	0.1	0.4	0.0	0.3	0.0	0.0	0.3	0.1	0.0	0.0	0.5	0.0	0.0	0.1	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.8	0.0	0.2	0.0	0.0	0.0	0.0	0.0	2.7	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.9	2.5	2.0	1.3	2.8	2.3	3.6	0.1	2.8	1.5	1.5	0.0	0.6	1.8	1.0	2.8	0.0	0.2	0.2	0.2	0.4	0.2	0.2	0.3	0.3	0.4	0.1	0.3	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
ALDH16A1	MGC10204	ENSG00000161618	"Aldehyde dehydrogenase 16 family member A1"	Q8IZ83	19	49453225-49471050	"Plasma proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA059488	Approved					NA	NA		600000	"Cluster 39: Non-specific - mRNA processing"	"Cluster 64: Macrophages - Immune response"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 39: Non-specific - Basic cellular processes"			"HPA059488: AB_2684037"	"unprognostic (2.39e-1)"	"unprognostic (3.95e-3)"	"unprognostic (7.10e-2)"	"unprognostic (1.11e-1)"	"unprognostic (1.74e-1)"	"unprognostic (2.95e-3)"	"unprognostic (5.58e-2)"	"unprognostic (1.45e-1)"	"unprognostic (3.92e-2)"	"unprognostic (4.90e-1)"	"unprognostic (1.19e-3)"	"unprognostic (4.28e-2)"	"unprognostic (1.91e-3)"	"unprognostic (2.94e-2)"	"unprognostic (4.19e-1)"	"unprognostic (1.27e-1)"	"unprognostic (5.23e-3)"	18.5	14.1	3.0	9.7	3.4	10.0	14.5	3.5	3.8	17.7	3.6	13.9	13.9	15.9	0.8	15.5	12.9	3.5	8.5	2.9	3.3	14.1	17.1	11.7	10.4	4.5	3.8	11.3	18.6	3.8	7.5	5.0	3.6	10.3	2.3	1.0	10.8	4.9	7.0	16.2	19.1	3.2	3.9	28.3	14.1	5.2	4.2	4.9	12.4	1.8	4.9	12.9	13.8	4.0	24.6	32.7	7.8	18.4	3.5	2.3	26.3	15.5	4.9	11.8	12.1	17.1	9.3	36.8	24.9	2.1	2.8	16.7	3.1	8.9	1.5	23.3	19.0	28.7	13.1	24.6	5.1	17.6	61.3	4.3	5.0	5.7	4.6	2.4	7.7	12.5	20.7	37.3	3.1	24.8	12.8	51.9	17.1	10.6	0.0	21.8	11.1	28.1	5.7	28.7	14.1	16.1	13.9	15.4	13.4	1.9	14.0	20.3	17.4	17.4	11.3	8.0	17.4	31.4	38.2	10.7	4.3	24.9	12.6	11.2	10.9	18.6	9.3	26.0	9.8	17.1	9.1	10.1	16.4	17.1	8.4	8.8	1.8	8.6	29.8	17.4	7.9	8.1	3.0	3.4	3.5	3.8	2.9	3.3	4.5	3.8	3.6	3.9	4.2	4.0	22.3	6.4	11.5	1.0	27.2	9.9	28.6	19.2	21.1	9.2	10.8	8.6	4.0	12.8	15.5	11.0	8.4	33.7	19.5	27.6	5.9	22.0	1.5	6.3	6.3	16.9	13.1	20.0	1.3	24.5	28.7	16.3	21.4	8.0	17.2	12.9	15.4	17.4	46.2	1.7	1.2	16.6	20.3	29.9	14.7	2.9	28.0	20.2	16.0	3.7	31.4	6.4	15.5	1.5	4.2	14.0	26.0	8.2	17.6	9.1	43.8	22.9	24.3	7.0	19.7	7.2	15.8	3.6	13.1	19.7	10.5	40.4	13.8	27.6	23.7	28.3
ALKBH8	"MGC10235, TRM9, TRMT9A"	ENSG00000137760	"AlkB homolog 8, tRNA methyltransferase"	Q96BT7	11	107502727-107565742	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"		"Methyltransferase, Multifunctional enzyme, RNA-binding, Transferase"	"Disease variant, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 25.2;Inhibitory neurons: 27.4;Oligodendrocyte precursor cells: 23.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA038724, HPA038725, HPA061514"	Approved		Supported	"Nucleoplasm,Nuclear bodies"		NA	NA			"Cluster 39: Non-specific - mRNA processing"	"Cluster 16: Immune cells - Immune response"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	"Nuclear bodies"	Nucleoplasm	"HPA038724: AB_2676176, HPA038725: AB_10674838, HPA061514: AB_2684547"	"unprognostic (2.66e-2)"	"unprognostic (3.82e-1)"	"unprognostic (8.19e-2)"	"unprognostic (3.76e-1)"	"unprognostic (4.04e-2)"	"unprognostic (2.97e-1)"	"unprognostic (1.22e-2)"	"unprognostic (1.95e-1)"	"unprognostic (4.45e-2)"	"unprognostic (7.67e-2)"	"unprognostic (1.89e-2)"	"unprognostic (7.95e-2)"	"unprognostic (2.81e-1)"	"unprognostic (2.03e-1)"	"unprognostic (2.04e-1)"	"unprognostic (2.34e-3)"	"unprognostic (1.01e-1)"	3.1	2.9	2.4	4.0	3.0	3.3	5.0	2.6	2.8	2.9	1.7	3.0	3.2	3.8	3.2	3.1	2.9	2.8	3.8	2.4	2.6	3.9	4.5	3.6	6.0	2.2	2.6	4.4	2.3	4.1	1.7	3.3	2.5	3.5	3.6	3.3	2.9	3.3	5.1	4.6	2.6	3.6	2.2	4.6	3.3	2.8	2.3	4.6	5.2	4.7	5.9	3.5	2.8	2.3	5.4	6.5	6.6	7.2	3.6	7.9	5.4	10.2	7.5	7.4	8.0	12.1	9.7	12.6	5.8	10.0	10.2	9.6	9.9	8.5	9.6	11.4	6.6	10.6	2.5	5.6	5.3	13.7	12.6	4.9	9.2	9.5	12.0	3.8	9.3	9.9	15.2	4.1	5.9	4.9	12.4	6.8	8.7	10.5	10.6	11.1	10.2	8.7	5.9	5.8	6.0	6.7	5.9	4.4	4.5	4.0	7.2	4.1	8.8	16.1	9.6	5.3	12.9	3.8	4.3	9.7	4.5	9.0	16.1	0.0	1.1	0.3	2.2	2.1	2.1	0.9	1.6	1.9	1.7	1.9	3.0	2.6	0.0	2.8	1.5	1.0	1.8	1.1	2.4	3.0	2.6	2.8	2.4	2.6	2.2	2.6	2.5	2.2	2.3	2.3	4.4	0.0	5.3	4.6	8.5	2.0	1.7	1.5	7.4	5.7	3.2	3.0	11.2	5.7	3.5	1.8	6.2	2.3	3.0	1.3	0.0	1.9	0.4	2.4	4.6	4.2	1.2	4.6	25.2	3.3	2.7	4.3	7.7	2.3	10.1	5.1	2.9	6.6	2.8	1.7	27.4	2.8	2.0	3.8	2.2	0.2	2.8	4.1	3.6	14.0	4.7	3.0	3.1	23.1	14.3	2.7	5.2	4.1	3.8	1.3	1.3	3.6	0.8	3.8	0.0	4.0	3.0	1.8	3.2	6.9	4.1	0.8	6.6	5.2	3.5	0.6
ALYREF	"ALY, ALY/REF, BEF, REF, THOC4"	ENSG00000183684	"Aly/REF export factor"		17	81887835-81891586	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"			"Tissue enhanced"	"Detected in all"		"bone marrow: 148.9"	"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB016281, HPA019799, HPA061282"	Supported		Enhanced	"Nuclear speckles"		NA	NA			"Cluster 39: Non-specific - mRNA processing"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 24: NB-4 - Immune response"	"Cluster 7: Non-specific - Mitochondria"	"Nuclear speckles"		"CAB016281: AB_626667, HPA019799: AB_1844788, HPA061282: AB_2684464"	"unprognostic (1.41e-1)"	"unprognostic (1.09e-2)"	"unprognostic (4.89e-3)"	"unprognostic (5.35e-2)"	"unprognostic (3.43e-1)"	"unprognostic (2.13e-2)"	"prognostic unfavorable (1.18e-4)"	"unprognostic (2.77e-2)"	"unprognostic (2.26e-1)"	"unprognostic (2.55e-3)"	"unprognostic (6.58e-2)"	"unprognostic (8.07e-2)"	"unprognostic (1.74e-3)"	"unprognostic (2.05e-2)"	"unprognostic (1.34e-1)"	"unprognostic (8.65e-2)"	"unprognostic (7.09e-2)"	39.0	30.0	19.2	50.2	19.6	148.9	34.9	20.2	22.9	33.1	17.7	37.4	32.9	35.1	17.1	57.6	31.3	19.6	37.8	19.8	20.0	37.7	29.6	36.0	62.4	19.6	20.7	32.4	26.9	21.3	28.9	32.1	20.9	30.0	24.3	9.4	30.3	15.9	61.5	45.7	34.5	21.1	20.9	44.7	31.6	72.7	19.8	65.7	30.6	21.2	48.8	35.7	36.4	22.1	263.7	237.8	165.5	164.6	34.4	44.8	213.8	130.0	68.0	257.0	161.0	269.4	173.7	291.4	100.8	104.9	155.6	150.5	241.9	137.5	111.7	111.8	425.9	210.8	151.2	295.1	68.6	341.4	183.0	46.1	61.8	155.3	62.0	37.8	155.5	204.6	275.9	175.2	97.2	279.8	721.2	587.2	231.3	152.0	254.2	472.3	206.1	155.1	54.1	152.1	229.8	299.0	123.9	304.8	110.4	89.9	222.1	343.3	103.9	275.1	270.9	130.0	443.2	201.8	107.3	377.6	143.7	217.0	238.2	0.3	1.1	0.1	1.5	1.2	1.0	1.0	1.1	1.0	1.2	1.2	0.3	0.8	0.2	0.9	1.1	2.2	0.6	0.6	19.2	19.6	20.2	22.9	19.8	20.0	19.6	20.7	20.9	20.9	19.8	22.1	68.4	0.0	16.0	1.3	22.9	34.9	22.9	7.5	9.1	11.0	24.7	32.5	13.0	11.5	8.4	20.2	0.0	9.8	59.0	16.1	1.9	5.2	2.3	52.9	49.0	23.4	12.6	43.3	1.7	8.4	23.1	24.9	17.3	53.7	15.2	39.1	8.9	14.8	17.9	5.0	1.7	24.3	6.1	13.9	33.8	3.2	3.4	31.3	14.2	3.7	12.7	21.5	8.2	2.5	5.0	10.5	10.1	4.1	46.4	33.1	7.4	4.3	8.4	7.6	0.0	27.9	30.6	16.5	8.8	22.6	43.0	16.6	27.6	38.2	21.9	31.6
ANAPC2	"APC2, KIAA1406"	ENSG00000176248	"Anaphase promoting complex subunit 2"	Q9UJX6	9	137174784-137188560	"Predicted intracellular proteins"	"Cell cycle, Cell division, Differentiation, Mitosis, Neurogenesis, Ubl conjugation pathway"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Late spermatids: 58.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB018692, HPA066539"	Enhanced		Enhanced	Nucleoplasm		NA	NA			"Cluster 39: Non-specific - mRNA processing"	"Cluster 71: Testis - DNA repair"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 10: Non-specific - Unknown function"	Nucleoplasm		"CAB018692: AB_2258285, HPA066539: AB_2685688"	"unprognostic (5.20e-2)"	"unprognostic (8.86e-3)"	"unprognostic (1.43e-2)"	"prognostic favorable (8.91e-5)"	"unprognostic (2.29e-1)"	"unprognostic (2.38e-2)"	"unprognostic (4.46e-1)"	"unprognostic (4.84e-2)"	"unprognostic (1.07e-1)"	"unprognostic (3.36e-1)"	"prognostic favorable (1.07e-7)"	"unprognostic (7.41e-2)"	"prognostic favorable (3.67e-4)"	"prognostic favorable (2.87e-4)"	"unprognostic (1.35e-1)"	"unprognostic (8.46e-2)"	"unprognostic (9.88e-2)"	14.4	17.7	8.8	11.3	9.6	15.0	15.8	8.9	13.4	15.2	8.6	14.4	11.9	15.8	3.1	15.8	14.7	8.6	15.6	9.7	8.1	14.2	20.2	13.1	14.5	11.5	9.1	15.2	20.7	7.4	13.8	7.2	10.2	17.5	3.1	4.3	18.2	8.9	18.9	19.2	16.5	5.3	8.1	19.9	17.0	25.5	8.8	10.2	15.5	8.3	6.1	13.8	13.4	12.9	20.9	45.6	10.7	17.5	12.6	7.5	33.5	18.5	11.5	16.9	12.8	27.8	20.9	22.4	21.3	12.3	15.8	41.9	12.9	13.8	2.5	28.9	22.5	13.3	55.1	24.9	14.9	20.7	22.1	15.0	10.9	11.3	6.1	8.3	20.8	20.7	20.3	26.4	8.0	58.2	24.7	28.7	21.6	27.4	34.6	29.3	26.5	41.4	13.1	18.1	14.1	21.3	28.2	36.5	11.9	5.1	39.2	27.8	22.4	24.8	19.8	30.1	16.7	12.9	20.5	24.5	20.1	14.1	18.3	0.3	0.6	0.1	0.5	0.6	0.3	0.3	0.3	0.4	0.5	0.2	0.3	0.4	0.2	0.3	0.9	0.6	0.3	1.1	8.8	9.6	8.9	13.4	9.7	8.1	11.5	9.1	10.2	8.1	8.8	12.9	9.3	0.0	0.5	6.2	12.2	9.3	7.9	14.2	6.2	5.7	13.0	12.6	3.2	11.5	11.5	11.0	4.2	25.9	11.1	19.0	13.7	10.0	40.5	4.2	4.0	9.0	10.2	9.5	2.4	10.9	11.1	9.0	27.0	5.0	11.4	8.5	12.1	11.1	15.6	1.7	2.5	19.1	12.2	8.8	7.8	58.4	11.1	7.6	14.2	1.0	13.9	3.7	6.2	1.5	4.3	8.6	8.0	9.4	15.3	6.8	21.2	15.8	10.2	4.7	0.0	9.8	17.4	40.5	26.4	11.9	9.5	24.5	9.4	5.9	15.4	7.1
AP1B1	"ADTB1, AP105A, BAM22, CLAPB2"	ENSG00000100280	"Adaptor related protein complex 1 subunit beta 1"	Q10567	22	29327680-29388583	"Disease related genes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Transporters"	"Protein transport, Transport"		"Deafness, Disease variant, Ichthyosis"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Hofbauer cells: 138.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA065226, HPA068520"	Approved		Supported	"Golgi apparatus,Vesicles,Cytosol"		NA	NA		660000	"Cluster 39: Non-specific - mRNA processing"	"Cluster 48: Parathyroid gland - membrane proteins"	"Cluster 15: RT4 - Unknown function"	"Cluster 4: Macrophages - Innate immune response"	"Golgi apparatus"	"Vesicles, Cytosol"	"HPA065226: AB_2685438, HPA068520: AB_2685998"	"unprognostic (1.78e-1)"	"prognostic favorable (4.81e-4)"	"unprognostic (2.40e-1)"	"unprognostic (2.21e-2)"	"unprognostic (2.37e-1)"	"unprognostic (1.03e-1)"	"prognostic unfavorable (5.55e-5)"	"unprognostic (4.99e-2)"	"unprognostic (1.59e-1)"	"unprognostic (1.27e-1)"	"unprognostic (4.98e-3)"	"unprognostic (1.60e-1)"	"prognostic favorable (7.24e-6)"	"unprognostic (1.85e-2)"	"unprognostic (3.78e-2)"	"unprognostic (2.94e-2)"	"unprognostic (3.76e-2)"	30.7	46.7	38.0	47.2	38.3	45.8	26.4	37.3	45.2	22.8	35.6	34.9	43.3	22.7	12.1	63.0	23.5	30.4	23.9	36.1	40.8	34.8	34.8	30.1	57.8	44.2	44.6	17.5	38.3	67.0	39.2	44.8	43.7	38.3	30.1	35.3	40.3	25.9	24.5	47.2	45.6	27.1	41.4	52.6	40.9	24.7	52.7	34.2	29.6	20.5	54.4	39.4	32.2	48.8	84.6	47.5	49.3	50.2	37.0	27.0	60.0	59.8	65.5	71.2	68.2	74.4	33.2	46.1	37.2	68.4	33.0	74.6	71.5	97.6	45.2	58.2	102.0	79.1	60.8	42.0	38.9	114.1	99.9	38.6	36.0	67.5	55.0	33.0	98.7	17.2	54.6	54.9	48.3	93.7	45.5	36.8	37.3	124.8	53.3	89.0	54.3	119.9	50.2	194.5	75.9	52.2	74.0	82.5	36.4	33.5	66.7	49.5	84.6	79.1	48.8	46.0	62.1	60.4	32.5	84.6	56.1	48.1	46.7	0.0	29.3	5.7	9.2	29.2	9.1	16.2	6.3	7.9	28.7	18.2	4.9	5.2	3.0	7.2	31.7	9.0	8.8	24.2	38.0	38.3	37.3	45.2	36.1	40.8	44.2	44.6	43.7	41.4	52.7	48.8	17.8	12.8	16.4	27.7	53.0	7.1	9.3	16.7	16.5	26.3	26.2	20.8	16.1	21.5	16.4	22.0	39.6	52.3	15.1	69.6	23.5	41.2	7.5	16.4	11.6	19.8	21.6	40.0	24.1	40.7	30.1	12.1	33.6	30.1	5.1	13.2	35.3	34.3	138.9	45.4	25.6	24.9	18.3	95.5	24.2	13.1	11.8	65.7	12.4	51.5	29.8	28.4	9.2	16.1	14.0	65.9	33.2	12.4	28.5	17.5	51.2	30.1	14.5	42.1	6.6	17.8	12.7	23.5	17.6	33.0	9.1	68.3	17.0	39.6	36.2	18.1
AP5S1	"C20orf29, FLJ11168"	ENSG00000125843	"Adaptor related protein complex 5 subunit sigma 1"	Q9NUS5	20	3820524-3828838	"Predicted intracellular proteins, Predicted membrane proteins"	"DNA damage, DNA repair, Protein transport, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB034200, HPA043533, HPA048244"	Uncertain		Approved	Nucleoplasm,Cytosol		No	No			"Cluster 39: Non-specific - mRNA processing"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 39: CACO-2 - Unknown function"	"Cluster 66: Spermatocytes - Spermatogenesis"	"Nucleoplasm, Cytosol"		"CAB034200: AB_1564201, HPA043533: AB_2732507, HPA048244: AB_2680328"	"unprognostic (1.07e-2)"	"unprognostic (1.43e-1)"	"unprognostic (8.52e-2)"	"unprognostic (2.74e-2)"	"unprognostic (1.34e-1)"	"unprognostic (2.05e-2)"	"unprognostic (5.49e-2)"	"unprognostic (7.76e-2)"	"unprognostic (1.33e-1)"	"unprognostic (8.91e-2)"	"unprognostic (5.15e-3)"	"unprognostic (8.17e-2)"	"prognostic favorable (5.53e-5)"	"unprognostic (2.92e-1)"	"unprognostic (1.62e-1)"	"unprognostic (6.09e-3)"	"unprognostic (5.08e-2)"	6.0	11.5	7.1	5.5	7.7	7.4	5.8	6.4	8.2	4.8	8.1	6.2	6.3	5.7	3.0	7.4	4.7	4.6	11.3	7.3	6.7	9.4	14.6	5.4	5.5	6.8	6.5	5.8	7.5	7.8	7.5	5.4	6.5	6.9	4.4	3.4	8.7	3.6	19.2	5.3	6.4	3.9	6.3	8.2	6.4	11.2	6.6	4.3	9.4	10.0	3.8	5.4	5.1	6.5	18.1	33.8	4.6	3.1	6.2	8.0	5.7	10.8	8.6	10.4	8.3	28.5	18.9	10.4	11.3	11.4	19.7	15.9	3.9	17.4	3.6	5.7	10.9	17.3	10.1	25.3	10.7	12.0	10.0	13.7	9.7	13.0	10.3	7.0	12.4	12.4	12.4	19.8	14.0	29.4	28.0	10.5	4.2	13.0	27.3	11.7	7.8	10.8	11.8	14.4	14.2	5.7	10.6	32.4	18.2	3.1	15.9	5.9	16.9	21.7	10.3	11.3	20.6	10.6	12.6	5.7	7.5	10.6	19.0	2.2	7.5	4.6	10.2	11.9	7.8	5.4	8.5	8.4	9.9	7.0	7.8	7.3	1.7	6.2	6.7	7.7	9.9	6.5	7.1	7.7	6.4	8.2	7.3	6.7	6.8	6.5	6.5	6.3	6.6	6.5	4.0	0.0	10.6	2.3	5.9	1.7	4.4	8.0	7.4	15.3	4.9	4.3	11.2	11.5	5.9	3.7	10.4	19.4	3.8	8.4	11.7	11.1	3.7	5.1	6.2	8.6	12.6	9.9	1.9	12.7	13.3	6.8	14.8	5.2	14.0	6.6	6.1	9.4	15.5	25.2	2.1	7.3	8.2	6.9	2.0	3.6	5.9	7.3	5.4	4.7	11.0	12.8	8.2	2.5	1.7	10.2	8.8	4.1	8.6	3.6	11.2	8.5	4.5	20.8	13.1	5.8	4.5	19.4	10.9	6.8	1.0	18.5	6.2	10.9	7.4	3.0
APH1A	"APH-1A, CGI-78"	ENSG00000117362	"Aph-1 homolog A, gamma-secretase subunit"	Q96BI3	1	150265399-150269580	"Predicted membrane proteins, Transporters"	"Notch signaling pathway"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			CAB037272	Approved					NA	NA			"Cluster 39: Non-specific - mRNA processing"	"Cluster 37: Intestine - Unknown function"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 32: Non-specific - Translation"			"CAB037272: AB_476776"	"unprognostic (1.00e-1)"	"unprognostic (5.55e-2)"	"unprognostic (8.84e-2)"	"unprognostic (1.20e-3)"	"unprognostic (4.92e-2)"	"unprognostic (3.55e-2)"	"unprognostic (2.75e-3)"	"unprognostic (4.42e-2)"	"unprognostic (1.20e-1)"	"unprognostic (1.68e-2)"	"unprognostic (2.42e-3)"	"unprognostic (1.53e-1)"	"unprognostic (6.99e-2)"	"unprognostic (4.48e-2)"	"unprognostic (1.66e-1)"	"unprognostic (2.53e-1)"	"unprognostic (1.87e-1)"	73.5	93.9	59.3	60.5	63.4	78.7	97.8	60.8	60.7	79.6	58.3	100.6	82.2	60.5	84.0	118.6	83.2	69.0	71.0	55.3	59.1	78.6	132.2	83.6	80.7	67.2	62.3	88.6	92.2	110.3	56.5	72.4	62.2	62.0	95.4	24.4	92.7	68.1	58.8	120.6	80.4	54.8	65.7	99.2	95.7	34.8	64.7	72.9	95.7	63.2	90.7	77.8	84.0	63.4	226.4	95.6	113.7	175.8	140.3	115.0	148.3	82.8	171.4	183.7	190.9	78.2	251.5	125.3	116.9	146.2	90.9	180.2	98.8	143.6	127.2	114.0	122.8	93.2	61.3	101.7	173.6	173.1	136.4	145.0	198.7	124.5	147.6	132.7	201.8	128.3	104.1	208.4	119.0	280.7	118.8	101.5	127.5	163.7	158.0	135.9	116.0	203.8	136.1	151.9	93.2	210.7	81.9	133.8	172.0	105.6	174.5	303.8	115.5	104.8	99.4	102.8	147.1	297.0	263.0	113.0	89.4	180.6	116.7	9.7	10.6	8.2	11.1	9.4	11.8	8.6	7.6	7.4	9.9	6.8	7.0	8.4	9.7	12.1	10.5	9.3	3.8	9.9	59.3	63.4	60.8	60.7	55.3	59.1	67.2	62.3	62.2	65.7	64.7	63.4	80.6	22.4	25.5	15.3	91.9	65.8	86.2	107.1	74.6	23.3	92.9	72.6	24.0	70.1	56.1	82.8	8.4	132.8	77.4	110.9	33.2	131.6	7.1	26.3	40.6	77.4	75.6	44.2	6.8	157.2	143.9	60.3	50.0	49.7	35.5	74.9	71.7	68.2	159.8	37.0	7.9	107.4	71.2	125.1	95.0	7.7	60.3	88.7	62.2	12.2	119.2	59.6	113.3	13.0	10.7	140.4	84.7	40.6	84.6	102.8	81.7	49.7	22.1	17.5	26.3	57.1	38.8	17.2	16.4	83.7	81.8	165.4	71.4	62.4	114.0	122.0
APOL3	"APOLIII, CG12-1"	ENSG00000128284	"Apolipoprotein L3"	O95236	22	36140330-36166177	"Predicted intracellular proteins"	"Lipid transport, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Adipocytes: 59.1;Endothelial cells: 69.8;Hepatic stellate cells: 69.7;Kupffer cells: 38.7;NK-cells: 46.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"ASC diff: 34.1;ASC TERT1: 54.1;HDLM-2: 25.6;Karpas-707: 59.0"														"Intracellular and membrane"	NA	NA			"Cluster 39: Non-specific - mRNA processing"	"Cluster 64: Macrophages - Immune response"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"				"prognostic favorable (6.82e-4)"	"unprognostic (5.93e-3)"	"unprognostic (6.79e-2)"	"unprognostic (2.70e-2)"	"unprognostic (2.22e-1)"	"unprognostic (7.05e-2)"	"unprognostic (6.30e-2)"	"unprognostic (2.67e-1)"	"unprognostic (8.94e-2)"	"unprognostic (1.09e-1)"	"unprognostic (2.95e-3)"	"unprognostic (2.46e-1)"	"prognostic unfavorable (1.23e-5)"	"unprognostic (7.87e-2)"	"unprognostic (4.69e-2)"	"unprognostic (1.07e-1)"	"unprognostic (1.07e-2)"	58.2	12.3	10.1	25.4	10.0	10.1	43.7	8.7	12.2	17.2	7.6	16.3	15.0	18.8	12.3	12.0	24.4	14.3	33.7	8.8	9.1	19.0	39.9	42.0	43.4	11.4	10.1	9.6	6.3	3.4	8.5	16.3	10.0	18.4	11.4	0.6	15.7	14.9	16.6	19.6	21.7	16.0	8.8	47.6	12.3	2.9	10.8	18.1	25.2	19.6	20.8	17.6	19.5	8.7	4.3	0.0	0.0	0.1	34.1	54.1	1.8	1.8	10.2	3.1	7.0	0.0	9.5	2.1	0.4	5.0	4.6	0.7	0.0	1.3	1.9	25.6	0.0	9.2	1.3	2.1	18.3	0.1	2.6	11.4	0.0	9.0	0.4	2.1	22.1	2.0	0.2	59.0	1.1	0.1	11.7	0.3	0.1	0.0	0.5	16.9	0.0	1.3	0.3	3.0	0.2	0.1	6.0	4.2	0.1	0.0	0.0	1.2	16.2	1.5	0.6	1.7	0.5	15.6	10.8	0.1	3.7	3.5	1.5	8.3	19.1	0.8	16.9	23.4	27.3	9.7	14.4	17.5	15.4	8.0	13.4	14.3	2.3	18.5	24.6	0.5	14.7	17.2	10.1	10.0	8.7	12.2	8.8	9.1	11.4	10.1	10.0	8.8	10.8	8.7	59.1	3.2	8.6	1.6	21.1	5.0	4.3	3.9	2.2	0.0	5.8	4.2	7.9	8.6	4.3	3.7	0.0	1.9	16.0	0.3	0.0	2.5	0.9	1.8	4.7	69.8	0.0	20.6	0.0	1.6	1.2	18.8	7.1	1.3	9.5	2.0	69.7	20.6	6.9	0.0	0.0	7.5	2.0	38.7	10.6	1.4	24.2	19.6	3.6	9.4	29.2	0.7	46.4	0.0	0.0	3.0	0.1	9.8	15.3	10.4	5.3	2.8	4.2	0.3	13.1	3.2	10.1	0.2	0.3	4.1	4.1	0.8	31.5	4.3	2.3	4.7
ARFGAP1	"ARF1GAP, bA261N11.3, FLJ10767"	ENSG00000101199	"ADP ribosylation factor GTPase activating protein 1"	Q8N6T3	20	63272785-63289790	"Plasma proteins, Predicted intracellular proteins"	"ER-Golgi transport, Protein transport, Transport"	"GTPase activation"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA051019, HPA056273"	Approved		Approved	"Golgi apparatus,Vesicles,Cytosol"		NA	NA			"Cluster 39: Non-specific - mRNA processing"	"Cluster 71: Testis - DNA repair"	"Cluster 39: CACO-2 - Unknown function"	"Cluster 53: Intestinal epithelial cells - Unknown function"	"Golgi apparatus, Vesicles"	Cytosol	"HPA051019: AB_2681313, HPA056273: AB_2683084"	"unprognostic (1.81e-1)"	"unprognostic (4.64e-2)"	"unprognostic (1.27e-1)"	"unprognostic (3.93e-1)"	"unprognostic (1.38e-1)"	"unprognostic (1.24e-1)"	"unprognostic (1.57e-3)"	"unprognostic (7.76e-2)"	"unprognostic (8.86e-3)"	"unprognostic (8.62e-2)"	"prognostic favorable (4.57e-4)"	"unprognostic (3.23e-2)"	"prognostic unfavorable (3.48e-7)"	"unprognostic (1.16e-1)"	"unprognostic (7.59e-2)"	"unprognostic (4.34e-2)"	"unprognostic (2.86e-1)"	12.9	16.7	13.1	15.5	14.3	12.1	13.0	13.1	20.6	19.1	8.4	19.1	13.1	20.8	8.6	15.8	16.1	16.8	14.1	14.4	11.0	15.9	17.8	16.1	16.1	14.1	12.0	17.7	28.3	11.8	63.9	15.4	14.2	20.1	9.5	11.7	18.4	13.4	14.1	19.1	18.1	12.5	9.1	20.5	18.5	24.2	12.5	14.2	17.9	7.5	11.3	16.5	14.9	15.9	32.6	60.2	25.6	30.6	30.3	32.5	51.2	46.4	36.5	90.7	45.5	145.2	35.2	24.5	41.7	55.4	41.5	43.2	23.5	73.8	28.5	15.8	26.7	19.4	64.7	128.4	46.2	28.8	38.4	28.5	46.9	44.0	24.9	30.5	32.9	25.5	34.9	27.8	25.1	53.2	52.9	28.0	34.5	34.3	51.9	29.7	36.8	23.6	22.3	38.8	27.3	29.9	55.1	58.7	59.2	20.7	42.8	36.4	42.8	56.0	77.3	35.0	37.6	28.4	20.2	26.5	56.9	20.0	35.3	4.8	5.7	6.4	5.6	7.1	6.4	3.0	3.1	5.3	5.7	4.2	3.0	3.0	2.4	4.7	9.5	4.2	4.1	6.0	13.1	14.3	13.1	20.6	14.4	11.0	14.1	12.0	14.2	9.1	12.5	15.9	12.6	22.4	30.7	34.9	11.2	10.1	6.0	8.6	4.0	26.6	17.6	14.4	12.4	11.5	14.4	12.9	33.3	12.5	15.4	37.6	9.8	12.2	15.9	11.0	17.1	14.2	24.5	9.5	14.5	15.4	24.9	16.3	50.4	14.9	15.9	30.6	13.6	23.3	14.9	21.9	14.9	40.4	2.0	14.4	11.5	23.3	12.5	13.5	12.4	5.6	12.3	11.8	15.5	18.6	24.8	28.2	18.3	9.8	17.8	11.6	17.4	11.5	18.8	20.1	6.6	11.1	14.9	21.3	7.4	6.7	8.5	15.2	10.3	16.8	24.0	9.2
ARHGEF1	"LBCL2, P115-RHOGEF, SUB1.5"	ENSG00000076928	"Rho guanine nucleotide exchange factor 1"	Q92888	19	41883173-41930150	"Disease related genes, Plasma proteins, Predicted intracellular proteins"		"GTPase activation, Guanine-nucleotide releasing factor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"lymphoid tissue: 168.4"	"Cell type enhanced"	"Detected in all"		"dendritic cells: 156.2;NK-cells: 187.4;T-cells: 159.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB009502, HPA012924, HPA060784"	Enhanced		Enhanced	"Plasma membrane,Cytosol"		NA	NA			"Cluster 39: Non-specific - mRNA processing"	"Cluster 2: Immune cells - Immune response"	"Cluster 43: THP-1 - Innate immune response"	"Cluster 63: NK-cells & T-cells - Immune response"	"Plasma membrane, Cytosol"		"CAB009502: AB_667785, HPA012924: AB_1845000, HPA060784: AB_2684363"	"prognostic favorable (5.92e-4)"	"unprognostic (2.09e-1)"	"unprognostic (8.29e-3)"	"unprognostic (8.10e-3)"	"unprognostic (7.63e-2)"	"unprognostic (7.59e-3)"	"unprognostic (4.99e-2)"	"unprognostic (7.28e-2)"	"unprognostic (5.88e-2)"	"unprognostic (1.84e-2)"	"unprognostic (6.59e-2)"	"unprognostic (3.29e-3)"	"prognostic unfavorable (3.36e-8)"	"unprognostic (3.54e-1)"	"unprognostic (1.95e-1)"	"unprognostic (8.00e-2)"	"unprognostic (4.65e-2)"	50.2	20.9	17.1	79.1	21.8	113.5	39.9	19.1	21.9	37.2	17.8	37.5	26.8	33.4	3.6	34.1	36.4	23.5	26.2	16.1	18.2	31.9	30.0	67.7	127.5	24.1	20.2	32.9	27.4	12.6	25.9	18.3	22.0	32.1	10.4	5.6	28.8	11.8	15.4	37.6	87.1	13.4	19.0	168.4	34.9	10.9	21.4	96.5	36.7	8.9	48.9	33.9	33.2	27.9	58.8	69.9	15.8	19.9	21.9	22.9	18.4	30.1	45.7	37.4	32.8	21.5	49.2	77.9	54.6	27.8	19.8	33.8	20.3	46.9	11.8	74.1	23.6	63.1	30.6	28.4	31.9	68.4	100.8	27.8	30.5	36.3	23.5	19.9	36.2	68.2	25.5	46.7	21.8	40.4	48.0	52.9	17.9	46.4	54.0	71.8	29.7	46.3	23.2	31.8	10.3	43.8	42.3	18.7	36.0	8.1	21.9	114.4	49.6	49.7	33.2	26.8	47.7	63.0	43.2	68.4	40.5	107.6	80.2	10.4	20.5	29.2	47.0	39.5	37.2	20.1	35.6	49.4	21.5	19.5	36.1	39.4	27.4	32.1	57.5	11.3	38.7	36.4	17.1	21.8	19.1	21.9	16.1	18.2	24.1	20.2	22.0	19.0	21.4	27.9	46.6	6.4	22.0	35.3	97.3	14.5	13.9	15.0	20.5	18.7	13.1	12.4	4.2	8.6	8.8	7.3	27.1	13.3	156.2	21.7	3.9	23.6	1.4	12.2	16.7	29.0	21.7	23.8	8.0	24.9	22.8	17.7	56.6	16.8	31.7	19.3	26.7	9.3	38.2	11.8	7.9	29.2	16.2	52.5	31.9	1.8	19.3	58.9	19.6	18.7	39.0	8.8	187.4	13.6	27.6	55.9	22.7	16.6	66.4	15.7	10.1	7.3	6.3	19.1	26.3	17.6	17.3	7.3	10.1	17.3	14.8	10.1	159.0	20.4	26.4	11.1
ARL14EPL		ENSG00000268223	"ADP ribosylation factor like GTPase 14 effector protein like"	P0DKL9	5	116032324-116060118	"Predicted intracellular proteins"				"Evidence at protein level"	"No human protein/transcript evidence"	"No human protein/transcript evidence"	"Evidence at protein level"	"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in some"		"Astrocytes: 1.0;Collecting duct cells: 1.8;Early spermatids: 3.2;Endometrial ciliated cells: 1.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	19	"HDLM-2: 81.5"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"									NA	NA			"Cluster 39: Non-specific - mRNA processing"		"Cluster 44: HDLM-2 - Immune response"	"Cluster 29: Early spermatids - Spermatogenesis"					"unprognostic (1.41e-1)"		"unprognostic (3.84e-1)"	"unprognostic (2.51e-2)"	"unprognostic (6.47e-3)"		"unprognostic (1.60e-2)"		"unprognostic (3.79e-2)"	"unprognostic (4.05e-2)"			"unprognostic (1.40e-1)"		"unprognostic (1.50e-1)"	"unprognostic (7.65e-2)"	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	1.7	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.1	0.0	2.1	0.0	0.0	0.0	0.0	81.5	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.7	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.1	3.2	1.4	0.1	0.0	0.0	0.0	0.1	0.0	0.3	0.1	0.0	0.5	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.5	0.0	0.0	0.0
ARMCX5	"FLJ12969, GASP5"	ENSG00000125962	"Armadillo repeat containing X-linked 5"	Q6P1M9	X	102599168-102604159	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"RH-30: 88.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA000996	Approved		Approved	"Nuclear speckles,Plasma membrane,Cytosol"		NA	NA			"Cluster 39: Non-specific - mRNA processing"	"Cluster 89: Fibroblasts - ECM organization"	"Cluster 31: RH-30 & LHCN-M2 - Muscle contraction"	"Cluster 59: Non-specific - Transcription"	"Nuclear speckles, Cytosol"	"Plasma membrane"	"HPA000996: AB_1078212"	"unprognostic (7.71e-2)"	"unprognostic (2.43e-2)"	"unprognostic (1.20e-1)"	"unprognostic (3.50e-2)"	"unprognostic (1.54e-1)"	"unprognostic (5.05e-2)"	"unprognostic (4.07e-2)"	"prognostic favorable (6.58e-5)"	"unprognostic (1.12e-1)"	"unprognostic (2.76e-2)"	"unprognostic (2.83e-1)"	"unprognostic (3.28e-3)"	"unprognostic (1.17e-1)"	"unprognostic (2.40e-1)"	"unprognostic (1.17e-2)"	"unprognostic (2.83e-1)"	"unprognostic (5.24e-2)"	8.2	11.0	10.4	8.8	10.6	10.3	17.8	10.0	11.5	13.7	6.9	12.8	10.8	15.2	15.5	11.0	15.0	10.0	10.7	11.4	9.3	12.6	11.3	11.2	10.4	7.7	7.0	20.3	14.7	19.9	7.2	8.4	7.6	20.6	15.3	10.6	15.7	13.5	9.3	11.2	12.3	13.9	7.3	8.0	13.5	5.4	9.6	16.2	19.5	10.1	13.3	11.2	6.5	11.4	17.8	15.7	36.4	19.4	15.9	17.8	20.4	17.1	13.1	19.5	34.5	18.7	21.5	0.0	20.3	17.2	22.3	15.1	32.8	16.3	22.1	0.0	13.1	17.9	19.2	15.6	20.6	32.7	20.0	22.3	20.7	16.9	20.3	15.5	20.0	0.0	17.6	0.1	26.3	15.8	23.3	3.9	16.4	30.3	29.5	22.7	88.9	0.1	14.5	24.2	17.1	15.4	30.5	15.7	24.7	10.4	10.8	15.4	20.3	14.5	12.8	16.5	12.3	0.0	13.0	0.0	11.4	32.7	37.8	0.1	11.8	3.2	13.9	12.3	13.3	12.5	12.8	10.9	11.3	6.4	17.8	14.0	1.0	9.3	7.8	10.0	9.7	11.1	10.4	10.6	10.0	11.5	11.4	9.3	7.7	7.0	7.6	7.3	9.6	11.4	6.9	6.4	6.9	0.0	9.0	5.6	11.7	8.0	19.4	16.5	8.9	7.7	4.4	7.2	10.3	9.2	20.9	5.7	9.2	6.8	21.5	10.0	0.3	5.9	8.3	9.6	9.6	3.4	0.0	9.7	2.6	9.9	10.7	5.7	1.3	7.8	5.7	9.6	6.0	1.7	0.0	9.8	4.1	7.2	3.5	0.5	8.4	6.6	8.8	0.0	4.6	6.5	10.3	0.0	0.0	9.3	3.8	6.0	12.0	9.3	9.6	10.6	13.7	20.8	0.0	6.7	7.8	3.0	5.3	14.5	5.7	3.7	9.5	7.5	9.7	11.1
ASB13	"FLJ13134, MGC19879"	ENSG00000196372	"Ankyrin repeat and SOCS box containing 13"	Q8WXK3	10	5638867-5666595	"Predicted intracellular proteins"	"Ubl conjugation pathway"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 44.0"	"Cell type enhanced"	"Detected in many"		"Bipolar cells: 45.0;Hepatocytes: 55.9;Proximal enterocytes: 41.1;Proximal tubular cells: 39.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Group enriched"	"Detected in many"	4	"dendritic cells: 13.6;monocytes: 12.9;T-cells: 4.1"	"Cell line enhanced"	"Detected in many"		"Daudi: 66.7;RPMI-8226: 68.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA048293, HPA061742"	Approved		Approved	"Nucleoplasm,Golgi apparatus"		NA	NA			"Cluster 39: Non-specific - mRNA processing"	"Cluster 41: Intestine & Liver - Lipid metabolism"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 2: Hepatocytes - Metabolism"	"Nucleoplasm, Golgi apparatus"		"HPA048293: AB_2680344, HPA061742: AB_2684599"	"unprognostic (3.64e-2)"	"unprognostic (3.60e-1)"	"unprognostic (7.39e-2)"	"unprognostic (2.21e-2)"	"unprognostic (4.83e-2)"	"unprognostic (2.77e-2)"	"unprognostic (1.74e-1)"	"unprognostic (2.47e-1)"	"unprognostic (2.90e-2)"	"unprognostic (2.87e-1)"	"unprognostic (6.93e-2)"	"unprognostic (3.42e-2)"	"unprognostic (4.58e-3)"	"unprognostic (1.16e-2)"	"unprognostic (3.03e-1)"	"unprognostic (2.87e-2)"	"unprognostic (1.40e-2)"	11.2	19.7	4.9	7.2	4.9	3.5	15.9	6.3	7.0	10.1	5.5	14.4	25.4	9.2	1.8	10.3	12.8	7.6	8.9	3.7	4.5	21.3	44.0	6.5	18.2	5.9	5.9	14.8	10.7	4.8	8.2	3.3	5.9	9.6	6.6	6.7	8.9	6.5	11.9	11.9	25.4	5.7	5.2	9.7	8.7	3.3	8.4	3.8	6.2	10.1	12.9	11.7	9.1	4.8	10.6	13.7	5.5	24.6	21.5	5.8	9.5	1.9	4.1	6.1	7.0	11.4	19.4	66.7	16.2	3.9	2.2	17.3	12.2	13.6	0.8	3.4	24.0	10.0	7.7	8.5	14.4	8.5	0.9	9.6	20.7	3.2	5.3	6.1	5.0	18.0	12.1	1.3	1.7	7.6	11.0	7.8	12.0	28.6	8.0	4.5	0.8	68.8	7.9	16.3	11.5	27.2	12.9	8.7	21.5	1.6	25.9	10.6	2.1	3.5	6.2	14.6	5.7	3.6	8.6	44.0	10.8	22.9	2.8	0.0	12.9	0.3	1.5	8.3	2.6	1.8	3.9	1.7	13.6	2.4	4.1	2.0	0.4	1.2	6.6	0.4	1.2	7.5	4.9	4.9	6.3	7.0	3.7	4.5	5.9	5.9	5.9	5.2	8.4	4.8	4.7	0.0	5.8	9.1	1.7	1.7	1.9	2.5	2.2	45.0	8.8	7.4	7.8	8.6	4.7	1.8	18.8	5.8	0.4	21.3	5.9	5.3	2.7	3.2	7.9	5.3	4.2	1.7	6.7	4.5	1.6	9.1	1.5	2.3	3.8	20.1	5.3	55.9	7.0	16.8	13.3	5.7	4.1	12.6	2.6	0.7	13.4	7.3	8.8	6.5	7.0	8.5	0.0	7.1	8.1	4.5	12.6	21.4	0.4	3.3	41.1	39.5	4.9	14.2	6.6	7.2	10.7	0.2	1.6	5.7	1.7	2.1	2.1	16.5	12.4	1.5
ATF1	TREB36	ENSG00000123268	"Activating transcription factor 1"	P18846	12	50763710-50821162	"Cancer-related genes, Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB016222, HPA055069, HPA055406"	Supported		Enhanced	Nucleoplasm		NA	NA			"Cluster 39: Non-specific - mRNA processing"	"Cluster 52: Non-specific - Ribosome"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 22: Epithelial cell types - Mixed function"	Nucleoplasm		"CAB016222: AB_2290030, HPA055069: AB_2682688, HPA055406: AB_2682807"	"unprognostic (1.71e-1)"	"unprognostic (1.50e-3)"	"unprognostic (1.50e-1)"	"unprognostic (9.05e-2)"	"unprognostic (6.68e-2)"	"unprognostic (1.58e-1)"	"prognostic unfavorable (1.53e-5)"	"unprognostic (3.65e-1)"	"unprognostic (8.17e-3)"	"unprognostic (5.94e-2)"	"unprognostic (4.31e-3)"	"unprognostic (5.52e-2)"	"unprognostic (1.73e-1)"	"unprognostic (2.74e-2)"	"unprognostic (2.46e-1)"	"unprognostic (2.27e-1)"	"unprognostic (8.75e-2)"	13.8	21.2	4.9	15.8	5.1	14.8	16.8	14.2	7.1	16.7	8.2	18.0	16.0	18.2	13.7	17.0	17.8	16.5	14.6	4.8	7.9	17.4	20.8	15.8	21.5	5.3	5.8	23.1	9.1	19.8	10.1	16.7	5.4	14.3	18.6	11.9	14.5	13.5	32.4	10.4	14.7	16.7	5.4	17.9	14.3	8.6	6.6	29.2	22.7	23.7	21.5	16.5	12.9	6.9	28.6	20.4	21.0	21.4	29.0	30.4	52.2	29.5	50.7	45.7	35.8	41.7	43.7	38.7	47.6	34.5	20.0	22.8	24.9	30.6	47.6	39.0	25.8	42.8	43.1	22.6	56.5	62.3	39.6	33.7	45.7	32.8	52.8	47.6	22.5	27.1	53.2	36.2	33.9	42.4	39.6	37.3	30.0	33.0	32.1	37.5	32.3	45.9	33.6	19.5	27.9	14.9	61.8	26.5	44.7	28.5	37.3	37.6	16.1	32.1	38.2	26.4	24.1	20.2	25.8	63.6	30.9	33.9	15.3	6.6	17.9	42.7	20.2	18.8	23.1	20.2	21.7	24.1	21.1	21.7	26.4	20.4	11.2	20.8	12.7	9.6	28.8	19.1	4.9	5.1	14.2	7.1	4.8	7.9	5.3	5.8	5.4	5.4	6.6	6.9	25.5	54.5	18.5	22.2	41.5	75.3	48.4	34.8	52.3	12.1	26.0	18.5	14.6	15.7	26.7	12.9	0.0	34.6	25.4	23.4	52.8	24.9	9.2	24.6	20.8	23.8	6.0	46.7	25.8	21.1	77.1	33.1	14.3	21.0	10.1	14.1	20.0	16.2	27.5	13.5	29.2	18.7	24.4	25.2	48.4	5.9	32.0	24.2	23.2	16.9	24.6	14.2	27.8	12.5	25.3	22.8	17.9	27.8	22.1	43.7	20.7	34.6	19.9	7.2	39.5	34.1	33.7	10.9	10.3	30.3	54.6	80.6	38.4	20.4	22.8	36.9
ATL3	DKFZP564J0863	ENSG00000184743	"Atlastin GTPase 3"	Q6DD88	11	63624087-63671921	"Disease related genes, Human disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"		Hydrolase	"Disease variant, Neuropathy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in many"	6	"Early spermatids: 264.4;Late spermatids: 728.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA065702, HPA076616"			Enhanced	"Endoplasmic reticulum"		NA	NA		58000	"Cluster 39: Non-specific - mRNA processing"	"Cluster 71: Testis - DNA repair"	"Cluster 20: HeLa - Mitochondria"	"Cluster 34: Spermatids - Unknown function"	"Endoplasmic reticulum"		"HPA065702: AB_2685536, HPA076616: AB_2732318"	"unprognostic (4.19e-2)"	"unprognostic (1.10e-1)"	"unprognostic (8.32e-2)"	"unprognostic (1.62e-1)"	"unprognostic (6.89e-2)"	"unprognostic (6.95e-2)"	"unprognostic (1.91e-2)"	"unprognostic (6.09e-3)"	"unprognostic (3.38e-2)"	"unprognostic (1.85e-1)"	"prognostic unfavorable (1.04e-4)"	"unprognostic (4.52e-2)"	"unprognostic (1.11e-3)"	"unprognostic (7.41e-2)"	"unprognostic (2.88e-1)"	"unprognostic (1.04e-1)"	"unprognostic (7.67e-3)"	30.6	18.1	11.6	17.9	16.6	13.2	22.1	14.9	12.6	23.0	22.0	26.0	9.9	24.3	16.5	24.5	20.1	15.9	11.5	9.8	13.9	12.6	17.7	18.8	12.6	19.8	16.4	16.9	15.4	13.3	6.6	14.9	18.9	16.7	16.6	4.0	15.4	20.4	6.3	25.2	13.7	33.2	16.8	16.9	17.4	36.9	15.5	10.8	20.9	9.6	15.4	27.1	19.4	20.6	44.2	39.4	11.7	28.4	59.2	82.5	0.2	53.2	60.0	51.9	35.0	32.9	69.7	26.3	53.8	93.6	40.0	28.3	21.8	34.8	69.8	40.4	5.8	27.9	41.8	0.2	40.7	53.2	39.2	54.0	55.6	69.1	42.8	34.7	56.3	28.5	30.6	70.2	59.6	46.6	19.2	30.7	14.9	14.1	33.7	40.7	29.3	37.8	41.2	29.7	6.3	17.0	174.3	37.6	50.5	14.5	65.7	19.1	79.1	109.0	51.9	105.3	38.3	19.0	29.6	51.4	57.7	33.6	67.1	7.1	8.3	3.7	8.9	11.4	9.8	5.3	7.4	7.3	8.6	4.2	5.9	8.2	3.5	6.9	13.4	4.3	9.3	7.8	11.6	16.6	14.9	12.6	9.8	13.9	19.8	16.4	18.9	16.8	15.5	20.6	56.7	44.8	27.2	16.6	18.8	43.7	45.7	36.4	30.1	4.8	31.9	18.4	8.5	30.0	29.9	33.1	0.0	6.7	28.5	45.2	1.9	41.2	264.4	23.8	46.4	48.2	10.7	29.5	13.5	50.2	20.1	46.2	19.4	63.8	17.1	20.3	49.6	51.3	37.6	5.0	12.1	21.0	28.5	55.3	43.0	728.4	54.3	35.7	42.7	16.9	49.5	12.6	24.7	16.6	35.6	72.7	24.7	67.4	21.0	55.3	27.7	24.7	21.5	8.5	72.3	35.9	55.2	36.0	29.0	32.9	40.6	4.0	28.2	25.6	19.8	50.9
ATP13A1	"ATP13A, CGI-152, FLJ31858, KIAA1825"	ENSG00000105726	"ATPase 13A1"	Q9HD20	19	19645198-19663676	"Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Protein transport, Transport"	Translocase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA031798, HPA049717"	Approved		Approved	Vesicles		NA	NA			"Cluster 39: Non-specific - mRNA processing"	"Cluster 64: Macrophages - Immune response"	"Cluster 25: RPMI-8226 - Immune response"	"Cluster 53: Intestinal epithelial cells - Unknown function"	Vesicles		"HPA031798: AB_2674048, HPA049717: AB_2680858"	"unprognostic (2.08e-1)"	"unprognostic (4.92e-2)"	"unprognostic (4.30e-2)"	"unprognostic (7.29e-2)"	"unprognostic (3.33e-1)"	"unprognostic (4.40e-3)"	"unprognostic (3.97e-3)"	"unprognostic (1.73e-2)"	"unprognostic (3.17e-1)"	"unprognostic (2.60e-2)"	"unprognostic (1.16e-2)"	"unprognostic (9.43e-3)"	"prognostic unfavorable (6.51e-4)"	"unprognostic (2.26e-3)"	"unprognostic (3.33e-2)"	"unprognostic (1.14e-1)"	"unprognostic (1.57e-1)"	12.9	17.0	7.3	21.8	6.5	16.1	13.9	5.4	8.6	17.1	12.3	15.6	18.6	16.2	8.0	15.6	15.0	14.0	9.7	7.4	7.9	12.8	12.9	14.0	21.4	7.9	6.5	20.8	21.1	23.4	18.1	12.9	6.9	15.1	13.0	8.8	17.7	12.6	12.8	16.2	22.2	11.6	6.1	26.4	16.7	15.8	7.6	15.9	20.2	5.8	17.5	13.9	14.4	9.0	32.8	45.2	24.3	52.8	38.2	25.3	66.1	28.9	40.1	24.5	24.9	43.5	54.3	44.9	48.6	34.4	14.0	17.8	37.2	37.0	13.4	16.5	77.6	24.6	48.7	34.5	39.3	46.8	70.1	36.7	34.2	26.5	31.8	27.1	17.9	32.1	43.0	97.5	24.7	53.9	31.8	33.7	44.5	40.6	54.7	25.0	17.4	100.9	25.8	44.7	33.4	56.7	26.8	42.6	30.0	11.4	26.9	50.6	28.7	51.5	7.7	59.2	35.3	78.8	50.6	26.8	36.0	59.6	39.5	0.0	3.5	3.5	2.8	5.6	3.1	2.2	3.3	3.1	6.5	1.9	2.1	2.7	0.1	1.4	8.6	5.0	2.9	2.4	7.3	6.5	5.4	8.6	7.4	7.9	7.9	6.5	6.9	6.1	7.6	9.0	11.3	9.6	5.8	12.1	22.7	5.9	7.4	8.2	9.6	12.0	13.0	8.5	5.5	11.5	9.0	14.7	18.8	20.3	12.5	28.5	1.9	19.1	10.3	11.5	9.8	9.0	18.6	11.1	11.2	18.4	18.2	10.2	31.6	13.6	5.7	16.2	10.8	13.2	20.0	5.0	11.0	22.9	12.2	12.2	9.5	5.1	14.0	18.3	7.2	7.5	13.6	12.6	8.2	9.0	11.0	15.6	22.4	9.8	50.4	11.9	28.6	6.6	12.8	10.8	6.6	9.2	11.4	14.7	14.6	12.6	6.1	15.3	13.9	20.2	22.2	6.4
BCAS1	"AIBC1, NABC1, PMES-2"	ENSG00000064787	"Brain enriched myelin associated protein 1"	O75363	20	53936777-54070594	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 890.2;choroid plexus: 301.2"	"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 182.6;Gastric mucus-secreting cells: 202.9;Intestinal goblet cells: 371.4;Oligodendrocyte precursor cells: 538.8;Oligodendrocytes: 718.8"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"T-reg: 2.1"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in some"		"MCF7: 44.2;OE19: 90.0;RT4: 179.5;SK-BR-3: 368.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB033558, HPA051816, HPA054745"	Enhanced		Approved	Vesicles		NA	NA			"Cluster 39: Non-specific - mRNA processing"	"Cluster 70: Brain - Nervous system development"	"Cluster 8: SK-BR-3 - Unknown function"	"Cluster 27: Mucus-secreting cells - Mucin production"	Vesicles		"CAB033558: AB_2274632, HPA051816: AB_2681623, HPA054745: AB_2682590"	"unprognostic (6.41e-2)"	"unprognostic (1.01e-2)"	"unprognostic (6.20e-2)"	"unprognostic (7.23e-2)"	"unprognostic (1.05e-1)"	"unprognostic (2.43e-2)"	"unprognostic (5.54e-2)"	"unprognostic (1.86e-1)"	"unprognostic (3.80e-1)"	"unprognostic (1.19e-1)"	"unprognostic (5.25e-2)"	"unprognostic (2.91e-2)"	"unprognostic (4.70e-3)"	"unprognostic (3.95e-1)"	"unprognostic (1.77e-1)"	"unprognostic (1.75e-1)"	"unprognostic (7.77e-3)"	1.2	0.2	506.5	6.4	627.9	0.1	3.4	551.3	890.2	7.3	301.2	69.5	19.0	1.3	2.2	7.2	1.5	8.6	0.4	421.4	525.8	3.3	0.4	2.9	0.6	749.3	660.7	0.4	0.9	0.0	1.0	0.1	649.9	33.4	74.3	0.2	22.3	0.3	0.5	1.4	31.1	2.8	584.8	0.5	159.8	3.4	562.0	0.7	0.3	0.8	6.5	35.7	7.5	724.7	0.0	8.0	0.2	0.0	0.0	0.0	0.5	0.0	0.0	0.2	0.0	0.1	0.7	0.2	0.1	0.0	0.2	0.6	0.0	0.0	0.0	27.8	0.2	0.0	0.3	4.0	0.0	0.0	0.2	0.6	0.0	0.1	0.0	0.0	0.0	0.0	0.3	0.6	0.0	44.2	0.1	0.2	0.2	90.0	0.0	2.3	0.0	1.2	0.0	179.5	0.2	0.1	0.0	368.6	0.4	0.0	12.2	0.0	0.0	0.0	0.1	3.2	0.0	0.9	0.5	1.0	0.9	0.0	0.3	0.3	0.1	0.0	0.2	0.0	1.2	0.6	0.4	0.1	0.0	0.2	0.0	0.0	0.3	0.1	0.1	0.1	2.1	0.1	506.5	627.9	551.3	890.2	421.4	525.8	749.3	660.7	649.9	584.8	562.0	724.7	0.8	9.6	1.1	1.6	2.8	0.8	6.3	8.5	0.6	0.1	6.2	1.9	2.2	7.2	35.9	3.7	0.0	0.2	0.4	182.6	1.9	2.9	15.6	9.4	11.1	0.4	8.4	0.0	1.6	22.5	0.1	0.8	202.9	11.8	4.5	0.0	0.4	0.1	0.1	0.0	2.5	371.4	18.3	0.0	2.5	16.1	0.3	1.7	16.0	0.0	0.0	0.8	0.0	538.8	718.8	22.9	102.0	0.0	1.0	21.3	12.0	0.1	100.5	0.5	0.0	1.4	2.2	15.4	6.1	0.3	0.3	0.0	1.7	0.4	35.6	56.7
BDP1	"HSA238520, KIAA1241, KIAA1689, TAF3B1, TFC5, TFIIIB150, TFIIIB90, TFNR"	ENSG00000145734	"B double prime 1, subunit of RNA polymerase III transcription initiation factor IIIB"	A6H8Y1	5	71455651-71567820	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	"Transcription, Transcription regulation"	Activator	"Deafness, Non-syndromic deafness"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in single"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"TIME: 16.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA064166, HPA077984"			Enhanced	Nucleoplasm		NA	NA			"Cluster 39: Non-specific - mRNA processing"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 17: WM-115 - Nervous system development"	"Cluster 52: Non-specific - Transcription"	Nucleoplasm		"HPA064166: , HPA077984: "	"unprognostic (4.96e-2)"	"unprognostic (2.19e-1)"	"unprognostic (6.65e-2)"	"unprognostic (3.01e-1)"	"unprognostic (3.47e-2)"	"unprognostic (1.44e-2)"	"unprognostic (7.72e-2)"	"unprognostic (2.02e-1)"	"unprognostic (9.59e-3)"	"unprognostic (8.20e-2)"	"unprognostic (2.85e-1)"	"unprognostic (1.23e-1)"	"unprognostic (3.86e-2)"	"unprognostic (1.52e-1)"	"unprognostic (7.83e-2)"	"unprognostic (2.50e-2)"	"unprognostic (5.86e-2)"	2.5	2.7	0.5	1.3	0.6	0.9	3.4	0.8	1.7	1.8	0.2	0.9	0.0	1.2	0.0	0.8	1.2	2.0	0.7	0.5	0.5	2.7	1.6	1.4	1.2	0.5	0.5	1.8	4.0	0.3	0.3	1.4	0.5	1.5	2.3	5.8	0.8	1.9	2.2	1.9	0.8	2.0	0.5	0.7	1.0	0.9	0.4	2.3	2.8	3.5	1.6	0.9	0.6	0.9	1.3	2.1	10.1	3.1	1.6	5.0	7.7	0.2	0.1	2.4	0.0	0.7	1.0	0.5	9.4	4.0	11.0	0.0	3.2	0.2	11.0	0.0	0.0	1.6	7.0	3.1	4.2	4.4	0.4	0.0	0.1	0.9	5.9	5.4	7.9	0.0	12.7	0.7	5.0	3.9	0.0	1.2	0.0	1.0	7.7	10.5	1.3	7.9	4.4	6.6	1.2	7.3	0.2	2.1	6.4	7.2	0.0	0.0	16.1	5.6	0.9	3.6	0.5	3.4	8.5	0.1	0.0	3.8	8.6	0.0	0.0	0.4	0.2	0.0	0.0	0.1	0.1	0.0	0.1	0.3	0.2	0.2	0.0	0.3	0.0	0.2	0.0	0.0	0.5	0.6	0.8	1.7	0.5	0.5	0.5	0.5	0.5	0.5	0.4	0.9	69.5	60.9	96.2	52.5	79.7	44.5	63.7	26.9	55.8	78.2	57.9	55.8	110.7	38.6	57.3	35.0	102.2	37.9	101.1	38.7	1.9	48.1	37.8	88.7	109.5	71.7	58.6	59.7	116.7	36.3	50.2	57.0	57.1	127.3	58.2	66.0	28.9	32.0	31.7	94.2	96.4	39.3	24.4	27.7	36.9	21.1	58.7	53.3	28.4	57.1	62.3	41.7	76.2	57.3	86.8	52.2	26.0	54.5	72.3	57.9	18.5	10.9	39.9	125.1	52.6	104.3	74.0	85.8	60.4	60.0	43.3	48.2	86.3	69.0	50.0	64.5
BRD2	"BRD2-IT1, D6S113E, FSRG1, KIAA9001, NAT, RING3"	ENSG00000204256	"Bromodomain containing 2"	P25440	6	32968594-32981505	"Predicted intracellular proteins"	"Host-virus interaction, Transcription, Transcription regulation"	"Chromatin regulator"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA042816	Approved		Enhanced	"Nuclear speckles"		NA	NA			"Cluster 39: Non-specific - mRNA processing"	"Cluster 72: Non-specific - Transcription"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 7: Non-specific - Mitochondria"	"Nuclear speckles"		"HPA042816: AB_10794766"	"unprognostic (2.13e-1)"	"unprognostic (2.43e-1)"	"unprognostic (1.10e-1)"	"unprognostic (4.60e-2)"	"unprognostic (1.45e-1)"	"unprognostic (9.89e-2)"	"unprognostic (5.03e-2)"	"unprognostic (2.54e-1)"	"unprognostic (6.85e-3)"	"unprognostic (1.39e-2)"	"unprognostic (1.95e-2)"	"unprognostic (3.42e-2)"	"unprognostic (1.38e-1)"	"unprognostic (2.98e-2)"	"unprognostic (1.49e-1)"	"unprognostic (1.20e-2)"	"unprognostic (1.44e-2)"	64.2	61.8	0.8	22.1	2.1	66.5	62.4	4.7	3.8	67.7	0.2	62.1	19.8	71.3	1.8	67.9	66.6	17.4	51.7	3.0	2.8	68.3	61.9	65.3	22.1	1.5	2.4	81.7	80.4	26.3	71.4	19.4	2.1	60.8	11.6	10.1	66.1	18.2	71.4	69.5	60.8	11.7	1.4	71.2	66.0	82.9	2.3	26.9	77.0	10.4	21.2	61.6	65.0	4.0	45.7	19.5	41.6	41.8	31.8	28.5	38.3	44.6	44.4	48.5	35.8	22.7	22.5	37.3	44.6	37.2	32.4	28.1	39.3	33.2	27.7	49.5	147.7	41.2	18.3	14.6	23.5	60.6	39.2	29.2	28.7	38.2	44.9	27.6	21.3	35.2	44.4	76.0	21.7	12.1	77.0	8.5	24.0	28.9	20.4	76.2	18.7	53.8	13.8	26.6	85.6	28.9	54.5	63.7	52.7	27.8	37.4	39.0	27.5	58.6	32.0	21.5	50.0	61.1	69.5	77.9	23.1	19.7	47.8	9.6	7.6	11.6	14.5	8.8	13.0	9.2	9.4	9.9	10.6	8.7	6.6	10.4	9.7	10.3	9.5	8.5	13.3	11.7	0.8	2.1	4.7	3.8	3.0	2.8	1.5	2.4	2.1	1.4	2.3	4.0	325.8	76.9	121.5	38.2	327.1	212.1	232.7	70.0	478.1	78.6	295.5	383.9	171.7	94.4	80.1	60.7	104.3	91.7	395.7	210.7	21.5	69.2	302.4	201.9	149.3	191.2	259.1	97.6	16.1	91.4	145.0	224.2	249.8	256.6	115.2	103.1	113.2	85.3	79.9	55.5	19.9	247.5	77.3	92.6	209.2	177.9	86.9	194.5	124.5	26.2	94.7	62.8	107.1	15.1	22.1	81.2	137.3	77.1	313.0	211.5	133.7	39.5	84.4	65.1	39.5	240.0	251.3	88.4	137.9	365.0	226.9	205.1	356.7	71.2	179.5	248.4
C1orf216	FLJ38984	ENSG00000142686	"Chromosome 1 open reading frame 216"	Q8TAB5	1	35713877-35718894	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 47.8"	"Cell type enhanced"	"Detected in many"		"Rod photoreceptor cells: 31.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA028299, HPA031343"	Uncertain		Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 39: Non-specific - mRNA processing"	"Cluster 10: Brain - Neuronal signaling"	"Cluster 33: SK-MEL-30 - Melanocyte processes"	"Cluster 46: Photoreceptor cells - Phototransduction"	"Nucleoplasm, Cytosol"		"HPA028299: AB_10601122, HPA031343: AB_2673834"	"unprognostic (1.17e-1)"	"unprognostic (2.43e-2)"	"unprognostic (9.84e-2)"	"unprognostic (1.51e-2)"	"unprognostic (1.83e-1)"	"unprognostic (1.63e-1)"	"prognostic unfavorable (2.15e-4)"	"unprognostic (2.23e-1)"	"unprognostic (3.81e-1)"	"unprognostic (2.07e-1)"	"unprognostic (4.67e-3)"	"unprognostic (1.86e-1)"	"prognostic unfavorable (7.68e-10)"	"unprognostic (3.31e-1)"	"unprognostic (3.08e-1)"	"unprognostic (2.48e-1)"	"unprognostic (5.93e-2)"	10.5	10.6	35.8	6.1	39.1	4.5	7.6	25.1	47.8	10.7	15.8	17.3	3.5	13.2	11.3	5.6	9.1	7.6	11.7	42.6	37.0	4.7	5.3	9.9	7.3	31.6	27.5	8.2	4.4	7.0	9.3	4.7	33.3	8.7	5.3	28.8	5.2	9.9	15.6	7.7	7.9	16.0	27.3	8.8	7.1	9.8	33.4	4.8	6.0	14.7	7.0	10.7	7.9	37.9	7.7	17.6	8.6	12.5	43.5	31.7	6.3	21.1	25.9	31.9	30.3	10.7	16.3	8.3	15.2	32.5	26.0	7.1	24.1	14.6	27.5	31.4	10.3	57.8	27.6	2.9	16.5	28.1	36.6	32.9	18.2	22.8	7.4	23.6	21.2	6.3	23.4	25.6	34.9	12.9	10.5	24.8	13.6	8.4	14.9	7.0	11.5	8.2	11.0	9.0	12.7	12.4	20.3	4.1	44.1	5.3	8.2	12.6	24.8	25.6	19.5	19.0	22.2	7.6	20.3	6.0	25.6	27.6	40.9	0.0	2.7	0.1	4.3	2.8	1.3	2.0	3.3	5.3	2.5	1.5	0.8	3.1	0.0	0.6	2.1	0.5	1.2	2.9	35.8	39.1	25.1	47.8	42.6	37.0	31.6	27.5	33.3	27.3	33.4	37.9	4.9	0.0	2.2	5.9	2.3	6.0	3.5	2.9	0.6	19.6	3.6	2.5	7.1	0.0	1.5	1.8	14.6	2.5	7.1	0.1	0.0	6.0	14.8	1.0	3.7	6.1	1.8	7.8	17.6	2.7	1.5	7.3	1.1	1.6	4.5	5.2	6.4	2.3	7.9	23.5	15.0	0.3	2.0	4.8	6.1	8.5	8.4	5.0	16.0	9.4	6.9	21.0	10.3	7.1	8.7	2.0	0.1	20.7	2.7	1.7	0.1	0.8	0.3	31.8	0.0	6.8	7.8	11.2	5.2	0.2	4.5	1.1	6.2	4.7	0.7	1.5
CACNA2D4		ENSG00000151062	"Calcium voltage-gated channel auxiliary subunit alpha2delta 4"	Q7Z3S7	12	1791963-1918666	"Disease related genes, FDA approved drug targets, Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Calcium transport, Ion transport, Transport"	"Calcium channel, Ion channel, Voltage-gated channel"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	39	"retina: 20.2"	"Cell type enhanced"	"Detected in many"		"Bipolar cells: 56.3;Cone photoreceptor cells: 156.4;Early spermatids: 56.3;Late spermatids: 117.6;Rod photoreceptor cells: 98.5"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Low immune cell specificity"	"Detected in many"			"Group enriched"	"Detected in many"	8	"dendritic cells: 2.9;monocytes: 4.4;T-cells: 4.2"	"Cell line enhanced"	"Detected in some"		"Hep G2: 4.7;HL-60: 2.8;HMC-1: 14.0;NB-4: 6.6"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			HPA031952	Uncertain					NA	NA			"Cluster 39: Non-specific - mRNA processing"	"Cluster 79: Retina - Phototransduction"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 9: Photoreceptor cells - Phototransduction"			"HPA031952: AB_10600798"	"unprognostic (5.04e-2)"	"unprognostic (2.82e-2)"	"unprognostic (5.32e-1)"	"unprognostic (7.50e-2)"	"unprognostic (1.15e-1)"	"unprognostic (8.18e-4)"	"unprognostic (1.10e-2)"	"unprognostic (1.31e-1)"	"unprognostic (2.08e-1)"	"unprognostic (3.30e-3)"	"unprognostic (1.24e-2)"	"unprognostic (1.41e-1)"	"unprognostic (1.62e-5)"	"unprognostic (1.11e-1)"	"unprognostic (1.07e-1)"	"unprognostic (2.04e-1)"	"unprognostic (2.13e-1)"	0.3	0.1	0.0	0.1	0.0	0.3	0.1	0.0	0.0	0.1	0.1	0.1	0.3	0.1	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.1	0.0	0.0	0.0	0.0	0.2	0.3	0.1	0.1	0.0	20.2	0.1	0.0	0.0	0.0	0.1	0.2	0.0	0.3	0.0	0.3	0.2	0.1	0.0	0.5	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	4.7	0.2	2.8	14.0	0.2	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.6	0.3	0.0	0.0	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	1.9	0.4	0.0	0.3	0.0	0.0	0.0	0.1	0.0	0.0	1.8	0.0	0.0	4.4	0.0	2.1	1.7	4.2	0.0	1.0	1.5	2.9	0.0	0.5	0.3	0.1	0.4	0.5	0.1	0.6	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.2	0.0	1.7	0.0	1.9	0.7	2.4	0.9	0.4	0.1	1.2	56.3	0.7	1.0	0.9	2.8	0.8	0.0	156.4	0.1	5.5	2.4	0.0	0.8	56.3	0.2	1.2	1.5	1.2	0.4	0.8	0.4	0.2	1.8	1.1	0.2	15.2	0.8	1.4	1.2	23.7	0.0	0.4	2.1	0.0	29.2	5.7	117.6	0.9	23.2	3.6	0.0	17.3	6.9	18.6	0.0	1.8	0.3	3.4	0.4	0.8	0.2	12.2	1.3	1.1	98.5	0.0	0.3	2.3	9.0	4.9	0.4	0.6	0.1	8.6	0.6	3.4	0.3
CAPN2	"CANPL2, CANPml, mCANP"	ENSG00000162909	"Calpain 2"	P17655	1	223701593-223776018	"Enzymes, Plasma proteins, Predicted intracellular proteins"		"Hydrolase, Protease, Thiol protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"TIME: 858.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA024470	Approved	Approved	Supported	Cytosol		NA	NA		2800000	"Cluster 39: Non-specific - mRNA processing"	"Cluster 46: Fibroblasts - ECM organization"	"Cluster 11: RPE1 & U-87MG - Synaptic function"	"Cluster 16: Pancreatic endocrine cells - Mixed function"	Cytosol		"HPA024470: AB_1845925"	"unprognostic (2.77e-2)"	"unprognostic (1.27e-3)"	"unprognostic (2.03e-1)"	"unprognostic (3.39e-2)"	"unprognostic (2.12e-1)"	"unprognostic (3.32e-2)"	"unprognostic (1.59e-1)"	"unprognostic (1.10e-1)"	"unprognostic (2.85e-1)"	"unprognostic (1.96e-1)"	"prognostic unfavorable (2.50e-4)"	"unprognostic (1.21e-1)"	"prognostic favorable (2.19e-4)"	"unprognostic (1.61e-1)"	"unprognostic (2.63e-1)"	"unprognostic (2.62e-1)"	"prognostic unfavorable (6.21e-4)"	118.8	93.9	40.2	64.9	50.0	40.9	92.4	45.3	39.6	110.4	29.4	140.1	46.2	67.7	58.0	134.3	120.5	119.7	71.8	36.9	42.7	115.2	31.2	182.5	35.5	51.9	46.1	83.2	55.1	136.3	28.0	68.3	46.6	47.5	131.4	19.2	151.2	91.2	82.2	41.6	58.5	87.3	43.4	42.5	130.4	26.3	49.1	27.0	80.9	81.6	54.3	85.6	89.3	49.3	419.9	263.7	79.2	54.9	257.6	356.6	79.4	383.9	541.3	267.2	151.1	209.2	323.6	0.4	125.0	417.1	209.1	255.1	86.3	593.1	243.4	109.8	95.2	7.8	124.9	25.6	232.3	21.5	13.9	193.3	187.3	416.6	217.8	472.3	537.1	0.1	123.2	106.8	789.3	8.6	1.0	19.4	45.5	49.7	346.3	35.4	262.4	7.3	454.9	24.3	17.7	94.7	198.1	524.2	122.8	189.7	80.9	98.7	858.1	252.7	212.0	220.6	498.4	32.5	66.8	1.4	625.3	46.2	284.7	7.9	118.6	7.2	106.8	77.9	89.8	34.4	72.6	103.2	163.9	16.6	22.9	62.2	6.1	24.5	73.7	7.4	81.7	136.6	40.2	50.0	45.3	39.6	36.9	42.7	51.9	46.1	46.6	43.4	49.1	49.3	240.0	394.2	134.9	82.9	42.3	47.3	136.6	197.5	38.7	12.0	35.7	32.8	38.4	115.8	264.4	53.3	33.3	24.4	72.4	356.0	181.9	271.4	94.5	70.0	52.7	125.3	24.6	6.9	13.3	195.9	92.0	105.0	103.5	93.3	27.8	47.8	35.7	9.7	38.9	13.5	23.1	104.4	242.1	50.0	239.3	232.8	77.3	86.4	112.1	22.5	66.0	22.6	78.2	48.7	21.6	373.0	191.5	68.8	83.3	237.7	104.1	23.6	288.8	18.0	39.5	85.0	107.9	3.4	3.3	67.5	27.6	8.2	83.5	63.5	98.2	268.2
CAPS	"CAPS1, MGC126562"	ENSG00000105519	Calcyphosine	Q13938	19	5912339-5916211	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"fallopian tube: 334.8"	"Group enriched"	"Detected in many"	6	"Endometrial ciliated cells: 2622.9;Respiratory ciliated cells: 1557.4"	"Cancer enriched"	"Detected in all"	5	"endometrial cancer: 171.3"	"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"OE19: 19.4;SK-BR-3: 65.1;U-266/70: 19.8"					"Low region specificity"	"Detected in all"			HPA043520	Enhanced		Approved	"Nucleoplasm,Plasma membrane,Cytosol"		NA	NA			"Cluster 39: Non-specific - mRNA processing"	"Cluster 42: Ciliated cells - Cilium & Cell projection"	"Cluster 8: SK-BR-3 - Unknown function"	"Cluster 49: Ciliated cells - Cilium organization"	"Plasma membrane"	"Nucleoplasm, Cytosol"	"HPA043520: AB_10964138"	"unprognostic (2.06e-1)"	"unprognostic (1.13e-2)"	"unprognostic (7.94e-3)"	"prognostic favorable (7.63e-5)"	"unprognostic (5.18e-1)"	"prognostic favorable (8.60e-4)"	"unprognostic (7.07e-2)"	"unprognostic (2.46e-3)"	"unprognostic (1.51e-1)"	"unprognostic (1.82e-1)"	"unprognostic (4.70e-2)"	"unprognostic (9.99e-2)"	"unprognostic (4.01e-2)"	"unprognostic (8.47e-2)"	"unprognostic (3.25e-1)"	"unprognostic (6.86e-3)"	"unprognostic (5.96e-3)"	12.2	25.9	37.5	10.9	35.1	10.0	11.6	55.0	30.1	47.2	55.4	16.1	6.9	21.7	4.6	12.9	334.8	11.2	13.5	40.2	69.6	38.3	21.5	49.5	12.2	72.6	105.3	13.8	24.0	3.3	27.9	9.3	85.7	40.4	2.8	2.2	24.9	30.9	4.3	16.2	18.7	2.3	60.9	25.2	37.5	6.4	50.0	5.7	30.8	1.1	4.2	44.2	13.7	66.1	2.2	2.3	0.9	6.3	2.1	3.2	4.0	0.7	0.7	0.3	0.6	1.5	13.8	0.9	4.0	1.5	0.7	2.3	0.1	0.6	0.0	4.7	1.9	0.8	4.8	4.7	2.5	0.8	3.5	4.1	4.2	0.4	0.8	4.0	1.0	4.7	0.7	5.4	0.7	4.4	2.4	4.0	0.7	19.4	12.6	3.1	0.3	4.7	1.8	6.2	1.0	4.9	1.0	65.1	6.6	2.0	4.3	4.7	1.5	0.6	0.4	4.6	17.1	19.8	6.5	1.1	7.7	1.8	2.8	0.4	0.7	0.3	1.7	0.6	0.9	0.9	1.0	1.3	0.8	1.8	0.8	0.7	0.7	1.8	0.4	1.5	1.0	0.8	37.5	35.1	55.0	30.1	40.2	69.6	72.6	105.3	85.7	60.9	50.0	66.1	5.3	12.8	16.5	11.1	3.3	4.8	32.1	122.8	1.8	2.5	8.9	8.8	2.2	0.0	161.5	121.4	4.2	24.3	7.4	5.3	35.2	34.7	6.5	2622.9	48.3	5.5	19.2	0.4	2.6	5.9	22.8	12.9	33.6	330.8	6.3	8.1	0.0	0.0	5.2	6.7	3.2	25.1	197.4	0.0	5.9	5.7	4.7	6.6	10.6	6.5	3.0	7.7	9.2	3.5	12.9	36.9	3.3	4.9	3.8	20.4	4.2	4.5	1557.4	4.2	6.6	3.5	42.7	0.4	0.6	0.9	4.1	20.5	9.2	3.3	9.3	128.6
CCAR2	"DBC-1, DBC1, KIAA1967, NET35"	ENSG00000158941	"Cell cycle and apoptosis regulator 2"	Q8N163	8	22604632-22621514	"Predicted intracellular proteins"	"Apoptosis, Biological rhythms, Cell cycle, DNA damage, mRNA processing, mRNA splicing, Transcription, Transcription regulation, Wnt signaling pathway"	"Activator, Metalloenzyme inhibitor, Repressor"	"Tumor suppressor"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA019907, HPA019943, CAB072827, CAB072828"	Enhanced		Enhanced	"Nucleoplasm,Nuclear bodies"		NA	NA		19000	"Cluster 39: Non-specific - mRNA processing"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 58: T-cells - T-cell receptor"	"Nucleoplasm, Nuclear bodies"		"CAB072827: , CAB072828: , HPA019907: AB_1852452, HPA019943: AB_1852454"	"unprognostic (3.42e-2)"	"unprognostic (5.78e-3)"	"unprognostic (2.46e-3)"	"unprognostic (1.33e-2)"	"unprognostic (6.87e-2)"	"unprognostic (2.23e-2)"	"unprognostic (5.13e-2)"	"unprognostic (8.56e-2)"	"unprognostic (2.97e-1)"	"unprognostic (1.77e-1)"	"unprognostic (2.32e-2)"	"unprognostic (1.54e-2)"	"prognostic favorable (5.60e-4)"	"unprognostic (1.71e-2)"	"unprognostic (2.46e-1)"	"unprognostic (7.54e-2)"	"unprognostic (1.77e-1)"	64.1	68.3	39.2	75.4	44.2	145.5	64.4	40.2	52.4	65.6	45.6	68.5	52.1	75.0	33.0	63.4	67.9	59.7	52.0	47.0	33.8	54.8	41.1	61.4	86.7	36.9	42.3	74.6	56.4	59.8	65.1	54.0	38.6	61.1	45.6	59.8	61.5	46.9	101.4	89.0	69.3	44.9	34.7	85.6	60.0	89.4	39.6	96.0	60.6	43.5	74.3	65.4	57.6	47.9	133.7	242.8	230.8	120.8	89.5	74.7	154.0	127.7	124.9	184.3	163.9	219.5	107.4	218.6	156.4	140.5	169.6	163.2	214.5	151.9	132.9	89.2	128.2	259.1	189.5	172.8	82.9	143.6	212.0	77.8	133.1	147.0	90.0	106.4	134.4	194.4	276.2	134.8	138.0	157.5	435.0	150.5	337.6	143.2	88.1	286.7	190.7	116.8	95.2	311.7	115.1	267.6	143.7	163.0	112.6	110.7	148.8	133.2	219.3	135.8	178.4	165.3	171.1	98.5	134.0	261.4	152.7	123.4	215.7	25.9	16.2	23.5	34.8	26.6	29.4	18.7	26.5	26.6	16.6	17.5	25.7	28.4	5.7	19.9	35.6	15.5	32.6	25.8	39.2	44.2	40.2	52.4	47.0	33.8	36.9	42.3	38.6	34.7	39.6	47.9	14.4	16.0	4.2	11.1	14.1	13.9	9.5	12.2	17.6	12.9	13.5	13.1	7.5	15.7	9.4	16.5	16.7	27.3	19.4	24.1	9.8	18.1	4.7	14.1	12.3	13.1	22.2	16.4	12.5	18.0	22.2	12.8	18.8	14.3	8.8	20.2	11.7	12.0	15.7	10.1	11.9	19.6	14.2	11.9	8.5	7.3	14.9	11.0	12.4	10.3	11.2	15.9	20.6	11.1	10.3	23.6	10.4	12.0	14.8	11.7	14.4	9.4	19.5	12.9	19.7	12.4	12.2	30.0	24.1	16.9	15.3	23.7	19.3	23.5	21.7	10.5
CCDC144A	"FLJ43983, KIAA0565"	ENSG00000170160	"Coiled-coil domain containing 144A"	A2RUR9	17	16689537-16777881	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Tissue enhanced"	"Detected in many"		"testis: 9.1"	"Cell type enhanced"	"Detected in many"		"Cone photoreceptor cells: 54.2;Early spermatids: 59.1;Rod photoreceptor cells: 49.4;Spermatocytes: 165.9"	"Not detected"	"Not detected"			"Group enriched"	"Detected in many"	6	"basal ganglia: 2.4;cerebellum: 7.6;cerebral cortex: 6.9;hippocampal formation: 4.9;white matter: 3.9"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"ASC TERT1: 9.5;TIME: 8.5"									"HPA022996, HPA047220, HPA047851, HPA066260"	Enhanced		Approved	Nucleoplasm,Vesicles		NA	NA			"Cluster 39: Non-specific - mRNA processing"	"Cluster 6: Brain - Smell perception"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 66: Spermatocytes - Spermatogenesis"	"Nucleoplasm, Vesicles"		"HPA022996: AB_1846136, HPA047220: AB_2679989, HPA047851: AB_2680182, HPA066260: "	"unprognostic (8.54e-2)"	"unprognostic (4.49e-3)"	"unprognostic (1.07e-1)"	"unprognostic (8.34e-2)"	"unprognostic (1.10e-1)"	"unprognostic (2.18e-2)"	"unprognostic (1.57e-1)"	"unprognostic (5.69e-2)"	"unprognostic (6.95e-2)"	"unprognostic (2.60e-2)"	"unprognostic (2.73e-1)"	"unprognostic (1.43e-1)"	"unprognostic (2.54e-1)"	"unprognostic (9.49e-2)"	"unprognostic (3.32e-1)"	"unprognostic (1.41e-1)"	"unprognostic (1.74e-1)"	1.3	1.3	0.6	2.1	2.4	4.2	1.5	7.6	6.9	1.1	0.0	1.7	0.7	3.5	2.5	0.8	1.6	1.2	1.2	4.9	0.0	0.5	1.1	1.3	1.7	0.8	0.0	4.5	2.7	0.4	1.6	2.7	0.8	1.5	0.9	7.4	1.2	1.0	1.0	2.5	1.0	1.6	0.0	1.8	1.5	9.1	0.0	3.3	0.8	2.3	1.2	1.6	0.9	3.9	0.5	3.4	0.8	2.1	3.0	9.5	0.4	0.2	0.0	0.2	0.2	4.4	0.1	0.5	2.8	6.2	0.2	5.3	4.4	0.3	0.2	3.2	0.2	0.4	0.5	0.3	0.2	0.7	2.7	1.7	0.1	2.1	0.2	0.9	0.1	0.1	0.4	0.3	2.0	0.1	0.0	1.1	0.6	0.9	0.4	1.4	0.2	0.1	0.1	4.1	1.1	1.2	0.6	0.2	1.2	1.5	3.4	0.1	8.5	0.7	0.4	4.6	1.4	5.7	6.3	0.2	0.3	6.2	1.6	0.2	0.1	0.0	0.5	0.1	0.3	0.2	0.5	0.3	0.1	0.1	0.9	0.5	0.2	0.2	0.4	0.2	0.5	0.0	0.6	2.4	7.6	6.9	4.9	0.0	0.8	0.0	0.8	0.0	0.0	3.9	5.9	0.0	14.9	15.7	3.1	4.0	6.4	1.9	0.0	40.8	4.5	2.5	2.8	2.8	2.9	0.0	54.2	4.9	6.4	1.7	0.0	1.8	59.1	8.0	25.8	9.1	1.2	1.7	21.2	0.0	7.1	9.7	2.0	10.4	26.0	6.2	3.6	2.0	4.2	33.7	19.8	2.4	2.0	6.8	7.7	6.5	7.2	6.3	5.4	1.0	3.6	7.1	6.2	17.1	4.0	1.7	3.8	9.1	1.7	8.6	1.2	1.1	3.9	49.4	6.6	11.7	10.2	165.9	36.1	0.2	3.7	1.9	6.9	22.2	2.1	4.6
CCDC22	"CXorf37, JM1"	ENSG00000101997	"Coiled-coil domain containing 22"	O60826	X	49235470-49250520	"Disease related genes, Human disease related genes, Potential drug targets, Predicted intracellular proteins, Transporters"	"Protein transport, Transport, Ubl conjugation pathway"		"Disease variant, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA000229, HPA000888, HPA075980"	Uncertain	Approved	Approved	"Endoplasmic reticulum,Vesicles"		NA	NA			"Cluster 39: Non-specific - mRNA processing"	"Cluster 18: Non-specific - Mitochondria"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 4: Macrophages - Innate immune response"	"Endoplasmic reticulum, Vesicles"		"HPA000229: , HPA000888: AB_1078420, HPA075980: "	"unprognostic (1.24e-2)"	"unprognostic (1.96e-2)"	"unprognostic (1.98e-2)"	"unprognostic (3.45e-1)"	"unprognostic (1.36e-1)"	"unprognostic (2.80e-2)"	"prognostic unfavorable (2.17e-4)"	"unprognostic (1.68e-2)"	"unprognostic (2.62e-2)"	"unprognostic (1.70e-1)"	"unprognostic (4.57e-3)"	"unprognostic (3.61e-2)"	"unprognostic (4.99e-2)"	"unprognostic (6.99e-2)"	"unprognostic (2.57e-1)"	"unprognostic (2.10e-2)"	"unprognostic (1.40e-3)"	10.3	12.3	9.4	10.1	10.0	18.6	10.3	9.9	10.8	11.7	8.8	12.1	10.4	12.2	5.3	14.2	11.3	6.4	12.8	9.4	9.2	12.3	12.9	10.7	15.0	10.8	9.4	11.2	14.2	8.7	11.2	6.9	10.1	13.5	5.2	4.7	12.3	8.7	17.2	13.8	13.4	6.0	9.6	20.5	12.9	3.8	10.0	13.6	11.0	7.7	8.5	11.9	11.1	10.8	18.8	16.0	9.6	33.5	8.8	8.9	20.4	10.9	7.9	12.0	13.6	16.3	16.0	6.9	15.9	9.7	14.3	15.0	10.6	18.0	4.9	18.1	23.6	7.3	15.6	15.5	14.7	20.8	12.4	8.2	15.2	15.9	8.6	6.1	11.9	13.7	14.7	11.8	8.6	58.3	15.3	24.4	11.2	9.5	23.2	22.0	15.6	30.1	9.4	9.4	11.4	8.8	16.7	19.4	15.0	9.8	30.2	20.2	13.3	15.4	16.5	19.2	11.6	21.2	12.6	12.5	16.8	38.5	12.3	8.6	37.0	23.8	18.3	30.9	20.1	18.9	18.8	21.3	38.2	16.8	16.7	19.6	2.8	10.8	27.1	15.1	21.8	28.0	9.4	10.0	9.9	10.8	9.4	9.2	10.8	9.4	10.1	9.6	10.0	10.8	8.6	0.0	4.4	3.3	15.0	5.6	9.6	13.0	6.2	11.6	7.4	6.1	2.4	15.7	12.0	11.0	6.2	15.2	11.2	12.5	15.6	13.9	0.3	5.8	4.6	7.8	6.7	8.6	3.7	7.3	14.8	7.6	7.1	6.9	11.4	8.6	11.0	7.2	32.0	1.7	2.9	18.2	8.2	14.4	11.9	0.4	8.1	13.8	7.2	1.9	18.0	9.9	9.2	1.0	4.2	8.6	7.6	7.5	10.2	6.2	15.6	12.1	5.6	8.0	6.6	9.1	9.5	0.1	0.9	8.0	6.7	20.2	13.3	11.0	15.7	8.3
CD44	"CD44R, CSPG8, HCELL, IN, MC56, MDU2, MDU3, MIC4, Pgp1"	ENSG00000026508	"CD44 molecule (Indian blood group)"	P16070	11	35138882-35232402	"Blood group antigen proteins, Cancer-related genes, CD markers, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins"	"Cell adhesion"	"Blood group antigen, Receptor"	"Cancer-related genes, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"salivary gland: 504.2"	"Cell type enhanced"	"Detected in many"		"Basal keratinocytes: 999.7;Ductal cells: 992.1;Exocrine glandular cells: 869.6;Langerhans cells: 1934.2;Suprabasal keratinocytes: 1024.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"hTERT-RPE1: 1650.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB000112, CAB000316, HPA005785"	Enhanced		Supported	"Golgi apparatus,Plasma membrane"	"Secreted to blood"	NA	NA		1200000000	"Cluster 39: Non-specific - mRNA processing"	"Cluster 11: Squamous epithelial cells - Epithelial cell function"	"Cluster 11: RPE1 & U-87MG - Synaptic function"	"Cluster 1: Pancreatic cells - Digestion"	"Plasma membrane"	"Golgi apparatus"	"CAB000112: , CAB000316: AB_2076596, HPA005785: AB_1078467"	"unprognostic (5.33e-2)"	"unprognostic (1.85e-1)"	"unprognostic (4.97e-2)"	"unprognostic (9.90e-3)"	"unprognostic (3.50e-3)"	"unprognostic (1.46e-2)"	"unprognostic (1.56e-2)"	"unprognostic (8.12e-2)"	"unprognostic (1.57e-1)"	"unprognostic (4.18e-2)"	"unprognostic (1.51e-3)"	"unprognostic (4.63e-2)"	"prognostic unfavorable (1.78e-8)"	"unprognostic (6.41e-2)"	"unprognostic (4.14e-2)"	"unprognostic (3.93e-2)"	"unprognostic (7.98e-2)"	143.7	42.4	29.2	218.0	33.9	308.1	164.7	63.0	25.1	146.0	16.8	91.1	53.0	200.4	20.1	227.8	69.0	129.7	30.4	33.0	116.5	31.3	31.0	214.1	108.8	114.9	102.3	11.7	263.2	6.0	8.1	74.1	118.3	87.3	111.5	38.0	504.2	57.0	17.1	433.3	60.8	175.8	114.3	83.8	61.5	6.6	62.8	64.2	76.2	27.7	188.7	235.2	193.4	114.9	493.0	448.6	4.3	1.2	252.6	691.5	1.6	962.2	740.3	521.3	288.2	30.4	150.4	0.7	126.5	1350.2	1065.4	820.1	9.9	1013.9	716.4	110.3	6.2	18.9	198.3	0.3	262.3	254.6	1124.3	315.4	778.3	693.2	552.7	1650.0	184.3	0.1	4.0	157.9	518.9	3.0	25.6	166.9	9.8	8.7	136.4	1.4	89.3	7.5	777.4	138.1	2.0	1.4	185.2	5.5	462.8	38.6	25.7	15.1	547.3	646.6	120.0	815.8	1006.0	281.6	327.7	3.7	980.4	145.1	969.8	127.4	403.0	35.4	140.6	257.8	196.5	122.5	210.1	186.5	229.0	90.0	179.7	153.6	92.6	322.3	356.1	79.9	309.7	437.3	29.2	33.9	63.0	25.1	33.0	116.5	114.9	102.3	118.3	114.3	62.8	114.9	41.0	96.1	361.8	54.5	250.1	999.7	297.7	335.3	228.2	0.6	139.6	71.2	8.6	27.1	125.6	20.2	2.1	4.5	257.0	14.0	1.9	992.1	41.3	43.6	395.4	50.9	100.1	94.4	0.4	869.6	3.6	282.2	39.8	196.9	763.2	25.2	13.2	3.6	226.6	0.0	0.4	93.3	30.5	474.3	1934.2	24.3	22.4	523.9	604.7	8.4	594.2	29.6	62.8	0.5	11.2	813.1	10.9	0.4	216.3	386.7	6.0	1.6	18.8	2.0	157.8	197.2	227.9	0.4	0.4	279.3	1024.9	17.9	430.8	1.0	79.1	330.7
CDK2		ENSG00000123374	"Cyclin dependent kinase 2"	P24941	12	55966781-55972789	"Cancer-related genes, Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	"Cell cycle, Cell division, DNA damage, DNA repair, Meiosis, Mitosis"	"Kinase, Serine/threonine-protein kinase, Transferase"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Cytotrophoblasts: 92.8;Extravillous trophoblasts: 84.7;Melanocytes: 87.2;Syncytiotrophoblasts: 170.7"	"Cancer enhanced"	"Detected in all"		"melanoma: 88.3"	"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"SK-MEL-30: 540.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB013115, HPA066915"	Enhanced		Enhanced	Nucleoplasm,Centrosome,Cytosol		NA	NA			"Cluster 39: Non-specific - mRNA processing"	"Cluster 28: Placenta - Pregnancy"	"Cluster 33: SK-MEL-30 - Melanocyte processes"	"Cluster 18: Syncytiotrophoblasts - Pregnancy hormone signaling"	Nucleoplasm	"Centrosome, Cytosol"	"CAB013115: AB_2536375, HPA066915: AB_2685748"	"unprognostic (2.36e-2)"	"unprognostic (2.60e-1)"	"unprognostic (3.71e-2)"	"unprognostic (1.83e-2)"	"unprognostic (1.75e-1)"	"prognostic unfavorable (9.94e-4)"	"prognostic unfavorable (8.61e-5)"	"unprognostic (3.48e-2)"	"unprognostic (1.31e-1)"	"unprognostic (4.67e-2)"	"unprognostic (5.38e-3)"	"unprognostic (4.69e-3)"	"prognostic unfavorable (1.46e-10)"	"unprognostic (1.05e-1)"	"unprognostic (1.76e-1)"	"unprognostic (6.16e-2)"	"unprognostic (6.75e-2)"	15.3	9.2	3.5	16.3	3.4	36.0	14.2	3.6	4.9	13.4	6.4	12.5	9.8	13.7	6.3	14.9	13.7	10.8	10.9	3.5	3.8	14.7	16.2	22.9	21.6	4.7	4.0	16.3	10.0	7.9	4.9	47.3	4.1	12.6	14.9	6.5	10.9	14.3	7.0	22.7	12.3	19.5	4.2	14.5	12.2	6.6	4.1	37.2	9.6	8.1	24.8	18.1	12.9	3.9	81.7	39.1	93.6	52.4	19.2	24.9	172.2	98.9	53.5	123.3	114.8	89.4	76.3	77.5	70.9	37.9	46.4	50.8	73.4	44.9	126.8	86.9	68.0	89.0	65.0	34.6	6.3	70.4	61.4	12.6	10.9	83.8	29.1	36.1	63.1	76.8	85.6	68.0	88.3	60.8	149.9	61.7	36.9	55.8	60.7	143.7	86.2	57.1	36.5	77.1	37.4	48.1	114.1	41.7	540.3	54.9	88.9	51.1	34.5	82.9	76.3	65.0	71.0	37.4	46.3	95.5	47.4	51.1	74.2	3.6	2.6	2.2	4.7	2.7	4.6	6.5	2.1	3.5	1.9	3.7	2.0	3.7	1.2	3.4	1.2	7.9	5.4	3.3	3.5	3.4	3.6	4.9	3.5	3.8	4.7	4.0	4.1	4.2	4.1	3.9	17.9	16.0	4.8	1.3	7.3	28.0	23.9	6.2	12.5	0.0	14.5	8.9	3.1	11.5	7.6	1.8	0.0	92.8	7.1	3.7	1.9	11.5	0.6	7.4	6.5	18.2	5.4	14.7	0.1	5.7	84.7	15.7	9.2	13.0	10.8	12.0	10.4	9.1	13.3	1.7	0.1	7.2	6.1	4.7	43.8	0.8	14.9	4.9	87.2	1.9	28.4	4.2	5.2	0.0	0.5	12.3	1.5	4.5	11.8	13.4	2.8	4.5	4.4	3.6	0.0	10.1	11.6	3.1	7.4	14.5	31.4	170.7	9.6	4.8	9.7	19.3
CENPO	"CENP-O, MGC11266"	ENSG00000138092	"Centromere protein O"	Q9BU64	2	24793136-24822376	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Erythroid cells: 11.2;Extravillous trophoblasts: 11.5;Spermatocytes: 11.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							HPA046189			Supported	"Nucleoplasm,Nuclear bodies"		NA	NA			"Cluster 39: Non-specific - mRNA processing"	"Cluster 53: Non-specific - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 12: Non-specific - Cell cycle regulation"	Nucleoplasm	"Nuclear bodies"	"HPA046189: AB_2679579"	"unprognostic (1.67e-2)"	"unprognostic (2.42e-1)"	"unprognostic (1.98e-2)"	"prognostic unfavorable (3.54e-4)"	"unprognostic (1.79e-1)"	"unprognostic (7.48e-3)"	"prognostic unfavorable (1.73e-6)"	"unprognostic (5.56e-2)"	"unprognostic (4.02e-1)"	"unprognostic (4.81e-2)"	"unprognostic (5.93e-2)"	"unprognostic (1.63e-2)"	"prognostic unfavorable (5.71e-13)"	"unprognostic (4.23e-2)"	"unprognostic (2.28e-1)"	"unprognostic (1.06e-1)"	"unprognostic (1.96e-1)"	5.2	4.0	3.5	3.5	3.3	9.2	4.6	2.9	4.1	4.0	2.3	3.3	3.2	3.1	0.8	4.5	3.0	1.5	2.8	3.7	3.5	2.9	2.6	3.6	4.9	3.7	3.4	4.5	1.9	1.6	3.6	3.2	3.5	3.1	3.7	1.4	2.5	1.1	3.0	3.8	3.9	2.2	3.2	4.3	2.7	8.3	3.8	11.4	3.4	2.0	5.8	2.5	3.7	3.1	31.1	36.4	40.7	21.7	4.8	7.3	22.7	36.8	21.7	51.0	38.7	46.2	15.5	21.4	4.2	22.8	29.8	16.3	40.6	14.0	34.1	28.1	21.1	34.3	23.9	31.0	2.4	28.7	24.4	3.6	2.5	51.5	11.4	9.3	24.0	25.4	40.3	23.8	31.8	21.8	39.2	20.6	29.3	21.0	22.8	31.0	53.4	11.5	12.9	18.6	27.0	29.3	22.1	16.9	7.9	18.5	16.3	11.8	15.4	46.9	42.8	15.9	41.6	14.5	20.1	42.8	14.5	27.5	36.4	0.0	0.3	0.0	1.0	0.2	0.4	0.4	0.4	0.5	0.4	0.3	0.3	0.7	0.1	0.7	0.3	1.1	0.7	0.3	3.5	3.3	2.9	4.1	3.7	3.5	3.7	3.4	3.5	3.2	3.8	3.1	0.7	3.2	2.2	4.2	1.5	1.1	0.7	1.3	2.2	0.9	1.9	1.4	6.5	0.0	1.2	3.7	0.0	3.9	1.9	3.0	1.9	1.5	3.9	1.5	2.2	2.0	0.0	11.2	5.3	1.3	11.5	2.4	6.6	1.5	1.3	6.5	1.8	0.9	4.9	1.7	4.9	1.6	0.0	1.6	1.1	9.6	0.3	1.1	1.8	3.7	1.2	1.6	1.0	2.0	2.5	1.1	0.5	1.2	8.6	0.5	1.8	1.7	0.7	0.7	0.0	1.1	3.3	11.7	9.5	3.3	1.4	2.9	1.4	2.8	2.7	0.9
CEP76	"C18orf9, FLJ12542, HsT1705"	ENSG00000101624	"Centrosomal protein 76"	Q8TAP6	18	12661833-12702777	"Cancer-related genes, Predicted intracellular proteins"			"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in many"	4	"Early spermatids: 209.7;Late spermatids: 57.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"OE19: 60.5"	"Region enriched"	"Detected in all"	9	"cerebellum: 55.0"	"Region enriched"	"Detected in all"	5	"cerebellum: 16.3"	HPA039395	Approved					NA	NA			"Cluster 39: Non-specific - mRNA processing"	"Cluster 34: Non-specific - Transcription"	"Cluster 21: OE19 - Mitochondria"	"Cluster 29: Early spermatids - Spermatogenesis"			"HPA039395: AB_10673357"	"unprognostic (3.39e-1)"	"unprognostic (2.99e-2)"	"unprognostic (2.26e-1)"	"unprognostic (9.31e-3)"	"unprognostic (1.65e-1)"	"unprognostic (1.37e-1)"	"unprognostic (2.57e-4)"	"unprognostic (2.99e-1)"	"unprognostic (4.00e-4)"	"unprognostic (7.88e-3)"	"unprognostic (2.45e-1)"	"unprognostic (8.70e-2)"	"unprognostic (1.67e-2)"	"unprognostic (4.39e-2)"	"unprognostic (2.37e-1)"	"unprognostic (5.70e-2)"	"unprognostic (8.21e-2)"	3.0	3.4	2.5	2.6	2.5	6.2	3.8	7.7	3.3	3.4	2.6	2.9	2.7	3.3	5.1	5.3	2.7	2.6	2.7	2.3	2.5	3.1	4.8	2.7	3.8	2.3	2.4	3.2	2.3	2.5	2.2	3.4	2.5	2.8	3.9	4.5	2.9	2.8	3.2	4.0	3.1	3.3	2.3	2.5	2.8	8.2	2.6	7.9	3.7	3.5	4.7	3.2	2.8	2.6	7.3	7.2	12.1	5.9	7.1	3.8	11.7	8.4	9.4	16.1	12.5	16.6	8.5	9.7	7.3	5.5	9.4	5.6	12.1	5.3	13.7	6.1	9.8	8.5	8.0	14.1	5.3	20.0	9.5	3.0	5.3	9.5	6.2	4.5	8.5	13.5	14.5	14.3	10.4	5.5	17.5	13.9	8.7	60.5	4.7	12.2	10.5	10.4	8.4	7.1	9.2	8.0	10.5	6.7	6.9	7.9	4.8	11.0	8.0	10.8	21.9	10.6	10.0	8.0	14.8	11.5	5.4	9.7	7.2	0.4	2.3	2.1	2.6	4.4	3.5	1.8	2.9	3.2	2.1	2.3	2.9	3.4	0.7	3.7	1.7	1.2	3.5	2.2	2.5	2.5	7.7	3.3	2.3	2.5	2.3	2.4	2.5	2.3	2.6	2.6	4.3	6.4	5.9	7.5	7.2	9.7	3.9	3.0	5.2	6.3	4.1	4.6	1.8	1.5	5.4	0.0	12.5	5.9	6.7	3.7	1.9	3.0	209.7	5.5	5.8	5.2	6.0	13.9	16.9	2.5	7.5	4.0	2.0	4.6	5.7	14.0	4.2	4.8	4.1	3.3	16.7	5.5	4.1	3.5	4.1	57.8	3.7	3.4	7.2	3.7	2.5	2.9	6.2	7.5	7.9	3.8	0.6	4.5	10.3	5.1	7.8	2.5	3.5	8.0	6.6	7.1	3.7	27.7	22.1	12.4	8.2	6.2	6.4	11.5	4.8	5.7
CHERP	"DAN16, ERPROT213-21"	ENSG00000085872	"Calcium homeostasis endoplasmic reticulum protein"	Q8IWX8	19	16517894-16542437	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"									NA	NA			"Cluster 39: Non-specific - mRNA processing"	"Cluster 72: Non-specific - Transcription"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 22: Epithelial cell types - Mixed function"				"unprognostic (1.74e-1)"	"unprognostic (8.09e-2)"	"unprognostic (2.29e-1)"	"unprognostic (1.33e-3)"	"unprognostic (2.40e-1)"	"unprognostic (2.05e-2)"	"unprognostic (9.09e-2)"	"unprognostic (3.35e-1)"	"unprognostic (3.72e-3)"	"unprognostic (4.05e-1)"	"unprognostic (7.38e-2)"	"unprognostic (6.39e-3)"	"unprognostic (9.86e-2)"	"unprognostic (1.74e-2)"	"unprognostic (4.72e-2)"	"unprognostic (6.26e-2)"	"unprognostic (9.62e-2)"	16.0	17.4	11.9	12.7	11.8	16.5	17.0	11.9	18.3	18.2	7.0	19.1	13.4	19.9	4.6	18.3	18.8	7.3	16.3	13.0	8.6	15.4	25.7	13.9	14.8	8.9	9.0	22.4	17.6	9.7	17.3	9.2	8.6	18.8	4.7	6.8	17.7	8.3	30.7	19.3	18.2	6.4	7.1	19.6	17.0	20.4	9.8	11.0	17.7	9.0	8.1	19.4	16.5	10.8	47.3	29.8	26.8	26.4	13.4	10.0	75.0	22.7	12.1	20.3	18.0	46.3	41.0	56.6	41.8	12.9	14.5	37.6	30.1	27.4	9.4	46.7	71.4	49.1	28.8	36.4	17.8	49.4	42.3	16.6	20.0	20.4	17.6	10.7	16.1	33.5	72.8	32.3	12.5	61.7	64.9	56.4	84.9	36.5	50.8	69.6	28.4	48.0	18.2	42.4	50.3	52.9	24.1	37.7	30.2	12.3	29.5	39.9	25.2	31.8	26.9	46.0	50.4	56.2	51.6	61.6	28.3	59.6	38.7	1.6	3.3	1.9	4.5	3.9	4.2	3.8	3.5	4.4	3.3	4.0	3.4	3.8	4.5	3.0	2.8	4.4	2.6	4.0	11.9	11.8	11.9	18.3	13.0	8.6	8.9	9.0	8.6	7.1	9.8	10.8	18.1	9.6	12.9	12.4	26.4	21.4	25.3	12.7	17.6	22.3	21.5	22.4	6.3	10.0	11.0	7.3	29.2	22.2	21.5	20.6	1.9	11.1	3.2	21.0	21.3	15.9	20.9	28.6	9.3	12.1	18.4	13.8	16.3	31.9	9.5	22.4	14.3	26.7	14.7	16.8	10.7	20.9	12.2	11.3	9.1	6.8	21.1	14.4	12.4	10.3	13.5	15.3	13.4	6.0	11.5	13.6	19.0	17.0	22.5	27.4	14.7	9.8	10.1	27.9	13.1	19.4	12.7	16.0	22.5	19.7	24.0	20.5	21.7	18.8	21.9	27.6
CLCN7	"CLC-7, CLC7, OPTA2, PPP1R63"	ENSG00000103249	"Chloride voltage-gated channel 7"	P51798	16	1444934-1475084	"Disease related genes, Human disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"	"Antiport, Ion transport, Transport"		"Disease variant, Osteopetrosis"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Horizontal cells: 74.0"	"Cancer enhanced"	"Detected in all"		"melanoma: 42.7"	"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA043019, HPA043586"	Supported					NA	NA			"Cluster 39: Non-specific - mRNA processing"	"Cluster 18: Non-specific - Mitochondria"	"Cluster 33: SK-MEL-30 - Melanocyte processes"	"Cluster 62: Horizontal cells - Visual perception"			"HPA043019: AB_10964727, HPA043586: AB_10965322"	"unprognostic (2.69e-1)"	"unprognostic (3.51e-2)"	"unprognostic (1.22e-1)"	"unprognostic (5.61e-2)"	"unprognostic (1.90e-2)"	"prognostic favorable (5.23e-4)"	"unprognostic (1.59e-2)"	"unprognostic (1.29e-2)"	"unprognostic (1.17e-1)"	"unprognostic (4.65e-2)"	"unprognostic (1.41e-2)"	"unprognostic (3.98e-1)"	"unprognostic (3.49e-3)"	"unprognostic (5.81e-2)"	"prognostic unfavorable (3.21e-4)"	"unprognostic (2.80e-1)"	"unprognostic (2.54e-1)"	18.1	37.3	14.4	16.9	14.2	34.3	17.3	12.8	18.0	18.7	18.0	20.0	16.6	20.3	6.3	12.4	17.0	12.3	16.6	14.2	14.1	21.1	22.0	19.1	18.3	17.9	19.2	15.1	21.8	20.8	21.7	12.4	20.7	16.5	7.1	9.2	16.8	12.0	28.0	23.1	22.7	13.2	11.9	27.3	22.3	19.2	18.0	15.6	23.1	8.3	12.1	16.0	11.9	15.8	14.2	36.9	21.0	33.7	41.3	21.5	34.3	18.9	36.4	35.2	41.5	30.8	51.2	16.3	38.6	23.7	73.8	29.4	18.4	21.0	11.4	26.1	31.5	11.6	37.9	30.0	72.4	29.4	45.1	42.9	28.4	32.1	28.5	23.9	23.0	36.3	48.0	29.2	18.5	28.4	21.3	50.6	21.7	9.0	21.8	96.7	13.3	45.2	16.4	18.2	22.5	24.9	30.8	37.5	120.2	11.8	33.6	78.0	26.3	34.9	16.2	39.1	18.4	47.3	32.1	16.5	28.2	54.3	22.6	0.0	1.6	1.2	0.8	2.7	0.3	1.0	0.4	0.4	1.2	1.0	0.2	0.3	0.3	0.3	3.4	1.1	0.1	1.0	14.4	14.2	12.8	18.0	14.2	14.1	17.9	19.2	20.7	11.9	18.0	15.8	12.6	0.0	7.5	25.1	16.5	7.4	5.5	6.3	9.1	45.0	14.5	12.7	4.4	4.3	8.2	20.2	35.5	10.2	12.3	20.4	1.9	16.2	10.2	14.0	14.9	11.1	12.0	8.0	22.3	17.8	8.9	11.0	18.8	17.9	6.3	24.0	16.8	15.6	36.3	74.0	20.6	14.5	4.1	28.3	11.5	8.6	11.5	29.6	39.2	24.4	22.4	27.3	13.4	8.5	17.9	17.9	7.3	8.2	9.3	9.0	14.5	14.7	7.8	28.1	0.0	9.9	11.9	13.5	10.7	5.6	6.8	15.5	9.4	19.4	15.1	5.2
COPZ2	MGC23008	ENSG00000005243	"COPI coat complex subunit zeta 2"	Q9P299	17	48026167-48038030	"Predicted intracellular proteins"	"ER-Golgi transport, Protein transport, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Basal keratinocytes: 49.8;Endometrial stromal cells: 63.8;Fibroblasts: 77.7;Leydig cells: 50.4;Smooth muscle cells: 49.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"ASC diff: 167.4;ASC TERT1: 185.6;BJ: 127.1;BJ hTERT+: 133.1;fHDF/TERT166: 271.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA055999	Uncertain					NA	NA			"Cluster 39: Non-specific - mRNA processing"	"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 33: Fibroblasts - ECM organization"			"HPA055999: AB_2683003"	"unprognostic (2.66e-1)"	"unprognostic (9.32e-2)"	"unprognostic (2.18e-2)"	"unprognostic (1.46e-1)"	"unprognostic (6.28e-2)"	"unprognostic (1.12e-1)"	"unprognostic (2.77e-2)"	"unprognostic (1.59e-1)"	"unprognostic (9.34e-2)"	"unprognostic (2.49e-1)"	"unprognostic (7.02e-2)"	"unprognostic (9.65e-2)"	"prognostic unfavorable (3.45e-9)"	"unprognostic (7.42e-3)"	"unprognostic (2.76e-2)"	"prognostic unfavorable (2.89e-6)"	"prognostic unfavorable (4.66e-4)"	71.7	28.6	11.8	11.7	12.6	1.0	46.4	13.0	19.1	41.8	22.8	57.0	6.2	38.3	21.4	15.9	32.6	22.9	57.1	12.4	16.4	19.2	33.2	22.1	5.8	15.3	12.5	13.6	19.7	24.3	14.8	22.5	15.1	34.2	14.7	5.1	23.4	36.8	90.8	35.3	18.2	45.6	14.0	11.7	27.1	11.6	13.1	4.9	32.1	48.6	6.9	37.3	33.1	15.7	38.7	7.5	4.1	0.0	167.4	185.6	0.0	127.1	133.1	35.0	38.6	0.0	4.4	0.0	28.3	271.6	0.0	39.5	0.0	0.5	34.9	1.7	0.1	13.6	21.3	0.1	68.4	0.0	0.8	111.7	16.0	26.2	3.5	41.1	5.3	0.3	0.1	0.8	86.9	18.1	0.4	0.0	0.2	2.6	2.5	0.0	0.0	6.1	2.4	0.0	0.2	5.7	24.6	0.0	28.3	1.0	6.0	4.2	34.4	91.5	14.5	72.9	0.5	91.6	11.1	1.3	99.3	0.0	13.1	0.0	0.5	0.0	0.3	0.4	0.0	0.0	0.1	0.5	0.1	0.0	0.0	0.4	0.0	0.1	0.2	0.0	0.0	0.1	11.8	12.6	13.0	19.1	12.4	16.4	15.3	12.5	15.1	14.0	13.1	15.7	31.6	9.6	2.2	8.1	2.6	49.8	16.7	9.4	9.1	1.2	7.3	30.1	37.1	0.0	1.4	7.3	0.0	1.0	7.5	0.4	11.7	1.0	7.0	2.1	63.8	15.6	0.0	0.0	1.4	5.1	1.2	77.7	0.0	1.5	1.3	2.7	16.4	39.0	6.9	0.0	1.7	2.3	2.0	4.4	28.4	21.1	50.4	3.4	28.4	7.5	0.8	34.8	4.1	2.5	7.6	2.5	0.0	41.8	3.5	6.0	0.1	19.1	0.6	1.3	6.6	21.6	49.2	14.1	3.7	3.1	26.0	2.3	3.7	8.5	0.4	11.7
CRAT	CAT1	ENSG00000095321	"Carnitine O-acetyltransferase"	P43155	9	129094142-129111189	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins, Transporters"	"Fatty acid metabolism, Lipid metabolism, Transport"	"Acyltransferase, Transferase"	Neurodegeneration	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 227.5;tongue: 201.3"	"Cell type enhanced"	"Detected in many"		"Early spermatids: 181.2;Late spermatids: 521.8;Proximal enterocytes: 136.4;Spermatocytes: 123.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA019230, HPA020260, HPA022815"	Enhanced		Approved	"Nucleoplasm,Nuclear membrane"		NA	NA		8100	"Cluster 39: Non-specific - mRNA processing"	"Cluster 55: Non-specific - Mitochondria & Proteasome"	"Cluster 6: T47d - Mammary gland"	"Cluster 25: Spermatids - Spermatogenesis"	"Nucleoplasm, Nuclear membrane"		"HPA019230: AB_1847212, HPA020260: AB_1847210, HPA022815: AB_2732427"	"unprognostic (5.13e-2)"	"unprognostic (9.79e-3)"	"unprognostic (1.99e-2)"	"prognostic favorable (2.36e-4)"	"unprognostic (2.19e-1)"	"unprognostic (1.14e-1)"	"unprognostic (1.15e-2)"	"unprognostic (2.18e-1)"	"unprognostic (5.11e-2)"	"unprognostic (3.24e-2)"	"unprognostic (3.13e-3)"	"unprognostic (2.03e-1)"	"prognostic favorable (0.00e+0)"	"unprognostic (1.38e-1)"	"unprognostic (9.27e-2)"	"unprognostic (1.26e-2)"	"unprognostic (7.65e-2)"	36.1	51.3	26.4	5.4	26.6	9.0	29.2	27.0	33.8	31.7	27.5	36.1	33.0	24.8	4.0	37.3	23.1	6.6	68.2	25.1	27.8	46.9	151.2	15.2	3.2	28.8	28.2	23.0	107.1	26.3	12.3	6.6	30.6	42.2	4.2	1.7	32.8	8.9	227.5	29.6	37.2	6.8	26.7	15.2	34.0	146.4	30.2	3.1	21.5	201.3	1.6	31.3	27.5	24.4	0.1	39.3	10.7	21.3	13.4	25.9	17.0	15.0	16.6	18.9	12.0	7.8	14.0	1.5	9.2	25.9	23.2	6.7	2.2	4.9	7.2	23.6	0.3	7.3	19.1	30.4	34.1	0.0	26.1	26.3	0.0	15.7	0.9	15.8	26.2	7.2	3.6	5.7	20.0	9.1	0.5	15.9	2.8	32.0	18.0	16.8	21.8	12.2	18.0	0.6	4.2	12.1	0.0	7.1	4.8	3.4	49.7	5.5	22.6	23.0	1.6	32.1	15.4	25.5	22.6	0.1	28.8	4.2	16.8	1.6	8.4	3.5	3.2	5.5	6.7	1.5	4.4	4.3	8.6	1.3	2.6	3.1	1.1	4.4	5.6	3.9	4.5	6.1	26.4	26.6	27.0	33.8	25.1	27.8	28.8	28.2	30.6	26.7	30.2	24.4	10.5	6.4	3.7	5.5	4.9	3.2	4.7	10.8	0.6	1.5	9.7	8.1	57.8	21.5	8.2	3.7	2.1	45.9	6.0	64.5	17.6	22.6	181.2	3.5	15.7	12.9	15.5	17.4	5.3	22.4	55.6	19.3	16.8	9.9	7.0	12.9	14.6	65.7	20.7	1.7	6.1	23.6	14.2	13.9	10.5	521.8	22.1	12.4	5.4	6.5	8.3	15.5	6.2	3.5	4.0	11.6	47.6	24.5	9.6	9.3	136.4	52.0	2.8	1.3	6.6	10.5	15.7	123.5	8.6	57.4	4.5	50.3	7.6	20.1	29.3	13.8
CSTF3	CstF-77	ENSG00000176102	"Cleavage stimulation factor subunit 3"	Q12996	11	33077188-33162371	"Predicted intracellular proteins"	"mRNA processing"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA039743, HPA040168"	Enhanced		Enhanced	Nucleoplasm		NA	NA			"Cluster 39: Non-specific - mRNA processing"	"Cluster 68: Epididymis - Unknown function"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 10: Non-specific - Unknown function"	Nucleoplasm		"HPA039743: AB_10795682, HPA040168: AB_10794025"	"unprognostic (2.38e-1)"	"unprognostic (1.46e-1)"	"prognostic favorable (1.63e-4)"	"unprognostic (3.77e-1)"	"unprognostic (4.04e-2)"	"unprognostic (4.35e-2)"	"prognostic unfavorable (8.20e-6)"	"unprognostic (1.47e-1)"	"unprognostic (1.67e-2)"	"unprognostic (6.42e-3)"	"unprognostic (9.73e-2)"	"unprognostic (2.41e-1)"	"prognostic unfavorable (1.61e-5)"	"unprognostic (4.64e-2)"	"unprognostic (1.86e-2)"	"unprognostic (1.15e-2)"	"unprognostic (1.01e-3)"	13.8	21.2	28.5	20.8	30.9	12.7	19.5	34.7	39.8	24.2	30.5	20.3	19.1	19.8	61.1	26.7	21.2	14.9	17.1	30.0	32.4	28.9	34.6	21.3	26.6	26.3	26.8	25.9	21.1	18.2	57.6	19.1	27.4	30.4	20.0	31.9	20.6	15.0	16.9	26.1	20.2	13.7	26.1	25.5	18.6	32.9	31.1	23.8	29.8	11.8	21.5	22.0	24.7	32.9	45.8	43.3	82.8	56.4	22.0	38.7	59.8	44.2	28.5	48.5	66.2	31.7	34.9	49.3	31.2	28.5	32.4	58.5	73.8	42.9	77.5	52.7	128.3	50.6	109.1	58.2	24.9	66.5	30.9	28.2	30.6	37.6	36.7	39.1	64.4	39.2	67.9	34.2	66.4	32.3	66.8	35.7	40.3	34.6	54.0	52.2	80.5	39.7	54.6	58.2	61.4	34.9	50.9	29.9	37.6	52.7	54.4	44.1	39.5	40.3	49.7	64.5	59.7	32.3	46.8	41.9	47.4	68.9	40.2	4.6	4.8	7.0	5.8	6.9	6.8	6.5	7.2	5.8	7.7	5.0	7.5	7.9	1.9	6.9	8.3	5.7	9.1	3.7	28.5	30.9	34.7	39.8	30.0	32.4	26.3	26.8	27.4	26.1	31.1	32.9	12.8	19.2	18.7	38.5	19.0	18.9	50.6	50.1	10.2	33.3	22.3	19.9	21.8	17.2	43.5	58.8	6.2	63.0	12.7	15.1	62.6	24.3	37.6	31.4	20.7	21.2	31.8	34.9	75.2	16.9	32.0	23.1	15.3	18.9	14.5	29.0	11.0	57.3	28.4	13.5	59.1	30.0	77.3	22.0	21.1	10.3	29.8	17.0	28.4	42.2	28.1	35.7	14.4	62.4	56.9	20.8	18.6	29.7	14.0	33.0	20.6	47.0	68.0	25.2	26.3	26.1	25.4	77.3	57.6	19.1	19.5	33.8	18.3	25.3	29.6	55.6
CTNNB1	"armadillo, beta-catenin, CTNNB"	ENSG00000168036	"Catenin beta 1"	P35222	3	41194741-41260096	"Cancer-related genes, Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"	"Cell adhesion, Host-virus interaction, Neurogenesis, Transcription, Transcription regulation, Wnt signaling pathway"	Activator	"Cancer-related genes, Disease variant, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Syncytiotrophoblasts: 539.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB000108, CAB001950, HPA029159, HPA029160"	Supported		Enhanced	"Plasma membrane"		NA	NA		2000000	"Cluster 39: Non-specific - mRNA processing"	"Cluster 37: Intestine - Unknown function"	"Cluster 33: SK-MEL-30 - Melanocyte processes"	"Cluster 41: Macrophages - Immune response"	"Plasma membrane"		"CAB000108: , CAB001950: , HPA029159: AB_10599619, HPA029160: AB_10600996"	"unprognostic (2.47e-1)"	"unprognostic (3.48e-2)"	"prognostic favorable (7.54e-4)"	"unprognostic (1.61e-1)"	"unprognostic (9.55e-2)"	"unprognostic (1.05e-2)"	"unprognostic (3.20e-3)"	"unprognostic (2.79e-1)"	"unprognostic (1.57e-1)"	"unprognostic (1.80e-2)"	"unprognostic (1.88e-2)"	"unprognostic (9.05e-2)"	"unprognostic (1.97e-3)"	"unprognostic (1.82e-2)"	"unprognostic (1.17e-1)"	"unprognostic (2.61e-1)"	"unprognostic (9.79e-2)"	130.8	112.2	106.7	98.7	85.3	162.4	194.3	147.8	87.5	179.4	94.7	141.2	136.9	149.4	84.4	113.7	131.0	121.8	109.9	88.1	105.3	106.5	147.9	132.9	81.9	101.3	112.9	173.9	93.3	137.2	84.7	200.0	94.0	132.3	134.5	88.8	110.9	126.3	87.3	99.0	142.9	178.4	104.9	92.5	81.8	59.5	129.4	95.6	140.6	89.9	99.5	158.3	109.3	108.4	161.6	210.0	423.6	242.8	226.9	184.7	333.8	179.6	249.7	288.2	284.3	146.3	224.0	131.7	157.8	314.1	129.0	119.6	315.8	510.0	306.2	123.3	215.7	215.5	261.0	523.7	169.5	121.8	99.1	271.6	226.7	345.5	208.7	235.7	258.1	63.0	153.7	80.3	324.1	161.8	87.3	68.3	397.2	211.0	159.3	64.9	281.9	88.3	177.9	494.8	102.9	172.4	296.2	147.1	809.4	509.8	242.1	248.6	340.8	217.1	163.6	139.3	264.0	50.7	82.7	138.4	221.5	150.5	369.7	4.7	7.3	6.4	9.2	12.3	10.9	7.7	8.6	10.1	11.8	8.0	8.6	9.4	6.6	9.6	12.6	10.0	10.8	5.6	106.7	85.3	147.8	87.5	88.1	105.3	101.3	112.9	94.0	104.9	129.4	108.4	171.7	137.8	179.5	58.1	71.7	213.5	130.1	75.3	116.1	40.7	232.5	168.1	84.7	90.1	119.2	62.5	33.3	318.9	99.0	251.6	35.2	132.2	11.0	90.3	125.9	187.3	93.8	43.8	50.9	78.5	115.6	116.8	53.0	95.5	116.6	137.0	139.2	172.5	115.1	13.5	82.4	145.9	42.7	154.6	228.1	9.5	59.7	161.1	202.7	124.6	98.3	89.2	49.4	70.9	62.9	139.8	249.5	86.9	55.5	128.3	160.3	93.2	96.1	62.0	46.0	175.6	137.3	78.4	40.1	70.9	174.9	539.5	77.0	245.6	189.6	127.9
CUL7	"dJ20C7.5, KIAA0076"	ENSG00000044090	"Cullin 7"	Q14999	6	43037617-43053943	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	"Host-virus interaction, Ubl conjugation pathway"		"Disease variant, Dwarfism"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB015449, HPA030095, HPA030096"	Approved					NA	NA			"Cluster 39: Non-specific - mRNA processing"	"Cluster 51: Non-specific - Unknown function"	"Cluster 23: AN3-CA - Transcription regulation"	"Cluster 52: Non-specific - Transcription"			"CAB015449: AB_629341, HPA030095: AB_10600659, HPA030096: AB_10600997"	"unprognostic (2.32e-2)"	"unprognostic (4.79e-2)"	"unprognostic (1.01e-3)"	"unprognostic (6.06e-2)"	"unprognostic (5.41e-3)"	"unprognostic (4.95e-2)"	"unprognostic (3.72e-2)"	"unprognostic (1.94e-2)"	"unprognostic (1.01e-1)"	"unprognostic (9.81e-2)"	"unprognostic (2.13e-3)"	"unprognostic (4.81e-1)"	"prognostic unfavorable (2.19e-4)"	"unprognostic (8.92e-2)"	"unprognostic (6.78e-2)"	"unprognostic (2.23e-1)"	"unprognostic (3.35e-1)"	7.5	13.7	5.0	6.6	5.0	4.4	8.8	5.7	5.3	14.4	7.9	7.6	7.7	11.7	9.0	6.9	14.2	7.6	5.9	5.4	7.0	11.0	9.7	7.4	6.2	3.8	4.4	15.9	15.7	6.9	26.0	10.2	4.9	11.0	5.4	5.5	8.5	8.7	13.2	7.5	8.0	9.2	3.5	9.7	9.4	5.7	6.9	6.1	12.9	10.7	5.4	8.9	9.6	4.0	10.6	8.2	27.1	32.0	27.9	40.7	2.2	15.7	21.0	18.8	19.0	18.0	7.9	4.9	35.2	27.0	19.1	3.9	9.9	13.9	8.8	12.4	10.5	12.2	9.1	25.5	23.2	4.4	14.2	42.5	13.1	16.2	17.4	33.7	18.0	5.6	10.7	12.3	24.1	21.8	5.6	10.9	4.5	32.2	6.7	9.1	6.5	12.7	16.6	14.4	14.6	18.2	12.2	11.3	11.1	12.4	16.6	8.3	18.9	28.1	12.0	9.1	6.9	25.6	7.0	12.9	11.2	4.8	16.5	0.0	0.7	0.4	0.6	0.6	0.4	0.5	0.4	0.2	0.7	0.7	0.2	0.4	0.2	0.6	0.5	0.9	0.3	0.6	5.0	5.0	5.7	5.3	5.4	7.0	3.8	4.4	4.9	3.5	6.9	4.0	3.9	6.4	10.5	6.5	4.5	2.5	1.7	5.2	4.0	6.0	7.2	6.0	4.6	1.5	4.6	3.7	6.2	4.8	1.7	3.8	0.0	6.4	0.6	8.4	7.7	5.8	7.2	2.1	6.0	4.8	3.7	6.9	10.7	6.3	4.5	15.9	5.7	2.2	5.0	1.7	5.9	8.2	6.1	2.2	1.8	0.2	9.3	2.7	1.8	5.6	1.2	4.1	1.0	3.0	3.1	4.6	2.6	7.5	3.9	2.2	6.4	4.9	12.9	7.8	0.0	7.5	4.9	0.8	2.5	4.2	1.7	4.4	2.8	17.3	4.6	1.5
CUL9	"H7AP1, KIAA0708, PARC"	ENSG00000112659	"Cullin 9"	Q8IWT3	6	43182184-43224587	"Plasma proteins, Predicted intracellular proteins"	"Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in many"	53	"Early spermatids: 513.7;Late spermatids: 1508.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA016434, HPA052004"	Approved		Approved	Cytosol		No	No			"Cluster 39: Non-specific - mRNA processing"	"Cluster 53: Non-specific - Cell cycle regulation"	"Cluster 21: OE19 - Mitochondria"	"Cluster 25: Spermatids - Spermatogenesis"	Cytosol		"HPA016434: AB_1848125, HPA052004: AB_2681690"	"prognostic favorable (5.28e-4)"	"unprognostic (1.47e-2)"	"prognostic unfavorable (2.48e-4)"	"unprognostic (5.20e-3)"	"unprognostic (1.56e-1)"	"prognostic favorable (2.37e-5)"	"unprognostic (3.05e-3)"	"unprognostic (1.83e-2)"	"unprognostic (2.53e-2)"	"unprognostic (1.29e-1)"	"prognostic favorable (8.07e-4)"	"unprognostic (8.22e-3)"	"unprognostic (2.03e-1)"	"unprognostic (2.68e-1)"	"unprognostic (2.31e-1)"	"unprognostic (9.94e-2)"	"prognostic favorable (4.87e-4)"	2.9	3.0	3.1	4.9	4.5	6.9	2.9	1.3	3.4	3.2	3.5	3.6	4.0	3.3	1.7	5.5	4.9	3.6	2.6	3.2	2.0	3.1	2.1	3.6	6.3	2.4	2.8	4.3	4.2	5.5	2.9	2.4	2.7	3.4	2.3	3.2	3.9	4.0	2.8	8.0	4.2	2.8	1.5	4.9	4.2	5.2	2.5	7.6	5.2	2.9	4.7	3.8	2.7	2.7	8.2	6.0	3.2	7.7	8.8	5.2	4.4	3.2	5.6	5.0	4.6	1.9	3.4	6.8	6.0	5.1	4.5	5.8	2.7	6.7	2.3	8.3	2.5	7.4	6.8	3.0	5.8	4.7	11.6	7.1	13.8	4.1	3.7	4.4	7.4	11.5	3.9	8.7	4.5	7.2	9.6	6.8	0.6	15.7	3.6	13.9	2.2	6.6	3.8	8.4	5.5	7.8	4.2	5.0	7.2	2.7	8.6	10.4	6.9	12.5	8.6	3.7	6.1	8.3	8.3	5.5	3.2	8.2	5.7	0.0	0.2	0.0	0.2	0.1	0.2	0.1	0.1	0.5	0.2	0.1	0.1	0.2	0.0	0.0	0.0	0.1	0.4	0.2	3.1	4.5	1.3	3.4	3.2	2.0	2.4	2.8	2.7	1.5	2.5	2.7	6.6	0.0	8.2	16.3	7.5	6.4	2.7	9.3	16.5	10.2	8.0	6.1	6.9	8.6	5.9	3.7	12.5	3.4	6.5	8.8	3.9	4.2	513.7	7.5	5.5	6.8	6.0	3.4	15.8	6.2	1.7	5.3	18.8	6.4	2.5	14.6	9.3	6.4	11.6	11.8	11.9	7.9	6.1	9.6	5.0	1508.3	11.1	8.5	3.6	9.4	6.3	9.6	5.2	11.6	11.2	6.5	2.1	8.2	4.1	2.3	8.5	6.7	8.5	10.0	13.1	6.4	3.6	14.5	10.1	14.2	5.5	2.6	7.1	5.6	7.2	2.9
CYP24A1	"CP24, CYP24, P450-CC24"	ENSG00000019186	"Cytochrome P450 family 24 subfamily A member 1"	Q07973	20	54153446-54173986	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"		"Monooxygenase, Oxidoreductase"	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"endometrium 1: 14.9;kidney: 35.3;lymphoid tissue: 10.5;placenta: 10.0;urinary bladder: 28.7"	"Cell type enhanced"	"Detected in some"		"Basal prostatic cells: 48.3;Basal respiratory cells: 142.7;Basal squamous epithelial cells: 74.0;Club cells: 47.0;Proximal tubular cells: 61.3;Urothelial cells: 36.7"	"Cancer enhanced"	"Detected in many"		"lung cancer: 18.3;urothelial cancer: 21.0"	"Low region specificity"	"Detected in some"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	17	"A549: 411.5;Hep G2: 122.6"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"HPA022261, HPA063771"	Enhanced		Approved	"Nucleoplasm,Plasma membrane,Mitochondria"		NA	Yes			"Cluster 39: Non-specific - mRNA processing"	"Cluster 7: Kidney - Transmembrane transport"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 26: Respiratory epithelial cells - Mucosal defense"	"Nucleoplasm, Mitochondria"	"Plasma membrane"	"HPA022261: AB_1847427, HPA063771: AB_2685120"	"unprognostic (1.19e-7)"	"unprognostic (1.73e-1)"	"unprognostic (2.24e-2)"	"unprognostic (7.69e-3)"	"unprognostic (3.30e-1)"	"unprognostic (2.30e-2)"		"unprognostic (1.11e-2)"	"unprognostic (2.12e-1)"	"unprognostic (2.09e-2)"	"unprognostic (5.37e-3)"	"unprognostic (1.23e-1)"	"unprognostic (6.05e-2)"	"unprognostic (5.98e-2)"	"unprognostic (1.36e-1)"	"unprognostic (4.38e-2)"	"unprognostic (2.12e-1)"	0.0	0.0	0.2	0.4	0.4	0.0	3.7	0.0	0.3	1.7	0.0	0.0	0.1	14.9	0.2	3.8	0.2	0.0	0.0	0.1	1.8	35.3	0.4	0.7	0.2	0.4	2.0	0.0	0.0	0.0	0.2	10.0	0.3	2.9	0.0	0.0	0.3	2.0	0.0	0.9	0.0	0.2	0.1	0.0	0.0	0.0	0.6	0.2	1.3	0.0	10.5	28.7	1.3	0.2	0.5	411.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.7	12.6	0.0	3.2	0.0	0.9	15.8	0.0	0.1	0.1	0.0	0.0	0.0	6.5	122.6	0.0	0.0	0.0	0.1	0.0	0.0	0.9	0.2	0.0	0.0	0.0	0.0	0.0	11.1	0.0	0.0	0.0	0.0	0.4	0.0	0.0	1.7	0.0	7.0	1.3	0.0	2.6	0.6	0.0	0.1	0.1	0.0	0.0	0.0	16.0	0.0	0.3	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.4	0.0	0.3	0.1	1.8	0.4	2.0	0.3	0.1	0.6	0.2	0.0	0.0	0.0	0.0	1.3	22.8	48.3	142.7	74.0	0.0	11.0	8.6	0.4	0.0	47.0	0.0	0.0	0.1	0.1	0.1	5.9	0.1	0.0	0.7	0.5	0.3	0.0	0.0	0.2	0.0	0.1	2.0	0.0	4.5	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	12.2	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.2	0.0	0.0	0.0	9.8	0.0	61.3	13.1	0.0	0.0	0.0	0.6	0.0	0.0	3.3	19.6	0.1	0.1	0.0	0.2	36.7
DBR1		ENSG00000138231	"Debranching RNA lariats 1"	Q9UK59	3	138160988-138174921	"Predicted intracellular proteins"	"mRNA processing"	Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA035365	Supported		Enhanced	Nucleoplasm		NA	NA			"Cluster 39: Non-specific - mRNA processing"	"Cluster 50: Non-specific - Ribosome"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 7: Non-specific - Mitochondria"	Nucleoplasm		"HPA035365: AB_10611956"	"unprognostic (1.20e-1)"	"unprognostic (3.72e-2)"	"unprognostic (8.48e-3)"	"unprognostic (2.04e-2)"	"unprognostic (2.83e-1)"	"unprognostic (9.40e-2)"	"prognostic unfavorable (1.36e-4)"	"unprognostic (2.33e-1)"	"unprognostic (5.24e-2)"	"unprognostic (9.99e-2)"	"unprognostic (2.60e-1)"	"unprognostic (3.33e-2)"	"prognostic favorable (1.36e-4)"	"unprognostic (5.37e-2)"	"unprognostic (1.71e-1)"	"unprognostic (5.35e-2)"	"unprognostic (4.79e-2)"	6.6	6.7	4.4	6.7	5.1	15.3	7.6	5.4	4.8	6.2	5.8	6.4	5.3	7.4	8.2	6.6	6.5	5.6	6.0	4.2	5.1	7.2	6.1	7.7	9.0	5.1	4.8	8.2	7.3	7.4	5.6	5.6	5.4	6.7	6.2	5.1	7.0	6.1	6.7	7.6	7.2	6.9	5.4	9.6	11.3	3.0	4.8	9.7	8.2	6.5	9.0	6.2	5.5	5.9	24.5	9.9	17.7	19.7	9.6	9.0	18.4	14.2	10.4	15.1	18.2	16.9	10.6	22.3	26.4	12.9	22.8	17.8	20.6	7.0	19.7	19.2	17.1	24.2	12.3	13.9	11.8	31.5	20.5	12.4	11.6	14.0	13.1	8.9	12.6	19.1	16.0	4.7	15.4	18.9	31.2	18.5	20.4	18.9	11.4	19.3	20.1	20.4	13.2	23.6	17.1	22.0	38.0	13.1	21.1	14.4	24.6	25.5	11.9	12.6	8.8	23.6	16.7	7.1	10.5	46.6	8.2	22.4	16.8	4.2	7.1	13.3	8.4	9.7	11.1	7.0	9.6	8.1	8.6	7.4	9.6	10.7	2.9	8.4	8.4	5.2	8.4	6.2	4.4	5.1	5.4	4.8	4.2	5.1	5.1	4.8	5.4	5.4	4.8	5.9	7.5	6.4	12.9	6.5	8.2	5.2	3.4	6.2	6.2	5.9	6.9	11.9	6.1	7.2	5.9	9.2	0.0	11.3	14.7	4.7	9.8	10.8	0.1	6.1	9.8	6.7	6.0	16.2	4.2	9.0	8.6	8.6	9.2	9.5	5.7	8.7	6.1	6.9	10.4	6.7	4.8	6.6	6.1	16.7	4.8	0.5	8.7	10.2	3.6	8.4	9.0	8.0	6.2	8.5	7.8	8.2	5.6	8.2	7.0	3.7	3.9	5.3	5.5	5.1	0.0	10.0	8.7	4.3	2.1	5.6	4.1	4.5	12.9	6.5	7.3	2.9
DDX3Y	DBY	ENSG00000067048	"DEAD-box helicase 3 Y-linked"	O15523	Y	12904108-12920478	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"		"DNA-binding, Helicase, Hydrolase, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 96.0"	"Cell type enhanced"	"Detected in many"		"Early spermatids: 275.5;Late spermatids: 575.3"	"Low cancer specificity"	"Detected in many"			"Region enriched"	"Detected in all"	6	"cerebral cortex: 31.8"	"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"Daudi: 153.7;HEL: 156.8;U-266/84: 133.1;U-698: 112.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA001648, HPA005631, HPA059583"	Enhanced	Supported	Supported	Nucleoplasm,Cytosol		NA	NA			"Cluster 39: Non-specific - mRNA processing"	"Cluster 40: Neutrophils - Inflammatory response"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 25: Spermatids - Spermatogenesis"	Cytosol	Nucleoplasm	"HPA001648: AB_1078635, HPA005631: AB_1078633, HPA059583: "			"unprognostic (3.89e-2)"		"unprognostic (1.70e-1)"	"prognostic favorable (4.70e-5)"	"unprognostic (6.50e-2)"	"unprognostic (4.74e-2)"	"unprognostic (2.22e-2)"		"unprognostic (4.17e-2)"	"unprognostic (3.37e-2)"	"unprognostic (9.61e-2)"	"unprognostic (2.58e-3)"	"unprognostic (1.74e-1)"	"unprognostic (2.66e-2)"	"unprognostic (7.87e-2)"	29.0	26.1	2.8	15.2	2.9	96.0	20.7	5.5	31.8	0.0	6.6	25.8	12.0	0.0	26.8	18.5	0.0	18.7	19.1	2.7	5.5	23.7	22.0	27.4	9.6	2.8	3.3	0.1	14.8	12.4	25.1	22.1	3.2	33.6	24.0	23.6	18.5	31.3	19.9	20.2	25.9	0.0	2.3	26.5	19.8	70.1	3.8	0.0	22.0	28.1	23.6	22.0	0.0	4.6	0.7	28.3	0.0	0.0	0.0	0.0	20.0	69.3	49.9	35.9	44.0	0.2	0.0	153.7	0.1	69.5	0.0	0.0	0.0	0.0	63.2	38.8	0.0	156.8	0.0	46.5	34.2	0.1	0.1	37.4	43.4	0.0	0.0	0.0	0.0	15.2	0.2	0.1	43.1	0.2	61.8	0.2	27.1	0.0	0.0	0.0	18.0	28.2	38.2	41.5	44.5	0.1	0.1	0.2	51.4	43.5	0.0	36.5	49.1	55.0	0.3	0.1	45.8	78.7	133.1	112.8	6.9	0.1	0.0	1.5	3.8	3.2	4.4	3.9	4.0	3.2	3.3	3.7	4.9	2.7	3.9	3.5	3.5	3.4	2.4	1.4	3.0	3.2	2.8	2.9	5.5	31.8	2.7	5.5	2.8	3.3	3.2	2.3	3.8	4.6	0.1	48.1	75.8	10.1	58.0	94.1	92.7	37.5	89.4	53.8	0.0	0.0	26.0	10.0	41.2	9.2	41.7	38.3	13.3	5.6	5.9	13.9	275.5	0.0	0.0	56.5	16.0	24.6	19.7	0.2	18.9	63.4	56.1	0.0	92.9	0.0	42.1	9.1	20.1	42.1	15.7	9.3	10.2	64.1	127.5	575.3	38.8	58.2	26.6	5.6	27.8	53.7	26.8	4.0	5.7	5.0	8.8	39.5	54.7	70.8	10.5	13.9	101.2	49.3	19.7	56.2	39.2	67.2	70.1	43.8	80.4	37.8	66.2	0.0	8.1	75.0
DDX50	"GU2, GUB, MGC3199, RH-II/GuB"	ENSG00000107625	"DExD-box helicase 50"	Q9BQ39	10	68901286-68946847	"Enzymes, Plasma proteins, Predicted intracellular proteins"		"Helicase, Hydrolase, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA037388, HPA037389, HPA058196"	Approved		Enhanced	Nucleoli		NA	NA			"Cluster 39: Non-specific - mRNA processing"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 10: Non-specific - Unknown function"	Nucleoli		"HPA037388: AB_10671752, HPA037389: AB_2675450, HPA058196: AB_2683635"	"unprognostic (2.05e-1)"	"unprognostic (3.36e-1)"	"unprognostic (9.90e-2)"	"unprognostic (9.75e-2)"	"unprognostic (1.29e-1)"	"unprognostic (1.23e-1)"	"unprognostic (1.47e-3)"	"unprognostic (2.62e-1)"	"unprognostic (1.97e-1)"	"unprognostic (8.78e-2)"	"unprognostic (4.57e-2)"	"unprognostic (1.44e-1)"	"unprognostic (4.22e-3)"	"unprognostic (1.22e-2)"	"unprognostic (2.38e-2)"	"unprognostic (4.91e-2)"	"unprognostic (1.02e-1)"	21.5	16.9	12.3	19.0	12.4	17.3	25.5	14.6	13.9	24.5	14.2	25.1	13.1	27.3	18.1	19.9	22.5	17.4	18.6	12.5	13.5	19.1	16.3	15.9	27.7	12.1	12.2	30.4	20.9	23.1	21.9	22.1	12.3	19.7	17.9	23.3	15.8	22.5	20.9	17.7	16.3	27.3	12.5	19.7	17.5	25.8	13.3	30.6	25.7	20.7	27.4	23.7	20.0	14.0	48.3	30.6	53.8	67.0	45.4	58.6	33.5	50.2	56.7	45.7	42.5	69.3	41.3	62.4	29.4	45.7	27.9	41.5	53.4	38.0	58.0	54.6	38.5	33.6	30.0	31.0	45.6	71.7	40.5	45.9	38.2	43.7	120.7	79.3	37.3	52.8	60.8	37.5	57.0	39.7	67.6	67.7	31.3	46.7	67.3	58.0	60.6	11.4	35.5	28.7	36.9	50.2	36.5	43.0	57.1	50.2	50.6	45.3	32.0	35.1	40.0	39.5	69.5	49.7	47.6	52.8	37.6	72.8	20.9	9.2	10.6	15.0	18.5	16.7	22.9	16.8	22.8	19.4	14.0	17.1	24.1	21.9	3.4	20.6	13.6	12.4	21.8	15.0	12.3	12.4	14.6	13.9	12.5	13.5	12.1	12.2	12.3	12.5	13.3	14.0	27.8	19.2	21.7	21.2	50.5	11.9	35.4	34.6	36.5	44.2	21.1	23.1	27.4	30.0	31.5	20.2	39.6	40.6	36.0	11.4	56.7	28.7	80.3	25.2	41.6	30.3	16.2	29.5	37.5	25.1	39.3	32.2	22.4	22.8	43.0	30.3	23.2	16.2	23.2	37.0	36.4	19.2	26.4	21.6	9.1	20.0	36.4	21.3	12.4	22.5	41.2	22.7	51.5	28.1	29.5	22.8	14.3	39.1	46.3	30.1	11.1	41.3	26.7	55.1	19.7	35.8	53.5	72.8	58.4	31.7	14.3	41.2	40.8	35.4	21.4	20.7
DENND1C	"FAM31C, FLJ22757"	ENSG00000205744	"DENN domain containing 1C"	Q8IV53	19	6467207-6482557	"Predicted intracellular proteins"		"Guanine-nucleotide releasing factor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"bone marrow: 21.2;intestine: 14.4;lymphoid tissue: 35.1"	"Cell type enhanced"	"Detected in many"		"B-cells: 27.5;dendritic cells: 30.1;granulocytes: 15.9;Hofbauer cells: 14.6;NK-cells: 35.0;T-cells: 34.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in some"		"Daudi: 22.5;HEL: 15.1;HMC-1: 44.7;MOLT-4: 14.7;THP-1: 13.8;U-937: 31.3"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA042758, HPA042839"	Enhanced		Approved	Nucleoplasm,Centrosome,Cytosol		NA	NA			"Cluster 39: Non-specific - mRNA processing"	"Cluster 16: Immune cells - Immune response"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 63: NK-cells & T-cells - Immune response"	Cytosol	"Nucleoplasm, Centrosome"	"HPA042758: AB_10962357, HPA042839: AB_10959898"	"unprognostic (5.94e-2)"	"unprognostic (1.41e-3)"	"unprognostic (4.26e-2)"	"unprognostic (1.93e-3)"	"unprognostic (1.21e-1)"	"unprognostic (1.72e-3)"	"unprognostic (3.91e-2)"	"prognostic favorable (1.23e-4)"	"unprognostic (7.76e-3)"	"unprognostic (4.45e-2)"	"unprognostic (1.89e-2)"	"prognostic unfavorable (8.95e-4)"	"prognostic favorable (7.51e-14)"	"unprognostic (1.37e-3)"	"unprognostic (1.27e-1)"	"unprognostic (4.53e-2)"	"prognostic favorable (5.62e-4)"	2.2	1.0	1.4	21.4	1.3	21.2	1.0	1.5	1.7	0.9	1.5	3.0	4.9	0.9	0.0	1.9	1.3	2.8	1.1	1.4	1.5	1.6	2.1	5.8	32.1	2.4	1.8	0.3	1.3	0.1	0.8	1.8	2.2	1.6	1.2	0.0	3.0	0.5	0.8	1.4	14.4	1.2	1.8	35.1	5.2	0.4	2.8	20.5	1.7	0.3	14.9	3.0	1.3	2.6	0.2	0.2	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.5	0.0	22.5	0.1	0.0	0.1	0.2	0.1	0.3	0.0	0.0	0.0	15.1	0.0	1.6	0.0	7.5	44.7	0.0	0.0	0.1	0.0	0.0	0.0	7.4	0.3	9.4	0.1	0.0	14.7	11.5	0.0	0.5	0.0	1.7	0.0	3.8	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.1	13.8	0.1	0.0	0.0	0.0	0.0	0.4	2.0	10.6	0.1	31.3	0.0	18.3	19.9	32.8	40.1	32.4	35.0	23.8	28.6	35.0	19.5	18.7	35.7	32.1	27.8	23.8	35.0	11.2	35.6	37.1	1.4	1.3	1.5	1.7	1.4	1.5	2.4	1.8	2.2	1.8	2.8	2.6	0.3	3.2	3.0	0.0	27.5	0.4	0.1	0.0	1.2	0.0	0.6	0.6	1.3	2.8	0.0	1.8	0.0	0.2	30.1	0.5	1.9	0.4	0.7	1.5	0.2	0.4	0.0	5.7	0.4	0.0	0.2	0.7	1.5	0.3	15.9	0.5	1.1	0.7	14.6	0.0	0.5	0.9	0.0	11.6	9.2	0.6	0.0	13.8	3.6	2.8	10.9	0.0	35.0	0.0	0.5	0.3	0.4	0.0	13.5	0.2	2.9	6.2	1.6	0.0	0.0	0.0	0.3	0.3	1.2	1.6	0.1	0.3	34.5	0.7	1.0	0.1
DERPC		ENSG00000286140	"DERPC proline and glycine rich nuclear protein"	P0CG12	16	69118010-69132151	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Not detected"	"Not detected"							"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA051872, HPA065522"	Approved		Enhanced	Nucleoplasm		NA	NA			"Cluster 39: Non-specific - mRNA processing"		"Cluster 26: Non-specific - Cell cycle regulation"		Nucleoplasm		"HPA051872: AB_2681647, HPA065522: AB_2685503"																		6.7	10.6	13.3	15.3	12.7	9.3	13.3	12.1	14.2	11.7	13.1	10.2	6.6	8.8	25.9	11.6	16.0	10.8	8.9	12.4	12.4	10.4	10.5	9.0	17.8	13.6	12.5	16.3	10.2	11.7		18.8	12.4	10.2	10.6	9.8	9.5	13.7	2.1	13.2	7.2	11.3	13.2	10.2	6.1	11.0	13.3	17.6	10.0	10.1	18.4	13.0		13.1	15.9	13.1	50.5	39.4	29.0	27.4	24.8	15.3	25.8	54.2	37.6	23.2	50.3	15.8	19.1	27.4	30.5	22.9	62.0	44.9	34.4	7.4	10.8	25.3	8.3	14.4	27.4	16.3	28.7	22.0	41.3	33.1	23.4	35.1	44.2	25.2	25.9	13.1	41.0	11.9	36.5	39.8	51.6	43.8	12.1	65.0	14.6	40.3	35.7	8.6	31.2	28.9	21.8	19.8	38.5	37.3	34.3	69.6	10.9	34.5	20.3	17.2	22.3	9.6	15.3	46.2	31.4	27.6	45.4	2.4	5.3	3.2	2.8	6.0	4.0	2.6	2.7	2.6	5.5	3.1	2.6	3.3	1.3	4.0	6.3	5.1	4.0	4.2	13.3	12.7	12.1	14.2	12.4	12.4	13.6	12.5	12.4	13.2	13.3	13.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
DHX35	"C20orf15, DDX35, FLJ22759, KAIA0875"	ENSG00000101452	"DEAH-box helicase 35"	Q9H5Z1	20	38962299-39039723	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"mRNA processing, mRNA splicing"	"Helicase, Hydrolase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 23.5;Inhibitory neurons: 21.5;Oligodendrocyte precursor cells: 22.6;Oligodendrocytes: 24.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA054451, HPA062700"	Uncertain		Approved	"Nucleoplasm,Nuclear bodies,Centrosome"		No	No			"Cluster 39: Non-specific - mRNA processing"	"Cluster 12: Smooth muscle tissue - Mixed function"	"Cluster 39: CACO-2 - Unknown function"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"	"Nuclear bodies"	"Nucleoplasm, Centrosome"	"HPA054451: AB_2682491, HPA062700: AB_2684838"	"unprognostic (8.31e-2)"	"unprognostic (2.34e-2)"	"unprognostic (5.51e-2)"	"prognostic unfavorable (4.25e-5)"	"unprognostic (1.29e-2)"	"unprognostic (8.38e-2)"	"prognostic unfavorable (5.63e-6)"	"unprognostic (9.83e-2)"	"unprognostic (2.21e-1)"	"unprognostic (6.22e-2)"	"unprognostic (4.47e-2)"	"unprognostic (5.67e-2)"	"unprognostic (8.57e-2)"	"unprognostic (1.88e-2)"	"unprognostic (1.66e-1)"	"unprognostic (1.11e-1)"	"unprognostic (3.31e-1)"	6.6	4.2	4.2	4.5	4.9	9.8	6.0	4.4	5.2	10.1	3.1	16.7	6.2	11.2	8.0	8.1	8.5	5.6	10.2	4.5	3.9	6.0	4.8	5.3	6.7	4.1	4.3	7.9	3.7	7.0	3.8	5.2	4.1	8.1	8.6	6.0	5.1	7.2	8.2	6.9	7.9	8.1	3.8	4.8	8.0	6.6	4.2	6.4	5.1	6.3	5.4	11.9	7.0	5.1	10.3	8.4	15.9	6.6	6.0	7.8	11.3	6.0	10.3	13.5	9.9	29.1	9.0	11.4	10.4	11.4	10.4	16.0	11.0	17.5	13.2	2.9	5.2	15.4	14.3	16.7	7.2	18.4	7.7	9.0	11.3	11.7	10.9	8.3	6.1	19.4	16.0	6.5	7.2	8.2	30.0	14.0	9.1	18.5	13.5	14.5	23.2	9.5	5.0	11.8	13.9	11.1	16.4	9.6	15.4	9.9	13.3	14.7	6.0	19.1	10.6	7.8	12.6	6.5	9.2	12.3	10.9	8.2	10.4	0.0	3.0	1.2	2.9	2.7	2.9	2.5	2.4	3.1	4.0	2.9	4.5	2.4	0.6	3.9	2.4	1.4	1.7	2.9	4.2	4.9	4.4	5.2	4.5	3.9	4.1	4.3	4.1	3.8	4.2	5.1	5.4	0.0	3.7	16.0	3.8	0.5	1.4	2.2	7.4	5.1	2.3	3.0	6.7	4.3	4.8	1.8	4.2	3.7	4.1	4.2	1.9	2.4	3.7	2.5	6.6	3.8	5.4	5.5	23.5	1.1	2.4	3.8	7.7	3.2	8.2	6.1	5.7	7.0	5.0	5.0	21.5	6.3	4.1	4.7	4.0	0.8	6.2	3.3	3.6	14.0	3.6	3.3	6.2	22.6	24.8	2.0	5.8	6.4	4.9	2.7	4.6	2.2	4.3	4.7	0.0	4.7	3.9	1.9	9.4	4.5	2.0	3.0	4.5	4.9	5.4	1.1
DHX37	"DDX37, Dhr1, KIAA1517, MGC2695, MGC4322"	ENSG00000150990	"DEAH-box helicase 37"	Q8IY37	12	124946825-124989131	"Disease related genes, Enzymes, Human disease related genes, Potential drug targets, Predicted intracellular proteins"		"Helicase, Hydrolase"	"Disease variant, Mental retardation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA047607	Approved		Approved	"Nuclear membrane"		NA	NA			"Cluster 39: Non-specific - mRNA processing"	"Cluster 50: Non-specific - Ribosome"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 39: Non-specific - Basic cellular processes"	"Nuclear membrane"		"HPA047607: AB_2680101"	"unprognostic (1.83e-1)"	"unprognostic (1.12e-1)"	"unprognostic (3.10e-1)"	"unprognostic (1.32e-1)"	"unprognostic (1.27e-1)"	"unprognostic (2.11e-1)"	"prognostic unfavorable (9.54e-10)"	"unprognostic (2.38e-2)"	"unprognostic (5.14e-2)"	"unprognostic (2.90e-2)"	"unprognostic (2.07e-1)"	"unprognostic (3.16e-2)"	"unprognostic (8.28e-3)"	"unprognostic (1.40e-2)"	"unprognostic (2.27e-1)"	"unprognostic (2.85e-2)"	"unprognostic (2.73e-1)"	4.3	3.2	2.9	6.8	3.4	8.8	3.6	3.0	3.6	3.5	1.4	3.4	4.4	3.8	1.3	4.7	3.4	2.8	3.6	2.9	2.5	3.3	3.0	2.8	7.4	4.1	3.6	4.5	6.6	2.6	1.6	2.9	3.4	3.3	1.6	0.5	4.3	2.6	10.8	4.0	3.8	2.5	3.0	5.2	3.9	2.6	3.2	4.6	3.2	4.9	3.9	5.0	3.6	4.3	17.3	45.5	5.2	21.9	6.7	6.6	27.4	13.8	7.3	19.5	11.6	44.7	9.4	37.5	24.6	11.4	19.7	21.9	19.8	15.6	4.5	32.7	38.2	23.0	13.8	23.7	13.4	27.7	30.5	8.8	10.8	24.3	4.0	7.2	10.0	17.4	44.4	7.5	7.5	23.9	29.5	28.5	39.2	15.1	36.4	31.4	11.0	21.5	8.6	22.6	17.6	11.1	14.0	16.3	16.0	5.1	19.3	19.5	13.1	16.1	20.2	20.0	27.6	31.6	33.2	44.0	15.1	22.2	27.2	0.0	1.5	0.0	1.6	1.7	1.4	1.8	1.3	1.6	1.4	1.4	0.9	1.4	0.0	0.9	0.8	1.1	0.7	1.4	2.9	3.4	3.0	3.6	2.9	2.5	4.1	3.6	3.4	3.0	3.2	4.3	5.5	3.2	5.2	3.3	10.3	4.2	3.4	2.8	4.0	3.5	6.2	5.3	3.8	2.8	4.1	0.0	0.0	4.1	6.7	8.8	3.9	4.8	1.7	5.3	9.6	5.7	9.0	5.0	3.0	6.2	6.0	4.8	8.2	7.8	6.3	9.3	2.2	6.2	5.4	13.5	2.0	7.1	6.1	7.2	2.5	2.0	5.3	4.9	0.0	1.9	6.6	2.2	6.2	3.0	4.0	9.0	2.2	2.6	9.2	4.9	2.8	4.7	4.1	2.1	6.6	7.1	3.8	1.5	5.6	8.0	4.0	2.9	7.7	5.9	9.3	4.0
DNAJC30	WBSCR18	ENSG00000176410	"DnaJ heat shock protein family (Hsp40) member C30"	Q96LL9	7	73680918-73683453	"Disease related genes, Human disease related genes, Predicted membrane proteins"	"ATP synthesis"	Chaperone	"Williams-Beuren syndrome"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Early spermatids: 120.1;Late spermatids: 230.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							HPA017318		Supported				NA	NA			"Cluster 39: Non-specific - mRNA processing"	"Cluster 35: Non-specific - Unknown function"	"Cluster 8: SK-BR-3 - Unknown function"	"Cluster 39: Non-specific - Basic cellular processes"			"HPA017318: AB_1858788"	"unprognostic (1.86e-2)"	"unprognostic (1.85e-1)"	"unprognostic (2.16e-1)"	"unprognostic (2.66e-1)"	"prognostic unfavorable (1.12e-4)"	"unprognostic (5.37e-2)"	"unprognostic (1.50e-1)"	"unprognostic (2.66e-2)"	"unprognostic (4.53e-1)"	"unprognostic (3.93e-2)"	"unprognostic (2.85e-3)"	"unprognostic (4.60e-2)"	"prognostic favorable (4.91e-8)"	"unprognostic (1.19e-1)"	"unprognostic (1.82e-1)"	"unprognostic (2.51e-1)"	"unprognostic (1.20e-2)"	6.4	14.7	7.2	3.1	7.9	2.9	6.3	7.1	8.3	5.5	5.5	6.0	3.8	7.1	4.6	5.4	6.4	2.0	11.3	7.9	7.1	9.7	11.9	3.9	3.5	7.0	6.9	6.2	7.9	6.6	10.5	2.7	7.2	6.6	3.2	3.8	6.1	4.7	9.3	5.0	5.2	2.9	5.1	6.0	6.3	12.5	6.9	3.7	8.7	4.8	2.9	6.2	4.4	7.2	6.5	6.3	4.6	9.2	7.0	4.9	4.8	10.0	7.3	7.6	7.4	6.1	6.6	5.7	2.5	8.0	11.2	9.0	4.1	5.6	4.3	6.7	8.4	3.3	6.0	6.5	7.2	5.6	4.5	5.5	4.6	6.9	5.9	5.3	6.6	7.3	6.8	5.0	7.5	13.0	9.1	11.3	3.9	6.0	10.6	6.2	3.6	14.1	9.9	7.5	12.3	6.6	10.2	17.7	7.9	4.6	16.1	3.7	6.5	8.0	5.8	8.4	7.2	5.3	3.9	5.4	6.4	3.8	10.0	5.4	6.2	3.9	6.3	5.7	7.7	7.4	7.7	7.6	6.0	9.8	9.1	7.8	0.8	6.0	4.4	6.3	5.6	5.2	7.2	7.9	7.1	8.3	7.9	7.1	7.0	6.9	7.2	5.1	6.9	7.2	10.0	19.2	6.2	2.3	14.7	5.9	16.6	19.9	12.5	34.9	13.9	11.9	19.7	14.3	15.8	18.4	14.6	43.6	18.6	7.2	56.7	30.2	120.1	15.9	13.3	10.6	17.4	6.9	5.6	28.0	16.2	13.9	16.3	11.3	12.7	20.8	15.0	25.3	22.3	20.2	6.1	12.8	12.2	13.2	5.3	230.1	24.5	9.3	14.2	2.8	26.9	24.6	32.0	2.5	8.9	19.2	8.4	18.4	9.4	13.3	15.4	81.8	10.0	29.5	19.7	12.6	12.4	69.6	16.5	16.9	8.2	36.0	11.2	56.0	17.1	12.6
DOP1A	"dJ202D23.2, DOPEY1, KIAA1117"	ENSG00000083097	"DOP1 leucine zipper like protein A"	Q5JWR5	6	83067666-83171350	"Predicted intracellular proteins, Predicted membrane proteins"	"Protein transport, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"Adipocytes: 5.7;Cardiomyocytes: 9.8;Cytotrophoblasts: 4.8;dendritic cells: 5.9;Hofbauer cells: 4.1;Plasma cells: 3.8;Syncytiotrophoblasts: 3.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in single"			"Low lineage specificity"	"Detected in single"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA027902, HPA027904"	Approved		Approved	Nucleoplasm,Vesicles		NA	NA			"Cluster 39: Non-specific - mRNA processing"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 24: Non-specific - Transcription regulation"	Nucleoplasm	Vesicles	"HPA027902: AB_10600003, HPA027904: AB_10600877"	"unprognostic (7.18e-2)"	"unprognostic (3.91e-1)"	"unprognostic (6.11e-2)"	"unprognostic (6.05e-3)"	"unprognostic (8.21e-3)"	"unprognostic (1.36e-2)"	"unprognostic (3.32e-1)"	"unprognostic (1.02e-2)"	"unprognostic (2.84e-1)"	"unprognostic (2.47e-1)"	"prognostic favorable (7.36e-4)"	"unprognostic (2.13e-1)"	"unprognostic (1.20e-1)"	"unprognostic (1.45e-1)"	"unprognostic (1.12e-1)"	"unprognostic (1.32e-1)"	"unprognostic (1.17e-1)"	5.2	4.9	5.0	6.2	5.7	4.9	10.9	8.7	6.4	8.9	3.5	8.0	7.9	10.4	7.4	7.1	9.4	7.2	9.0	5.1	4.2	6.9	6.2	6.8	7.2	3.8	3.7	13.8	9.1	11.6	7.7	6.0	3.7	9.6	8.8	24.0	9.5	10.7	6.3	13.6	8.9	7.5	5.0	8.2	7.2	12.7	4.1	10.6	13.6	9.4	7.5	6.2	5.0	11.0	4.2	3.0	9.8	8.9	8.7	9.1	4.6	7.0	5.9	4.7	6.8	6.4	1.0	8.2	4.9	7.7	5.9	5.5	10.0	7.6	5.9	7.2	11.3	6.8	4.2	2.4	4.7	10.1	6.9	7.3	10.4	6.6	17.0	6.2	7.0	12.6	14.4	5.9	5.1	3.9	3.0	4.5	2.0	3.1	6.1	8.2	7.4	3.0	6.1	11.7	17.6	3.2	5.2	3.3	1.3	7.0	5.3	5.7	11.8	5.9	2.1	6.0	5.5	7.3	5.7	4.6	3.2	4.6	4.7	0.0	0.3	0.4	0.5	0.4	0.4	0.6	0.4	1.1	0.7	0.4	0.8	0.4	0.0	0.4	0.3	0.3	0.4	0.4	5.0	5.7	8.7	6.4	5.1	4.2	3.8	3.7	3.7	5.0	4.1	11.0	5.7	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.8	0.0	0.0	0.0	0.0	4.8	5.9	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.0	1.1	2.3	0.0	0.0	0.0	0.0	0.0	0.0	4.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.4	0.0	0.0	0.0	0.0	3.4	0.8	0.0	0.0	0.0
DPH1	"DPH2L, DPH2L1, OVCA1"	ENSG00000108963	"Diphthamide biosynthesis 1"	Q9BZG8	17	2030137-2043898	"Disease related genes, Enzymes, Human disease related genes, Potential drug targets, Predicted intracellular proteins"		Transferase	"Disease variant, Dwarfism, Ectodermal dysplasia, Hypotrichosis, Mental retardation, Tumor suppressor"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Basal squamous epithelial cells: 19.4;Gastric mucus-secreting cells: 21.4;Plasma cells: 12.0;Squamous epithelial cells: 13.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA069750, HPA073864"	Approved		Approved	"Nucleoplasm,Cell Junctions"		NA	NA			"Cluster 39: Non-specific - mRNA processing"	"Cluster 72: Non-specific - Transcription"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 59: Non-specific - Transcription"	Nucleoplasm	"Cell Junctions"	"HPA069750: AB_2686188, HPA073864: "	"unprognostic (5.54e-2)"	"unprognostic (1.99e-1)"	"unprognostic (1.62e-1)"	"unprognostic (1.86e-2)"	"unprognostic (1.50e-2)"	"unprognostic (1.46e-1)"	"unprognostic (2.21e-1)"	"unprognostic (1.10e-1)"	"unprognostic (3.93e-2)"	"unprognostic (2.30e-1)"	"prognostic favorable (1.78e-5)"	"unprognostic (2.74e-3)"	"unprognostic (2.10e-2)"	"unprognostic (1.03e-1)"	"unprognostic (3.40e-1)"	"unprognostic (7.30e-2)"	"unprognostic (1.41e-1)"	24.5	32.3	13.1	6.0	12.8	5.3	22.2	16.8	17.7	29.1	10.7	26.8	8.0	28.8	5.6	19.8	31.0	9.1	19.2	13.7	11.9	28.0	36.3	16.6	7.5	10.3	10.9	26.6	32.0	14.2	59.3	8.5	10.3	36.2	6.2	12.4	23.7	11.0	42.3	29.3	20.8	8.9	10.1	24.3	27.0	20.3	11.7	6.7	28.6	13.7	6.0	24.2	22.3	11.5	15.4	24.9	6.3	16.0	22.2	14.2	18.7	19.3	26.8	29.7	18.7	24.1	11.6	29.0	23.6	52.5	11.2	11.6	20.7	21.1	15.9	9.0	52.4	6.3	10.5	13.1	19.4	8.3	10.2	20.3	20.3	22.7	19.0	20.5	13.9	16.8	23.4	11.2	11.9	18.2	14.7	4.8	6.5	17.3	25.9	16.6	5.7	22.0	13.3	8.0	13.1	15.2	17.4	17.9	17.2	6.9	25.9	6.8	10.1	19.4	10.1	26.2	16.7	10.3	8.3	6.8	20.3	10.8	8.5	0.8	4.5	0.8	8.0	6.1	8.9	8.8	6.5	7.4	7.7	7.2	9.6	6.9	0.3	6.7	4.5	5.5	10.2	5.2	13.1	12.8	16.8	17.7	13.7	11.9	10.3	10.9	10.3	10.1	11.7	11.5	0.9	3.2	9.2	1.3	9.3	0.4	0.9	0.5	19.4	2.1	0.8	0.8	1.5	0.0	2.7	0.0	2.1	1.4	0.9	0.6	0.0	0.5	1.2	1.5	1.2	1.7	0.0	9.0	4.0	0.6	0.9	4.5	21.4	0.8	2.5	1.0	0.7	0.0	0.6	1.7	3.7	0.8	0.0	0.0	0.8	1.5	0.6	3.9	0.0	1.0	0.4	0.9	2.1	1.5	1.4	0.0	0.2	0.4	12.0	0.5	0.5	0.5	3.0	2.8	0.0	1.3	3.2	1.2	0.5	13.0	0.3	1.4	5.4	1.3	0.4	0.6
DPM1	"CDGIE, MPDS"	ENSG00000000419	"Dolichyl-phosphate mannosyltransferase subunit 1, catalytic"	O60762	20	50934867-50958555	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"		"Glycosyltransferase, Transferase"	"Congenital disorder of glycosylation, Congenital muscular dystrophy, Disease variant, Dystroglycanopathy"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA051818	Approved					NA	NA			"Cluster 39: Non-specific - mRNA processing"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 39: CACO-2 - Unknown function"	"Cluster 26: Respiratory epithelial cells - Mucosal defense"			"HPA051818: AB_2681624"	"unprognostic (2.21e-2)"	"unprognostic (4.94e-2)"	"unprognostic (1.16e-1)"	"unprognostic (4.24e-3)"	"unprognostic (1.65e-1)"	"unprognostic (3.27e-2)"	"prognostic unfavorable (1.94e-6)"	"unprognostic (1.10e-1)"	"unprognostic (7.49e-2)"	"unprognostic (2.53e-2)"	"unprognostic (1.29e-2)"	"unprognostic (3.61e-2)"	"unprognostic (3.02e-3)"	"unprognostic (4.98e-2)"	"unprognostic (2.59e-1)"	"unprognostic (3.58e-1)"	"unprognostic (2.74e-1)"	40.9	53.4	23.0	34.3	23.9	59.3	42.7	24.4	31.9	31.5	26.1	38.6	36.9	39.4	47.6	45.3	32.6	36.1	60.6	24.4	24.5	47.0	63.1	29.7	56.0	23.3	22.8	38.7	48.6	43.0	25.4	45.1	23.5	34.3	42.7	27.2	38.5	31.0	57.3	34.6	39.0	37.4	23.8	37.1	38.1	39.7	23.1	43.9	48.4	55.2	53.6	51.6	33.3	27.6	139.9	55.4	83.6	50.5	72.1	80.8	92.1	52.6	62.1	102.9	80.7	252.1	110.2	84.1	112.9	71.1	141.9	156.2	68.5	129.0	103.9	40.7	53.9	87.7	69.5	171.2	101.6	141.4	50.5	70.0	187.0	71.5	73.7	66.4	80.1	89.0	135.3	104.2	103.3	61.3	127.6	148.9	85.3	131.8	124.8	69.7	120.7	112.6	102.6	83.4	62.5	68.5	135.8	203.8	189.1	64.2	138.8	164.5	66.1	130.8	109.2	76.6	112.6	74.2	99.7	122.0	143.7	92.4	60.4	13.5	16.3	17.6	16.4	18.5	20.0	17.9	18.6	17.9	20.3	16.1	20.0	22.4	20.0	19.1	18.6	21.7	19.5	16.1	23.0	23.9	24.4	31.9	24.4	24.5	23.3	22.8	23.5	23.8	23.1	27.6	36.8	19.2	42.3	27.1	37.3	116.5	143.4	248.4	29.0	11.7	37.1	24.9	48.8	35.8	119.5	31.3	2.1	153.1	46.4	31.7	117.4	75.9	207.8	49.3	38.0	53.0	23.4	30.7	35.6	73.8	104.9	53.7	18.8	57.5	74.3	25.1	49.2	67.9	87.9	5.0	31.0	52.5	144.5	42.0	58.4	43.8	56.8	36.7	49.8	18.7	65.8	27.3	43.3	20.1	34.2	70.5	50.2	51.6	33.2	73.7	40.7	96.4	135.7	12.6	72.3	50.4	71.5	109.9	103.6	32.0	105.6	245.4	47.8	36.5	55.3	125.9
DUSP7	"MKP-X, PYST2"	ENSG00000164086	"Dual specificity phosphatase 7"	Q16829	3	52048919-52056571	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		"Hydrolase, Protein phosphatase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Basal keratinocytes: 117.3;Squamous epithelial cells: 51.6;Suprabasal keratinocytes: 135.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in all"		"hTCEpi: 109.8;hTERT-HME1: 92.6"	"Low region specificity"	"Detected in all"							HPA073007	Approved					NA	NA			"Cluster 39: Non-specific - mRNA processing"	"Cluster 27: Brain & Skin - Unknown function"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 28: Keratinocytes - Keratinization"			"HPA073007: "	"unprognostic (1.19e-1)"	"unprognostic (1.89e-1)"	"unprognostic (1.66e-1)"	"unprognostic (1.04e-1)"	"unprognostic (1.88e-1)"	"unprognostic (6.16e-3)"	"unprognostic (2.32e-2)"	"unprognostic (2.75e-1)"	"unprognostic (1.44e-1)"	"unprognostic (8.67e-3)"	"unprognostic (7.38e-3)"	"unprognostic (7.74e-3)"	"prognostic unfavorable (8.84e-6)"	"unprognostic (4.86e-2)"	"unprognostic (1.24e-1)"	"unprognostic (2.29e-2)"	"unprognostic (9.46e-2)"	13.1	10.0	23.3	7.6	28.4	3.6	11.5	19.5	27.5	27.0	7.5	8.4	4.1	14.6	3.9	64.1	10.1	8.7	22.2	24.2	21.2	10.6	5.2	24.9	10.2	25.8	27.2	8.7	7.0	6.2	7.2	14.1	22.3	11.5	3.8	2.6	13.2	7.9	23.1	65.6	7.9	6.7	19.5	26.2	9.1	12.0	27.2	8.1	9.1	20.5	10.8	13.5	45.5	38.4	21.3	4.4	5.2	11.9	16.4	14.1	6.2	21.0	39.8	20.4	14.7	5.8	10.6	5.8	5.7	31.3	10.3	24.6	19.8	76.0	13.8	5.0	8.1	27.8	10.9	10.3	13.3	25.1	16.2	14.8	109.8	26.5	92.6	14.1	19.8	16.8	16.2	16.4	16.5	5.9	18.7	35.2	12.9	5.9	37.6	15.5	4.5	15.6	8.5	9.1	6.5	19.0	9.4	8.5	14.9	4.2	3.0	59.4	26.0	39.1	25.3	41.7	65.4	7.9	7.9	9.3	21.7	41.5	12.7	0.9	3.4	1.7	5.3	10.3	7.2	0.9	6.3	3.8	4.7	0.5	4.5	4.1	1.3	2.5	10.3	7.1	4.5	1.7	23.3	28.4	19.5	27.5	24.2	21.2	25.8	27.2	22.3	19.5	27.2	38.4	17.0	9.6	1.1	0.0	2.9	117.3	31.5	13.5	21.1	4.9	6.6	7.2	18.9	0.0	5.2	0.0	0.0	0.6	13.4	1.6	1.9	3.1	1.7	2.9	8.1	18.7	2.4	1.7	5.5	2.6	4.3	7.8	0.5	2.8	0.0	1.3	23.6	0.9	8.1	0.0	4.4	2.5	0.0	16.7	12.0	0.5	8.7	9.0	21.4	5.6	10.3	0.9	9.2	5.5	20.2	12.1	1.3	4.9	1.6	17.5	0.6	1.3	1.5	1.0	26.3	3.3	8.6	3.5	5.5	51.6	135.2	1.2	7.3	4.1	3.4	29.3
EDA	"ED1, ED1-A1, ED1-A2, EDA-A1, EDA-A2, EDA1, EDA2, HED, ODT1, XHED, XLHED"	ENSG00000158813	"Ectodysplasin A"	Q92838	X	69616067-70039472	"Disease related genes, Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins"	Differentiation	"Developmental protein"	"Disease variant, Ectodermal dysplasia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Microglial cells: 84.3;Oligodendrocyte precursor cells: 30.2;Oligodendrocytes: 45.9"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"intermediate monocyte: 1.2;MAIT T-cell: 1.3"	"Group enriched"	"Detected in many"	5	"monocytes: 1.2;T-cells: 1.3"	"Cell line enhanced"	"Detected in many"		"EFO-21: 5.2;Hep G2: 17.9;OE19: 5.1;RPMI-8226: 6.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in some"			"HPA037972, HPA037973"			Supported	"Vesicles,Lipid droplets"	"Secreted - unknown location"	NA	NA			"Cluster 39: Non-specific - mRNA processing"	"Cluster 89: Fibroblasts - ECM organization"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 50: Fibroblasts - ECM organization"	Vesicles	"Lipid droplets"	"HPA037972: AB_2675761, HPA037973: AB_2675762"	"unprognostic (3.76e-2)"	"unprognostic (8.29e-2)"	"unprognostic (1.59e-1)"	"unprognostic (3.59e-3)"	"unprognostic (7.85e-2)"	"unprognostic (1.25e-4)"	"unprognostic (4.33e-4)"	"unprognostic (5.03e-2)"	"unprognostic (1.53e-1)"	"unprognostic (1.12e-1)"	"unprognostic (1.02e-2)"	"unprognostic (2.01e-1)"	"prognostic favorable (1.04e-9)"	"unprognostic (8.63e-4)"	"unprognostic (7.64e-2)"	"unprognostic (9.85e-2)"	"unprognostic (2.79e-1)"	4.2	8.5	2.4	0.7	3.0	0.1	2.8	2.2	2.6	4.9	5.2	2.6	0.5	3.0	3.2	1.5	3.8	2.0	10.4	2.1	2.4	3.7	2.1	3.2	0.8	3.2	2.8	4.9	4.2	9.7	1.3	1.8	3.0	3.4	1.1	0.3	2.2	2.2	1.7	4.2	1.1	2.1	2.3	1.4	3.8	1.2	3.1	1.2	6.0	2.0	0.6	2.3	3.9	4.6	0.0	0.6	0.3	2.8	0.5	0.0	0.2	0.0	0.1	0.0	0.0	1.3	0.1	0.3	5.2	0.2	0.2	0.5	3.8	1.4	0.0	0.0	4.5	0.0	0.0	17.9	1.0	0.0	1.1	1.8	1.3	0.0	0.9	0.0	0.5	3.5	0.0	4.9	0.0	1.2	0.0	0.0	2.8	5.1	0.3	0.0	1.2	6.0	0.1	0.0	1.5	0.0	0.1	0.3	0.1	2.0	0.3	0.1	0.5	1.7	2.2	2.3	0.0	0.0	0.2	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	1.2	1.3	0.0	0.6	0.2	0.0	0.0	0.3	0.0	0.0	0.2	0.8	0.0	0.0	0.1	2.4	3.0	2.2	2.6	2.1	2.4	3.2	2.8	3.0	2.3	3.1	4.6	3.3	3.2	0.5	21.2	0.3	3.8	2.6	2.0	6.8	0.2	0.9	1.5	12.1	0.0	1.1	5.5	0.0	0.2	0.1	1.0	0.0	1.3	21.3	4.6	1.2	2.2	1.8	0.0	17.9	1.3	0.2	6.0	5.6	12.2	0.0	0.5	11.0	1.2	4.1	0.0	9.6	0.6	0.0	4.8	1.2	9.2	4.7	2.8	1.8	84.3	0.1	1.3	0.0	30.2	45.9	1.1	0.1	2.2	0.2	2.3	0.4	3.1	1.3	0.1	6.6	10.7	5.4	1.7	3.5	3.2	4.1	0.0	2.1	0.4	0.9	1.5
EEFSEC	"EFSEC, SELB"	ENSG00000132394	"Eukaryotic elongation factor, selenocysteine-tRNA specific"	P57772	3	128153481-128408646	"Predicted intracellular proteins"	"Protein biosynthesis"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Late spermatids: 71.6"	"Low cancer specificity"	"Detected in all"			"Not detected"	"Not detected"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in some"		"Daudi: 15.2;GAMG: 12.3;MOLT-4: 7.9;SH-SY5Y: 10.4;SK-BR-3: 17.7;SK-MEL-30: 15.4;T-47d: 9.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA035795	Approved		Approved	"Nucleoplasm,Nuclear bodies,Cytosol"		NA	NA			"Cluster 39: Non-specific - mRNA processing"	"Cluster 72: Non-specific - Transcription"	"Cluster 8: SK-BR-3 - Unknown function"	"Cluster 25: Spermatids - Spermatogenesis"	"Nucleoplasm, Nuclear bodies"	Cytosol	"HPA035795: AB_10696512"	"unprognostic (1.01e-1)"	"prognostic favorable (2.98e-5)"	"unprognostic (2.53e-1)"	"unprognostic (1.32e-3)"	"unprognostic (1.12e-1)"	"unprognostic (3.03e-1)"	"unprognostic (4.37e-3)"	"unprognostic (6.06e-2)"	"unprognostic (6.78e-3)"	"unprognostic (2.84e-1)"	"unprognostic (1.61e-2)"	"unprognostic (3.83e-2)"	"unprognostic (1.12e-2)"	"unprognostic (4.31e-2)"	"unprognostic (1.99e-1)"	"unprognostic (1.70e-1)"	"unprognostic (4.11e-2)"	13.5	8.2	0.2	0.2	0.2	0.1	12.5	0.2	0.6	14.2	0.1	11.3	0.0	15.6	0.0	12.3	13.9	0.1	25.5	0.2	0.3	14.3	21.8	9.6	2.2	0.4	0.2	12.3	11.7	3.0	8.8	1.6	0.3	12.1	0.6	0.5	9.7	1.9	24.0	16.5	10.7	0.0	0.2	13.4	11.0	19.3	0.4	0.1	9.9	0.0	1.2	12.7	12.3	0.2	0.5	0.1	4.1	1.7	0.1	0.2	0.5	0.0	0.3	0.2	0.2	0.3	6.9	15.2	0.1	3.8	12.3	1.1	0.4	0.1	0.1	0.3	0.3	0.0	0.1	0.1	5.7	0.3	0.3	0.1	0.1	4.0	0.1	0.2	0.3	0.0	0.1	0.2	3.5	0.2	7.9	0.4	0.4	0.1	0.1	0.3	0.2	1.0	0.0	0.0	0.3	10.4	0.0	17.7	15.4	0.3	9.6	0.7	0.0	0.1	0.0	0.2	0.2	0.4	0.7	0.4	0.1	0.4	0.2	0.4	6.3	6.1	5.0	6.0	3.9	5.4	4.4	4.4	8.7	3.9	4.0	5.0	0.0	7.5	4.8	3.7	5.7	4.3	0.2	0.2	0.2	0.6	0.2	0.3	0.4	0.2	0.3	0.2	0.4	0.2	9.4	0.0	6.0	15.0	17.2	6.4	9.3	9.1	7.4	7.8	6.9	8.6	10.1	8.6	4.4	16.5	2.1	22.3	15.7	6.4	15.6	7.9	27.7	3.1	12.5	8.2	11.4	5.9	25.3	7.1	18.3	10.0	10.2	4.5	28.5	10.0	8.9	14.8	14.6	13.5	36.6	11.7	18.3	7.9	8.2	71.6	13.1	11.4	12.4	28.1	9.8	9.3	17.5	45.8	27.1	5.6	2.7	8.6	17.1	9.4	8.6	25.7	2.7	8.2	26.3	9.0	9.1	27.9	16.9	10.8	9.9	29.7	13.7	11.9	10.6	6.0
EIF3E	"eIF3-p48, EIF3S6, INT6"	ENSG00000104408	"Eukaryotic translation initiation factor 3 subunit E"	P60228	8	108162787-108443496	"Cancer-related genes, Predicted intracellular proteins, Predicted membrane proteins"	"Protein biosynthesis"	"Initiation factor"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA023973	Approved		Supported	Cytosol		NA	NA		21000	"Cluster 39: Non-specific - mRNA processing"	"Cluster 50: Non-specific - Ribosome"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 32: Non-specific - Translation"	Cytosol		"HPA023973: AB_1848083"	"unprognostic (8.18e-2)"	"unprognostic (4.28e-2)"	"unprognostic (6.26e-2)"	"unprognostic (1.51e-1)"	"unprognostic (3.52e-3)"	"unprognostic (6.93e-3)"	"unprognostic (2.29e-2)"	"unprognostic (2.57e-2)"	"unprognostic (3.47e-1)"	"unprognostic (1.96e-1)"	"unprognostic (1.67e-3)"	"unprognostic (3.63e-1)"	"prognostic unfavorable (3.06e-7)"	"unprognostic (2.46e-1)"	"unprognostic (1.60e-1)"	"unprognostic (1.81e-1)"	"unprognostic (2.77e-2)"	269.0	201.4	104.7	94.2	107.2	251.7	418.1	113.6	178.1	360.4	110.9	281.2	93.5	232.5	243.3	256.3	263.0	163.5	187.7	104.6	110.0	178.0	199.1	174.2	231.1	107.7	108.9	449.4	409.1	138.5	157.2	161.1	111.2	204.8	155.7	63.6	214.1	186.4	343.2	230.9	181.7	135.6	107.3	157.6	237.0	83.9	107.6	283.0	183.9	241.1	208.9	248.7	267.2	112.7	339.4	208.1	211.3	193.3	518.2	1098.8	139.9	193.0	430.3	415.4	443.0	238.0	260.1	653.0	213.0	288.6	134.2	187.6	421.1	507.6	502.6	216.1	485.0	595.8	218.6	472.3	357.6	287.5	169.0	813.2	745.9	272.8	678.6	534.7	636.8	405.6	477.5	196.8	469.6	453.7	384.2	898.4	196.2	577.7	403.6	300.6	278.8	436.6	520.0	305.2	223.5	192.2	122.0	78.0	363.2	288.2	263.8	413.7	279.1	131.7	241.7	139.9	201.9	167.4	171.6	426.5	171.6	483.1	149.8	79.5	165.6	32.6	104.0	161.0	197.1	214.7	205.5	148.4	218.7	178.0	301.0	225.9	14.6	166.8	153.1	116.6	202.5	317.3	104.7	107.2	113.6	178.1	104.6	110.0	107.7	108.9	111.2	107.3	107.6	112.7	216.8	134.6	204.6	36.9	565.3	1036.0	1105.8	1174.4	805.3	64.5	569.8	274.2	93.1	317.4	463.5	158.2	54.2	614.4	288.0	101.3	606.5	332.3	377.4	173.8	399.2	365.6	297.5	319.8	36.3	354.3	770.9	366.9	196.7	220.5	378.3	277.1	403.4	212.6	424.2	58.9	36.2	400.5	443.5	662.4	875.2	73.8	454.2	368.7	517.6	37.5	621.8	154.8	268.8	59.8	69.2	272.3	279.1	327.6	251.0	728.2	273.8	799.7	201.7	74.6	190.7	434.6	564.5	276.7	102.8	532.6	1117.1	620.3	488.1	490.0	568.6	914.3
ELK1		ENSG00000126767	"ETS transcription factor ELK1"	P19419	X	47635521-47650604	"Predicted intracellular proteins, RAS pathway related proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enriched"	"Detected in many"	5	"Granulosa cells: 251.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"CAB003808, HPA036084, HPA064381"	Enhanced		Enhanced	Nucleoplasm		NA	NA			"Cluster 39: Non-specific - mRNA processing"	"Cluster 10: Brain - Neuronal signaling"	"Cluster 16: U-266 - Nucleosome"	"Cluster 40: Granulosa cells - Unknown function"	Nucleoplasm		"CAB003808: AB_562282, HPA036084: AB_2674931, HPA064381: AB_2685250"	"unprognostic (2.25e-1)"	"unprognostic (1.83e-2)"	"unprognostic (4.77e-2)"	"unprognostic (1.40e-2)"	"unprognostic (2.31e-1)"	"unprognostic (2.73e-1)"	"unprognostic (1.16e-2)"	"unprognostic (1.69e-1)"	"unprognostic (1.47e-1)"	"unprognostic (2.59e-3)"	"unprognostic (1.17e-1)"	"unprognostic (8.39e-2)"	"prognostic unfavorable (3.25e-5)"	"unprognostic (1.02e-1)"	"unprognostic (2.03e-1)"	"unprognostic (1.79e-2)"	"unprognostic (1.67e-2)"	16.8	30.7	71.7	12.4	53.1	13.7	12.0	37.1	62.5	15.0	19.9	12.8	9.0	17.0	17.4	15.0	18.6	10.1	19.3	58.5	32.8	12.6	26.4	16.2	12.3	26.7	26.2	54.2	12.9	17.0	12.7	9.2	27.5	15.4	9.6	7.7	13.1	11.2	32.9	15.2	12.9	10.9	23.4	18.9	13.6	21.2	52.2	12.9	10.5	18.5	12.3	14.8	11.9	40.6	35.6	27.2	14.3	39.1	23.3	26.5	19.8	31.1	34.9	34.8	34.5	19.3	26.4	29.0	16.1	31.0	59.9	21.2	37.6	31.7	31.5	31.1	34.8	23.4	25.0	17.9	49.3	26.3	39.4	27.9	27.2	53.4	33.5	28.8	20.8	40.4	47.9	32.9	27.8	46.5	28.2	30.8	33.7	16.7	59.1	30.0	36.0	45.8	19.7	15.3	31.0	25.6	48.5	17.8	43.4	31.8	44.7	16.7	16.1	39.5	41.2	53.9	29.2	53.5	83.2	27.8	44.5	45.3	25.0	1.7	6.3	2.8	5.3	7.2	6.4	5.2	6.8	6.3	9.5	4.6	5.7	5.0	3.1	3.4	6.5	6.5	9.8	5.6	71.7	53.1	37.1	62.5	58.5	32.8	26.7	26.2	27.5	23.4	52.2	40.6	10.1	0.0	6.7	4.2	12.0	16.8	14.3	7.5	15.9	15.2	15.0	10.4	9.0	5.7	5.3	7.3	4.2	7.7	6.3	7.5	5.9	7.6	4.0	8.0	13.3	9.8	10.2	14.9	7.7	7.3	9.6	18.0	6.6	9.2	8.2	251.8	20.3	14.6	10.3	5.0	5.7	7.8	4.1	9.5	19.0	3.3	14.0	15.0	7.2	2.8	16.8	9.0	6.2	5.0	2.9	7.1	5.6	29.7	10.3	12.8	4.6	6.3	2.1	7.2	6.6	18.7	20.0	2.6	11.1	12.3	15.9	8.9	11.1	48.8	10.0	11.8
ENO1	"ENO1L1, MBP-1, MPB1, PPH"	ENSG00000074800	"Enolase 1"	P06733	1	8861000-8879190	"Cancer-related genes, Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	"Glycolysis, Plasminogen activation, Transcription, Transcription regulation"	"DNA-binding, Lyase, Repressor"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Ductal cells: 2259.3;Extravillous trophoblasts: 2078.5;Muller glia cells: 2624.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB018614, HPA068284, HPA068721, CAB069394, CAB080034"	Supported		Enhanced	"Plasma membrane,Cytosol"		NA	NA		310000000	"Cluster 39: Non-specific - mRNA processing"	"Cluster 27: Brain & Skin - Unknown function"	"Cluster 11: RPE1 & U-87MG - Synaptic function"	"Cluster 16: Pancreatic endocrine cells - Mixed function"	"Plasma membrane, Cytosol"		"CAB018614: AB_2099061, CAB069394: , CAB080034: , HPA068284: , HPA068721: AB_2732119"	"unprognostic (6.51e-3)"	"unprognostic (9.50e-3)"	"unprognostic (3.56e-2)"	"unprognostic (1.86e-1)"	"prognostic unfavorable (2.71e-4)"	"unprognostic (1.82e-2)"	"prognostic unfavorable (1.30e-8)"	"unprognostic (2.37e-2)"	"unprognostic (5.58e-2)"	"unprognostic (9.72e-2)"	"unprognostic (1.67e-2)"	"unprognostic (1.46e-1)"	"unprognostic (7.53e-2)"	"unprognostic (6.20e-2)"	"unprognostic (1.97e-1)"	"unprognostic (2.22e-1)"	"unprognostic (1.36e-3)"	463.4	418.4	552.9	553.3	591.7	792.8	409.1	679.7	749.9	370.7	585.6	382.6	401.2	321.7	125.7	1049.4	281.6	302.0	328.2	638.1	599.6	1063.6	612.2	453.2	492.4	624.1	607.7	295.0	220.8	347.2	245.7	362.7	602.9	279.2	358.3	741.5	581.3	354.2	231.0	548.1	382.3	471.3	583.4	394.9	321.6	217.7	585.3	455.6	271.4	146.5	695.4	485.9	519.7	571.5	3637.0	3088.4	1461.8	1258.6	1194.2	1323.8	1316.6	1919.1	2110.9	4044.1	3767.4	1986.9	2041.5	2586.5	2496.8	2328.5	1651.8	1736.8	2511.5	5127.7	4081.0	1780.5	2645.9	2191.3	2848.0	2511.0	1789.6	4421.6	1290.1	1377.4	1526.1	3208.9	4825.9	3045.2	2630.1	1294.6	2444.4	982.3	2664.2	1784.1	1685.2	2354.5	1600.3	1290.4	3063.4	1712.4	2172.9	4259.0	4815.0	843.6	1961.4	1211.1	2251.0	3232.5	2407.8	1748.4	1621.8	1302.1	2424.7	2774.5	2444.5	2402.3	3328.3	2771.0	2120.4	3906.9	4313.8	3556.1	2388.6	195.9	1198.7	232.3	528.4	822.7	597.3	411.2	552.5	543.2	1216.4	386.1	443.4	466.0	230.6	635.3	830.6	336.1	700.0	2171.2	552.9	591.7	679.7	749.9	638.1	599.6	624.1	607.7	602.9	583.4	585.3	571.5	140.0	278.9	499.1	99.6	222.3	416.5	570.9	1939.8	348.8	178.2	242.7	324.6	69.6	283.1	657.4	606.9	70.9	1045.4	194.0	455.9	925.4	2259.3	281.3	205.3	227.7	314.3	189.0	145.4	32.0	1399.1	2078.5	303.5	144.8	248.4	297.2	408.6	133.5	351.7	1147.4	482.9	33.2	297.3	787.3	356.4	524.5	699.6	171.5	454.2	448.2	30.9	1558.2	2624.9	279.1	28.6	26.9	1433.6	366.9	135.1	211.0	555.7	742.2	1005.4	245.7	216.6	151.2	156.1	402.5	215.1	154.3	468.1	349.6	1001.8	285.6	609.8	528.4	444.2
ENOPH1	"E1, MASA, mtnC"	ENSG00000145293	"Enolase-phosphatase 1"	Q9UHY7	4	82430590-82461177	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	"Amino-acid biosynthesis, Methionine biosynthesis"	Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004985, HPA044607"	Enhanced		Approved	"Nucleoplasm,Nuclear bodies"		NA	NA		240000	"Cluster 39: Non-specific - mRNA processing"	"Cluster 48: Parathyroid gland - membrane proteins"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 39: Non-specific - Basic cellular processes"	Nucleoplasm	"Nuclear bodies"	"CAB004985: AB_426046, HPA044607: AB_2679019"	"unprognostic (6.64e-3)"	"unprognostic (3.05e-1)"	"unprognostic (6.77e-3)"	"unprognostic (1.05e-3)"	"unprognostic (1.46e-1)"	"unprognostic (1.68e-3)"	"prognostic unfavorable (1.74e-5)"	"unprognostic (9.99e-3)"	"unprognostic (1.18e-1)"	"unprognostic (2.17e-1)"	"unprognostic (1.59e-1)"	"unprognostic (2.05e-1)"	"unprognostic (9.30e-3)"	"unprognostic (3.68e-2)"	"unprognostic (2.22e-1)"	"unprognostic (6.52e-3)"	"unprognostic (3.52e-2)"	17.0	24.2	61.3	21.2	70.0	26.6	26.2	69.8	102.7	20.7	52.3	21.1	20.3	16.7	35.9	23.5	16.5	14.7	18.7	60.0	66.6	33.5	22.1	18.3	29.0	70.5	67.4	19.8	23.5	34.1	20.6	29.1	69.1	26.6	23.9	42.0	19.2	18.0	18.1	21.8	18.5	17.9	68.1	22.2	22.3	10.6	65.9	30.8	28.6	18.7	31.6	21.9	17.8	80.1	56.6	36.6	64.3	40.4	38.3	37.6	69.7	63.7	42.6	57.2	50.6	67.3	61.3	110.8	64.8	49.0	62.6	29.8	86.1	81.3	103.3	67.2	39.2	67.1	33.7	91.0	62.0	113.3	56.0	36.5	84.9	59.7	70.6	41.4	58.8	69.2	88.3	60.1	76.1	73.2	125.8	67.6	59.2	141.8	28.8	88.1	98.2	61.0	94.7	55.5	90.5	55.2	36.2	109.7	86.3	57.3	49.4	54.5	43.3	70.9	52.8	71.2	85.7	67.5	62.4	138.5	45.9	69.5	97.5	5.8	13.9	7.2	21.8	17.1	27.1	20.2	25.9	25.0	20.5	16.9	29.4	24.2	1.2	24.7	14.9	22.4	30.4	20.6	61.3	70.0	69.8	102.7	60.0	66.6	70.5	67.4	69.1	68.1	65.9	80.1	24.6	16.0	10.5	9.4	31.8	68.6	40.8	47.3	30.7	36.6	22.9	19.8	13.5	18.6	27.5	12.9	16.7	86.7	24.7	10.7	88.0	48.1	7.7	15.2	14.2	25.6	29.3	24.6	18.5	25.7	61.3	22.4	15.3	19.5	38.1	15.3	17.9	10.8	57.7	28.6	21.4	24.8	61.1	23.2	27.9	5.1	26.4	23.1	39.2	6.5	35.6	62.8	29.9	15.1	37.9	41.1	11.1	24.0	28.0	52.6	17.7	56.2	18.8	37.7	13.1	16.4	23.8	9.0	24.9	37.8	64.1	46.7	34.3	27.5	26.7	39.9
ENTPD6	"CD39L2, dJ738P15.3, IL6ST2, NTPDase-6"	ENSG00000197586	"Ectonucleoside triphosphate diphosphohydrolase 6"	O75354	20	25195693-25228075	"Enzymes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins"		Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"SK-MEL-30: 289.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA015491, HPA069555"	Approved		Supported	"Golgi apparatus"	"Secreted to blood"	NA	NA		41000	"Cluster 39: Non-specific - mRNA processing"	"Cluster 22: Non-specific - Unknown function"	"Cluster 33: SK-MEL-30 - Melanocyte processes"	"Cluster 53: Intestinal epithelial cells - Unknown function"	"Golgi apparatus"		"HPA015491: AB_2669200, HPA069555: AB_2686152"	"unprognostic (3.24e-1)"	"unprognostic (1.27e-2)"	"unprognostic (5.91e-2)"	"unprognostic (1.16e-1)"	"unprognostic (1.76e-1)"	"unprognostic (4.44e-1)"	"unprognostic (2.10e-3)"	"unprognostic (7.41e-3)"	"unprognostic (2.74e-3)"	"unprognostic (1.17e-1)"	"unprognostic (2.14e-1)"	"unprognostic (1.03e-1)"	"unprognostic (8.14e-3)"	"unprognostic (1.78e-2)"	"unprognostic (2.74e-1)"	"unprognostic (4.86e-2)"	"unprognostic (4.48e-2)"	24.8	55.4	54.3	22.8	64.0	15.2	27.7	39.7	65.9	22.9	26.5	61.0	60.0	21.8	18.4	25.3	23.2	26.5	75.9	56.0	49.8	40.4	38.9	25.4	16.1	29.6	32.2	36.2	49.6	23.5	60.0	25.2	45.2	55.7	44.9	15.7	71.2	17.2	38.7	19.4	63.0	18.6	25.7	19.8	47.2	36.3	48.5	29.8	28.8	21.9	13.0	24.5	21.8	38.9	78.8	122.8	32.9	64.0	41.0	50.8	70.8	63.0	45.0	54.0	48.3	65.5	60.0	47.6	91.4	60.9	104.7	100.3	40.1	96.2	35.5	29.2	36.2	38.3	18.2	150.4	60.7	52.7	57.3	47.4	53.1	67.7	51.4	39.4	43.7	46.1	51.5	78.8	40.0	75.6	49.2	32.6	20.8	63.9	96.0	27.1	102.9	108.4	67.8	46.3	52.0	26.7	17.7	105.1	289.4	29.6	75.3	43.4	48.6	61.9	63.7	51.6	75.7	50.5	43.8	21.0	44.5	34.1	116.3	0.1	25.2	4.9	18.8	17.0	25.6	8.7	16.5	15.0	26.4	11.0	16.9	15.5	1.1	14.1	7.6	18.5	17.2	22.1	54.3	64.0	39.7	65.9	56.0	49.8	29.6	32.2	45.2	25.7	48.5	38.9	6.4	19.2	28.5	12.4	9.9	9.8	16.2	23.6	6.2	19.2	25.8	21.8	5.8	25.8	14.8	18.4	10.4	63.2	11.0	81.4	9.8	42.5	22.1	10.5	7.6	7.6	34.0	4.2	18.6	40.1	21.7	12.8	52.5	15.4	3.8	65.2	14.3	15.0	26.7	25.2	19.4	57.5	26.4	17.7	17.4	65.2	20.5	17.6	10.6	11.2	16.0	4.2	10.3	13.0	9.2	33.8	59.8	42.2	16.5	27.9	68.4	13.5	10.7	9.1	6.6	6.3	9.6	3.0	8.8	8.6	6.0	59.8	12.0	25.8	72.6	12.1
ESPL1	"ESP1, KIAA0165, SEPA"	ENSG00000135476	"Extra spindle pole bodies like 1, separase"	Q14674	12	53268299-53293638	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins"	"Chromosome partition"	"Hydrolase, Protease, Thiol protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"bone marrow: 8.5;esophagus: 15.4;lymphoid tissue: 10.7"	"Cell type enhanced"	"Detected in many"		"Ionocytes: 22.4;Proximal enterocytes: 22.6;Squamous epithelial cells: 7.4"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"CAB012185, HPA073188"	Approved		Supported	Nucleoplasm,Vesicles		NA	Yes			"Cluster 39: Non-specific - mRNA processing"	"Cluster 53: Non-specific - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 45: Enterocytes - Digestion"	Nucleoplasm	Vesicles	"CAB012185: AB_304056, HPA073188: "	"unprognostic (1.57e-1)"	"unprognostic (3.56e-2)"	"unprognostic (3.84e-2)"	"prognostic unfavorable (5.32e-5)"	"unprognostic (2.91e-1)"	"unprognostic (1.11e-1)"	"prognostic unfavorable (2.01e-5)"	"prognostic unfavorable (7.14e-4)"	"unprognostic (1.59e-2)"	"unprognostic (2.48e-1)"	"unprognostic (4.17e-3)"	"unprognostic (1.18e-2)"	"unprognostic (7.42e-13)"	"prognostic favorable (7.10e-4)"	"unprognostic (2.39e-1)"	"unprognostic (7.41e-2)"	"unprognostic (1.42e-1)"	0.4	0.2	0.0	2.4	0.0	8.5	0.5	0.0	0.0	3.5	0.0	1.5	3.9	0.2	0.0	15.4	0.2	0.4	0.1	0.0	0.0	0.9	0.6	0.4	4.4	0.0	0.0	0.1	0.1	0.0	0.0	1.1	0.0	0.1	1.4	0.0	2.0	0.1	0.0	2.6	4.3	0.7	0.0	1.0	0.9	6.2	0.1	10.7	0.1	0.0	4.9	0.6	5.9	0.0	27.8	23.6	27.6	21.1	0.6	1.9	17.5	15.9	8.6	28.8	19.2	15.8	22.7	49.9	9.5	6.8	17.4	20.2	32.6	9.9	14.3	13.7	32.8	30.6	24.1	11.1	0.1	19.5	25.2	0.6	0.6	15.5	7.6	2.8	15.4	22.2	42.6	41.0	9.1	29.2	30.6	16.4	22.5	14.5	12.9	29.3	30.2	21.4	4.2	11.6	18.9	15.8	11.9	20.4	10.1	13.0	36.9	12.7	8.2	14.5	27.2	11.9	25.5	32.5	29.7	31.9	8.2	19.0	27.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	1.5	0.0	0.0	0.3	0.6	0.9	0.3	0.5	0.6	0.0	1.0	1.3	0.9	0.0	0.4	3.7	0.0	1.9	0.6	2.7	0.0	0.2	0.8	0.2	0.8	1.0	3.5	1.3	0.7	0.0	2.3	1.1	3.6	0.7	0.0	4.4	0.7	6.8	2.6	0.0	0.4	2.7	22.4	0.6	2.1	1.2	0.0	1.3	0.0	1.0	0.0	0.0	0.0	0.0	0.5	1.5	1.3	0.4	2.1	0.4	22.6	6.6	0.2	0.0	0.0	0.4	0.9	5.5	4.1	7.4	0.6	0.3	0.4	0.1	2.8	0.4
FAAP100	"C17orf70, FLJ22175"	ENSG00000185504	"FA core complex associated protein 100"	Q0VG06	17	81539885-81553961	"Predicted intracellular proteins"	"DNA damage, DNA repair"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA023954, HPA024626, HPA026532"	Uncertain		Supported	Nucleoplasm,Cytosol		NA	NA			"Cluster 39: Non-specific - mRNA processing"	"Cluster 72: Non-specific - Transcription"	"Cluster 24: NB-4 - Immune response"	"Cluster 59: Non-specific - Transcription"	Nucleoplasm	Cytosol	"HPA023954: AB_1845601, HPA024626: AB_1845602, HPA026532: AB_1845603"	"unprognostic (5.25e-2)"	"unprognostic (5.40e-2)"	"unprognostic (1.31e-1)"	"unprognostic (2.03e-2)"	"unprognostic (2.91e-1)"	"unprognostic (1.85e-2)"	"unprognostic (4.87e-3)"	"unprognostic (1.30e-1)"	"unprognostic (1.16e-1)"	"unprognostic (3.49e-2)"	"unprognostic (1.05e-3)"	"unprognostic (6.91e-2)"	"prognostic unfavorable (1.00e-7)"	"unprognostic (1.14e-1)"	"unprognostic (1.45e-1)"	"unprognostic (9.85e-2)"	"unprognostic (4.24e-1)"	14.7	16.8	6.7	13.8	7.0	10.1	15.9	14.7	9.5	18.6	6.8	15.8	12.0	17.3	3.1	16.2	18.8	9.5	16.3	6.7	6.4	21.2	22.7	16.0	15.9	8.1	6.5	19.5	26.6	7.8	22.4	7.2	6.3	20.7	4.9	3.7	14.6	7.8	13.2	16.1	18.8	6.9	5.1	38.1	15.5	13.3	7.3	8.8	24.1	6.0	7.3	17.9	15.5	8.8	11.7	21.3	9.4	26.8	11.0	11.5	14.6	11.2	5.9	14.3	8.9	14.5	14.0	21.0	8.6	15.5	13.8	15.0	4.9	14.5	3.3	6.1	13.9	13.5	23.3	20.0	11.6	15.4	16.0	14.0	10.7	10.4	11.7	17.6	27.0	22.0	20.7	16.5	7.0	23.0	24.4	25.8	11.3	13.6	7.7	22.1	9.4	19.3	10.4	21.1	20.5	17.1	8.5	24.4	10.4	9.7	26.2	20.7	22.8	30.6	18.8	8.3	18.9	18.3	1.5	10.7	8.0	9.9	14.3	0.0	3.0	1.2	2.4	2.8	1.9	3.0	1.6	1.6	2.9	2.0	1.5	1.2	0.4	2.4	1.4	3.2	1.6	2.2	6.7	7.0	14.7	9.5	6.7	6.4	8.1	6.5	6.3	5.1	7.3	8.8	11.4	3.2	7.5	0.0	7.5	0.0	3.5	0.0	4.6	10.3	9.8	10.9	8.9	10.0	2.5	14.7	4.2	6.1	8.5	7.1	3.9	8.2	1.9	4.5	7.3	7.5	7.3	11.8	0.0	6.9	4.8	8.3	15.8	6.8	0.0	14.9	6.8	11.7	8.4	6.7	0.0	6.2	0.0	14.1	0.0	3.0	5.0	7.0	0.0	0.0	8.9	6.2	4.1	0.0	0.0	8.9	4.4	5.3	6.6	5.3	12.7	6.8	1.5	4.9	0.0	7.4	6.4	7.3	7.5	9.5	0.0	3.1	6.2	10.7	7.3	3.6
FAM160B2	"FLJ21801, RAI16"	ENSG00000158863	"Family with sequence similarity 160 member B2"	Q86V87	8	22089150-22104911	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA025040	Approved		Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 39: Non-specific - mRNA processing"	"Cluster 18: Non-specific - Mitochondria"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 43: Cardiomyocytes - Nuclear processes"	Nucleoplasm	Cytosol	"HPA025040: AB_1856049"	"unprognostic (3.45e-1)"	"unprognostic (2.08e-3)"	"unprognostic (1.60e-1)"	"unprognostic (8.85e-3)"	"unprognostic (2.28e-2)"	"prognostic favorable (4.56e-4)"	"unprognostic (2.35e-2)"	"unprognostic (4.82e-2)"	"unprognostic (1.01e-1)"	"unprognostic (2.90e-2)"	"unprognostic (8.38e-3)"	"unprognostic (7.67e-3)"	"unprognostic (3.38e-2)"	"unprognostic (6.30e-2)"	"unprognostic (1.08e-2)"	"unprognostic (1.25e-1)"	"unprognostic (2.75e-3)"	13.9	11.5	4.5	3.9	4.1	3.6	15.8	3.5	5.5	12.5	3.5	16.2	5.8	12.3	4.9	13.6	12.7	5.6	21.7	3.6	3.5	14.6	10.5	10.6	6.3	4.8	4.2	10.0	22.3	8.2	13.2	5.2	4.1	14.6	2.5	3.0	16.7	10.6	17.7	14.0	13.5	6.9	3.7	11.4	17.4	6.1	4.8	4.2	15.4	7.2	2.2	16.2	12.0	4.6	4.4	8.7	4.3	6.8	9.2	8.1	7.8	8.0	13.6	8.6	5.8	3.9	4.7	4.9	7.7	19.7	7.8	6.3	3.3	9.3	1.9	4.1	4.2	7.3	2.8	2.2	12.4	1.9	5.7	13.6	6.9	6.6	4.4	8.9	9.1	8.8	4.6	3.3	8.3	8.0	5.0	2.9	2.1	8.0	3.8	5.1	3.7	2.5	7.4	8.9	1.8	5.8	4.6	6.6	5.2	4.5	4.3	3.2	10.3	8.4	7.2	8.0	4.6	3.5	0.9	0.9	9.0	3.1	9.7	0.0	0.4	0.1	0.8	0.2	0.5	0.7	0.5	0.6	0.2	0.5	0.4	0.7	0.0	0.4	0.4	0.2	0.0	0.7	4.5	4.1	3.5	5.5	3.6	3.5	4.8	4.2	4.1	3.7	4.8	4.6	16.4	12.8	17.2	17.0	11.6	5.9	10.1	9.9	12.5	22.0	16.4	13.5	26.1	12.8	8.8	12.9	27.1	8.5	10.1	15.5	0.0	9.7	3.7	8.9	14.5	16.8	13.2	1.3	12.3	15.0	15.5	12.5	23.0	11.8	7.0	19.1	16.8	13.6	7.4	23.5	12.0	10.8	0.0	9.4	4.7	2.5	10.8	8.2	1.8	8.4	4.4	8.7	9.2	12.1	11.0	17.1	17.1	5.7	6.3	15.1	14.7	5.0	10.8	23.8	0.0	11.0	14.7	1.5	7.0	16.1	7.5	14.9	11.2	9.6	9.9	12.4
FAM78A	"C9orf59, FLJ00024"	ENSG00000126882	"Family with sequence similarity 78 member A"	Q5JUQ0	9	131258076-131276510	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"skeletal muscle: 53.7;testis: 31.9"	"Cell type enhanced"	"Detected in many"		"Bipolar cells: 55.7;Early spermatids: 90.6;Granulosa cells: 167.2;Late spermatids: 120.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"BEWO: 39.3;HEL: 38.6;HL-60: 38.7;NB-4: 60.7;THP-1: 53.5;U-937: 35.9"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA021472, HPA023914"	Uncertain		Uncertain	Nucleoplasm,Vesicles	"Intracellular and membrane"	NA	NA			"Cluster 39: Non-specific - mRNA processing"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 32: U-937 - Innate immune response"	"Cluster 40: Granulosa cells - Unknown function"	"Nucleoplasm, Vesicles"		"HPA021472: AB_1848411, HPA023914: AB_1848412"	"unprognostic (5.16e-2)"	"prognostic favorable (3.67e-4)"	"unprognostic (3.65e-2)"	"unprognostic (2.07e-2)"	"unprognostic (2.71e-1)"	"prognostic favorable (2.00e-4)"	"unprognostic (3.24e-1)"	"unprognostic (5.49e-2)"	"unprognostic (1.46e-2)"	"unprognostic (5.83e-1)"	"unprognostic (5.84e-2)"	"unprognostic (6.79e-2)"	"unprognostic (1.59e-3)"	"unprognostic (2.61e-3)"	"unprognostic (7.42e-2)"	"unprognostic (2.61e-2)"	"unprognostic (2.39e-1)"	2.9	2.0	3.8	13.8	5.6	21.7	1.7	3.6	6.3	1.4	1.8	2.4	2.7	1.5	0.3	1.7	1.3	3.1	26.5	5.1	3.7	1.6	1.5	6.1	24.5	5.6	4.1	1.4	1.1	1.1	1.2	5.3	4.9	1.4	1.6	4.6	2.7	0.9	53.7	1.2	8.9	1.8	4.6	21.6	3.8	31.9	5.8	21.1	1.6	20.2	14.9	3.5	1.1	5.7	0.7	0.3	2.5	5.6	1.7	0.5	39.3	0.3	0.3	0.5	0.2	0.3	0.2	17.1	0.2	0.3	0.8	0.1	16.0	0.2	0.1	4.4	1.4	38.6	0.6	0.3	0.6	38.7	1.5	0.4	0.8	0.0	0.1	0.5	22.2	10.8	13.8	4.7	0.5	6.0	1.7	60.7	2.6	0.3	0.6	4.0	2.3	23.7	0.2	0.1	1.5	2.1	2.3	0.8	2.4	0.9	1.4	53.5	0.6	2.3	2.4	1.3	0.1	3.4	1.9	9.7	0.3	35.9	0.6	0.5	9.7	17.6	9.2	12.6	7.4	14.2	8.9	10.1	6.0	15.9	11.0	9.3	9.8	3.1	9.9	2.7	9.5	8.7	3.8	5.6	3.6	6.3	5.1	3.7	5.6	4.1	4.9	4.6	5.8	5.7	3.2	0.0	1.5	0.0	15.5	0.9	0.0	0.0	0.0	55.7	0.4	0.5	17.6	0.0	0.0	1.8	0.0	1.1	19.0	0.0	0.0	0.1	90.6	0.1	0.2	6.8	0.0	3.4	5.0	0.0	37.6	3.1	0.5	0.1	1.3	167.2	6.4	0.5	25.7	0.0	1.7	0.0	0.0	21.7	10.6	120.3	5.0	14.8	1.8	15.9	15.6	0.8	30.9	1.0	0.1	0.1	0.0	3.4	12.0	0.0	0.0	0.2	0.0	1.8	0.0	0.6	6.3	2.2	1.2	0.0	0.9	1.4	17.4	1.0	0.0	0.1
FEM1B		ENSG00000169018	"Fem-1 homolog B"	Q9UK73	15	68277745-68295862	"Predicted intracellular proteins"	"Apoptosis, Ubl conjugation pathway"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in many"	5	"Early spermatids: 835.0;Late spermatids: 289.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041920, HPA042192"	Approved		Supported	Nucleoplasm,Cytosol		NA	NA			"Cluster 39: Non-specific - mRNA processing"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 29: Early spermatids - Spermatogenesis"	Nucleoplasm	Cytosol	"HPA041920: AB_10796788, HPA042192: AB_10796574"	"unprognostic (1.50e-1)"	"unprognostic (1.27e-1)"	"unprognostic (1.12e-1)"	"unprognostic (1.16e-1)"	"unprognostic (2.87e-2)"	"unprognostic (6.29e-2)"	"unprognostic (1.83e-1)"	"unprognostic (3.27e-1)"	"unprognostic (9.91e-2)"	"unprognostic (1.52e-1)"	"unprognostic (2.72e-1)"	"unprognostic (6.84e-2)"	"unprognostic (1.89e-2)"	"unprognostic (3.49e-3)"	"unprognostic (1.35e-1)"	"unprognostic (2.89e-2)"	"unprognostic (4.67e-2)"	17.3	13.6	15.1	16.2	16.8	60.1	23.7	21.3	18.7	18.0	6.9	17.5	15.4	26.8	14.6	24.6	15.3	14.9	19.8	17.3	14.7	13.7	20.1	16.4	15.8	12.9	12.5	20.0	11.6	18.0	9.0	18.9	16.2	18.6	16.4	22.6	12.7	20.8	49.3	23.3	16.6	30.2	13.8	17.2	12.9	71.7	14.3	18.9	17.1	27.4	18.6	22.0	16.1	23.1	17.3	31.2	31.7	29.9	27.8	25.6	21.1	24.1	25.1	24.5	22.3	21.1	22.7	39.8	17.1	33.2	17.6	61.6	66.5	30.7	20.3	19.1	26.3	43.7	36.8	13.4	24.1	35.8	26.1	23.8	64.9	29.6	71.3	34.9	19.5	19.9	37.3	47.2	20.9	20.1	26.0	18.2	32.2	13.9	10.0	37.1	35.5	51.6	15.5	62.1	42.2	26.6	25.0	25.6	67.4	39.8	23.1	33.0	25.6	42.2	37.1	14.8	22.3	30.7	71.2	42.4	24.1	38.3	25.6	0.0	3.1	2.0	3.0	4.2	2.8	2.0	2.9	3.2	2.4	2.3	3.5	2.7	2.3	3.7	3.6	1.7	1.6	2.0	15.1	16.8	21.3	18.7	17.3	14.7	12.9	12.5	16.2	13.8	14.3	23.1	25.2	22.4	35.4	12.7	16.9	98.7	56.3	32.1	48.3	31.5	29.2	25.7	51.6	21.5	23.7	18.4	12.5	17.1	20.8	25.8	0.0	23.4	835.0	21.7	34.3	24.4	19.9	21.4	33.4	12.0	12.7	26.5	15.3	25.6	14.5	26.9	16.1	30.9	31.8	38.7	29.4	23.2	12.2	27.3	33.4	289.6	24.5	24.9	40.9	30.0	22.4	17.6	10.3	17.6	33.5	20.8	17.9	27.8	14.9	37.0	22.2	13.3	29.4	13.1	26.3	26.7	31.3	25.2	8.9	49.5	111.2	16.8	17.2	23.6	20.3	59.3
FLNA	"ABP-280, FLN, FLN1, OPD1, OPD2"	ENSG00000196924	"Filamin A"	P21333	X	154348524-154374634	"Disease related genes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Transporters"	"Cilium biogenesis/degradation"	Actin-binding	"Deafness, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"endometrium 1: 1203.7;intestine: 1462.2"	"Cell type enhanced"	"Detected in many"		"Peritubular cells: 500.6;Sertoli cells: 420.7;Smooth muscle cells: 459.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB000356, HPA000368, HPA001016, HPA001115, HPA002925"	Enhanced	Approved	Enhanced	"Plasma membrane,Actin filaments,Cytosol"		NA	NA		730000000	"Cluster 39: Non-specific - mRNA processing"	"Cluster 12: Smooth muscle tissue - Mixed function"	"Cluster 38: EFO-21 - Unknown function"	"Cluster 48: Smooth muscle cells - ECM organization"	"Plasma membrane, Actin filaments, Cytosol"		"CAB000356: , HPA000368: AB_2797215, HPA001016: , HPA001115: AB_1078871, HPA002925: AB_1078869"	"unprognostic (1.39e-1)"	"unprognostic (9.40e-3)"	"prognostic unfavorable (7.37e-4)"	"unprognostic (3.68e-2)"	"unprognostic (2.55e-1)"	"unprognostic (6.05e-3)"	"unprognostic (5.08e-2)"	"unprognostic (1.08e-1)"	"unprognostic (6.02e-2)"	"unprognostic (1.30e-1)"	"unprognostic (3.23e-2)"	"unprognostic (9.58e-2)"	"prognostic unfavorable (1.54e-6)"	"unprognostic (5.49e-3)"	"unprognostic (1.78e-1)"	"unprognostic (1.62e-1)"	"prognostic unfavorable (3.88e-4)"	267.4	55.9	14.4	223.2	18.5	157.9	164.2	15.2	43.0	392.1	54.7	1462.2	89.9	1203.7	35.5	454.7	609.4	137.9	108.4	14.8	23.0	70.5	21.2	238.9	65.0	39.9	19.9	236.7	50.5	13.4	30.5	79.2	24.4	369.2	86.9	9.0	80.3	617.2	49.7	124.7	354.6	706.6	21.1	102.7	508.0	33.7	34.0	48.1	85.6	31.2	38.1	1053.9	286.4	21.5	947.2	719.2	246.7	316.1	209.8	278.4	400.9	614.0	680.1	552.5	489.8	469.2	169.4	80.5	1551.4	966.4	970.1	528.3	224.0	538.1	152.7	333.6	77.8	262.2	914.9	159.7	375.9	309.3	324.9	266.1	126.1	825.5	327.0	533.8	417.1	94.9	74.7	538.7	401.3	210.7	148.5	93.1	258.3	97.9	470.9	147.8	221.2	71.6	197.2	193.4	52.9	119.7	515.8	80.2	381.1	187.3	79.1	96.3	1016.6	625.2	586.8	640.0	1147.1	333.7	212.8	162.3	580.3	202.4	638.7	7.6	24.9	11.8	32.6	23.1	21.2	10.2	15.6	29.2	22.4	4.6	6.0	14.3	3.6	10.5	34.2	2.7	20.7	56.2	14.4	18.5	15.2	43.0	14.8	23.0	39.9	19.9	24.4	21.1	34.0	21.5	105.1	57.7	38.7	30.0	76.9	124.3	85.9	127.8	85.4	3.5	40.9	153.5	34.5	38.6	26.1	35.0	0.0	24.6	257.7	2.6	1.9	272.0	2.1	33.8	186.3	107.0	1.8	39.7	11.8	133.1	90.9	137.9	13.3	55.8	26.0	334.5	81.8	4.3	120.3	11.8	8.6	2.5	22.4	141.0	263.0	13.7	122.4	227.7	88.9	30.9	207.9	39.4	270.8	8.0	2.6	347.4	1.5	500.6	98.7	96.1	1.9	3.0	9.1	4.3	420.7	118.3	459.3	4.1	8.9	48.8	73.6	20.0	172.3	134.7	3.3	35.3
FOXK1	IMAGE:5164497	ENSG00000164916	"Forkhead box K1"	P85037	7	4682295-4771442	"Predicted intracellular proteins, Transcription factors"	"Differentiation, Host-virus interaction, Myogenesis, Transcription, Transcription regulation"	"Activator, Developmental protein, DNA-binding, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in all"		"Late spermatids: 113.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA017998, HPA018864"	Enhanced		Supported	"Nucleoplasm,Nucleoli fibrillar center"		NA	NA			"Cluster 39: Non-specific - mRNA processing"	"Cluster 35: Non-specific - Unknown function"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 25: Spermatids - Spermatogenesis"	Nucleoplasm	"Nucleoli fibrillar center"	"HPA017998: AB_1849077, HPA018864: AB_1849079"	"unprognostic (3.05e-2)"	"unprognostic (5.01e-2)"	"unprognostic (1.54e-1)"	"unprognostic (1.55e-2)"	"unprognostic (3.51e-1)"	"unprognostic (3.03e-1)"	"prognostic unfavorable (2.54e-6)"	"unprognostic (2.34e-2)"	"unprognostic (2.62e-2)"	"unprognostic (1.73e-3)"	"unprognostic (2.66e-3)"	"unprognostic (4.96e-2)"	"unprognostic (3.79e-3)"	"unprognostic (1.08e-1)"	"unprognostic (1.50e-1)"	"unprognostic (4.34e-2)"	"unprognostic (3.72e-1)"	6.3	11.3	6.9	4.2	7.1	9.5	5.7	1.4	8.9	7.1	0.0	9.8	3.0	9.1	2.1	7.5	7.6	2.3	7.5	9.2	5.2	6.0	4.8	8.6	4.0	9.2	6.6	7.7	6.5	2.7	12.5	3.0	7.6	5.9	2.6	3.6	4.6	4.0	11.0	9.7	5.8	4.8	5.9	6.3	6.3	9.2	8.7	4.0	4.9	4.8	3.4	6.9	7.4	7.5	11.8	14.8	9.4	18.6	9.0	6.8	11.6	5.3	4.6	3.7	4.2	14.8	13.0	19.9	6.0	8.5	11.9	18.9	10.2	12.9	3.7	5.8	6.3	9.4	16.1	8.4	8.8	11.7	10.3	13.0	7.1	8.9	12.3	6.0	7.2	7.5	20.5	4.3	4.5	13.5	4.5	20.9	14.1	4.8	7.4	16.7	9.4	12.7	5.4	17.2	8.4	10.6	8.0	17.2	6.2	7.2	9.6	15.4	22.4	6.4	20.1	10.0	11.4	11.9	10.5	12.9	8.6	13.4	10.3	0.9	0.9	0.4	1.7	1.6	2.5	1.2	1.7	1.7	1.1	1.1	1.8	1.8	0.5	1.6	1.6	0.9	0.9	1.4	6.9	7.1	1.4	8.9	9.2	5.2	9.2	6.6	7.6	5.9	8.7	7.5	15.7	32.1	17.5	25.5	16.8	33.4	15.2	31.9	12.0	18.0	15.7	15.2	12.9	8.6	14.4	14.7	22.9	13.6	26.0	11.4	5.9	10.6	44.7	17.8	20.4	17.2	13.1	3.6	42.0	15.2	4.0	18.6	9.7	25.1	7.6	29.5	16.1	11.6	10.6	23.5	35.2	11.3	12.2	17.5	17.9	113.2	19.3	11.4	16.0	30.9	21.4	10.3	54.6	25.1	58.2	19.7	9.6	28.6	6.0	29.1	8.1	15.5	14.7	13.9	19.7	17.6	25.3	19.1	20.4	15.3	50.0	4.0	19.3	17.9	17.9	21.5
FTSJ3	SPB1	ENSG00000108592	"FtsJ RNA 2'-O-methyltransferase 3"	Q8IY81	17	63819433-63830012	"Metabolic proteins, Predicted intracellular proteins"	"Ribosome biogenesis, rRNA processing"	"Methyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA055544, HPA062628"	Supported		Enhanced	"Nucleoli,Nucleoli rim,Mitotic chromosome"		Yes	No			"Cluster 39: Non-specific - mRNA processing"	"Cluster 52: Non-specific - Ribosome"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 10: Non-specific - Unknown function"	"Nucleoli, Nucleoli rim"	"Mitotic chromosome"	"HPA055544: AB_2682843, HPA062628: AB_2684813"	"unprognostic (1.33e-1)"	"unprognostic (1.41e-1)"	"unprognostic (6.60e-2)"	"unprognostic (7.82e-2)"	"unprognostic (6.45e-2)"	"unprognostic (2.92e-1)"	"prognostic unfavorable (1.44e-5)"	"unprognostic (1.27e-1)"	"unprognostic (2.57e-1)"	"unprognostic (2.41e-2)"	"unprognostic (2.85e-1)"	"unprognostic (1.12e-1)"	"unprognostic (4.99e-2)"	"unprognostic (1.28e-1)"	"unprognostic (1.19e-1)"	"unprognostic (5.10e-1)"	"unprognostic (3.43e-1)"	20.7	20.7	11.8	18.2	12.4	15.8	18.0	12.3	12.7	20.4	12.0	20.5	14.2	20.2	17.2	19.0	18.8	15.1	20.8	11.3	12.0	23.3	18.8	14.8	20.9	12.6	12.1	22.3	15.7	20.6	12.4	13.1	12.5	18.7	18.0	8.8	17.7	18.1	28.8	23.9	18.4	22.6	12.3	21.0	17.8	15.2	12.3	21.0	17.2	14.6	23.8	20.1	18.7	12.7	63.0	97.0	36.8	52.5	57.9	49.5	57.0	61.4	44.7	68.8	54.2	81.4	40.9	83.4	24.7	36.2	36.0	42.6	69.3	58.4	87.8	14.4	69.2	75.0	68.6	76.6	42.2	95.9	52.5	35.1	45.3	106.9	51.2	34.9	58.2	50.2	75.9	33.1	46.5	105.5	84.9	31.1	99.4	70.2	97.7	74.6	100.9	58.6	44.8	56.3	33.9	132.5	72.3	60.9	43.1	72.7	58.0	31.8	52.7	50.9	71.6	57.4	115.1	79.5	120.9	81.4	45.6	62.6	50.3	4.5	11.4	7.0	11.0	13.0	14.5	9.6	11.6	14.5	13.6	8.6	9.2	11.5	2.5	13.9	10.1	10.3	15.1	10.0	11.8	12.4	12.3	12.7	11.3	12.0	12.6	12.1	12.5	12.3	12.3	12.7	16.2	32.1	30.2	4.2	17.3	13.8	13.6	16.1	26.7	6.6	10.6	12.6	27.7	18.6	25.7	14.7	10.4	16.0	19.4	15.7	13.7	28.0	8.8	23.5	27.5	25.1	12.7	20.8	2.0	33.8	17.0	18.4	11.2	24.1	24.1	17.5	14.3	19.9	14.2	3.3	2.0	12.0	16.2	13.8	9.3	17.8	24.2	16.3	8.8	1.9	19.3	16.0	15.5	1.5	3.8	30.6	14.0	19.2	18.6	10.6	15.5	29.8	24.3	9.3	46.0	21.0	20.5	11.7	15.7	20.8	12.8	16.3	18.6	15.7	21.1	9.5
GANAB	"G2AN, GIIA, GluII, KIAA0088"	ENSG00000089597	"Glucosidase II alpha subunit"	Q14697	11	62624826-62646726	"Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"		"Glycosidase, Hydrolase"	"Disease variant, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA026874, HPA061426"	Enhanced		Approved	"Endoplasmic reticulum"	"Intracellular and membrane"	NA	NA		23000000	"Cluster 39: Non-specific - mRNA processing"	"Cluster 29: Non-specific - Vesicular transport"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 55: Plasma cells - Humoral immune response"	"Endoplasmic reticulum"		"HPA026874: AB_1849745, HPA061426: AB_2684516"	"unprognostic (2.12e-1)"	"unprognostic (5.95e-3)"	"unprognostic (4.35e-2)"	"unprognostic (2.12e-1)"	"unprognostic (1.20e-2)"	"unprognostic (3.65e-2)"	"prognostic unfavorable (1.27e-5)"	"unprognostic (5.80e-3)"	"unprognostic (1.09e-1)"	"unprognostic (1.79e-1)"	"unprognostic (1.68e-3)"	"unprognostic (5.91e-2)"	"unprognostic (1.01e-3)"	"unprognostic (3.81e-2)"	"unprognostic (1.82e-2)"	"unprognostic (1.39e-1)"	"prognostic unfavorable (9.54e-4)"	93.9	73.7	31.8	88.2	34.5	83.7	92.8	36.6	36.7	112.6	51.6	104.7	95.6	102.1	151.7	66.4	106.9	75.3	67.9	31.7	41.2	98.5	171.7	86.8	81.7	38.5	34.9	115.5	88.1	130.6	21.8	141.8	38.1	97.5	116.8	79.4	101.8	111.1	39.4	74.7	90.5	126.0	36.5	86.7	85.2	66.1	39.8	105.2	132.6	53.0	94.8	90.7	34.2	43.4	298.2	245.9	318.2	552.0	464.1	389.0	332.9	312.4	480.4	436.2	362.1	222.2	515.9	201.2	616.0	572.5	337.8	376.4	375.2	376.7	443.8	155.8	191.3	202.9	317.8	125.6	389.0	325.7	248.7	397.2	248.4	433.6	475.3	533.0	422.3	199.6	278.5	352.9	398.2	313.6	167.6	193.4	262.3	236.6	237.7	209.5	368.7	513.1	285.7	230.3	168.6	221.2	451.1	308.2	370.8	321.6	380.9	304.8	311.6	430.0	272.2	342.9	309.9	360.8	423.8	152.2	473.9	173.1	421.7	23.9	19.3	19.1	23.8	23.4	23.1	15.9	17.2	20.0	20.8	14.9	20.9	21.3	8.9	29.8	22.2	18.4	17.3	22.6	31.8	34.5	36.6	36.7	31.7	41.2	38.5	34.9	38.1	36.5	39.8	43.4	42.7	12.8	20.7	17.3	29.8	28.3	29.4	45.8	13.6	31.4	57.4	53.8	7.8	52.9	24.2	68.0	60.5	81.7	33.4	40.1	5.9	47.0	18.5	31.4	59.1	42.2	31.8	25.0	12.6	42.6	137.3	45.9	27.5	46.5	11.4	72.8	48.2	98.0	57.9	35.3	16.0	48.9	34.6	45.8	25.1	16.4	58.4	32.7	35.6	15.9	38.9	36.5	38.1	11.1	16.5	39.5	29.3	68.1	50.4	34.0	47.8	27.0	26.3	41.4	32.9	36.4	34.7	25.3	47.4	21.2	31.3	80.2	25.2	63.1	56.3	32.4
GATD1	"FLJ34283, PDDC1"	ENSG00000177225	"Glutamine amidotransferase like class 1 domain containing 1"	Q8NB37	11	767220-777488	"Enzymes, Predicted intracellular proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Alveolar cells type 1: 44.8;Alveolar cells type 2: 22.1;Collecting duct cells: 22.0;Theca cells: 25.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"HEK 293: 120.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA008812	Uncertain		Supported	Nucleoplasm	"Secreted to blood"	NA	NA			"Cluster 39: Non-specific - mRNA processing"	"Cluster 35: Non-specific - Unknown function"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 7: Non-specific - Mitochondria"	Nucleoplasm		"HPA008812: AB_10962724"	"unprognostic (3.39e-1)"	"unprognostic (2.48e-2)"	"unprognostic (1.31e-1)"	"unprognostic (3.58e-2)"	"unprognostic (2.82e-2)"	"unprognostic (3.03e-2)"	"prognostic unfavorable (3.98e-4)"	"unprognostic (3.50e-2)"	"unprognostic (2.19e-1)"	"unprognostic (5.67e-2)"	"unprognostic (5.23e-3)"	"unprognostic (4.89e-3)"	"prognostic favorable (3.79e-5)"	"unprognostic (2.84e-2)"	"unprognostic (8.40e-2)"	"unprognostic (6.11e-2)"	"unprognostic (6.61e-3)"	15.9	37.5	37.7	11.3	35.8	7.9	16.7	35.1	37.8	22.7	36.6	23.3	15.4	24.9	12.6	23.7	22.7	7.3	16.3	37.4	36.5	24.0	19.3	15.4	11.2	46.4	41.8	25.9	15.9	10.5	30.1	9.2	35.8	23.0	6.5	9.7	17.5	12.2	14.4	21.0	18.2	7.9	38.4	19.6	17.8	18.6	45.3	8.8	22.0	6.5	6.8	19.7	20.4	37.5	41.3	22.3	22.2	23.9	10.2	15.6	20.9	24.2	10.5	22.0	19.3	15.8	62.5	22.1	8.6	16.0	23.2	42.7	16.7	21.6	11.0	28.1	120.5	13.0	38.8	36.0	17.5	25.4	27.8	22.4	23.2	9.3	14.2	19.9	17.1	25.8	34.2	20.0	12.4	11.0	29.3	27.5	21.3	13.4	42.8	31.4	15.1	28.0	19.2	9.1	56.9	22.3	22.9	32.0	16.6	5.7	28.5	16.8	31.3	23.2	17.5	12.7	18.8	23.4	12.9	28.4	35.4	33.9	19.6	1.0	5.2	0.9	2.9	6.6	2.1	2.7	3.0	2.9	6.9	2.3	2.4	1.7	0.5	1.2	2.6	4.0	1.4	2.0	37.7	35.8	35.1	37.8	37.4	36.5	46.4	41.8	35.8	38.4	45.3	37.5	8.7	44.8	22.1	0.0	4.4	0.0	0.0	0.0	0.0	0.0	11.9	10.4	0.0	0.0	7.4	22.0	0.0	13.8	5.2	0.0	5.9	10.3	0.0	11.8	15.2	3.8	0.0	0.0	0.0	7.6	7.9	8.5	0.0	9.6	6.3	19.2	0.0	0.0	13.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.2	0.0	0.0	4.6	0.0	0.0	0.0	0.0	16.6	0.0	0.0	1.3	0.0	0.0	14.7	7.3	0.0	0.0	0.0	5.8	0.0	0.0	0.0	0.0	9.6	3.9	25.8	0.0	0.0
GEMIN5		ENSG00000082516	"Gem nuclear organelle associated protein 5"	Q8TEQ6	5	154887411-154938211	"Predicted intracellular proteins"	"mRNA processing, mRNA splicing, Protein biosynthesis, Translation regulation"	RNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA037392, HPA037393"	Uncertain		Enhanced	"Nuclear bodies,Cytosol"		NA	NA			"Cluster 39: Non-specific - mRNA processing"	"Cluster 52: Non-specific - Ribosome"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 59: Non-specific - Transcription"	Cytosol	"Nuclear bodies"	"HPA037392: AB_2675453, HPA037393: AB_10672489"	"unprognostic (1.14e-2)"	"unprognostic (2.81e-3)"	"unprognostic (5.41e-3)"	"prognostic unfavorable (6.23e-5)"	"unprognostic (5.44e-2)"	"unprognostic (1.69e-1)"	"prognostic unfavorable (1.78e-4)"	"unprognostic (9.91e-2)"	"unprognostic (8.70e-2)"	"unprognostic (3.61e-2)"	"unprognostic (9.38e-2)"	"unprognostic (5.11e-2)"	"prognostic unfavorable (2.05e-4)"	"unprognostic (1.02e-1)"	"unprognostic (2.54e-1)"	"unprognostic (9.40e-3)"	"unprognostic (5.01e-2)"	8.3	4.4	5.0	5.0	5.9	3.3	8.2	5.4	5.6	5.9	5.0	5.4	3.3	6.2	4.6	5.3	6.1	3.4	6.7	5.1	5.4	4.7	6.0	4.3	6.5	5.2	5.2	8.4	5.5	6.4	4.4	4.8	5.4	5.8	4.6	4.1	4.6	5.9	12.3	7.3	4.0	6.9	5.2	5.6	4.3	6.0	5.4	7.5	5.3	10.2	7.3	6.8	5.0	6.9	17.2	25.0	15.9	37.0	16.8	14.2	20.4	16.4	9.9	28.0	20.6	41.6	15.0	45.0	20.2	15.7	28.8	17.8	47.7	29.8	38.0	9.0	22.3	27.3	15.6	25.2	9.3	48.0	15.2	10.7	13.6	38.9	23.2	10.1	23.2	10.7	43.9	10.7	21.2	23.6	26.0	19.2	22.3	13.4	19.4	33.3	31.2	37.4	11.6	11.6	20.9	14.4	18.9	20.7	13.3	15.7	24.6	11.0	14.2	25.1	18.0	19.1	37.2	10.7	17.5	34.5	10.7	38.8	22.6	0.0	1.9	1.7	2.4	2.3	3.9	3.4	2.2	2.2	2.6	2.7	3.2	3.5	0.1	2.8	2.2	1.9	2.2	2.1	5.0	5.9	5.4	5.6	5.1	5.4	5.2	5.2	5.4	5.2	5.4	6.9	6.7	0.0	6.4	6.8	8.4	10.3	6.7	5.3	10.2	6.3	5.2	5.0	15.0	1.5	12.3	3.7	0.0	4.4	5.0	1.9	0.0	5.7	3.4	4.3	9.5	8.4	1.2	8.8	19.1	4.2	4.4	11.1	5.1	4.8	1.3	15.6	4.6	9.2	4.5	16.8	20.5	3.9	0.0	14.4	2.6	4.1	10.8	4.5	7.2	11.2	6.0	7.0	5.2	15.1	19.3	3.4	1.1	13.2	4.5	7.0	2.6	4.5	2.5	4.3	0.0	11.5	8.6	11.7	16.1	8.2	15.9	2.1	5.6	15.6	4.7	4.9
GMDS	"GMD, SDR3E1"	ENSG00000112699	"GDP-mannose 4,6-dehydratase"	O60547	6	1623806-2245605	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		Lyase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"intestine: 106.0;salivary gland: 105.4;stomach 1: 97.1"	"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 208.5;Gastric mucus-secreting cells: 276.8;Intestinal goblet cells: 367.6;Proximal enterocytes: 190.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"OE19: 246.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA031528	Enhanced					NA	NA		72000	"Cluster 39: Non-specific - mRNA processing"	"Cluster 37: Intestine - Unknown function"	"Cluster 21: OE19 - Mitochondria"	"Cluster 27: Mucus-secreting cells - Mucin production"			"HPA031528: AB_10601016"	"unprognostic (5.94e-2)"	"unprognostic (3.92e-2)"	"unprognostic (1.12e-1)"	"prognostic favorable (5.89e-4)"	"unprognostic (4.37e-1)"	"unprognostic (1.53e-1)"	"unprognostic (1.10e-3)"	"unprognostic (7.15e-2)"	"unprognostic (2.29e-1)"	"unprognostic (8.02e-2)"	"unprognostic (2.38e-1)"	"unprognostic (4.41e-1)"	"prognostic favorable (5.93e-4)"	"unprognostic (2.45e-1)"	"unprognostic (2.84e-1)"	"unprognostic (6.68e-2)"	"unprognostic (1.12e-1)"	10.7	7.6	8.6	30.1	7.1	9.1	14.6	5.8	7.1	29.4	9.7	87.7	106.0	7.8	10.4	65.8	11.5	20.5	9.5	7.6	7.0	19.6	31.1	9.0	14.2	6.6	6.9	6.7	43.8	20.5	12.9	7.1	6.7	18.3	82.4	1.5	105.4	8.0	5.1	10.6	87.3	10.3	6.1	11.4	97.1	9.2	7.3	13.9	11.9	4.9	20.8	13.7	14.2	6.2	45.9	10.6	7.4	52.6	11.8	32.0	17.9	12.5	25.7	22.7	21.2	23.1	26.1	21.7	37.3	13.6	22.4	18.3	22.9	43.8	26.2	30.0	28.8	21.0	11.2	110.3	13.2	34.2	22.5	35.6	14.9	18.0	37.2	21.9	26.9	73.0	13.9	9.8	14.7	26.3	49.0	40.1	11.4	246.4	36.0	24.8	16.8	112.4	55.4	59.5	41.4	9.9	11.5	17.7	28.8	33.6	16.4	21.4	11.7	17.4	13.1	17.7	22.5	22.1	33.6	23.1	11.4	23.6	23.4	7.0	12.9	1.5	7.8	8.3	10.3	10.5	9.4	7.5	14.5	5.0	7.6	10.8	3.8	13.1	6.8	6.1	13.2	8.3	8.6	7.1	5.8	7.1	7.6	7.0	6.6	6.9	6.7	6.1	7.3	6.2	19.7	0.0	4.5	40.8	19.8	4.2	20.1	38.3	27.3	3.7	33.1	19.3	2.9	12.8	40.5	38.6	0.0	18.7	6.5	104.1	119.3	36.5	5.7	7.8	7.3	23.0	111.7	9.7	208.5	69.7	30.8	12.4	276.8	11.9	4.5	13.2	18.2	19.6	13.5	8.4	167.5	367.6	50.8	10.9	7.6	4.6	12.2	11.0	23.2	143.4	14.7	3.3	9.2	83.9	50.2	47.0	85.5	16.6	53.1	40.7	190.7	38.1	38.3	0.7	13.1	5.8	16.6	6.5	33.1	20.1	6.1	16.7	18.6	13.4	165.1	43.5
GNE	"IBM2, Uae1"	ENSG00000159921	"Glucosamine (UDP-N-acetyl)-2-epimerase/N-acetylmannosamine kinase"	Q9Y223	9	36214441-36277042	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"		"Allosteric enzyme, Hydrolase, Kinase, Multifunctional enzyme, Transferase"	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in all"	4	"intestine: 48.4;liver: 90.5;salivary gland: 55.3"	"Cell type enhanced"	"Detected in all"		"Distal enterocytes: 59.3;Hepatocytes: 119.3;Intestinal goblet cells: 88.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in many"		"RPTEC TERT1: 107.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA007045, HPA027258"	Approved		Supported	Cytosol		NA	NA			"Cluster 39: Non-specific - mRNA processing"	"Cluster 85: Liver - Metabolism"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 27: Mucus-secreting cells - Mucin production"	Cytosol		"HPA007045: AB_1079003, HPA027258: AB_1849873"	"unprognostic (7.54e-2)"	"unprognostic (1.61e-2)"	"unprognostic (1.07e-3)"	"unprognostic (7.28e-2)"	"unprognostic (7.00e-2)"	"unprognostic (1.85e-2)"	"unprognostic (2.78e-3)"	"unprognostic (5.39e-2)"	"unprognostic (1.73e-1)"	"unprognostic (1.70e-2)"	"unprognostic (2.88e-3)"	"unprognostic (4.20e-2)"	"prognostic favorable (9.28e-11)"	"unprognostic (2.90e-1)"	"unprognostic (8.28e-2)"	"unprognostic (2.95e-1)"	"unprognostic (1.72e-2)"	11.9	9.0	5.5	8.7	7.4	15.5	15.8	8.9	6.5	11.3	7.9	34.0	4.3	10.3	3.5	11.6	9.1	7.4	7.7	5.5	7.3	10.0	90.5	6.8	7.3	7.7	7.3	14.8	10.2	6.1	4.8	14.2	8.9	15.3	48.4	8.0	55.3	7.2	7.9	3.8	7.6	11.7	6.6	6.2	4.6	4.8	7.1	6.2	6.9	15.3	9.5	14.2	7.5	10.5	9.9	44.4	20.1	17.1	22.5	22.4	29.9	13.5	17.9	19.5	25.1	10.5	32.6	13.5	14.2	24.2	50.5	3.9	15.3	4.6	21.8	25.1	1.4	11.0	26.0	15.2	15.4	0.2	31.2	14.4	4.6	32.0	30.6	14.3	8.4	20.7	14.4	27.3	19.3	1.8	19.1	6.3	11.8	6.7	23.7	15.5	16.3	3.8	107.7	19.4	16.7	15.2	13.7	5.3	12.6	7.1	4.8	12.0	12.2	12.7	12.9	15.5	12.2	11.7	26.0	7.0	17.0	9.8	18.2	0.2	0.5	0.2	0.7	0.6	0.5	0.6	0.9	0.8	0.4	0.9	1.0	1.2	0.3	0.7	0.8	0.6	0.4	0.6	5.5	7.4	8.9	6.5	5.5	7.3	7.7	7.3	8.9	6.6	7.1	10.5	9.7	9.6	10.0	9.4	7.1	1.9	3.1	6.7	1.8	8.4	8.2	7.5	6.7	10.0	16.9	9.2	6.2	8.6	4.3	59.3	1.9	10.4	3.4	7.2	12.1	6.3	11.5	7.8	12.8	6.0	9.5	8.3	2.6	10.6	10.1	9.1	7.1	119.3	2.9	11.8	15.6	88.1	16.2	7.8	4.4	2.4	10.8	5.4	1.8	5.6	6.1	1.9	2.1	32.2	28.2	5.3	20.3	6.4	7.9	6.9	2.9	2.2	18.8	6.9	13.1	10.0	6.3	1.8	2.7	1.2	1.6	19.8	5.7	2.3	26.8	13.4
GNL1	HSR1	ENSG00000204590	"G protein nucleolar 1 (putative)"	P36915	6	30541377-30557174	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Late spermatids: 193.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in single"			"Low lineage specificity"	"Detected in single"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB033575, HPA043338, HPA050455"	Uncertain		Supported	Vesicles		NA	NA		11000	"Cluster 39: Non-specific - mRNA processing"	"Cluster 71: Testis - DNA repair"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 25: Spermatids - Spermatogenesis"	Vesicles		"CAB033575: AB_2109945, HPA043338: AB_2678437, HPA050455: AB_2681132"	"unprognostic (2.76e-2)"	"unprognostic (3.68e-2)"	"unprognostic (2.21e-1)"	"unprognostic (3.53e-2)"	"unprognostic (3.30e-2)"	"unprognostic (2.75e-1)"	"unprognostic (4.22e-2)"	"unprognostic (8.33e-2)"	"unprognostic (1.03e-1)"	"unprognostic (3.84e-2)"	"unprognostic (3.95e-3)"	"unprognostic (7.32e-2)"	"unprognostic (5.67e-3)"	"unprognostic (4.42e-2)"	"unprognostic (2.10e-1)"	"unprognostic (4.15e-1)"	"unprognostic (1.78e-1)"	22.6	19.6	3.3	3.5	3.5	2.0	21.7	2.0	4.0	30.5	1.7	19.3	0.6	27.3	3.9	17.0	26.2	2.4	15.2	2.3	4.8	21.2	13.1	27.8	2.3	3.3	3.0	37.5	24.3	7.8	23.8	2.8	3.5	19.9	3.4	4.1	16.6	3.9	15.0	23.3	17.4	4.5	2.7	18.7	20.0	38.0	4.7	5.0	23.3	1.6	4.6	21.1	22.9	5.4	10.5	2.2	5.9	16.9	10.9	12.8	0.4	3.2	6.4	2.6	4.0	15.1	6.5	4.8	6.2	10.4	25.8	6.9	15.4	12.7	4.4	1.8	9.0	7.8	7.9	1.4	0.0	1.3	5.0	11.0	9.9	20.4	6.7	0.0	1.1	18.6	14.2	0.3	6.5	2.4	3.8	0.2	3.4	8.4	1.6	7.3	3.6	5.3	8.7	4.5	5.2	4.9	4.2	3.1	1.6	2.0	3.0	4.9	6.2	10.5	3.0	2.0	3.7	7.9	9.3	9.9	0.1	6.6	13.1	0.2	0.2	0.2	0.7	0.2	1.0	0.4	0.8	0.9	0.0	0.3	0.1	0.3	0.2	0.4	0.2	0.1	0.5	0.5	3.3	3.5	2.0	4.0	2.3	4.8	3.3	3.0	3.5	2.7	4.7	5.4	48.2	44.8	41.8	17.3	45.0	59.3	104.0	44.1	56.3	40.6	35.4	40.6	14.3	34.3	28.8	25.8	41.7	72.6	36.3	22.6	23.5	38.4	113.1	30.0	40.2	50.8	46.0	13.3	26.2	35.3	65.5	46.4	27.5	47.5	31.7	40.9	50.7	16.9	28.5	16.8	27.0	25.8	26.4	19.8	32.5	193.5	36.4	24.6	28.4	9.4	14.8	30.9	18.6	11.1	10.8	29.9	22.1	32.0	42.6	56.2	32.4	30.3	20.7	34.6	39.5	47.9	58.1	108.4	51.8	36.1	40.6	160.1	46.0	40.9	27.0	66.7
GPR174	FKSG79	ENSG00000147138	"G protein-coupled receptor 174"	Q9BXC1	X	79144688-79175318	"G-protein coupled receptors, Predicted membrane proteins"		"G-protein coupled receptor, Receptor, Transducer"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	5	"lymphoid tissue: 16.9"	"Cell type enhanced"	"Detected in some"		"B-cells: 6.6;dendritic cells: 30.6;Plasma cells: 4.2;T-cells: 18.5"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Group enriched"	"Detected in some"	6	"JURKAT: 42.3;MOLT-4: 75.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA041025, HPA058306"	Enhanced		Supported	"Vesicles,Plasma membrane,Centriolar satellite"		NA	NA			"Cluster 39: Non-specific - mRNA processing"	"Cluster 3: T-cells - Adaptive immune response"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 7: Non-specific - Mitochondria"	"Plasma membrane"	"Vesicles, Centriolar satellite"	"HPA041025: AB_10794260, HPA058306: "	"unprognostic (6.38e-3)"	"unprognostic (9.87e-3)"	"unprognostic (4.36e-2)"	"unprognostic (1.18e-2)"	"unprognostic (1.84e-1)"	"unprognostic (8.48e-4)"	"unprognostic (7.12e-2)"	"unprognostic (1.05e-2)"	"unprognostic (1.75e-1)"	"unprognostic (2.02e-1)"	"unprognostic (2.46e-1)"	"unprognostic (1.05e-1)"	"unprognostic (6.53e-5)"	"unprognostic (2.27e-1)"	"unprognostic (2.64e-2)"	"unprognostic (1.21e-1)"	"unprognostic (1.78e-2)"	0.8	0.4	0.5	6.9	0.3	2.5	0.9	0.6	0.6	0.4	0.3	1.0	2.0	0.5	0.6	0.3	0.3	1.1	0.3	0.4	0.4	0.5	1.0	1.9	15.2	0.7	0.5	0.2	0.1	0.1	0.1	0.2	0.7	0.7	1.6	0.2	1.5	0.1	0.2	0.2	3.6	0.3	0.3	8.1	2.1	0.1	0.4	16.9	0.9	0.1	10.4	1.4	0.6	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	2.9	0.1	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	42.3	0.0	1.2	0.0	0.0	75.1	0.1	0.0	0.0	0.0	2.5	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.4	0.0	0.2	0.0	0.0	0.0	6.5	0.0	3.6	3.6	2.0	1.2	2.5	4.8	6.1	0.1	2.6	4.2	4.9	0.3	4.6	5.5	1.0	4.8	1.6	0.5	0.3	0.6	0.6	0.4	0.4	0.7	0.5	0.7	0.3	0.4	0.5	0.7	0.0	2.4	0.0	6.6	0.1	0.0	0.0	0.0	0.0	0.7	0.6	0.0	0.0	0.6	1.8	0.0	0.0	30.6	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.0	0.0	0.0	0.0	0.0	2.4	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.3	0.0	0.0	0.1	0.0	3.1	0.0	0.0	0.0	0.0	0.0	4.2	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	18.5	0.1	0.0	0.0
GRSF1		ENSG00000132463	"G-rich RNA sequence binding factor 1"	Q12849	4	70815783-70839897	"Predicted intracellular proteins"	"mRNA processing, tRNA processing"	RNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 275.2"	"Cell type enhanced"	"Detected in all"		"monocytes: 301.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA036984, HPA036985"	Enhanced		Enhanced	Mitochondria		NA	NA			"Cluster 39: Non-specific - mRNA processing"	"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 3: Monocytes - Immune response regulation"	Mitochondria		"HPA036984: AB_2675415, HPA036985: AB_10672785"	"unprognostic (1.45e-3)"	"unprognostic (1.82e-2)"	"prognostic favorable (1.47e-5)"	"unprognostic (8.63e-2)"	"unprognostic (6.73e-2)"	"unprognostic (4.15e-3)"	"prognostic unfavorable (8.29e-5)"	"unprognostic (1.94e-1)"	"unprognostic (1.43e-1)"	"unprognostic (1.66e-2)"	"unprognostic (7.68e-2)"	"unprognostic (8.05e-2)"	"prognostic favorable (2.72e-9)"	"unprognostic (6.12e-2)"	"unprognostic (1.23e-1)"	"unprognostic (1.78e-1)"	"unprognostic (9.65e-3)"	38.0	61.2	38.4	36.9	37.7	23.7	37.7	42.5	47.1	36.3	58.9	54.6	43.1	32.5	34.0	42.0	43.0	35.2	80.7	41.0	44.5	55.8	54.4	35.5	47.4	40.3	42.3	38.4	62.0	48.8	21.5	43.8	41.6	39.9	62.7	25.4	83.9	35.3	275.2	32.0	41.3	40.0	40.7	34.6	50.8	32.8	40.9	76.0	45.7	155.0	53.7	50.3	25.8	46.1	116.9	78.1	90.0	94.5	93.5	108.1	128.3	138.2	87.3	102.3	83.5	80.5	117.1	167.6	102.9	143.7	53.0	43.4	161.3	108.6	135.9	91.3	52.8	88.4	75.2	112.4	115.1	130.8	48.7	91.9	102.2	103.6	71.6	123.0	106.9	91.9	102.6	94.7	144.2	124.9	217.4	92.0	96.3	127.1	80.9	88.2	139.8	71.6	126.1	144.0	93.4	84.0	65.3	183.6	234.3	104.7	79.8	63.3	98.4	95.1	99.7	79.4	88.7	78.1	66.2	106.4	78.6	83.6	94.5	12.7	17.4	7.7	10.1	12.3	12.2	7.4	14.6	15.5	28.1	6.1	14.4	12.6	2.0	20.0	15.2	27.2	13.3	8.4	38.4	37.7	42.5	47.1	41.0	44.5	40.3	42.3	41.6	40.7	40.9	46.1	27.8	32.1	36.6	19.6	38.0	50.0	53.7	32.9	48.3	18.2	37.7	28.3	135.5	40.0	30.4	27.6	25.0	106.2	57.4	52.9	74.3	70.3	7.6	53.8	40.4	33.0	69.0	41.2	35.1	61.3	141.3	41.2	65.2	44.5	17.2	60.2	35.0	50.9	63.2	28.6	30.5	73.5	36.7	66.3	53.7	6.7	34.8	45.4	62.2	24.4	301.5	23.8	41.2	21.6	28.0	60.1	46.7	39.1	58.7	65.9	47.1	74.1	27.6	19.6	19.7	38.4	46.2	35.0	61.8	69.7	50.4	77.2	45.1	99.0	89.3	67.0
GUF1	FLJ13220	ENSG00000151806	"GUF1 homolog, GTPase"	Q8N442	4	44678420-44700928	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	"Protein biosynthesis"	Hydrolase	"Disease variant, Epilepsy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA003934, HPA024222"	Approved		Approved	Nucleoplasm,Mitochondria		NA	NA			"Cluster 39: Non-specific - mRNA processing"	"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 39: Non-specific - Basic cellular processes"	"Nucleoplasm, Mitochondria"		"HPA003934: AB_1079034, HPA024222: AB_2671488"	"unprognostic (1.32e-2)"	"unprognostic (1.55e-1)"	"unprognostic (1.66e-2)"	"unprognostic (3.65e-3)"	"unprognostic (7.56e-2)"	"unprognostic (1.37e-1)"	"unprognostic (5.59e-2)"	"unprognostic (2.60e-1)"	"unprognostic (1.37e-2)"	"unprognostic (3.03e-2)"	"unprognostic (1.56e-3)"	"unprognostic (7.38e-3)"	"prognostic favorable (2.66e-6)"	"unprognostic (4.98e-3)"	"unprognostic (1.74e-1)"	"prognostic unfavorable (1.65e-5)"	"unprognostic (5.40e-2)"	5.2	4.1	2.5	3.9	3.2	6.3	5.2	4.3	3.6	3.5	0.6	5.7	4.6	4.8	3.8	5.2	4.1	2.7	6.1	3.3	2.5	6.9	7.1	3.1	4.7	1.6	1.9	4.9	3.7	4.3	2.4	3.7	1.9	4.9	5.9	6.7	4.0	3.5	15.8	5.0	6.3	3.5	2.4	4.8	7.9	5.9	2.2	4.4	5.3	17.0	4.6	3.9	3.8	4.4	11.9	6.0	10.9	13.9	4.4	9.0	24.0	16.1	8.2	16.2	12.4	10.5	8.3	25.8	12.3	7.7	14.9	9.2	18.7	18.2	18.2	8.7	12.2	30.7	5.3	7.2	14.3	33.4	12.7	9.2	8.1	12.1	10.5	7.6	11.8	15.0	31.7	4.9	13.2	5.9	19.1	7.0	7.0	8.5	13.8	13.5	22.5	11.0	4.8	4.6	14.8	11.1	10.1	4.2	11.2	8.4	6.8	9.6	11.7	11.0	12.7	14.8	19.1	17.9	17.4	18.3	11.9	19.7	9.6	0.5	2.2	2.3	2.0	2.9	2.6	2.1	2.1	1.8	2.1	1.7	1.9	2.0	0.0	2.3	1.9	2.3	3.6	1.9	2.5	3.2	4.3	3.6	3.3	2.5	1.6	1.9	1.9	2.4	2.2	4.4	7.2	6.4	9.5	9.8	11.6	4.0	9.6	6.0	5.2	10.5	9.8	7.5	22.8	7.2	9.1	7.3	2.1	13.1	10.1	11.5	13.7	10.3	2.0	12.0	14.3	8.1	11.4	14.9	20.3	10.2	17.6	9.7	18.3	8.8	1.3	16.6	7.9	13.9	12.1	11.8	19.5	12.4	4.1	11.7	5.4	2.9	5.6	9.0	7.2	9.4	9.2	9.2	14.4	18.6	19.0	16.4	6.6	7.2	13.9	9.8	11.3	12.2	16.7	10.3	0.0	6.8	10.0	12.3	14.6	14.9	7.1	13.4	9.5	18.9	13.3	10.6
H1-5	"H1b, H1F5, H1s-3, HIST1H1B"	ENSG00000184357	"H1.5 linker histone, cluster member"	P16401	6	27866792-27867588	"Plasma proteins, Predicted intracellular proteins"		DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	7	"bone marrow: 7.8;brain: 4.6;choroid plexus: 4.1;lymphoid tissue: 2.1"	"Cell type enhanced"	"Detected in some"		"Cytotrophoblasts: 1.5;dendritic cells: 2.2;Extravillous trophoblasts: 4.7;Hofbauer cells: 3.3"	"Cancer enhanced"	"Detected in many"		"colorectal cancer: 4.6"	"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in many"			"Group enriched"	"Detected in many"	5	"B-cells: 10.3;dendritic cells: 12.1;T-cells: 3.3"	"Cell line enhanced"	"Detected in some"		"MOLT-4: 9.2;NB-4: 4.9;U-698: 3.9"	"Not detected"	"Not detected"							"CAB012241, HPA055907, HPA060331"	Supported		Supported	Nucleoplasm		NA	NA		2300000	"Cluster 39: Non-specific - mRNA processing"	"Cluster 76: Brain & Bone marrow - Chromatin organization"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 24: Non-specific - Transcription regulation"	Nucleoplasm		"CAB012241: , HPA055907: AB_2682966, HPA060331: "	"unprognostic (2.34e-1)"	"unprognostic (3.75e-4)"	"unprognostic (2.12e-2)"	"unprognostic (3.63e-2)"	"unprognostic (1.05e-1)"	"unprognostic (2.37e-2)"	"unprognostic (1.91e-2)"	"unprognostic (4.93e-2)"	"unprognostic (1.20e-1)"	"unprognostic (8.47e-2)"	"unprognostic (6.23e-3)"	"unprognostic (5.85e-2)"		"unprognostic (5.68e-4)"	"unprognostic (2.10e-1)"	"unprognostic (9.79e-2)"	"unprognostic (1.35e-1)"	0.1	0.0	1.5	0.2	0.9	7.8	0.1	4.0	1.0	0.0	4.1	0.3	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.5	1.2	0.0	0.0	0.1	1.6	1.8	2.3	0.0	0.0	0.0	0.0	0.3	3.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.7	0.0	1.5	0.4	0.1	0.1	3.8	2.1	0.0	0.0	0.3	0.3	0.0	4.6	1.4	0.0	0.5	0.0	0.0	0.0	1.0	0.4	0.3	0.7	0.3	0.4	0.9	1.7	0.2	0.5	0.4	0.5	0.0	0.0	0.0	0.6	0.8	2.2	0.1	0.0	0.0	0.0	0.5	0.0	0.0	0.7	0.0	0.0	0.5	1.1	1.7	1.2	0.0	0.2	9.2	4.9	1.4	1.3	0.0	2.7	0.0	0.0	0.2	0.0	1.2	0.6	1.5	0.3	0.0	0.4	0.6	1.6	0.5	0.8	0.1	0.8	0.6	1.8	0.0	3.9	1.2	0.6	0.8	0.0	0.9	0.0	3.1	0.8	1.5	4.6	2.9	3.2	5.1	10.3	1.7	1.9	0.8	1.7	1.1	12.1	3.3	2.1	1.5	0.9	4.0	1.0	0.5	1.2	1.8	2.3	3.0	1.5	3.8	4.6	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	1.5	2.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	4.7	0.2	0.0	0.0	0.0	0.0	0.0	0.0	3.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.2	0.0	0.0	0.0
H2AC21	HIST2H2AB	ENSG00000184270	"H2A clustered histone 21"	Q8IUE6	1	149887469-149887965	"Predicted intracellular proteins"		DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	4	"brain: 15.3"	"Not detected"	"Not detected"			"Low cancer specificity"	"Detected in some"			"Region enhanced"	"Detected in many"		"cerebellum: 15.3"	"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in some"		"MOLT-4: 3.3;NB-4: 1.9;U-266/70: 1.6;U-266/84: 1.9"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"CAB011483, HPA041189"	Supported		Supported	Nucleoplasm		NA	NA			"Cluster 39: Non-specific - mRNA processing"	"Cluster 69: Cerebellum - Gene expression regulation"	"Cluster 24: NB-4 - Immune response"	"Cluster 24: Non-specific - Transcription regulation"	Nucleoplasm		"CAB011483: AB_732909, HPA041189: AB_2677357"	"unprognostic (6.31e-2)"	"unprognostic (6.63e-2)"	"unprognostic (2.22e-2)"	"unprognostic (2.31e-1)"	"unprognostic (3.09e-1)"	"unprognostic (3.34e-1)"	"unprognostic (2.42e-3)"	"unprognostic (1.99e-1)"	"unprognostic (1.53e-1)"	"unprognostic (2.03e-1)"	"unprognostic (1.84e-1)"	"unprognostic (1.69e-1)"		"unprognostic (9.97e-3)"	"unprognostic (5.33e-2)"	"unprognostic (2.00e-2)"	"unprognostic (4.36e-2)"	0.2	0.1	3.3	0.0	4.6	3.4	0.3	15.3	3.0	0.4	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	1.7	3.0	0.1	0.1	0.2	0.0	0.5	1.3	0.3	0.1	0.0	0.0	0.0	1.0	0.1	0.0	0.0	0.1	0.0	0.2	0.6	0.5	0.0	1.5	0.3	0.1	0.1	2.3	0.3	0.1	0.0	0.0	0.1	0.2	3.7	0.5	0.0	0.2	0.2	0.0	0.0	0.4	0.3	0.0	0.0	0.4	0.0	0.3	0.4	0.2	0.0	0.0	0.4	0.3	0.0	0.0	0.1	0.7	0.2	0.4	0.2	0.0	0.0	0.5	0.0	0.0	0.2	0.0	0.0	0.0	0.3	0.4	0.3	0.2	0.0	3.3	1.9	0.4	0.3	0.5	0.7	0.2	0.7	0.0	0.1	0.6	0.4	0.8	0.0	0.1	0.0	0.2	1.4	0.0	0.3	1.2	0.0	0.3	1.6	1.9	0.5	0.6	0.1	0.2	1.5	1.9	0.8	2.2	1.7	2.0	3.7	3.7	3.3	2.1	6.6	2.3	2.5	9.8	3.6	2.0	4.0	2.0	0.5	3.3	4.6	15.3	3.0	1.7	3.0	0.5	1.3	1.0	1.5	2.3	3.7	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.1	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0
H2BC10	"H2B/k, H2BFK, HIST1H2BI"	ENSG00000278588	"H2B clustered histone 10"	P62807	6	26272931-26273412	"Plasma proteins, Predicted intracellular proteins"		"Antibiotic, Antimicrobial, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	6	"bone marrow: 2.1;brain: 3.4;choroid plexus: 1.7;lymphoid tissue: 2.1"	"Not detected"	"Not detected"			"Cancer enhanced"	"Detected in some"		"colorectal cancer: 1.5"	"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"MOLT-4: 8.7;THP-1: 3.7"									"HPA042205, HPA043013, HPA048671"	Supported		Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 39: Non-specific - mRNA processing"	"Cluster 76: Brain & Bone marrow - Chromatin organization"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 24: Non-specific - Transcription regulation"	Nucleoplasm	Cytosol	"HPA042205: AB_2677900, HPA043013: AB_2678269, HPA048671: AB_2680488"	"unprognostic (1.59e-1)"	"unprognostic (7.10e-2)"	"unprognostic (8.53e-2)"	"unprognostic (1.52e-1)"	"unprognostic (2.80e-1)"	"unprognostic (2.03e-2)"		"unprognostic (1.02e-1)"		"unprognostic (7.22e-3)"				"unprognostic (4.82e-2)"	"unprognostic (1.05e-1)"	"unprognostic (1.10e-1)"	"unprognostic (1.01e-2)"	0.3	0.0	0.1	0.2	0.3	2.1	0.1	3.4	0.9	0.3	1.7	0.2	0.0	0.0	0.0	0.2	0.1	0.1	0.1	0.3	0.4	0.1	0.1	0.4	0.9	1.4	1.2	0.0	0.0	0.0	0.0	0.1	1.4	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.4	0.0	0.9	0.4	0.1	0.3	1.5	2.1	0.2	0.0	0.2	0.1	0.4	1.9	1.1	0.4	0.6	0.0	0.0	0.0	0.1	0.5	0.3	0.9	2.5	0.4	0.1	0.5	0.3	0.2	0.4	0.6	0.9	0.2	0.4	1.6	0.0	0.2	0.5	0.3	0.0	0.0	0.2	0.0	0.2	0.0	0.0	0.0	0.8	1.3	0.0	2.2	0.0	0.3	8.7	1.5	1.6	0.3	0.0	2.3	0.0	2.7	0.0	0.2	0.2	0.5	0.6	0.5	0.0	0.0	0.0	3.7	0.5	0.4	0.0	0.3	1.8	1.9	0.3	0.0	0.5	0.3	1.2	0.0	0.2	0.0	1.2	0.5	0.7	0.7	1.2	1.6	0.2	1.4	0.4	0.3	0.3	0.1	0.0	0.1	0.5	0.1	0.1	0.3	3.4	0.9	0.3	0.4	1.4	1.2	1.4	0.9	1.5	1.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0
H2BC14	"dJ160A22.3, H2B/e, H2BFE, HIST1H2BM"	ENSG00000273703	"H2B clustered histone 14"	Q99879	6	27815022-27815489	"Predicted intracellular proteins"		DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"bone marrow: 3.5;lymphoid tissue: 3.1"	"Not detected"	"Not detected"			"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in some"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"Karpas-707: 14.8;NB-4: 9.9;REH: 6.2;U-266/70: 12.3;U-698: 5.9"	"Not detected"	"Not detected"							"HPA042205, HPA043013, HPA048671"	Supported		Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 39: Non-specific - mRNA processing"	"Cluster 53: Non-specific - Cell cycle regulation"	"Cluster 29: U-266 - Adaptive immune response"	"Cluster 24: Non-specific - Transcription regulation"	Nucleoplasm	Cytosol	"HPA042205: AB_2677900, HPA043013: AB_2678269, HPA048671: AB_2680488"	"unprognostic (3.83e-1)"	"unprognostic (8.85e-4)"	"unprognostic (3.74e-1)"	"unprognostic (2.00e-1)"	"unprognostic (3.00e-1)"	"unprognostic (1.11e-1)"		"unprognostic (1.38e-1)"		"unprognostic (3.37e-1)"	"unprognostic (9.46e-3)"	"unprognostic (3.02e-1)"		"unprognostic (1.04e-1)"	"unprognostic (5.70e-1)"		"unprognostic (2.65e-1)"	0.5	0.0	0.1	0.3	0.5	3.5	0.0	1.2	0.6	1.1	0.2	0.3	0.0	0.1	0.0	0.4	0.0	0.3	0.1	0.4	0.4	0.3	0.2	0.5	1.5	0.4	0.7	0.2	0.0	0.0	0.0	0.1	0.7	0.5	0.2	0.0	0.1	0.0	0.0	0.2	0.2	0.0	0.6	1.0	0.2	0.4	0.8	3.1	0.2	0.0	1.1	0.0	1.0	1.1	1.5	0.0	0.2	0.0	0.0	0.0	1.0	0.3	0.2	0.3	1.5	0.3	0.2	1.9	0.0	0.0	0.4	0.9	0.0	0.0	0.0	1.1	0.0	0.7	0.2	0.6	0.0	0.0	1.6	0.0	0.0	0.6	0.0	0.0	0.0	0.5	0.1	14.8	0.0	0.4	4.0	9.9	2.8	0.9	0.6	6.2	0.0	0.3	0.0	0.0	0.2	1.7	0.6	0.9	0.0	0.1	0.8	3.0	0.0	0.0	1.6	1.0	0.1	12.3	0.5	5.9	0.9	1.0	0.7	0.0	0.0	0.0	0.2	0.0	0.4	0.3	0.4	0.3	0.1	0.4	0.0	0.2	0.0	0.3	0.0	0.0	0.1	0.0	0.1	0.5	1.2	0.6	0.4	0.4	0.4	0.7	0.7	0.6	0.8	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
H3C12	"H3/j, H3FJ, HIST1H3J"	ENSG00000197153	"H3 clustered histone 12"	P68431	6	27890315-27893106	"Disease related genes, Predicted intracellular proteins"		DNA-binding	"Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"bone marrow: 1.2;brain: 2.1;choroid plexus: 1.3;lymphoid tissue: 1.1"	"Not detected"	"Not detected"			"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in some"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"Daudi: 4.4;U-266/84: 11.7"									HPA042570	Approved					NA	NA			"Cluster 39: Non-specific - mRNA processing"	"Cluster 76: Brain & Bone marrow - Chromatin organization"	"Cluster 16: U-266 - Nucleosome"				"HPA042570: AB_2678056"	"unprognostic (1.15e-1)"	"unprognostic (4.48e-2)"	"unprognostic (1.99e-1)"	"unprognostic (1.47e-2)"	"unprognostic (3.18e-1)"	"unprognostic (1.71e-4)"	"unprognostic (2.91e-2)"	"unprognostic (4.09e-3)"	"unprognostic (6.37e-3)"	"unprognostic (6.67e-2)"	"unprognostic (4.68e-3)"	"unprognostic (1.34e-1)"	"unprognostic (2.63e-8)"	"unprognostic (2.11e-1)"	"unprognostic (2.51e-1)"	"unprognostic (4.82e-3)"	"unprognostic (8.04e-2)"	0.0	0.0	0.2	0.0	0.4	1.2	0.1	0.6	0.6	0.1	1.3	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.3	0.4	0.0	0.1	0.1	1.0	0.9	2.1	0.0	0.0	0.0	0.0	0.2	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.6	0.4	0.0	0.3	0.9	1.1	0.0	0.0	0.2	0.1	0.1	1.3	0.9	0.3	1.3	0.6	0.5	0.2	0.6	0.3	0.0	0.7	0.1	0.0	0.2	4.4	0.7	0.2	0.5	0.1	0.9	0.5	0.0	0.2	0.4	0.8	1.8	0.0	0.2	0.1	0.1	0.0	0.0	0.3	0.0	0.0	0.3	0.5	1.9	1.0	0.0	0.5	2.0	2.5	1.7	0.8	0.2	1.0	0.3	0.4	0.0	0.0	2.3	1.0	1.5	1.4	0.0	0.2	0.4	0.5	0.0	0.5	0.0	0.1	0.2	3.1	11.7	1.1	0.5	0.4	1.4	0.0	0.0	0.0	0.4	0.1	0.0	0.0	0.7	0.9	0.7	0.5	0.1	0.2	0.0	0.3	0.2	0.1	0.7	0.1	0.2	0.4	0.6	0.6	0.3	0.4	0.9	2.1	1.5	0.6	0.9	1.3	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0
H3C2	"H3/l, H3FL, HIST1H3B"	ENSG00000286522	"H3 clustered histone 2"	P68431	6	26031589-26032099	"Cancer-related genes, Disease related genes, Predicted intracellular proteins"		DNA-binding	"Cancer-related genes, Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	13	"bone marrow: 6.4;brain: 4.1;choroid plexus: 1.6;lymphoid tissue: 1.7"	"Not detected"	"Not detected"							"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"U-266/84: 8.4"									HPA042570	Approved					NA	NA			"Cluster 39: Non-specific - mRNA processing"		"Cluster 16: U-266 - Nucleosome"				"HPA042570: AB_2678056"																		0.0	0.1	1.3	0.1	0.8	6.4	0.1	0.3	1.0	0.0	1.6	0.1	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.6	0.7	0.0	0.0	0.0	0.5	1.0	2.2	0.0	0.0	0.0		0.1	2.2	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.6	0.0	0.0	0.1	4.1	1.7	0.1	0.2	0.0	0.0		3.2	1.2	2.7	1.1	2.5	0.0	0.2	0.0	0.1	0.4	0.4	0.4	0.6	0.9	2.0	1.4	0.2	0.7	0.4	0.9	0.7	0.9	1.4	2.7	2.1	4.0	0.8	0.0	1.6	1.4	1.6	0.0	0.3	0.0	0.0	0.5	0.6	4.3	3.8	0.6	0.6	5.0	5.0	2.0	0.5	1.9	2.9	1.8	5.6	0.3	0.0	1.3	1.1	3.9	1.0	0.3	0.0	1.8	1.0	0.9	0.8	3.1	0.4	1.2	6.3	8.4	2.6	2.1	2.9	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.2	0.4	1.3	0.8	0.3	1.0	0.6	0.7	1.0	2.2	2.2	0.6	4.1	3.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
HMGXB3	"HMGX3, KIAA0194, SMF"	ENSG00000113716	"HMG-box containing 3"	Q12766	5	150000046-150053142	"Plasma proteins, Predicted intracellular proteins, Transcription factors"		DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	6	"parathyroid gland: 117.1"	"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA005967			Approved	Nucleoli		NA	NA			"Cluster 39: Non-specific - mRNA processing"	"Cluster 48: Parathyroid gland - membrane proteins"	"Cluster 4: Mesenchymal cell lines - Antiviral immune response"	"Cluster 52: Non-specific - Transcription"	Nucleoli		"HPA005967: AB_1080044"	"unprognostic (3.66e-2)"	"unprognostic (3.74e-1)"	"unprognostic (1.47e-1)"	"unprognostic (1.33e-3)"	"unprognostic (1.17e-1)"	"unprognostic (3.82e-2)"	"prognostic unfavorable (3.37e-5)"	"unprognostic (9.72e-2)"	"unprognostic (3.36e-1)"	"unprognostic (3.89e-3)"	"unprognostic (3.74e-2)"	"unprognostic (2.11e-1)"	"unprognostic (3.24e-3)"	"unprognostic (1.30e-1)"	"unprognostic (2.11e-1)"	"unprognostic (2.06e-1)"	"unprognostic (2.14e-2)"	13.9	17.0	10.4	9.5	11.4	20.0	17.3	10.2	12.0	14.1	14.2	11.8	8.0	14.2	15.3	10.6	14.5	12.4	12.7	11.0	10.6	14.6	13.5	16.5	11.8	10.5	11.4	15.3	13.6	117.1	17.1	12.5	10.3	20.2	11.0	11.6	13.3	12.5	14.6	15.2	11.6	11.4	10.1	16.1	14.1	14.3	12.9	14.9	16.0	13.3	12.0	12.4	11.8	12.3	23.5	27.2	19.4	30.6	27.2	22.6	32.8	22.2	41.1	33.0	41.7	39.7	28.5	22.3	25.4	31.3	70.7	17.0	36.9	39.9	29.0	20.9	26.0	19.4	30.8	20.1	38.3	38.0	42.8	30.1	29.3	48.9	39.1	42.6	24.5	17.8	26.2	23.2	36.4	19.5	23.5	20.9	14.4	16.1	41.2	20.6	26.1	21.9	20.8	29.6	24.1	24.6	19.3	48.2	51.4	16.8	22.3	25.6	20.5	49.3	21.0	24.2	42.2	27.0	27.0	31.5	57.2	29.2	26.0	3.5	2.5	2.3	3.3	3.1	2.6	3.0	2.8	2.4	3.2	2.6	2.1	2.4	0.2	1.2	2.1	2.5	4.4	2.1	10.4	11.4	10.2	12.0	11.0	10.6	10.5	11.4	10.3	10.1	12.9	12.3	34.8	9.6	12.8	14.0	22.0	11.3	27.0	14.2	17.6	29.5	33.2	26.7	8.0	11.5	17.0	9.2	35.5	16.3	36.1	13.3	21.5	22.2	6.2	47.7	37.5	24.7	15.5	12.8	20.4	21.9	12.6	23.9	30.1	47.5	18.3	36.7	15.0	12.6	27.9	72.3	20.0	12.8	6.1	11.9	13.7	3.1	13.4	18.9	3.6	16.9	23.5	19.8	29.9	15.1	18.5	34.3	8.4	12.4	29.5	41.1	7.4	13.8	24.7	43.1	13.1	23.5	19.5	28.9	24.4	15.6	12.1	15.5	23.3	42.8	15.6	29.4
HNRNPA0	HNRPA0	ENSG00000177733	"Heterogeneous nuclear ribonucleoprotein A0"	Q13151	5	137745651-137754363	"Plasma proteins, Predicted intracellular proteins"		"Ribonucleoprotein, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA036569, HPA059404"	Enhanced		Enhanced	Nucleoplasm		No	No		150000	"Cluster 39: Non-specific - mRNA processing"	"Cluster 50: Non-specific - Ribosome"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 48: Smooth muscle cells - ECM organization"	Nucleoplasm		"HPA036569: AB_10670840, HPA059404: AB_2684004"	"unprognostic (5.51e-2)"	"unprognostic (4.86e-2)"	"unprognostic (2.00e-2)"	"unprognostic (3.78e-1)"	"unprognostic (8.99e-2)"	"unprognostic (2.52e-1)"	"unprognostic (2.65e-3)"	"unprognostic (1.06e-1)"	"unprognostic (1.77e-1)"	"unprognostic (1.23e-1)"	"prognostic favorable (3.74e-4)"	"unprognostic (6.86e-2)"	"prognostic favorable (1.99e-4)"	"unprognostic (2.34e-1)"	"unprognostic (4.57e-1)"	"unprognostic (2.66e-2)"	"unprognostic (7.39e-2)"	21.9	23.8	11.1	14.5	10.9	32.1	19.2	14.8	12.1	22.3	8.3	19.0	13.7	28.5	10.7	20.1	23.2	10.2	18.1	10.8	13.4	14.8	14.8	19.1	15.7	10.9	10.4	30.3	17.5	12.3	15.5	15.6	10.9	15.2	10.7	10.9	14.5	11.9	18.1	19.8	19.1	16.1	10.2	18.0	19.4	12.9	12.6	28.7	17.6	12.8	14.6	19.1	19.1	11.8	36.9	36.2	68.6	69.7	33.1	20.9	70.3	27.6	22.7	24.2	27.8	67.8	28.3	66.3	38.9	23.7	26.6	33.1	37.4	42.8	29.4	33.6	52.1	42.9	22.5	41.6	30.4	39.8	43.9	34.0	29.6	19.2	22.0	26.6	34.0	59.0	35.7	43.2	24.7	47.8	75.0	53.2	53.7	17.3	26.1	88.6	50.0	33.8	24.2	41.7	86.6	70.5	35.6	24.5	49.1	74.8	31.1	45.6	33.4	38.6	32.8	21.6	53.3	43.4	37.6	46.8	25.0	45.4	38.9	2.7	1.4	4.6	2.9	2.1	3.4	2.1	2.8	3.0	2.3	2.5	3.0	3.2	1.3	4.4	2.5	3.2	1.7	1.1	11.1	10.9	14.8	12.1	10.8	13.4	10.9	10.4	10.9	10.2	12.6	11.8	151.5	86.6	53.6	7.2	251.2	550.9	436.4	290.2	390.9	85.1	197.5	136.1	36.1	155.8	138.6	101.2	37.5	347.9	234.6	88.8	172.1	257.5	25.5	108.6	172.1	204.4	236.4	179.6	11.3	146.5	478.1	237.2	141.7	126.8	95.8	162.4	192.1	77.0	191.7	84.1	11.5	181.2	229.9	142.3	416.4	44.9	157.8	142.4	281.1	11.2	228.6	137.1	213.1	15.6	16.8	201.6	157.2	150.8	138.9	313.1	147.3	146.9	65.3	62.9	85.5	271.8	221.9	144.0	72.8	247.6	484.3	365.7	267.5	155.8	242.0	401.0
HNRNPA1	"ALS20, hnRNP-A1, HNRPA1"	ENSG00000135486	"Heterogeneous nuclear ribonucleoprotein A1"	P09651	12	54280193-54287088	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"	"Host-virus interaction, mRNA processing, mRNA splicing, mRNA transport, Transport"	"Ribonucleoprotein, RNA-binding"	"Amyotrophic lateral sclerosis, Disease variant, Neurodegeneration"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA001609, HPA001666, HPA005812, HPA007185, CAB010894"	Supported		Enhanced	Nucleoplasm		NA	NA		9300000	"Cluster 39: Non-specific - mRNA processing"	"Cluster 50: Non-specific - Ribosome"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 32: Non-specific - Translation"	Nucleoplasm		"CAB010894: AB_261962, HPA001609: AB_2666383, HPA001666: AB_1850836, HPA005812: AB_2667441, HPA007185: AB_2667768"	"unprognostic (1.38e-3)"	"unprognostic (1.90e-1)"	"unprognostic (1.59e-2)"	"unprognostic (5.98e-3)"	"unprognostic (2.82e-2)"	"unprognostic (2.46e-1)"	"unprognostic (1.22e-2)"	"unprognostic (9.71e-2)"	"unprognostic (3.34e-2)"	"unprognostic (2.91e-2)"	"unprognostic (3.72e-2)"	"unprognostic (3.51e-2)"	"unprognostic (6.88e-3)"	"unprognostic (2.32e-2)"	"unprognostic (1.14e-1)"	"unprognostic (1.48e-1)"	"unprognostic (9.54e-3)"	531.6	410.2	339.5	528.1	362.6	1087.9	640.6	348.2	424.9	750.3	326.5	542.3	447.5	625.3	474.8	510.3	589.2	214.7	391.4	320.7	363.0	501.4	277.0	380.6	685.7	363.3	348.2	1410.2	556.7	359.8	327.2	447.9	364.8	458.9	445.9	261.2	398.9	409.6	437.4	506.3	436.4	382.1	380.9	434.1	431.0	168.9	343.9	1010.9	396.3	174.4	824.8	513.7	580.9	372.6	1246.7	815.8	2072.5	1717.3	550.5	1057.0	1204.0	911.9	1405.6	1311.7	1153.1	1225.4	1306.6	3183.8	983.8	671.8	354.7	1045.9	1486.5	1393.4	1425.5	1216.4	1041.7	1700.0	1156.1	2250.0	320.4	2712.4	1078.2	845.2	568.3	642.9	1056.1	868.7	1408.6	1474.7	1930.7	1215.3	968.2	1244.6	2969.1	2880.9	2571.8	844.0	675.9	2911.7	1588.9	1574.1	1239.4	1395.0	1260.4	1739.0	758.0	1675.2	1392.3	1031.6	1010.9	1744.5	1063.1	781.6	1164.2	820.6	1395.1	1185.7	1349.3	2249.7	572.5	1646.7	744.0	140.4	423.5	165.9	572.8	513.1	893.3	576.5	746.2	657.5	704.5	501.8	851.2	810.1	41.0	823.3	437.7	556.5	683.4	1333.2	339.5	362.6	348.2	424.9	320.7	363.0	363.3	348.2	364.8	380.9	343.9	372.6	372.4	304.5	521.4	20.9	1018.9	1416.1	1039.8	1252.9	900.9	254.1	745.1	541.3	166.2	697.7	612.0	294.3	93.8	2076.2	900.8	407.3	739.6	1296.2	181.5	304.7	706.7	624.8	824.0	1032.4	16.5	2124.2	2894.5	600.5	458.7	400.7	528.9	790.7	562.2	183.1	1006.9	109.4	18.3	1130.9	459.8	863.9	1048.2	115.6	1050.7	609.2	588.7	21.5	1374.4	411.0	1304.9	23.1	34.1	1162.7	731.2	741.8	702.2	696.8	693.2	838.6	288.3	195.2	453.6	714.5	704.1	217.0	338.1	1030.6	1261.9	2178.8	958.6	690.9	1543.8	897.8
HNRNPM	"CEAR, HNRNPM4, HNRPM, HNRPM4, HTGR1, NAGR1"	ENSG00000099783	"Heterogeneous nuclear ribonucleoprotein M"	P52272	19	8444767-8489114	"Plasma proteins, Predicted intracellular proteins"	"mRNA processing, mRNA splicing"	"Ribonucleoprotein, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB016113, HPA024344"	Supported		Enhanced	Nucleoplasm		NA	NA		440000	"Cluster 39: Non-specific - mRNA processing"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 10: Non-specific - Unknown function"	Nucleoplasm		"CAB016113: AB_627739, HPA024344: AB_1850879"	"unprognostic (2.12e-1)"	"unprognostic (8.59e-2)"	"unprognostic (2.51e-2)"	"unprognostic (2.06e-2)"	"unprognostic (1.27e-1)"	"unprognostic (1.52e-3)"	"prognostic unfavorable (1.80e-6)"	"unprognostic (2.44e-1)"	"unprognostic (2.59e-2)"	"unprognostic (6.91e-3)"	"unprognostic (4.70e-3)"	"unprognostic (7.34e-2)"	"unprognostic (3.62e-2)"	"unprognostic (1.22e-3)"	"unprognostic (1.02e-1)"	"unprognostic (2.17e-1)"	"unprognostic (1.73e-1)"	97.2	83.9	55.6	126.3	63.0	230.9	94.4	66.0	63.8	104.4	61.4	108.3	98.4	113.8	57.1	126.4	92.5	54.4	89.1	51.6	61.0	92.4	89.4	90.6	141.3	60.7	59.1	121.9	84.1	90.5	71.5	87.5	60.8	76.6	91.9	127.7	93.0	75.4	148.6	106.5	100.8	88.0	57.2	110.5	90.9	78.1	59.8	166.3	93.2	62.1	156.0	93.2	101.5	69.3	477.5	315.7	580.8	236.3	131.4	145.2	373.7	279.3	208.5	340.3	256.9	452.4	141.4	697.4	363.4	254.3	242.4	286.3	603.3	349.4	425.1	437.5	501.0	620.1	312.2	439.8	136.3	640.0	317.4	150.5	173.4	289.2	119.9	100.0	309.7	256.3	632.3	193.6	273.3	324.3	617.2	556.8	505.1	258.2	381.1	687.8	508.1	330.5	179.6	452.9	320.7	356.8	469.5	250.4	278.8	276.8	299.0	378.4	362.9	294.5	357.4	313.6	529.2	285.4	560.8	791.4	221.7	511.4	329.1	21.3	78.4	48.0	91.2	93.4	91.7	69.6	79.0	91.6	86.6	61.4	84.3	83.0	20.0	86.0	71.8	86.3	87.6	94.5	55.6	63.0	66.0	63.8	51.6	61.0	60.7	59.1	60.8	57.2	59.8	69.3	157.1	128.2	189.0	48.6	154.1	166.3	204.8	240.8	105.9	199.6	143.8	125.1	92.1	118.7	240.8	117.7	70.9	272.8	170.3	95.5	97.8	237.4	13.2	150.6	194.7	164.3	190.4	211.5	43.3	273.1	304.4	141.7	76.0	190.2	267.4	136.3	111.4	148.5	174.4	138.0	46.5	154.6	138.4	127.2	139.8	18.3	113.4	137.7	110.3	59.0	212.5	186.1	219.4	60.8	79.8	202.2	102.9	142.1	118.7	92.7	77.8	106.0	193.1	213.6	210.4	194.1	231.2	182.3	150.6	106.3	137.0	262.4	168.7	125.4	183.3	131.3
HOMEZ	KIAA1443	ENSG00000215271	"Homeobox and leucine zipper encoding"	Q8IX15	14	23272422-23299447	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"testis: 34.4"	"Group enriched"	"Detected in all"	6	"Early spermatids: 309.7;Late spermatids: 78.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA036316, HPA036317"	Enhanced		Supported	Nucleoplasm,Nucleoli		NA	NA			"Cluster 39: Non-specific - mRNA processing"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 15: RT4 - Unknown function"	"Cluster 23: Spermatids - Flagellum & Golgi organization"	"Nucleoplasm, Nucleoli"		"HPA036316: AB_2675056, HPA036317: AB_10669787"	"unprognostic (3.70e-2)"	"unprognostic (7.58e-2)"	"unprognostic (6.36e-2)"	"unprognostic (3.93e-2)"	"unprognostic (9.11e-2)"	"unprognostic (5.23e-2)"	"unprognostic (1.20e-2)"	"unprognostic (1.59e-2)"	"unprognostic (1.37e-1)"	"prognostic favorable (2.41e-5)"	"unprognostic (2.23e-1)"	"unprognostic (1.77e-1)"	"prognostic favorable (1.17e-11)"	"unprognostic (2.62e-1)"	"unprognostic (2.00e-1)"	"prognostic favorable (1.75e-4)"	"unprognostic (3.23e-1)"	6.1	4.9	4.6	4.7	6.2	1.5	6.7	5.9	5.8	6.5	4.0	6.7	7.3	5.3	8.0	9.8	7.0	5.2	7.8	4.8	5.5	9.4	6.2	6.1	4.6	6.8	5.5	9.9	7.8	8.8	3.6	5.7	6.3	6.5	6.2	6.0	7.0	9.6	9.0	7.7	5.0	7.2	4.9	5.6	7.8	34.4	6.7	9.4	7.3	14.9	7.9	10.9	5.7	6.4	7.0	7.2	13.0	12.3	19.8	8.7	14.8	7.2	9.4	6.8	8.7	3.3	14.6	15.2	6.1	7.1	16.0	23.3	17.3	18.0	8.5	8.4	6.6	5.2	6.0	14.1	25.8	7.6	4.4	13.5	17.7	5.4	11.8	15.1	13.1	17.0	15.6	6.0	11.8	16.1	5.9	5.2	5.3	21.3	4.1	9.2	9.7	6.7	12.5	28.5	4.2	5.2	6.9	19.3	7.8	19.7	12.0	8.9	14.6	4.7	2.1	5.9	3.3	25.1	11.3	5.0	2.5	5.5	7.2	2.9	5.0	7.3	3.5	4.5	2.8	2.6	3.0	2.9	4.8	2.3	3.2	3.9	0.8	2.4	3.4	2.9	4.1	2.9	4.6	6.2	5.9	5.8	4.8	5.5	6.8	5.5	6.3	4.9	6.7	6.4	3.7	6.4	7.0	4.6	5.6	2.8	18.4	19.9	9.1	5.8	7.0	5.7	6.9	12.8	14.4	23.9	6.2	6.9	4.6	6.8	13.7	11.0	309.7	4.4	4.2	5.7	3.6	5.0	1.9	10.9	6.6	5.2	13.7	6.9	3.8	8.2	5.3	6.9	8.7	10.1	2.0	9.2	8.2	6.1	5.1	78.9	6.8	5.8	3.6	6.5	15.1	6.9	5.2	3.0	6.8	9.1	5.5	7.5	6.1	16.3	8.6	19.8	12.9	3.7	6.6	4.7	4.7	15.2	5.3	10.1	5.1	9.3	4.2	3.8	7.9	29.1
HPDL	"4-HPPD-L, GLOXD1, MGC15668"	ENSG00000186603	"4-hydroxyphenylpyruvate dioxygenase like"	Q96IR7	1	45326895-45328679	"Human disease related genes, Predicted intracellular proteins"		"Dioxygenase, Oxidoreductase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in some"			"Cell type enhanced"	"Detected in many"		"Cytotrophoblasts: 29.1;Gastric mucus-secreting cells: 8.2;Undifferentiated cells: 7.6"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"BEWO: 111.7;HL-60: 34.2;NB-4: 42.8;SK-BR-3: 72.5"	"Low region specificity"	"Detected in many"							"HPA031997, HPA057346"			Supported	Nucleoplasm,Mitochondria		No	NA			"Cluster 39: Non-specific - mRNA processing"	"Cluster 69: Cerebellum - Gene expression regulation"	"Cluster 28: BEWO - Transcription regulation"	"Cluster 47: Cytotrophoblasts - Unknown function"	Mitochondria	Nucleoplasm	"HPA031997: AB_10602909, HPA057346: AB_2683415"	"prognostic favorable (1.81e-4)"	"unprognostic (1.36e-1)"	"unprognostic (2.46e-1)"	"prognostic unfavorable (1.60e-5)"	"unprognostic (1.02e-2)"	"unprognostic (6.71e-2)"	"unprognostic (3.93e-3)"	"unprognostic (1.25e-1)"	"unprognostic (1.63e-1)"	"prognostic favorable (1.03e-4)"	"unprognostic (1.08e-3)"	"unprognostic (2.52e-2)"	"unprognostic (6.66e-2)"	"unprognostic (1.26e-2)"	"unprognostic (1.00e-1)"	"unprognostic (3.03e-2)"	"unprognostic (1.43e-1)"	0.4	0.2	1.0	1.3	1.3	1.8	0.4	3.1	1.0	1.2	0.0	3.7	2.4	0.6	0.0	2.2	0.6	0.0	0.3	0.9	0.9	0.6	0.1	0.3	1.0	1.3	1.2	0.6	0.3	0.0	0.3	2.1	1.3	0.6	2.8	0.4	1.0	0.2	1.6	0.8	2.5	0.3	0.8	1.8	3.4	0.3	1.3	1.2	0.6	0.6	0.9	0.5	1.1	1.3	0.1	1.1	0.5	0.1	0.1	0.4	111.7	1.5	0.0	2.0	0.4	28.7	7.7	5.8	0.3	1.5	0.0	7.0	0.0	0.4	0.7	0.2	0.3	0.6	13.4	0.0	0.7	34.2	0.9	1.1	0.2	1.2	0.0	0.1	2.2	0.2	0.0	5.2	0.2	14.6	22.1	42.8	0.5	23.0	0.0	6.6	0.1	19.4	0.4	0.4	22.2	1.5	14.6	72.5	11.4	1.6	0.2	6.3	1.0	0.0	0.3	1.3	0.0	0.9	0.6	21.3	0.1	0.1	1.4	0.0	0.0	0.0	0.1	0.0	0.3	0.6	0.1	0.2	0.2	0.0	0.2	0.1	0.0	0.5	0.0	0.0	0.1	0.1	1.0	1.3	3.1	1.0	0.9	0.9	1.3	1.2	1.3	0.8	1.3	1.3	0.1	0.0	0.0	2.9	1.0	0.1	2.3	0.5	1.2	0.2	0.7	1.0	0.4	0.0	0.1	0.0	0.0	29.1	0.3	3.0	3.9	0.4	0.2	0.1	1.5	0.7	1.2	4.2	0.0	0.0	5.8	0.8	8.2	0.2	0.0	0.9	0.4	0.1	2.5	0.0	0.2	3.3	0.0	0.0	0.3	0.0	0.3	0.2	0.0	0.0	0.1	0.0	0.0	0.5	0.0	1.8	1.9	0.0	5.2	2.2	0.4	0.3	0.0	0.4	0.0	0.6	0.8	0.0	1.9	2.1	1.1	5.1	0.4	1.2	7.6	1.5
HSPD1	"GroEL, HSP60, SPG13"	ENSG00000144381	"Heat shock protein family D (Hsp60) member 1"	P10809	2	197486584-197516737	"Cancer-related genes, Disease related genes, Enzymes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Host-virus interaction"	"Chaperone, Isomerase"	"Cancer-related genes, Disease variant, Hereditary spastic paraplegia, Leukodystrophy, Neurodegeneration"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"adrenal gland: 790.6"	"Cell type enhanced"	"Detected in all"		"Basal prostatic cells: 1737.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA001523, CAB002775, HPA050025, CAB072816"	Supported		Enhanced	Mitochondria		NA	NA		18000000	"Cluster 39: Non-specific - mRNA processing"	"Cluster 35: Non-specific - Unknown function"	"Cluster 39: CACO-2 - Unknown function"	"Cluster 22: Epithelial cell types - Mixed function"	Mitochondria		"CAB002775: , CAB072816: , HPA001523: AB_1079028, HPA050025: AB_2680995"	"unprognostic (2.79e-2)"	"unprognostic (1.72e-2)"	"unprognostic (5.21e-2)"	"prognostic unfavorable (1.61e-4)"	"unprognostic (2.59e-1)"	"unprognostic (3.57e-3)"	"prognostic unfavorable (2.25e-4)"	"unprognostic (3.51e-2)"	"unprognostic (9.91e-2)"	"unprognostic (8.63e-3)"	"unprognostic (3.47e-2)"	"unprognostic (7.83e-3)"	"unprognostic (5.64e-3)"	"unprognostic (1.73e-2)"	"unprognostic (1.52e-1)"	"unprognostic (2.61e-2)"	"unprognostic (4.10e-2)"	179.4	790.6	188.6	128.3	191.6	110.6	168.8	204.9	401.9	96.9	217.8	170.0	158.1	90.8	89.3	124.5	132.6	69.1	145.0	184.3	198.6	374.9	462.6	136.6	149.2	199.6	198.5	167.6	219.0	159.2	116.0	148.6	205.3	104.5	195.1	71.8	93.9	93.6	162.7	83.3	148.7	104.5	195.1	94.6	155.4	57.6	198.6	99.3	138.7	176.7	172.7	144.6	92.3	201.4	559.7	650.1	541.3	496.9	373.6	389.2	786.5	573.2	304.7	686.1	495.6	2219.1	326.2	1724.4	730.0	304.1	834.2	538.4	2232.9	633.2	943.0	417.0	888.2	1209.8	984.8	2562.8	353.2	1331.4	349.1	445.5	717.1	599.5	1053.2	471.4	542.6	919.1	1535.3	606.8	501.7	690.4	853.6	1304.2	1086.4	735.2	1424.9	1000.1	679.7	1235.5	709.5	539.7	716.5	400.8	582.0	608.5	771.0	1116.3	425.0	789.4	242.2	405.8	570.4	532.8	910.0	331.1	861.4	1399.5	485.7	795.3	456.7	12.1	52.3	11.4	36.4	81.8	71.7	63.8	59.6	54.3	84.6	54.0	81.0	70.3	11.0	62.6	72.1	49.4	51.8	70.6	188.6	191.6	204.9	401.9	184.3	198.6	199.6	198.5	205.3	195.1	198.6	201.4	216.4	166.7	172.5	38.8	220.4	246.6	1737.2	247.5	264.0	75.8	216.0	263.1	239.2	195.9	287.9	79.1	256.5	825.7	197.7	213.7	375.6	235.0	6.2	322.2	304.5	233.9	274.6	241.6	31.9	145.9	419.8	356.0	215.6	445.2	299.5	407.1	63.1	312.5	328.0	95.9	47.2	302.2	166.8	88.6	479.3	12.8	130.5	381.9	163.7	30.0	138.5	125.7	68.0	20.6	35.6	171.4	163.2	113.6	322.9	705.9	160.1	797.1	328.6	117.1	85.5	199.0	471.7	88.5	106.0	262.4	207.1	1001.2	467.2	1017.4	512.1	861.5
IARS1	"IARS, ILRS"	ENSG00000196305	"Isoleucyl-tRNA synthetase 1"	P41252	9	92210207-92293756	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Protein biosynthesis"	"Aminoacyl-tRNA synthetase, Ligase"	"Disease variant, Mental retardation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"Cardiomyocytes: 47.6;Cytotrophoblasts: 29.8;Extravillous trophoblasts: 31.7;Hofbauer cells: 17.2;Syncytiotrophoblasts: 17.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA029806	Approved		Approved	Nucleoplasm,Cytosol		NA	NA		100000	"Cluster 39: Non-specific - mRNA processing"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 24: Non-specific - Transcription regulation"	"Nucleoplasm, Cytosol"		"HPA029806: AB_10601818"	"unprognostic (1.32e-3)"	"unprognostic (2.94e-2)"	"unprognostic (2.27e-2)"	"unprognostic (8.23e-2)"	"unprognostic (1.33e-1)"	"unprognostic (1.26e-2)"	"prognostic unfavorable (4.98e-7)"	"unprognostic (2.00e-2)"	"unprognostic (3.80e-2)"	"unprognostic (1.10e-1)"	"unprognostic (4.96e-2)"	"unprognostic (3.67e-2)"	"unprognostic (1.40e-2)"	"unprognostic (2.88e-2)"	"unprognostic (4.71e-2)"	"unprognostic (2.21e-1)"	"unprognostic (7.76e-3)"	22.2	24.3	6.3	28.8	5.8	13.2	27.4	8.8	11.5	26.4	10.7	29.1	17.9	32.5	15.1	31.8	27.7	16.1	32.2	6.8	10.7	28.4	19.6	18.9	28.3	5.9	7.3	20.4	40.1	52.3	11.7	27.7	8.6	27.7	33.3	25.2	25.5	31.6	43.1	21.7	16.2	42.6	3.6	19.7	31.4	20.0	5.2	27.5	64.6	47.2	37.6	28.2	11.7	6.9	150.7	154.9	83.3	132.2	110.5	142.2	126.8	156.4	146.2	118.8	138.5	52.2	99.0	216.0	54.9	231.4	130.5	194.9	254.4	197.9	149.3	126.1	97.9	135.3	128.3	62.8	235.6	181.3	90.6	134.1	194.9	208.9	348.9	78.3	123.6	230.1	229.2	189.8	145.0	79.3	173.2	31.6	139.7	294.5	143.3	116.2	129.3	103.0	72.9	72.6	110.2	91.5	118.2	117.0	128.8	87.8	95.2	94.4	101.3	89.5	104.6	149.3	119.1	134.8	156.4	99.5	218.7	133.3	173.3	2.8	5.9	0.7	11.9	7.0	16.4	13.9	11.8	11.9	12.7	9.7	12.8	12.7	0.5	19.5	6.3	4.8	10.9	9.0	6.3	5.8	8.8	11.5	6.8	10.7	5.9	7.3	8.6	3.6	5.2	6.9	7.4	0.0	0.0	0.0	2.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	47.6	0.0	0.0	0.0	0.0	29.8	7.8	0.0	0.0	0.0	0.0	0.0	0.0	2.8	0.0	0.0	0.0	0.0	31.7	8.6	0.0	0.0	0.0	0.0	0.0	0.0	17.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.8	0.0	0.0	0.0	0.0	17.4	1.1	0.0	0.0	0.0
IDUA	"MPS1, MPSI"	ENSG00000127415	Alpha-L-iduronidase	P35475	4	986997-1004564	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"		"Glycosidase, Hydrolase"	"Disease variant, Mucopolysaccharidosis"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Leydig cells: 19.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"U-266/70: 29.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB025901, HPA046979, HPA054254"	Enhanced		Supported	Vesicles	"Intracellular and membrane"	NA	NA		170000	"Cluster 39: Non-specific - mRNA processing"	"Cluster 72: Non-specific - Transcription"	"Cluster 29: U-266 - Adaptive immune response"	"Cluster 55: Plasma cells - Humoral immune response"	Vesicles		"CAB025901: , HPA046979: AB_2679888, HPA054254: AB_2682429"	"unprognostic (3.62e-2)"	"unprognostic (9.08e-2)"	"prognostic unfavorable (3.13e-4)"	"unprognostic (7.23e-2)"	"unprognostic (1.45e-1)"	"unprognostic (2.31e-2)"	"unprognostic (1.83e-1)"	"unprognostic (1.67e-1)"	"unprognostic (1.43e-2)"	"unprognostic (1.89e-3)"	"unprognostic (2.64e-2)"	"unprognostic (4.61e-3)"	"prognostic unfavorable (7.87e-5)"	"unprognostic (2.24e-1)"	"unprognostic (1.55e-1)"	"unprognostic (2.46e-2)"	"prognostic favorable (8.04e-5)"	13.5	17.6	3.4	2.2	3.4	2.9	16.1	9.2	7.5	17.5	2.9	10.3	3.6	15.4	2.4	9.9	16.3	3.7	11.6	3.8	1.5	15.9	13.6	13.9	3.5	3.2	2.1	17.0	21.0	2.8	17.2	1.7	2.4	18.5	1.8	1.8	16.6	4.5	3.7	8.9	14.3	2.0	1.0	18.9	17.1	5.6	2.9	3.4	17.0	0.7	1.3	12.0	13.9	2.6	1.8	0.4	0.0	1.1	12.7	3.6	5.3	10.7	8.5	1.2	1.7	0.6	6.4	0.8	10.7	5.0	1.0	0.5	0.1	0.3	0.4	6.1	0.6	1.0	0.8	0.1	5.8	0.8	4.6	9.3	3.1	0.6	0.0	3.4	1.0	0.7	0.6	0.0	1.6	0.0	2.2	2.5	0.8	11.9	5.5	2.7	0.0	1.1	3.5	0.9	0.1	3.3	0.3	0.0	5.7	1.3	1.2	2.3	9.3	9.0	1.6	2.6	1.2	29.0	1.4	0.4	7.8	3.3	1.8	0.0	1.5	0.0	1.4	1.2	1.8	0.1	1.1	0.9	1.8	0.2	1.3	0.7	0.0	1.5	1.7	1.1	0.6	0.5	3.4	3.4	9.2	7.5	3.8	1.5	3.2	2.1	2.4	1.0	2.9	2.6	8.7	6.4	5.0	4.9	5.2	3.6	11.5	1.1	8.6	2.0	8.5	9.1	2.6	1.5	1.5	7.3	4.2	0.4	4.3	5.0	0.0	1.6	0.9	4.1	9.0	4.9	10.7	1.3	4.4	2.4	1.7	13.4	16.8	6.0	2.5	8.2	6.1	2.6	6.5	0.0	2.9	4.2	0.0	5.0	3.6	0.9	19.6	7.3	5.4	1.0	1.6	1.1	4.1	5.5	3.3	1.4	6.9	10.5	15.7	7.7	6.9	1.4	1.4	2.1	0.0	5.5	4.4	3.7	1.6	4.7	1.8	0.4	5.6	4.7	4.3	7.9
IFI44	"MTAP44, p44, TLDC5"	ENSG00000137965	"Interferon induced protein 44"	Q8TCB0	1	78649796-78664078	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 100.8"	"Cell type enhanced"	"Detected in many"		"Adipocytes: 54.6;Endothelial cells: 54.5;Microglial cells: 53.4;Oligodendrocyte precursor cells: 51.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"BJ hTERT+ SV40 Large T+: 176.5;BJ hTERT+ SV40 Large T+ RasG12V: 216.2;GAMG: 177.9"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			"HPA027148, HPA043858"	Approved		Approved	Nucleoplasm		NA	NA			"Cluster 39: Non-specific - mRNA processing"	"Cluster 40: Neutrophils - Inflammatory response"	"Cluster 4: Mesenchymal cell lines - Antiviral immune response"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"	Nucleoplasm		"HPA027148: AB_1851411, HPA043858: AB_2678702"	"unprognostic (1.20e-1)"	"unprognostic (6.53e-2)"	"unprognostic (5.70e-2)"	"unprognostic (4.13e-3)"	"unprognostic (1.63e-1)"	"unprognostic (8.81e-2)"	"unprognostic (5.52e-2)"	"unprognostic (8.30e-2)"	"unprognostic (1.88e-1)"	"unprognostic (1.78e-2)"	"unprognostic (2.72e-3)"	"unprognostic (1.51e-1)"	"prognostic unfavorable (1.37e-8)"	"unprognostic (1.71e-1)"	"unprognostic (2.07e-3)"	"unprognostic (8.89e-2)"	"unprognostic (4.90e-2)"	18.8	16.8	19.0	25.3	20.0	100.8	16.6	17.7	33.0	19.3	17.6	9.7	20.0	15.4	34.9	10.8	12.1	45.4	21.8	17.6	19.0	21.6	21.0	30.9	20.0	27.0	19.6	13.9	8.8	3.8	14.2	21.4	21.2	9.7	9.3	1.3	71.7	11.4	5.8	10.3	14.5	18.5	24.4	65.0	21.0	7.5	20.3	31.0	16.5	10.9	11.6	21.1	9.6	21.0	7.7	0.3	1.3	0.3	5.3	35.9	0.2	5.0	65.5	176.5	216.2	0.0	22.0	10.3	49.9	4.7	177.9	4.1	0.0	2.9	28.6	22.5	0.0	26.8	20.6	0.0	7.3	0.0	0.0	22.7	0.3	76.8	1.0	13.8	33.5	6.7	0.0	35.1	42.5	0.2	22.7	1.9	0.0	0.1	14.4	17.4	53.6	1.2	5.2	5.0	0.6	1.4	1.8	0.5	82.9	0.0	0.0	1.1	41.6	32.3	13.4	3.6	33.9	3.0	3.8	0.3	50.1	30.4	9.2	0.4	15.4	0.1	6.9	15.4	13.8	2.4	10.0	6.6	7.1	1.7	4.2	5.6	4.5	7.8	8.4	2.0	5.1	6.0	19.0	20.0	17.7	33.0	17.6	19.0	27.0	19.6	21.2	24.4	20.3	21.0	54.6	28.9	16.2	10.7	4.7	3.6	10.2	16.3	5.7	0.0	4.6	5.2	5.4	2.8	21.0	9.2	0.0	0.2	9.9	1.1	0.0	13.1	0.6	6.7	4.4	54.5	6.7	4.6	0.0	12.3	0.3	15.8	11.7	7.0	18.3	25.1	43.5	3.6	29.5	0.0	2.1	1.7	6.1	34.2	7.6	1.1	13.4	38.1	5.4	53.4	27.8	0.6	5.2	51.8	0.5	11.8	0.1	17.3	3.2	5.1	3.8	2.7	20.7	0.3	19.7	12.3	12.4	0.3	0.5	4.4	4.5	0.0	22.4	24.8	2.5	14.0
IGHMBP2	"CATF1, CMT2S, HCSA, HMN6, SMARD1, SMUBP2, ZFAND7"	ENSG00000132740	"Immunoglobulin mu DNA binding protein 2"	P38935	11	68903863-68940602	"Disease related genes, Enzymes, Human disease related genes, Potential drug targets, Predicted intracellular proteins"	"Transcription, Transcription regulation"	"Activator, DNA-binding, Helicase, Hydrolase, Ribonucleoprotein, RNA-binding, tRNA-binding"	"Charcot-Marie-Tooth disease, Disease variant, Neurodegeneration, Neuropathy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Early spermatids: 94.6;Late spermatids: 46.9;Spermatocytes: 51.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA004092, HPA060994"			Supported	"Nucleoplasm,Nuclear bodies"		NA	NA			"Cluster 39: Non-specific - mRNA processing"	"Cluster 71: Testis - DNA repair"	"Cluster 33: SK-MEL-30 - Melanocyte processes"	"Cluster 66: Spermatocytes - Spermatogenesis"	Nucleoplasm	"Nuclear bodies"	"HPA004092: , HPA060994: AB_2684406"	"unprognostic (1.17e-1)"	"unprognostic (1.04e-1)"	"unprognostic (7.17e-2)"	"unprognostic (3.96e-1)"	"unprognostic (1.54e-1)"	"unprognostic (1.69e-1)"	"unprognostic (3.59e-3)"	"unprognostic (4.31e-2)"	"unprognostic (3.81e-1)"	"unprognostic (1.19e-1)"	"prognostic favorable (5.89e-4)"	"unprognostic (1.03e-1)"	"prognostic unfavorable (1.29e-8)"	"unprognostic (1.69e-1)"	"unprognostic (3.73e-2)"	"unprognostic (4.06e-2)"	"unprognostic (2.18e-2)"	5.2	4.0	1.2	2.5	1.3	6.0	5.4	0.7	1.7	7.0	0.1	11.8	1.5	7.8	0.6	5.5	6.7	1.7	5.2	1.6	1.2	4.4	6.3	5.1	3.3	0.8	0.4	6.1	5.2	2.8	4.0	2.0	0.7	6.3	1.5	1.4	6.4	3.1	8.5	7.7	6.3	2.6	0.5	5.7	6.2	15.4	0.6	4.3	4.9	3.8	1.7	6.3	5.8	1.1	5.1	7.3	4.0	7.4	3.6	3.1	5.2	5.8	3.9	7.8	4.6	14.5	7.0	7.3	9.7	3.3	6.9	8.0	5.8	4.9	1.8	8.3	6.2	6.6	9.6	5.6	5.5	6.5	7.4	1.8	4.9	9.2	4.6	4.5	4.6	11.1	10.6	4.6	2.3	5.1	11.1	8.9	2.3	7.9	10.3	9.4	5.7	7.6	3.3	5.9	8.6	5.4	7.4	6.1	16.6	3.0	9.3	6.0	6.6	5.3	3.8	7.7	6.6	6.0	6.3	6.9	5.3	6.1	5.1	0.0	2.0	0.8	1.5	1.8	1.3	1.0	0.9	1.0	1.8	0.6	0.5	0.7	0.6	0.1	1.1	0.3	0.6	1.3	1.2	1.3	0.7	1.7	1.6	1.2	0.8	0.4	0.7	0.5	0.6	1.1	6.6	6.4	7.7	7.5	5.7	5.7	3.8	3.5	6.2	9.1	5.6	3.8	6.3	8.6	6.1	1.8	20.9	4.9	10.2	6.0	1.9	5.1	94.6	7.0	8.1	6.4	3.0	9.3	7.4	5.1	4.4	5.5	6.1	14.0	7.0	10.7	3.3	6.1	5.8	11.8	6.4	4.1	2.0	3.5	4.3	46.9	7.8	7.2	1.8	5.6	7.3	6.6	9.2	6.0	5.2	6.5	8.4	7.2	5.8	7.5	3.9	2.9	3.8	10.1	0.0	5.1	10.1	51.6	7.1	5.3	6.7	6.7	8.0	4.6	7.1	6.3
IL10RA	"CD210, CD210a, CDW210A, HIL-10R, IL10R"	ENSG00000110324	"Interleukin 10 receptor subunit alpha"	Q13651	11	117986370-118003037	"CD markers, Disease related genes, Human disease related genes, Predicted membrane proteins"		Receptor	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 63.6;lymphoid tissue: 73.7"	"Cell type enhanced"	"Detected in many"		"dendritic cells: 87.5;Extravillous trophoblasts: 93.0;Kupffer cells: 190.7;Langerhans cells: 145.0;Macrophages: 128.6;monocytes: 175.7;NK-cells: 110.2;Plasma cells: 129.5;T-cells: 105.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in some"		"Daudi: 30.5;HDLM-2: 76.6;Karpas-707: 27.7;RPMI-8226: 35.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA065647, HPA069086"			Supported	"Plasma membrane,Cytosol"		NA	NA			"Cluster 39: Non-specific - mRNA processing"	"Cluster 2: Immune cells - Immune response"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 24: Non-specific - Transcription regulation"	"Plasma membrane"	Cytosol	"HPA065647: , HPA069086: "	"unprognostic (1.01e-2)"	"unprognostic (2.07e-3)"	"unprognostic (1.58e-2)"	"unprognostic (7.08e-2)"	"unprognostic (8.27e-2)"	"prognostic favorable (4.47e-4)"	"unprognostic (5.27e-2)"	"unprognostic (4.84e-2)"	"unprognostic (7.70e-3)"	"unprognostic (5.94e-2)"	"unprognostic (2.14e-2)"	"unprognostic (3.83e-1)"	"prognostic unfavorable (1.45e-5)"	"unprognostic (1.82e-1)"	"unprognostic (8.43e-3)"	"unprognostic (2.19e-1)"	"unprognostic (1.27e-1)"	13.9	8.9	4.7	39.8	4.9	63.6	6.1	4.4	7.0	5.6	4.9	12.0	8.0	3.5	2.7	6.4	5.2	17.9	5.3	4.2	5.9	4.1	13.1	23.8	51.7	6.9	5.1	3.1	2.4	2.6	3.6	14.2	5.5	4.7	14.5	0.5	5.2	3.2	1.7	3.2	24.8	10.4	6.0	73.7	9.2	1.9	5.3	16.9	4.2	3.3	32.4	20.7	3.7	7.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	30.5	0.2	0.0	0.7	0.0	0.5	0.0	0.0	76.6	0.0	0.2	0.0	0.0	0.0	0.0	8.1	0.0	0.0	0.0	0.0	0.0	0.0	0.6	5.6	27.7	0.0	0.0	0.4	6.0	0.1	0.0	0.0	0.0	0.0	35.5	0.0	0.1	0.4	0.1	0.0	0.0	0.0	0.1	0.0	2.2	0.0	0.0	0.0	0.1	0.0	5.6	1.0	8.0	0.0	11.4	0.0	3.3	48.9	2.4	52.8	68.6	38.3	12.6	51.0	62.1	44.7	6.2	17.9	33.3	3.4	70.2	58.6	17.3	88.7	84.1	4.7	4.9	4.4	7.0	4.2	5.9	6.9	5.1	5.5	6.0	5.3	7.5	2.2	6.4	16.0	0.3	52.8	5.7	0.4	0.0	5.7	0.1	1.0	1.9	2.7	0.0	1.3	0.0	0.0	1.3	87.5	0.5	0.0	0.2	0.1	0.4	0.5	4.9	0.0	9.3	0.8	0.8	93.0	2.3	6.6	0.7	12.6	0.0	3.6	1.4	60.4	0.0	1.2	0.0	0.0	190.7	145.0	0.5	0.3	128.6	17.8	22.5	175.7	0.4	110.2	0.0	0.6	0.1	0.1	0.0	129.5	0.0	0.0	1.0	1.5	0.1	0.0	1.6	2.7	0.1	0.3	1.2	4.1	3.3	105.5	0.0	0.7	0.4
IL21R	CD360	ENSG00000103522	"Interleukin 21 receptor"	Q9HBE5	16	27402174-27452042	"Cancer-related genes, CD markers, Disease related genes, Predicted membrane proteins"		Receptor	"Cancer-related genes, Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	5	"bone marrow: 7.6;lymphoid tissue: 24.7"	"Cell type enhanced"	"Detected in some"		"B-cells: 15.5;dendritic cells: 21.8;Langerhans cells: 11.4;NK-cells: 23.7;Plasma cells: 13.4;T-cells: 25.1"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"Daudi: 25.9;HDLM-2: 110.8;Karpas-707: 49.3;RH-30: 37.2;RPMI-8226: 63.0;U-266/70: 24.7"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA042296	Uncertain		Uncertain	"Plasma membrane,Cytosol"		NA	NA			"Cluster 39: Non-specific - mRNA processing"	"Cluster 3: T-cells - Adaptive immune response"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 24: Non-specific - Transcription regulation"	"Plasma membrane, Cytosol"		"HPA042296: AB_10806236"	"unprognostic (2.91e-2)"	"unprognostic (2.65e-3)"	"unprognostic (6.64e-4)"	"unprognostic (1.58e-3)"	"unprognostic (2.14e-1)"	"prognostic favorable (7.29e-4)"	"unprognostic (8.33e-2)"	"unprognostic (2.06e-1)"	"unprognostic (8.50e-6)"	"unprognostic (2.26e-2)"	"unprognostic (1.13e-2)"	"unprognostic (8.71e-2)"	"unprognostic (2.34e-10)"	"unprognostic (8.79e-2)"	"unprognostic (4.42e-2)"	"unprognostic (1.50e-1)"	"unprognostic (9.58e-2)"	0.5	0.4	1.4	11.9	1.0	7.6	0.2	1.1	2.6	0.2	0.9	0.8	0.6	0.3	0.2	0.3	0.2	1.1	0.7	0.9	2.3	0.9	0.4	2.9	24.7	2.1	2.3	0.2	0.3	0.0	0.5	0.8	3.3	0.4	0.9	1.1	0.6	0.1	0.3	0.8	2.1	0.7	1.2	5.5	1.5	1.1	1.2	14.4	0.6	0.0	18.8	2.2	0.2	1.6	0.1	0.2	0.3	0.2	0.0	1.3	0.8	0.8	0.1	0.1	2.2	0.2	0.2	25.9	0.2	2.1	1.4	0.1	0.0	0.1	0.1	110.8	0.1	5.4	0.2	0.7	3.4	0.2	1.5	3.8	0.0	6.8	0.1	0.7	0.0	0.6	0.3	49.3	3.8	0.2	0.1	0.5	0.9	0.1	0.0	0.4	37.2	63.0	0.0	0.1	0.2	0.2	0.1	0.1	2.7	0.2	0.1	1.3	2.8	1.9	0.7	0.6	0.2	24.7	9.4	5.9	5.2	1.4	0.2	0.5	0.4	0.1	13.4	8.3	4.9	1.8	8.6	14.2	2.3	14.2	9.2	9.3	0.9	9.5	27.0	1.1	10.8	7.3	1.4	1.0	1.1	2.6	0.9	2.3	2.1	2.3	3.3	1.2	1.2	1.6	0.2	0.0	1.3	0.0	15.5	0.4	0.1	0.0	0.0	2.0	0.2	0.1	1.9	0.0	0.0	0.0	4.2	0.1	21.8	0.1	0.0	0.0	6.5	0.1	0.2	0.9	0.0	0.0	0.4	0.0	0.1	0.3	1.5	0.2	0.0	0.0	1.1	0.2	8.2	0.0	0.5	0.0	0.0	5.0	11.4	5.7	0.0	3.6	1.8	2.8	1.8	0.2	23.7	0.5	0.0	0.0	0.0	0.0	13.4	0.0	0.0	0.2	0.0	0.5	0.0	0.8	0.8	0.2	0.0	0.0	0.9	0.1	25.1	0.1	0.1	0.1
INTS5	"INT5, KIAA1698"	ENSG00000185085	"Integrator complex subunit 5"	Q6P9B9	11	62646848-62653302	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA046181, HPA056915"	Uncertain		Supported	Nucleoplasm,Cytosol		NA	NA			"Cluster 39: Non-specific - mRNA processing"	"Cluster 59: Non-specific - Translation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 10: Non-specific - Unknown function"	Nucleoplasm	Cytosol	"HPA046181: , HPA056915: AB_2683276"	"unprognostic (2.87e-1)"	"unprognostic (9.51e-2)"	"unprognostic (9.11e-2)"	"unprognostic (9.70e-2)"	"unprognostic (2.71e-1)"	"unprognostic (6.41e-2)"	"unprognostic (1.97e-2)"	"unprognostic (5.52e-2)"	"unprognostic (1.90e-1)"	"unprognostic (5.95e-2)"	"unprognostic (2.33e-1)"	"unprognostic (5.09e-2)"	"prognostic favorable (8.44e-5)"	"unprognostic (7.08e-3)"	"unprognostic (2.97e-2)"	"unprognostic (3.36e-1)"	"unprognostic (1.35e-2)"	8.3	9.3	5.5	8.0	5.7	5.4	8.5	5.7	6.0	10.1	5.5	9.1	7.8	11.4	5.3	12.1	12.9	5.8	8.1	5.7	5.4	8.6	12.6	7.7	10.6	6.0	5.6	10.2	10.3	8.8	6.6	6.0	5.8	9.2	5.8	2.8	11.7	6.9	13.9	12.4	8.8	8.3	5.5	10.5	9.5	6.1	5.8	8.3	7.8	8.3	9.2	9.1	8.7	5.8	17.5	21.1	12.2	11.4	23.5	17.1	11.4	14.2	14.4	18.7	13.4	15.1	19.0	33.1	25.0	18.0	15.5	26.7	24.6	32.9	9.0	20.8	17.1	17.2	15.8	10.2	21.2	19.0	15.7	19.9	25.3	20.1	17.1	14.2	18.8	14.5	26.6	18.9	16.3	35.8	22.0	22.1	18.7	20.7	26.4	22.2	16.5	39.9	14.3	11.3	16.4	13.8	15.9	22.0	22.2	8.6	31.3	12.9	15.7	17.8	13.6	27.6	12.9	26.5	21.9	23.8	20.5	14.3	17.2	4.3	5.3	3.9	6.4	3.5	10.1	4.1	5.9	5.7	5.5	5.0	6.9	6.4	1.9	7.7	4.1	5.5	4.6	6.3	5.5	5.7	5.7	6.0	5.7	5.4	6.0	5.6	5.8	5.5	5.8	5.8	5.0	3.2	7.8	2.3	8.8	2.2	7.1	8.2	4.6	7.5	6.6	6.3	3.1	7.2	9.3	3.7	0.0	14.0	10.7	4.8	11.7	12.0	6.4	5.7	5.0	6.9	6.7	2.5	2.0	10.6	9.3	5.2	4.1	4.4	8.9	6.7	9.7	11.5	8.7	10.1	2.1	7.9	8.2	7.0	3.1	8.9	6.5	4.3	0.0	1.9	12.6	10.4	8.2	2.0	1.0	9.7	2.2	7.9	7.3	8.5	8.7	10.2	13.2	3.8	13.1	5.1	8.6	10.8	11.3	5.4	4.1	19.8	6.8	9.1	7.6	5.9
IPO13	"IMP13, KIAA0724, RANBP13"	ENSG00000117408	"Importin 13"	O94829	1	43946950-43968022	"Predicted intracellular proteins, Transporters"	"Protein transport, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 122.1;skeletal muscle: 128.3"	"Cell type enhanced"	"Detected in many"		"Early spermatids: 53.5;Late spermatids: 91.1;Oligodendrocytes: 79.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			CAB070425	Uncertain					NA	NA			"Cluster 39: Non-specific - mRNA processing"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 31: Spermatids - Spermatogenesis"			"CAB070425: AB_11157631"	"unprognostic (7.15e-3)"	"unprognostic (1.85e-1)"	"unprognostic (1.56e-1)"	"unprognostic (2.04e-1)"	"unprognostic (4.15e-2)"	"unprognostic (7.11e-2)"	"prognostic unfavorable (8.26e-7)"	"unprognostic (1.21e-1)"	"unprognostic (9.61e-2)"	"unprognostic (1.56e-1)"	"prognostic favorable (2.21e-4)"	"unprognostic (1.18e-1)"	"unprognostic (1.93e-3)"	"unprognostic (6.42e-2)"	"unprognostic (4.22e-2)"	"unprognostic (8.13e-2)"	"unprognostic (5.93e-3)"	11.9	22.6	67.6	9.8	94.1	9.6	11.7	80.4	82.5	15.8	49.3	20.8	9.2	18.9	13.8	20.0	14.1	9.3	44.7	66.5	69.4	26.8	18.9	12.2	9.8	84.6	85.8	13.4	13.7	27.5	26.4	10.2	79.2	18.9	10.1	23.9	15.8	16.1	128.3	14.9	14.0	15.7	70.2	15.4	16.8	48.5	95.9	14.2	21.2	74.1	10.4	18.0	15.2	122.1	22.2	17.7	17.5	27.8	46.5	24.0	14.6	20.8	19.3	30.5	23.2	13.6	11.0	23.1	21.0	27.3	19.3	24.3	31.7	36.7	20.1	23.6	27.1	24.1	34.0	18.9	32.7	16.2	21.6	24.6	36.7	39.6	24.6	22.8	20.5	17.7	24.6	20.7	24.6	15.4	16.5	21.3	16.1	18.9	29.4	22.6	22.0	24.2	22.4	21.2	27.8	12.9	19.5	32.5	27.5	22.7	20.4	22.3	16.8	30.3	18.1	26.7	23.9	23.0	30.4	11.0	19.3	34.6	26.9	0.0	1.4	1.2	2.0	1.6	1.7	1.1	1.3	2.0	2.3	0.8	1.1	1.5	0.5	1.9	1.6	2.3	1.7	1.0	67.6	94.1	80.4	82.5	66.5	69.4	84.6	85.8	79.2	70.2	95.9	122.1	4.2	0.0	2.0	13.1	7.4	3.3	3.2	9.1	2.8	18.9	5.6	4.1	23.4	12.8	6.3	11.0	8.4	6.4	5.1	8.6	1.9	7.3	53.5	8.0	5.6	5.8	3.0	4.8	9.8	4.2	3.7	5.2	6.1	6.0	0.0	12.6	3.6	11.5	16.3	28.6	8.8	5.3	12.2	8.3	3.3	91.1	8.4	5.8	8.8	1.9	7.1	11.6	4.1	5.5	79.2	5.9	1.1	15.8	6.2	4.3	9.1	18.2	8.6	8.7	0.0	6.4	10.4	32.4	12.3	7.1	4.3	4.1	3.6	8.4	7.3	3.8
IPO5	"IMB3, KPNB3, MGC2068, Pse1, RANBP5"	ENSG00000065150	"Importin 5"	O00410	13	97953658-98024296	"Plasma proteins, Predicted intracellular proteins, Transporters"	"Host-virus interaction, Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"testis: 209.8"	"Group enriched"	"Detected in all"	11	"Early spermatids: 1152.2;Late spermatids: 2185.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB009110, HPA040983, HPA056548"	Approved		Supported	Nucleoplasm,Cytosol		NA	NA		790000	"Cluster 39: Non-specific - mRNA processing"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 31: Spermatids - Spermatogenesis"	Cytosol	Nucleoplasm	"CAB009110: AB_2264985, HPA040983: AB_2677236, HPA056548: AB_2683169"	"unprognostic (5.20e-2)"	"unprognostic (6.94e-2)"	"unprognostic (9.47e-2)"	"unprognostic (1.31e-1)"	"unprognostic (2.96e-3)"	"unprognostic (2.16e-3)"	"unprognostic (2.19e-2)"	"unprognostic (5.27e-3)"	"unprognostic (6.19e-2)"	"unprognostic (2.51e-1)"	"unprognostic (1.45e-1)"	"unprognostic (1.06e-1)"	"unprognostic (9.64e-2)"	"unprognostic (1.82e-1)"	"unprognostic (2.40e-1)"	"unprognostic (1.66e-1)"	"unprognostic (2.73e-1)"	53.0	27.4	20.2	37.8	26.8	37.6	44.9	20.3	31.9	46.3	14.9	36.9	23.9	45.2	27.3	41.7	45.1	30.1	60.5	28.2	20.0	44.4	42.6	28.6	42.9	20.9	20.0	76.4	63.3	36.8	17.1	36.1	20.5	35.4	40.0	41.4	31.5	47.1	135.1	25.8	24.9	57.9	21.7	30.0	31.8	209.8	18.6	48.5	55.3	115.6	54.8	45.6	23.7	29.2	168.9	111.8	205.0	188.7	136.4	344.0	124.7	241.8	190.3	334.3	235.7	231.4	127.0	485.4	82.3	294.2	75.4	142.5	430.0	166.6	456.6	123.6	135.8	265.1	197.4	183.0	97.4	287.3	90.8	194.5	107.6	271.9	225.4	142.3	193.3	147.0	186.3	63.9	288.1	46.8	219.2	78.4	206.0	253.3	132.3	277.9	232.5	143.4	79.6	109.3	151.0	123.5	123.8	143.6	90.9	247.2	109.5	156.9	137.4	224.0	111.8	113.6	223.3	84.2	102.9	146.8	230.4	179.6	156.9	0.5	5.0	1.3	7.0	8.2	12.3	7.8	8.3	9.1	11.7	7.6	11.5	9.7	0.4	11.4	5.8	5.7	9.3	6.8	20.2	26.8	20.3	31.9	28.2	20.0	20.9	20.0	20.5	21.7	18.6	29.2	27.0	19.2	27.8	27.7	27.0	41.4	45.9	24.3	44.3	32.9	29.9	22.4	76.6	40.0	22.3	22.0	6.2	41.0	19.9	14.5	27.4	31.8	1152.2	24.9	37.5	39.5	35.3	72.8	53.4	42.3	47.5	45.1	21.4	29.3	14.5	75.6	32.9	44.2	23.9	63.9	39.5	24.8	18.3	33.3	31.6	2185.2	52.8	24.7	26.6	14.0	28.4	44.3	16.5	27.6	36.1	35.3	11.9	44.0	46.5	79.4	9.5	42.7	20.7	22.6	26.3	63.7	49.0	142.9	57.8	40.7	36.9	32.3	23.6	47.2	41.1	39.7
IREB2	IRP2	ENSG00000136381	"Iron responsive element binding protein 2"	P48200	15	78437431-78501453	"Disease related genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"		RNA-binding	"Disease variant, Neurodegeneration"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB032885, HPA040371, HPA068982"	Uncertain		Approved	"Cell Junctions,Cytosol"		NA	NA			"Cluster 39: Non-specific - mRNA processing"	"Cluster 34: Non-specific - Transcription"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 52: Non-specific - Transcription"	"Cell Junctions"	Cytosol	"CAB032885: AB_2126703, HPA040371: AB_2676945, HPA068982: AB_2686064"	"unprognostic (1.00e-2)"	"unprognostic (1.30e-1)"	"unprognostic (6.54e-2)"	"unprognostic (3.44e-2)"	"unprognostic (3.39e-2)"	"unprognostic (2.29e-1)"	"unprognostic (2.33e-1)"	"unprognostic (1.06e-1)"	"unprognostic (7.30e-2)"	"unprognostic (1.01e-1)"	"unprognostic (1.38e-1)"	"unprognostic (6.51e-2)"	"unprognostic (3.85e-3)"	"unprognostic (4.09e-1)"	"unprognostic (1.36e-1)"	"unprognostic (1.47e-2)"	"unprognostic (9.40e-2)"	17.1	25.2	7.5	18.2	7.7	27.7	18.8	16.3	9.3	15.2	8.4	17.4	17.9	17.9	11.8	15.2	14.6	14.9	12.5	7.4	10.5	18.3	23.1	14.9	22.8	7.0	7.2	22.0	11.4	17.8	8.2	21.8	7.1	16.5	20.3	19.4	10.6	15.4	18.8	14.4	18.4	16.1	7.0	24.8	16.4	15.1	9.5	29.7	28.7	23.5	20.9	13.4	11.7	8.8	19.9	34.9	52.8	33.2	45.5	29.7	35.5	33.3	26.0	29.7	26.9	34.6	33.8	73.1	22.1	28.0	20.3	37.8	124.7	33.2	26.1	23.4	43.0	63.6	35.0	24.4	23.8	69.4	65.7	31.5	22.4	22.9	27.7	30.2	35.4	42.6	67.9	25.4	25.5	29.7	42.8	35.2	69.1	24.1	12.4	49.6	53.0	20.8	32.4	54.2	31.7	47.3	45.1	31.4	35.7	59.2	29.5	59.7	28.9	30.3	20.8	16.8	29.2	31.5	74.8	41.7	21.8	63.1	22.2	3.8	2.5	2.0	2.4	3.3	3.1	2.7	2.6	2.4	3.5	2.6	2.5	3.5	2.8	3.0	2.6	4.0	2.3	1.4	7.5	7.7	16.3	9.3	7.4	10.5	7.0	7.2	7.1	7.0	9.5	8.8	24.3	22.4	40.7	33.0	37.5	14.1	16.6	19.3	14.8	55.6	23.1	18.4	24.9	25.8	26.1	23.9	66.7	35.0	56.2	45.3	0.0	19.9	18.1	19.3	38.2	26.6	31.9	42.3	52.3	19.6	23.7	27.7	32.1	21.2	17.7	66.2	38.9	41.8	26.1	79.1	55.6	31.0	18.3	61.3	18.4	10.8	32.9	37.7	14.2	28.1	52.9	22.4	54.6	50.3	49.0	26.3	49.8	30.5	28.5	33.7	49.1	19.6	25.7	51.1	6.6	29.5	23.2	33.9	29.6	24.5	18.6	30.6	33.9	56.3	36.0	29.6
IRF2BP1	"DKFZP434M154, IRF-2BP1"	ENSG00000170604	"Interferon regulatory factor 2 binding protein 1"	Q8IU81	19	45883608-45886141	"Enzymes, Predicted intracellular proteins"	"Transcription, Transcription regulation, Ubl conjugation pathway"	"Repressor, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in all"		"NB-4: 82.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA042164, HPA049480"	Approved		Supported	Nucleoplasm		NA	NA			"Cluster 39: Non-specific - mRNA processing"	"Cluster 35: Non-specific - Unknown function"	"Cluster 24: NB-4 - Immune response"	"Cluster 39: Non-specific - Basic cellular processes"	Nucleoplasm		"HPA042164: AB_2677882, HPA049480: AB_2680785"	"unprognostic (5.90e-2)"	"unprognostic (1.34e-1)"	"unprognostic (8.86e-2)"	"unprognostic (9.49e-2)"	"unprognostic (1.78e-1)"	"unprognostic (2.61e-2)"	"unprognostic (1.62e-1)"	"unprognostic (1.67e-1)"	"unprognostic (3.03e-1)"	"unprognostic (1.01e-1)"	"prognostic favorable (2.32e-4)"	"unprognostic (2.60e-1)"	"prognostic favorable (3.85e-5)"	"unprognostic (1.33e-2)"	"unprognostic (6.99e-2)"	"unprognostic (2.66e-1)"	"unprognostic (5.07e-3)"	11.1	15.8	12.2	4.6	11.9	3.6	12.3	13.8	15.8	17.8	3.8	17.6	7.3	20.0	3.6	11.8	16.9	3.2	16.6	12.7	10.8	14.2	21.0	8.3	5.2	15.2	11.9	21.7	15.7	7.1	20.6	3.1	11.8	15.3	2.0	4.3	13.7	6.9	22.0	14.4	13.8	3.0	10.3	13.6	16.4	9.3	11.8	6.1	12.3	7.9	2.8	15.9	12.0	14.8	18.1	27.1	6.5	14.6	5.5	3.4	10.8	13.0	7.4	10.2	8.9	10.1	8.4	14.5	9.6	6.7	6.1	16.7	4.7	4.9	3.0	18.4	46.4	14.6	7.6	13.1	11.1	15.2	13.1	4.8	6.6	5.3	3.8	6.4	6.3	17.8	23.4	11.2	4.0	14.1	31.0	82.8	12.3	6.7	23.8	35.2	7.7	12.6	7.4	9.9	19.4	33.3	13.8	17.8	17.3	2.5	14.8	27.8	9.2	8.8	17.7	6.8	18.6	30.4	36.2	8.6	11.9	14.3	13.0	0.0	0.3	0.1	0.7	0.4	0.7	0.7	0.6	0.6	0.3	0.6	0.9	0.5	0.4	0.7	0.2	0.5	0.6	0.4	12.2	11.9	13.8	15.8	12.7	10.8	15.2	11.9	11.8	10.3	11.8	14.8	6.0	0.0	1.1	2.6	8.4	10.7	5.8	4.1	14.2	15.2	13.5	11.4	1.3	11.5	2.4	11.0	0.0	10.9	8.4	8.9	13.7	7.8	2.0	6.0	6.7	6.3	9.6	10.1	2.2	9.5	6.6	8.2	7.1	6.9	0.0	8.3	7.9	9.3	5.0	10.1	3.2	11.2	0.0	2.2	8.6	1.5	18.6	5.1	8.8	3.7	4.5	10.2	5.2	2.0	3.7	7.5	11.9	10.9	2.5	7.4	9.3	13.5	3.0	7.0	19.7	10.7	11.7	3.8	2.2	8.9	11.2	8.8	7.3	9.9	8.7	3.0
ISY1-RAB43		ENSG00000261796	"ISY1-RAB43 readthrough"		3	129087575-129161036	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"			"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"Excitatory neurons: 1.5;granulocytes: 1.3;Oligodendrocytes: 1.0"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in many"											"HPA006312, HPA016995"	Approved		Enhanced	"Nuclear speckles"		NA	NA			"Cluster 39: Non-specific - mRNA processing"	"Cluster 34: Non-specific - Transcription"	"Cluster 4: Mesenchymal cell lines - Antiviral immune response"	"Cluster 11: Alveolar cells - Smell perception"	"Nuclear speckles"		"HPA006312: AB_1079734, HPA016995: AB_1852387"	"unprognostic (1.09e-1)"	"unprognostic (5.42e-2)"			"unprognostic (1.52e-1)"	"unprognostic (9.05e-3)"		"unprognostic (2.81e-1)"	"unprognostic (3.15e-1)"	"unprognostic (1.63e-1)"	"unprognostic (2.52e-1)"	"unprognostic (1.51e-3)"	"unprognostic (1.89e-1)"	"unprognostic (1.40e-1)"		"unprognostic (5.67e-2)"	"unprognostic (1.87e-1)"	7.6	7.2	2.4	10.1	2.8	7.1	7.5	2.4	5.7	7.3	2.5	7.6	3.9	8.1	4.4	5.2	6.9	4.2	5.7	2.3	2.9	7.8	9.6	9.4	8.1	2.5	2.6	9.4	7.2	8.8	5.6	6.5	3.2	7.6	7.4	2.7	6.6	8.3	3.9	5.5	6.7	7.7	2.1	9.2	6.8	5.1	2.7	16.7	7.6	3.7	9.0	7.6	4.6	3.5	26.1	5.7	12.9	11.9	15.8	9.3	5.6	12.2	28.5	19.4	23.6	3.0	13.1	0.9	17.7	22.0	22.2	9.8	5.1	20.4	11.9	9.9	1.0	2.4	2.5	10.2	27.1	10.8	12.9	21.5	10.7	12.1	7.7	19.2	25.4	23.7	4.2	9.9	16.9	10.8	16.3	7.7	9.1	27.7	6.7	13.7	5.6	9.1	20.8	9.9	0.9	5.8	5.8	13.1	18.9	10.7	6.5	10.3	21.0	9.4	7.9	13.5	5.6	14.3	7.0	4.4	10.7	1.1	13.3	0.1	0.5	0.1	0.6	0.2	0.6	0.0	0.6	0.8	0.2	0.1	0.8	0.7	0.6	0.6	0.4	0.2	0.4	0.6	2.4	2.8	2.4	5.7	2.3	2.9	2.5	2.6	3.2	2.1	2.7	3.5	0.0	0.0	0.5	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	1.5	0.0	0.0	0.2	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0
JAK3	"JAK-3, JAK3_HUMAN, JAKL, L-JAK, LJAK"	ENSG00000105639	"Janus kinase 3"	P52333	19	17824780-17848071	"Cancer-related genes, Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Predicted intracellular proteins"	"Adaptive immunity, Immunity, Innate immunity"	"Kinase, Transferase, Tyrosine-protein kinase"	"Cancer-related genes, Disease variant, FDA approved drug targets, SCID"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 55.1"	"Cell type enhanced"	"Detected in many"		"B-cells: 27.8;dendritic cells: 20.1;Macrophages: 17.9;NK-cells: 18.6;Plasma cells: 18.4;T-cells: 37.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in some"		"HDLM-2: 35.7;HEL: 15.9;HMC-1: 15.5;Karpas-707: 40.2;U-266/70: 15.4;U-266/84: 24.7;U-937: 24.2"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA070314	Enhanced		Approved	"Plasma membrane,Cytosol"		NA	NA			"Cluster 39: Non-specific - mRNA processing"	"Cluster 2: Immune cells - Immune response"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 58: T-cells - T-cell receptor"	"Plasma membrane, Cytosol"		"HPA070314: AB_2686251"	"unprognostic (5.59e-3)"	"prognostic favorable (6.42e-5)"	"unprognostic (5.71e-2)"	"unprognostic (2.34e-1)"	"unprognostic (6.13e-3)"	"unprognostic (1.11e-3)"	"unprognostic (4.21e-2)"	"unprognostic (2.60e-1)"	"unprognostic (2.38e-2)"	"unprognostic (2.36e-1)"	"unprognostic (3.58e-2)"	"unprognostic (1.94e-1)"	"prognostic unfavorable (2.89e-14)"	"unprognostic (2.28e-1)"	"unprognostic (2.21e-2)"	"unprognostic (4.43e-2)"	"unprognostic (7.61e-2)"	6.7	2.5	4.0	36.3	4.4	18.6	4.0	3.9	5.6	3.3	3.7	4.0	3.0	2.2	2.4	2.8	5.3	4.8	3.2	4.1	6.7	6.2	2.9	13.1	40.5	7.3	6.1	15.5	1.8	1.9	3.1	5.7	6.4	4.4	3.1	0.6	3.5	1.9	0.7	1.7	15.4	3.5	5.5	55.1	4.6	2.6	6.6	11.3	4.9	0.9	29.7	7.4	3.1	6.1	0.2	0.6	0.5	1.8	0.6	2.4	0.4	0.8	0.0	0.1	0.1	0.0	1.6	0.7	3.3	0.7	0.4	0.2	0.0	0.4	0.0	35.7	0.0	15.9	0.1	1.5	1.2	0.0	15.5	8.4	0.5	0.1	0.0	0.1	0.3	3.6	0.1	40.2	0.0	0.7	6.5	0.0	0.3	0.9	1.3	8.2	0.0	0.7	0.8	0.0	0.0	0.6	0.2	0.4	0.1	0.2	3.5	2.4	0.7	0.0	0.7	0.0	0.0	15.4	24.7	4.3	0.1	24.2	0.3	2.0	7.5	0.3	17.8	14.6	20.2	9.4	21.1	18.6	6.8	10.3	20.2	18.5	25.1	13.4	14.2	5.5	18.0	12.4	4.0	4.4	3.9	5.6	4.1	6.7	7.3	6.1	6.4	5.5	6.6	6.1	5.5	0.0	4.6	2.3	27.8	0.8	0.6	0.5	0.6	0.6	0.5	0.8	1.9	0.0	1.0	1.8	0.0	1.1	20.1	0.0	0.0	0.5	1.0	0.3	2.1	8.0	0.0	6.1	4.3	0.4	0.8	4.6	2.0	0.4	5.1	0.8	9.7	0.4	14.5	0.0	2.6	0.0	0.0	9.2	1.9	2.0	12.5	17.9	3.6	4.7	16.6	0.9	18.6	0.0	0.4	0.5	0.0	14.7	18.4	0.5	0.0	0.3	0.9	0.7	6.6	0.3	2.9	0.3	0.7	0.3	1.0	1.4	37.7	14.8	0.1	0.6
JMJD8	C16orf20	ENSG00000161999	"Jumonji domain containing 8"	Q96S16	16	681670-684528	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"								"Intracellular and membrane"	NA	NA			"Cluster 39: Non-specific - mRNA processing"	"Cluster 29: Non-specific - Vesicular transport"	"Cluster 25: RPMI-8226 - Immune response"	"Cluster 7: Non-specific - Mitochondria"				"unprognostic (2.32e-2)"	"unprognostic (1.38e-2)"	"unprognostic (1.13e-1)"	"unprognostic (1.54e-2)"	"unprognostic (8.38e-2)"	"unprognostic (1.03e-2)"	"unprognostic (2.87e-1)"	"unprognostic (4.79e-2)"	"unprognostic (1.46e-1)"	"unprognostic (1.50e-2)"	"unprognostic (4.33e-2)"	"unprognostic (1.63e-2)"	"unprognostic (4.96e-3)"	"unprognostic (5.53e-2)"	"unprognostic (1.86e-1)"	"unprognostic (3.29e-1)"	"unprognostic (7.04e-2)"	24.5	25.9	19.9	14.5	19.8	17.4	17.3	18.9	23.7	25.9	31.4	21.0	17.5	24.9	30.5	24.7	29.6	21.3	37.2	20.1	20.0	23.0	23.1	19.2	15.6	22.4	19.9	23.7	41.0	31.5	14.0	15.4	19.9	23.8	10.9	7.5	40.5	32.6	13.1	22.4	15.3	21.9	20.2	15.7	19.3	15.7	21.8	15.1	32.2	14.5	10.8	22.3	15.5	19.6	21.5	59.5	14.6	63.0	59.8	22.9	8.5	26.3	49.0	26.9	30.6	33.7	49.8	7.4	28.2	38.1	0.3	36.8	17.4	34.2	10.2	28.6	27.5	15.5	32.5	4.3	26.4	35.7	27.3	27.3	22.8	18.0	20.9	20.1	41.4	14.9	20.0	40.8	16.1	52.8	18.8	28.1	34.9	35.5	25.3	22.6	3.8	76.3	54.0	13.4	26.1	28.3	38.1	43.0	9.3	8.4	44.3	33.3	21.8	1.9	21.5	12.8	15.6	23.7	14.5	9.5	7.1	16.6	22.5	0.2	6.3	0.1	5.0	5.2	6.5	3.9	5.7	5.0	7.3	4.6	4.8	4.8	0.2	3.4	4.8	4.9	6.7	3.0	19.9	19.8	18.9	23.7	20.1	20.0	22.4	19.9	19.9	20.2	21.8	19.6	33.8	9.6	21.3	5.5	14.0	13.8	21.1	7.2	14.2	15.2	34.5	37.6	11.5	21.5	11.3	23.9	14.6	35.8	19.8	26.2	29.4	46.4	21.2	22.5	23.9	19.8	21.6	9.2	4.3	42.0	40.7	29.1	15.8	18.8	2.5	29.9	15.4	26.8	20.5	16.8	5.0	17.0	8.2	16.1	17.3	50.1	23.3	13.9	17.8	1.9	15.5	31.8	17.5	3.5	4.4	31.0	10.7	29.3	19.9	23.3	15.4	30.6	11.0	21.2	0.0	16.3	32.0	22.4	13.0	18.8	19.5	30.4	14.2	39.2	23.5	18.3
KANSL3	"FLJ10081, KIAA1310, NSL3, Rcd1"	ENSG00000114982	"KAT8 regulatory NSL complex subunit 3"	Q9P2N6	2	96593170-96642787	"Metabolic proteins, Predicted intracellular proteins"		"Chromatin regulator"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA035017, HPA035018"	Approved		Supported	Nucleoplasm,Vesicles		NA	NA			"Cluster 39: Non-specific - mRNA processing"	"Cluster 52: Non-specific - Ribosome"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 40: Granulosa cells - Unknown function"	Nucleoplasm	Vesicles	"HPA035017: AB_2674414, HPA035018: AB_10601763"	"unprognostic (2.19e-1)"	"unprognostic (6.94e-2)"	"unprognostic (5.62e-2)"	"unprognostic (8.72e-3)"	"unprognostic (3.28e-1)"	"unprognostic (4.35e-3)"	"prognostic unfavorable (5.34e-4)"	"unprognostic (6.34e-2)"	"unprognostic (1.41e-1)"	"unprognostic (2.02e-1)"	"unprognostic (3.01e-2)"	"unprognostic (2.99e-2)"	"unprognostic (2.04e-3)"	"unprognostic (3.28e-1)"	"unprognostic (1.92e-1)"	"unprognostic (8.30e-3)"	"unprognostic (4.99e-3)"	11.8	9.9	1.9	8.6	2.4	14.9	12.3	1.6	3.1	13.7	8.1	11.8	7.2	15.0	7.7	8.9	12.5	6.9	10.7	2.9	2.6	8.8	6.4	9.9	8.2	2.1	2.9	15.1	9.8	15.1	8.8	9.0	2.3	11.2	6.9	6.3	12.5	14.7	33.9	10.8	12.0	10.6	3.3	10.1	9.8	12.8	3.3	13.1	12.9	21.1	8.9	13.0	10.8	2.3	13.1	7.9	26.0	19.4	10.6	6.4	11.4	9.7	15.2	20.1	21.4	15.1	7.8	18.1	14.6	16.2	14.7	8.2	18.8	9.4	17.5	12.8	14.8	26.0	8.1	16.2	15.0	17.4	9.0	15.0	5.8	12.8	11.4	12.0	11.0	21.0	18.6	12.8	12.8	6.9	32.3	13.5	12.5	6.7	12.8	26.2	16.5	10.6	12.4	12.7	26.8	16.9	12.3	11.8	11.8	14.7	11.4	5.5	15.9	13.5	11.8	9.8	8.9	10.1	6.7	15.7	7.0	19.9	12.2	2.4	1.3	0.5	2.8	1.5	2.1	1.6	1.7	2.9	0.7	1.5	1.2	2.3	0.2	3.1	1.3	0.7	1.1	1.7	1.9	2.4	1.6	3.1	2.9	2.6	2.1	2.9	2.3	3.3	3.3	2.3	11.6	44.8	30.8	29.0	10.5	4.6	9.9	8.1	9.1	15.0	14.8	12.2	23.8	10.0	18.8	11.0	43.8	8.1	10.0	15.0	3.9	10.5	13.4	13.0	13.7	12.1	13.1	6.7	35.6	9.6	4.3	12.7	17.3	13.5	18.3	33.1	15.7	12.7	8.1	15.2	36.2	18.4	10.2	12.5	5.6	28.6	9.9	11.2	7.2	16.9	13.7	10.2	9.2	29.7	37.3	13.2	7.9	12.8	10.6	10.3	10.7	5.8	13.1	29.5	13.1	16.0	13.6	23.3	9.7	11.3	6.5	11.1	14.2	18.3	15.6	10.1
KCNAB2	"AKR6A5, HKvbeta2.1, HKvbeta2.2, KCNA2B"	ENSG00000069424	"Potassium voltage-gated channel subfamily A regulatory beta subunit 2"	Q13303	1	5990927-6101193	"Plasma proteins, Predicted intracellular proteins"	"Ion transport, Potassium transport, Transport"	"Ion channel, Oxidoreductase, Voltage-gated channel"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 188.3"	"Cell type enhanced"	"Detected in many"		"dendritic cells: 50.3;Excitatory neurons: 67.8;Hofbauer cells: 63.6;Inhibitory neurons: 49.2;Kupffer cells: 86.2;Macrophages: 51.3;Melanocytes: 64.0;NK-cells: 51.5"	"Cancer enriched"	"Detected in all"	7	"melanoma: 29.3"	"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HL-60: 278.8;JURKAT: 142.7;U-937: 289.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			CAB001975	Enhanced					NA	NA			"Cluster 39: Non-specific - mRNA processing"	"Cluster 10: Brain - Neuronal signaling"	"Cluster 32: U-937 - Innate immune response"	"Cluster 63: NK-cells & T-cells - Immune response"			"CAB001975: "	"unprognostic (6.60e-2)"	"unprognostic (2.33e-2)"	"unprognostic (3.97e-3)"	"unprognostic (2.30e-2)"	"unprognostic (1.76e-2)"	"unprognostic (8.18e-3)"	"unprognostic (4.30e-2)"	"unprognostic (1.05e-1)"	"unprognostic (4.85e-2)"	"unprognostic (1.58e-2)"	"unprognostic (7.71e-3)"	"unprognostic (8.83e-3)"	"prognostic unfavorable (3.50e-5)"	"unprognostic (2.88e-2)"	"unprognostic (3.10e-2)"	"unprognostic (2.35e-1)"	"unprognostic (5.24e-2)"	12.8	7.7	69.2	28.6	94.1	63.8	8.0	7.4	188.3	5.6	0.0	8.8	5.4	7.2	2.3	5.0	8.6	11.2	22.1	141.6	12.8	26.0	10.1	31.1	43.6	78.7	5.3	5.6	4.0	1.5	20.3	5.9	77.5	6.2	4.6	17.8	6.4	3.4	12.6	12.3	23.9	6.3	1.5	65.8	6.5	5.6	18.9	27.0	6.2	15.8	24.7	8.8	5.1	89.7	11.3	27.0	2.5	4.5	1.5	5.0	10.3	6.3	40.0	6.3	7.8	10.6	4.1	62.0	23.3	6.1	7.7	5.4	2.7	1.0	3.2	84.6	9.6	71.1	25.3	21.1	6.0	278.8	1.9	6.5	1.3	3.4	7.5	6.3	3.6	142.7	2.7	114.2	3.1	9.8	61.9	115.9	1.1	3.9	15.4	13.8	9.7	78.9	0.1	0.2	20.6	6.2	5.3	6.4	101.0	2.7	5.4	117.3	1.1	1.3	9.4	14.4	7.5	84.4	122.4	100.4	12.7	289.2	1.9	4.4	34.3	18.6	29.8	27.2	26.8	7.5	18.2	28.0	31.0	8.7	18.7	20.6	14.4	19.4	25.0	12.7	19.1	43.2	69.2	94.1	7.4	188.3	141.6	12.8	78.7	5.3	77.5	1.5	18.9	89.7	3.0	0.0	6.6	7.5	23.0	4.8	1.7	1.8	1.8	24.0	1.2	2.3	15.7	7.2	1.5	1.8	6.2	0.5	50.3	0.3	0.0	0.3	5.8	3.4	1.9	3.1	0.0	11.1	67.8	1.4	2.3	3.5	2.0	0.6	8.8	2.9	3.9	1.0	63.6	6.7	49.2	0.5	2.0	86.2	19.0	5.2	3.7	51.3	64.0	5.6	26.6	4.9	51.5	8.5	6.1	0.6	0.1	2.6	23.4	0.4	0.1	40.8	8.7	11.8	0.0	2.1	3.1	3.2	2.9	0.7	2.8	0.8	44.3	2.5	0.3	0.6
KDM5C	"DXS1272E, JARID1C, MRX13, SMCX, XE169"	ENSG00000126012	"Lysine demethylase 5C"	P41229	X	53191321-53225422	"Cancer-related genes, Disease related genes, Enzymes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Transcription factors"	"Biological rhythms, Transcription, Transcription regulation"	"Chromatin regulator, Dioxygenase, Oxidoreductase, Repressor"	"Cancer-related genes, Disease variant, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA038244, HPA046147"			Enhanced	Nucleoplasm,Cytosol		NA	NA			"Cluster 39: Non-specific - mRNA processing"	"Cluster 59: Non-specific - Translation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 44: Endometrium - Transcription"	Nucleoplasm	Cytosol	"HPA038244: AB_2675911, HPA046147: AB_2679555"	"unprognostic (1.19e-1)"	"unprognostic (1.13e-1)"	"unprognostic (1.56e-2)"	"unprognostic (7.10e-2)"	"unprognostic (9.75e-2)"	"unprognostic (2.19e-1)"	"prognostic unfavorable (2.11e-4)"	"unprognostic (2.08e-2)"	"unprognostic (2.11e-1)"	"unprognostic (1.24e-1)"	"unprognostic (5.45e-2)"	"unprognostic (1.58e-2)"	"unprognostic (5.05e-3)"	"unprognostic (1.96e-2)"	"unprognostic (6.91e-2)"	"unprognostic (1.30e-1)"	"unprognostic (1.00e-1)"	22.3	29.0	19.2	28.2	19.7	34.8	22.7	23.0	21.7	35.5	22.2	25.5	26.0	35.5	14.8	35.2	33.2	17.1	22.7	19.6	20.1	21.1	24.1	27.2	33.4	19.8	19.0	39.9	26.4	33.8	31.4	23.8	19.0	23.8	15.4	24.6	29.4	18.5	51.0	34.2	28.2	26.9	16.8	30.9	25.8	13.5	20.9	44.2	27.6	25.5	26.5	25.9	35.4	20.8	45.3	60.4	63.6	49.0	43.2	39.1	45.2	27.7	32.2	36.8	34.0	41.3	28.9	41.8	35.0	36.7	103.2	39.5	72.6	59.1	27.8	31.6	107.9	40.6	66.7	29.6	52.9	48.5	77.6	31.0	42.8	72.0	87.7	52.3	55.2	34.2	80.8	27.2	27.3	57.9	35.9	55.4	54.1	23.3	56.3	40.1	37.8	45.9	23.5	42.6	47.6	61.4	84.0	76.8	32.2	58.4	53.9	42.3	37.8	40.6	35.0	36.9	27.2	39.0	34.2	31.5	52.6	56.9	30.8	0.9	1.2	0.8	1.6	1.1	1.4	1.2	1.0	1.6	0.9	0.8	1.2	0.8	1.4	0.8	1.2	1.3	1.3	1.2	19.2	19.7	23.0	21.7	19.6	20.1	19.8	19.0	19.0	16.8	20.9	20.8	17.6	12.8	14.9	33.0	17.8	12.1	10.5	12.1	14.8	24.7	19.7	15.0	10.0	11.5	15.2	7.3	25.0	13.1	21.2	32.2	3.9	15.0	0.8	28.2	25.2	17.7	31.2	17.2	36.1	21.9	15.1	14.2	21.4	35.7	13.3	25.5	15.0	25.5	14.4	25.2	37.0	25.8	16.2	18.2	8.8	2.6	14.6	17.1	14.2	27.2	14.9	9.8	16.5	31.2	49.2	26.4	26.3	15.8	17.0	17.9	22.1	5.8	16.4	16.9	0.0	17.2	16.8	10.3	15.8	16.2	15.9	20.8	18.0	22.6	18.9	21.6
KDM5D	"HY, HYA, JARID1D, KIAA0234, SMCY"	ENSG00000012817	"Lysine demethylase 5D"	Q9BY66	Y	19703865-19744939	"Enzymes, Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Chromatin regulator, Dioxygenase, Oxidoreductase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Plasma cells: 46.3"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HEL: 60.4;U-698: 51.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			HPA049086			Approved	"Nucleoli fibrillar center"		NA	NA			"Cluster 39: Non-specific - mRNA processing"	"Cluster 64: Macrophages - Immune response"	"Cluster 36: HEL - Hemostasis"	"Cluster 63: NK-cells & T-cells - Immune response"	"Nucleoli fibrillar center"		"HPA049086: "			"unprognostic (8.38e-2)"		"unprognostic (2.20e-1)"	"prognostic favorable (3.58e-5)"	"unprognostic (6.08e-3)"	"unprognostic (1.50e-2)"	"unprognostic (3.10e-2)"		"unprognostic (4.57e-2)"	"unprognostic (1.22e-1)"	"unprognostic (1.15e-2)"	"unprognostic (4.00e-2)"	"unprognostic (7.92e-2)"	"unprognostic (1.30e-2)"	"unprognostic (1.80e-2)"	16.0	29.9	2.3	11.8	2.4	17.4	12.8	3.2	13.2	0.0	5.3	22.2	18.0	0.0	15.2	12.3	0.0	11.7	13.3	2.2	2.5	12.1	12.7	16.7	8.7	2.9	2.0	0.0	18.9	4.9	16.2	9.2	2.8	25.5	21.6	9.0	15.6	18.0	15.7	12.9	35.2	0.0	1.6	30.8	16.0	12.1	2.6	0.0	18.6	25.7	20.5	19.9	0.0	4.4	0.1	8.0	0.0	0.0	0.0	0.0	15.9	15.4	12.9	8.6	9.4	0.0	0.0	0.3	0.0	12.6	0.0	0.0	0.0	0.0	9.4	22.6	0.0	60.4	0.0	18.5	11.5	0.1	0.0	12.9	12.9	0.0	0.0	0.0	0.0	10.6	0.0	0.0	20.1	0.0	24.6	0.1	11.6	0.0	0.1	0.0	10.1	10.9	17.0	28.7	13.2	0.1	0.0	0.0	5.9	27.2	0.0	12.5	18.9	25.9	0.2	0.2	6.6	24.2	16.6	51.4	2.5	0.1	0.0	0.0	1.8	2.1	2.3	1.1	1.7	3.2	2.2	2.2	1.7	2.6	2.4	1.9	0.2	1.9	0.9	2.6	1.8	1.3	2.3	2.4	3.2	13.2	2.2	2.5	2.9	2.0	2.8	1.6	2.6	4.4	0.0	19.2	16.5	9.4	22.2	6.4	9.2	5.3	18.2	39.9	0.0	0.0	12.2	2.8	7.7	18.4	20.9	7.0	14.6	2.8	5.9	5.4	0.8	0.0	0.0	10.8	3.5	22.7	26.0	0.0	2.5	10.6	19.9	0.0	11.4	0.0	13.2	3.1	4.8	13.5	23.2	5.8	2.0	7.6	12.1	3.8	36.7	10.3	10.6	10.3	14.5	7.5	13.4	12.1	15.2	1.7	5.0	33.8	46.3	8.6	13.9	4.2	5.5	30.5	26.3	8.5	8.5	3.3	9.7	12.2	10.9	5.6	16.4	0.0	6.6	8.8
KHK		ENSG00000138030	Ketohexokinase	P50053	2	27086747-27100762	"Disease related genes, Enzymes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Carbohydrate metabolism"	"Kinase, Transferase"	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	14	"intestine: 121.2;kidney: 104.4;liver: 180.5"	"Cell type enhanced"	"Detected in many"		"Hepatocytes: 428.5;Proximal enterocytes: 1858.7;Proximal tubular cells: 1019.7"	"Group enriched"	"Detected in all"	7	"liver cancer: 62.2;renal cancer: 32.5"	"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"HEL: 32.8;Hep G2: 48.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA007040	Enhanced		Approved	Vesicles,Cytosol		NA	NA		620000	"Cluster 39: Non-specific - mRNA processing"	"Cluster 41: Intestine & Liver - Lipid metabolism"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	Cytosol	Vesicles	"HPA007040: AB_1079185"	"unprognostic (8.44e-2)"	"unprognostic (1.49e-1)"	"unprognostic (1.70e-1)"	"prognostic unfavorable (7.62e-8)"	"unprognostic (2.25e-1)"	"unprognostic (1.21e-1)"	"unprognostic (3.08e-2)"	"unprognostic (3.13e-2)"	"unprognostic (1.67e-2)"	"unprognostic (2.50e-2)"	"unprognostic (3.01e-2)"	"unprognostic (1.30e-1)"	"unprognostic (1.68e-2)"	"unprognostic (2.56e-3)"	"unprognostic (2.32e-1)"	"unprognostic (2.44e-1)"	"unprognostic (1.02e-2)"	2.2	4.6	4.2	3.0	4.3	1.7	2.0	7.1	5.9	2.6	1.2	4.2	112.4	3.8	0.6	2.4	4.3	1.3	1.4	4.8	3.9	104.4	180.5	1.6	1.9	5.4	4.0	3.6	9.4	2.6	1.4	0.5	5.5	1.6	1.2	1.5	4.4	1.4	3.8	2.4	121.2	1.9	3.6	2.0	2.9	3.2	3.8	0.7	1.1	2.0	1.2	1.8	2.3	4.7	25.0	18.5	2.8	11.0	2.0	0.5	2.5	1.7	1.1	2.3	1.4	9.0	5.3	3.7	5.8	0.1	2.6	10.7	9.4	3.1	0.8	8.8	17.2	32.8	5.2	48.0	1.1	4.6	3.7	0.1	1.3	2.7	0.2	1.2	2.1	5.1	5.9	6.1	0.2	16.0	5.4	3.6	4.0	22.3	7.2	18.9	1.4	20.9	2.7	3.0	10.2	15.8	3.6	6.2	6.9	1.0	2.7	2.0	1.9	0.7	3.6	1.6	6.5	7.5	14.4	6.3	3.0	10.7	1.8	0.0	5.4	0.3	4.1	3.1	5.5	3.8	6.6	6.0	4.9	3.6	4.7	5.8	0.5	4.9	1.4	6.1	4.7	4.9	4.2	4.3	7.1	5.9	4.8	3.9	5.4	4.0	5.5	3.6	3.8	4.7	6.5	3.2	3.7	1.6	6.8	3.6	2.6	0.8	6.8	3.6	4.7	5.8	1.8	20.0	1.0	40.5	2.1	4.1	1.3	7.4	129.1	3.2	1.2	0.1	0.6	5.5	6.0	15.6	3.4	3.0	3.6	2.4	3.6	0.3	4.5	2.9	9.7	428.5	8.3	6.7	2.7	89.6	4.1	11.9	2.0	6.2	1.8	10.8	8.8	0.0	1.9	9.8	4.1	2.5	2.3	2.1	95.7	1.5	8.0	0.7	1858.7	1019.7	0.0	5.4	0.0	5.0	5.0	1.1	5.8	4.6	6.8	9.4	6.8	0.8	82.6	2.2
KLHDC7B	MGC16635	ENSG00000130487	"Kelch domain containing 7B"	Q96G42	22	50545899-50551023	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"lymphoid tissue: 5.2;parathyroid gland: 13.7"	"Cell type enhanced"	"Detected in some"		"B-cells: 5.2;Collecting duct cells: 5.5;granulocytes: 5.7;Kupffer cells: 5.2;monocytes: 21.1;NK-cells: 10.3;T-cells: 5.7"	"Group enriched"	"Detected in many"	4	"cervical cancer: 42.3;head and neck cancer: 11.4;urothelial cancer: 40.7"	"Not detected"	"Not detected"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enriched"	"Detected in some"	4	"HMC-1: 97.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA000518, HPA076540"	Uncertain		Approved	"Plasma membrane"		NA	NA			"Cluster 39: Non-specific - mRNA processing"	"Cluster 48: Parathyroid gland - membrane proteins"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 3: Monocytes - Immune response regulation"	"Plasma membrane"		"HPA000518: AB_1079213, HPA076540: "	"prognostic favorable (1.30e-4)"	"unprognostic (3.18e-2)"	"unprognostic (2.74e-2)"	"unprognostic (2.21e-1)"	"unprognostic (3.96e-2)"	"unprognostic (6.04e-3)"	"unprognostic (3.91e-1)"	"unprognostic (1.07e-1)"	"unprognostic (1.07e-2)"	"unprognostic (7.13e-2)"	"unprognostic (3.33e-3)"	"unprognostic (2.48e-1)"	"unprognostic (2.09e-3)"	"unprognostic (2.89e-1)"	"unprognostic (4.69e-2)"	"unprognostic (3.49e-1)"	"unprognostic (1.02e-1)"	0.2	0.2	0.2	2.1	0.1	1.0	0.3	0.1	0.2	0.5	0.1	0.3	0.4	0.2	0.3	0.4	0.1	0.3	0.0	0.1	0.2	3.7	0.4	0.7	2.3	0.5	0.2	0.0	0.1	13.7	1.0	0.1	0.3	0.4	0.1	0.0	1.3	0.2	0.0	0.3	1.1	0.1	0.2	2.7	0.5	0.2	0.4	5.2	2.0	0.0	1.3	1.5	0.2	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.2	0.0	0.1	0.0	0.8	0.0	0.8	0.1	0.3	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	22.0	0.2	97.7	0.1	1.2	0.0	0.2	0.1	0.0	0.0	0.0	11.6	0.0	0.0	0.0	8.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.7	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.1	0.0	1.8	0.3	0.0	0.1	1.1	1.1	0.1	2.0	1.9	1.4	1.9	2.1	2.6	0.9	1.3	2.3	2.0	0.2	0.7	1.4	0.3	2.0	1.5	0.2	0.1	0.1	0.2	0.1	0.2	0.5	0.2	0.3	0.2	0.4	0.2	0.0	0.0	0.6	0.0	5.2	0.1	0.0	1.6	0.0	0.0	3.0	1.4	0.5	0.0	1.6	5.5	0.0	0.0	2.5	0.1	0.0	0.8	0.0	0.2	0.0	0.1	0.0	0.4	0.0	0.7	0.1	0.2	0.5	0.3	5.7	0.0	0.0	0.1	1.6	0.0	0.0	0.0	0.0	5.2	1.2	0.0	0.0	2.7	0.0	0.0	21.1	0.0	10.3	0.0	0.0	1.3	0.0	0.0	2.8	0.1	0.0	0.3	1.6	0.0	0.0	0.1	0.3	0.1	0.1	0.0	0.0	0.0	5.7	0.0	0.0	0.2
LANCL2	"GPR69B, TASP"	ENSG00000132434	"LanC like 2"	Q9NS86	7	55365337-55433737	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Early spermatids: 52.5;Late spermatids: 55.3;Oligodendrocyte precursor cells: 52.8;Oligodendrocytes: 67.3"	"Group enriched"	"Detected in all"	5	"glioma: 52.5;testis cancer: 19.2"	"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enriched"	"Detected in all"	8	"A-431: 144.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA019711, HPA029535"	Uncertain		Supported	Nucleoplasm,Cytosol		NA	NA		13000	"Cluster 39: Non-specific - mRNA processing"	"Cluster 10: Brain - Neuronal signaling"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	"Nucleoplasm, Cytosol"		"HPA019711: AB_1852699, HPA029535: AB_10602342"	"unprognostic (1.11e-1)"	"unprognostic (6.89e-2)"	"unprognostic (7.28e-2)"	"unprognostic (1.28e-2)"	"unprognostic (1.20e-1)"	"unprognostic (1.76e-2)"	"unprognostic (1.01e-1)"	"unprognostic (1.31e-1)"	"unprognostic (2.56e-1)"	"prognostic favorable (1.89e-4)"	"unprognostic (1.35e-3)"	"unprognostic (5.58e-2)"	"prognostic favorable (1.03e-6)"	"unprognostic (4.58e-3)"	"unprognostic (1.04e-2)"	"unprognostic (3.94e-1)"	"unprognostic (1.45e-1)"	3.9	6.2	17.4	2.6	18.8	3.9	5.9	11.5	18.6	5.7	8.7	4.9	5.1	10.4	5.1	4.1	5.4	3.8	4.1	21.2	14.2	6.0	5.0	3.1	3.5	12.5	12.9	9.1	4.7	9.2	6.0	4.0	12.4	5.8	4.7	8.4	4.7	6.4	7.0	5.5	5.0	6.7	13.2	3.6	4.4	6.2	14.2	4.7	6.5	5.1	2.9	3.9	4.0	17.4	144.8	4.9	9.7	6.6	2.9	5.0	5.4	6.4	7.6	9.7	8.2	5.0	4.1	10.1	5.9	9.3	9.7	6.4	5.2	3.5	5.9	4.4	10.4	3.6	3.8	5.1	5.1	11.2	6.4	9.0	3.7	7.2	2.3	5.1	4.8	4.7	6.4	6.4	9.1	4.4	2.9	5.2	18.8	3.9	6.1	4.3	4.5	5.0	6.3	11.3	16.9	16.0	9.3	13.6	3.9	3.6	5.6	11.8	8.1	6.1	8.3	11.6	12.5	6.1	7.8	10.6	4.8	2.5	11.8	0.1	1.5	0.3	1.0	1.9	1.7	1.1	1.3	1.5	1.9	1.0	1.2	1.0	0.2	1.5	1.4	1.5	2.6	1.1	17.4	18.8	11.5	18.6	21.2	14.2	12.5	12.9	12.4	13.2	14.2	17.4	3.0	3.2	8.9	28.7	5.9	4.0	6.3	5.5	5.7	8.9	6.8	6.7	9.4	10.0	5.1	11.0	6.2	12.5	5.1	8.8	5.9	7.1	52.5	6.7	11.2	5.4	12.6	12.6	41.7	12.2	12.1	16.3	5.1	7.7	11.4	10.2	7.1	10.0	7.7	15.2	39.6	9.1	4.1	7.3	4.8	55.3	9.0	5.4	0.0	8.4	9.5	10.8	6.2	52.8	67.3	7.8	7.6	7.5	5.1	5.5	9.8	27.7	7.7	7.6	0.0	19.4	5.9	22.7	17.8	7.5	3.8	19.0	4.3	12.8	9.7	6.0
LIMK1	LIMK	ENSG00000106683	"LIM domain kinase 1"	P53667	7	74082933-74122525	"Cancer-related genes, Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"		"Kinase, Serine/threonine-protein kinase, Transferase"	"Cancer-related genes, Williams-Beuren syndrome"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 77.9"	"Cell type enhanced"	"Detected in many"		"Granulosa cells: 27.6;Horizontal cells: 35.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"U-87 MG: 136.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA028516, HPA073571"	Approved		Supported	"Nuclear speckles,Cytosol"		NA	NA			"Cluster 39: Non-specific - mRNA processing"	"Cluster 70: Brain - Nervous system development"	"Cluster 11: RPE1 & U-87MG - Synaptic function"	"Cluster 4: Macrophages - Innate immune response"	"Nuclear speckles, Cytosol"		"HPA028516: AB_10601751, HPA073571: "	"unprognostic (1.45e-2)"	"unprognostic (2.75e-1)"	"prognostic unfavorable (4.95e-5)"	"unprognostic (2.77e-2)"	"unprognostic (1.40e-3)"	"unprognostic (3.35e-2)"	"prognostic unfavorable (7.79e-6)"	"unprognostic (1.90e-2)"	"unprognostic (2.16e-1)"	"unprognostic (1.18e-1)"	"unprognostic (3.32e-2)"	"unprognostic (3.16e-2)"	"prognostic unfavorable (6.63e-8)"	"unprognostic (4.14e-2)"	"unprognostic (7.00e-2)"	"unprognostic (3.84e-2)"	"unprognostic (5.79e-2)"	11.1	10.5	31.1	18.7	32.7	6.8	9.4	28.3	77.9	21.4	0.2	8.9	6.6	13.1	3.5	11.3	7.3	10.1	9.4	35.0	43.8	10.8	4.6	13.2	23.5	75.5	40.0	13.2	11.4	5.8	13.9	7.3	73.0	12.3	4.1	4.0	17.9	8.2	23.7	11.4	12.1	7.1	31.8	22.3	9.2	15.6	59.1	8.1	11.2	7.8	18.2	13.1	14.7	38.3	47.4	37.2	27.2	45.4	35.1	47.0	20.0	28.8	27.3	22.6	25.4	21.3	45.6	30.2	12.7	35.5	76.9	28.1	10.1	17.8	8.6	53.7	18.6	23.2	13.1	24.6	40.5	17.2	81.4	46.8	15.6	18.5	9.6	68.3	34.4	20.9	15.1	9.0	28.8	41.4	14.8	31.4	52.1	16.6	23.7	21.1	43.3	18.2	26.5	10.1	10.7	25.2	18.6	43.7	23.5	29.7	13.9	15.4	41.1	36.0	33.7	94.5	47.7	10.2	12.5	54.9	136.5	12.4	25.2	0.1	6.1	3.5	1.8	6.0	1.4	3.4	0.4	1.2	7.0	1.7	0.1	0.5	0.5	5.8	3.8	0.7	0.3	3.3	31.1	32.7	28.3	77.9	35.0	43.8	75.5	40.0	73.0	31.8	59.1	38.3	2.9	3.2	2.7	7.5	14.4	2.9	5.2	6.6	1.8	6.6	7.7	6.9	3.4	7.2	3.8	1.8	2.1	2.5	11.9	2.9	0.0	6.6	1.2	2.7	9.7	4.1	2.4	0.4	15.4	6.5	6.3	9.2	3.1	5.1	5.7	27.6	3.3	2.1	25.0	35.3	20.8	2.7	0.0	13.5	10.8	2.2	7.2	15.6	3.6	6.5	14.9	3.5	22.6	6.6	2.4	13.5	2.3	6.0	10.0	9.0	0.3	2.8	3.1	3.3	0.0	5.3	4.5	3.4	11.5	1.8	3.1	3.7	11.1	6.9	2.4	7.2
LYSMD4	FLJ33008	ENSG00000183060	"LysM domain containing 4"	Q5XG99	15	99715697-99733561	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA029152, HPA059824"	Approved		Approved	"Actin filaments,Cytosol"		NA	NA			"Cluster 39: Non-specific - mRNA processing"	"Cluster 31: Skin - Epidermis development"	"Cluster 21: OE19 - Mitochondria"	"Cluster 62: Horizontal cells - Visual perception"	Cytosol	"Actin filaments"	"HPA029152: AB_10602033, HPA059824: AB_2684135"	"unprognostic (2.43e-3)"	"unprognostic (1.30e-2)"	"unprognostic (1.53e-1)"	"unprognostic (2.81e-1)"	"unprognostic (4.07e-3)"	"unprognostic (3.80e-2)"	"unprognostic (1.53e-3)"	"unprognostic (3.75e-1)"	"unprognostic (1.37e-1)"	"unprognostic (1.88e-1)"	"unprognostic (6.35e-3)"	"unprognostic (9.77e-2)"	"unprognostic (1.02e-2)"	"unprognostic (2.06e-1)"	"unprognostic (9.23e-2)"	"unprognostic (3.29e-2)"	"unprognostic (3.30e-1)"	7.1	5.5	6.3	1.7	6.8	3.1	6.7	6.3	7.1	8.4	6.2	9.7	4.8	9.4	3.4	11.1	8.1	1.5	20.2	6.4	6.0	11.8	11.8	7.6	2.3	5.9	6.4	8.9	8.0	5.7	7.1	2.8	6.2	9.5	3.2	5.2	9.5	4.2	10.3	16.7	7.9	3.8	5.9	8.0	7.8	7.7	7.0	3.9	5.0	5.9	3.8	7.9	9.4	6.8	3.5	3.3	6.5	3.8	7.1	6.4	3.9	3.9	2.7	3.3	4.8	8.2	3.0	3.8	2.3	3.6	5.8	10.1	5.1	6.3	3.8	0.8	9.2	2.5	7.2	5.7	4.1	1.8	4.6	3.7	9.2	3.0	3.6	2.0	4.5	10.9	6.2	4.8	2.2	4.1	4.8	5.1	4.3	9.7	3.7	3.4	4.6	1.9	5.9	9.0	3.7	3.3	7.2	2.2	3.9	8.3	1.5	3.5	5.8	2.7	7.3	3.7	1.7	6.3	9.1	3.1	3.5	4.5	2.9	0.0	1.3	5.3	2.1	1.9	1.7	1.0	3.0	2.6	0.6	1.7	3.5	1.6	0.4	0.7	2.7	3.0	3.2	2.4	6.3	6.8	6.3	7.1	6.4	6.0	5.9	6.4	6.2	5.9	7.0	6.8	7.0	6.4	3.3	4.6	2.5	8.7	8.1	4.6	8.0	8.0	3.5	6.3	12.8	7.2	3.9	3.7	10.4	2.6	4.9	4.4	1.9	4.1	7.3	1.3	3.0	4.8	3.0	6.1	9.8	9.7	2.0	6.8	3.6	1.7	0.0	2.9	3.9	3.4	4.3	10.1	11.4	6.2	6.1	2.2	3.7	8.1	5.3	3.9	1.8	8.4	8.1	11.6	3.1	6.0	7.4	7.2	3.0	6.8	3.9	2.1	3.9	5.3	2.5	10.0	13.1	3.9	5.7	12.7	11.3	8.1	9.1	1.4	2.9	2.2	2.6	3.5
LZTR1	"BTBD29, LZTR-1"	ENSG00000099949	"Leucine zipper like transcription regulator 1"	Q8N653	22	20982269-20999032	"Cancer-related genes, Disease related genes, Human disease related genes, Predicted intracellular proteins"	"Ubl conjugation pathway"		"Cancer-related genes, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in single"			"Low lineage specificity"	"Detected in single"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA067852, HPA068772, HPA071248"	Approved		Approved	Nucleoplasm,Centrosome,Cytosol		No	No			"Cluster 39: Non-specific - mRNA processing"	"Cluster 72: Non-specific - Transcription"	"Cluster 1: K-562 - Erythropoiesis"	"Cluster 52: Non-specific - Transcription"	Nucleoplasm	"Centrosome, Cytosol"	"HPA067852: , HPA068772: AB_2686031, HPA071248: AB_2686372"	"unprognostic (1.88e-2)"	"unprognostic (1.01e-1)"	"unprognostic (1.90e-1)"	"unprognostic (1.08e-1)"	"unprognostic (1.06e-1)"	"unprognostic (2.44e-2)"	"prognostic unfavorable (5.15e-4)"	"unprognostic (9.81e-2)"	"unprognostic (3.55e-1)"	"unprognostic (3.78e-2)"	"unprognostic (1.01e-2)"	"unprognostic (2.64e-1)"	"unprognostic (1.16e-3)"	"unprognostic (4.29e-2)"	"unprognostic (1.65e-1)"	"unprognostic (6.25e-2)"	"unprognostic (1.25e-2)"	18.4	15.2	9.0	8.9	9.7	6.0	17.3	8.9	10.1	20.1	7.2	20.1	9.9	23.3	4.4	12.6	18.5	9.4	13.4	9.1	9.1	15.8	12.0	16.0	7.3	10.3	9.5	19.5	12.4	11.5	24.7	9.8	10.8	16.2	6.4	3.4	13.0	8.6	14.7	13.6	15.9	11.3	8.1	18.3	13.9	8.2	8.9	6.5	18.8	8.0	5.7	18.1	15.8	9.3	10.3	8.4	12.2	15.0	27.6	18.9	9.6	20.8	14.6	11.6	15.8	4.9	4.2	11.0	7.6	23.4	10.7	13.7	9.3	17.1	4.7	20.5	21.0	11.8	11.8	7.4	14.6	6.4	14.9	17.5	8.5	14.7	10.6	18.4	22.9	10.0	49.8	18.5	13.4	6.3	11.5	6.0	3.8	12.6	9.1	13.4	17.8	4.4	9.2	13.9	11.9	17.9	11.3	19.5	12.4	7.4	9.1	11.7	20.6	27.0	13.3	12.3	11.5	8.0	7.4	3.2	12.2	6.2	13.5	0.0	0.5	0.0	0.7	0.7	0.4	0.4	0.3	0.8	0.4	0.1	0.4	0.3	0.0	0.3	1.0	0.3	0.1	0.5	9.0	9.7	8.9	10.1	9.1	9.1	10.3	9.5	10.8	8.1	8.9	9.3	12.4	12.8	8.6	20.5	7.9	2.2	1.8	3.7	4.0	9.5	7.5	7.6	11.7	5.7	5.2	9.2	6.2	4.1	11.9	10.7	1.9	7.0	0.9	5.5	12.7	10.1	9.1	2.5	14.2	4.9	4.0	10.9	11.2	8.4	5.7	14.7	12.1	8.5	7.7	3.3	13.2	10.0	6.1	8.8	3.5	1.6	8.7	7.1	7.2	14.0	5.0	5.6	5.2	8.0	17.6	6.1	8.9	9.8	9.2	2.3	7.0	7.6	7.3	9.8	0.0	7.0	11.6	4.5	1.5	5.9	3.7	3.6	7.7	10.1	6.7	1.4
LZTS2	"KIAA1813, LAPSER1"	ENSG00000107816	"Leucine zipper tumor suppressor 2"	Q9BRK4	10	100996618-101007836	"Predicted intracellular proteins"	"Cell cycle, Cell division, Mitosis, Wnt signaling pathway"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Oligodendrocytes: 70.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA044956	Approved		Approved	"Plasma membrane,Cytosol"		No	Yes			"Cluster 39: Non-specific - mRNA processing"	"Cluster 35: Non-specific - Unknown function"	"Cluster 33: SK-MEL-30 - Melanocyte processes"	"Cluster 10: Non-specific - Unknown function"	"Plasma membrane, Cytosol"		"HPA044956: AB_10795989"	"unprognostic (1.42e-2)"	"unprognostic (1.96e-1)"	"prognostic unfavorable (8.23e-4)"	"unprognostic (8.18e-2)"	"unprognostic (4.64e-2)"	"unprognostic (1.56e-1)"	"unprognostic (5.49e-3)"	"unprognostic (3.56e-1)"	"unprognostic (7.57e-2)"	"unprognostic (4.58e-2)"	"unprognostic (2.72e-1)"	"unprognostic (1.38e-1)"	"prognostic unfavorable (3.39e-4)"	"unprognostic (7.63e-2)"	"unprognostic (1.86e-1)"	"unprognostic (5.46e-3)"	"unprognostic (1.76e-3)"	69.9	66.0	46.8	14.9	65.5	14.4	63.3	58.0	54.1	74.3	25.8	96.3	17.5	90.3	17.7	41.0	69.2	19.8	58.9	41.2	45.8	51.8	18.0	57.1	12.1	63.7	64.3	78.6	29.5	29.1	43.6	28.5	58.5	69.5	8.9	5.9	44.3	40.6	37.8	48.9	43.0	26.6	49.0	44.4	54.9	36.2	64.1	10.8	57.6	18.0	8.1	84.1	54.4	78.9	32.9	43.1	34.6	59.7	45.0	36.3	70.8	38.7	72.8	31.9	36.0	50.5	26.6	13.1	35.1	52.5	23.0	54.6	21.5	28.2	7.8	12.8	31.9	12.1	46.4	66.3	63.6	6.4	15.2	66.1	20.2	25.1	30.1	67.3	32.8	15.6	38.7	7.3	28.7	31.6	5.8	15.8	38.8	12.6	35.2	74.7	101.3	13.5	24.4	39.3	8.4	62.8	26.3	11.9	99.9	18.6	61.0	51.6	42.1	37.9	42.6	40.5	20.7	14.0	10.2	3.3	64.0	17.7	19.4	0.0	0.7	0.4	2.7	0.4	3.7	2.3	3.4	3.0	1.1	2.9	3.5	3.0	0.3	2.9	0.1	1.8	3.0	1.5	46.8	65.5	58.0	54.1	41.2	45.8	63.7	64.3	58.5	49.0	64.1	78.9	34.7	16.0	10.5	20.2	5.3	13.4	9.0	12.4	19.4	14.4	21.7	20.3	5.2	11.5	9.4	5.5	6.2	18.6	1.9	8.0	7.9	19.1	6.8	7.9	20.5	22.9	16.7	5.0	6.8	12.6	13.2	21.8	14.8	13.0	1.3	38.9	18.5	2.6	22.2	18.5	7.7	17.8	16.2	7.2	9.2	4.1	25.7	8.4	16.0	13.1	4.8	18.9	4.1	9.0	70.3	13.3	7.9	29.3	5.4	18.1	6.5	8.3	6.1	4.0	26.3	21.1	40.7	3.8	15.0	10.8	12.1	47.1	6.0	26.9	15.1	9.7
MAGEE1	"DAMAGE, KIAA1587"	ENSG00000198934	"MAGE family member E1"	Q9HCI5	X	76427710-76431342	"Plasma proteins, Predicted intracellular proteins"	"Ubl conjugation pathway"	"Tumor antigen"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 20.6"	"Cell type enhanced"	"Detected in many"		"Bipolar cells: 11.2;Excitatory neurons: 12.2;Horizontal cells: 28.6;Inhibitory neurons: 12.2;Sertoli cells: 19.7"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"GAMG: 7.8"	"Low region specificity"	"Detected in all"							HPA003047	Approved		Approved	"Cytokinetic bridge,Cytosol"		Yes	No			"Cluster 39: Non-specific - mRNA processing"	"Cluster 10: Brain - Neuronal signaling"	"Cluster 23: AN3-CA - Transcription regulation"	"Cluster 62: Horizontal cells - Visual perception"	Cytosol	"Cytokinetic bridge"	"HPA003047: AB_1079298"	"unprognostic (9.30e-2)"	"unprognostic (2.14e-1)"	"unprognostic (2.24e-1)"	"unprognostic (1.65e-3)"	"unprognostic (1.76e-1)"	"unprognostic (3.94e-2)"	"unprognostic (5.61e-3)"	"unprognostic (8.72e-3)"	"unprognostic (2.41e-3)"	"unprognostic (1.43e-1)"	"prognostic favorable (3.95e-4)"	"unprognostic (7.91e-2)"	"prognostic favorable (6.86e-6)"	"unprognostic (4.60e-3)"	"unprognostic (2.71e-1)"	"unprognostic (6.03e-3)"	"unprognostic (5.99e-3)"	1.6	3.2	10.0	1.6	10.2	0.3	1.6	3.0	20.6	2.8	0.0	2.2	0.5	3.3	1.7	1.0	2.5	1.1	2.2	12.1	17.0	2.1	0.3	1.3	2.5	7.7	5.1	4.7	2.6	6.1	6.0	0.0	7.9	3.2	0.9	6.4	1.7	4.0	1.1	1.8	1.8	2.6	1.0	2.7	1.6	0.4	9.8	2.9	2.1	0.9	1.9	2.1	1.7	6.7	0.2	3.8	3.9	7.5	2.7	1.5	3.4	2.9	2.9	2.4	1.3	0.8	0.6	0.8	1.4	2.5	7.8	2.9	5.8	5.4	1.9	1.9	0.1	0.0	0.0	2.5	0.5	1.5	0.5	1.1	2.4	0.6	0.6	0.1	0.9	4.2	0.3	0.0	3.6	0.5	4.3	0.2	4.7	0.0	5.8	3.4	2.9	0.0	3.1	0.0	0.0	2.0	0.0	0.4	0.6	3.9	1.7	0.1	0.5	3.6	4.5	3.8	0.0	0.0	0.0	0.6	1.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.4	0.1	0.2	0.5	0.0	0.2	0.3	0.3	0.0	0.3	0.0	0.0	0.0	0.1	10.0	10.2	3.0	20.6	12.1	17.0	7.7	5.1	7.9	1.0	9.8	6.7	0.8	3.2	2.6	3.3	1.7	0.5	0.7	1.2	1.2	11.2	0.9	1.9	1.9	1.5	1.1	1.8	4.2	0.2	1.4	0.3	1.9	1.4	0.0	0.4	1.3	2.4	0.0	0.4	12.2	1.5	0.4	1.3	1.1	0.4	1.3	1.5	1.8	0.2	0.1	28.6	12.2	0.4	0.0	0.3	0.0	0.1	1.5	0.1	0.0	3.7	0.1	5.5	2.1	5.5	5.0	0.7	0.0	4.5	0.3	0.3	0.0	1.3	0.3	5.0	19.7	2.7	3.6	0.3	0.2	0.6	0.1	0.1	2.5	0.8	0.1	0.2
MAT2A	"MATA2, MATII, SAMS2"	ENSG00000168906	"Methionine adenosyltransferase 2A"	P31153	2	85539168-85545281	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	"One-carbon metabolism"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"pancreas: 874.7"	"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB009968, HPA043028"	Approved		Approved	Nucleoplasm,Cytosol		NA	NA		1800000	"Cluster 39: Non-specific - mRNA processing"	"Cluster 22: Non-specific - Unknown function"	"Cluster 24: NB-4 - Immune response"	"Cluster 41: Macrophages - Immune response"	Nucleoplasm	Cytosol	"CAB009968: AB_675710, HPA043028: AB_10960707"	"unprognostic (1.38e-3)"	"unprognostic (2.58e-2)"	"unprognostic (3.96e-2)"	"prognostic unfavorable (5.29e-5)"	"unprognostic (9.89e-3)"	"unprognostic (5.90e-3)"	"prognostic unfavorable (4.87e-4)"	"prognostic favorable (8.94e-4)"	"prognostic unfavorable (5.94e-5)"	"unprognostic (4.07e-2)"	"unprognostic (2.02e-1)"	"unprognostic (2.59e-2)"	"unprognostic (9.63e-3)"	"unprognostic (1.04e-1)"	"unprognostic (2.02e-1)"	"unprognostic (4.39e-2)"	"unprognostic (1.77e-2)"	270.4	277.5	184.1	153.2	226.7	98.3	136.1	199.3	235.9	173.0	152.6	193.2	141.4	165.5	236.0	166.2	200.1	209.5	189.6	191.5	207.3	203.6	115.7	168.5	121.8	226.8	219.3	211.0	874.7	165.8	284.1	122.3	208.0	196.2	146.5	248.7	137.7	120.0	278.9	141.1	155.6	127.2	194.4	116.7	225.5	132.3	219.2	102.1	388.8	112.0	127.7	262.9	168.2	289.7	175.3	253.0	290.4	181.6	195.3	236.7	171.1	213.5	195.6	219.3	232.4	208.4	569.9	404.5	137.0	261.0	178.9	264.3	369.6	318.6	279.8	207.0	271.0	242.5	408.7	181.9	355.6	364.3	259.7	215.9	315.8	237.4	164.1	278.1	211.5	230.7	277.9	309.0	505.1	149.5	334.4	398.2	193.5	148.7	320.8	350.3	275.0	264.2	328.9	271.2	227.9	209.6	193.2	183.4	354.6	145.9	156.0	192.3	207.7	267.4	160.9	149.3	260.5	189.0	161.4	290.6	175.0	447.3	143.8	9.1	24.7	8.2	22.3	26.9	32.7	19.8	25.2	23.7	23.6	18.9	23.1	20.5	2.5	27.3	22.3	16.6	24.2	24.9	184.1	226.7	199.3	235.9	191.5	207.3	226.8	219.3	208.0	194.4	219.2	289.7	150.5	48.1	83.6	122.4	104.2	143.5	217.1	47.1	206.1	73.5	116.3	134.6	6.5	82.9	57.6	71.7	68.8	36.2	126.3	60.6	19.6	59.2	75.2	28.8	49.2	83.6	83.3	87.1	56.1	58.5	40.6	121.9	106.0	47.4	84.4	83.3	45.0	44.6	67.4	26.9	60.4	65.1	26.4	118.8	141.9	25.8	72.1	165.7	67.6	26.2	64.6	58.8	27.8	28.6	95.5	53.6	48.0	83.8	78.4	66.7	73.8	138.7	35.2	89.0	111.7	298.5	231.0	54.1	56.2	168.2	118.3	38.2	102.0	51.1	70.6	88.4
MBLAC2	"DKFZp686P15118, MGC46734"	ENSG00000176055	"Metallo-beta-lactamase domain containing 2"	Q68D91	5	90458209-90474771	"Predicted intracellular proteins"		Hydrolase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA037757, HPA037758"	Uncertain		Approved	Nucleoplasm,Mitochondria		NA	NA			"Cluster 39: Non-specific - mRNA processing"	"Cluster 68: Epididymis - Unknown function"	"Cluster 25: RPMI-8226 - Immune response"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	Mitochondria	Nucleoplasm	"HPA037757: AB_10670528, HPA037758: "	"unprognostic (6.32e-2)"	"unprognostic (2.48e-1)"	"unprognostic (9.22e-3)"	"unprognostic (1.21e-2)"	"unprognostic (9.27e-2)"	"unprognostic (1.96e-3)"	"unprognostic (9.98e-3)"	"unprognostic (1.82e-2)"	"unprognostic (3.33e-2)"	"unprognostic (4.00e-3)"	"unprognostic (4.16e-2)"	"unprognostic (1.95e-1)"	"unprognostic (1.83e-2)"	"unprognostic (1.44e-1)"	"unprognostic (3.34e-1)"	"unprognostic (6.31e-2)"	"unprognostic (1.63e-2)"	2.6	3.8	4.3	3.3	4.4	1.5	5.2	4.7	5.9	4.4	1.2	3.1	3.3	5.1	3.3	3.8	3.8	2.4	2.8	4.6	4.8	5.0	6.3	2.3	4.2	3.0	5.1	8.6	3.1	8.1	2.4	2.9	3.5	4.5	3.2	3.4	4.6	3.9	2.3	5.2	3.0	3.7	3.3	3.8	2.6	3.1	6.4	4.3	5.2	2.2	3.9	2.5	2.9	4.7	6.4	2.7	4.6	5.9	6.0	8.0	5.6	5.0	4.5	4.2	4.4	2.1	4.7	14.9	2.9	4.4	5.8	6.4	6.0	7.5	6.6	8.5	4.1	6.7	4.6	4.8	6.3	6.7	2.8	7.0	9.9	3.0	11.6	4.9	5.4	7.9	10.2	8.0	7.2	3.9	6.5	9.1	3.0	1.3	13.1	6.9	7.7	20.5	6.3	2.3	7.9	9.3	4.5	6.5	12.1	2.7	5.4	4.9	6.7	5.2	3.6	6.4	6.5	5.6	6.8	6.5	4.5	13.8	7.2	0.0	0.7	0.5	1.4	1.8	1.6	1.3	1.5	1.5	1.3	2.4	2.0	1.6	0.0	1.6	0.9	0.4	0.6	1.1	4.3	4.4	4.7	5.9	4.6	4.8	3.0	5.1	3.5	3.3	6.4	4.7	3.8	3.2	3.6	2.9	4.7	2.7	1.2	2.8	8.6	8.1	4.6	5.0	4.9	2.8	1.7	1.8	8.4	3.9	3.9	1.9	1.9	1.6	0.3	2.0	5.0	4.2	4.2	6.3	14.4	1.3	3.1	3.5	3.1	2.0	0.0	5.3	3.6	5.8	2.6	3.3	16.4	2.9	4.1	5.1	1.0	0.6	4.1	2.1	1.8	6.5	2.1	5.5	3.1	8.5	15.6	1.8	1.8	5.3	2.1	1.2	3.0	5.5	2.4	6.7	0.0	4.3	4.9	2.5	6.1	7.3	3.3	0.8	3.7	12.6	3.9	0.7
MBTPS2	"KFSD, S2P"	ENSG00000012174	"Membrane bound transcription factor peptidase, site 2"	O43462	X	21839617-21885423	"Disease related genes, Enzymes, Human disease related genes, Potential drug targets, Predicted membrane proteins"	"Cholesterol metabolism, Lipid metabolism, Steroid metabolism, Sterol metabolism"	"Hydrolase, Metalloprotease, Protease"	"Disease variant, Ichthyosis, Osteogenesis imperfecta, Palmoplantar keratoderma"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA005494, CAB009486"	Approved		Approved	Nucleoplasm,Mitochondria,Cytosol		NA	NA			"Cluster 39: Non-specific - mRNA processing"	"Cluster 85: Liver - Metabolism"	"Cluster 4: Mesenchymal cell lines - Antiviral immune response"	"Cluster 52: Non-specific - Transcription"	"Nucleoplasm, Mitochondria, Cytosol"		"CAB009486: AB_2140370, HPA005494: AB_1079329"	"unprognostic (7.97e-3)"	"unprognostic (9.12e-2)"	"unprognostic (5.38e-2)"	"unprognostic (1.18e-2)"	"unprognostic (2.65e-1)"	"unprognostic (1.50e-1)"	"unprognostic (1.85e-1)"	"unprognostic (7.22e-2)"	"unprognostic (3.32e-1)"	"unprognostic (9.30e-2)"	"unprognostic (1.99e-1)"	"unprognostic (1.77e-1)"	"unprognostic (8.38e-2)"	"unprognostic (7.76e-2)"	"unprognostic (1.07e-1)"	"unprognostic (3.61e-1)"	"unprognostic (3.05e-2)"	8.6	10.6	3.5	5.2	4.0	1.7	8.8	7.8	4.9	7.5	4.5	5.1	5.2	9.7	6.0	5.8	7.3	6.7	7.7	3.7	4.1	9.4	18.7	5.5	5.0	4.4	4.1	12.5	7.3	11.0	3.8	11.6	4.9	10.5	6.0	8.8	6.6	8.5	7.1	3.7	4.2	10.1	4.1	4.8	5.8	4.1	4.2	4.9	9.0	9.1	4.7	6.8	4.0	6.1	16.9	34.5	16.1	16.5	19.8	24.4	7.7	24.4	24.7	22.7	19.7	13.8	22.5	14.6	12.4	26.2	44.4	15.4	22.4	14.0	27.9	10.9	17.8	7.2	19.7	11.4	27.1	15.6	6.8	23.2	14.8	34.3	25.1	23.0	17.8	8.4	20.3	15.8	26.1	10.5	6.4	8.1	15.0	8.8	25.1	7.9	29.8	16.4	15.7	8.4	3.9	32.8	34.3	21.5	30.5	21.3	28.9	13.2	21.2	28.4	6.6	41.9	18.5	19.1	26.0	6.9	31.6	6.4	28.0	0.0	2.2	0.8	2.2	2.5	2.0	1.9	1.6	2.0	3.6	1.7	2.2	2.6	0.2	2.6	2.6	2.4	3.2	1.7	3.5	4.0	7.8	4.9	3.7	4.1	4.4	4.1	4.9	4.1	4.2	6.1	5.5	9.6	11.5	16.6	5.8	5.5	4.8	7.0	8.0	11.8	7.5	5.1	13.3	8.6	7.1	7.3	18.8	7.0	2.2	3.8	0.0	5.9	0.3	4.0	11.5	5.6	2.4	2.1	16.8	8.9	7.1	10.8	6.1	3.7	10.8	14.5	7.5	18.7	9.4	30.3	25.0	3.4	12.2	9.2	4.0	1.9	10.5	4.8	10.6	11.2	5.0	7.3	3.1	21.6	22.2	6.1	2.4	13.2	9.1	7.4	4.9	7.2	10.7	14.5	0.0	8.6	8.3	2.7	1.5	6.5	2.7	4.8	5.1	12.3	4.3	4.9
MCM3AP	"GANP, KIAA0572, Map80, SAC3"	ENSG00000160294	"Minichromosome maintenance complex component 3 associated protein"	O60318	21	46235133-46286297	"Disease related genes, Enzymes, Human disease related genes, Potential drug targets, Predicted intracellular proteins, Transporters"	"Immunity, mRNA transport, Protein transport, Translocation, Transport"	"Acyltransferase, Transferase"	"Mental retardation, Neuropathy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA021527, HPA032103"	Approved		Supported	"Nucleoplasm,Nuclear membrane,Cytosol"		NA	NA			"Cluster 39: Non-specific - mRNA processing"	"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 1: K-562 - Erythropoiesis"	"Cluster 59: Non-specific - Transcription"	"Nuclear membrane, Cytosol"	Nucleoplasm	"HPA021527: AB_1853626, HPA032103: AB_2674152"	"unprognostic (1.75e-1)"	"unprognostic (1.31e-1)"	"unprognostic (2.31e-1)"	"unprognostic (2.20e-1)"	"unprognostic (1.72e-1)"	"unprognostic (6.31e-3)"	"unprognostic (1.48e-2)"	"unprognostic (2.06e-1)"	"unprognostic (4.17e-2)"	"unprognostic (4.76e-3)"	"prognostic favorable (2.05e-4)"	"unprognostic (1.96e-1)"	"unprognostic (2.81e-3)"	"unprognostic (1.04e-1)"	"unprognostic (1.05e-1)"	"unprognostic (3.85e-3)"	"unprognostic (2.28e-1)"	16.8	12.0	10.0	20.3	11.5	19.7	13.6	8.9	10.7	14.7	17.0	15.1	14.0	16.5	8.3	14.3	15.2	14.2	15.1	8.5	7.8	13.0	9.7	16.0	21.0	10.8	10.4	17.6	15.4	16.9	9.2	16.3	9.5	14.2	15.0	12.8	13.7	13.4	41.3	13.8	16.1	17.1	9.4	19.6	15.4	14.1	11.0	21.7	16.0	28.7	21.5	13.6	11.2	14.6	38.0	36.3	41.8	45.5	33.1	41.4	38.0	40.8	48.1	37.1	30.2	33.1	21.9	53.6	32.9	43.2	40.3	21.9	55.9	34.0	32.7	55.7	50.8	87.9	35.0	25.9	29.6	40.6	47.7	31.7	28.7	51.2	35.2	25.4	40.7	31.7	107.3	39.6	43.3	21.1	43.5	26.8	72.3	40.0	30.2	56.3	26.6	48.9	17.8	34.1	35.2	37.6	52.4	33.7	39.0	31.5	46.0	41.2	51.6	39.1	29.7	33.1	31.0	71.8	86.2	33.0	35.3	38.0	51.8	0.6	2.0	1.6	2.3	1.9	2.4	1.1	1.3	2.6	1.9	1.6	1.2	1.3	1.2	1.1	1.1	1.6	1.8	2.1	10.0	11.5	8.9	10.7	8.5	7.8	10.8	10.4	9.5	9.4	11.0	14.6	17.3	9.6	18.9	28.1	21.3	7.0	7.1	9.0	22.2	21.8	13.8	13.0	4.7	14.3	12.7	11.0	20.9	11.4	20.6	17.5	1.9	11.3	3.5	16.8	23.7	14.8	12.0	18.5	28.0	14.2	11.7	12.8	27.0	17.7	8.8	20.1	11.7	18.6	15.4	16.8	34.2	19.2	10.2	19.7	8.4	4.3	18.3	18.6	10.6	34.7	24.3	9.3	16.5	37.2	35.3	15.9	8.6	14.3	21.6	14.0	13.8	6.6	15.5	21.7	19.7	17.9	12.9	19.7	15.0	21.2	10.4	9.3	19.1	16.0	17.9	7.9
MED24	"CRSP100, CRSP4, DRIP100, KIAA0130, MED5, THRAP4, TRAP100"	ENSG00000008838	"Mediator complex subunit 24"	O75448	17	40019097-40061215	"Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Transcription, Transcription regulation"	Activator		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Basal respiratory cells: 178.1;Club cells: 100.6;Ionocytes: 99.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"HBEC3-KT: 244.1;SK-BR-3: 283.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"									NA	NA			"Cluster 39: Non-specific - mRNA processing"	"Cluster 59: Non-specific - Translation"	"Cluster 8: SK-BR-3 - Unknown function"	"Cluster 26: Respiratory epithelial cells - Mucosal defense"				"unprognostic (3.93e-2)"	"unprognostic (1.65e-1)"	"unprognostic (4.10e-2)"	"unprognostic (8.27e-2)"	"unprognostic (1.60e-1)"	"unprognostic (1.46e-1)"	"unprognostic (1.07e-3)"	"unprognostic (1.61e-1)"	"unprognostic (2.56e-1)"	"unprognostic (1.33e-1)"	"unprognostic (1.19e-2)"	"unprognostic (4.04e-2)"	"unprognostic (3.18e-3)"	"unprognostic (4.36e-2)"	"unprognostic (1.03e-1)"	"unprognostic (2.16e-1)"	"unprognostic (3.97e-1)"	28.4	30.6	21.6	24.8	23.0	37.3	29.1	20.7	29.2	37.8	18.3	29.5	28.6	33.9	19.0	32.6	31.8	16.8	35.3	24.2	19.0	29.1	25.7	46.5	26.7	18.3	21.2	38.8	25.6	31.2	39.1	23.8	19.5	28.1	24.5	26.4	31.4	17.9	84.0	35.2	30.1	24.3	16.9	30.1	30.5	35.8	19.3	32.7	28.9	48.9	27.9	25.8	30.1	19.6	31.8	63.3	57.3	59.1	38.7	36.1	44.6	41.7	32.5	56.7	50.4	63.1	42.2	65.0	71.6	46.5	28.2	72.8	89.7	244.1	45.3	59.8	147.2	34.0	59.2	84.0	32.2	84.4	63.0	45.0	45.5	56.3	34.1	36.8	75.0	42.8	98.1	41.9	38.6	42.1	93.7	55.2	37.7	36.7	72.4	71.2	45.2	54.5	29.7	36.5	79.9	57.8	43.9	283.0	33.4	49.3	62.4	75.4	45.2	31.1	26.0	34.5	53.6	39.0	41.4	49.5	56.5	42.2	42.7	0.5	4.8	6.0	5.3	6.0	4.2	4.6	3.7	6.1	6.8	4.0	3.5	4.2	0.3	3.5	3.9	2.8	3.9	5.1	21.6	23.0	20.7	29.2	24.2	19.0	18.3	21.2	19.5	16.9	19.3	19.6	14.9	22.4	51.3	13.1	12.7	11.3	25.1	178.1	13.1	11.9	31.4	24.9	16.3	20.0	100.6	23.9	16.7	28.9	8.3	24.8	15.6	15.1	14.8	20.6	10.2	43.3	28.1	27.0	17.6	18.0	23.3	12.2	42.3	27.0	10.8	28.5	9.3	14.8	20.0	10.1	20.3	34.1	99.7	12.0	19.2	8.6	9.9	8.6	14.2	9.4	15.4	10.8	6.2	13.6	13.9	18.5	43.7	9.4	14.2	10.4	23.7	17.6	66.3	11.5	6.6	10.9	13.5	13.4	15.5	12.0	18.6	22.6	10.7	18.0	33.3	28.6
MSTO1	"FLJ10504, LST005, misato, MST"	ENSG00000125459	"Misato mitochondrial distribution and morphology regulator 1"	Q9BUK6	1	155610205-155614951	"Disease related genes, Predicted intracellular proteins"			"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enriched"	"Detected in many"	4	"Late spermatids: 1482.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA005899, HPA005914, HPA006075"	Approved		Enhanced	Cytosol		NA	NA			"Cluster 39: Non-specific - mRNA processing"	"Cluster 18: Non-specific - Mitochondria"	"Cluster 8: SK-BR-3 - Unknown function"	"Cluster 31: Spermatids - Spermatogenesis"	Cytosol		"HPA005899: AB_2667460, HPA005914: AB_2667466, HPA006075: "	"unprognostic (1.80e-2)"	"unprognostic (3.43e-1)"	"unprognostic (6.49e-2)"	"unprognostic (2.65e-1)"	"unprognostic (1.15e-1)"	"unprognostic (4.46e-1)"	"prognostic unfavorable (1.90e-4)"	"unprognostic (9.63e-2)"	"unprognostic (1.26e-1)"	"unprognostic (5.28e-2)"	"unprognostic (3.73e-2)"	"unprognostic (3.67e-2)"	"prognostic unfavorable (0.00e+0)"	"unprognostic (1.56e-1)"	"unprognostic (1.12e-1)"	"unprognostic (5.35e-2)"	"unprognostic (1.28e-1)"	18.5	18.2	7.9	10.2	8.2	7.3	18.9	9.0	9.4	18.0	7.6	11.7	8.7	16.1	18.0	14.7	16.7	7.2	14.1	9.0	8.8	17.8	31.7	12.7	11.5	10.0	9.4	17.0	25.1	14.9	24.3	8.6	10.3	20.7	9.0	7.8	14.4	14.8	6.8	11.9	15.7	11.8	7.9	21.2	14.6	23.1	10.0	8.6	18.5	4.7	10.7	15.9	12.8	8.4	23.0	31.1	26.7	41.1	21.9	18.5	33.3	28.8	24.5	35.1	27.9	30.8	14.3	39.5	26.1	25.9	22.6	24.7	40.2	38.8	24.2	15.3	33.6	34.1	29.5	17.8	34.8	36.7	26.4	19.2	19.4	38.8	55.7	15.6	29.2	28.5	28.4	17.3	29.3	37.7	24.7	24.9	35.4	38.6	40.8	21.2	25.0	35.4	29.6	23.1	22.0	26.7	20.2	60.6	26.3	31.2	33.5	49.2	19.5	22.2	24.3	24.0	44.9	36.4	33.8	29.3	25.0	35.6	30.9	3.5	5.9	0.4	10.0	8.3	11.2	7.4	9.4	9.1	8.4	5.5	9.8	6.2	0.7	9.6	5.5	8.4	7.5	6.8	7.9	8.2	9.0	9.4	9.0	8.8	10.0	9.4	10.3	7.9	10.0	8.4	4.6	6.4	6.0	3.9	8.8	2.7	6.1	8.6	5.2	9.1	6.6	4.4	9.7	2.8	7.2	7.3	22.9	7.9	5.8	2.9	3.9	9.6	324.5	4.2	8.2	6.1	5.4	3.8	2.0	13.4	23.7	6.3	12.8	4.7	14.5	9.5	2.2	7.1	8.7	11.8	2.1	4.9	2.0	2.6	3.5	1482.8	9.0	5.5	3.6	1.0	6.3	4.6	3.1	2.5	2.2	8.0	0.9	11.3	17.0	5.5	2.8	9.9	10.9	9.7	0.0	6.7	6.4	23.0	12.6	6.3	1.4	6.6	7.2	7.1	4.6	2.8
MT1G	"MT1, MT1K"	ENSG00000125144	"Metallothionein 1G"	P13640	16	56666730-56668065	"Cancer-related genes, Predicted intracellular proteins"			"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"kidney: 3543.0;liver: 6959.4;thyroid gland: 2886.6"	"Cell type enriched"	"Detected in many"	4	"Proximal tubular cells: 77919.3"	"Group enriched"	"Detected in all"	4	"liver cancer: 320.1;ovarian cancer: 106.9;prostate cancer: 103.9;testis cancer: 269.9;thyroid cancer: 369.1"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in many"	4	"U-937: 1103.8"														"Intracellular and membrane"	NA	NA			"Cluster 39: Non-specific - mRNA processing"	"Cluster 81: Kidney & Liver - Metabolism"	"Cluster 32: U-937 - Innate immune response"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"				"unprognostic (1.62e-1)"	"unprognostic (4.21e-1)"	"unprognostic (2.77e-2)"	"unprognostic (3.15e-1)"	"unprognostic (1.32e-2)"	"unprognostic (1.73e-3)"	"unprognostic (1.26e-1)"	"unprognostic (1.45e-1)"	"unprognostic (1.12e-1)"	"unprognostic (5.97e-2)"	"unprognostic (2.49e-2)"	"unprognostic (4.21e-1)"	"prognostic unfavorable (1.67e-7)"	"unprognostic (1.42e-1)"	"unprognostic (3.50e-2)"	"unprognostic (7.92e-2)"	"unprognostic (2.26e-2)"	250.2	21.5	434.9	105.8	515.9	2.9	28.1	469.3	912.6	21.9	396.7	821.1	513.8	8.4	2.4	255.4	75.5	12.0	9.3	430.3	455.6	3543.0	6959.4	49.9	5.6	494.0	474.4	3.2	1806.7	0.3	21.7	2.1	465.6	425.3	516.5	42.6	44.2	5.9	8.4	58.4	1096.4	76.3	431.0	3.9	1262.3	4.0	466.6	0.9	2886.6	0.9	2.6	14.2	25.8	430.1	0.4	0.0	0.0	0.0	0.0	0.0	4.4	8.6	1.7	1.1	0.4	0.0	0.0	0.1	16.2	0.0	0.1	1.8	0.2	1.2	0.9	0.8	0.0	4.3	0.0	3.5	4.5	1.0	0.6	1.7	0.0	11.4	0.0	0.1	0.0	0.0	0.3	1.2	0.7	0.0	3.7	251.3	0.5	0.0	0.0	0.0	0.8	70.8	40.8	0.0	21.8	3.0	0.5	1.3	1.1	10.8	0.0	107.8	0.0	0.0	0.8	1.7	0.3	0.6	1.9	0.6	2.0	1103.8	0.0	0.2	0.3	0.1	0.3	0.3	0.3	0.0	0.4	0.6	0.3	0.0	0.4	0.7	0.0	0.0	0.1	0.1	0.7	0.5	434.9	515.9	469.3	912.6	430.3	455.6	494.0	474.4	465.6	431.0	466.6	430.1	10.6	28.9	8.7	38.5	338.7	57.9	26.0	4.5	46.1	0.0	87.0	116.2	11.7	330.3	9.1	2302.6	0.0	3.9	9.8	3657.8	6849.7	74.4	0.3	2960.7	777.1	49.2	246.7	878.6	0.1	283.4	403.2	50.7	443.9	8167.8	17.2	16.8	310.2	16307.3	26.3	0.0	0.1	3688.0	0.0	379.5	4.9	0.9	23.3	765.6	30.2	2.8	10.6	0.0	2.1	2.0	0.1	339.8	10431.2	2.2	26.3	823.7	8631.3	77919.3	3.9	0.0	0.0	25.1	42.9	0.3	0.8	42.2	77.9	132.7	247.5	4.7	3786.7	21.1
MUTYH	MYH	ENSG00000132781	"MutY DNA glycosylase"	Q9UIF7	1	45329163-45340893	"Cancer-related genes, Disease related genes, Enzymes, Human disease related genes, Potential drug targets, Predicted intracellular proteins"	"DNA damage, DNA repair"	"Glycosidase, Hydrolase"	"Cancer-related genes, Disease variant, Tumor suppressor"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Cytotrophoblasts: 40.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											HPA008732	Uncertain		Supported	Nucleoplasm		NA	NA			"Cluster 39: Non-specific - mRNA processing"	"Cluster 70: Brain - Nervous system development"	"Cluster 5: NTERA-2 - Transcription"	"Cluster 47: Cytotrophoblasts - Unknown function"	Nucleoplasm		"HPA008732: AB_1854219"	"unprognostic (6.30e-3)"	"unprognostic (7.12e-2)"	"unprognostic (6.29e-2)"	"unprognostic (8.80e-2)"	"unprognostic (3.43e-1)"	"unprognostic (5.16e-3)"	"prognostic unfavorable (4.76e-8)"	"unprognostic (2.80e-2)"	"unprognostic (7.12e-3)"	"unprognostic (3.05e-2)"	"unprognostic (7.80e-2)"	"unprognostic (1.14e-1)"	"prognostic unfavorable (7.25e-5)"	"unprognostic (3.50e-3)"	"unprognostic (1.62e-1)"	"unprognostic (5.57e-2)"	"unprognostic (5.49e-3)"	5.0	5.0	11.9	5.5	12.7	6.7	5.3	16.7	15.6	7.6	10.6	6.0	6.4	6.3	4.6	5.1	5.7	4.2	4.0	11.6	11.9	7.0	5.9	4.4	7.7	12.8	12.4	7.3	5.1	5.1	5.9	6.4	12.7	5.8	5.6	4.9	4.5	5.0	5.6	5.9	6.1	3.6	11.7	7.8	5.8	3.3	12.2	9.8	6.6	4.7	7.0	5.9	5.8	14.4	7.9	6.9	15.5	10.5	11.3	8.4	26.6	5.7	7.4	11.8	9.2	14.3	11.2	22.5	9.0	3.6	9.5	11.3	8.7	11.0	5.4	18.1	7.0	10.2	11.4	10.5	10.0	9.4	7.1	4.6	10.3	16.0	25.7	3.1	8.6	28.6	17.5	7.4	5.0	13.3	27.3	8.7	39.6	19.5	7.9	36.2	12.6	12.3	6.1	14.6	14.5	11.8	11.3	8.7	18.2	20.1	6.7	11.1	4.9	8.3	6.2	7.2	8.2	11.6	14.6	13.3	8.0	14.6	7.5	1.6	7.0	2.9	11.5	11.8	17.2	8.1	11.8	11.5	8.1	8.0	12.7	12.2	1.4	8.8	9.1	6.5	13.4	8.6	11.9	12.7	16.7	15.6	11.6	11.9	12.8	12.4	12.7	11.7	12.2	14.4	10.0	0.0	5.6	17.0	12.1	6.9	10.7	8.1	6.2	15.6	6.7	8.8	3.2	1.5	6.9	7.3	2.1	40.2	8.8	16.5	3.9	6.5	0.9	3.2	5.1	7.6	7.8	6.7	4.0	5.3	14.3	7.5	16.8	3.2	10.8	8.4	5.7	4.3	10.0	5.0	7.0	15.1	12.2	4.0	10.2	1.6	10.8	5.6	7.2	8.4	8.2	12.0	10.3	11.6	12.7	3.8	16.4	12.0	7.5	9.5	12.9	12.2	8.6	20.1	13.1	8.7	7.6	10.5	11.2	5.2	5.4	22.2	13.9	9.5	13.5	8.0
NCLN	"NET59, NICALIN"	ENSG00000125912	Nicalin	Q969V3	19	3185563-3209575	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Theca cells: 115.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA006625	Approved		Approved	"Nucleoplasm,Lipid droplets"		NA	NA			"Cluster 39: Non-specific - mRNA processing"	"Cluster 18: Non-specific - Mitochondria"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 53: Intestinal epithelial cells - Unknown function"	"Lipid droplets"	Nucleoplasm	"HPA006625: AB_1079453"	"unprognostic (4.32e-2)"	"unprognostic (1.88e-1)"	"unprognostic (1.89e-1)"	"prognostic favorable (1.19e-4)"	"unprognostic (8.55e-2)"	"unprognostic (2.79e-1)"	"prognostic unfavorable (2.15e-4)"	"unprognostic (9.27e-2)"	"unprognostic (1.22e-1)"	"unprognostic (9.38e-2)"	"unprognostic (2.02e-2)"	"unprognostic (1.26e-3)"	"prognostic unfavorable (8.37e-5)"	"prognostic favorable (8.82e-5)"	"unprognostic (1.75e-1)"	"unprognostic (1.25e-1)"	"unprognostic (7.38e-2)"	25.8	62.4	19.7	16.2	18.5	33.3	22.3	18.6	25.2	23.1	13.9	36.5	31.1	25.9	4.3	31.0	23.4	6.9	28.0	22.2	15.7	29.5	59.8	33.1	12.7	20.4	18.8	22.0	53.6	11.0	23.5	7.5	18.6	28.9	8.7	3.5	22.9	8.0	29.2	25.8	35.8	8.6	17.4	42.8	29.7	21.8	21.1	8.6	24.4	10.5	6.6	26.3	21.7	17.5	70.8	74.2	21.6	60.3	20.3	15.4	55.4	84.5	33.2	57.5	45.5	103.6	36.8	43.3	67.0	49.4	37.8	87.2	24.7	57.1	12.7	57.4	61.3	31.7	46.2	73.2	41.1	56.8	51.3	29.0	36.2	46.4	24.7	15.2	31.7	41.7	84.1	41.4	25.6	59.3	48.9	64.1	59.3	43.2	63.6	77.8	23.2	71.9	36.5	42.6	45.3	47.1	31.1	56.2	50.3	10.3	38.3	61.9	47.6	45.4	45.8	77.3	100.4	59.0	58.1	36.0	51.1	71.5	72.7	1.4	13.4	9.8	7.1	13.1	5.8	5.4	4.3	7.9	9.2	4.5	4.6	6.2	7.6	4.8	5.6	18.8	4.2	9.6	19.7	18.5	18.6	25.2	22.2	15.7	20.4	18.8	18.6	17.4	21.1	17.5	15.3	16.0	14.7	12.1	19.8	8.3	9.4	18.2	5.7	15.1	15.6	11.9	10.2	15.7	14.8	11.0	10.4	20.4	26.0	71.0	3.9	31.0	15.0	11.3	15.6	14.3	12.6	12.4	13.6	37.4	49.3	14.9	30.5	17.4	15.9	31.1	12.8	43.8	39.3	23.5	14.6	41.2	14.2	18.8	9.2	49.1	9.3	18.1	14.2	8.4	19.2	5.8	14.4	9.0	10.3	35.8	45.3	9.1	51.7	22.0	75.7	11.7	10.5	13.2	13.1	11.8	16.9	13.6	20.1	12.4	12.5	17.0	12.0	115.1	72.7	14.2
NEDD4	"KIAA0093, MGC176705, NEDD4-1, RPF1"	ENSG00000069869	"NEDD4 E3 ubiquitin protein ligase"	P46934	15	55826922-55993660	"Enzymes, Metabolic proteins, Predicted intracellular proteins, Transporters"	"Host-virus interaction, Neurogenesis, Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 67.6;tongue: 58.1"	"Cell type enhanced"	"Detected in many"		"Alveolar cells type 1: 93.0;Alveolar cells type 2: 116.7;granulocytes: 73.2;Oligodendrocyte precursor cells: 69.9;Respiratory ciliated cells: 75.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB001991, HPA039883, CAB072833"	Approved		Approved	Cytosol		NA	NA		6500	"Cluster 39: Non-specific - mRNA processing"	"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 11: RPE1 & U-87MG - Synaptic function"	"Cluster 11: Alveolar cells - Smell perception"	Cytosol		"CAB001991: , CAB072833: , HPA039883: AB_10795683"	"unprognostic (1.18e-1)"	"unprognostic (2.10e-2)"	"unprognostic (5.66e-3)"	"unprognostic (1.15e-1)"	"unprognostic (6.97e-2)"	"unprognostic (2.23e-1)"	"unprognostic (3.18e-3)"	"prognostic unfavorable (5.14e-4)"	"unprognostic (1.36e-2)"	"unprognostic (1.62e-1)"	"unprognostic (4.96e-2)"	"unprognostic (1.43e-2)"	"prognostic unfavorable (3.74e-6)"	"unprognostic (6.38e-3)"	"unprognostic (2.98e-1)"	"unprognostic (2.22e-1)"	"unprognostic (2.35e-2)"	6.2	3.6	1.7	4.0	2.0	6.2	6.9	1.9	2.0	5.4	1.9	5.7	4.1	7.1	2.9	4.3	3.5	5.6	4.5	1.5	2.7	6.7	27.4	5.3	3.1	2.5	1.9	4.0	1.8	5.4	2.1	15.6	2.6	5.5	4.4	4.5	3.1	7.6	67.6	9.2	8.1	8.0	2.0	4.9	3.4	1.8	2.2	5.6	7.1	58.1	3.0	5.6	4.4	2.6	21.5	32.8	9.0	8.8	11.5	18.5	14.1	40.0	62.9	29.1	28.5	14.5	6.3	4.8	10.4	15.4	70.2	34.6	9.7	26.3	48.2	11.1	5.6	26.1	7.2	7.9	59.0	10.6	2.3	30.8	64.7	35.2	58.9	14.2	24.3	14.9	11.5	0.0	86.4	10.7	15.2	0.1	2.2	10.9	5.1	10.5	67.5	3.1	11.9	42.3	0.7	5.1	17.4	12.5	15.7	15.8	15.2	8.8	84.5	63.9	20.6	13.5	66.0	3.4	8.1	12.3	42.0	24.6	15.7	0.0	0.1	0.0	0.1	0.4	0.3	0.0	0.2	0.1	0.0	0.0	0.2	0.2	0.2	0.1	0.2	0.2	0.1	0.1	1.7	2.0	1.9	2.0	1.5	2.7	2.5	1.9	2.6	2.0	2.2	2.6	35.9	93.0	116.7	28.4	1.6	12.1	3.4	5.5	8.6	0.7	4.6	8.0	5.7	7.2	44.8	0.0	22.9	23.2	2.0	5.2	1.9	3.3	1.7	1.7	13.3	31.1	0.0	17.5	4.2	5.8	7.5	18.5	5.1	1.6	73.2	4.2	17.5	20.5	4.7	0.0	11.9	4.0	2.0	2.2	2.3	1.6	5.6	8.8	1.8	30.0	1.1	8.6	6.2	69.9	28.7	2.9	0.8	7.2	1.9	4.5	25.8	13.4	75.5	6.7	0.0	11.5	17.7	5.3	7.2	7.1	10.4	13.8	9.4	4.8	5.6	1.9
NFU1	"CGI-33, HIRIP5, NifU, NIFUC"	ENSG00000169599	"NFU1 iron-sulfur cluster scaffold"	Q9UMS0	2	69396113-69437628	"Disease related genes, Human disease related genes, Predicted intracellular proteins"			"Disease variant, Primary mitochondrial disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Distal tubular cells: 189.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA035826	Uncertain		Supported	Nucleoplasm,Cytosol		NA	NA			"Cluster 39: Non-specific - mRNA processing"	"Cluster 38: Heart - Muscle contraction"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 39: Non-specific - Basic cellular processes"	Cytosol	Nucleoplasm	"HPA035826: AB_2674803"	"unprognostic (4.49e-3)"	"unprognostic (5.62e-2)"	"unprognostic (5.40e-2)"	"unprognostic (1.84e-1)"	"unprognostic (2.81e-1)"	"unprognostic (2.16e-3)"	"unprognostic (2.63e-2)"	"unprognostic (1.76e-1)"	"unprognostic (6.12e-2)"	"unprognostic (1.55e-1)"	"unprognostic (1.31e-1)"	"unprognostic (2.12e-1)"	"unprognostic (2.21e-3)"	"unprognostic (2.63e-1)"	"unprognostic (1.14e-1)"	"unprognostic (1.91e-2)"	"unprognostic (2.87e-1)"	66.8	46.3	36.8	22.5	39.3	33.4	56.8	40.0	56.0	35.6	37.4	51.4	31.3	35.9	51.9	27.9	35.3	29.0	110.4	37.5	40.9	64.2	39.5	31.8	30.0	40.2	39.7	38.0	39.9	43.3	45.1	38.1	41.4	34.3	38.1	56.9	41.2	36.5	140.8	22.3	33.4	33.1	39.9	31.0	43.8	34.6	39.0	22.8	41.9	120.2	29.5	44.8	31.1	42.0	59.3	59.2	56.1	55.5	70.4	75.4	61.6	61.0	62.0	59.0	47.8	114.7	56.9	42.4	30.0	57.0	85.6	25.4	63.7	64.2	79.5	77.8	62.3	43.5	38.2	102.0	70.1	73.7	59.2	58.4	37.2	67.5	41.2	56.0	65.6	41.8	80.1	41.8	99.1	11.9	39.1	119.0	53.9	62.9	64.3	42.6	85.5	15.6	83.5	57.6	45.9	34.3	35.2	32.2	92.5	57.6	40.8	49.4	67.8	71.3	47.1	52.2	80.8	53.8	48.4	23.1	54.2	74.7	55.8	20.2	13.6	25.5	15.9	18.6	15.6	21.7	16.3	18.9	12.4	25.1	16.9	18.6	4.3	18.0	28.5	25.0	24.8	12.3	36.8	39.3	40.0	56.0	37.5	40.9	40.2	39.7	41.4	39.9	39.0	42.0	30.6	32.1	22.5	9.8	37.0	16.2	35.9	96.7	21.1	23.9	33.2	29.6	92.3	37.1	42.6	38.6	12.5	113.9	34.1	34.6	189.8	56.9	111.0	40.0	27.1	34.9	53.3	25.7	15.4	60.9	70.5	30.9	20.4	25.3	58.3	21.6	33.5	32.0	82.6	18.5	18.8	47.7	57.0	35.8	24.0	34.2	34.8	30.2	39.2	10.3	66.8	55.6	46.4	21.1	27.1	50.3	39.7	36.9	25.4	28.8	56.3	163.0	58.9	33.4	46.0	36.9	44.1	82.9	60.4	18.8	14.9	61.3	33.3	42.7	46.3	35.4
NLRC3	"CLR16.2, FLJ00348, NOD3"	ENSG00000167984	"NLR family CARD domain containing 3"	Q7RTR2	16	3539033-3577403	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 6.5;lymphoid tissue: 13.6"	"Cell type enhanced"	"Detected in many"		"B-cells: 10.3;dendritic cells: 18.8;NK-cells: 37.0;T-cells: 23.8"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"Daudi: 8.8;HEL: 8.7;HL-60: 18.6;HMC-1: 9.0;JURKAT: 9.2;NB-4: 19.7;U-698: 28.9;U-937: 13.6"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			HPA048062			Supported	"Vesicles,Centriolar satellite,Cytosol"		NA	NA			"Cluster 39: Non-specific - mRNA processing"	"Cluster 16: Immune cells - Immune response"	"Cluster 24: NB-4 - Immune response"	"Cluster 63: NK-cells & T-cells - Immune response"	Cytosol	"Vesicles, Centriolar satellite"	"HPA048062: AB_2680242"	"unprognostic (4.93e-3)"	"unprognostic (3.84e-4)"	"unprognostic (7.61e-4)"	"unprognostic (4.94e-7)"	"unprognostic (9.56e-2)"	"unprognostic (3.76e-5)"	"unprognostic (1.86e-3)"	"unprognostic (6.70e-3)"	"unprognostic (2.66e-2)"	"unprognostic (7.02e-2)"	"unprognostic (3.40e-2)"	"unprognostic (5.20e-2)"	"unprognostic (1.40e-2)"	"unprognostic (5.13e-2)"	"unprognostic (7.15e-3)"	"unprognostic (4.54e-2)"	"unprognostic (2.08e-2)"	1.0	0.8	0.3	7.8	0.4	4.1	0.7	0.8	0.7	0.9	1.0	1.5	1.7	0.9	0.4	0.8	1.2	1.4	1.5	0.3	0.0	1.3	1.1	2.4	13.6	0.3	0.3	0.7	0.5	0.2	0.9	0.9	0.1	1.1	1.2	1.1	1.1	0.3	1.1	0.5	6.5	0.5	0.0	11.8	2.1	0.9	0.3	11.3	1.5	0.9	11.1	1.5	0.8	0.1	0.1	0.0	0.2	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.3	8.8	0.2	0.0	0.0	0.1	0.1	0.0	0.0	0.4	0.2	8.7	0.1	0.0	0.0	18.6	9.0	0.0	0.0	0.0	0.0	0.5	0.2	9.2	0.2	0.0	0.0	0.4	7.7	19.7	0.0	0.0	0.1	5.1	0.0	0.1	0.0	0.0	0.2	0.2	0.0	0.0	0.3	0.1	0.1	4.9	0.5	0.3	0.1	0.2	0.1	0.4	0.2	28.9	0.2	13.6	0.1	2.9	0.0	0.0	2.3	0.0	2.1	0.8	1.7	2.2	0.0	0.6	1.4	1.5	0.0	2.6	0.0	0.0	2.0	2.1	0.3	0.4	0.8	0.7	0.3	0.0	0.3	0.3	0.1	0.0	0.3	0.1	1.7	3.2	0.0	1.0	10.3	0.0	0.3	0.0	0.0	1.6	0.4	0.3	4.6	1.5	0.6	1.8	4.2	0.0	18.8	0.0	0.0	0.0	4.0	1.3	0.8	2.3	0.0	6.5	3.8	0.0	0.0	0.5	1.5	0.7	2.5	0.2	3.9	0.1	0.1	0.0	3.7	0.0	0.0	1.0	0.0	1.3	0.0	1.1	0.0	1.9	1.3	0.3	37.0	1.0	0.6	0.0	0.0	0.0	6.2	0.1	0.0	0.1	0.7	5.1	0.0	0.9	0.7	0.5	0.3	0.0	0.0	0.0	23.8	0.1	0.0	0.3
NMRAL1	"FLJ25918, HSCARG, SDR48A1"	ENSG00000153406	"NmrA like redox sensor 1"	Q9HBL8	16	4461691-4495763	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041353, HPA062287"	Uncertain		Enhanced	Nucleoplasm		NA	NA			"Cluster 39: Non-specific - mRNA processing"	"Cluster 22: Non-specific - Unknown function"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 47: Cytotrophoblasts - Unknown function"	Nucleoplasm		"HPA041353: AB_10796343, HPA062287: AB_2684738"	"unprognostic (2.56e-1)"	"prognostic favorable (3.33e-7)"	"unprognostic (4.16e-1)"	"unprognostic (4.04e-3)"	"unprognostic (1.15e-1)"	"unprognostic (1.24e-1)"	"unprognostic (1.05e-1)"	"unprognostic (2.20e-1)"	"unprognostic (3.90e-1)"	"unprognostic (1.28e-1)"	"unprognostic (2.86e-1)"	"unprognostic (5.52e-2)"	"unprognostic (8.48e-2)"	"unprognostic (2.06e-2)"	"unprognostic (1.13e-1)"	"unprognostic (5.79e-2)"	"unprognostic (2.21e-1)"	20.8	39.6	40.2	8.8	42.5	13.4	25.5	41.2	49.4	25.5	36.7	23.3	16.1	24.0	24.7	27.4	23.8	16.1	25.3	41.0	40.4	36.7	57.3	19.9	18.1	42.5	40.4	30.3	44.1	16.2	27.3	13.9	42.4	36.7	11.5	5.0	32.8	19.3	5.2	34.3	23.6	13.6	39.6	26.2	41.4	11.5	41.2	18.6	27.3	4.3	14.8	22.2	24.0	43.5	36.7	47.6	10.3	28.5	26.1	23.7	34.9	26.5	12.0	32.9	25.3	44.3	69.2	0.8	46.2	41.8	9.9	35.3	26.3	43.7	15.7	28.5	10.5	31.1	38.0	24.5	50.5	36.5	22.2	32.4	54.4	41.5	16.7	28.6	39.8	116.3	32.7	0.9	19.2	116.0	81.7	39.2	31.4	55.8	39.7	73.7	0.7	42.4	42.1	21.2	12.9	26.6	50.4	78.1	27.4	6.5	66.5	39.4	17.9	17.5	0.8	14.9	0.3	0.9	0.6	57.1	8.9	35.6	31.5	13.1	59.3	6.1	61.1	35.9	45.6	38.9	42.6	57.2	53.9	35.0	43.2	44.3	32.5	27.9	26.6	52.7	42.3	53.7	40.2	42.5	41.2	49.4	41.0	40.4	42.5	40.4	42.4	39.6	41.2	43.5	16.2	25.6	26.0	11.1	19.3	27.3	38.1	48.8	43.3	11.7	48.7	46.4	22.6	40.0	38.7	42.3	0.0	105.8	30.6	29.1	52.8	34.6	12.5	24.9	21.8	19.0	20.4	20.8	9.1	49.8	102.5	23.8	46.4	34.4	20.8	41.3	26.4	78.7	67.1	5.0	11.1	38.2	30.5	29.5	18.7	35.7	29.2	23.1	35.6	8.4	30.9	45.5	54.6	7.5	19.0	37.4	36.5	30.5	27.8	29.0	46.3	114.5	35.7	10.0	26.3	10.6	24.0	5.4	37.3	29.6	30.5	64.2	32.9	37.9	38.5	32.8
NOP14	"C4orf9, NOL14, RES4-25, UTP2"	ENSG00000087269	"NOP14 nucleolar protein"	P78316	4	2937933-2963406	"Plasma proteins, Predicted intracellular proteins"	"Ribosome biogenesis, rRNA processing"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA039596, HPA055652"	Approved		Enhanced	Nucleoplasm,Nucleoli		NA	NA			"Cluster 39: Non-specific - mRNA processing"	"Cluster 59: Non-specific - Translation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 10: Non-specific - Unknown function"	Nucleoli	Nucleoplasm	"HPA039596: AB_2676590, HPA055652: AB_2682876"	"unprognostic (4.70e-2)"	"unprognostic (6.47e-2)"	"prognostic favorable (3.93e-5)"	"unprognostic (7.32e-2)"	"unprognostic (3.28e-1)"	"unprognostic (2.07e-2)"	"prognostic unfavorable (9.10e-4)"	"unprognostic (2.41e-2)"	"unprognostic (8.62e-2)"	"unprognostic (2.09e-1)"	"unprognostic (1.30e-1)"	"unprognostic (2.55e-3)"	"unprognostic (1.16e-1)"	"unprognostic (1.27e-3)"	"unprognostic (1.44e-1)"	"unprognostic (7.15e-2)"	"unprognostic (4.77e-2)"	17.5	15.7	4.6	18.4	5.9	22.9	16.5	11.2	5.1	13.2	6.9	13.7	12.4	13.2	6.0	18.3	12.2	9.3	13.0	4.3	5.8	11.5	19.0	12.4	23.4	5.5	5.4	19.2	24.6	11.1	11.0	12.1	5.6	11.6	12.7	7.1	13.9	9.0	41.7	22.3	13.6	11.5	4.6	15.2	15.4	7.7	6.1	15.7	15.5	14.6	19.7	19.8	14.6	6.8	52.7	43.8	25.6	52.9	33.6	37.9	44.6	47.4	33.5	48.2	39.6	57.5	54.1	148.0	32.8	38.7	35.1	35.5	71.1	61.5	51.6	28.4	67.8	117.8	40.5	52.6	44.3	129.3	49.2	38.6	54.2	54.7	49.5	23.9	41.3	44.6	108.7	50.9	37.0	37.7	137.4	94.4	66.6	48.0	70.7	87.8	38.7	49.3	24.1	83.2	52.6	30.9	39.4	28.8	37.9	23.0	55.0	50.3	51.7	40.3	23.3	49.6	88.3	37.9	65.8	124.8	41.9	93.6	42.6	1.0	2.1	0.4	2.8	2.4	4.9	2.1	3.4	4.3	2.5	3.5	4.1	3.1	0.2	3.2	1.6	3.1	2.5	2.1	4.6	5.9	11.2	5.1	4.3	5.8	5.5	5.4	5.6	4.6	6.1	6.8	13.3	19.2	30.5	3.6	22.2	25.9	23.4	11.6	27.9	9.6	12.2	12.2	20.2	12.8	23.9	1.8	14.6	16.8	21.0	11.8	11.7	19.5	2.6	13.6	27.8	16.5	9.0	22.3	4.7	24.0	18.4	16.3	20.9	16.4	20.8	25.9	8.6	24.3	11.0	20.2	5.7	11.6	4.1	7.0	12.1	2.6	12.5	14.6	0.0	3.7	15.3	6.3	10.3	3.0	4.7	21.3	6.5	9.8	28.1	27.1	5.1	14.1	12.0	7.7	13.1	23.3	19.7	11.8	19.1	32.5	32.5	11.5	24.1	38.5	17.0	21.4
NSA2	"FLJ94393, HCLG1, HUSSY-29, TINP1"	ENSG00000164346	"NSA2 ribosome biogenesis factor"	O95478	5	74766991-74780113	"Plasma proteins, Predicted intracellular proteins, Ribosomal proteins"	"Ribosome biogenesis, rRNA processing"	Ribonucleoprotein		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA043487	Approved		Enhanced	Nucleoplasm,Nucleoli		No	No			"Cluster 39: Non-specific - mRNA processing"	"Cluster 59: Non-specific - Translation"	"Cluster 43: THP-1 - Innate immune response"	"Cluster 32: Non-specific - Translation"	"Nucleoplasm, Nucleoli"		"HPA043487: AB_2678507"	"unprognostic (4.79e-3)"	"unprognostic (1.92e-1)"	"unprognostic (5.49e-2)"	"unprognostic (7.80e-2)"	"unprognostic (1.54e-1)"	"unprognostic (4.07e-2)"	"unprognostic (6.14e-3)"	"unprognostic (4.24e-1)"	"unprognostic (2.15e-2)"	"unprognostic (9.14e-2)"	"unprognostic (8.66e-2)"	"unprognostic (1.03e-1)"	"unprognostic (4.92e-2)"	"unprognostic (3.98e-1)"	"unprognostic (1.64e-1)"	"unprognostic (2.31e-2)"	"unprognostic (1.44e-1)"	32.0	36.5	17.1	33.2	18.9	39.3	28.7	19.3	22.2	43.7	15.6	36.4	30.4	29.9	25.0	26.7	35.0	12.2	28.3	17.4	19.0	30.9	26.6	20.3	36.9	19.1	17.9	60.4	37.7	20.6	28.1	17.3	19.2	28.5	22.8	22.6	28.1	11.5	67.9	22.2	26.0	16.9	19.9	25.8	31.2	31.8	18.2	23.5	22.1	19.0	32.0	35.9	30.6	20.4	65.2	35.4	42.5	57.6	26.6	48.9	64.8	45.8	24.5	29.5	24.9	61.2	62.3	53.0	94.0	27.3	70.2	39.6	34.6	51.9	41.9	36.1	53.7	27.9	65.8	68.3	24.8	47.9	61.7	32.4	48.2	39.8	29.6	46.5	25.5	47.3	28.0	42.8	32.2	50.1	81.4	120.4	28.3	27.8	29.9	58.4	49.8	100.5	37.7	70.9	45.3	58.5	27.8	52.8	135.7	32.6	49.5	135.8	28.0	22.0	67.4	41.8	133.3	42.7	61.1	90.0	54.6	84.3	33.3	9.3	12.1	7.5	16.3	20.6	23.5	27.1	24.6	24.7	18.5	19.5	28.7	29.8	2.2	21.4	15.9	17.2	26.4	10.3	17.1	18.9	19.3	22.2	17.4	19.0	19.1	17.9	19.2	19.9	18.2	20.4	125.8	80.1	95.9	6.5	237.4	94.1	162.1	95.9	215.1	34.6	164.2	218.3	83.7	140.2	94.5	62.5	14.6	142.3	183.7	122.9	150.6	143.1	418.6	145.2	303.6	101.1	139.6	129.2	13.1	237.9	196.2	107.6	112.1	192.8	119.2	165.4	129.2	207.7	137.4	50.5	13.2	234.6	52.9	233.2	100.2	159.1	278.4	161.9	83.6	7.5	229.6	85.8	188.4	10.1	13.4	181.2	147.9	171.5	139.4	144.4	147.5	281.7	55.9	37.7	138.1	132.8	138.0	250.2	96.3	171.7	86.0	135.4	176.1	176.8	246.1	192.5
NUDCD1	"CML66, FLJ14991"	ENSG00000120526	"NudC domain containing 1"	Q96RS6	8	109240919-109334121	"Predicted intracellular proteins"	Immunity	"Tumor antigen"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Early spermatids: 122.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA023183	Uncertain		Supported	Nucleoplasm,Cytosol		NA	NA		7300	"Cluster 39: Non-specific - mRNA processing"	"Cluster 28: Placenta - Pregnancy"	"Cluster 4: Mesenchymal cell lines - Antiviral immune response"	"Cluster 23: Spermatids - Flagellum & Golgi organization"	Nucleoplasm	Cytosol	"HPA023183: AB_1854695"	"unprognostic (5.08e-3)"	"unprognostic (3.73e-2)"	"unprognostic (2.52e-2)"	"unprognostic (9.03e-3)"	"unprognostic (7.52e-2)"	"unprognostic (3.62e-3)"	"prognostic unfavorable (1.39e-5)"	"prognostic unfavorable (4.37e-5)"	"unprognostic (2.13e-1)"	"unprognostic (9.49e-2)"	"prognostic unfavorable (6.94e-4)"	"unprognostic (8.22e-2)"	"prognostic unfavorable (8.71e-6)"	"unprognostic (1.95e-1)"	"unprognostic (1.63e-1)"	"unprognostic (3.35e-1)"	"unprognostic (1.65e-1)"	11.1	5.0	3.3	6.0	3.5	1.3	9.5	3.7	4.2	7.7	3.1	5.5	2.8	7.2	5.2	5.7	6.9	4.8	6.6	3.3	3.5	7.8	6.4	7.0	9.3	3.7	3.6	6.3	6.9	5.8	4.2	15.1	3.4	5.9	6.7	4.7	6.1	6.8	6.1	4.3	5.1	7.9	4.1	7.3	5.8	13.0	3.4	10.1	9.0	9.3	8.5	11.4	6.8	3.8	28.9	16.7	24.7	13.7	13.1	18.0	13.1	20.6	24.8	57.8	54.4	17.6	21.8	18.5	13.1	22.5	16.3	17.1	36.3	34.3	79.8	23.6	12.6	28.8	9.9	19.6	27.2	13.7	10.6	12.7	18.4	28.1	40.3	18.3	53.0	22.7	32.2	9.5	49.5	23.3	33.3	15.1	17.3	59.7	22.7	21.4	20.4	18.3	35.6	14.8	20.5	18.1	9.4	26.1	21.6	25.6	19.2	9.9	14.2	28.2	17.2	12.1	17.6	6.9	9.4	22.3	10.4	22.2	24.1	0.0	0.4	0.5	0.8	1.3	1.4	1.2	1.0	1.6	1.4	1.1	1.1	1.6	0.0	1.7	1.7	0.9	1.5	0.7	3.3	3.5	3.7	4.2	3.3	3.5	3.7	3.6	3.4	4.1	3.4	3.8	25.4	3.2	10.0	6.2	11.3	17.7	24.4	19.4	10.2	5.0	7.4	6.3	11.3	2.8	23.2	3.7	6.2	23.4	9.7	2.5	7.9	17.1	122.3	11.2	19.2	26.5	9.0	14.5	22.9	11.0	21.2	16.2	5.6	10.2	17.7	11.8	8.9	6.2	9.8	5.0	23.5	5.7	14.2	4.7	11.5	22.5	13.1	8.7	7.2	13.1	16.9	4.4	5.2	15.1	15.3	14.1	4.7	6.8	12.1	29.6	3.4	13.0	15.4	9.0	0.0	13.7	15.8	53.3	36.4	8.9	16.8	8.2	9.5	12.5	9.9	22.7
NUMA1		ENSG00000137497	"Nuclear mitotic apparatus protein 1"	Q14980	11	72002864-72080693	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins"	"Cell cycle, Cell division, Chromosome partition, Mitosis"		"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA019841, HPA019859, HPA029912"	Enhanced		Supported	Nucleoplasm,Cytosol		NA	Yes		62000	"Cluster 39: Non-specific - mRNA processing"	"Cluster 89: Fibroblasts - ECM organization"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 44: Endometrium - Transcription"	Nucleoplasm	Cytosol	"HPA019841: AB_1854708, HPA019859: AB_1854709, HPA029912: AB_10602811"	"unprognostic (1.60e-2)"	"unprognostic (3.31e-1)"	"unprognostic (2.06e-2)"	"unprognostic (2.84e-1)"	"unprognostic (1.14e-1)"	"unprognostic (6.47e-2)"	"unprognostic (5.75e-2)"	"unprognostic (8.74e-3)"	"unprognostic (5.91e-2)"	"unprognostic (9.45e-2)"	"unprognostic (1.60e-2)"	"unprognostic (2.51e-2)"	"prognostic favorable (7.92e-4)"	"unprognostic (1.28e-1)"	"unprognostic (1.37e-1)"	"unprognostic (1.49e-1)"	"unprognostic (1.39e-1)"	55.2	59.9	27.8	51.1	45.6	69.6	67.1	37.4	40.5	75.4	36.2	77.7	59.6	111.2	43.3	67.9	82.7	62.7	47.6	24.0	33.0	49.9	29.8	65.4	57.9	40.4	34.3	112.3	68.8	98.6	42.1	60.8	41.9	111.4	54.5	46.2	78.1	85.6	82.5	93.8	61.9	86.7	28.4	56.8	59.0	42.4	36.0	79.3	73.9	54.8	53.2	75.2	65.9	83.4	64.4	80.0	97.2	66.4	85.1	88.2	48.8	85.0	97.2	86.4	74.6	83.9	115.5	86.7	72.0	104.0	61.6	134.2	89.7	85.8	78.0	89.9	43.1	105.8	130.4	64.1	69.1	81.1	74.0	94.0	55.7	84.1	84.3	133.0	74.0	76.7	63.4	101.1	59.4	124.2	105.6	45.2	61.2	122.3	57.6	127.9	170.0	67.6	64.2	98.6	117.3	166.6	134.9	123.5	123.6	42.3	166.4	47.1	103.0	90.6	69.9	130.1	56.9	64.8	69.7	120.0	61.1	38.0	53.0	3.7	4.1	1.9	6.4	2.3	4.7	3.4	4.0	5.0	3.5	5.8	4.9	3.6	2.8	5.0	4.4	8.2	5.2	6.0	27.8	45.6	37.4	40.5	24.0	33.0	40.4	34.3	41.9	28.4	36.0	83.4	52.4	41.7	41.3	42.7	36.6	25.9	30.1	25.3	74.0	60.7	62.3	63.4	5.7	34.3	32.2	53.3	73.0	25.5	42.6	56.3	17.6	27.9	31.9	55.5	48.5	44.9	47.4	43.3	27.5	32.1	13.4	41.9	57.6	92.8	31.0	84.7	37.9	23.6	28.7	52.2	34.0	68.3	32.6	32.1	24.9	17.8	69.0	36.3	19.6	33.7	26.8	51.8	53.5	27.6	58.9	30.9	31.2	50.8	40.8	29.6	57.0	26.9	35.4	59.8	39.5	64.3	36.9	14.8	21.4	51.9	28.1	45.0	44.8	44.2	52.2	26.0
NUP205	"C7orf14, KIAA0225"	ENSG00000155561	"Nucleoporin 205"	Q92621	7	135557917-135648757	"Disease related genes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"mRNA transport, Protein transport, Translocation, Transport"		"Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"									NA	NA		24000	"Cluster 39: Non-specific - mRNA processing"	"Cluster 34: Non-specific - Transcription"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 59: Non-specific - Transcription"				"unprognostic (3.64e-2)"	"unprognostic (2.13e-1)"	"unprognostic (6.05e-2)"	"unprognostic (3.66e-3)"	"unprognostic (4.00e-1)"	"unprognostic (2.96e-2)"	"prognostic unfavorable (1.90e-7)"	"unprognostic (2.33e-2)"	"unprognostic (2.12e-2)"	"unprognostic (3.27e-2)"	"unprognostic (7.53e-2)"	"unprognostic (4.55e-2)"	"unprognostic (3.22e-2)"	"unprognostic (3.23e-2)"	"unprognostic (1.34e-1)"	"unprognostic (2.11e-1)"	"unprognostic (1.35e-2)"	7.5	6.7	2.0	13.1	3.3	10.7	11.5	6.7	2.6	8.9	3.8	10.0	8.0	10.7	7.2	11.0	10.4	6.4	4.9	1.7	3.1	8.0	6.6	8.4	15.0	2.7	2.7	11.8	6.1	15.1	5.2	11.0	3.2	8.7	12.3	14.8	11.8	9.0	8.0	9.6	8.3	12.7	2.6	10.3	9.0	11.6	3.2	21.8	8.4	8.0	17.3	9.9	6.9	4.4	66.4	52.8	69.5	68.2	16.2	26.6	45.4	41.0	31.5	62.4	69.1	55.1	46.8	84.2	31.7	24.6	63.0	50.1	88.5	46.0	80.1	41.9	63.3	48.9	52.1	25.1	12.2	96.5	37.0	14.5	20.5	61.4	40.8	21.9	47.3	58.9	115.6	39.1	47.6	45.0	105.0	29.4	107.0	51.6	46.3	77.6	64.6	66.6	18.8	52.4	69.3	70.4	67.8	54.8	31.8	52.4	31.6	36.5	38.6	51.0	25.3	62.7	79.5	28.7	57.2	112.3	51.7	74.3	70.1	1.6	1.3	0.4	2.4	3.1	2.8	2.3	2.9	2.5	3.0	2.1	2.3	2.7	0.5	2.9	1.7	1.9	2.9	1.4	2.0	3.3	6.7	2.6	1.7	3.1	2.7	2.7	3.2	2.6	3.2	4.4	7.9	12.8	13.4	24.8	15.3	13.0	6.8	10.3	11.4	6.3	8.6	5.2	5.3	7.2	10.6	16.5	12.5	13.1	7.5	8.2	3.9	7.8	0.9	7.4	8.1	9.3	9.1	21.3	22.7	9.6	9.3	9.4	13.3	8.4	8.2	18.5	7.9	10.7	10.3	5.0	24.1	10.4	6.1	14.1	11.7	2.4	8.1	12.2	10.6	17.8	11.4	4.9	3.1	26.2	23.3	11.9	6.4	7.5	17.4	10.3	3.9	4.6	12.4	9.7	0.0	12.6	8.2	14.5	10.8	14.8	15.5	7.7	11.9	6.1	10.9	9.4
NUP210	"FLJ22389, GP210, KIAA0906, POM210"	ENSG00000132182	"Nucleoporin 210"	Q8TEM1	3	13316235-13420322	"Metabolic proteins, Predicted membrane proteins, Transporters"	"mRNA transport, Protein transport, Translocation, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 53.4;lymphoid tissue: 41.7"	"Cell type enhanced"	"Detected in many"		"dendritic cells: 57.7;Granulosa cells: 70.0;NK-cells: 69.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"RPMI-8226: 232.7;U-266/84: 261.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA066888	Approved					NA	NA		78000	"Cluster 39: Non-specific - mRNA processing"	"Cluster 66: Lymphoid tissue - Immune response regulation"	"Cluster 16: U-266 - Nucleosome"	"Cluster 40: Granulosa cells - Unknown function"			"HPA066888: AB_2685741"	"unprognostic (3.17e-2)"	"unprognostic (2.09e-1)"	"unprognostic (2.53e-1)"	"unprognostic (3.60e-2)"	"unprognostic (2.33e-1)"	"unprognostic (9.72e-3)"	"prognostic unfavorable (6.03e-6)"	"unprognostic (1.30e-1)"	"unprognostic (3.15e-1)"	"unprognostic (2.19e-2)"	"unprognostic (1.41e-1)"	"unprognostic (5.87e-2)"	"unprognostic (1.96e-3)"	"unprognostic (1.44e-1)"	"unprognostic (1.60e-1)"	"unprognostic (1.59e-2)"	"unprognostic (1.63e-2)"	2.0	5.2	5.3	23.2	5.8	53.4	5.4	7.8	6.5	2.3	4.8	6.4	7.3	2.6	8.4	7.1	4.1	4.6	2.3	5.0	6.2	8.8	19.8	7.6	41.3	6.1	6.7	1.2	13.0	9.7	13.5	6.4	5.5	5.4	5.6	4.8	6.4	2.8	5.2	5.6	22.2	2.4	5.2	32.5	8.5	9.2	5.8	41.7	8.1	1.8	29.0	5.8	2.2	7.3	41.5	72.0	34.8	90.8	0.0	0.0	138.1	0.6	0.0	8.6	0.4	37.2	66.3	167.7	55.6	0.1	3.9	23.8	77.5	0.0	3.2	135.9	57.9	65.2	81.1	39.6	0.0	210.8	22.7	0.0	0.0	0.0	0.0	6.3	0.1	124.1	102.5	174.9	0.0	103.8	112.6	83.4	40.2	12.8	14.8	0.2	0.2	232.7	16.9	38.4	39.8	39.8	51.3	67.7	21.0	15.5	64.8	172.6	0.5	0.1	11.7	0.2	31.8	176.1	261.0	144.9	0.1	116.0	0.3	0.0	2.5	0.9	7.3	3.2	5.8	5.4	5.2	7.2	5.4	3.1	4.3	5.8	0.1	5.5	2.0	5.6	4.8	3.7	5.3	5.8	7.8	6.5	5.0	6.2	6.1	6.7	5.5	5.2	5.8	7.3	0.7	16.0	5.4	16.6	37.3	1.7	1.3	0.5	0.0	25.4	9.6	5.3	11.6	8.6	4.1	5.5	14.6	17.6	57.7	2.9	3.9	5.7	19.2	4.3	1.0	1.0	8.3	41.8	17.9	4.4	5.6	1.1	3.6	8.3	5.1	70.0	3.6	17.0	16.7	35.3	23.4	8.8	4.1	11.3	4.9	23.5	0.6	14.9	1.8	10.3	16.7	3.0	69.0	30.2	17.7	2.6	0.8	0.4	43.7	2.6	2.1	4.5	3.0	19.4	0.0	2.1	1.1	6.4	10.0	3.5	2.4	4.9	37.2	17.8	11.5	1.9
NUP43	"bA350J20.1, FLJ13287"	ENSG00000120253	"Nucleoporin 43"	Q8NFH3	6	149724315-149749665	"Metabolic proteins, Predicted intracellular proteins, Transporters"	"Cell cycle, Cell division, Chromosome partition, Mitosis, mRNA transport, Protein transport, Translocation, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Late spermatids: 78.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA027126, HPA027291, HPA028500"	Enhanced		Approved	"Nucleoplasm,Nuclear speckles,Cytosol"		NA	NA			"Cluster 39: Non-specific - mRNA processing"	"Cluster 16: Immune cells - Immune response"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 10: Non-specific - Unknown function"	"Nucleoplasm, Nuclear speckles"	Cytosol	"HPA027126: AB_10599301, HPA027291: AB_10601851, HPA028500: AB_10602287"	"prognostic unfavorable (2.08e-4)"	"unprognostic (3.02e-1)"	"unprognostic (3.86e-2)"	"unprognostic (1.45e-3)"	"unprognostic (2.29e-1)"	"unprognostic (8.19e-3)"	"prognostic unfavorable (7.13e-7)"	"unprognostic (5.14e-2)"	"unprognostic (2.45e-1)"	"unprognostic (2.35e-1)"	"unprognostic (1.11e-1)"	"unprognostic (1.06e-2)"	"unprognostic (2.74e-2)"	"unprognostic (6.25e-3)"	"unprognostic (2.02e-1)"	"unprognostic (2.72e-2)"	"unprognostic (3.60e-2)"	8.4	8.6	6.2	11.4	7.5	6.2	13.6	7.2	6.9	9.7	6.5	9.4	8.7	9.8	7.5	9.5	8.2	6.4	10.8	5.6	6.6	9.9	9.6	8.0	15.9	6.6	6.6	9.1	12.2	8.9	5.6	11.4	6.9	10.3	9.7	9.8	8.8	9.2	14.2	13.5	10.9	9.4	6.6	13.6	9.8	7.9	6.5	12.8	11.1	11.6	17.0	9.0	9.1	8.3	21.1	34.9	31.1	49.6	20.0	23.7	48.9	36.3	20.3	34.0	43.0	49.5	19.5	61.4	36.6	20.2	32.1	33.5	54.6	31.6	58.3	27.8	38.2	70.9	35.5	49.6	13.4	73.2	44.1	15.3	16.4	49.9	33.1	13.0	27.5	34.6	71.4	33.6	29.6	20.7	52.2	30.4	28.3	24.1	21.0	50.2	43.2	20.6	23.2	28.9	12.9	21.2	43.4	27.1	14.2	25.6	28.7	30.9	21.3	28.3	30.2	41.2	53.9	20.5	43.3	63.9	25.2	49.3	40.5	2.9	4.9	3.4	3.5	5.4	3.8	4.3	4.2	3.5	2.6	6.2	4.3	5.5	1.9	3.7	4.8	5.0	4.9	2.2	6.2	7.5	7.2	6.9	5.6	6.6	6.6	6.6	6.9	6.6	6.5	8.3	5.8	3.2	7.8	9.1	11.5	7.9	5.5	4.7	2.8	11.9	4.5	5.0	14.3	11.5	5.2	3.7	6.2	10.9	11.3	4.7	3.9	9.0	33.3	4.3	8.7	5.7	10.2	7.6	4.8	7.8	12.2	6.4	6.1	6.0	0.0	12.8	8.2	4.4	7.8	6.7	5.1	6.9	2.0	11.9	6.9	78.9	10.2	6.5	8.8	9.4	15.1	10.5	9.2	11.1	17.4	6.6	2.3	10.5	8.7	6.2	3.9	5.4	4.2	9.5	13.1	6.9	22.1	7.1	9.2	5.5	8.5	6.6	7.6	7.4	8.4	6.7
NXF1	"DKFZp667O0311, Mex67, TAP"	ENSG00000162231	"Nuclear RNA export factor 1"	Q9UBU9	11	62792123-62806302	"Predicted intracellular proteins, Transporters"	"Host-virus interaction, mRNA transport, Protein transport, Translocation, Transport"	RNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB016327, HPA061593"	Supported		Supported	Nucleoplasm		NA	NA			"Cluster 39: Non-specific - mRNA processing"	"Cluster 18: Non-specific - Mitochondria"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 7: Non-specific - Mitochondria"	Nucleoplasm		"CAB016327: AB_627608, HPA061593: AB_2684565"	"unprognostic (2.45e-2)"	"unprognostic (1.15e-3)"	"unprognostic (2.34e-1)"	"unprognostic (1.68e-3)"	"unprognostic (2.36e-1)"	"unprognostic (1.45e-2)"	"unprognostic (5.40e-3)"	"unprognostic (7.21e-3)"	"unprognostic (2.54e-2)"	"unprognostic (2.64e-1)"	"prognostic favorable (4.08e-4)"	"unprognostic (4.33e-3)"	"unprognostic (8.08e-2)"	"unprognostic (1.18e-1)"	"unprognostic (3.38e-1)"	"unprognostic (3.66e-3)"	"unprognostic (1.25e-2)"	90.2	103.4	57.2	47.9	56.8	204.6	81.8	61.6	71.9	100.1	66.8	106.0	39.4	94.6	55.2	80.2	86.8	51.8	78.0	57.3	59.0	100.3	130.0	82.0	69.9	56.6	57.2	97.3	98.3	63.8	136.7	58.9	56.1	107.2	45.6	49.9	77.3	57.8	75.7	110.6	96.1	66.6	55.2	143.8	97.1	59.5	58.2	75.5	123.1	41.5	56.1	83.1	78.8	59.9	44.6	48.5	82.8	56.5	69.6	50.2	50.2	67.5	60.5	89.0	52.6	66.8	35.1	70.0	39.1	54.4	35.7	54.1	89.9	42.3	80.2	55.5	61.3	52.9	82.1	56.4	52.8	66.3	73.6	74.5	59.9	65.6	31.5	66.5	58.9	60.7	69.3	50.7	64.4	61.1	81.3	85.1	50.4	54.8	41.6	77.5	46.0	74.6	61.7	51.7	43.6	36.5	66.4	52.8	49.8	59.9	60.3	57.9	60.3	51.2	41.5	64.6	61.3	61.4	56.8	70.2	39.6	55.2	52.1	7.6	21.3	23.5	18.9	26.0	20.5	16.0	18.4	18.5	23.6	12.8	19.6	18.4	16.1	20.2	23.6	18.3	24.0	17.1	57.2	56.8	61.6	71.9	57.3	59.0	56.6	57.2	56.1	55.2	58.2	59.9	53.2	38.5	45.3	14.7	40.2	83.4	27.0	29.4	42.7	13.2	45.9	74.7	24.6	21.5	23.4	22.0	31.3	50.4	44.1	42.2	9.8	17.6	32.6	30.4	36.8	36.8	31.6	17.7	11.0	12.3	25.9	35.1	43.3	51.7	49.9	19.8	26.0	18.6	28.6	5.0	13.0	35.9	22.4	33.8	43.2	12.3	36.7	62.5	32.0	11.2	21.8	12.7	21.6	7.1	10.1	14.7	28.6	25.9	29.7	22.0	24.0	10.2	18.6	17.2	26.3	48.6	40.4	28.2	19.9	53.4	70.0	99.2	42.3	15.4	30.4	15.2
OGDH	"E1k, KGD1, OGDC-E1, OGDH2"	ENSG00000105953	"Oxoglutarate dehydrogenase"	Q02218	7	44606572-44709066	"Citric acid cycle related proteins, Enzymes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	Glycolysis	Oxidoreductase	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"heart muscle: 324.0;skeletal muscle: 363.6;tongue: 374.7"	"Cell type enhanced"	"Detected in all"		"Cardiomyocytes: 114.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA019514, HPA020347"	Supported		Enhanced	Mitochondria		No	No		130000	"Cluster 39: Non-specific - mRNA processing"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 54: Cardiomyocytes - Muscle contraction"	Mitochondria		"HPA019514: AB_1854772, HPA020347: AB_1854773"	"unprognostic (1.96e-2)"	"unprognostic (1.40e-1)"	"unprognostic (4.39e-1)"	"unprognostic (5.64e-3)"	"unprognostic (3.02e-3)"	"unprognostic (1.20e-1)"	"unprognostic (3.45e-1)"	"unprognostic (7.58e-2)"	"unprognostic (1.74e-1)"	"unprognostic (1.52e-2)"	"unprognostic (3.38e-1)"	"unprognostic (3.30e-2)"	"prognostic favorable (2.22e-14)"	"unprognostic (1.53e-1)"	"unprognostic (1.62e-1)"	"unprognostic (2.23e-2)"	"unprognostic (5.88e-3)"	64.9	67.4	35.0	39.2	39.4	32.1	32.0	42.8	45.4	33.8	119.6	56.3	95.6	40.9	16.6	61.6	34.0	26.9	324.0	34.4	50.6	89.7	39.8	43.4	40.0	44.6	44.4	24.8	27.5	99.9	34.9	33.1	44.2	37.9	41.5	25.9	43.0	46.9	363.6	56.4	87.5	51.0	35.7	39.0	52.5	36.2	43.6	32.1	54.9	374.7	41.5	42.5	37.7	35.6	35.8	73.5	42.2	66.0	63.4	69.8	41.9	54.2	51.3	59.5	50.9	67.2	71.7	156.0	63.0	79.2	119.2	108.2	85.7	81.4	58.4	92.0	22.8	47.4	140.6	33.5	32.8	59.4	51.2	66.0	60.5	85.4	60.9	43.0	82.4	50.7	55.8	45.4	63.7	50.1	59.2	34.1	39.8	97.7	81.8	55.9	30.1	175.9	68.5	104.4	73.2	35.0	78.8	107.6	34.4	75.8	64.2	58.7	66.4	43.4	38.5	76.3	64.0	40.9	84.0	85.9	78.4	65.7	80.4	9.9	21.8	12.6	17.9	28.5	19.5	11.1	20.7	18.1	22.0	9.3	8.5	10.8	12.2	19.3	35.4	10.8	42.1	23.2	35.0	39.4	42.8	45.4	34.4	50.6	44.6	44.4	44.2	35.7	43.6	35.6	19.6	6.4	22.5	49.3	23.1	19.5	12.3	15.9	22.8	21.4	14.4	18.2	114.3	12.8	14.2	47.8	18.8	24.0	20.0	64.5	31.3	14.9	51.0	26.1	15.6	16.0	23.4	32.0	43.3	16.9	16.4	20.6	35.2	38.9	21.5	15.5	17.9	22.6	33.8	62.2	53.1	32.6	12.2	24.5	43.4	24.5	11.8	33.8	21.4	29.0	22.7	14.3	16.5	22.1	36.6	20.9	38.0	17.3	27.8	16.4	82.0	51.8	17.0	24.0	19.7	24.7	20.2	10.6	19.9	28.1	26.3	36.7	27.7	30.3	33.5	18.1
OGT	"FLJ23071, HRNT1, MGC22921, O-GLCNAC, OGT1"	ENSG00000147162	"O-linked N-acetylglucosamine (GlcNAc) transferase"	O15294	X	71533104-71575892	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"	"Apoptosis, Biological rhythms, Host-virus interaction, Ubl conjugation pathway"	"Chromatin regulator, Glycosyltransferase, Transferase"	"Disease variant, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA030751, HPA030752, HPA030753, HPA030754, CAB034099"	Approved		Supported	"Nucleoplasm,Plasma membrane"		Yes	No			"Cluster 39: Non-specific - mRNA processing"	"Cluster 50: Non-specific - Ribosome"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 65: Plasmacytoid DCs - Unknown function"	Nucleoplasm	"Plasma membrane"	"CAB034099: AB_2157067, HPA030751: AB_10600217, HPA030752: AB_10601445, HPA030753: AB_2673594, HPA030754: AB_2673595"	"unprognostic (1.37e-1)"	"unprognostic (2.20e-1)"	"unprognostic (2.32e-2)"	"prognostic unfavorable (8.33e-4)"	"unprognostic (3.40e-2)"	"prognostic favorable (1.97e-4)"	"unprognostic (9.56e-3)"	"unprognostic (1.96e-3)"	"unprognostic (5.58e-2)"	"unprognostic (2.29e-1)"	"unprognostic (1.06e-1)"	"unprognostic (9.74e-3)"	"prognostic unfavorable (2.36e-6)"	"unprognostic (2.99e-3)"	"unprognostic (2.28e-1)"	"unprognostic (8.03e-3)"	"prognostic favorable (6.85e-7)"	59.3	55.9	39.7	38.3	42.4	61.5	62.7	43.3	51.6	72.7	40.1	62.5	30.6	56.0	62.2	52.8	76.4	26.4	55.5	43.9	35.5	61.6	45.8	70.7	71.9	36.1	35.8	85.5	102.4	24.3	46.9	26.4	37.9	75.4	39.6	36.9	64.1	27.1	62.8	68.6	86.4	24.5	36.1	122.8	67.4	19.0	36.2	57.2	70.7	39.2	57.8	55.7	67.4	44.3	40.5	37.0	47.1	41.5	49.6	45.6	31.6	30.3	54.3	32.1	49.1	39.3	45.4	47.9	20.7	37.3	33.3	49.1	52.0	29.5	39.4	41.1	53.4	30.4	98.6	28.5	37.6	62.9	48.1	43.6	59.2	35.1	65.7	55.5	30.5	100.7	31.1	160.4	31.1	34.3	48.9	75.2	31.6	35.5	49.8	47.8	52.7	62.1	50.0	45.9	24.1	21.2	46.9	30.9	30.2	35.5	22.8	42.4	35.5	34.6	27.9	36.6	17.9	43.5	33.5	56.5	24.4	65.0	21.6	2.8	4.6	2.0	7.5	5.7	6.8	7.4	6.3	6.2	6.1	6.2	7.2	7.4	1.9	10.4	5.7	6.2	6.2	5.6	39.7	42.4	43.3	51.6	43.9	35.5	36.1	35.8	37.9	36.1	36.2	44.3	31.1	35.3	85.2	52.9	67.2	88.1	37.9	23.5	58.6	26.5	49.6	34.0	42.8	20.0	31.1	49.7	8.4	15.8	130.7	31.1	9.8	14.4	2.4	32.1	49.8	39.8	34.9	51.3	110.7	14.4	8.5	47.5	54.6	53.3	27.8	26.4	45.7	27.5	16.1	40.4	94.6	37.3	22.4	60.9	69.7	4.8	53.4	45.8	35.6	71.2	51.6	11.3	51.5	92.0	97.9	17.6	34.9	29.7	147.2	53.8	34.8	15.1	28.0	21.8	32.9	44.8	42.2	2.5	6.1	63.3	84.1	10.9	82.1	62.0	34.0	50.8
OSBP2	"KIAA1664, ORP-4, ORP4, OSBPL1"	ENSG00000184792	"Oxysterol binding protein 2"	Q969R2	22	30693782-30907824	"Predicted intracellular proteins"	"Lipid transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 52.7;retina: 160.8"	"Cell type enhanced"	"Detected in many"		"Early spermatids: 135.4;Excitatory neurons: 132.8;Inhibitory neurons: 156.3;Late spermatids: 304.4;Oligodendrocytes: 182.8;Rod photoreceptor cells: 619.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"HEL: 41.9;HeLa: 146.4;hTERT-HME1: 38.2;SiHa: 39.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA021514	Uncertain		Approved	Cytosol		NA	NA			"Cluster 39: Non-specific - mRNA processing"	"Cluster 77: Retina - Visual perception"	"Cluster 20: HeLa - Mitochondria"	"Cluster 46: Photoreceptor cells - Phototransduction"	Cytosol		"HPA021514: AB_1854813"	"unprognostic (2.89e-1)"	"unprognostic (2.04e-1)"	"unprognostic (2.83e-1)"	"unprognostic (6.94e-3)"	"unprognostic (2.61e-1)"	"unprognostic (1.10e-1)"	"unprognostic (1.38e-5)"	"unprognostic (3.01e-1)"	"unprognostic (2.57e-1)"	"unprognostic (2.79e-2)"	"unprognostic (1.39e-1)"	"unprognostic (2.31e-1)"	"prognostic favorable (3.79e-6)"	"unprognostic (9.00e-2)"	"unprognostic (2.68e-1)"	"unprognostic (2.93e-1)"	"unprognostic (1.53e-2)"	1.4	11.8	6.2	2.8	14.4	52.7	1.5	17.0	20.5	1.6	2.1	1.7	7.5	2.0	14.6	3.7	2.0	3.0	12.2	8.5	4.4	2.6	1.0	1.6	2.3	9.6	9.8	1.6	5.0	9.3	20.9	4.6	10.0	2.3	1.7	160.8	2.9	2.4	2.8	5.4	5.6	1.2	1.8	4.8	3.5	28.7	21.3	0.6	3.2	3.2	1.3	4.4	2.1	15.1	7.1	15.4	1.5	6.7	1.0	5.8	1.6	1.3	3.1	4.8	4.8	14.0	3.9	12.5	5.7	1.9	1.5	4.1	6.2	0.6	3.5	6.7	1.8	41.9	146.4	2.7	0.9	0.2	2.5	0.3	16.8	11.8	38.2	1.6	12.1	4.8	26.7	0.5	11.0	7.8	1.3	4.5	3.8	3.3	13.8	3.5	0.5	0.7	0.6	2.7	16.7	6.8	39.2	4.1	0.4	2.9	4.9	2.2	8.8	3.4	18.1	3.2	6.8	3.2	4.8	2.3	13.3	0.0	2.7	0.0	0.7	0.4	0.5	1.1	1.0	0.5	1.0	0.4	0.6	0.6	1.0	1.1	0.7	1.0	0.9	0.2	0.7	2.0	6.2	14.4	17.0	20.5	8.5	4.4	9.6	9.8	10.0	1.8	21.3	15.1	1.2	0.0	3.1	37.9	0.2	5.2	0.9	0.4	0.6	93.2	1.3	0.8	11.2	2.8	1.0	1.8	81.3	0.2	0.3	1.3	1.9	1.8	135.4	1.6	0.5	2.8	7.2	91.3	132.8	1.5	0.2	1.6	2.0	1.6	0.0	3.2	0.4	0.1	0.2	18.5	156.3	2.8	0.0	0.3	1.8	304.4	2.5	1.7	1.8	8.4	0.4	31.4	0.0	35.7	182.8	0.8	5.2	1.9	1.4	1.2	0.7	0.8	1.3	619.5	0.0	1.1	2.3	48.6	4.4	1.4	9.5	0.3	0.5	1.2	1.2	1.3
OSBPL7	"MGC71150, ORP7"	ENSG00000006025	"Oxysterol binding protein like 7"	Q9BZF2	17	47807372-47821834	"Predicted intracellular proteins"	"Lipid transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 29.5;Gastric mucus-secreting cells: 118.7;Paneth cells: 29.9;Proximal enterocytes: 34.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"HaCaT: 43.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA036076, HPA053083, HPA073967"	Uncertain		Approved	"Nucleoplasm,Plasma membrane,Cytosol"		NA	NA			"Cluster 39: Non-specific - mRNA processing"	"Cluster 14: B-cells - Humoral immune response"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 27: Mucus-secreting cells - Mucin production"	"Nucleoplasm, Cytosol"	"Plasma membrane"	"HPA036076: AB_10601042, HPA053083: AB_2682038, HPA073967: "	"unprognostic (3.88e-2)"	"unprognostic (2.01e-1)"	"unprognostic (2.25e-1)"	"unprognostic (1.90e-1)"	"unprognostic (1.13e-1)"	"unprognostic (6.55e-3)"	"unprognostic (2.05e-3)"	"unprognostic (1.19e-1)"	"unprognostic (3.95e-2)"	"unprognostic (3.33e-1)"	"unprognostic (1.97e-1)"	"unprognostic (6.78e-2)"	"prognostic unfavorable (8.30e-4)"	"unprognostic (2.17e-1)"	"unprognostic (1.36e-1)"	"unprognostic (3.08e-1)"	"prognostic favorable (1.19e-5)"	5.0	3.7	10.6	4.9	10.4	7.2	5.4	9.5	14.0	11.1	7.3	22.7	22.3	8.6	1.6	3.4	7.6	5.3	6.5	10.3	9.9	9.9	2.2	8.5	7.5	10.6	10.2	9.6	17.3	2.6	10.1	2.3	10.7	14.3	8.7	3.1	9.0	6.1	20.2	1.7	22.7	3.5	9.2	17.2	34.0	1.4	10.5	4.9	11.3	3.5	3.8	9.1	7.0	10.9	6.0	6.9	3.0	3.4	3.3	4.6	2.5	2.2	3.2	3.7	4.2	7.1	17.8	6.0	8.7	3.2	1.3	43.2	1.7	4.8	1.2	20.8	2.4	4.4	15.0	4.8	3.0	9.4	0.1	7.4	0.9	2.4	1.7	11.5	7.7	10.5	4.4	8.1	5.8	7.8	9.5	10.0	1.8	23.8	8.9	8.6	4.7	8.3	5.0	4.5	3.1	7.0	3.7	1.2	3.3	3.7	6.4	5.9	8.9	5.6	4.9	0.0	1.8	14.6	5.8	5.8	6.1	7.9	2.2	0.0	0.6	0.6	1.8	0.4	0.8	1.0	0.7	1.1	0.6	0.4	0.5	0.8	0.3	0.4	0.0	1.0	0.9	0.9	10.6	10.4	9.5	14.0	10.3	9.9	10.6	10.2	10.7	9.2	10.5	10.9	5.5	0.0	3.9	10.4	4.5	0.1	1.1	2.5	1.2	6.1	2.9	2.5	2.7	1.5	7.4	3.7	6.2	0.2	15.4	29.5	0.0	2.7	0.1	2.1	2.7	4.3	6.0	3.2	7.3	14.7	0.1	2.0	118.7	1.7	2.5	7.1	5.3	0.5	2.7	11.8	6.3	25.8	4.1	3.4	0.8	0.3	2.8	2.3	1.8	1.0	2.7	7.1	8.2	3.5	9.3	9.3	29.9	2.6	11.4	1.7	34.5	1.2	3.4	8.2	0.0	2.5	1.9	0.0	0.3	1.3	0.1	0.5	10.0	3.3	17.6	1.3
P2RY8	P2Y8	ENSG00000182162	"P2Y receptor family member 8"	Q86VZ1	X	1462581-1537185	"Cancer-related genes, G-protein coupled receptors, Predicted intracellular proteins, Predicted membrane proteins"		"G-protein coupled receptor, Receptor, Transducer"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"bone marrow: 31.2;lymphoid tissue: 40.1"	"Group enriched"	"Detected in some"	4	"B-cells: 42.0;dendritic cells: 56.2;monocytes: 26.1;NK-cells: 56.7;Plasma cells: 49.3;T-cells: 40.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"Daudi: 119.2;MOLT-4: 60.6;NB-4: 59.6;RPMI-8226: 74.3;THP-1: 73.7;U-266/70: 96.8;U-698: 192.8;U-937: 60.6"					"Low region specificity"	"Detected in single"			HPA003631	Enhanced					NA	NA			"Cluster 39: Non-specific - mRNA processing"	"Cluster 66: Lymphoid tissue - Immune response regulation"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 63: NK-cells & T-cells - Immune response"			"HPA003631: AB_1079543"	"unprognostic (4.32e-2)"	"unprognostic (3.22e-5)"	"unprognostic (6.31e-2)"	"unprognostic (2.51e-2)"	"unprognostic (1.17e-1)"	"prognostic favorable (7.80e-5)"	"prognostic favorable (1.73e-4)"	"unprognostic (5.27e-3)"	"unprognostic (5.76e-3)"	"unprognostic (5.52e-3)"	"prognostic favorable (6.54e-4)"	"unprognostic (4.29e-2)"	"unprognostic (8.45e-3)"	"unprognostic (2.90e-1)"	"unprognostic (4.00e-2)"	"unprognostic (3.55e-1)"	"unprognostic (2.80e-1)"	3.5	4.6	0.4	19.2	0.5	31.2	2.4	0.8	1.1	0.7	0.8	3.4	3.4	0.8	0.9	1.3	0.7	3.8	4.9	0.2	0.7	3.6	1.9	3.0	40.1	1.5	0.5	1.1	2.1	2.1	2.1	1.2	0.9	1.5	3.2	0.7	3.4	1.1	2.6	1.8	7.5	1.4	0.5	20.0	5.1	0.4	1.4	16.4	7.9	1.4	33.4	4.4	0.5	1.8	0.6	0.5	0.5	1.5	0.0	0.0	1.3	0.2	0.1	0.0	0.1	0.4	0.7	119.2	0.6	0.0	0.5	0.5	0.0	0.1	0.0	4.7	0.4	1.0	1.3	6.1	0.1	53.2	12.3	0.1	0.1	0.1	0.0	1.1	0.0	35.1	1.1	48.9	0.1	0.1	60.6	59.6	0.7	0.1	1.3	54.1	0.6	74.3	0.1	0.9	0.2	0.8	0.4	1.1	0.3	1.1	0.6	73.7	0.3	1.0	1.1	0.5	0.3	96.8	19.6	192.8	0.2	60.6	0.2	49.9	18.9	31.1	58.6	12.7	53.6	34.2	44.5	55.8	13.6	38.3	34.7	36.4	11.3	37.5	5.2	3.6	37.6	53.3	0.4	0.5	0.8	1.1	0.2	0.7	1.5	0.5	0.9	0.5	1.4	1.8	5.9	0.0	1.8	0.3	42.0	0.4	0.0	0.0	0.0	0.7	0.3	0.0	1.2	0.0	0.6	1.8	0.0	0.0	56.2	0.1	0.0	0.0	0.0	0.1	0.1	5.2	0.0	9.9	0.7	0.2	0.0	0.4	2.6	0.1	1.3	0.3	3.9	0.3	1.9	0.0	0.7	0.0	0.0	11.2	1.8	0.0	0.0	8.7	1.8	1.9	26.1	0.0	56.7	1.0	0.4	0.0	0.0	0.0	49.3	0.1	0.0	0.3	0.0	0.2	0.0	0.1	0.8	0.0	0.0	0.0	0.4	0.0	40.7	0.9	0.2	0.0
PABPC1	"PAB1, PABP1, PABPC2, PABPL1"	ENSG00000070756	"Poly(A) binding protein cytoplasmic 1"	P11940	8	100685816-100722809	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins"	"mRNA processing, mRNA splicing, Nonsense-mediated mRNA decay"	RNA-binding	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"CAB011536, HPA045423, HPA067156"	Supported		Supported	Cytosol		NA	NA		3900000	"Cluster 39: Non-specific - mRNA processing"	"Cluster 24: Salivary gland - Salivary secretion"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 32: Non-specific - Translation"	Cytosol		"CAB011536: AB_777008, HPA045423: AB_2679320, HPA067156: AB_2685793"	"unprognostic (5.00e-2)"	"unprognostic (2.64e-2)"	"unprognostic (3.18e-1)"	"unprognostic (4.50e-1)"	"prognostic favorable (2.51e-4)"	"unprognostic (1.93e-2)"	"prognostic unfavorable (5.80e-4)"	"unprognostic (2.51e-3)"	"unprognostic (5.70e-2)"	"unprognostic (1.50e-2)"	"unprognostic (3.21e-3)"	"unprognostic (7.24e-2)"	"prognostic unfavorable (5.70e-12)"	"unprognostic (6.22e-2)"	"unprognostic (2.55e-1)"	"unprognostic (6.98e-3)"	"unprognostic (1.40e-2)"	627.6	341.5	48.8	490.8	73.4	364.0	575.7	54.9	58.6	700.3	86.2	524.3	450.2	453.5	68.3	1353.3	437.0	227.1	233.8	35.3	80.2	296.4	347.7	490.3	542.4	104.1	58.7	724.0	728.0	126.7	167.7	214.5	92.2	473.9	270.3	80.2	1287.6	172.7	197.7	732.4	502.0	226.5	64.1	483.1	524.7	507.9	92.7	421.0	303.4	75.8	532.3	630.5	853.3	81.6	2069.1	644.4	372.2	842.0	585.0	1050.0	793.4	504.4	593.5	451.8	468.7	791.5	1107.8	3230.4	1609.1	809.5	291.3	792.4	554.6	1092.3	459.5	758.2	555.4	1713.1	302.2	562.6	835.7	673.3	891.0	1338.6	1050.2	554.8	2126.1	950.7	690.8	1071.8	1339.4	1120.1	477.5	857.3	2617.8	949.5	882.3	1487.3	929.6	967.5	541.7	1074.2	301.8	953.1	629.2	650.1	415.8	548.6	1200.7	513.2	1031.7	949.5	1005.1	512.4	809.4	723.9	897.9	753.6	606.1	1523.2	609.7	1378.1	538.8	122.8	401.3	131.2	159.3	405.2	348.9	297.4	333.0	264.3	421.4	263.0	437.4	370.4	112.5	306.9	468.5	277.2	301.5	568.0	48.8	73.4	54.9	58.6	35.3	80.2	104.1	58.7	92.2	64.1	92.7	81.6	348.4	371.8	939.1	28.7	1089.1	787.4	1075.3	735.0	1067.7	66.5	1036.1	641.2	139.7	459.0	1020.8	110.3	50.1	454.2	872.8	457.0	264.1	467.0	1727.8	352.1	628.4	523.0	477.1	999.1	42.4	769.0	860.8	458.8	530.1	436.1	1054.1	357.3	570.8	308.3	615.5	72.3	34.1	853.8	360.1	1520.8	1162.9	306.0	498.9	1144.3	370.0	53.4	1583.7	167.7	679.7	29.7	41.1	626.9	698.0	424.3	674.4	655.3	446.1	388.4	473.5	88.4	499.6	530.4	876.7	1433.1	476.0	929.6	765.3	777.9	1041.1	408.3	1061.2	1296.9
PAXIP1	"CAGF28, CAGF29, PAXIP1L, PTIP, TNRC2"	ENSG00000157212	"PAX interacting protein 1"	Q6ZW49	7	154943687-155003124	"Predicted intracellular proteins"	"DNA damage, DNA recombination, DNA repair, Transcription, Transcription regulation"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"lymphoid tissue: 26.6"	"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Region enriched"	"Detected in all"	4	"cerebellum: 12.0"	"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA006694, HPA016950"	Enhanced		Approved	Nucleoplasm,Vesicles		NA	NA			"Cluster 39: Non-specific - mRNA processing"	"Cluster 34: Non-specific - Transcription"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 52: Non-specific - Transcription"	"Nucleoplasm, Vesicles"		"HPA006694: AB_1855011, HPA016950: AB_2669489"	"unprognostic (2.44e-2)"	"unprognostic (1.28e-1)"	"unprognostic (2.14e-2)"	"unprognostic (2.66e-2)"	"unprognostic (1.39e-1)"	"unprognostic (1.63e-2)"	"unprognostic (7.39e-3)"	"unprognostic (2.65e-2)"	"unprognostic (1.34e-3)"	"unprognostic (1.19e-2)"	"unprognostic (1.33e-1)"	"unprognostic (2.36e-1)"	"unprognostic (3.28e-2)"	"unprognostic (4.99e-3)"	"unprognostic (3.98e-1)"	"unprognostic (2.44e-3)"	"unprognostic (2.30e-1)"	4.3	3.9	2.3	5.8	2.5	9.8	5.4	12.0	2.6	4.8	2.7	4.9	4.8	4.6	4.8	5.4	4.2	4.4	3.9	2.3	2.4	4.6	5.7	4.2	8.8	2.8	2.6	5.7	4.4	6.2	3.8	6.1	2.9	4.4	4.9	3.9	5.7	3.6	5.9	6.5	5.7	3.7	2.5	5.6	5.2	8.7	2.6	26.6	5.5	4.6	6.0	5.3	4.7	2.8	17.7	14.2	18.4	31.2	7.8	6.5	16.4	7.6	8.0	10.3	11.9	15.7	13.6	22.9	9.4	9.1	21.3	13.6	23.7	12.1	12.7	23.0	18.4	17.4	10.7	13.6	5.5	23.9	22.3	6.3	9.0	10.3	4.2	5.8	9.9	22.8	24.3	15.1	10.4	24.3	51.1	19.9	29.8	17.1	9.5	28.8	18.7	24.8	10.7	14.6	14.6	9.4	20.3	14.9	9.5	16.6	11.4	20.1	5.1	8.6	1.5	12.3	18.6	15.2	9.5	31.0	21.1	27.7	23.6	0.2	0.9	0.5	0.9	1.1	1.4	0.5	1.5	1.1	1.0	0.9	2.4	0.7	0.5	1.3	1.3	1.2	1.2	0.9	2.3	2.5	12.0	2.6	2.3	2.4	2.8	2.6	2.9	2.5	2.6	2.8	5.2	6.4	6.3	18.9	5.8	6.4	5.1	4.7	4.0	18.9	8.9	6.6	6.9	7.2	7.1	9.2	10.4	9.0	3.8	6.8	5.9	3.9	2.3	5.5	6.9	5.2	2.4	10.3	21.4	3.3	8.0	6.9	5.6	6.5	2.5	8.8	5.0	9.2	4.4	3.3	24.2	8.4	2.0	6.1	7.1	2.8	8.7	4.8	3.6	15.9	6.3	8.0	7.2	27.2	27.4	4.4	4.3	9.4	4.9	8.0	5.2	4.2	4.3	12.3	0.0	11.1	5.1	22.6	18.7	8.9	7.0	6.2	4.9	6.3	9.8	4.5
PDCD11	"ALG-4, KIAA0185, NFBP, RRP5"	ENSG00000148843	"Programmed cell death 11"	Q14690	10	103396626-103446294	"Plasma proteins, Predicted intracellular proteins"	"rRNA processing"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Early spermatids: 61.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA017924, CAB026472"	Approved		Supported	"Nucleoli rim,Vesicles"		NA	NA			"Cluster 39: Non-specific - mRNA processing"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 29: Early spermatids - Spermatogenesis"	"Nucleoli rim"	Vesicles	"CAB026472: , HPA017924: AB_10601045"	"unprognostic (1.34e-1)"	"unprognostic (6.84e-2)"	"unprognostic (1.48e-1)"	"unprognostic (2.31e-2)"	"unprognostic (1.80e-1)"	"unprognostic (8.94e-2)"	"prognostic unfavorable (2.79e-4)"	"unprognostic (2.11e-1)"	"unprognostic (1.89e-1)"	"unprognostic (1.16e-1)"	"unprognostic (6.49e-2)"	"unprognostic (3.25e-2)"	"unprognostic (9.29e-2)"	"unprognostic (1.01e-2)"	"unprognostic (1.77e-1)"	"unprognostic (6.28e-2)"	"unprognostic (5.59e-2)"	8.1	7.8	4.1	10.0	4.8	7.5	9.4	4.5	4.6	8.7	4.5	7.7	5.9	9.9	5.9	11.7	9.0	4.4	7.5	4.4	4.7	9.8	9.1	7.3	11.0	4.4	4.5	10.4	11.6	8.5	6.4	7.5	4.6	8.0	7.9	6.1	7.2	6.2	15.8	15.5	7.7	9.1	4.1	9.5	7.3	14.8	5.1	11.9	6.9	8.1	11.8	9.9	8.4	5.0	27.4	39.8	27.2	77.0	23.3	20.9	30.5	29.6	20.7	29.2	23.7	54.7	26.3	74.9	20.5	21.4	18.0	48.0	70.6	37.1	32.5	34.8	47.5	43.7	26.0	44.2	27.7	88.0	28.7	21.8	33.3	44.8	101.3	21.0	31.6	19.4	71.5	32.7	28.4	30.9	44.5	49.9	55.9	21.7	37.9	44.3	39.0	34.1	18.1	26.6	18.2	34.1	19.9	23.2	32.6	26.4	22.8	24.8	34.5	21.5	27.0	29.0	55.9	41.2	61.8	69.5	19.0	83.3	16.2	0.1	2.8	0.9	3.2	2.6	5.2	3.4	3.1	2.7	2.8	2.2	2.7	3.2	0.3	2.1	2.3	3.3	2.3	2.5	4.1	4.8	4.5	4.6	4.4	4.7	4.4	4.5	4.6	4.1	5.1	5.0	8.8	12.8	14.1	5.9	13.6	16.4	9.3	10.8	8.0	15.0	18.6	15.6	14.6	20.0	17.4	9.2	29.2	12.8	18.1	9.6	13.7	23.6	61.2	12.6	25.4	14.4	9.5	14.9	11.8	15.8	15.8	14.0	5.6	11.7	18.9	18.5	8.9	24.5	10.9	6.7	9.3	12.9	4.1	7.7	5.2	19.6	11.1	10.7	10.6	8.4	9.8	4.9	9.2	7.5	7.6	29.1	4.9	10.1	9.6	17.9	4.4	8.2	20.2	13.8	6.6	16.8	11.0	27.5	30.7	14.0	16.9	8.2	11.6	19.0	19.9	8.7
PDE8A	HsT19550	ENSG00000073417	"Phosphodiesterase 8A"	O60658	15	84980440-85139145	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		Hydrolase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enriched"	"Detected in many"	7	"Oligodendrocytes: 968.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in all"		"RT4: 89.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA007722	Approved		Approved	"Golgi apparatus"		NA	NA			"Cluster 39: Non-specific - mRNA processing"	"Cluster 45: Intestine - Brush border"	"Cluster 15: RT4 - Unknown function"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"	"Golgi apparatus"		"HPA007722: AB_1855130"	"unprognostic (1.68e-1)"	"unprognostic (2.83e-2)"	"unprognostic (4.81e-2)"	"unprognostic (4.97e-2)"	"unprognostic (6.25e-2)"	"unprognostic (3.47e-2)"	"unprognostic (2.97e-2)"	"unprognostic (3.94e-2)"	"unprognostic (1.03e-1)"	"unprognostic (2.45e-1)"	"unprognostic (8.99e-3)"	"unprognostic (2.75e-2)"	"unprognostic (3.42e-1)"	"unprognostic (3.72e-1)"	"unprognostic (4.26e-1)"	"unprognostic (1.31e-1)"	"unprognostic (1.94e-2)"	16.7	16.6	20.9	8.5	32.3	3.3	10.5	21.9	22.4	11.6	15.2	24.0	15.3	9.1	7.3	6.4	9.0	15.8	8.0	17.3	20.1	24.3	30.0	10.8	5.6	23.8	28.5	12.7	14.5	16.9	6.7	11.4	23.6	6.9	21.9	14.5	6.4	9.6	5.8	6.3	13.6	10.6	19.5	6.3	11.0	11.0	26.9	4.6	12.3	6.5	5.1	17.7	7.0	45.2	29.0	48.4	7.9	5.4	32.7	17.2	9.6	19.4	21.1	16.6	18.9	10.9	16.9	5.8	14.6	25.9	19.7	20.2	33.8	14.9	22.0	10.8	20.2	7.7	30.3	15.6	23.5	4.5	11.3	17.4	9.1	19.6	18.6	14.3	21.6	6.4	15.6	18.3	15.2	24.5	2.6	4.5	3.8	9.5	8.6	3.6	6.5	8.1	13.2	89.0	18.3	14.1	18.9	20.3	55.5	8.7	6.7	8.7	17.1	38.4	13.6	13.9	31.6	8.9	16.7	6.2	26.1	18.1	11.0	0.0	0.9	0.6	0.3	0.7	0.6	0.2	0.5	0.6	0.5	0.3	0.7	0.3	0.0	0.2	1.6	0.0	1.1	0.2	20.9	32.3	21.9	22.4	17.3	20.1	23.8	28.5	23.6	19.5	26.9	45.2	30.7	6.4	26.5	83.9	14.8	11.3	11.1	13.9	18.2	13.0	6.6	5.2	6.8	41.5	15.4	7.3	12.5	8.0	5.5	58.7	7.9	11.3	6.4	12.5	21.6	24.3	14.5	0.8	60.8	9.6	7.1	16.2	26.5	20.6	22.1	17.9	14.3	23.3	10.8	10.1	126.2	19.0	4.1	12.3	18.9	5.6	10.8	19.2	10.6	85.3	9.0	2.6	10.3	119.1	968.6	11.5	31.8	11.3	7.2	25.4	22.1	21.1	10.5	31.2	39.5	17.8	24.5	25.6	17.3	7.5	10.4	4.5	10.8	25.3	28.5	26.4
PDXDC1	KIAA0251	ENSG00000179889	"Pyridoxal dependent decarboxylase domain containing 1"	Q6P996	16	14974591-15139339	"Predicted intracellular proteins"		"Decarboxylase, Lyase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Early spermatids: 483.6;Late spermatids: 733.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"T-47d: 121.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA047369, HPA049121, HPA051484"	Approved		Enhanced	"Golgi apparatus,Vesicles"		NA	NA		9600	"Cluster 39: Non-specific - mRNA processing"	"Cluster 71: Testis - DNA repair"	"Cluster 6: T47d - Mammary gland"	"Cluster 34: Spermatids - Unknown function"	"Golgi apparatus, Vesicles"		"HPA047369: AB_2680015, HPA049121: AB_2680641, HPA051484: AB_2681502"	"unprognostic (3.67e-2)"	"unprognostic (4.99e-1)"	"unprognostic (1.97e-3)"	"unprognostic (1.84e-1)"	"unprognostic (9.08e-2)"	"unprognostic (2.18e-1)"	"unprognostic (6.47e-3)"	"unprognostic (4.97e-2)"	"unprognostic (2.43e-1)"	"unprognostic (2.74e-1)"	"unprognostic (7.61e-2)"	"unprognostic (1.32e-1)"	"prognostic favorable (3.13e-4)"	"unprognostic (4.58e-2)"	"unprognostic (8.11e-2)"	"unprognostic (2.15e-1)"	"unprognostic (2.88e-1)"	33.3	37.9	4.9	20.9	5.0	12.9	33.1	14.7	6.5	35.7	7.9	61.3	52.5	31.9	17.0	43.4	29.2	20.8	39.1	6.0	4.1	47.6	104.5	34.6	13.4	6.2	4.7	31.1	70.4	27.1	63.2	23.5	7.5	55.8	47.8	13.4	80.5	25.2	52.0	27.8	61.1	18.5	1.2	31.8	56.7	113.2	7.2	11.7	42.9	16.5	15.0	39.1	34.7	5.7	21.4	30.9	31.1	26.1	16.9	20.4	51.4	19.6	17.4	14.3	19.7	38.0	45.3	40.7	42.0	26.5	20.5	34.0	22.1	20.1	20.5	25.0	30.2	24.7	51.8	100.2	44.3	19.7	56.4	21.5	20.4	25.0	20.9	28.0	15.3	21.6	18.5	26.0	34.1	52.2	12.9	10.4	15.3	20.8	11.7	19.9	12.9	48.6	22.7	33.9	31.9	22.8	52.6	30.0	50.9	19.7	121.0	30.3	23.8	11.0	10.0	12.3	25.7	24.2	25.1	39.3	22.7	16.4	35.8	2.9	7.8	11.6	9.4	7.7	10.8	8.3	6.8	7.7	11.7	9.0	8.2	8.1	1.0	7.5	6.2	5.4	6.6	8.2	4.9	5.0	14.7	6.5	6.0	4.1	6.2	4.7	7.5	1.2	7.2	5.7	29.6	38.5	64.6	32.7	33.0	38.2	42.2	21.6	18.8	32.1	57.9	27.8	45.7	58.6	52.9	29.5	31.3	51.7	30.6	149.8	27.4	38.2	483.6	48.1	41.7	35.1	161.2	33.2	80.7	58.3	56.5	36.0	71.9	75.3	39.3	42.1	27.5	123.6	30.5	40.4	68.3	216.7	24.4	33.1	16.8	733.8	49.0	30.9	26.6	31.9	27.5	19.7	39.1	55.8	45.0	46.5	114.4	45.5	45.4	58.1	115.6	53.4	48.3	47.4	46.0	24.0	28.0	142.3	72.7	24.6	42.6	80.7	33.9	21.2	127.2	76.5
PEPD		ENSG00000124299	"Peptidase D"	P12955	19	33386950-33521791	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Collagen degradation"	"Dipeptidase, Hydrolase, Metalloprotease, Protease"	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"intestine: 209.5;kidney: 277.7"	"Group enriched"	"Detected in all"	4	"Proximal enterocytes: 833.0;Proximal tubular cells: 1278.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA015599, HPA072045"	Enhanced		Approved	Nucleoplasm		NA	NA		860000000	"Cluster 39: Non-specific - mRNA processing"	"Cluster 87: Intestine & Kidney - Transmembrane transport"	"Cluster 13: SH-SY5Y - Nervous system development"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	Nucleoplasm		"HPA015599: AB_1855192, HPA072045: AB_2732194"	"unprognostic (1.39e-1)"	"unprognostic (2.62e-2)"	"unprognostic (2.27e-1)"	"unprognostic (4.01e-2)"	"unprognostic (2.98e-1)"	"unprognostic (6.77e-2)"	"unprognostic (2.82e-1)"	"unprognostic (3.64e-2)"	"unprognostic (3.96e-1)"	"unprognostic (5.10e-2)"	"unprognostic (1.11e-2)"	"unprognostic (1.99e-1)"	"prognostic favorable (6.50e-9)"	"unprognostic (4.38e-2)"	"unprognostic (1.99e-1)"	"unprognostic (1.65e-1)"	"unprognostic (1.29e-1)"	53.2	56.0	28.5	26.9	35.5	14.3	43.6	35.6	30.5	36.9	33.5	44.2	180.5	49.7	9.9	42.8	34.2	31.2	24.3	28.7	30.9	277.7	117.8	38.1	30.7	36.2	30.8	35.9	27.1	29.3	42.5	21.9	36.3	23.6	14.8	11.8	33.6	22.9	35.6	43.1	209.5	24.5	34.6	38.2	33.6	18.3	33.4	20.8	37.0	23.2	21.3	40.1	28.2	43.4	43.2	118.7	26.4	53.1	114.9	44.9	80.6	37.4	65.3	45.6	52.7	104.7	34.2	18.8	53.5	73.2	33.9	11.2	39.5	28.5	23.4	51.3	50.4	107.7	24.6	108.3	91.6	29.6	128.8	63.6	29.0	38.2	18.3	27.8	56.4	34.4	22.7	49.4	44.2	54.3	19.0	11.7	46.2	79.6	48.8	45.3	41.0	51.2	39.4	108.8	40.3	106.4	64.2	31.3	62.5	18.2	25.1	36.3	56.6	48.3	46.6	62.3	41.8	45.2	59.1	13.1	49.5	48.2	65.8	113.7	117.2	8.3	75.5	123.6	65.5	49.6	74.0	69.8	100.6	50.5	47.1	55.6	6.1	55.6	92.5	31.0	76.1	119.6	28.5	35.5	35.6	30.5	28.7	30.9	36.2	30.8	36.3	34.6	33.4	43.4	56.9	22.4	27.4	11.4	29.0	19.4	32.9	36.0	11.4	33.3	16.2	24.4	13.3	52.9	23.8	73.5	4.2	21.4	32.6	17.6	197.6	77.2	8.0	15.0	20.1	50.7	17.3	25.4	19.9	44.2	67.3	38.6	18.3	13.0	57.6	41.9	52.8	180.3	227.2	62.2	14.9	35.6	30.5	59.7	40.9	13.2	49.4	75.3	67.6	15.9	102.2	73.6	34.0	21.6	24.3	33.8	79.3	60.5	31.5	22.9	833.0	1278.3	27.1	33.7	39.5	37.0	43.1	10.2	44.5	34.3	20.3	30.4	33.7	48.7	44.6	22.2
PEX10	RNF69	ENSG00000157911	"Peroxisomal biogenesis factor 10"	O60683	1	2403964-2413797	"Disease related genes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Peroxisome biogenesis"		"Disease variant, Peroxisome biogenesis disorder, Zellweger syndrome"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Late spermatids: 194.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"Hep G2: 55.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA049458, HPA049755"	Approved		Uncertain	Nucleoplasm		NA	NA			"Cluster 39: Non-specific - mRNA processing"	"Cluster 35: Non-specific - Unknown function"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 25: Spermatids - Spermatogenesis"	Nucleoplasm		"HPA049458: AB_2680775, HPA049755: AB_2680867"	"prognostic favorable (4.50e-6)"	"unprognostic (1.96e-1)"	"unprognostic (1.05e-1)"	"unprognostic (8.15e-2)"	"unprognostic (2.50e-1)"	"unprognostic (2.16e-1)"	"unprognostic (1.81e-2)"	"unprognostic (2.91e-1)"	"unprognostic (9.06e-2)"	"unprognostic (1.17e-1)"	"unprognostic (1.71e-1)"	"unprognostic (1.95e-1)"	"prognostic favorable (4.16e-6)"	"unprognostic (4.78e-2)"	"unprognostic (1.21e-1)"	"unprognostic (1.19e-1)"	"unprognostic (1.42e-1)"	14.9	28.9	22.2	2.2	24.3	3.1	13.9	23.5	25.7	10.8	19.7	11.3	6.7	11.4	8.5	17.2	10.0	4.2	16.1	20.6	21.6	18.1	22.0	8.8	4.3	25.4	22.6	12.8	19.8	10.4	18.5	3.8	22.1	16.1	4.4	4.6	14.3	6.9	18.6	14.0	9.6	4.1	23.4	10.2	12.7	22.0	23.3	3.7	13.1	10.2	3.4	12.9	11.3	25.3	18.6	16.9	13.2	7.4	7.9	9.7	11.5	9.6	10.9	14.2	11.3	27.2	13.9	10.8	27.1	11.9	8.7	12.1	11.6	16.3	8.1	16.8	21.9	8.5	17.2	55.3	16.4	14.2	4.2	9.0	9.3	10.8	16.0	10.4	13.9	12.5	9.9	7.4	14.7	26.2	9.1	6.0	9.6	8.0	31.3	7.8	13.8	18.9	17.8	6.3	18.2	15.3	13.0	8.2	29.2	7.1	8.3	3.5	14.8	6.7	5.9	17.2	10.8	19.0	7.6	8.6	17.6	10.9	6.1	1.6	5.8	1.7	3.8	8.7	4.4	5.9	3.3	5.1	9.4	4.9	3.8	3.0	0.6	3.6	7.6	7.8	2.1	4.2	22.2	24.3	23.5	25.7	20.6	21.6	25.4	22.6	22.1	23.4	23.3	25.3	12.8	3.2	4.4	3.3	9.5	8.8	13.7	15.4	15.9	16.8	16.4	15.4	1.1	11.5	8.9	14.7	0.0	26.7	6.7	8.3	35.2	26.8	51.7	8.5	9.0	11.2	13.2	9.2	5.1	30.3	25.2	11.5	12.8	10.3	0.0	22.8	7.5	10.5	22.9	13.5	5.6	10.3	12.2	11.2	7.2	194.7	10.5	9.6	23.2	2.8	18.7	45.2	8.2	8.0	6.7	21.0	7.7	13.5	14.9	14.6	17.5	27.8	8.6	14.8	0.0	15.5	10.9	28.9	22.8	22.4	6.1	27.5	6.9	30.2	14.6	14.1
PFKL		ENSG00000141959	"Phosphofructokinase, liver type"	P17858	21	44300051-44327376	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	Glycolysis	"Allosteric enzyme, Kinase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Distal enterocytes: 273.7;Proximal enterocytes: 331.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA030047	Approved		Uncertain	Nucleoli,Mitochondria		NA	NA		1100000	"Cluster 39: Non-specific - mRNA processing"	"Cluster 41: Intestine & Liver - Lipid metabolism"	"Cluster 25: RPMI-8226 - Immune response"	"Cluster 53: Intestinal epithelial cells - Unknown function"	"Nucleoli, Mitochondria"		"HPA030047: AB_10602815"	"unprognostic (6.21e-3)"	"unprognostic (2.93e-1)"	"unprognostic (4.46e-2)"	"unprognostic (1.23e-2)"	"unprognostic (1.87e-2)"	"unprognostic (1.23e-1)"	"unprognostic (1.10e-1)"	"unprognostic (6.98e-2)"	"unprognostic (9.75e-2)"	"prognostic unfavorable (4.41e-4)"	"unprognostic (5.69e-2)"	"unprognostic (5.40e-2)"	"unprognostic (1.55e-1)"	"unprognostic (4.99e-1)"	"unprognostic (2.49e-1)"	"unprognostic (8.06e-2)"	"unprognostic (3.01e-2)"	62.7	36.1	36.5	41.6	40.3	45.2	57.3	43.8	40.7	60.0	36.0	79.5	99.9	47.9	12.9	79.7	42.9	40.9	41.5	35.6	29.7	95.4	60.6	51.0	42.1	54.0	45.6	42.6	40.0	21.1	38.8	41.7	50.3	47.6	24.9	23.8	58.5	38.1	18.8	68.7	92.2	18.6	48.4	59.6	64.6	44.7	54.3	26.0	47.7	17.8	23.1	57.5	58.2	57.7	127.9	54.8	38.4	111.2	58.0	43.2	167.6	93.9	60.2	53.3	51.9	74.5	27.5	74.9	108.8	62.5	50.3	67.6	30.3	84.4	12.3	62.9	67.7	152.5	47.2	123.4	45.1	116.1	93.1	57.0	51.0	54.5	27.0	80.6	79.2	53.9	95.9	83.7	36.9	161.3	50.8	89.9	60.2	114.0	60.2	122.1	35.7	206.6	23.9	139.0	67.0	49.7	137.3	114.9	60.7	15.4	90.9	101.6	116.7	80.4	50.9	53.0	37.1	159.7	45.6	31.1	132.9	89.7	65.4	17.7	71.5	17.2	37.8	119.0	31.2	41.0	48.9	34.4	83.4	54.5	28.3	22.9	14.0	26.1	126.8	52.4	78.5	84.2	36.5	40.3	43.8	40.7	35.6	29.7	54.0	45.6	50.3	48.4	54.3	57.7	56.2	22.4	27.9	53.2	45.3	35.7	40.3	95.2	37.0	74.6	41.3	36.6	14.4	27.1	51.6	92.0	66.7	119.6	38.7	273.7	99.7	85.5	2.3	40.7	29.6	49.0	46.3	45.6	15.7	51.4	174.8	44.6	126.4	83.1	41.9	61.2	40.7	70.0	108.6	30.3	9.3	131.4	57.0	64.7	44.5	8.2	39.1	60.0	69.4	29.0	129.4	67.6	33.0	10.1	41.7	52.7	174.2	55.7	39.2	54.9	331.6	142.4	33.7	53.6	26.3	21.3	47.8	1.8	12.2	42.3	36.1	160.8	31.8	31.2	178.6	54.2
PHLDA2	"BWR1C, HLDA2, IPL, TSSC3"	ENSG00000181649	"Pleckstrin homology like domain family A member 2"	Q53GA4	11	2928273-2929420	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 42.6;placenta: 79.7"	"Cell type enhanced"	"Detected in many"		"Cytotrophoblasts: 4600.4;Extravillous trophoblasts: 2222.5;Syncytiotrophoblasts: 9959.7;Urothelial cells: 2892.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Group enriched"	"Detected in many"	17	"dendritic cells: 1.9;monocytes: 1.2;T-cells: 1.8"	"Cell line enhanced"	"Detected in many"		"HDLM-2: 395.9;PC-3: 326.0;SK-MEL-30: 289.9;WM-115: 358.2"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			HPA003994			Uncertain	Nucleoli		NA	NA			"Cluster 39: Non-specific - mRNA processing"	"Cluster 11: Squamous epithelial cells - Epithelial cell function"	"Cluster 17: WM-115 - Nervous system development"	"Cluster 18: Syncytiotrophoblasts - Pregnancy hormone signaling"	Nucleoli		"HPA003994: AB_1855311"	"unprognostic (1.90e-1)"	"unprognostic (3.13e-2)"	"unprognostic (9.93e-3)"	"unprognostic (6.16e-2)"	"unprognostic (4.28e-2)"	"unprognostic (8.01e-3)"	"prognostic unfavorable (4.22e-5)"	"unprognostic (1.24e-3)"	"unprognostic (3.84e-2)"	"unprognostic (8.35e-2)"	"unprognostic (1.67e-2)"	"unprognostic (6.56e-2)"	"prognostic unfavorable (2.63e-6)"	"unprognostic (2.83e-1)"	"unprognostic (6.13e-2)"	"unprognostic (2.16e-2)"	"unprognostic (1.59e-1)"	9.3	2.8	1.6	3.6	1.7	1.2	5.3	2.2	2.6	12.6	1.5	14.7	7.3	4.7	0.7	42.6	4.7	3.0	2.9	1.6	2.7	21.8	5.9	7.8	0.3	5.1	3.4	2.4	4.1	0.4	2.8	79.7	4.7	15.4	1.7	0.0	10.2	0.9	0.9	21.4	6.4	0.8	1.9	2.7	17.8	0.8	2.4	0.1	5.6	0.4	1.3	12.7	18.7	2.4	42.2	31.1	1.9	0.5	0.4	9.8	43.4	72.4	21.4	12.9	11.8	15.4	91.8	0.0	41.9	12.1	32.2	51.8	0.1	42.8	2.4	395.9	14.1	0.0	13.9	10.4	32.7	0.1	23.5	13.9	20.2	11.1	12.1	8.8	10.9	0.0	9.2	0.7	6.5	148.9	0.1	6.1	16.5	26.8	326.0	0.0	0.0	29.6	32.2	13.7	4.1	0.3	31.6	25.0	289.9	2.0	7.4	3.3	51.9	31.2	13.6	45.7	32.1	0.6	0.8	0.3	28.2	5.4	358.2	0.0	1.2	0.0	0.3	1.1	0.4	0.0	1.8	0.3	1.9	0.0	0.5	0.1	0.0	0.0	0.3	0.0	0.8	0.5	1.6	1.7	2.2	2.6	1.6	2.7	5.1	3.4	4.7	1.9	2.4	2.4	27.1	19.2	28.9	1.0	13.0	394.7	1494.1	518.9	116.1	0.0	274.4	221.4	6.0	64.3	328.3	44.1	0.0	4600.4	9.2	506.0	9.8	164.7	2.4	84.9	28.6	37.8	197.3	2.7	2.1	143.7	2222.5	92.0	278.8	175.6	82.6	0.4	15.7	6.2	405.9	0.0	1.0	384.5	258.4	12.9	303.6	0.8	3.7	79.6	103.2	1.9	10.5	0.1	0.0	0.0	0.4	502.3	871.7	3.0	13.2	1318.1	201.9	1.7	133.0	0.4	52.6	10.5	293.5	0.4	3.8	545.6	685.5	9959.7	50.5	0.2	292.8	2892.3
PHRF1	"KIAA1542, PPP1R125, RNF221"	ENSG00000070047	"PHD and ring finger domains 1"	Q9P1Y6	11	576470-612222	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"Hep G2: 24.2;MOLT-4: 39.0;U-138 MG: 21.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA019867, HPA062933"	Uncertain					NA	NA			"Cluster 39: Non-specific - mRNA processing"	"Cluster 72: Non-specific - Transcription"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 10: Non-specific - Unknown function"			"HPA019867: AB_1852416, HPA062933: AB_2684907"	"unprognostic (5.67e-2)"	"unprognostic (1.00e-2)"	"unprognostic (3.94e-2)"	"unprognostic (9.65e-2)"	"unprognostic (1.79e-3)"	"unprognostic (1.25e-2)"	"prognostic unfavorable (6.00e-5)"	"unprognostic (6.28e-2)"	"unprognostic (2.57e-1)"	"unprognostic (1.03e-1)"	"unprognostic (1.31e-1)"	"unprognostic (3.50e-2)"	"unprognostic (2.33e-1)"	"unprognostic (3.47e-2)"	"unprognostic (1.94e-1)"	"unprognostic (1.62e-1)"	"unprognostic (1.42e-1)"	14.3	17.5	1.2	1.0	2.6	3.1	13.9	1.4	3.6	14.4	0.9	14.2	0.0	13.2	1.3	18.7	13.5	1.1	14.0	1.1	1.1	12.5	26.5	14.5	0.0	1.5	1.1	14.6	14.4	0.0	13.9	0.0	1.5	14.5	0.0	0.2	13.8	1.2	18.7	22.2	16.3	1.0	0.5	17.6	14.3	17.9	1.7	0.1	13.5	0.0	2.1	12.6	14.4	1.7	2.6	1.6	0.4	7.9	0.0	0.4	1.5	6.2	0.5	0.6	0.0	0.0	0.2	14.8	14.7	0.3	0.3	3.1	0.2	0.0	0.0	4.6	10.5	0.9	0.0	24.2	0.0	1.7	1.6	3.6	0.0	0.0	3.9	0.0	0.3	13.1	3.5	0.0	0.0	0.8	39.0	0.5	1.9	0.2	7.2	1.4	1.5	0.0	0.0	0.3	11.4	1.8	4.3	12.9	0.1	8.9	0.4	5.1	1.2	21.2	7.4	0.5	1.5	2.7	3.7	1.5	0.5	1.2	0.0	0.0	0.3	0.0	0.3	0.2	0.3	0.1	0.4	0.5	0.3	0.4	0.4	0.2	0.5	0.3	0.1	0.4	0.3	0.2	1.2	2.6	1.4	3.6	1.1	1.1	1.5	1.1	1.5	0.5	1.7	1.7	11.5	6.4	11.1	10.1	14.9	17.6	10.1	7.4	18.2	12.2	11.6	7.9	7.8	11.5	8.2	14.7	8.4	8.0	17.1	24.1	0.0	11.6	2.1	14.0	12.9	11.9	11.4	16.0	5.9	10.6	8.0	11.3	23.4	17.7	5.1	14.7	4.6	17.5	9.5	20.2	6.6	14.2	2.0	10.6	11.7	2.8	11.8	13.1	3.6	10.3	11.3	8.2	23.7	4.5	8.4	18.0	12.2	10.5	17.5	12.4	21.8	7.0	12.5	16.0	13.1	14.1	12.2	26.4	28.0	17.4	17.8	8.9	17.2	13.0	14.9	13.6
PI4K2A	"DKFZP761G1923, PI4KII, PIK42A"	ENSG00000155252	"Phosphatidylinositol 4-kinase type 2 alpha"	Q9BTU6	10	97640686-97676434	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		"Kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Hofbauer cells: 38.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"CAB030649, HPA076857"	Approved		Approved	"Plasma membrane"		NA	NA			"Cluster 39: Non-specific - mRNA processing"	"Cluster 76: Brain & Bone marrow - Chromatin organization"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 4: Macrophages - Innate immune response"	"Plasma membrane"		"CAB030649: , HPA076857: AB_2686817"	"unprognostic (1.34e-1)"	"unprognostic (3.50e-2)"	"prognostic unfavorable (4.21e-5)"	"unprognostic (1.80e-2)"	"unprognostic (2.12e-1)"	"unprognostic (1.75e-2)"	"unprognostic (2.84e-3)"	"unprognostic (1.60e-2)"	"unprognostic (1.39e-3)"	"unprognostic (1.38e-2)"	"unprognostic (1.02e-2)"	"unprognostic (1.65e-1)"	"unprognostic (9.92e-2)"	"unprognostic (1.27e-1)"	"unprognostic (1.80e-1)"	"unprognostic (1.45e-1)"	"unprognostic (2.90e-1)"	12.0	25.7	15.5	10.0	15.1	24.1	9.3	15.1	18.9	12.6	13.4	10.7	9.8	12.7	13.0	20.7	9.6	14.0	14.2	15.5	17.8	12.6	15.0	14.2	11.2	20.2	18.8	10.0	8.4	16.6	15.8	18.0	22.0	10.9	8.7	12.9	10.5	10.4	12.7	17.4	10.8	13.0	15.8	14.6	9.4	10.8	17.3	9.8	9.5	13.0	10.6	14.5	12.7	15.2	28.7	21.3	17.2	30.7	36.0	25.8	13.8	28.0	61.5	43.3	45.7	19.4	27.7	10.4	16.2	35.8	31.8	27.1	19.3	55.9	35.8	12.6	16.4	9.3	14.6	17.7	34.5	8.4	12.7	27.3	46.9	45.4	80.1	47.4	22.4	19.9	14.7	16.5	30.4	14.6	18.4	6.4	11.1	14.7	19.8	8.6	17.8	10.3	29.7	26.6	5.8	18.9	23.9	5.9	35.5	24.0	16.4	13.2	25.0	20.6	15.2	24.6	22.1	14.6	18.4	16.9	38.1	5.0	6.8	0.0	1.2	0.0	1.3	0.8	1.0	1.4	0.5	1.1	1.3	0.6	0.4	0.9	0.4	0.7	0.6	0.6	1.2	0.6	15.5	15.1	15.1	18.9	15.5	17.8	20.2	18.8	22.0	15.8	17.3	15.2	4.9	3.2	5.4	9.8	12.0	13.4	4.5	6.5	8.0	14.7	10.7	8.9	10.4	10.0	4.3	5.5	12.5	14.0	12.5	8.6	3.9	4.9	2.4	6.8	15.4	6.9	3.0	8.2	10.9	4.9	6.4	12.0	7.1	7.6	1.3	5.7	3.6	9.9	38.1	11.8	10.9	4.0	6.1	15.0	24.7	2.2	4.4	19.0	10.6	12.2	15.0	8.0	18.6	5.5	6.0	7.2	0.8	9.1	9.4	5.8	9.0	7.3	4.8	15.1	6.6	11.9	8.0	11.0	6.1	6.3	14.3	27.1	9.7	12.4	3.6	7.8
PIDD1	"DKFZp434D229, LRDD, MGC16925, PIDD"	ENSG00000177595	"P53-induced death domain protein 1"	Q9HB75	11	799179-809753	"Predicted intracellular proteins"	Apoptosis	Hydrolase	"Disease variant, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Cytotrophoblasts: 29.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"BEWO: 26.6"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"CAB012647, HPA055473, HPA066948"	Supported		Approved	"Golgi apparatus,Cytosol"		NA	Yes			"Cluster 39: Non-specific - mRNA processing"	"Cluster 55: Non-specific - Mitochondria & Proteasome"	"Cluster 28: BEWO - Transcription regulation"	"Cluster 47: Cytotrophoblasts - Unknown function"	"Golgi apparatus, Cytosol"		"CAB012647: , HPA055473: AB_2682827, HPA066948: "	"unprognostic (1.38e-1)"	"prognostic favorable (8.19e-5)"	"unprognostic (5.07e-3)"	"prognostic favorable (3.32e-5)"	"unprognostic (7.25e-2)"	"prognostic favorable (3.91e-4)"	"unprognostic (8.17e-3)"	"unprognostic (5.97e-2)"	"unprognostic (3.10e-1)"	"unprognostic (1.03e-1)"	"unprognostic (3.37e-3)"	"unprognostic (2.17e-2)"	"prognostic unfavorable (1.52e-4)"	"unprognostic (2.84e-3)"	"unprognostic (8.46e-2)"	"unprognostic (2.24e-1)"	"unprognostic (2.22e-2)"	3.3	3.1	2.3	2.3	2.8	7.4	3.3	2.5	4.1	3.6	2.8	3.9	3.0	3.0	0.1	4.0	3.3	1.1	2.9	2.1	2.2	3.1	5.5	2.7	3.2	3.6	2.6	2.8	3.7	0.9	2.8	1.9	3.5	4.3	0.6	0.2	3.2	1.0	6.5	5.5	4.5	0.7	2.5	5.0	4.0	2.4	3.0	3.2	3.8	0.8	1.0	3.2	3.1	4.6	5.4	6.2	2.9	6.2	0.6	2.2	26.6	7.5	2.0	2.7	3.6	5.7	10.2	4.4	2.3	1.1	2.5	7.9	2.1	3.0	0.5	9.0	12.3	3.8	5.0	12.0	6.8	4.3	9.4	8.4	5.3	1.4	0.3	0.5	5.0	10.3	4.5	3.3	1.1	2.6	12.0	7.2	4.0	5.8	4.3	19.4	4.2	8.6	1.1	1.9	5.1	6.8	3.1	8.2	2.0	1.6	6.0	7.3	2.7	3.4	7.6	2.5	4.9	10.5	6.4	8.5	4.4	3.5	5.6	0.0	0.5	0.0	0.4	0.4	0.4	0.3	0.3	0.4	0.8	0.4	0.4	0.4	0.0	0.1	0.4	0.2	0.9	0.4	2.3	2.8	2.5	4.1	2.1	2.2	3.6	2.6	3.5	2.5	3.0	4.6	4.9	3.2	8.8	25.8	7.2	0.0	3.6	0.0	6.2	14.9	7.3	8.1	4.2	5.7	5.6	3.7	10.4	29.2	8.9	12.0	1.9	2.5	1.4	6.7	4.2	3.7	9.0	5.7	12.8	4.6	7.5	4.4	10.7	4.2	1.3	14.0	2.2	10.3	5.5	1.7	14.2	8.1	0.0	3.5	0.0	1.9	7.2	3.8	0.0	7.5	4.1	7.0	2.1	6.6	26.9	3.5	9.9	4.1	6.0	4.4	10.0	3.8	0.0	15.4	0.0	5.7	3.5	25.2	20.8	6.7	0.0	9.7	6.3	7.5	10.5	3.6
PIP4K2B	"PIP5K2B, PIP5KIIB, PIP5KIIbeta"	ENSG00000276293	"Phosphatidylinositol-5-phosphate 4-kinase type 2 beta"	P78356	17	38765691-38800126	"Cancer-related genes, Enzymes, Metabolic proteins, Predicted intracellular proteins"		"Kinase, Transferase"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA062220			Supported	Nucleoplasm		NA	NA			"Cluster 39: Non-specific - mRNA processing"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 12: NES - Nervous system development"	"Cluster 52: Non-specific - Transcription"	Nucleoplasm		"HPA062220: AB_2684715"	"unprognostic (7.77e-2)"	"unprognostic (8.37e-2)"	"unprognostic (3.74e-2)"	"unprognostic (1.13e-1)"	"unprognostic (2.67e-1)"	"unprognostic (1.91e-1)"	"prognostic unfavorable (4.54e-4)"	"unprognostic (2.64e-1)"	"unprognostic (2.33e-1)"	"unprognostic (1.50e-2)"	"unprognostic (6.10e-3)"	"unprognostic (3.79e-1)"	"unprognostic (4.82e-3)"	"unprognostic (3.38e-2)"	"unprognostic (3.22e-1)"	"prognostic favorable (1.36e-4)"	"unprognostic (2.48e-1)"	19.9	27.0	82.5	15.5	85.6	7.3	20.8	62.3	93.9	30.1	43.3	24.2	10.3	28.8	23.3	15.4	29.1	16.3	30.2	90.7	75.2	20.1	14.4	21.4	20.5	65.9	65.7	49.8	16.4	16.6	25.2	22.8	67.1	22.2	14.0	36.0	16.9	25.3	99.0	24.6	17.3	29.5	63.2	23.2	16.4	13.0	80.4	23.4	20.3	75.6	20.4	22.9	20.9	81.4	18.1	40.2	66.0	69.9	56.7	45.5	12.2	31.6	38.2	43.1	35.0	28.2	18.4	44.8	17.2	59.8	36.3	35.9	44.9	28.7	41.4	27.8	17.2	38.4	27.3	40.7	26.2	43.7	23.5	40.0	34.2	33.7	24.2	59.2	36.3	48.6	34.2	22.3	46.8	14.2	44.0	34.0	32.0	20.7	15.8	44.6	63.7	25.6	31.3	22.3	34.0	46.1	30.9	13.9	34.5	68.5	43.6	44.5	33.4	35.8	21.6	29.4	28.9	27.4	36.5	19.7	42.0	36.8	32.9	1.3	1.9	0.6	3.4	1.6	3.5	2.3	2.9	3.3	2.4	2.3	3.2	2.9	1.8	2.8	1.4	2.2	3.0	3.3	82.5	85.6	62.3	93.9	90.7	75.2	65.9	65.7	67.1	63.2	80.4	81.4	15.8	19.2	11.4	21.5	6.7	6.1	3.5	4.6	7.4	31.6	11.5	13.3	23.4	4.3	7.5	5.5	10.4	7.0	14.8	3.7	1.9	5.3	9.2	10.8	17.7	17.3	11.5	9.0	33.5	4.9	5.0	13.8	5.6	9.0	1.3	22.6	18.2	12.7	8.8	43.7	29.1	7.4	2.0	11.3	4.9	21.1	15.2	8.6	1.8	18.7	6.9	14.8	10.3	22.1	24.0	6.0	4.1	16.6	6.2	4.9	5.4	7.7	6.4	14.0	6.6	13.8	13.2	4.6	7.4	9.9	4.4	2.5	8.1	17.3	7.2	2.7
PLBD2	p76	ENSG00000151176	"Phospholipase B domain containing 2"	Q8NHP8	12	113358566-113391629	"Predicted intracellular proteins"	"Lipid degradation, Lipid metabolism"	Hydrolase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"adrenal gland: 139.0"	"Group enriched"	"Detected in many"	5	"Early spermatids: 139.8;Late spermatids: 398.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in all"		"ASC diff: 246.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA017163	Approved				"Intracellular and membrane"	NA	NA		820000	"Cluster 39: Non-specific - mRNA processing"	"Cluster 43: Testis - Unknown function"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 25: Spermatids - Spermatogenesis"			"HPA017163: AB_1853029"	"unprognostic (8.28e-2)"	"unprognostic (1.97e-1)"	"unprognostic (1.50e-2)"	"unprognostic (4.13e-1)"	"unprognostic (2.36e-3)"	"unprognostic (7.59e-3)"	"unprognostic (5.92e-3)"	"unprognostic (2.39e-2)"	"unprognostic (2.35e-1)"	"unprognostic (3.85e-2)"	"unprognostic (1.24e-2)"	"unprognostic (1.10e-1)"	"prognostic unfavorable (3.58e-11)"	"unprognostic (7.55e-3)"	"unprognostic (5.88e-2)"	"unprognostic (1.09e-1)"	"unprognostic (5.48e-2)"	26.7	139.0	23.6	16.7	21.3	9.0	16.4	31.0	30.3	20.5	5.7	12.9	8.1	19.7	25.9	12.6	13.9	20.2	31.7	23.2	33.4	11.8	23.3	20.9	10.8	47.4	35.2	48.6	26.1	17.5	27.2	12.8	44.7	17.9	12.8	13.0	17.9	15.9	23.8	19.1	11.4	27.1	26.9	13.5	13.2	50.7	40.9	5.8	18.0	14.3	10.8	20.5	15.4	24.5	20.1	36.2	15.4	58.6	246.3	136.9	20.9	41.6	82.0	28.8	35.7	30.9	11.8	9.3	34.0	113.1	46.9	21.3	14.9	24.6	32.0	19.0	10.9	16.4	21.5	37.3	76.9	19.8	49.3	115.8	32.0	34.6	20.5	87.4	45.4	8.3	49.9	22.1	44.9	34.1	3.7	21.2	17.1	16.2	16.6	15.8	16.2	25.0	33.8	27.7	15.5	15.3	57.3	44.6	25.5	26.5	29.4	18.8	73.5	67.9	26.3	68.9	24.4	11.8	21.9	11.4	112.3	16.5	40.6	0.0	3.5	0.2	1.2	2.1	1.0	0.4	1.4	1.5	3.5	0.4	1.0	1.4	0.3	0.9	1.5	1.3	0.9	2.0	23.6	21.3	31.0	30.3	23.2	33.4	47.4	35.2	44.7	26.9	40.9	24.5	6.5	9.6	6.4	11.8	5.3	5.4	4.6	2.1	5.7	9.8	5.4	4.3	10.0	5.7	1.4	1.8	6.2	4.6	6.4	3.6	0.0	20.5	139.8	2.6	13.5	7.0	5.3	13.9	12.4	13.8	11.1	29.5	6.6	5.8	10.2	13.3	8.2	16.1	32.5	20.2	14.2	2.9	0.0	25.8	8.4	398.5	40.4	27.0	21.4	3.7	39.4	3.1	4.1	9.0	11.8	11.5	3.4	48.2	5.9	6.4	6.4	5.0	2.2	5.2	6.6	10.7	11.3	11.1	8.1	6.2	1.8	4.4	5.3	33.6	4.0	3.7
PLEC	"EBS1, PCN, PLEC1, PLTN"	ENSG00000178209	Plectin	Q15149	8	143915153-143976734	"Cancer-related genes, Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"		Actin-binding	"Cancer-related genes, Disease variant, Epidermolysis bullosa, Limb-girdle muscular dystrophy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 256.5"	"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 257.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in all"		"PC-3: 384.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB003847, HPA025967, HPA029906"	Enhanced		Supported	"Intermediate filaments,Focal adhesion sites,Cytosol"		NA	NA		7400000	"Cluster 39: Non-specific - mRNA processing"	"Cluster 59: Non-specific - Translation"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 53: Intestinal epithelial cells - Unknown function"	"Intermediate filaments, Cytosol"	"Focal adhesion sites"	"CAB003847: AB_562198, HPA025967: AB_10601671, HPA029906: AB_10602279"	"unprognostic (1.02e-1)"	"unprognostic (1.37e-3)"	"prognostic unfavorable (4.29e-4)"	"unprognostic (2.09e-2)"	"unprognostic (1.04e-1)"	"unprognostic (1.05e-2)"	"unprognostic (1.76e-3)"	"prognostic unfavorable (5.33e-4)"	"unprognostic (1.72e-3)"	"unprognostic (1.13e-2)"	"unprognostic (2.85e-3)"	"unprognostic (5.48e-2)"	"prognostic unfavorable (7.98e-6)"	"unprognostic (2.30e-1)"	"unprognostic (4.04e-2)"	"unprognostic (6.58e-2)"	"unprognostic (5.58e-3)"	41.8	30.9	44.2	22.6	25.4	43.2	37.9	20.4	39.7	57.4	6.7	58.0	21.1	55.2	8.5	59.7	47.9	22.8	78.9	42.2	31.0	30.0	31.3	49.2	22.1	48.5	28.6	47.1	27.6	8.1	33.0	18.3	30.8	49.5	13.0	3.9	42.9	19.8	256.5	83.1	53.8	27.7	28.8	46.1	49.1	15.3	43.2	14.4	25.7	74.7	15.8	56.5	55.7	25.9	92.6	247.3	15.1	20.3	31.6	66.9	62.8	125.9	49.3	32.3	18.7	39.2	88.5	8.9	82.9	179.7	54.6	98.9	10.3	162.6	13.3	58.7	10.0	24.9	268.0	34.0	54.0	9.6	26.1	71.8	40.7	84.6	164.2	28.3	43.0	7.6	16.2	25.9	39.7	175.3	5.1	19.8	12.2	29.4	384.8	1.8	46.2	24.6	67.7	147.7	16.6	16.8	217.4	50.0	21.1	21.7	55.7	12.4	125.7	117.8	217.3	110.6	155.1	4.7	3.7	6.3	106.9	15.2	176.2	0.0	2.0	0.1	0.6	1.7	1.3	0.6	1.2	0.9	1.6	0.6	0.8	0.5	0.4	0.3	1.2	1.3	1.4	2.0	44.2	25.4	20.4	39.7	42.2	31.0	48.5	28.6	30.8	28.8	43.2	25.9	83.8	28.9	15.6	78.0	27.0	108.0	53.1	62.9	50.7	15.8	29.4	27.9	39.3	31.5	42.9	40.5	25.0	34.4	27.1	257.8	0.0	39.3	1.4	39.4	52.6	68.2	32.2	11.8	47.3	20.2	32.1	45.7	170.2	57.3	8.2	14.4	63.1	69.0	35.2	30.3	36.5	79.9	10.2	67.5	100.4	5.0	44.4	61.2	33.8	27.2	54.9	11.2	15.5	14.6	3.4	157.8	194.1	74.9	39.3	144.9	124.9	4.6	50.3	10.8	6.6	42.1	61.5	1.2	7.1	72.2	76.7	69.0	35.0	18.8	61.6	121.0
PLEKHG2	"ARHGEF42, CLG, FLJ00018"	ENSG00000090924	"Pleckstrin homology and RhoGEF domain containing G2"	Q9H7P9	19	39412669-39428415	"Disease related genes, Human disease related genes, Predicted intracellular proteins"		"Guanine-nucleotide releasing factor"	"Disease variant, Leukodystrophy, Mental retardation, Tumor suppressor"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Skeletal myocytes: 64.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in all"		"REH: 86.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA017973, HPA048054"	Uncertain		Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 39: Non-specific - mRNA processing"	"Cluster 64: Macrophages - Immune response"	"Cluster 12: NES - Nervous system development"	"Cluster 50: Fibroblasts - ECM organization"	Nucleoplasm	Cytosol	"HPA017973: AB_2669719, HPA048054: AB_2680241"	"unprognostic (3.55e-1)"	"unprognostic (6.73e-2)"	"prognostic unfavorable (3.53e-4)"	"unprognostic (3.97e-2)"	"unprognostic (1.54e-1)"	"unprognostic (1.41e-3)"	"unprognostic (1.24e-2)"	"unprognostic (4.48e-2)"	"unprognostic (1.39e-1)"	"unprognostic (8.09e-2)"	"unprognostic (2.10e-1)"	"unprognostic (4.99e-1)"	"prognostic unfavorable (3.79e-8)"	"unprognostic (8.01e-2)"	"unprognostic (3.90e-2)"	"unprognostic (7.52e-2)"	"unprognostic (1.63e-1)"	32.6	10.7	4.6	22.8	3.8	22.1	20.3	4.6	7.5	28.2	11.3	24.5	8.1	31.2	4.4	10.1	24.9	17.4	25.6	4.3	3.7	27.7	8.0	42.2	20.7	7.1	4.4	20.1	7.1	5.2	12.2	23.0	5.1	21.0	5.2	4.6	8.4	15.1	6.3	9.0	18.9	18.5	4.7	33.4	15.6	15.7	9.3	21.1	19.1	4.9	18.3	20.9	17.4	5.2	8.5	40.8	73.0	39.9	6.9	9.0	10.6	21.9	17.3	14.9	12.8	26.5	14.9	14.7	15.8	28.8	12.4	2.8	11.1	19.4	7.9	49.3	10.2	19.3	23.5	12.4	11.9	2.2	23.1	20.7	3.3	17.9	8.7	25.8	19.3	41.7	13.2	16.9	24.1	17.0	24.2	7.5	17.3	7.8	3.9	86.1	8.9	4.6	12.7	15.4	2.0	23.6	4.9	1.8	7.0	25.2	21.9	21.8	24.8	38.8	30.0	14.5	14.4	12.6	4.1	21.4	21.6	8.7	22.0	1.3	0.5	0.1	1.4	0.2	0.9	1.2	0.7	0.8	0.3	1.1	1.0	1.2	0.8	0.4	0.7	1.4	1.3	1.1	4.6	3.8	4.6	7.5	4.3	3.7	7.1	4.4	5.1	4.7	9.3	5.2	30.4	6.4	27.4	1.6	9.7	4.0	5.5	2.9	6.8	0.6	4.6	11.7	6.4	2.8	6.4	0.0	0.0	0.8	8.7	5.0	0.0	5.6	14.2	11.9	20.1	17.7	1.2	1.7	0.5	4.9	2.9	16.9	13.3	30.4	2.5	6.9	8.2	0.8	9.9	0.0	0.8	3.7	0.0	12.8	21.1	19.8	7.2	25.6	5.4	2.8	5.4	1.1	4.1	2.5	0.3	4.2	2.1	8.2	9.1	3.0	2.6	0.2	2.2	2.4	6.6	64.5	26.8	2.5	4.1	6.5	2.8	1.1	12.2	2.4	3.1	1.9
PLOD3	LH3	ENSG00000106397	"Procollagen-lysine,2-oxoglutarate 5-dioxygenase 3"	O60568	7	101205977-101218420	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins, Predicted secreted proteins"		"Dioxygenase, Glycosyltransferase, Multifunctional enzyme, Oxidoreductase, Transferase"	"Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Cancer enhanced"	"Detected in all"		"melanoma: 115.2"	"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Group enriched"	"Detected in all"	4	"dendritic cells: 20.3;monocytes: 22.5;T-cells: 12.6"	"Cell line enhanced"	"Detected in all"		"Karpas-707: 695.6;WM-115: 680.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA001236	Uncertain				"Secreted to extracellular matrix"	NA	NA		1600000	"Cluster 39: Non-specific - mRNA processing"	"Cluster 15: Liver - Metabolism"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 38: Extravillous trophoblasts - Unknown function"			"HPA001236: AB_1855474"	"unprognostic (1.15e-1)"	"prognostic unfavorable (1.91e-5)"	"prognostic unfavorable (3.26e-4)"	"unprognostic (1.39e-1)"	"unprognostic (2.76e-3)"	"unprognostic (1.04e-2)"	"unprognostic (6.26e-3)"	"unprognostic (1.11e-3)"	"unprognostic (8.00e-3)"	"unprognostic (1.18e-2)"	"unprognostic (4.18e-2)"	"unprognostic (1.66e-1)"	"unprognostic (1.21e-3)"	"unprognostic (1.68e-1)"	"unprognostic (1.54e-1)"	"unprognostic (8.52e-3)"	"unprognostic (9.87e-2)"	41.9	27.3	43.6	22.9	53.2	19.6	32.8	54.9	58.5	33.3	46.8	37.8	25.7	38.9	11.7	12.2	32.5	18.8	42.6	43.6	46.3	36.3	54.1	37.5	14.6	61.1	52.3	26.3	41.8	21.5	27.1	35.0	58.9	24.2	15.3	3.9	19.4	18.6	15.3	19.1	35.9	26.0	49.4	35.3	30.0	12.9	51.7	8.0	25.3	11.8	7.5	35.2	25.2	71.9	71.7	62.4	27.1	168.2	116.2	83.9	51.4	125.5	135.9	122.7	88.6	98.0	89.0	5.6	140.2	211.4	100.7	83.0	50.0	72.0	31.2	37.8	23.8	7.2	70.7	97.3	157.6	31.5	57.4	90.8	67.6	71.6	55.4	120.2	110.9	4.6	68.4	695.6	84.2	194.5	3.4	72.1	53.5	120.5	94.9	21.8	35.1	108.3	42.0	19.1	21.2	116.0	81.1	116.2	288.1	66.8	21.9	105.2	100.5	188.1	94.9	228.1	155.0	38.5	75.9	5.2	112.4	74.2	680.2	0.0	18.1	4.4	12.6	21.8	10.9	3.7	9.3	8.3	16.5	2.2	4.1	4.5	1.8	3.6	22.5	20.3	6.7	9.5	43.6	53.2	54.9	58.5	43.6	46.3	61.1	52.3	58.9	49.4	51.7	71.9	34.1	22.4	8.7	11.1	9.7	8.9	10.8	18.9	8.0	5.7	8.1	9.1	16.1	21.5	8.7	25.8	14.6	20.4	22.0	37.6	1.9	40.2	0.6	10.8	29.9	28.5	16.2	19.1	11.9	31.6	71.6	34.2	17.9	20.5	19.7	25.9	26.7	18.3	50.1	8.4	10.8	18.0	4.1	23.3	18.3	2.1	26.1	23.2	62.2	4.7	18.9	7.7	12.3	10.1	33.4	36.1	37.8	14.7	19.7	8.0	45.8	8.8	9.3	7.3	19.7	14.3	29.8	8.9	12.4	1.9	4.8	18.9	12.5	18.4	27.3	5.2
PNPO	PDXPO	ENSG00000108439	"Pyridoxamine 5'-phosphate oxidase"	Q9NVS9	17	47941506-47949308	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"	"Pyridoxine biosynthesis"	Oxidoreductase	"Disease variant, Epilepsy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 88.8"	"Cell type enhanced"	"Detected in many"		"Distal tubular cells: 62.6;Hepatocytes: 53.4;Proximal tubular cells: 86.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA023204, HPA027776"	Enhanced		Approved	Nucleoplasm,Cytosol		NA	NA		450000	"Cluster 39: Non-specific - mRNA processing"	"Cluster 15: Liver - Metabolism"	"Cluster 39: CACO-2 - Unknown function"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	"Nucleoplasm, Cytosol"		"HPA023204: AB_1855506, HPA027776: AB_10601246"	"unprognostic (1.88e-2)"	"unprognostic (1.17e-1)"	"unprognostic (1.17e-1)"	"unprognostic (1.07e-1)"	"unprognostic (9.25e-2)"	"unprognostic (2.39e-2)"	"unprognostic (1.23e-2)"	"unprognostic (1.41e-1)"	"unprognostic (2.62e-1)"	"unprognostic (1.97e-2)"	"unprognostic (6.65e-2)"	"unprognostic (8.34e-2)"	"unprognostic (2.02e-3)"	"unprognostic (7.47e-3)"	"unprognostic (8.75e-2)"	"unprognostic (3.34e-2)"	"unprognostic (2.74e-1)"	7.3	15.8	16.5	6.2	15.9	3.5	10.6	16.7	22.0	7.0	12.9	8.8	10.2	5.0	11.6	10.7	10.1	6.6	13.2	16.0	21.9	35.1	88.8	6.4	6.9	19.1	21.2	5.8	10.9	26.6	9.2	7.0	20.6	8.0	8.6	5.4	10.4	7.8	21.1	6.7	9.6	6.1	16.5	7.2	8.6	6.6	20.6	5.8	17.8	19.6	7.7	6.7	7.3	14.3	37.9	30.9	2.4	5.8	15.3	11.7	0.0	12.2	7.7	14.0	11.9	51.1	27.6	35.2	57.4	12.7	5.5	22.0	19.4	34.7	20.3	43.4	16.4	24.6	13.9	53.6	16.3	22.6	16.6	15.4	26.9	25.8	32.7	13.1	18.0	26.1	24.4	12.2	16.5	28.3	25.3	7.8	4.5	37.4	37.1	18.8	10.4	26.2	40.2	19.5	12.1	9.5	11.2	18.6	10.7	8.5	32.4	9.1	19.1	22.6	12.8	22.2	26.2	27.8	34.0	19.0	18.4	19.2	11.7	2.5	12.3	2.8	7.2	17.7	8.2	6.7	6.3	7.6	13.5	5.3	8.2	8.1	1.1	7.9	11.9	9.8	7.0	10.3	16.5	15.9	16.7	22.0	16.0	21.9	19.1	21.2	20.6	16.5	20.6	14.3	7.6	12.8	13.9	7.5	3.9	1.5	6.7	5.0	5.7	1.1	16.2	14.4	1.9	18.6	6.8	12.9	4.2	8.4	7.8	7.3	62.6	18.2	0.8	11.2	6.4	5.9	3.6	7.4	4.2	15.6	1.9	5.3	4.6	13.3	12.7	8.8	6.4	53.4	17.2	3.3	6.2	11.6	2.0	11.4	2.4	0.9	9.9	10.6	1.8	2.8	8.6	7.1	3.1	2.5	3.2	15.0	8.9	6.0	4.9	9.0	20.2	86.3	5.9	1.9	0.0	4.1	3.8	0.7	1.3	7.2	2.3	6.3	4.7	19.5	15.4	5.0
POLG	"POLG1, POLGA"	ENSG00000140521	"DNA polymerase gamma, catalytic subunit"	P54098	15	89305198-89334861	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"	"DNA replication"	"DNA-binding, DNA-directed DNA polymerase, Nucleotidyltransferase, Transferase"	"Disease variant, Epilepsy, Leigh syndrome, Neurodegeneration, Neuropathy, Primary mitochondrial disease, Progressive external ophthalmoplegia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA056821, HPA078482"	Approved		Supported	Mitochondria		NA	NA			"Cluster 39: Non-specific - mRNA processing"	"Cluster 72: Non-specific - Transcription"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 65: Plasmacytoid DCs - Unknown function"	Mitochondria		"HPA056821: AB_2683247, HPA078482: "	"unprognostic (1.87e-1)"	"unprognostic (4.71e-2)"	"unprognostic (2.61e-2)"	"unprognostic (3.64e-1)"	"unprognostic (1.62e-1)"	"unprognostic (3.19e-1)"	"unprognostic (2.22e-1)"	"unprognostic (1.13e-1)"	"unprognostic (8.41e-2)"	"unprognostic (2.63e-1)"	"unprognostic (1.41e-1)"	"prognostic unfavorable (5.73e-4)"	"unprognostic (2.65e-3)"	"unprognostic (1.58e-2)"	"unprognostic (4.29e-2)"	"unprognostic (2.07e-1)"	"unprognostic (3.45e-1)"	13.3	11.1	6.8	4.0	5.0	2.6	12.0	4.8	6.3	12.0	4.5	13.3	5.5	12.9	0.4	14.6	11.2	0.9	13.8	6.1	3.5	10.1	12.9	13.8	3.0	9.0	5.8	10.8	10.7	2.9	8.4	2.5	6.5	10.5	0.9	1.4	12.3	2.2	25.0	16.0	14.5	1.3	5.4	16.2	11.9	5.4	5.7	7.3	10.5	10.9	2.4	12.2	12.7	6.3	8.0	17.0	6.7	10.0	7.7	1.6	16.4	16.4	2.7	7.9	5.9	28.0	10.9	14.4	33.6	5.9	16.9	11.8	14.3	4.8	0.9	35.8	31.3	19.4	19.5	11.1	10.8	21.3	33.6	2.4	8.7	7.0	3.0	8.3	12.2	26.8	19.5	5.4	6.1	22.8	16.3	16.5	8.7	13.7	8.2	18.2	13.7	17.4	3.2	19.2	24.5	6.9	26.8	9.6	16.8	6.0	7.7	10.8	17.3	12.8	15.6	28.5	14.2	17.0	9.4	18.6	9.5	14.3	11.6	3.3	4.3	6.1	5.5	4.0	4.3	2.0	4.6	6.8	6.0	3.0	3.7	4.4	1.8	5.0	3.5	4.1	3.3	5.3	6.8	5.0	4.8	6.3	6.1	3.5	9.0	5.8	6.5	5.4	5.7	6.3	15.7	12.8	11.9	11.4	17.2	12.2	11.0	10.7	9.1	7.6	12.0	10.3	19.0	11.5	9.5	11.0	2.1	15.0	33.8	17.2	9.8	10.4	1.3	8.4	9.4	12.4	5.4	9.0	12.9	10.9	15.8	11.9	21.4	11.3	8.2	14.8	14.6	17.8	12.7	3.3	9.9	24.9	4.1	18.5	14.7	1.5	14.3	17.2	19.6	8.4	21.8	6.1	30.9	9.5	11.9	11.4	15.9	10.5	16.8	17.7	10.5	7.5	7.8	6.4	6.6	13.3	12.9	9.2	11.1	11.8	11.9	21.8	21.7	14.8	17.6	15.5
POLL		ENSG00000166169	"DNA polymerase lambda"	Q9UGP5	10	101578882-101588270	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	"DNA damage, DNA repair, DNA replication, DNA synthesis"	"DNA-binding, DNA-directed DNA polymerase, Lyase, Nucleotidyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA076828			Supported	Nucleoplasm	"Intracellular and membrane"	NA	NA			"Cluster 39: Non-specific - mRNA processing"	"Cluster 22: Non-specific - Unknown function"	"Cluster 6: T47d - Mammary gland"	"Cluster 66: Spermatocytes - Spermatogenesis"	Nucleoplasm		"HPA076828: "	"unprognostic (3.71e-3)"	"unprognostic (6.93e-3)"	"unprognostic (1.73e-2)"	"unprognostic (2.47e-2)"	"unprognostic (9.52e-2)"	"unprognostic (1.80e-2)"	"unprognostic (2.11e-2)"	"unprognostic (1.24e-1)"	"unprognostic (8.11e-2)"	"unprognostic (1.71e-2)"	"unprognostic (1.12e-2)"	"unprognostic (7.19e-2)"	"unprognostic (4.74e-2)"	"unprognostic (1.06e-2)"	"unprognostic (1.94e-1)"	"unprognostic (3.86e-1)"	"unprognostic (1.64e-3)"	17.4	22.4	17.3	12.4	18.0	12.8	19.6	15.9	19.0	21.1	18.2	21.8	16.8	19.4	22.6	18.1	22.1	15.6	19.9	17.5	16.0	24.8	26.9	15.6	17.0	16.3	16.3	26.3	45.6	21.3	28.5	13.7	17.2	26.0	17.1	17.4	20.8	15.4	34.4	16.1	18.7	14.2	14.1	22.7	27.6	41.4	17.1	7.4	26.1	18.2	17.1	20.9	17.7	17.4	23.5	21.0	16.2	23.0	16.2	30.0	22.7	15.3	26.4	22.9	23.9	15.5	27.8	5.7	23.5	13.9	12.6	28.8	18.4	22.6	18.4	20.8	24.8	18.1	23.1	17.7	29.8	19.0	16.2	27.5	30.3	25.0	51.8	64.1	24.7	11.1	20.4	19.2	14.7	18.8	0.0	20.8	8.6	13.0	12.4	0.1	14.6	9.9	19.2	14.1	11.2	16.6	9.4	15.7	26.5	23.8	47.3	11.0	13.5	8.1	16.4	9.8	16.8	28.4	15.3	8.9	17.5	16.6	6.3	0.6	9.2	1.3	6.5	6.6	10.6	8.4	7.4	6.8	11.6	6.8	11.7	8.0	1.0	9.5	6.7	0.2	10.2	7.6	17.3	18.0	15.9	19.0	17.5	16.0	16.3	16.3	17.2	14.1	17.1	17.4	7.5	6.4	12.9	13.7	11.4	3.7	6.7	9.7	7.4	16.9	14.7	19.0	8.6	11.5	7.4	7.3	47.9	16.9	7.5	9.1	5.9	9.6	25.2	7.3	7.5	7.6	13.1	25.9	10.4	21.5	9.8	9.6	20.9	6.6	14.0	20.9	8.6	10.9	11.2	21.9	7.9	13.6	18.3	17.7	6.0	51.6	14.0	9.6	10.6	2.8	18.0	10.1	13.4	8.5	9.9	13.7	9.2	11.3	10.9	6.5	13.7	11.6	7.2	24.0	13.1	10.8	9.6	35.5	11.0	8.4	2.0	11.5	9.4	14.4	15.6	5.6
POLR3E	"C37, FLJ10509, RPC5, SIN"	ENSG00000058600	"RNA polymerase III subunit E"	Q9NVU0	16	22297375-22335101	"Metabolic proteins, Predicted intracellular proteins, RNA polymerase related proteins"	"Antiviral defense, Immunity, Innate immunity, Transcription"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 62.6"	"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041419, HPA041477"	Approved		Enhanced	Nucleoplasm		Yes	No			"Cluster 39: Non-specific - mRNA processing"	"Cluster 59: Non-specific - Translation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 24: Non-specific - Transcription regulation"	Nucleoplasm		"HPA041419: AB_2677468, HPA041477: AB_10796345"	"unprognostic (3.09e-2)"	"unprognostic (8.59e-2)"	"unprognostic (8.23e-2)"	"unprognostic (1.04e-1)"	"unprognostic (1.51e-1)"	"unprognostic (7.28e-2)"	"unprognostic (2.42e-2)"	"unprognostic (7.73e-2)"	"unprognostic (2.96e-2)"	"unprognostic (1.34e-1)"	"unprognostic (2.03e-1)"	"prognostic unfavorable (1.74e-4)"	"unprognostic (8.14e-2)"	"unprognostic (1.91e-1)"	"unprognostic (8.96e-2)"	"unprognostic (8.19e-3)"	"unprognostic (3.41e-2)"	12.2	17.0	2.8	6.6	4.5	7.8	12.0	4.3	3.7	10.7	16.1	12.9	6.3	12.7	2.4	13.0	11.8	4.5	15.4	4.1	4.4	8.4	13.3	10.2	5.3	4.8	5.5	11.3	16.1	10.7	12.8	4.6	4.5	11.3	3.0	3.1	12.2	8.2	62.6	14.8	10.0	4.9	3.7	8.9	14.2	11.2	4.2	8.5	12.8	15.5	5.7	12.0	10.4	5.3	21.1	29.0	6.9	19.5	12.1	9.7	27.5	16.1	6.1	9.4	4.2	36.3	14.8	41.7	21.8	11.1	7.9	18.7	35.6	20.6	7.6	28.7	52.3	21.0	31.8	70.9	15.1	34.4	23.0	8.7	19.5	22.1	25.8	3.5	25.9	17.1	63.1	17.0	10.9	34.5	33.6	11.8	37.5	20.2	22.8	45.0	16.7	54.2	8.0	12.4	28.9	20.6	15.6	29.2	14.0	4.2	17.2	16.3	17.3	11.0	12.4	9.2	18.3	23.6	45.6	40.3	11.1	23.0	21.1	0.0	4.7	2.8	8.6	4.8	9.1	7.4	9.1	8.7	7.7	6.0	8.4	7.3	0.5	7.4	4.5	4.4	10.0	6.9	2.8	4.5	4.3	3.7	4.1	4.4	4.8	5.5	4.5	3.7	4.2	5.3	9.4	3.2	14.7	14.4	20.3	32.5	23.0	10.9	12.5	24.0	16.4	19.7	18.9	11.5	13.4	18.4	31.3	25.2	27.3	8.9	5.9	12.0	34.9	21.0	13.3	13.3	15.0	10.5	12.8	12.8	20.2	14.1	13.7	28.5	27.9	23.1	8.9	11.1	13.1	20.2	16.3	13.7	10.2	10.1	22.2	20.9	12.5	11.0	14.2	11.2	9.7	10.4	21.6	18.6	17.9	15.0	11.7	9.1	26.0	28.5	13.6	11.8	16.6	40.9	13.1	21.0	12.2	19.7	16.1	16.5	39.6	28.3	30.3	20.5	16.2	26.3
POLRMT	"APOLMT, h-mtRPOL, MTRNAP, MTRPOL"	ENSG00000099821	"RNA polymerase mitochondrial"	O00411	19	617221-633537	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	Transcription	"Nucleotidyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Late spermatids: 84.0;Spermatogonia: 84.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA006366	Uncertain		Supported	Mitochondria		NA	NA			"Cluster 39: Non-specific - mRNA processing"	"Cluster 21: Non-specific - Transcription"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 20: Spermatogonia & Spermatocytes - Spermatogenesis"	Mitochondria		"HPA006366: AB_1079654"	"unprognostic (3.24e-1)"	"unprognostic (4.31e-2)"	"unprognostic (7.96e-2)"	"prognostic favorable (4.50e-4)"	"unprognostic (9.46e-2)"	"unprognostic (2.94e-2)"	"unprognostic (3.04e-2)"	"unprognostic (9.41e-2)"	"unprognostic (1.45e-1)"	"unprognostic (3.48e-1)"	"unprognostic (7.64e-3)"	"unprognostic (1.81e-2)"	"unprognostic (1.62e-1)"	"unprognostic (1.28e-3)"	"unprognostic (1.66e-1)"	"unprognostic (2.92e-1)"	"unprognostic (1.01e-1)"	17.2	23.9	19.5	9.1	20.5	6.8	18.1	20.7	28.5	19.3	16.9	22.3	14.5	19.7	10.0	21.0	19.2	5.3	38.0	20.1	17.5	26.2	41.3	16.0	9.6	24.4	20.4	20.7	26.3	11.4	22.7	5.0	21.3	20.7	7.2	5.7	17.2	9.2	69.2	27.9	23.9	6.6	17.8	22.5	21.8	66.6	20.9	11.0	20.1	14.9	7.5	21.5	17.7	24.4	24.5	43.6	9.7	42.1	19.7	11.0	35.7	11.1	12.9	15.7	14.5	44.2	15.9	24.9	22.0	10.2	7.9	24.5	35.5	21.0	11.8	28.3	86.8	19.3	26.4	56.9	20.5	32.6	34.7	10.7	29.3	16.4	19.7	11.3	22.9	34.0	37.3	23.6	14.8	34.3	43.7	44.7	38.4	31.1	30.2	42.0	13.3	42.4	21.4	20.7	30.7	22.1	10.2	26.7	28.4	10.3	15.4	29.9	14.1	17.2	22.0	26.9	33.3	57.4	51.0	38.7	36.9	27.3	21.8	0.0	2.9	2.5	6.2	3.8	5.0	5.6	4.6	4.6	5.5	6.3	3.9	4.5	0.5	6.0	4.2	5.4	3.1	4.6	19.5	20.5	20.7	28.5	20.1	17.5	24.4	20.4	21.3	17.8	20.9	24.4	10.3	12.8	11.5	2.6	14.2	8.0	6.1	5.8	10.2	18.3	9.1	8.0	18.0	15.7	7.9	16.5	18.8	15.5	13.3	31.5	7.9	6.7	39.8	7.7	6.1	9.7	13.1	9.4	2.7	8.0	8.7	8.9	14.3	8.6	12.7	15.1	8.2	21.9	10.4	11.8	2.7	12.7	4.1	8.3	7.4	84.0	12.5	8.0	10.6	3.7	7.4	8.4	18.6	1.5	4.6	6.5	12.4	13.2	7.8	10.3	26.0	15.1	6.4	18.1	6.6	8.9	10.0	31.6	84.9	10.6	7.2	7.7	12.7	15.6	24.4	6.2
POT1	"DKFZp586D211, hPot1"	ENSG00000128513	"Protection of telomeres 1"	Q9NUX5	7	124822386-124929983	"Cancer-related genes, Disease related genes, Predicted intracellular proteins"		DNA-binding	"Cancer-related genes, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Inhibitory neurons: 41.5;Oligodendrocytes: 66.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA068538			Supported	Nucleoplasm		NA	NA			"Cluster 39: Non-specific - mRNA processing"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 66: Spermatocytes - Spermatogenesis"	Nucleoplasm		"HPA068538: AB_2686001"	"unprognostic (1.39e-3)"	"unprognostic (1.34e-1)"	"unprognostic (2.04e-1)"	"unprognostic (5.71e-2)"	"unprognostic (1.69e-1)"	"unprognostic (1.49e-1)"	"unprognostic (1.38e-3)"	"unprognostic (7.88e-2)"	"unprognostic (2.26e-2)"	"unprognostic (1.51e-1)"	"unprognostic (2.48e-2)"	"unprognostic (9.89e-2)"	"unprognostic (1.42e-1)"	"unprognostic (2.92e-1)"	"unprognostic (1.75e-2)"	"unprognostic (4.77e-3)"	"unprognostic (7.42e-2)"	5.6	5.7	3.2	5.7	3.8	4.1	10.4	3.7	3.6	7.9	4.0	5.6	4.5	9.5	6.1	4.5	8.1	6.0	6.2	3.2	4.2	9.7	9.9	6.1	8.8	3.9	3.4	10.1	5.3	9.8	6.4	6.9	4.1	7.1	6.4	9.9	3.9	6.7	3.2	4.1	4.2	7.2	3.8	8.1	5.8	13.8	3.2	13.0	12.9	4.4	9.6	7.7	4.5	6.1	24.0	6.9	14.0	9.9	9.2	16.2	10.3	12.1	14.9	14.3	19.7	7.3	25.9	24.4	8.5	11.1	23.6	9.5	14.8	15.0	21.7	21.4	17.5	18.9	10.3	3.2	15.4	22.6	12.4	13.1	13.6	12.8	21.8	14.5	16.6	10.1	38.1	51.9	15.0	4.1	29.8	12.5	17.4	13.2	14.1	19.1	14.0	27.5	9.9	9.8	13.9	16.6	18.7	19.8	15.6	20.3	8.0	12.3	8.4	14.3	5.5	19.1	17.1	23.2	27.0	39.8	20.4	23.6	22.7	0.6	2.2	1.0	2.3	2.3	4.3	3.2	2.6	3.0	2.5	2.5	4.3	3.0	0.4	3.7	1.8	2.2	2.8	1.9	3.2	3.8	3.7	3.6	3.2	4.2	3.9	3.4	4.1	3.8	3.2	6.1	9.7	6.4	4.1	36.9	10.1	4.6	6.7	5.5	13.1	9.2	7.1	7.1	8.8	8.6	3.6	12.9	10.4	7.0	8.0	1.5	19.6	5.0	19.3	4.3	6.9	7.1	9.0	16.0	34.7	4.5	8.0	6.9	8.2	4.2	3.8	9.4	7.1	10.5	6.3	8.4	41.5	4.0	2.0	10.9	7.0	8.3	8.7	8.7	16.0	24.4	5.6	12.6	4.1	37.2	66.8	3.8	1.7	4.5	7.6	2.8	0.8	11.2	4.9	10.0	0.0	5.4	6.3	35.2	14.4	7.6	2.6	4.5	8.5	4.8	4.9	3.5
PPP2R5D	"B56D, B56delta"	ENSG00000112640	"Protein phosphatase 2 regulatory subunit B'delta"	Q14738	6	42984553-43012342	"Disease related genes, Human disease related genes, Predicted intracellular proteins"			"Disease variant, Mental retardation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Proximal enterocytes: 35.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA029045, HPA029046"	Approved		Approved	Nucleoplasm,Cytosol		NA	NA		29000	"Cluster 39: Non-specific - mRNA processing"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 21: OE19 - Mitochondria"	"Cluster 45: Enterocytes - Digestion"	"Nucleoplasm, Cytosol"		"HPA029045: AB_10598912, HPA029046: AB_10600988"	"unprognostic (2.25e-1)"	"unprognostic (7.14e-2)"	"unprognostic (4.73e-2)"	"unprognostic (6.89e-2)"	"unprognostic (1.74e-2)"	"unprognostic (1.70e-1)"	"prognostic unfavorable (3.89e-4)"	"unprognostic (4.08e-2)"	"unprognostic (1.24e-1)"	"unprognostic (9.44e-2)"	"unprognostic (2.59e-1)"	"unprognostic (2.71e-1)"	"unprognostic (1.21e-1)"	"unprognostic (9.96e-2)"	"unprognostic (2.70e-1)"	"unprognostic (7.95e-2)"	"unprognostic (6.05e-2)"	23.2	20.2	29.9	17.5	32.5	18.3	20.2	25.7	38.1	30.9	17.2	27.2	29.7	28.7	4.3	24.3	28.5	15.2	30.3	33.1	26.8	18.2	20.8	18.7	19.9	31.0	26.6	28.6	19.1	24.5	15.9	18.1	30.8	24.8	23.5	29.7	19.8	21.2	40.6	27.8	35.8	30.6	21.1	18.7	22.3	28.6	29.6	44.4	18.3	41.2	24.0	24.7	27.4	31.2	71.3	38.0	72.6	88.2	61.0	63.6	32.6	38.3	39.9	108.5	86.6	58.7	24.9	55.8	36.3	71.8	67.3	38.6	108.6	66.4	94.6	45.3	67.5	62.9	51.2	81.8	33.5	51.4	43.6	45.6	47.3	88.5	35.1	54.1	87.2	68.7	67.4	41.1	63.0	44.0	114.9	40.0	26.2	228.1	36.3	86.3	73.8	37.3	45.3	39.0	77.9	45.7	56.2	38.7	47.3	63.2	47.9	55.5	57.1	57.2	50.9	55.8	61.4	39.6	54.6	109.0	21.2	48.0	51.6	18.4	13.8	21.9	18.4	11.6	19.2	10.1	16.9	21.2	13.7	9.2	12.8	15.6	8.1	14.3	8.9	14.4	23.9	20.1	29.9	32.5	25.7	38.1	33.1	26.8	31.0	26.6	30.8	21.1	29.6	31.2	6.2	9.6	6.7	6.8	7.6	8.4	2.9	5.1	13.1	12.9	6.9	6.6	4.9	4.3	6.3	7.3	10.4	7.5	10.1	15.7	5.9	6.9	6.4	7.7	19.9	7.4	9.0	12.4	10.5	7.8	11.0	9.7	7.1	9.5	8.2	10.8	6.4	11.3	9.2	3.3	10.3	8.3	8.2	6.2	5.2	7.0	9.6	6.9	10.6	3.7	6.8	8.1	3.1	3.0	5.3	9.8	9.0	14.7	7.7	3.7	35.7	5.2	5.1	7.5	6.6	8.7	10.8	8.3	10.2	13.3	9.5	4.5	11.1	6.1	13.0	2.5
PRYP3		ENSG00000169763	"PTPN13 like Y-linked pseudogene 3"	O14603	Y	23681440-23694579	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	15	"brain: 1.7;epididymis: 1.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	12	"A549: 4.5;HDLM-2: 7.7"									HPA059887			Approved	Nucleoplasm,Nucleoli,Cytosol		NA	NA			"Cluster 39: Non-specific - mRNA processing"		"Cluster 44: HDLM-2 - Immune response"		"Nucleoplasm, Nucleoli"	Cytosol	"HPA059887: "																		0.0	0.0	0.5	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	1.5	0.9	0.0	0.0	0.0		0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0		0.2	0.0	4.5	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.5	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.2	0.0	0.1	0.0	0.7	1.5	0.9	1.2	1.7	0.4	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
PSKH1		ENSG00000159792	"Protein serine kinase H1"	P11801	16	67893254-67929676	"Enzymes, Metabolic proteins, Predicted membrane proteins"		"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA053927, HPA062763"	Approved		Supported	"Nuclear speckles,Cytosol"		NA	NA			"Cluster 39: Non-specific - mRNA processing"	"Cluster 29: Non-specific - Vesicular transport"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 40: Granulosa cells - Unknown function"	"Nuclear speckles, Cytosol"		"HPA053927: AB_2682312, HPA062763: "	"unprognostic (2.57e-2)"	"unprognostic (8.91e-3)"	"unprognostic (1.88e-1)"	"unprognostic (5.79e-2)"	"unprognostic (3.26e-1)"	"unprognostic (3.89e-1)"	"unprognostic (1.64e-1)"	"unprognostic (1.29e-2)"	"unprognostic (3.03e-1)"	"unprognostic (1.66e-2)"	"unprognostic (9.85e-3)"	"unprognostic (8.32e-2)"	"prognostic favorable (4.28e-10)"	"unprognostic (1.46e-1)"	"unprognostic (1.99e-1)"	"unprognostic (4.15e-2)"	"unprognostic (3.90e-3)"	14.3	18.6	12.8	9.6	14.5	5.2	14.0	12.2	13.5	13.5	19.5	18.2	13.7	19.3	10.0	16.9	18.7	10.1	17.6	11.2	11.5	20.5	16.5	12.7	10.6	15.0	14.9	19.4	26.3	32.9	13.2	7.6	13.4	15.1	10.8	4.0	18.1	12.7	15.3	13.8	15.7	15.7	13.2	12.8	21.4	21.8	13.6	12.0	15.0	13.5	8.5	16.5	9.5	14.9	13.0	22.7	25.2	28.1	38.4	19.3	16.3	15.2	23.0	15.8	14.0	17.2	18.2	12.2	22.7	25.7	12.7	19.2	14.7	15.6	5.3	4.8	16.4	13.9	16.8	22.0	26.3	13.4	8.0	35.7	26.7	18.8	19.6	21.3	23.3	22.5	21.6	5.1	16.7	28.7	18.3	8.6	24.2	14.0	13.9	27.7	9.7	25.3	18.6	16.0	21.8	26.0	47.3	12.8	15.8	9.9	23.5	23.9	20.8	17.7	6.2	15.0	7.7	15.3	8.7	26.2	21.4	8.8	19.9	0.0	2.0	1.9	2.0	2.2	1.4	1.5	1.5	2.0	2.1	1.2	1.2	1.7	1.0	2.1	1.5	1.5	0.8	1.7	12.8	14.5	12.2	13.5	11.2	11.5	15.0	14.9	13.4	13.2	13.6	14.9	5.5	0.0	3.6	4.6	2.9	1.1	3.1	5.2	2.2	11.1	5.3	4.6	2.3	7.2	3.8	5.5	6.2	6.2	3.0	11.5	11.7	6.0	14.4	5.8	6.5	5.2	10.8	3.0	4.6	7.4	4.8	5.4	5.1	4.8	6.3	13.0	5.3	10.3	4.8	6.7	6.1	6.2	10.2	6.3	1.6	22.1	4.7	2.9	5.4	3.7	4.8	11.0	3.1	5.5	9.2	7.6	4.5	7.9	3.0	3.6	10.0	8.1	4.9	6.9	13.1	6.3	6.1	6.7	6.1	5.4	1.6	5.9	3.8	10.7	7.4	2.2
PTBP1	"HNRNP-I, HNRPI, pPTB, PTB, PTB-1, PTB2, PTB3, PTB4"	ENSG00000011304	"Polypyrimidine tract binding protein 1"	P26599	19	797075-812327	"Plasma proteins, Predicted intracellular proteins"	"mRNA processing, mRNA splicing"	"Activator, Repressor, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			CAB013507	Supported		Supported	Nucleoplasm		NA	NA		4500000	"Cluster 39: Non-specific - mRNA processing"	"Cluster 18: Non-specific - Mitochondria"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 7: Non-specific - Mitochondria"	Nucleoplasm		"CAB013507: AB_2533082"	"unprognostic (2.82e-1)"	"unprognostic (2.75e-1)"	"unprognostic (1.22e-2)"	"unprognostic (1.24e-1)"	"unprognostic (6.01e-2)"	"unprognostic (6.22e-2)"	"prognostic unfavorable (2.71e-4)"	"unprognostic (4.06e-3)"	"unprognostic (2.08e-2)"	"unprognostic (1.92e-2)"	"unprognostic (5.47e-2)"	"unprognostic (4.62e-3)"	"unprognostic (2.41e-2)"	"unprognostic (7.91e-3)"	"unprognostic (4.28e-2)"	"unprognostic (8.31e-2)"	"unprognostic (3.72e-2)"	101.5	84.7	29.9	104.7	33.4	138.2	94.9	33.5	34.9	92.7	51.7	95.9	91.4	90.5	48.9	137.7	86.9	54.0	64.7	29.9	33.6	111.8	123.5	102.3	90.1	38.1	35.5	99.5	100.8	66.4	80.9	79.0	36.7	86.3	56.0	11.8	90.7	45.6	35.2	123.8	96.6	49.7	34.4	117.2	86.0	45.5	36.2	91.9	98.0	19.7	79.2	80.3	101.5	34.8	517.8	377.1	242.8	224.3	70.1	90.3	385.1	299.7	128.8	230.2	169.2	394.1	243.6	428.0	192.5	188.9	88.0	299.8	342.7	260.0	239.3	433.8	361.2	352.9	362.6	429.8	141.8	479.4	355.1	83.5	179.0	265.5	164.2	84.4	232.2	201.3	523.0	223.0	385.6	434.8	610.4	258.5	446.4	190.2	245.2	648.8	182.0	254.2	140.4	467.5	272.9	317.4	358.4	213.4	174.8	168.5	228.9	286.4	335.4	247.5	286.9	306.0	557.4	238.0	500.7	591.2	153.2	357.7	307.9	12.9	32.5	23.1	31.8	38.6	32.3	23.7	26.3	30.0	36.0	23.7	25.1	26.2	13.4	33.5	36.7	22.3	29.1	38.3	29.9	33.4	33.5	34.9	29.9	33.6	38.1	35.5	36.7	34.4	36.2	34.8	99.8	41.7	66.9	11.8	88.7	76.7	91.8	47.0	84.8	19.6	114.5	91.9	39.1	82.9	44.3	47.8	35.5	116.5	96.1	134.3	35.2	73.3	22.3	62.2	62.2	92.1	101.1	87.7	12.4	87.5	172.7	70.4	70.3	80.5	90.8	92.0	74.6	87.9	78.7	33.7	12.1	145.0	36.7	60.6	62.7	20.6	79.9	75.1	39.2	20.6	59.8	29.9	59.8	10.1	12.9	99.4	107.5	65.8	90.0	90.5	89.9	46.9	49.9	21.3	59.2	74.8	71.1	40.5	54.3	97.2	82.0	133.4	89.7	68.7	144.9	100.7
PTPA	"PPP2R4, PR53"	ENSG00000119383	"Protein phosphatase 2 phosphatase activator"	Q15257	9	129110950-129148946	"Enzymes, Plasma proteins, Predicted intracellular proteins"		"Isomerase, Rotamase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Breast glandular cells: 51.9;Collecting duct cells: 53.3;Cytotrophoblasts: 49.5;Distal tubular cells: 54.8;Ductal cells: 70.3;Exocrine glandular cells: 62.3;Hofbauer cells: 53.9;Pancreatic endocrine cells: 61.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA005695, CAB022068, CAB035999"	Approved		Enhanced	Nucleoplasm,Cytosol		NA	NA		4300000	"Cluster 39: Non-specific - mRNA processing"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 7: Non-specific - Mitochondria"	Nucleoplasm	Cytosol	"CAB022068: , CAB035999: , HPA005695: AB_1855658"	"unprognostic (4.97e-2)"	"unprognostic (1.70e-2)"	"unprognostic (1.13e-2)"	"prognostic favorable (6.50e-5)"	"unprognostic (1.56e-2)"	"unprognostic (1.15e-1)"	"unprognostic (6.65e-2)"	"unprognostic (6.44e-3)"	"unprognostic (2.22e-1)"	"unprognostic (1.15e-2)"	"unprognostic (3.20e-2)"	"unprognostic (1.37e-1)"	"unprognostic (1.01e-2)"	"unprognostic (1.92e-2)"	"unprognostic (1.18e-1)"	"unprognostic (1.48e-1)"	"unprognostic (1.69e-1)"	47.2	118.0	157.8	56.2	154.0	52.9	60.9	136.2	185.0	73.5	124.6	105.2	49.6	87.4	55.8	116.8	77.3	49.3	176.7	158.5	141.6	125.5	154.2	72.6	49.9	151.3	148.8	63.8	70.4	146.7	73.1	49.8	147.6	119.0	51.3	43.4	97.1	86.8	340.8	73.7	57.1	92.1	143.2	82.8	83.5	124.5	162.7	59.1	75.3	206.2	54.9	71.1	62.2	148.5	108.9	183.9	111.0	219.9	74.4	94.5	118.3	115.5	120.2	144.8	100.1	103.4	135.4	113.9	83.3	187.3	173.1	184.1	110.9	138.2	100.6	198.6	68.1	64.6	193.6	101.7	229.1	113.1	147.2	114.6	133.1	109.8	101.8	230.9	146.5	120.3	102.0	124.7	117.1	293.8	103.0	76.6	186.8	301.0	193.0	108.3	93.7	216.2	159.0	119.8	120.6	86.9	220.4	237.3	147.3	99.4	253.4	55.0	101.7	127.6	113.8	129.9	165.2	114.9	284.1	96.8	153.2	79.1	180.7	7.6	19.2	9.8	20.8	18.4	19.9	10.8	15.8	18.5	23.0	13.4	13.8	13.9	6.1	20.4	18.3	16.4	16.9	20.4	157.8	154.0	136.2	185.0	158.5	141.6	151.3	148.8	147.6	143.2	162.7	148.5	19.8	3.2	8.3	0.0	3.1	0.0	0.0	0.0	0.0	0.0	51.9	38.6	0.0	0.0	3.1	53.3	0.0	49.5	9.2	0.0	54.8	70.3	0.0	33.7	21.8	19.0	0.0	0.0	0.0	62.3	44.2	12.2	0.0	32.9	8.8	24.8	0.0	0.0	53.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	11.0	0.0	0.0	21.7	0.0	0.0	0.0	0.0	61.8	0.0	0.0	0.9	0.0	0.0	41.9	0.0	0.0	0.0	0.0	18.6	0.0	0.0	0.0	0.0	37.9	4.0	31.8	0.0	0.0
PYGB		ENSG00000100994	"Glycogen phosphorylase B"	P11216	20	25248085-25298012	"Candidate cardiovascular disease genes, Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	"Carbohydrate metabolism, Glycogen metabolism"	"Allosteric enzyme, Glycosyltransferase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Cardiomyocytes: 122.8;Distal enterocytes: 185.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"PC-3: 407.8;SK-MEL-30: 528.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA031067	Approved		Approved	Cytosol		NA	NA		14000000	"Cluster 39: Non-specific - mRNA processing"	"Cluster 44: Heart - Cardiac muscle contraction"	"Cluster 33: SK-MEL-30 - Melanocyte processes"	"Cluster 53: Intestinal epithelial cells - Unknown function"	Cytosol		"HPA031067: AB_2673722"	"unprognostic (6.13e-2)"	"unprognostic (5.98e-2)"	"unprognostic (1.21e-1)"	"unprognostic (2.22e-1)"	"unprognostic (1.21e-1)"	"unprognostic (1.05e-1)"	"prognostic unfavorable (4.37e-4)"	"prognostic unfavorable (1.10e-4)"	"unprognostic (1.23e-3)"	"unprognostic (8.39e-3)"	"unprognostic (1.58e-3)"	"unprognostic (1.98e-1)"	"unprognostic (1.22e-2)"	"unprognostic (3.41e-2)"	"unprognostic (1.69e-1)"	"unprognostic (1.40e-1)"	"prognostic unfavorable (1.43e-4)"	50.8	36.4	78.2	27.7	77.9	14.1	61.1	84.1	82.4	37.0	35.4	140.9	27.0	51.9	21.4	106.6	37.8	39.1	163.9	77.3	74.9	43.7	14.6	32.1	19.1	85.4	80.8	25.9	25.4	18.1	61.5	11.5	81.2	107.9	72.6	25.4	125.1	106.3	18.7	85.3	44.8	59.8	84.7	22.6	51.3	25.2	80.3	18.4	45.2	10.5	17.3	154.2	53.0	84.8	31.5	220.1	39.1	38.3	97.9	182.7	28.7	62.2	80.9	51.4	43.0	50.1	38.0	37.1	71.8	83.6	96.1	123.9	44.5	165.8	27.9	21.1	27.5	29.5	18.6	86.9	115.7	44.7	40.0	107.1	152.4	130.5	191.3	63.5	66.6	23.0	16.5	91.4	73.0	87.1	45.1	34.6	35.2	38.2	407.8	33.7	71.0	49.8	280.5	56.8	58.4	36.5	42.7	74.0	528.7	31.0	51.9	28.4	147.4	60.3	36.5	65.1	128.7	35.2	58.8	14.4	67.9	34.8	335.3	4.6	14.1	7.1	10.2	19.4	9.9	5.4	8.1	9.2	14.5	4.6	10.3	12.9	3.3	11.2	23.4	7.1	9.6	23.4	78.2	77.9	84.1	82.4	77.3	74.9	85.4	80.8	81.2	84.7	80.3	84.8	10.0	9.6	34.6	43.1	8.7	11.9	23.1	20.7	22.2	35.8	31.6	43.6	122.8	11.5	14.6	25.8	37.5	7.1	10.7	185.2	11.7	17.6	3.5	12.7	17.2	13.5	28.2	8.6	22.9	16.5	7.2	15.3	40.2	21.6	6.3	16.2	8.9	5.8	10.8	18.5	26.9	47.3	57.0	13.8	10.7	9.2	27.4	18.5	35.6	15.0	16.6	21.3	15.5	11.6	19.1	27.0	68.5	86.5	22.9	17.6	20.9	11.1	11.9	9.3	0.0	13.5	23.1	2.0	8.5	15.3	10.1	4.4	12.9	20.3	72.0	9.7
RANBP10	KIAA1464	ENSG00000141084	"RAN binding protein 10"	Q6VN20	16	67723070-67806652	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Erythroid cells: 67.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in single"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"									NA	NA			"Cluster 39: Non-specific - mRNA processing"	"Cluster 55: Non-specific - Mitochondria & Proteasome"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 6: Erythroid cells - Oxygen transport"				"unprognostic (2.64e-1)"	"unprognostic (1.35e-1)"	"unprognostic (3.37e-1)"	"unprognostic (2.46e-3)"	"unprognostic (4.51e-2)"	"unprognostic (8.00e-3)"	"unprognostic (9.04e-2)"	"unprognostic (2.27e-2)"	"unprognostic (1.31e-1)"	"unprognostic (4.06e-1)"	"unprognostic (2.77e-3)"	"unprognostic (7.46e-3)"	"prognostic favorable (7.52e-4)"	"unprognostic (2.80e-1)"	"unprognostic (1.17e-1)"	"unprognostic (1.17e-2)"	"unprognostic (2.16e-1)"	9.6	23.0	8.6	7.9	8.3	44.2	10.1	13.1	9.7	16.5	8.4	11.0	7.2	12.9	6.8	14.1	14.4	7.8	10.6	8.6	8.2	12.4	31.2	10.4	9.6	7.9	8.7	15.2	13.1	12.0	11.8	9.1	8.3	12.1	8.1	8.2	9.8	8.1	25.1	15.0	10.6	10.0	6.7	16.6	9.4	10.7	8.3	10.2	10.6	13.3	10.0	9.7	14.0	8.0	9.8	13.4	13.1	13.0	15.6	8.7	20.2	8.9	15.3	16.7	16.5	14.0	8.5	16.4	12.5	9.5	6.4	14.7	13.4	11.9	13.6	8.9	10.5	6.9	10.9	12.2	12.1	14.1	37.5	9.2	13.5	15.0	16.4	12.7	15.3	21.5	18.8	5.0	8.7	14.2	13.3	14.6	10.4	10.8	7.2	22.8	8.3	13.6	9.2	11.6	8.8	9.8	42.6	8.0	15.8	8.4	16.5	13.3	13.4	9.4	9.4	11.6	9.6	11.2	14.8	26.3	8.5	14.8	15.1	0.0	0.6	0.9	0.6	0.7	1.0	0.4	0.6	0.6	0.9	0.5	0.5	0.8	0.3	0.6	0.6	0.7	1.0	0.5	8.6	8.3	13.1	9.7	8.6	8.2	7.9	8.7	8.3	6.7	8.3	8.0	9.2	12.8	8.9	16.0	7.8	4.5	3.2	5.4	4.6	5.4	8.8	6.7	7.7	5.7	4.7	1.8	16.7	5.6	6.2	7.4	3.9	6.5	4.1	21.6	10.8	8.0	4.9	67.1	29.4	4.9	4.2	5.0	6.6	9.1	0.0	9.6	7.5	22.2	5.8	10.1	24.3	6.3	2.0	7.5	2.3	5.1	4.4	5.4	0.0	13.1	6.7	3.6	9.2	15.1	14.4	6.2	6.3	3.8	6.1	5.4	5.4	3.4	16.7	9.2	0.0	6.2	5.9	4.8	5.0	6.4	5.5	8.5	5.6	8.8	6.5	3.7
RASA3	"GAP1IP4BP, GAPIII"	ENSG00000185989	"RAS p21 protein activator 3"	Q14644	13	113977783-114132623	"Plasma proteins, Predicted intracellular proteins, RAS pathway related proteins"		"GTPase activation"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"dendritic cells: 55.0;Horizontal cells: 60.6;NK-cells: 48.4;Plasma cells: 40.0;T-cells: 45.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"RPMI-8226: 60.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA046759	Uncertain					NA	NA		1400000	"Cluster 39: Non-specific - mRNA processing"	"Cluster 64: Macrophages - Immune response"	"Cluster 25: RPMI-8226 - Immune response"	"Cluster 63: NK-cells & T-cells - Immune response"			"HPA046759: AB_10959887"	"unprognostic (3.41e-1)"	"unprognostic (1.34e-2)"	"unprognostic (1.83e-2)"	"unprognostic (2.75e-1)"	"unprognostic (6.15e-3)"	"unprognostic (1.37e-1)"	"unprognostic (2.06e-3)"	"unprognostic (4.01e-2)"	"unprognostic (3.92e-1)"	"unprognostic (2.02e-1)"	"unprognostic (1.15e-2)"	"unprognostic (1.47e-1)"	"prognostic unfavorable (1.99e-6)"	"unprognostic (8.98e-2)"	"unprognostic (8.16e-3)"	"unprognostic (5.08e-2)"	"unprognostic (4.11e-2)"	32.2	3.5	7.6	10.9	8.7	12.7	23.2	6.5	9.8	24.4	3.8	17.0	2.9	13.7	1.1	4.9	19.2	4.6	12.9	8.5	8.3	11.2	5.0	19.3	15.6	9.6	8.9	7.6	10.8	0.7	15.2	5.3	9.3	11.3	2.7	2.6	6.8	3.6	14.2	13.0	15.8	4.7	8.0	22.6	9.4	5.9	10.0	9.0	14.4	4.2	7.7	18.5	15.0	14.6	3.8	4.6	20.2	5.8	19.2	21.3	0.0	14.8	22.1	13.1	10.9	0.4	11.6	0.4	8.2	24.1	10.9	0.0	3.0	7.0	10.1	0.9	1.3	29.4	14.1	0.1	9.7	12.3	2.5	19.2	1.4	12.7	9.1	16.2	22.3	0.6	2.2	3.3	19.9	5.1	27.1	20.5	4.3	3.2	6.8	13.6	7.4	60.6	11.9	0.1	2.9	2.1	3.5	15.2	7.5	8.3	3.8	44.7	30.5	19.7	5.4	7.2	16.2	0.1	0.0	0.8	25.7	11.9	32.1	16.7	4.5	6.4	16.9	7.6	12.8	5.2	15.6	17.0	3.0	3.9	16.3	16.4	2.5	12.7	15.3	1.0	19.2	16.9	7.6	8.7	6.5	9.8	8.5	8.3	9.6	8.9	9.3	8.0	10.0	14.6	5.3	0.0	4.2	27.1	20.6	3.7	1.2	0.7	2.2	7.9	2.0	4.6	7.5	1.5	3.5	1.8	0.0	0.1	55.0	0.3	0.0	1.1	1.5	7.8	13.3	9.3	3.0	5.5	25.6	2.0	0.2	15.2	3.6	5.1	26.0	1.8	3.9	2.4	9.3	60.6	12.2	2.6	2.0	15.1	12.1	0.7	8.7	19.6	10.6	36.5	11.4	1.3	48.4	17.6	27.5	12.5	0.2	3.8	40.0	1.6	0.1	0.4	13.2	3.5	0.0	18.9	11.5	8.6	5.4	0.4	4.8	0.5	45.2	2.5	0.7	1.6
RAVER1	KIAA1978	ENSG00000161847	"Ribonucleoprotein, PTB binding 1"	Q8IY67	19	10316212-10333638	"Predicted intracellular proteins"		RNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 15.2;Enteroendocrine cells: 16.3;Plasma cells: 15.3;Proximal enterocytes: 14.0;Undifferentiated cells: 14.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"NB-4: 255.5"					"Low region specificity"	"Detected in all"			"HPA043575, HPA049457"	Enhanced		Supported	Nucleoplasm		NA	NA			"Cluster 39: Non-specific - mRNA processing"	"Cluster 72: Non-specific - Transcription"	"Cluster 24: NB-4 - Immune response"	"Cluster 59: Non-specific - Transcription"	Nucleoplasm		"HPA043575: AB_2678562, HPA049457: AB_2680774"	"unprognostic (2.04e-1)"	"unprognostic (3.15e-2)"	"unprognostic (1.54e-1)"	"unprognostic (2.34e-2)"	"unprognostic (2.36e-1)"	"unprognostic (1.80e-2)"	"unprognostic (1.59e-1)"	"unprognostic (4.22e-2)"	"unprognostic (2.01e-2)"	"unprognostic (7.20e-2)"	"unprognostic (2.64e-2)"	"unprognostic (3.22e-2)"	"unprognostic (3.40e-2)"	"unprognostic (1.14e-2)"	"unprognostic (1.53e-1)"	"unprognostic (8.98e-2)"	"unprognostic (2.97e-1)"	12.4	12.9	4.1	11.8	4.9	19.0	12.6	3.9	5.5	17.9	6.2	20.4	17.7	22.8	0.7	15.1	19.8	3.3	9.7	3.7	4.4	12.0	8.3	13.1	11.1	6.9	5.0	19.3	11.7	4.4	17.5	6.0	4.4	15.2	3.2	1.1	13.1	7.5	8.5	11.8	22.6	4.0	3.8	21.7	13.9	11.5	5.0	11.4	14.3	2.2	5.2	16.8	14.0	4.5	62.0	38.9	14.1	21.6	5.6	7.0	31.0	31.9	14.0	24.7	21.8	42.7	17.3	65.0	43.7	10.4	19.9	31.5	15.8	21.1	4.9	55.2	93.5	100.3	25.7	48.6	12.6	63.5	62.4	8.2	7.2	16.6	6.2	8.2	16.2	48.6	80.9	56.2	7.6	57.8	85.6	255.5	55.1	13.1	73.9	78.3	20.5	57.2	6.9	24.4	40.3	46.7	34.7	22.3	18.3	4.8	32.0	30.5	22.5	63.7	32.4	56.7	54.5	122.1	109.0	54.9	42.1	44.2	42.5	0.2	1.3	1.8	3.3	1.5	1.7	1.4	2.8	4.6	2.1	2.0	1.9	1.7	1.2	1.9	3.3	0.9	1.1	2.2	4.1	4.9	3.9	5.5	3.7	4.4	6.9	5.0	4.4	3.8	5.0	4.5	1.2	0.0	1.1	6.5	7.8	0.8	0.3	0.5	10.2	0.8	2.0	1.1	0.7	0.0	0.4	0.0	0.0	2.0	2.3	15.2	0.0	4.5	0.4	1.6	2.2	1.1	16.3	12.0	4.8	4.3	1.9	1.6	6.1	1.2	4.5	0.6	0.4	0.3	1.3	0.0	4.5	9.3	0.0	0.0	0.8	0.0	0.0	2.0	0.0	6.5	6.8	0.3	0.0	4.0	4.2	5.4	10.2	0.7	15.3	0.3	14.0	0.6	1.1	1.0	0.0	0.8	2.4	0.7	0.3	6.1	0.1	1.5	5.5	0.6	14.3	0.2
RBAK	ZNF769	ENSG00000146587	"RB associated KRAB zinc finger"	Q9NYW8	7	5045821-5069487	"Metabolic proteins, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA071231			Supported	Nucleoplasm		NA	NA			"Cluster 39: Non-specific - mRNA processing"	"Cluster 34: Non-specific - Transcription"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 52: Non-specific - Transcription"	Nucleoplasm		"HPA071231: AB_2686370"	"unprognostic (2.82e-2)"	"unprognostic (1.98e-2)"	"unprognostic (7.40e-2)"	"unprognostic (1.85e-2)"	"unprognostic (5.04e-1)"	"unprognostic (4.32e-1)"	"unprognostic (2.62e-1)"	"unprognostic (2.32e-1)"	"unprognostic (4.67e-2)"	"unprognostic (5.91e-2)"	"unprognostic (6.84e-2)"	"unprognostic (5.10e-2)"	"unprognostic (1.28e-1)"	"unprognostic (2.50e-1)"	"unprognostic (3.66e-2)"	"unprognostic (6.12e-3)"	"unprognostic (5.75e-2)"	4.3	3.8	4.1	4.4	4.0	3.7	5.8	6.7	5.4	4.7	3.7	4.6	4.5	5.2	4.7	5.8	4.4	3.7	4.3	3.8	4.5	4.4	6.5	4.0	6.4	4.5	5.0	4.8	5.5	6.9	3.9	4.5	4.4	4.7	4.9	8.4	4.6	4.7	4.2	6.0	5.1	4.4	4.2	5.1	5.0	2.9	4.8	5.6	5.5	6.1	6.7	4.1	4.6	4.8	8.9	6.7	9.2	17.0	6.6	6.1	7.5	5.5	4.3	5.3	6.3	8.3	5.4	10.5	4.5	6.4	10.0	10.8	10.4	8.5	8.2	2.3	7.4	7.7	9.2	6.9	7.0	12.9	8.9	5.9	9.9	5.3	11.8	7.7	5.3	6.1	16.2	3.7	6.7	15.7	3.2	11.9	14.5	3.0	7.0	5.3	14.9	7.7	6.1	11.3	9.4	15.4	7.7	12.6	11.5	11.7	7.7	15.3	4.5	6.3	10.0	7.3	9.1	11.4	9.7	9.2	6.3	9.5	8.2	0.0	0.2	0.4	0.5	0.4	0.7	0.3	0.4	0.3	0.3	0.3	0.5	0.4	0.0	0.5	0.1	0.4	0.3	0.1	4.1	4.0	6.7	5.4	3.8	4.5	4.5	5.0	4.4	4.2	4.8	4.8	7.4	0.0	8.2	0.0	6.5	4.2	3.4	4.7	5.2	8.2	6.1	3.9	13.4	7.2	7.3	0.0	10.4	2.8	7.9	5.1	1.9	5.9	1.1	7.5	10.1	6.1	4.9	11.6	0.0	5.8	2.2	6.7	8.6	6.9	5.7	11.7	7.9	5.3	3.7	21.9	0.0	5.6	2.0	8.2	4.0	1.4	8.1	5.2	3.6	0.0	5.7	6.0	5.2	0.0	0.0	6.0	3.8	8.6	6.7	5.9	5.6	3.7	8.8	8.2	0.0	8.8	7.0	5.0	3.2	7.5	7.0	1.9	6.4	9.1	6.1	4.2
RBM12	"HRIHFB2091, KIAA0765, SWAN"	ENSG00000244462	"RNA binding motif protein 12"	Q9NTZ6	20	35648925-35664956	"Disease related genes, Predicted intracellular proteins"		RNA-binding	"Disease variant, Schizophrenia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA043258, HPA043621"	Enhanced		Enhanced	Nucleoplasm		NA	NA			"Cluster 39: Non-specific - mRNA processing"	"Cluster 34: Non-specific - Transcription"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 65: Plasmacytoid DCs - Unknown function"	Nucleoplasm		"HPA043258: AB_2678395, HPA043621: AB_2678584"	"unprognostic (8.94e-2)"	"unprognostic (2.39e-1)"	"unprognostic (1.04e-3)"	"unprognostic (7.57e-2)"	"unprognostic (1.04e-1)"	"unprognostic (4.19e-2)"	"prognostic unfavorable (1.54e-4)"	"unprognostic (7.96e-2)"	"unprognostic (8.56e-2)"	"unprognostic (1.28e-1)"	"unprognostic (7.47e-2)"	"unprognostic (3.34e-2)"	"unprognostic (3.67e-1)"	"unprognostic (3.29e-1)"	"unprognostic (4.44e-1)"	"unprognostic (3.92e-1)"	"unprognostic (6.87e-2)"	24.5	20.2	2.6	28.7	3.5	30.2	22.6	23.2	8.0	18.2	7.6	24.5	20.3	28.6	12.4	23.4	26.6	23.7	18.4	2.9	9.6	17.7	18.5	22.9	39.9	4.1	4.1	39.0	19.9	25.2	13.9	30.2	3.7	23.4	24.1	27.4	19.3	19.3	19.2	17.6	20.2	28.5	0.9	27.0	22.2	23.0	6.2	50.6	23.0	17.2	44.8	36.4	17.0	10.4	87.9	57.6	121.3	74.5	29.1	57.0	74.5	47.7	56.1	65.5	64.0	80.4	60.3	157.5	51.8	96.0	68.3	60.7	144.8	121.9	83.3	74.8	52.2	132.0	56.6	54.2	50.0	145.1	67.9	82.0	61.7	75.2	49.7	41.8	73.9	84.0	128.1	73.9	58.0	64.3	172.8	40.8	88.4	56.7	59.2	104.2	149.0	77.0	47.0	142.2	63.9	82.9	85.1	66.0	64.3	99.2	85.1	52.4	104.9	54.8	81.0	54.3	71.7	79.7	93.4	165.3	48.3	55.3	72.9	6.7	10.5	8.9	11.7	11.6	13.6	12.2	10.4	13.7	12.7	11.5	10.7	9.8	7.5	9.9	9.8	8.1	10.1	11.5	2.6	3.5	23.2	8.0	2.9	9.6	4.1	4.1	3.7	0.9	6.2	10.4	22.6	25.6	24.1	0.0	28.7	29.6	23.8	17.4	19.4	15.8	19.4	19.3	22.5	17.2	19.2	3.7	27.1	21.5	35.8	17.1	1.9	14.9	4.8	20.7	24.0	18.7	24.6	25.2	0.0	17.8	18.5	22.6	11.2	24.9	26.6	31.5	20.0	14.0	18.5	8.4	0.0	20.4	20.3	24.6	20.6	4.8	14.6	25.7	16.0	0.0	23.7	13.5	21.6	0.0	0.0	21.0	14.6	16.6	22.9	18.5	15.0	9.8	25.3	14.4	6.6	28.0	22.6	15.1	17.4	21.8	29.5	17.5	29.7	18.7	19.8	27.8
RBM14	"COAA, DKFZp779J0927, SIP, SYTIP1"	ENSG00000239306	"RNA binding motif protein 14"	Q96PK6	11	66616626-66629934	"Predicted intracellular proteins"	"Immunity, Innate immunity, Transcription, Transcription regulation"	"Repressor, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA006628	Supported		Supported	"Nuclear speckles"		NA	NA		31000	"Cluster 39: Non-specific - mRNA processing"	"Cluster 43: Testis - Unknown function"	"Cluster 17: WM-115 - Nervous system development"	"Cluster 39: Non-specific - Basic cellular processes"	"Nuclear speckles"		"HPA006628: AB_1078546"	"unprognostic (6.96e-2)"	"unprognostic (4.79e-2)"	"unprognostic (4.34e-3)"	"unprognostic (4.45e-2)"	"unprognostic (2.15e-1)"	"unprognostic (9.56e-3)"	"prognostic unfavorable (2.02e-7)"	"unprognostic (4.21e-2)"	"unprognostic (1.54e-3)"	"unprognostic (1.08e-2)"	"prognostic favorable (1.04e-4)"	"unprognostic (9.38e-3)"	"unprognostic (8.59e-3)"	"unprognostic (1.29e-2)"	"unprognostic (3.32e-1)"	"unprognostic (1.02e-1)"	"unprognostic (1.94e-1)"	26.9	32.0	39.9	25.0	40.2	32.6	24.1	52.6	48.0	37.2	48.5	29.4	15.7	30.8	19.1	33.9	37.6	10.7	33.2	40.1	38.9	50.6	40.4	27.3	28.3	39.4	40.6	45.1	34.1	17.5	34.5	19.6	39.4	36.3	18.2	35.8	25.3	14.6	29.7	28.4	29.1	15.6	37.1	40.4	30.1	44.0	39.6	25.7	28.4	11.6	29.2	30.4	28.6	48.6	83.0	77.9	55.9	43.2	25.3	16.8	97.0	45.0	16.4	40.8	24.0	79.2	60.6	130.9	49.2	21.9	45.0	69.0	63.4	36.5	43.3	63.9	68.7	81.7	67.1	71.2	14.1	71.5	70.0	11.8	13.3	41.9	23.3	24.1	31.0	38.2	98.6	83.9	40.2	70.3	122.4	79.4	107.2	69.0	85.7	125.3	65.4	67.3	34.2	71.5	67.0	61.9	78.0	55.9	33.9	45.9	77.3	63.5	50.5	49.4	97.9	40.5	72.6	49.8	75.2	109.0	41.8	68.9	120.1	19.7	24.3	27.3	27.9	26.1	27.2	21.3	24.1	26.8	33.6	21.8	24.3	28.2	9.0	21.7	27.2	21.3	23.1	34.0	39.9	40.2	52.6	48.0	40.1	38.9	39.4	40.6	39.4	37.1	39.6	48.6	12.6	9.6	17.0	0.0	27.4	38.1	45.7	20.7	15.4	24.8	19.1	16.3	16.3	18.6	17.2	14.7	29.2	56.3	32.7	17.7	17.6	26.5	37.3	18.1	16.5	21.3	21.6	23.1	0.0	18.4	54.4	20.1	9.7	17.5	19.7	20.4	22.5	24.5	29.0	11.8	0.0	20.9	24.4	16.0	30.2	27.0	17.1	20.1	12.4	0.0	25.4	18.1	34.0	0.0	0.0	19.3	21.7	16.1	20.7	26.9	19.0	12.2	23.2	49.4	6.6	15.1	21.5	53.9	40.1	20.9	31.1	69.2	29.0	13.7	25.2	32.6
RCN1	"FLJ37041, PIG20, Rcal, RCN"	ENSG00000049449	"Reticulocalbin 1"	Q15293	11	32091074-32105722	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	5	"epididymis: 660.2"	"Cell type enhanced"	"Detected in all"		"Extravillous trophoblasts: 288.2;Muller glia cells: 327.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"							"HPA038474, HPA062104"	Approved		Supported	"Endoplasmic reticulum"	"Intracellular and membrane"	NA	NA		9400000	"Cluster 39: Non-specific - mRNA processing"	"Cluster 68: Epididymis - Unknown function"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 33: Fibroblasts - ECM organization"	"Endoplasmic reticulum"		"HPA038474: AB_10672595, HPA062104: AB_2684683"	"unprognostic (1.65e-1)"	"unprognostic (7.69e-3)"	"unprognostic (1.24e-1)"	"unprognostic (2.03e-2)"	"unprognostic (7.20e-3)"	"unprognostic (1.70e-2)"	"unprognostic (6.92e-3)"	"prognostic unfavorable (7.13e-6)"	"unprognostic (8.85e-2)"	"unprognostic (1.30e-2)"	"unprognostic (2.12e-1)"	"unprognostic (9.32e-2)"	"prognostic unfavorable (2.70e-13)"	"unprognostic (1.78e-2)"	"unprognostic (2.04e-1)"	"unprognostic (1.14e-1)"	"unprognostic (6.93e-3)"	81.8	54.4	26.7	58.3	39.6	8.1	64.6	24.0	28.2	73.9	37.2	54.7	43.4	79.7	660.2	25.7	69.5	50.1	46.0	26.4	37.2	39.2	100.7	50.6	29.2	29.9	27.6	83.6	21.9	62.2	67.3	129.0	29.0	85.6	53.7	48.7	89.9	82.5	32.7	26.8	41.5	79.5	31.8	35.9	40.7	22.5	36.7	19.0	63.4	28.8	23.1	113.1	41.1	31.3	130.0	143.7	335.9	217.4	720.2	548.1	340.4	425.5	501.5	286.6	515.6	123.6	157.2	0.4	293.3	718.4	380.4	157.6	118.0	135.2	450.2	63.9	231.9	28.2	104.7	58.4	519.7	21.7	42.0	780.1	154.8	197.1	215.4	333.7	647.7	60.6	17.4	25.8	342.1	116.0	61.4	50.2	137.2	2.7	143.9	45.1	393.5	39.2	270.1	355.8	82.1	42.6	117.1	26.2	333.1	227.2	171.0	77.5	350.8	417.0	215.8	338.5	364.6	1.0	0.9	1.7	514.2	28.3	224.9	0.3	13.6	0.5	14.9	16.2	11.8	6.2	6.9	12.3	15.2	4.8	5.1	9.5	0.6	10.9	10.3	8.2	2.7	9.3	26.7	39.6	24.0	28.2	26.4	37.2	29.9	27.6	29.0	31.8	36.7	31.3	131.3	54.5	34.8	9.8	11.8	41.6	80.8	78.2	34.1	40.4	47.9	37.5	9.0	42.9	55.1	47.8	12.5	172.6	10.5	14.3	7.9	143.4	210.4	60.7	154.9	112.1	53.2	16.4	8.0	45.7	288.2	152.1	23.0	110.2	12.7	100.3	85.3	61.7	44.2	15.2	5.9	80.9	38.7	17.8	33.9	173.8	80.5	19.9	32.0	8.4	50.3	327.4	19.6	16.6	1.3	39.7	30.8	73.0	38.6	184.9	6.7	14.1	30.4	17.0	26.3	80.8	91.7	17.0	7.2	33.2	28.3	217.0	13.6	55.8	75.3	99.8
REEP3	"C10orf74, Yip2b"	ENSG00000165476	"Receptor accessory protein 3"	Q6NUK4	10	63521401-63625128	"Predicted membrane proteins"	"Cell cycle, Cell division, Mitosis"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Early spermatids: 346.0;Urothelial cells: 270.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"									NA	NA			"Cluster 39: Non-specific - mRNA processing"	"Cluster 73: Brain - Neuropeptide signaling"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 22: Epithelial cell types - Mixed function"				"unprognostic (4.85e-2)"	"unprognostic (7.07e-3)"	"unprognostic (2.89e-2)"	"unprognostic (6.25e-2)"	"unprognostic (3.50e-3)"	"prognostic unfavorable (7.83e-4)"	"prognostic unfavorable (3.19e-4)"	"unprognostic (1.13e-2)"	"unprognostic (9.33e-2)"	"unprognostic (2.87e-1)"	"prognostic unfavorable (1.32e-4)"	"unprognostic (1.16e-1)"	"unprognostic (1.29e-1)"	"unprognostic (1.89e-2)"	"unprognostic (6.82e-2)"	"unprognostic (2.18e-1)"	"unprognostic (4.06e-2)"	26.5	16.0	10.9	10.3	21.8	2.1	15.9	20.0	12.9	23.5	19.4	16.3	28.3	19.9	16.2	17.1	10.6	15.6	10.5	9.8	15.0	14.0	21.0	17.2	8.8	23.9	20.2	7.4	9.1	29.1	7.0	20.7	23.8	21.6	17.1	6.7	19.8	19.1	6.9	15.5	29.0	25.7	17.8	11.3	13.3	9.2	17.9	6.2	21.0	8.1	9.1	23.6	9.9	35.4	53.6	23.7	21.6	20.7	77.9	76.9	24.3	40.0	66.0	29.9	42.2	33.5	81.2	4.9	14.9	58.5	9.9	61.7	8.7	56.1	52.6	16.3	17.8	11.2	9.7	21.5	50.4	12.5	0.2	65.0	43.2	42.0	63.3	74.2	52.6	6.4	5.5	23.4	54.9	16.3	9.0	19.3	7.5	10.2	50.0	16.0	14.5	10.1	43.1	31.0	6.4	21.7	37.1	36.1	34.7	30.5	35.7	28.6	39.9	28.6	8.6	26.0	31.2	20.0	32.6	7.5	25.8	0.1	30.6	0.1	3.3	2.1	1.6	4.6	3.4	2.0	3.5	2.4	2.9	1.5	1.3	1.9	1.5	1.7	3.0	3.1	5.1	1.6	10.9	21.8	20.0	12.9	9.8	15.0	23.9	20.2	23.8	17.8	17.9	35.4	96.6	28.9	30.4	46.0	25.4	64.5	108.2	46.8	31.9	13.6	76.4	57.1	24.5	34.3	65.9	82.8	27.1	66.7	23.1	113.8	29.4	71.5	346.0	28.9	56.1	64.2	43.0	21.0	96.7	72.1	97.4	56.2	37.8	34.4	9.5	10.7	65.3	71.8	44.2	20.2	37.5	47.0	54.9	38.5	45.4	107.5	105.9	47.6	39.2	65.6	47.1	16.9	13.4	75.9	145.3	156.4	88.3	124.8	47.2	190.8	179.2	46.5	52.1	22.5	98.6	32.0	72.0	133.6	8.8	38.6	73.2	117.5	30.4	42.7	29.4	270.2
RELA	"NFKB3, p65"	ENSG00000173039	"RELA proto-oncogene, NF-kB subunit"	Q04206	11	65653597-65663090	"Cancer-related genes, Disease related genes, Predicted intracellular proteins, RAS pathway related proteins, Transcription factors"	"Host-virus interaction, Transcription, Transcription regulation"	"Activator, DNA-binding"	"Cancer-related genes, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004264, CAB005030, HPA063461"	Supported		Enhanced	Cytosol		NA	NA			"Cluster 39: Non-specific - mRNA processing"	"Cluster 89: Fibroblasts - ECM organization"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 22: Epithelial cell types - Mixed function"	Cytosol		"CAB004264: AB_628017, CAB005030: AB_562171, HPA063461: AB_2685016"	"unprognostic (9.17e-2)"	"unprognostic (1.79e-1)"	"unprognostic (2.04e-1)"	"unprognostic (3.22e-1)"	"unprognostic (7.67e-2)"	"unprognostic (5.39e-2)"	"prognostic unfavorable (9.18e-4)"	"unprognostic (1.30e-3)"	"unprognostic (1.69e-2)"	"unprognostic (1.33e-1)"	"unprognostic (6.03e-2)"	"unprognostic (2.37e-1)"	"prognostic unfavorable (5.66e-4)"	"unprognostic (2.78e-1)"	"unprognostic (1.46e-1)"	"unprognostic (9.81e-2)"	"unprognostic (2.53e-1)"	67.3	42.8	27.4	38.5	29.9	79.7	63.1	28.7	35.0	61.7	26.9	63.3	31.3	61.0	23.0	60.8	62.3	34.7	49.4	27.3	29.6	50.0	66.6	70.3	39.7	35.5	30.0	65.3	49.0	25.9	32.3	27.8	31.8	55.6	23.8	9.8	54.4	35.4	74.9	66.1	49.1	39.8	29.1	59.7	56.8	24.1	31.4	30.3	45.0	26.9	36.7	60.3	59.4	33.4	66.9	68.4	31.4	45.2	49.1	49.6	32.2	52.9	65.6	62.3	49.9	33.0	71.1	53.0	85.5	75.4	72.0	63.9	36.8	66.6	35.5	62.1	53.2	57.5	50.1	47.5	56.7	43.8	78.8	55.4	65.3	70.4	79.2	58.9	76.6	43.7	56.6	61.4	48.5	90.3	74.1	38.5	20.9	43.6	64.6	61.5	29.6	80.6	50.7	60.9	26.6	59.5	47.1	72.7	72.4	22.2	82.3	29.4	100.3	65.8	55.3	103.3	50.9	86.0	80.5	53.6	71.7	30.8	65.4	12.5	14.0	18.6	22.7	17.1	25.5	17.3	19.8	22.4	15.4	14.0	18.4	20.0	21.2	25.2	15.4	15.3	21.4	16.5	27.4	29.9	28.7	35.0	27.3	29.6	35.5	30.0	31.8	29.1	31.4	33.4	43.2	32.1	25.5	9.1	33.9	47.3	54.4	41.3	33.0	9.4	31.6	27.9	23.1	17.2	30.9	11.0	8.4	24.0	40.7	30.9	29.4	41.4	5.1	32.8	25.7	43.9	19.7	19.0	5.5	45.1	24.8	30.1	33.1	50.0	44.3	26.2	32.9	20.3	24.3	15.2	5.9	25.0	32.6	24.9	40.4	7.7	28.9	28.0	32.0	10.3	35.2	14.5	28.8	7.5	13.8	65.4	20.8	26.4	30.7	66.8	22.2	17.4	23.4	9.5	13.1	30.5	34.7	14.3	20.3	29.2	43.2	43.6	37.9	21.0	21.6	75.1
RHOT2	"ARHT2, C16orf39, MIRO-2"	ENSG00000140983	"Ras homolog family member T2"	Q8IXI1	16	668105-674174	"Predicted intracellular proteins, Predicted membrane proteins"		Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Cone photoreceptor cells: 264.8;Rod photoreceptor cells: 284.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA012624, HPA012895"	Approved		Supported	Mitochondria		NA	NA			"Cluster 39: Non-specific - mRNA processing"	"Cluster 18: Non-specific - Mitochondria"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 9: Photoreceptor cells - Phototransduction"	Mitochondria		"HPA012624: AB_1856272, HPA012895: AB_1856271"	"unprognostic (1.59e-1)"	"unprognostic (8.24e-2)"	"unprognostic (1.03e-1)"	"unprognostic (4.50e-2)"	"unprognostic (1.09e-1)"	"prognostic favorable (5.01e-4)"	"unprognostic (4.68e-3)"	"unprognostic (4.66e-2)"	"unprognostic (3.41e-2)"	"unprognostic (7.55e-2)"	"unprognostic (7.87e-3)"	"unprognostic (3.25e-1)"	"prognostic favorable (5.43e-4)"	"unprognostic (1.51e-2)"	"unprognostic (2.38e-1)"	"unprognostic (1.24e-1)"	"unprognostic (2.17e-2)"	32.3	48.6	28.9	20.4	28.4	28.1	34.9	27.9	36.4	38.7	32.8	42.8	29.1	32.8	7.8	37.7	38.2	12.8	53.6	29.2	27.4	46.6	44.9	34.4	26.0	29.1	28.1	34.5	34.2	20.4	51.5	14.7	28.0	50.3	8.1	36.4	35.9	17.3	33.5	38.7	45.1	9.2	27.0	57.1	41.4	36.7	28.8	20.3	45.7	15.5	11.6	37.5	35.6	28.1	25.0	52.4	25.6	39.7	13.1	13.7	44.7	41.7	19.2	33.9	26.2	70.3	37.1	29.5	28.8	16.6	11.8	47.3	17.7	39.6	8.7	41.9	77.2	32.5	65.5	52.2	24.7	29.9	44.2	21.3	29.5	25.0	14.2	17.9	24.5	35.9	62.6	22.1	17.3	108.2	33.1	32.5	67.3	21.5	33.5	72.6	30.5	59.1	20.6	48.8	57.7	70.1	39.2	50.6	22.8	11.0	49.6	46.4	38.9	25.4	41.7	23.5	30.8	56.0	40.0	38.6	17.9	28.3	39.6	5.5	19.5	21.8	22.9	23.0	13.9	11.6	18.3	18.4	19.4	12.1	13.7	11.7	16.8	12.0	18.4	20.3	23.0	17.6	28.9	28.4	27.9	36.4	29.2	27.4	29.1	28.1	28.0	27.0	28.8	28.1	30.1	32.1	27.5	53.2	37.1	33.8	26.8	80.0	25.6	98.6	29.6	25.8	25.7	30.0	38.3	29.5	264.8	63.2	46.7	63.3	21.5	40.2	6.3	16.5	21.7	26.6	43.0	17.1	46.5	35.8	52.1	26.5	51.0	21.9	51.4	40.6	20.0	34.7	35.8	85.8	36.2	52.2	61.1	30.3	29.8	7.5	27.1	26.0	28.4	20.6	45.2	40.1	46.4	17.1	27.3	43.8	46.8	25.6	23.7	25.0	47.3	24.3	27.9	284.9	52.6	19.9	31.5	44.5	51.4	19.3	31.7	67.0	42.1	45.5	54.2	23.3
RNF26	MGC2642	ENSG00000173456	"Ring finger protein 26"	Q9BY78	11	119334527-119337309	"Enzymes, Predicted membrane proteins"	"Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Extravillous trophoblasts: 66.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"							"Low region specificity"	"Detected in all"			HPA027620	Uncertain		Approved	Nucleoplasm,Vesicles,Cytosol		NA	Yes			"Cluster 39: Non-specific - mRNA processing"	"Cluster 85: Liver - Metabolism"	"Cluster 1: K-562 - Erythropoiesis"	"Cluster 12: Non-specific - Cell cycle regulation"	Nucleoplasm	"Vesicles, Cytosol"	"HPA027620: AB_1856356"	"unprognostic (9.23e-3)"	"unprognostic (3.54e-2)"	"unprognostic (1.36e-1)"	"unprognostic (8.68e-3)"	"unprognostic (3.40e-1)"	"unprognostic (1.07e-2)"	"prognostic unfavorable (3.19e-4)"	"unprognostic (2.14e-2)"	"unprognostic (3.26e-1)"	"unprognostic (1.69e-1)"	"unprognostic (7.24e-3)"	"unprognostic (6.22e-2)"	"prognostic favorable (3.45e-6)"	"unprognostic (9.61e-2)"	"unprognostic (3.50e-2)"	"unprognostic (4.41e-2)"	"prognostic unfavorable (7.73e-4)"	14.3	15.8	12.7	11.5	12.6	22.0	13.3	13.7	15.1	15.4	10.6	19.2	14.5	23.5	10.3	20.9	16.6	10.5	13.2	12.7	12.5	13.6	23.6	12.4	11.8	15.2	13.1	17.1	13.8	18.5	10.4	14.2	15.5	14.8	12.6	8.4	14.9	18.6	8.5	15.7	17.0	19.0	12.7	14.6	19.1	15.1	14.7	13.3	13.2	7.1	12.8	18.9	14.2	13.1	43.8	47.4	43.4	51.4	41.8	32.8	46.0	46.3	49.7	52.8	41.5	80.6	88.9	38.3	62.5	55.5	80.1	77.2	61.9	69.8	33.0	46.0	34.2	101.0	21.8	67.3	31.9	42.8	40.4	34.3	35.2	66.1	59.0	34.7	40.8	58.1	50.0	58.4	36.9	94.9	39.5	44.3	43.5	50.2	59.8	40.5	44.5	30.4	32.7	31.1	30.8	29.9	37.4	46.8	12.5	41.4	106.1	35.4	27.0	63.5	41.8	33.7	43.0	14.0	24.6	0.4	21.3	71.0	50.6	9.5	21.6	5.6	20.8	19.2	13.4	11.1	15.7	18.4	19.0	16.7	17.5	15.5	1.5	14.0	20.2	11.0	8.7	24.9	12.7	12.6	13.7	15.1	12.7	12.5	15.2	13.1	15.5	12.7	14.7	13.1	5.1	3.2	9.4	1.0	9.1	6.9	13.3	15.4	12.5	9.2	10.9	9.8	0.8	22.8	11.1	11.0	2.1	44.0	6.2	9.3	5.9	20.8	6.6	5.9	7.9	8.6	13.8	18.5	3.2	17.0	66.0	11.5	9.2	5.9	7.6	16.9	11.4	23.4	21.5	5.0	2.9	13.0	8.2	14.8	5.9	8.6	14.0	6.6	1.8	1.0	11.6	11.6	15.5	4.5	2.7	14.1	7.5	17.7	4.3	14.2	15.6	12.5	4.8	9.4	6.6	6.5	10.6	19.9	10.5	14.3	8.5	24.4	8.3	8.8	18.6	9.8
RPS4Y1	"MGC119100, MGC5070, RPS4Y, S4"	ENSG00000129824	"Ribosomal protein S4 Y-linked 1"	P22090	Y	2841602-2932000	"Predicted intracellular proteins, Ribosomal proteins"		"Ribonucleoprotein, Ribosomal protein, RNA-binding, rRNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Basal respiratory cells: 1273.9"	"Cancer enhanced"	"Detected in many"		"prostate cancer: 187.7"	"Region enriched"	"Detected in all"	28	"cerebral cortex: 427.8"	"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"Daudi: 1076.6;HSkMC: 1195.7;U-698: 1701.8"									HPA000857	Approved					NA	NA			"Cluster 39: Non-specific - mRNA processing"	"Cluster 29: Non-specific - Vesicular transport"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 32: Non-specific - Translation"			"HPA000857: AB_1079849"			"unprognostic (7.04e-2)"		"unprognostic (2.21e-2)"	"unprognostic (1.32e-3)"	"unprognostic (3.93e-2)"	"unprognostic (6.31e-2)"	"unprognostic (7.35e-2)"		"unprognostic (1.26e-2)"	"unprognostic (1.75e-1)"	"unprognostic (8.11e-2)"	"unprognostic (5.87e-3)"	"unprognostic (1.81e-1)"	"unprognostic (1.49e-2)"	"unprognostic (4.55e-2)"	262.4	239.9	12.9	80.7	13.5	227.3	234.8	13.1	427.8	0.2	14.7	220.0	79.9	0.4	302.0	177.6	0.3	129.8	178.2	12.6	14.9	252.9	174.1	176.3	59.1	15.1	13.7	0.9	327.4	116.8	115.7	116.3	14.6	297.2	258.4	83.4	178.5	225.3	295.6	242.4	188.4	0.2	14.5	202.7	221.9	102.5	14.1	0.0	172.8	382.7	253.8	215.0	0.6	15.1	2.8	270.9	0.0	0.1	0.2	0.8	383.9	452.8	783.0	697.8	586.5	0.5	0.0	1076.6	1.4	645.0	0.0	0.6	0.0	0.3	849.8	317.4	0.1	683.8	0.1	829.0	953.5	1.4	0.7	1195.7	784.4	0.0	0.0	0.0	0.6	97.3	1.7	0.0	717.3	0.4	615.0	1.9	0.6	0.0	0.9	0.6	342.6	163.5	658.9	507.6	391.3	1.2	1.0	1.0	1.3	252.6	0.7	481.4	579.5	263.3	4.5	0.9	451.8	410.9	1.1	1701.8	0.0	1.1	0.1	42.4	97.3	21.2	112.8	84.1	168.6	156.3	187.2	116.0	159.3	142.4	227.6	213.3	21.8	125.1	56.8	65.4	170.1	252.1	12.9	13.5	13.1	427.8	12.6	14.9	15.1	13.7	14.6	14.5	14.1	15.1	0.0	201.9	459.1	9.8	493.4	849.9	981.5	1273.9	537.3	115.3	0.0	0.0	109.8	343.1	479.2	215.2	41.7	568.8	126.2	24.6	471.6	302.8	13.7	0.0	0.0	354.9	99.5	292.5	10.9	8.3	368.5	281.0	208.5	0.0	354.6	0.0	476.2	51.1	281.6	53.8	9.4	159.2	256.3	426.3	758.3	52.3	809.3	248.7	588.7	11.2	407.2	321.0	472.7	5.0	6.4	213.6	56.1	431.8	202.7	816.8	115.7	893.6	314.5	153.4	276.1	292.4	214.8	103.3	227.3	594.7	989.7	464.4	523.1	0.0	183.8	904.0
RSAD1	"FLJ11164, HemW"	ENSG00000136444	"Radical S-adenosyl methionine domain containing 1"	Q9HA92	17	50478860-50485974	"Predicted intracellular proteins"		Chaperone		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"HPA022436, HPA022967, HPA024459"	Approved		Approved	"Mitotic chromosome,Mitochondria"		Yes	NA			"Cluster 39: Non-specific - mRNA processing"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 39: CACO-2 - Unknown function"	"Cluster 52: Non-specific - Transcription"	Mitochondria	"Mitotic chromosome"	"HPA022436: AB_2180789, HPA022967: AB_1856484, HPA024459: "	"unprognostic (8.21e-2)"	"unprognostic (4.11e-3)"	"unprognostic (3.72e-2)"	"unprognostic (1.83e-2)"	"unprognostic (3.49e-2)"	"unprognostic (2.93e-2)"	"unprognostic (6.01e-2)"	"unprognostic (1.07e-2)"	"unprognostic (2.52e-1)"	"unprognostic (1.13e-2)"	"prognostic favorable (5.04e-4)"	"unprognostic (1.06e-1)"	"unprognostic (1.65e-2)"	"unprognostic (4.89e-2)"	"unprognostic (2.95e-1)"	"unprognostic (7.85e-2)"	"unprognostic (3.22e-2)"	23.9	41.4	34.7	16.4	37.8	12.8	23.5	37.5	43.4	36.9	32.9	24.3	17.1	24.2	17.5	17.3	24.5	12.5	43.3	34.4	33.9	40.9	44.0	21.1	19.8	34.5	34.9	31.8	48.9	27.5	23.6	12.4	35.1	25.2	17.6	21.2	27.3	14.9	66.0	22.2	23.9	14.4	34.2	31.8	32.5	14.2	35.4	18.4	29.1	57.0	17.8	26.1	23.6	37.0	13.0	43.2	20.3	33.7	34.0	27.6	7.2	22.2	21.6	27.9	23.5	43.0	16.1	34.9	48.0	15.6	27.6	12.1	23.2	31.0	23.9	38.9	42.0	47.0	20.5	42.4	23.7	28.6	31.7	20.2	33.7	18.6	35.7	23.0	27.5	84.1	36.9	32.3	23.7	30.3	48.1	20.9	8.2	54.6	45.9	19.6	23.2	31.6	34.0	19.4	11.1	37.9	5.7	26.3	29.7	25.6	39.6	28.7	19.6	29.0	30.8	22.3	26.4	50.0	37.6	13.5	21.8	40.3	20.6	1.1	4.2	3.8	8.5	4.4	8.5	4.5	7.3	8.4	4.9	6.9	9.4	9.5	0.0	6.6	4.2	5.4	6.2	5.7	34.7	37.8	37.5	43.4	34.4	33.9	34.5	34.9	35.1	34.2	35.4	37.0	15.1	3.2	13.1	18.3	16.0	10.1	4.4	7.2	19.4	14.8	12.1	12.8	29.4	12.8	7.7	16.5	2.1	21.4	24.1	10.8	23.5	14.4	8.8	5.3	10.4	12.4	25.2	12.0	24.0	29.5	11.1	13.1	12.2	7.4	3.8	15.8	10.0	18.5	16.1	8.4	21.5	11.7	8.2	7.2	6.1	7.4	15.5	9.6	17.8	16.9	12.5	32.1	19.6	13.6	12.4	11.8	6.2	10.9	18.7	6.5	11.1	11.1	3.8	7.8	13.1	16.0	11.3	11.5	21.9	10.6	9.9	10.1	18.7	43.6	12.9	3.4
RTEL1	"bK3184A7.3, C20orf41, DKFZP434C013, KIAA1088, NHL, RTEL"	ENSG00000258366	"Regulator of telomere elongation helicase 1"	Q9NZ71	20	63657810-63696253	"Disease related genes, Enzymes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"DNA damage, DNA repair"	"DNA-binding, Helicase, Hydrolase"	"Disease variant, Dyskeratosis congenita"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"		"B-cells: 1.0;Erythroid cells: 3.8;Gastric mucus-secreting cells: 3.1;Plasma cells: 3.0;Squamous epithelial cells: 1.1"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			"HPA020622, HPA067329, HPA078328"			Approved	"Nuclear speckles,Nuclear bodies"		NA	NA			"Cluster 39: Non-specific - mRNA processing"	"Cluster 71: Testis - DNA repair"	"Cluster 39: CACO-2 - Unknown function"	"Cluster 59: Non-specific - Transcription"	"Nuclear speckles, Nuclear bodies"		"HPA020622: AB_2732425, HPA067329: AB_2685823, HPA078328: AB_2732380"	"unprognostic (3.63e-2)"	"unprognostic (8.08e-3)"	"unprognostic (4.80e-2)"	"unprognostic (1.12e-1)"	"unprognostic (4.27e-1)"	"unprognostic (9.30e-3)"	"unprognostic (2.59e-1)"	"unprognostic (3.64e-2)"	"unprognostic (3.30e-2)"	"unprognostic (9.05e-2)"	"unprognostic (4.09e-2)"	"unprognostic (9.50e-2)"	"unprognostic (8.77e-3)"	"unprognostic (1.17e-1)"	"unprognostic (2.55e-1)"	"unprognostic (2.80e-2)"	"unprognostic (8.84e-2)"	4.9	7.0	1.3	6.1	1.6	8.2	5.2	5.7	4.7	6.8	0.5	8.5	4.8	10.0	3.0	4.6	6.2	3.0	3.9	1.2	0.9	4.1	4.8	6.0	4.2	2.9	0.6	6.4	8.6	2.8	12.2	4.2	1.8	6.7	2.1	2.5	6.3	4.5	5.4	4.5	5.8	3.1	0.2	6.1	6.6	7.6	1.2	4.8	7.8	2.3	2.4	6.5	6.0	1.5	8.3	11.7	7.9	15.5	1.6	1.7	14.5	16.8	4.5	26.0	6.6	22.2	7.0	11.0	8.6	5.2	9.8	15.3	5.5	11.1	6.1	5.5	11.0	13.8	21.2	21.5	5.7	13.4	24.1	2.2	6.0	6.4	7.9	4.9	9.0	19.6	17.4	10.4	5.8	8.7	21.3	17.5	7.8	7.1	22.3	17.2	7.4	11.6	4.1	9.7	15.7	9.3	9.3	27.5	2.2	3.6	7.2	15.2	12.1	29.4	9.5	10.1	13.2	9.4	4.2	7.1	7.1	9.5	10.4	0.0	1.0	0.0	0.9	1.1	0.5	0.3	0.5	0.6	1.3	0.5	0.9	0.4	0.0	0.1	1.0	1.1	0.5	0.8	1.3	1.6	5.7	4.7	1.2	0.9	2.9	0.6	1.8	0.2	1.2	1.5	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.6	0.1	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.0	0.0	0.1	0.0	0.5	0.6	0.0	3.8	0.0	0.0	0.0	0.4	3.1	0.1	0.0	0.3	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.4	3.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.1	0.2	0.0	1.1	0.1	0.0	0.7	0.0	0.0	0.0
SCAF4	"DKFZp434E098, KIAA1172, SFRS15, SRA4"	ENSG00000156304	"SR-related CTD associated factor 4"	O95104	21	31671000-31732118	"Plasma proteins, Predicted intracellular proteins"	"Transcription, Transcription regulation"	RNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA018319, HPA018668, HPA021504, HPA028807"	Enhanced		Enhanced	Nucleoplasm		NA	NA			"Cluster 39: Non-specific - mRNA processing"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 59: Non-specific - Transcription"	Nucleoplasm		"HPA018319: AB_1856784, HPA018668: AB_1856783, HPA021504: AB_1856785, HPA028807: AB_10602927"	"unprognostic (9.18e-2)"	"unprognostic (1.17e-1)"	"unprognostic (9.29e-2)"	"unprognostic (1.79e-1)"	"unprognostic (1.88e-1)"	"unprognostic (1.85e-2)"	"unprognostic (3.99e-3)"	"unprognostic (4.31e-1)"	"unprognostic (2.19e-1)"	"unprognostic (2.66e-2)"	"unprognostic (3.28e-1)"	"unprognostic (6.11e-2)"	"unprognostic (1.85e-3)"	"unprognostic (2.87e-1)"	"unprognostic (7.65e-3)"	"unprognostic (1.10e-1)"	"unprognostic (2.16e-3)"	14.1	10.6	6.8	12.7	7.3	13.7	13.2	9.3	9.0	14.9	5.5	14.1	12.3	14.6	9.1	16.1	12.8	8.5	11.3	7.1	9.7	9.6	17.1	14.2	18.4	7.8	7.4	16.1	11.8	11.4	11.2	12.7	7.1	12.5	10.1	10.6	13.0	9.0	17.9	18.5	16.3	9.5	5.4	16.3	13.4	17.5	7.3	18.9	11.4	10.8	17.2	13.3	15.1	8.6	31.4	20.5	40.3	29.4	21.4	16.1	27.4	22.6	23.8	23.7	22.0	39.5	22.2	63.9	13.4	22.3	25.9	18.9	44.3	22.1	25.8	28.6	25.8	50.9	16.8	33.4	24.5	54.8	20.5	18.2	24.6	31.6	27.1	15.1	20.9	25.0	68.4	32.4	19.9	41.7	58.4	39.7	51.7	30.5	17.3	57.1	44.8	21.1	16.5	24.3	27.5	29.7	34.9	26.8	19.7	22.1	20.7	36.7	24.4	24.5	23.6	23.5	23.5	20.6	20.7	72.0	17.6	43.4	23.3	6.6	7.9	10.9	9.7	10.6	9.6	10.9	5.6	9.3	9.7	9.7	6.5	7.2	4.0	7.6	9.6	6.8	5.2	8.1	6.8	7.3	9.3	9.0	7.1	9.7	7.8	7.4	7.1	5.4	7.3	8.6	16.5	6.4	14.5	25.8	46.5	46.7	35.5	15.2	53.5	22.8	23.0	13.8	9.4	18.6	13.8	11.0	25.0	16.6	31.2	39.4	3.9	16.4	9.9	14.9	26.7	19.9	19.8	48.4	34.9	14.0	17.8	21.6	19.4	22.9	11.4	21.9	18.9	24.4	15.7	21.9	34.5	18.7	22.4	23.1	37.8	3.8	22.1	22.7	33.8	36.5	24.5	12.5	32.0	34.7	45.5	17.9	23.4	14.3	23.9	31.2	31.6	6.7	18.2	24.6	13.1	29.9	18.3	25.6	23.9	41.7	41.1	18.9	33.1	12.5	22.2	33.5
SEPTIN9	"AF17q25, KIAA0991, MSF, MSF1, PNUTL4, SEPT9, SeptD1"	ENSG00000184640	"Septin 9"	Q9UHD8	17	77280569-77500596	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"	"Cell cycle, Cell division"		"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"Adipocytes: 29.9;Cytotrophoblasts: 78.2;dendritic cells: 34.8;Extravillous trophoblasts: 152.8;Hofbauer cells: 67.5;Syncytiotrophoblasts: 70.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA042564, HPA050627"	Approved		Enhanced	"Actin filaments"		No	No		770000	"Cluster 39: Non-specific - mRNA processing"	"Cluster 3: T-cells - Adaptive immune response"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 24: Non-specific - Transcription regulation"	"Actin filaments"		"HPA042564: AB_2678054, HPA050627: AB_2681193"	"unprognostic (7.65e-2)"	"unprognostic (5.44e-2)"	"unprognostic (5.46e-3)"	"unprognostic (2.34e-1)"	"unprognostic (2.65e-2)"	"unprognostic (2.71e-1)"	"prognostic unfavorable (1.61e-5)"	"unprognostic (4.23e-3)"	"unprognostic (1.56e-1)"	"unprognostic (8.48e-2)"	"unprognostic (1.99e-1)"	"unprognostic (2.45e-1)"	"unprognostic (1.49e-2)"	"unprognostic (1.25e-1)"	"unprognostic (1.35e-1)"	"unprognostic (1.33e-1)"	"unprognostic (2.80e-1)"	68.7	87.9	58.8	148.8	61.7	89.2	72.8	81.6	85.3	99.3	59.9	137.8	94.9	127.5	27.0	81.9	89.0	88.3	70.5	68.1	68.6	75.2	99.5	77.8	223.8	111.5	62.0	76.4	38.7	67.2	63.3	80.7	76.6	96.0	51.9	15.6	76.8	75.6	73.1	80.3	145.1	84.5	68.2	152.8	103.1	60.0	65.7	260.2	52.9	43.1	151.5	122.9	82.4	71.8	246.1	342.0	221.3	186.4	257.0	417.1	121.7	188.9	214.1	122.4	89.0	278.4	243.4	338.7	153.4	388.5	161.2	149.1	96.6	354.8	90.4	6.2	65.0	128.8	147.3	483.2	212.0	84.6	218.3	215.6	128.8	159.6	136.0	180.3	167.5	196.4	144.6	44.1	110.7	258.1	628.1	72.0	207.5	281.4	281.1	290.7	192.6	117.1	197.5	337.9	171.0	324.3	214.2	349.6	207.2	248.6	260.2	60.7	243.6	165.8	147.6	197.4	130.2	10.5	19.5	562.6	245.6	73.7	348.7	4.2	18.4	31.1	22.3	46.3	19.0	16.3	28.7	26.4	17.0	17.4	29.6	25.8	6.1	16.9	55.3	38.7	31.8	24.9	58.8	61.7	81.6	85.3	68.1	68.6	111.5	62.0	76.6	68.2	65.7	71.8	29.9	0.0	0.0	0.0	6.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	13.5	0.0	0.0	0.0	0.0	78.2	34.8	0.0	0.0	0.0	0.0	0.0	0.0	5.9	0.0	0.0	0.0	0.0	152.8	9.4	0.0	0.0	0.0	0.0	0.0	0.0	67.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	12.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.7	0.0	0.0	0.0	0.0	70.6	6.8	0.0	0.0	0.0
SERF1B	"FAM2B, H4F5C"	ENSG00000205572	"Small EDRK-rich factor 1B"	O75920	5	70025247-70043113	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"testis: 154.4"	"Cell type enriched"	"Detected in some"	4	"Cardiomyocytes: 40.3"	"Low cancer specificity"	"Detected in single"			"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"EFO-21: 11.3"									HPA075271			Approved	"Nuclear bodies"		NA	NA			"Cluster 39: Non-specific - mRNA processing"	"Cluster 71: Testis - DNA repair"	"Cluster 38: EFO-21 - Unknown function"	"Cluster 43: Cardiomyocytes - Nuclear processes"	"Nuclear bodies"		"HPA075271: AB_2686740"	"unprognostic (1.00e-1)"	"unprognostic (2.52e-4)"	"unprognostic (2.60e-2)"	"unprognostic (1.07e-2)"	"unprognostic (1.61e-1)"	"unprognostic (2.32e-1)"	"unprognostic (5.98e-2)"	"unprognostic (4.92e-3)"	"unprognostic (1.48e-2)"	"unprognostic (2.14e-1)"	"unprognostic (3.08e-4)"	"unprognostic (1.22e-1)"	"unprognostic (2.16e-2)"	"unprognostic (2.44e-2)"	"unprognostic (7.82e-2)"	"unprognostic (6.74e-2)"	"unprognostic (3.52e-1)"	27.3	27.0	0.8	1.6	1.3	1.7	30.3	1.3	2.1	34.4	0.3	45.0	0.7	31.9	0.5	28.6	25.5	1.0	44.7	1.5	2.3	36.4	14.9	30.5	2.1	0.8	0.7	27.1	27.7	1.4	38.0	1.0	0.9	30.4	1.2	11.4	25.1	2.1	46.5	22.7	30.8	2.9	0.8	23.3	28.4	154.4	0.7	1.3	33.8	1.2	1.6	28.3	32.4	1.5	2.6	0.7	4.1	6.0	3.8	1.5	1.1	1.0	1.8	1.7	3.7	0.6	3.0	3.1	11.3	1.1	3.8	1.3	2.6	1.9	1.6	8.0	0.9	3.0	1.3	1.6	1.5	0.1	2.9	1.2	5.3	1.9	0.3	1.3	1.7	0.9	1.2	2.5	0.5	0.2	4.7	2.1	3.6	0.0	0.4	2.4	6.3	5.0	1.3	1.5	7.8	5.1	2.7	0.1	3.7	1.8	2.6	1.1	6.3	1.6	1.8	1.0	1.7	2.0	3.4	3.5	1.6	0.2	3.2	0.3	0.2	1.8	4.1	1.5	4.8	3.3	5.9	2.9	2.9	6.3	7.0	4.9	0.5	2.6	1.5	4.6	2.8	1.9	0.8	1.3	1.3	2.1	1.5	2.3	0.8	0.7	0.9	0.8	0.7	1.5	0.4	9.6	2.2	0.0	1.0	0.4	0.7	0.3	1.2	0.1	0.5	0.5	40.3	0.0	3.2	0.0	2.1	0.1	0.4	0.6	1.9	0.2	1.6	0.3	0.7	4.4	0.0	0.4	0.0	0.0	0.1	3.4	0.0	0.2	0.0	0.3	0.0	0.1	0.1	0.0	0.0	0.1	0.0	0.0	0.7	1.0	1.8	0.2	0.0	0.0	0.0	0.2	1.0	0.0	0.0	0.0	0.0	0.0	0.8	0.4	0.1	1.1	5.2	1.4	0.0	0.5	8.8	1.6	0.6	0.9	0.6	0.0	0.7	0.1	0.4	0.4
SF1	"ZCCHC25, ZFM1, ZNF162"	ENSG00000168066	"Splicing factor 1"	Q15637	11	64764606-64778786	"Plasma proteins, Predicted intracellular proteins"	"mRNA processing, mRNA splicing, Transcription, Transcription regulation"	"Repressor, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							HPA018883	Supported		Supported	Nucleoplasm		NA	NA		130000	"Cluster 39: Non-specific - mRNA processing"	"Cluster 59: Non-specific - Translation"	"Cluster 14: REH - Unknown function"	"Cluster 57: B-cells - Immune response"	Nucleoplasm		"HPA018883: AB_1856763"	"unprognostic (1.24e-1)"	"unprognostic (2.42e-1)"	"unprognostic (1.18e-1)"	"unprognostic (4.01e-2)"	"unprognostic (1.50e-1)"	"unprognostic (4.35e-1)"	"prognostic unfavorable (4.85e-5)"	"unprognostic (3.72e-1)"	"unprognostic (4.51e-3)"	"unprognostic (1.39e-1)"	"unprognostic (4.62e-3)"	"unprognostic (6.20e-2)"	"unprognostic (8.00e-2)"	"unprognostic (2.18e-1)"	"unprognostic (1.42e-1)"	"unprognostic (2.62e-2)"	"unprognostic (1.78e-1)"	111.7	89.1	47.2	73.1	47.9	230.4	100.8	70.8	73.7	106.8	39.7	112.6	62.3	110.5	46.3	98.2	118.7	53.8	93.0	44.2	64.4	97.9	100.4	85.0	95.8	51.5	40.2	142.4	103.3	52.0	97.7	53.4	42.2	105.7	42.5	46.3	87.4	58.4	149.2	96.3	110.5	63.4	27.7	133.6	104.5	110.2	53.3	91.2	99.6	73.3	80.4	98.4	92.3	57.9	141.2	165.4	151.1	131.0	82.4	65.5	178.8	98.9	83.6	130.3	100.3	142.0	154.8	223.6	120.2	111.4	119.4	163.8	172.2	171.0	110.3	167.1	115.0	144.6	107.6	107.0	130.7	155.0	143.7	86.0	87.1	165.2	172.3	77.0	118.9	145.0	216.4	141.5	100.8	145.1	294.2	217.9	206.5	126.2	117.5	253.2	104.7	177.7	87.5	151.8	119.6	157.4	138.1	118.8	138.3	95.6	182.7	163.6	104.6	145.1	131.7	134.5	158.2	163.6	139.4	205.6	129.1	132.2	180.2	3.4	9.7	10.7	12.9	10.8	12.9	9.3	9.6	12.7	9.6	7.3	11.2	11.9	13.7	9.2	9.7	10.9	10.5	9.4	47.2	47.9	70.8	73.7	44.2	64.4	51.5	40.2	42.2	27.7	53.3	57.9	131.9	60.9	88.7	82.3	326.5	184.2	205.1	121.4	350.0	267.2	158.4	127.8	63.5	107.2	87.2	55.2	225.2	118.6	194.5	133.6	37.2	80.4	156.9	156.6	180.5	134.3	209.8	115.7	60.6	73.8	116.8	126.1	138.6	170.1	107.8	212.6	164.2	120.7	98.2	175.0	52.1	115.6	109.9	137.2	167.6	67.1	157.5	122.0	96.0	72.1	146.4	121.9	166.9	62.4	141.0	88.3	106.3	113.2	188.1	192.8	118.5	56.0	83.1	325.8	78.9	145.3	132.0	116.8	84.3	246.9	183.8	148.7	250.2	249.6	129.6	194.3
SF3B3	"KIAA0017, RSE1, SAP130, SF3b130"	ENSG00000189091	"Splicing factor 3b subunit 3"	Q15393	16	70523791-70577670	"Plasma proteins, Predicted intracellular proteins"	"mRNA processing, mRNA splicing"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041134, HPA042986"	Supported		Supported	"Nucleoplasm,Nucleoli,Nucleoli rim"		No	No		50000	"Cluster 39: Non-specific - mRNA processing"	"Cluster 34: Non-specific - Transcription"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 59: Non-specific - Transcription"	"Nucleoplasm, Nucleoli, Nucleoli rim"		"HPA041134: AB_2677317, HPA042986: AB_10960386"	"unprognostic (3.39e-2)"	"unprognostic (1.53e-1)"	"unprognostic (7.47e-2)"	"unprognostic (1.87e-1)"	"unprognostic (2.05e-2)"	"unprognostic (3.59e-2)"	"unprognostic (1.06e-2)"	"unprognostic (7.67e-2)"	"unprognostic (2.07e-1)"	"unprognostic (2.29e-1)"	"unprognostic (6.97e-2)"	"unprognostic (2.29e-1)"	"unprognostic (3.28e-2)"	"unprognostic (1.60e-1)"	"unprognostic (8.76e-2)"	"unprognostic (7.91e-2)"	"unprognostic (1.73e-1)"	15.7	11.2	7.9	19.2	8.2	22.2	13.8	15.9	9.6	16.3	11.4	17.1	13.6	17.0	10.2	19.9	16.4	11.6	12.1	8.8	9.7	12.5	12.3	11.7	24.3	7.0	6.9	22.3	13.8	16.8	7.9	14.1	7.5	11.6	13.2	16.3	12.6	10.7	23.6	19.9	12.9	16.0	6.5	13.9	13.2	10.2	10.4	23.7	14.5	11.7	26.6	14.2	14.4	12.0	72.4	72.6	93.4	65.3	45.5	41.6	74.0	66.3	55.5	84.5	67.3	75.6	55.8	97.1	52.6	51.8	49.9	81.4	98.0	55.7	133.0	31.5	71.1	75.1	56.7	81.0	30.6	106.1	83.9	39.8	40.1	93.9	68.8	54.1	50.9	55.3	104.6	34.2	67.4	87.5	92.9	51.6	85.2	44.8	41.9	163.2	73.3	109.7	26.9	96.4	81.4	59.8	217.7	33.8	33.8	39.2	73.9	53.0	52.7	61.9	67.8	49.2	71.6	37.4	90.4	260.7	40.9	66.9	61.3	23.4	26.1	28.1	35.8	30.8	39.3	28.4	33.1	37.5	35.3	34.3	38.8	33.7	8.3	35.5	31.2	19.1	40.2	37.4	7.9	8.2	15.9	9.6	8.8	9.7	7.0	6.9	7.5	6.5	10.4	12.0	18.9	25.6	25.7	16.6	33.0	22.4	23.2	23.4	13.1	35.5	20.5	18.3	29.3	14.3	25.4	23.9	14.6	33.6	21.6	19.7	7.9	20.7	6.3	17.8	31.9	25.4	21.1	36.8	23.2	23.2	34.7	24.2	20.4	17.5	17.7	52.3	17.5	23.6	23.6	40.4	26.5	21.8	24.4	20.6	12.8	10.3	33.8	19.2	17.8	24.4	22.7	19.4	25.7	26.2	26.7	24.9	14.0	33.1	25.1	30.2	18.1	15.7	18.8	26.7	6.6	30.2	18.8	28.7	33.3	37.6	26.1	25.4	28.3	48.2	31.6	24.7
SGSH	"HSS, MPS3A, SFMD"	ENSG00000181523	"N-sulfoglucosamine sulfohydrolase"	P51688	17	80206716-80220923	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"		Hydrolase	"Disease variant, Mucopolysaccharidosis"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Theca cells: 32.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HHSteC: 62.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA023436, HPA023451"	Enhanced				"Intracellular and membrane"	NA	NA			"Cluster 39: Non-specific - mRNA processing"	"Cluster 17: Adrenal gland - Steroid metabolism"	"Cluster 8: SK-BR-3 - Unknown function"	"Cluster 52: Non-specific - Transcription"			"HPA023436: AB_1856806, HPA023451: AB_1856807"	"unprognostic (4.33e-2)"	"unprognostic (4.03e-2)"	"unprognostic (1.06e-2)"	"unprognostic (4.01e-2)"	"unprognostic (4.26e-3)"	"unprognostic (1.39e-3)"	"prognostic unfavorable (7.71e-4)"	"prognostic favorable (2.72e-4)"	"unprognostic (6.08e-2)"	"unprognostic (3.65e-1)"	"prognostic favorable (3.10e-4)"	"unprognostic (2.05e-1)"	"prognostic unfavorable (2.66e-4)"	"unprognostic (1.42e-2)"	"prognostic unfavorable (5.37e-4)"	"unprognostic (7.50e-2)"	"unprognostic (3.68e-2)"	16.6	45.9	1.7	12.2	2.3	3.6	17.2	0.7	5.2	13.5	8.8	14.8	12.7	17.2	4.6	11.0	16.0	10.6	9.9	2.0	5.4	15.7	9.5	18.1	13.4	4.4	7.6	12.3	20.4	16.0	17.0	12.4	4.2	19.7	6.5	2.8	21.8	11.1	7.0	18.9	16.7	10.6	2.5	28.4	17.8	3.9	5.3	4.2	21.2	4.6	6.9	15.5	11.5	1.8	2.6	7.9	9.8	15.6	22.5	20.2	10.4	16.0	40.4	27.7	24.2	9.0	9.5	0.1	25.7	24.9	13.2	9.9	6.2	11.7	4.7	5.3	9.6	0.0	22.3	25.0	62.2	0.0	5.9	33.9	12.0	9.9	10.5	5.8	50.7	4.7	7.1	26.2	17.9	16.2	0.3	0.2	3.3	10.0	13.2	1.4	3.7	21.1	20.2	18.5	2.0	11.7	18.4	44.1	10.6	4.9	32.8	0.5	32.5	31.9	7.0	11.4	7.4	26.1	3.6	3.9	13.6	0.0	16.3	0.0	20.6	0.0	12.1	8.0	16.0	3.5	10.5	11.3	20.4	3.8	8.2	6.7	2.1	9.3	8.0	1.5	13.5	12.7	1.7	2.3	0.7	5.2	2.0	5.4	4.4	7.6	4.2	2.5	5.3	1.8	7.5	3.2	10.8	4.2	5.5	5.1	3.7	5.9	5.7	3.7	9.3	9.3	1.7	5.7	7.3	7.3	8.4	18.2	5.2	12.0	0.0	8.9	0.2	5.3	9.2	10.1	3.0	2.7	2.6	15.9	8.7	10.1	17.9	10.0	0.0	13.6	9.7	4.5	17.7	0.0	3.4	9.3	4.1	18.2	7.6	0.5	11.5	13.0	1.8	2.8	8.4	4.1	6.2	4.5	1.7	6.8	6.0	14.3	5.5	5.5	8.1	4.9	3.8	3.9	13.1	4.0	5.3	0.3	0.5	6.4	5.5	27.0	7.2	32.0	8.0	2.9
SLC25A22	"EIEE3, FLJ13044, GC1, NET44"	ENSG00000177542	"Solute carrier family 25 member 22"	Q9H936	11	790475-798281	"Disease related genes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted membrane proteins, Transporters"	"Symport, Transport"		"Disease variant, Epilepsy"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 83.1;pancreas: 83.4"	"Cell type enhanced"	"Detected in many"		"Bipolar cells: 143.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA014662	Approved		Uncertain	Nucleoplasm,Mitochondria		NA	NA			"Cluster 39: Non-specific - mRNA processing"	"Cluster 22: Non-specific - Unknown function"	"Cluster 7: SCLC-21H - Neuronal signaling"	"Cluster 56: Bipolar cells - Visual perception"	Mitochondria	Nucleoplasm	"HPA014662: AB_10600808"	"unprognostic (1.01e-2)"	"unprognostic (2.12e-1)"	"unprognostic (7.28e-2)"	"unprognostic (4.68e-2)"	"unprognostic (2.09e-3)"	"unprognostic (1.43e-1)"	"unprognostic (2.72e-3)"	"unprognostic (8.67e-3)"	"unprognostic (4.19e-2)"	"unprognostic (3.70e-1)"	"unprognostic (2.46e-2)"	"unprognostic (1.16e-1)"	"unprognostic (8.97e-3)"	"unprognostic (2.61e-2)"	"unprognostic (8.47e-2)"	"unprognostic (1.08e-1)"	"unprognostic (1.50e-1)"	15.8	13.6	49.1	11.0	59.8	7.5	11.2	17.9	83.1	9.0	0.0	10.0	12.9	9.6	2.1	15.2	10.4	4.1	7.7	74.2	7.9	15.1	40.2	15.1	10.1	24.5	11.1	12.7	83.4	4.0	48.7	5.0	25.4	13.9	3.0	16.1	14.4	4.3	2.0	14.2	12.2	3.7	2.4	13.9	13.5	19.1	19.1	6.3	9.4	0.5	6.2	10.3	10.3	40.2	56.2	35.7	20.4	18.6	8.3	14.8	19.4	26.3	21.3	28.0	17.7	34.9	37.1	16.8	19.2	21.6	31.9	48.8	22.4	31.1	6.3	31.9	41.4	15.4	18.2	21.9	35.8	24.7	25.0	14.9	18.6	21.4	22.6	8.8	13.0	19.3	31.8	25.3	12.7	33.9	26.3	23.5	44.8	33.9	53.7	30.9	11.2	38.9	16.8	9.2	100.3	45.3	15.0	35.9	18.7	3.1	17.4	12.5	13.0	32.1	21.5	14.8	25.0	22.1	14.3	21.5	37.8	22.2	19.3	0.0	1.6	2.5	3.7	3.3	2.2	1.3	2.3	3.9	1.8	1.0	1.3	2.3	0.9	2.0	3.4	0.5	1.3	1.6	49.1	59.8	17.9	83.1	74.2	7.9	24.5	11.1	25.4	2.4	19.1	40.2	5.7	6.4	8.6	7.8	8.4	12.6	8.7	9.5	9.1	143.2	9.1	7.5	2.5	8.6	5.0	9.2	33.3	7.1	8.8	3.9	3.9	22.0	12.4	9.5	9.0	7.0	13.1	2.5	11.8	19.3	10.3	5.1	12.8	11.2	2.5	7.2	3.3	17.6	4.3	43.7	10.0	7.6	2.0	2.8	4.6	7.7	4.7	4.1	3.6	3.7	6.6	16.0	13.4	2.5	1.4	14.1	7.8	4.9	13.7	23.8	13.0	7.1	5.8	32.0	0.0	2.8	6.7	1.8	10.4	7.4	13.4	3.1	8.2	13.7	5.9	8.8
SLC25A25	"KIAA1896, MCSC, PCSCL"	ENSG00000148339	"Solute carrier family 25 member 25"	Q6KCM7	9	128068201-128109245	"Predicted intracellular proteins, Transporters"	Transport			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 136.5"	"Cell type enhanced"	"Detected in many"		"Cone photoreceptor cells: 127.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA020381	Uncertain		Supported	Vesicles,Mitochondria	"Intracellular and membrane"	NA	NA			"Cluster 39: Non-specific - mRNA processing"	"Cluster 55: Non-specific - Mitochondria & Proteasome"	"Cluster 16: U-266 - Nucleosome"	"Cluster 44: Endometrium - Transcription"	"Vesicles, Mitochondria"		"HPA020381: AB_1857037"	"unprognostic (4.62e-2)"	"unprognostic (2.66e-2)"	"unprognostic (2.56e-2)"	"unprognostic (1.59e-1)"	"unprognostic (2.89e-1)"	"unprognostic (1.40e-1)"	"prognostic favorable (1.01e-4)"	"unprognostic (1.20e-1)"	"unprognostic (1.66e-1)"	"unprognostic (1.60e-2)"	"unprognostic (4.96e-2)"	"unprognostic (3.70e-2)"	"prognostic favorable (4.65e-6)"	"unprognostic (1.21e-1)"	"unprognostic (1.05e-2)"	"unprognostic (1.66e-3)"	"unprognostic (1.42e-2)"	55.3	22.9	16.0	12.5	16.5	9.5	22.9	14.7	19.7	33.2	10.6	17.2	11.9	26.8	3.3	35.0	40.7	39.9	12.8	18.1	17.4	28.6	136.5	27.9	11.2	19.9	18.1	25.3	82.6	19.6	45.7	11.5	17.9	15.2	7.8	31.2	16.5	14.2	82.0	24.4	18.3	26.3	15.4	15.6	23.7	7.6	19.6	15.3	18.9	21.1	6.2	19.0	21.4	14.9	9.5	9.8	13.6	19.8	10.1	8.6	9.0	19.3	17.8	15.9	10.5	17.7	9.7	12.2	5.8	9.0	8.8	16.6	10.8	6.3	6.0	14.3	8.9	7.1	21.6	10.7	16.0	8.3	15.7	11.0	6.0	15.5	11.3	5.2	10.9	20.1	26.1	25.7	10.1	22.9	14.7	8.4	13.8	30.5	15.1	14.3	11.6	26.1	6.1	9.8	33.6	14.5	20.2	12.9	27.8	5.3	14.2	4.7	7.0	17.9	10.6	13.6	19.3	22.3	42.2	13.2	12.1	4.4	15.0	2.6	1.7	0.9	3.0	5.1	1.6	1.2	3.4	3.1	3.1	1.8	2.7	4.9	0.3	1.0	6.1	1.0	2.7	3.2	16.0	16.5	14.7	19.7	18.1	17.4	19.9	18.1	17.9	15.4	19.6	14.9	59.3	22.4	34.2	17.6	9.3	26.1	46.2	24.3	56.3	18.8	71.7	73.5	3.2	58.6	22.8	20.2	127.2	10.1	7.6	45.6	11.7	11.2	0.3	72.0	34.5	44.7	51.7	11.0	19.7	11.5	12.9	21.0	43.8	110.3	8.2	18.7	26.0	84.5	9.1	18.5	20.5	26.5	28.5	20.1	42.9	1.5	9.3	16.8	21.4	13.1	12.6	15.2	12.3	11.1	2.4	12.1	42.7	8.2	14.5	28.6	47.7	10.2	30.8	70.4	19.7	48.1	40.3	5.6	7.9	89.5	43.0	23.0	14.2	11.9	22.3	58.3
SLC25A32	MFTC	ENSG00000164933	"Solute carrier family 25 member 32"	Q9H2D1	8	103398635-103415189	"Disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins, Transporters"	Transport		"Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											"HPA024763, HPA047402"	Uncertain		Approved	Nucleoplasm,Mitochondria		NA	NA			"Cluster 39: Non-specific - mRNA processing"	"Cluster 55: Non-specific - Mitochondria & Proteasome"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 59: Non-specific - Transcription"	Mitochondria	Nucleoplasm	"HPA024763: , HPA047402: AB_2680032"	"unprognostic (2.45e-3)"	"unprognostic (8.19e-2)"	"unprognostic (3.87e-3)"	"prognostic unfavorable (7.23e-4)"	"unprognostic (2.06e-2)"	"unprognostic (6.50e-3)"	"unprognostic (1.22e-2)"	"prognostic unfavorable (2.09e-4)"	"unprognostic (9.47e-2)"	"unprognostic (8.43e-2)"	"unprognostic (2.08e-1)"	"unprognostic (9.21e-2)"	"prognostic unfavorable (1.53e-6)"	"unprognostic (7.82e-2)"	"unprognostic (2.12e-1)"	"unprognostic (1.62e-1)"	"unprognostic (4.49e-2)"	13.5	7.2	3.1	12.5	3.9	14.6	11.2	4.1	4.8	8.6	2.9	7.7	6.8	10.7	7.5	7.3	9.3	11.5	9.7	4.1	4.5	9.6	17.9	8.5	16.9	4.7	4.6	9.6	8.5	8.8	11.3	10.1	4.6	8.0	7.7	1.4	6.4	7.5	9.6	6.9	7.6	10.9	4.6	12.7	7.0	6.4	4.0	8.7	7.1	9.2	12.8	15.0	7.0	5.3	33.7	11.5	10.5	18.3	21.3	23.3	10.3	27.4	39.9	30.6	31.4	14.0	19.6	73.8	25.8	29.5	17.7	20.4	22.5	22.5	47.0	45.5	16.1	53.5	8.5	18.3	37.4	26.5	23.1	23.1	17.9	34.5	51.2	8.6	32.5	19.4	33.9	25.9	30.5	13.5	45.0	21.6	17.1	39.3	23.6	33.6	16.3	50.8	20.8	12.7	28.0	17.2	13.6	22.3	48.9	10.5	19.3	18.5	22.6	36.7	24.9	44.2	36.2	19.2	19.7	76.8	31.0	38.1	27.5	0.6	3.3	1.6	6.0	3.7	7.3	7.0	6.4	6.9	4.1	4.8	6.5	6.7	0.8	5.2	4.3	3.5	5.5	5.7	3.1	3.9	4.1	4.8	4.1	4.5	4.7	4.6	4.6	4.6	4.0	5.3	28.9	3.2	3.3	10.1	46.9	23.1	16.7	6.9	32.5	9.4	10.3	6.7	10.4	11.5	5.4	5.5	6.2	11.9	20.9	4.1	7.9	9.8	4.8	8.3	14.0	22.2	11.4	16.2	30.3	9.4	13.6	19.6	27.0	9.1	8.9	8.0	20.0	15.2	10.2	8.4	25.8	7.1	8.2	7.3	11.6	4.7	9.3	16.2	10.6	24.4	9.9	7.6	15.5	25.6	46.6	10.0	3.1	8.6	56.3	14.4	4.1	9.5	2.6	8.1	19.7	13.5	14.7	22.9	17.1	32.6	25.9	14.0	27.7	9.5	7.5	15.1
SLC25A6	"ANT3, ANT3Y, MGC17525"	ENSG00000169100	"Solute carrier family 25 member 6"	P12236	X	1386152-1392113	"FDA approved drug targets, Metabolic proteins, Plasma proteins, Predicted membrane proteins, Transporters"	"Antiport, Apoptosis, Host-virus interaction, Transport"		"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			"HPA046835, HPA071684"	Approved		Supported	Mitochondria		NA	NA		450000	"Cluster 39: Non-specific - mRNA processing"	"Cluster 25: Pancreas - Digestion"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 32: Non-specific - Translation"	Mitochondria		"HPA046835: AB_2679831, HPA071684: AB_2686431"	"unprognostic (1.13e-1)"	"unprognostic (1.65e-2)"	"unprognostic (4.79e-2)"	"unprognostic (1.45e-1)"	"unprognostic (2.14e-1)"	"unprognostic (1.41e-1)"	"unprognostic (1.01e-3)"	"unprognostic (1.34e-1)"	"unprognostic (8.07e-2)"	"unprognostic (1.48e-1)"	"unprognostic (1.37e-3)"	"unprognostic (2.51e-1)"	"unprognostic (3.96e-2)"	"unprognostic (2.73e-1)"	"unprognostic (1.69e-1)"	"unprognostic (2.85e-1)"	"unprognostic (4.57e-3)"	356.6	410.1	227.8	223.3	241.4	441.5	307.3	210.8	296.7	253.7	351.6	350.9	466.0	277.9	80.6	344.8	243.4	127.2	201.5	227.9	216.1	386.8	130.0	239.4	275.0	222.6	222.8	460.8	626.9	323.5	275.8	147.1	228.0	264.1	141.5	108.3	697.7	178.8	115.5	331.3	387.7	129.4	208.3	263.7	413.9	62.2	227.4	232.7	321.5	89.2	159.3	292.0	244.6	219.2	290.4	596.8	393.8	422.6	267.5	527.4	466.2	396.8	386.1	296.8	289.2	796.7	330.6	1023.0	334.1	264.9	445.6	179.2	269.5	482.0	89.8	260.3	886.0	545.0	396.0	899.7	642.2	398.1	649.8	870.1	882.2	235.8	335.9	367.5	441.6	315.7	407.2	233.8	284.5	575.4	791.1	733.3	516.0	105.5	802.2	378.8	333.8	828.3	351.4	693.6	682.9	1096.5	271.1	817.7	1239.7	224.1	466.1	832.5	505.5	305.1	169.6	596.5	422.1	606.7	110.5	705.9	48.7	389.9	170.3	34.2	739.8	47.2	319.5	808.7	466.9	671.4	431.3	377.9	985.9	532.5	396.1	399.7	34.4	359.9	832.3	461.2	447.6	1120.7	227.8	241.4	210.8	296.7	227.9	216.1	222.6	222.8	228.0	208.3	227.4	219.2	194.2	147.4	244.3	13.7	724.4	1151.2	1447.6	1800.6	421.8	286.1	981.3	710.8	106.0	371.8	704.7	316.3	98.0	1581.2	448.5	690.4	1659.2	752.6	11.4	164.4	388.1	473.0	928.4	471.3	15.1	1473.5	1229.8	507.8	374.1	245.3	343.6	698.0	529.4	149.7	1264.7	242.3	20.4	1208.1	819.9	1553.5	1299.4	45.8	667.9	764.0	754.2	17.8	1450.5	184.6	531.4	8.0	13.7	789.8	1127.8	366.3	604.9	1452.4	1564.9	1320.8	180.3	280.0	341.8	631.7	665.6	13.3	80.7	796.7	1321.5	1744.1	494.7	847.8	1524.3	1723.2
SLC35E2B		ENSG00000189339	"Solute carrier family 35 member E2B"	P0CK96	1	1659529-1692795	"Predicted membrane proteins, Transporters"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Cone photoreceptor cells: 77.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA045641, HPA062711"	Uncertain		Uncertain	Nucleoplasm		NA	NA			"Cluster 39: Non-specific - mRNA processing"	"Cluster 68: Epididymis - Unknown function"	"Cluster 11: RPE1 & U-87MG - Synaptic function"	"Cluster 9: Photoreceptor cells - Phototransduction"	Nucleoplasm		"HPA045641: AB_2679402, HPA062711: AB_2684844"	"unprognostic (9.00e-2)"	"unprognostic (2.13e-1)"	"unprognostic (8.74e-3)"	"unprognostic (1.01e-1)"	"unprognostic (1.82e-1)"	"prognostic favorable (7.64e-4)"	"unprognostic (1.18e-1)"	"unprognostic (4.09e-2)"	"unprognostic (5.70e-2)"	"unprognostic (5.83e-2)"	"unprognostic (2.04e-2)"	"unprognostic (2.20e-1)"	"unprognostic (2.92e-1)"	"unprognostic (2.68e-2)"	"unprognostic (6.61e-2)"	"unprognostic (2.54e-2)"	"prognostic favorable (5.15e-4)"	21.0	29.7	38.1	20.9	35.9	17.3	25.8	30.7	38.5	35.3	31.3	30.8	31.9	31.8	34.2	20.8	29.2	19.5	19.4	38.8	27.8	27.8	26.1	22.9	32.4	28.8	29.9	39.0	30.7	20.3	43.1	20.4	29.4	30.2	22.1	42.6	29.1	22.5	29.1	29.5	34.1	30.6	26.2	40.1	28.7	10.9	31.1	34.5	30.8	14.6	28.0	26.0	26.5	33.3	13.0	17.4	58.3	49.8	42.3	40.0	16.9	15.6	35.8	16.9	19.7	12.8	33.6	22.6	24.2	33.7	20.9	16.9	23.0	14.9	16.8	28.4	20.1	30.6	37.2	21.7	31.5	24.6	26.2	35.0	31.2	21.4	30.5	47.3	35.5	40.9	31.1	30.8	19.4	9.2	32.3	29.2	19.0	11.2	18.5	28.3	15.9	29.5	29.1	13.1	50.9	46.8	26.4	31.5	50.8	23.8	38.9	34.8	33.5	29.9	12.6	11.7	8.6	25.0	19.6	35.2	22.8	45.2	16.5	1.8	3.7	2.8	7.0	3.3	7.6	3.9	5.9	8.1	2.4	3.9	6.8	5.9	5.5	4.0	2.4	7.6	6.0	5.0	38.1	35.9	30.7	38.5	38.8	27.8	28.8	29.9	29.4	26.2	31.1	33.3	8.2	12.8	28.3	9.8	19.8	7.4	7.1	14.1	18.8	35.5	12.0	8.6	17.1	34.3	24.6	3.7	77.2	14.1	26.0	28.3	0.0	5.7	1.1	9.1	14.8	16.8	25.4	21.5	12.0	6.1	9.6	18.4	30.5	6.8	23.4	13.9	25.4	22.2	10.5	30.3	12.1	24.3	18.3	31.5	8.2	3.9	30.4	13.8	12.4	9.4	21.8	12.3	29.9	14.6	12.9	6.2	17.8	26.7	28.0	9.3	38.1	3.4	23.4	66.5	6.6	16.8	12.0	8.5	16.1	16.3	9.7	8.8	23.1	10.1	26.4	8.7
SLC38A2	"ATA2, KIAA1382, SAT2, SNAT2"	ENSG00000134294	"Solute carrier family 38 member 2"	Q96QD8	12	46358188-46372773	"FDA approved drug targets, Metabolic proteins, Predicted membrane proteins, Transporters"	"Amino-acid transport, Ion transport, Sodium transport, Symport, Transport"		"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Basal keratinocytes: 1118.3;Suprabasal keratinocytes: 1078.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"hTERT-HME1: 1198.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA035180, HPA069672"	Approved		Supported	"Plasma membrane"		NA	NA			"Cluster 39: Non-specific - mRNA processing"	"Cluster 85: Liver - Metabolism"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 7: Non-specific - Mitochondria"	"Plasma membrane"		"HPA035180: AB_10669901, HPA069672: "	"unprognostic (6.61e-3)"	"unprognostic (2.87e-2)"	"unprognostic (4.88e-2)"	"unprognostic (2.51e-2)"	"unprognostic (2.96e-1)"	"unprognostic (1.00e-2)"	"unprognostic (7.78e-2)"	"unprognostic (5.50e-3)"	"unprognostic (1.20e-1)"	"unprognostic (3.79e-1)"	"unprognostic (9.24e-3)"	"unprognostic (1.75e-1)"	"unprognostic (1.47e-1)"	"unprognostic (5.08e-2)"	"unprognostic (3.80e-1)"	"unprognostic (1.83e-1)"	"unprognostic (8.68e-2)"	112.8	113.0	36.1	71.6	48.5	95.4	88.5	53.9	50.2	91.7	25.8	58.3	33.6	92.9	38.6	108.1	83.6	131.3	60.7	32.4	46.1	64.8	307.3	117.0	67.1	52.2	42.7	130.1	74.7	91.5	27.9	162.1	53.5	52.8	49.7	27.0	77.2	43.1	108.5	204.4	54.4	115.8	44.2	75.3	63.0	25.4	44.2	100.4	63.1	174.7	78.1	98.9	88.0	73.0	83.7	179.9	157.6	444.1	356.7	347.7	118.1	382.8	921.2	313.0	254.0	108.2	151.2	0.1	504.2	627.9	215.3	271.1	107.9	335.1	299.1	67.0	61.0	105.8	208.7	339.9	548.8	88.0	108.7	357.2	718.4	199.5	1198.9	778.5	265.7	116.3	103.8	163.1	560.4	100.0	110.3	122.8	138.2	0.1	185.1	97.5	115.5	200.9	191.6	173.4	103.9	89.8	263.5	68.5	233.7	171.0	140.5	193.8	467.3	156.7	121.8	67.8	62.2	187.8	194.3	100.6	148.0	304.5	76.8	41.1	24.9	18.9	22.7	13.1	17.4	19.2	19.0	23.0	35.2	17.8	23.5	24.8	17.5	51.6	18.4	40.6	23.7	27.6	36.1	48.5	53.9	50.2	32.4	46.1	52.2	42.7	53.5	44.2	44.2	73.0	237.7	83.3	77.4	31.3	187.7	1118.3	134.1	262.8	653.9	40.5	315.7	252.2	153.6	108.7	123.9	57.0	70.9	53.8	292.3	114.6	5.9	41.2	5.5	228.5	245.0	234.7	76.7	109.0	54.6	51.1	49.3	219.1	328.2	464.0	81.6	138.3	227.7	265.9	54.0	53.8	58.9	175.0	130.2	143.3	303.6	12.4	263.2	193.8	250.8	59.0	52.6	74.3	70.0	42.3	136.2	79.4	83.5	85.0	322.2	181.7	67.4	24.4	50.3	68.7	282.7	184.8	339.5	6.7	15.5	532.6	1078.3	38.4	252.4	84.0	110.7	150.8
SLC41A1	MgtE	ENSG00000133065	"Solute carrier family 41 member 1"	Q8IVJ1	1	205789094-205813748	"Metabolic proteins, Predicted membrane proteins, Transporters"	"Ion transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"heart muscle: 99.3;tongue: 75.9"	"Cell type enhanced"	"Detected in many"		"Cardiomyocytes: 175.0;Theca cells: 100.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in single"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA014721, HPA015138"	Uncertain		Approved	Mitochondria		NA	NA			"Cluster 39: Non-specific - mRNA processing"	"Cluster 38: Heart - Muscle contraction"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 54: Cardiomyocytes - Muscle contraction"	Mitochondria		"HPA014721: , HPA015138: AB_1857160"	"unprognostic (1.18e-1)"	"prognostic unfavorable (1.48e-4)"	"unprognostic (2.77e-2)"	"unprognostic (1.30e-2)"	"unprognostic (2.30e-1)"	"unprognostic (1.38e-2)"	"unprognostic (2.37e-3)"	"unprognostic (5.23e-2)"	"unprognostic (5.53e-3)"	"unprognostic (1.11e-1)"	"unprognostic (1.87e-2)"	"unprognostic (4.46e-2)"	"unprognostic (3.09e-3)"	"unprognostic (2.60e-1)"	"unprognostic (1.67e-1)"	"unprognostic (1.95e-1)"	"unprognostic (1.65e-1)"	9.7	10.8	10.1	6.4	10.4	5.8	4.7	11.0	8.2	4.8	36.7	5.8	2.1	6.5	5.1	5.6	11.0	7.1	99.3	8.6	6.4	9.2	1.4	8.4	7.4	11.1	10.2	11.3	61.6	9.3	4.6	3.7	9.5	7.5	1.8	6.1	3.7	6.7	48.8	3.8	3.8	6.0	8.9	5.3	9.8	18.5	13.7	5.7	17.8	75.9	5.1	6.2	3.9	9.5	18.2	16.1	9.6	15.6	11.7	11.6	13.2	17.9	17.8	18.2	15.9	8.0	10.1	25.9	11.3	16.5	14.9	18.5	9.5	13.4	6.2	48.6	14.8	6.4	16.5	1.2	11.2	0.0	17.4	14.9	10.8	20.8	14.7	14.9	11.3	20.5	11.9	10.5	14.7	11.2	11.8	1.8	11.5	4.8	7.1	13.8	29.0	6.4	4.1	22.0	8.1	10.4	14.0	12.3	11.0	8.0	8.8	6.7	14.3	21.5	13.8	19.9	19.2	34.7	24.9	8.5	16.6	8.3	13.6	0.0	0.1	0.0	1.6	0.1	2.0	0.6	1.5	1.5	0.0	0.7	1.4	1.5	0.0	0.4	0.0	0.0	1.5	1.0	10.1	10.4	11.0	8.2	8.6	6.4	11.1	10.2	9.5	8.9	13.7	9.5	18.2	3.2	23.0	20.5	11.2	20.8	24.3	4.6	10.8	14.6	14.4	10.2	175.0	5.7	8.5	0.0	50.1	1.8	11.5	1.6	1.9	9.6	2.4	6.8	9.8	24.1	6.0	6.5	5.3	11.0	14.5	15.7	11.7	6.2	7.0	13.9	8.6	2.2	3.4	18.5	6.6	2.7	4.1	2.4	6.5	2.7	9.9	3.5	8.8	15.9	0.8	17.0	8.2	7.1	8.3	9.3	1.3	9.4	8.3	24.9	0.0	15.7	7.9	20.3	0.0	29.7	16.1	8.1	12.9	7.5	18.2	3.1	14.5	100.2	1.5	22.0
SMG5	"EST1B, KIAA1089, LPTS-RP1, LPTSRP1, RP11-54H19.7, SMG-5"	ENSG00000198952	"SMG5 nonsense mediated mRNA decay factor"	Q9UPR3	1	156249224-156282825	"Predicted membrane proteins"	"Nonsense-mediated mRNA decay"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA072651			Uncertain	"Cytoplasmic bodies"		No	No			"Cluster 39: Non-specific - mRNA processing"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 43: THP-1 - Innate immune response"	"Cluster 53: Intestinal epithelial cells - Unknown function"	"Cytoplasmic bodies"		"HPA072651: AB_2686544"	"unprognostic (2.09e-2)"	"unprognostic (3.45e-2)"	"unprognostic (1.58e-1)"	"prognostic unfavorable (3.39e-4)"	"unprognostic (3.20e-1)"	"unprognostic (4.06e-2)"	"prognostic unfavorable (6.70e-9)"	"unprognostic (1.28e-1)"	"unprognostic (3.21e-3)"	"unprognostic (6.90e-2)"	"unprognostic (1.82e-2)"	"unprognostic (1.71e-2)"	"unprognostic (1.23e-1)"	"unprognostic (1.42e-2)"	"unprognostic (4.28e-1)"	"unprognostic (8.77e-2)"	"unprognostic (4.26e-2)"	25.2	43.2	44.5	22.0	46.5	46.7	23.7	43.6	46.0	25.6	42.1	35.4	27.3	27.5	24.6	37.3	27.1	18.8	58.8	42.0	42.8	43.4	47.5	32.7	25.8	49.9	48.3	25.7	28.3	46.3	39.0	26.5	46.9	35.2	22.0	35.3	26.8	23.8	62.8	36.4	32.3	28.0	44.4	33.8	33.4	27.7	50.3	29.4	29.9	43.3	24.8	31.2	25.9	53.3	53.4	45.8	54.8	40.9	52.2	29.5	79.0	54.0	48.2	80.0	67.7	116.2	67.4	48.1	61.6	64.8	63.7	62.8	97.3	68.3	51.4	54.5	80.9	55.6	45.8	64.2	67.6	58.8	54.5	37.4	66.7	76.9	81.5	41.2	52.1	70.4	77.0	47.1	56.9	54.5	48.3	47.5	110.9	97.0	94.6	77.2	41.8	51.1	52.1	63.4	73.4	61.1	68.5	100.6	61.8	71.9	86.8	124.3	44.0	55.4	61.6	59.1	79.6	71.7	17.9	89.1	48.8	57.8	71.7	1.6	3.7	5.2	3.8	3.9	3.1	2.9	2.9	2.8	2.4	2.5	2.5	2.7	4.1	3.0	4.2	2.4	2.0	3.6	44.5	46.5	43.6	46.0	42.0	42.8	49.9	48.3	46.9	44.4	50.3	53.3	9.1	16.0	13.4	21.9	16.8	14.7	7.8	7.3	17.6	12.8	14.7	9.8	39.5	18.6	9.6	20.2	33.3	17.8	10.4	44.8	7.9	12.3	2.8	14.1	9.1	12.9	22.7	9.9	23.9	14.5	10.7	9.4	35.2	16.1	12.7	18.4	9.7	21.6	12.4	18.5	21.4	20.3	8.2	14.4	8.6	5.5	8.4	11.1	5.4	19.7	13.5	11.2	7.2	12.1	24.2	17.9	24.2	7.2	17.9	14.3	23.7	15.5	12.8	12.6	6.6	9.2	10.5	8.5	7.8	16.9	12.1	17.1	14.0	11.4	23.6	15.4
SMN1	"BCD541, GEMIN1, SMA, SMA@, SMA1, SMA2, SMA3, SMNT, TDRD16A"	ENSG00000172062	"Survival of motor neuron 1, telomeric"	Q16637	5	70925030-70953942	"Disease related genes, FDA approved drug targets, Human disease related genes, Predicted intracellular proteins"	"mRNA processing, mRNA splicing, Neurogenesis"	RNA-binding	"Disease variant, FDA approved drug targets, Neurodegeneration"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Club cells: 29.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"MOLT-4: 120.5;NB-4: 77.9;T-47d: 88.9;WM-115: 120.3"									"CAB016324, HPA045271, CAB069888, HPA073601"	Supported		Supported	"Nuclear bodies,Cytosol"		NA	NA			"Cluster 39: Non-specific - mRNA processing"	"Cluster 72: Non-specific - Transcription"	"Cluster 17: WM-115 - Nervous system development"	"Cluster 11: Alveolar cells - Smell perception"	"Nuclear bodies, Cytosol"		"CAB016324: AB_627931, CAB069888: AB_10001257, HPA045271: AB_2679280, HPA073601: "	"unprognostic (1.32e-1)"	"unprognostic (1.59e-1)"	"unprognostic (3.18e-1)"	"unprognostic (2.09e-1)"	"unprognostic (2.85e-1)"	"unprognostic (9.52e-3)"	"unprognostic (2.10e-2)"	"unprognostic (2.43e-1)"	"unprognostic (9.91e-3)"	"unprognostic (1.13e-2)"	"unprognostic (1.01e-1)"	"unprognostic (4.41e-1)"	"prognostic unfavorable (6.62e-13)"	"unprognostic (2.04e-1)"	"unprognostic (2.17e-1)"	"unprognostic (8.06e-2)"	"unprognostic (4.14e-2)"	28.0	21.8	5.7	4.9	6.1	21.8	26.8	7.6	7.5	33.8	5.0	25.8	2.1	24.7	12.8	25.8	31.5	7.4	20.4	6.3	7.1	22.6	37.6	22.0	15.5	6.5	5.7	36.8	27.6	6.9	26.4	5.1	6.1	25.6	7.8	12.1	21.5	3.8	31.5	24.0	19.6	8.2	5.9	22.6	20.3	24.8	5.7	2.4	24.2	1.5	1.9	26.1	27.6	6.6	11.3	2.1	3.5	4.0	19.3	23.0	62.8	3.5	4.9	5.3	3.8	4.1	4.1	4.6	69.5	9.9	5.8	7.4	5.4	3.7	4.2	1.0	5.2	65.4	6.2	6.2	1.3	7.9	5.8	1.5	29.8	1.8	1.8	31.4	3.0	4.1	2.7	6.4	2.7	3.2	120.5	77.9	4.4	0.9	2.1	6.0	15.9	58.0	2.4	5.2	11.4	16.2	6.5	23.4	69.4	2.4	88.9	21.2	32.7	33.8	3.8	3.1	7.5	4.2	3.0	60.0	4.9	4.8	120.3	9.8	7.4	4.3	6.4	12.2	17.6	13.2	10.2	7.7	11.2	7.2	13.1	14.5	2.1	8.7	13.5	13.1	16.1	6.3	5.7	6.1	7.6	7.5	6.3	7.1	6.5	5.7	6.1	5.9	5.7	6.6	5.0	9.6	11.5	0.0	5.6	13.9	4.6	10.7	0.6	4.7	4.1	4.3	22.4	7.2	29.9	1.8	10.4	7.9	7.0	2.3	5.9	6.8	18.2	5.6	5.5	6.8	6.0	9.9	1.3	4.6	8.4	11.8	4.1	4.4	19.6	4.0	5.0	2.9	4.8	3.3	1.1	4.2	10.2	3.4	4.4	12.9	9.3	5.2	5.4	0.0	6.1	1.4	12.3	1.0	1.3	6.5	1.8	6.4	5.1	2.9	3.8	4.5	28.1	7.8	13.1	7.4	8.5	16.0	17.2	6.9	12.5	8.8	7.2	5.6	4.2	4.1
SMN2	"BCD541, GEMIN1, SMNC, TDRD16B"	ENSG00000205571	"Survival of motor neuron 2, centromeric"	Q16637	5	70049638-70078522	"Disease related genes, FDA approved drug targets, Human disease related genes, Predicted intracellular proteins"	"mRNA processing, mRNA splicing, Neurogenesis"	RNA-binding	"Disease variant, FDA approved drug targets, Neurodegeneration"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Cardiomyocytes: 41.8;Club cells: 20.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"BEWO: 122.7;MOLT-4: 125.1;NB-4: 106.2"									"CAB009344, HPA045271, HPA073601"	Supported		Supported	"Nuclear bodies,Cytosol"		NA	NA			"Cluster 39: Non-specific - mRNA processing"	"Cluster 72: Non-specific - Transcription"	"Cluster 24: NB-4 - Immune response"	"Cluster 43: Cardiomyocytes - Nuclear processes"	"Nuclear bodies, Cytosol"		"CAB009344: AB_2193083, HPA045271: AB_2679280, HPA073601: "	"unprognostic (2.07e-2)"	"unprognostic (5.70e-3)"	"unprognostic (1.23e-1)"	"unprognostic (1.59e-1)"	"unprognostic (2.77e-1)"	"unprognostic (1.89e-1)"	"unprognostic (1.40e-3)"	"unprognostic (2.08e-1)"	"unprognostic (1.22e-4)"	"unprognostic (1.17e-1)"	"unprognostic (2.21e-1)"	"unprognostic (5.19e-2)"	"unprognostic (2.98e-5)"	"unprognostic (2.36e-2)"	"unprognostic (1.76e-1)"	"unprognostic (2.67e-1)"	"unprognostic (1.19e-1)"	19.7	15.6	1.6	4.5	1.8	13.8	19.4	1.0	2.3	20.3	1.0	19.2	0.5	20.0	16.9	17.1	15.2	13.6	16.0	1.1	7.2	14.4	23.2	16.4	13.8	1.7	2.0	25.9	18.3	8.4	20.5	3.8	2.0	18.8	5.6	3.0	15.1	5.8	26.0	17.0	13.6	14.0	1.3	14.7	14.5	16.5	1.6	0.1	17.3	0.0	0.1	16.0	20.9	2.3	61.3	0.6	0.6	0.4	16.1	20.9	122.7	31.7	21.1	42.0	44.0	0.4	0.4	1.2	86.6	31.8	1.1	28.8	0.9	0.0	50.1	0.8	1.2	68.6	0.0	2.1	0.0	1.1	0.0	0.3	36.0	0.0	1.1	14.3	0.7	0.0	0.0	0.6	0.0	0.6	125.1	106.2	0.5	0.0	0.5	0.0	45.8	55.3	31.5	0.3	30.5	70.7	60.2	6.7	89.7	0.0	41.4	25.2	53.4	27.2	1.3	0.4	0.7	0.6	1.1	72.4	0.4	0.0	76.2	8.0	9.9	5.2	12.1	16.5	14.6	16.8	14.4	10.1	16.6	20.0	17.0	14.8	1.8	10.9	11.4	16.3	12.7	13.4	1.6	1.8	1.0	2.3	1.1	7.2	1.7	2.0	2.0	1.3	1.6	2.3	2.0	6.4	7.8	0.0	2.7	13.6	3.4	9.7	1.8	0.3	2.7	2.8	41.8	0.0	20.2	1.8	0.0	6.9	4.0	1.1	5.9	2.7	14.1	3.3	4.0	6.6	1.8	3.4	0.0	1.0	3.3	10.1	2.6	3.2	8.2	1.2	2.5	3.1	2.6	1.7	0.0	3.1	6.1	2.6	6.8	8.9	7.2	3.3	1.8	0.0	2.9	0.6	2.1	0.0	0.0	2.3	1.6	5.3	2.5	1.7	2.7	3.8	14.0	1.1	0.0	5.3	6.4	12.0	11.4	3.1	12.6	7.1	5.0	1.0	2.5	2.8
SMPD4	"FLJ20297, FLJ20756, KIAA1418, NET13, nSMase-3, NSMASE3"	ENSG00000136699	"Sphingomyelin phosphodiesterase 4"	Q9NXE4	2	130151392-130182750	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"		Hydrolase	"Disease variant, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA046279, HPA049426"	Approved		Approved	"Nuclear membrane,Cytosol"		NA	Yes			"Cluster 39: Non-specific - mRNA processing"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 39: CACO-2 - Unknown function"	"Cluster 44: Endometrium - Transcription"	"Nuclear membrane"	Cytosol	"HPA046279: AB_2679611, HPA049426: AB_2680762"	"unprognostic (5.02e-2)"	"unprognostic (9.61e-3)"	"unprognostic (6.31e-2)"	"prognostic unfavorable (7.47e-5)"	"unprognostic (1.69e-1)"	"unprognostic (8.80e-2)"	"prognostic unfavorable (8.37e-6)"	"unprognostic (3.27e-2)"	"unprognostic (1.72e-1)"	"unprognostic (7.47e-2)"	"unprognostic (1.49e-2)"	"prognostic unfavorable (1.73e-4)"	"prognostic unfavorable (8.16e-8)"	"unprognostic (1.74e-1)"	"unprognostic (2.28e-1)"	"unprognostic (1.47e-3)"	"unprognostic (2.09e-1)"	9.9	10.8	4.2	11.1	4.9	25.4	10.9	5.3	6.2	15.5	3.1	12.1	9.5	15.5	5.0	13.8	15.9	9.2	11.7	4.0	7.0	8.6	9.2	10.6	15.7	7.5	5.0	14.6	13.3	15.2	22.7	14.9	6.3	11.8	11.1	4.7	12.9	11.7	13.3	13.5	11.5	12.9	2.4	11.2	10.3	17.7	6.0	19.8	16.0	12.0	15.7	11.8	12.3	10.0	89.1	41.5	46.2	39.2	29.1	21.8	58.7	41.5	42.0	76.3	62.8	119.2	47.0	56.2	41.2	49.9	36.3	43.8	64.0	64.4	40.4	72.7	61.2	60.5	36.2	90.1	31.2	68.5	34.7	25.6	39.4	77.0	27.2	21.1	44.9	51.4	82.2	40.8	40.7	44.3	72.2	32.0	77.0	40.1	56.4	74.3	44.2	59.0	27.0	38.6	66.8	36.3	42.8	54.5	22.7	24.9	37.8	34.8	32.8	57.0	49.3	33.0	49.4	34.3	44.0	79.2	51.4	38.7	44.0	1.8	9.2	14.8	12.9	11.2	14.3	8.9	9.6	11.6	9.6	9.1	9.0	10.5	4.3	12.1	8.1	6.0	9.2	10.4	4.2	4.9	5.3	6.2	4.0	7.0	7.5	5.0	6.3	2.4	6.0	10.0	17.4	3.2	11.3	4.9	20.8	15.0	9.1	8.8	12.0	19.8	21.5	23.0	3.9	5.7	8.0	7.3	12.5	23.8	16.4	7.9	9.8	9.2	22.7	16.0	19.7	12.0	13.1	21.2	6.9	12.2	26.5	12.2	18.8	26.3	6.3	29.0	10.4	17.3	14.1	15.2	6.7	12.8	4.1	13.2	7.7	41.7	14.6	10.2	16.0	1.0	8.8	9.9	11.3	7.5	10.4	11.8	10.5	18.4	27.0	9.4	7.7	5.9	9.9	16.0	0.0	14.1	12.8	25.0	25.6	18.7	20.6	15.6	15.6	16.0	15.2	9.6
SNRPA1	"Lea1, U2A'"	ENSG00000131876	"Small nuclear ribonucleoprotein polypeptide A'"	P09661	15	101281510-101295282	"Plasma proteins, Predicted intracellular proteins"	"mRNA processing, mRNA splicing"	"Ribonucleoprotein, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA045622, HPA048499"	Supported		Supported	"Nucleoplasm,Nuclear speckles,Nuclear bodies"		NA	NA		48000	"Cluster 39: Non-specific - mRNA processing"	"Cluster 53: Non-specific - Cell cycle regulation"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 66: Spermatocytes - Spermatogenesis"	Nucleoplasm	"Nuclear speckles, Nuclear bodies"	"HPA045622: AB_2679394, HPA048499: AB_2680421"	"unprognostic (2.73e-1)"	"unprognostic (1.48e-1)"	"unprognostic (8.09e-2)"	"unprognostic (2.20e-1)"	"unprognostic (8.08e-2)"	"unprognostic (1.07e-1)"	"prognostic unfavorable (8.56e-5)"	"unprognostic (5.80e-2)"	"unprognostic (1.66e-3)"	"prognostic favorable (8.83e-5)"	"unprognostic (4.74e-2)"	"unprognostic (6.77e-3)"	"prognostic unfavorable (0.00e+0)"	"unprognostic (3.06e-2)"	"unprognostic (2.84e-1)"	"unprognostic (2.43e-1)"	"unprognostic (1.37e-2)"	19.0	18.2	11.0	35.5	11.4	68.1	20.8	13.2	15.4	14.7	14.7	30.6	24.3	15.5	33.0	33.8	18.6	12.7	25.8	12.0	11.6	25.2	25.5	19.5	43.3	11.5	11.3	13.6	22.2	18.3	13.9	30.4	11.7	16.3	30.8	15.5	23.1	12.6	19.7	18.5	30.1	19.3	10.9	25.2	23.2	37.8	12.4	37.4	18.3	12.4	51.9	26.3	18.2	12.6	175.5	119.5	112.7	57.4	31.3	25.6	111.3	158.2	72.8	139.2	105.1	255.8	150.7	192.9	89.2	107.8	109.0	101.7	170.2	113.1	148.1	98.0	262.5	151.4	196.7	137.3	24.0	175.1	103.7	21.0	83.0	89.0	111.3	30.9	90.9	147.1	216.1	175.8	86.5	194.6	177.6	185.7	144.5	232.0	100.1	174.5	121.7	194.8	103.3	450.2	88.6	92.7	97.2	109.0	125.1	117.1	105.2	136.4	66.2	74.1	141.0	86.8	160.3	143.5	464.8	378.9	59.9	162.9	89.3	3.8	36.6	21.5	55.7	47.2	55.3	53.0	57.7	56.1	58.0	47.4	46.6	59.0	6.8	48.5	44.0	54.7	68.9	39.0	11.0	11.4	13.2	15.4	12.0	11.6	11.5	11.3	11.7	10.9	12.4	12.6	41.5	19.2	54.6	16.3	71.6	65.6	73.4	141.6	70.6	37.8	41.8	52.6	30.5	18.6	80.3	36.8	12.5	124.3	69.6	37.4	68.4	94.6	96.2	52.7	42.5	47.2	27.0	61.4	30.9	109.0	154.1	51.5	27.0	55.6	65.8	37.7	21.4	35.5	67.0	37.0	29.2	44.2	126.1	24.1	39.2	22.4	34.8	36.4	42.7	13.1	76.4	39.6	47.4	16.6	28.6	95.3	41.8	28.6	76.1	142.3	78.7	87.1	89.2	34.9	13.1	37.9	67.1	192.9	65.9	68.3	50.6	112.3	68.1	42.3	52.4	101.6
SNX33	"MGC32065, SH3PX3, SH3PXD3C, SNX30"	ENSG00000173548	"Sorting nexin 33"	Q8WV41	15	75647912-75662301	"Predicted intracellular proteins"	"Cell cycle, Cell division, Endocytosis, Mitosis, Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA040988	Approved					NA	NA			"Cluster 39: Non-specific - mRNA processing"	"Cluster 11: Squamous epithelial cells - Epithelial cell function"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 50: Fibroblasts - ECM organization"			"HPA040988: AB_10794983"	"unprognostic (1.83e-2)"	"unprognostic (2.75e-2)"	"unprognostic (1.09e-2)"	"unprognostic (1.94e-3)"	"unprognostic (1.73e-1)"	"unprognostic (3.18e-1)"	"unprognostic (2.51e-2)"	"unprognostic (9.93e-2)"	"unprognostic (1.46e-1)"	"prognostic unfavorable (5.24e-4)"	"unprognostic (5.00e-3)"	"unprognostic (3.00e-2)"	"unprognostic (5.23e-3)"	"unprognostic (5.99e-2)"	"unprognostic (1.15e-2)"	"unprognostic (1.14e-1)"	"unprognostic (8.54e-2)"	26.2	17.2	11.1	7.1	11.1	0.5	21.3	9.5	9.8	29.3	11.8	19.7	12.1	23.6	8.4	42.5	21.9	14.3	19.6	10.2	9.9	12.5	29.0	19.3	8.2	14.2	10.8	25.6	27.2	11.1	7.0	11.9	10.3	23.5	10.0	1.6	20.6	16.6	5.9	29.6	15.5	14.6	10.1	11.8	18.8	3.5	13.0	7.6	16.7	9.2	10.6	20.2	30.2	9.1	14.9	13.1	12.6	13.5	48.7	31.5	13.9	14.3	29.8	15.6	14.2	8.3	15.3	0.4	10.3	31.7	22.3	35.1	15.7	37.4	8.3	16.4	5.3	4.6	15.5	15.2	32.3	0.4	4.7	32.6	44.5	15.2	21.2	37.4	10.0	1.4	11.0	2.0	18.4	2.9	0.1	9.4	12.1	9.3	7.3	2.3	9.9	0.7	15.9	22.1	1.1	8.6	21.1	22.7	17.4	23.4	13.6	10.5	14.6	22.1	10.4	16.6	7.7	0.3	0.4	0.1	22.3	5.4	6.0	0.0	0.5	0.0	0.2	0.1	0.2	0.0	0.3	0.0	0.4	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.2	11.1	11.1	9.5	9.8	10.2	9.9	14.2	10.8	10.3	10.1	13.0	9.1	8.3	6.4	5.6	2.9	0.2	12.1	3.4	9.3	6.2	0.0	6.8	5.7	3.8	2.8	8.2	7.3	2.1	3.1	1.2	13.5	0.0	7.5	0.3	4.8	7.5	5.7	9.1	0.4	0.5	6.5	4.1	13.3	14.3	4.8	1.3	6.8	10.0	12.6	5.1	0.0	0.1	8.1	8.2	2.8	7.8	0.6	13.1	2.9	3.6	2.8	3.0	3.8	0.0	2.5	0.2	15.9	7.6	15.1	1.1	7.5	12.4	3.7	9.5	0.2	19.7	8.5	9.5	0.1	0.6	5.5	11.2	1.4	1.8	2.5	7.3	11.3
SPTBN1		ENSG00000115306	"Spectrin beta, non-erythrocytic 1"	Q01082	2	54456317-54671446	"Plasma proteins, Predicted intracellular proteins"		"Actin capping, Actin-binding, Calmodulin-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Adipocytes: 615.4;Peritubular cells: 663.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA012685, HPA013149"	Supported		Approved	"Golgi apparatus"		NA	Yes		1500000	"Cluster 39: Non-specific - mRNA processing"	"Cluster 57: Non-specific - Angiogenesis"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"	"Golgi apparatus"		"HPA012685: AB_1857433, HPA013149: AB_1857434"	"unprognostic (2.72e-1)"	"unprognostic (4.44e-3)"	"unprognostic (3.00e-2)"	"unprognostic (3.25e-1)"	"unprognostic (4.09e-2)"	"unprognostic (7.95e-2)"	"unprognostic (9.24e-2)"	"unprognostic (3.72e-2)"	"unprognostic (7.31e-2)"	"unprognostic (1.67e-1)"	"unprognostic (2.26e-2)"	"unprognostic (7.25e-2)"	"prognostic favorable (2.59e-5)"	"unprognostic (2.31e-1)"	"unprognostic (2.73e-1)"	"unprognostic (1.68e-3)"	"unprognostic (5.18e-3)"	187.3	70.9	210.6	34.7	205.1	37.6	78.7	97.4	166.1	54.1	94.2	62.8	32.7	52.0	36.3	41.7	56.2	69.2	135.9	156.2	99.7	65.3	83.8	131.6	28.9	141.2	154.4	73.2	45.5	129.2	27.8	97.4	120.4	43.8	52.4	56.0	55.1	74.4	54.0	39.4	46.8	59.9	134.8	58.7	55.6	32.6	214.6	29.3	72.8	87.2	30.0	45.6	38.6	163.6	96.5	150.5	60.4	57.2	234.7	158.8	74.8	40.2	82.3	63.7	61.4	101.7	66.6	0.4	112.1	142.0	55.1	110.9	85.1	128.0	66.0	0.8	35.6	43.7	118.4	166.2	97.7	59.7	24.4	62.3	64.8	193.8	119.7	77.6	151.6	95.1	50.0	64.0	86.1	21.6	105.0	14.5	66.3	129.6	70.2	116.2	95.0	37.2	92.2	120.6	36.3	113.3	121.5	39.5	88.1	58.9	19.6	9.9	235.2	89.9	79.0	110.2	58.2	62.8	42.8	32.7	98.1	17.7	163.7	2.3	0.4	2.8	3.7	0.0	3.9	3.7	3.4	3.6	1.3	3.5	5.0	3.6	0.6	5.2	0.0	1.1	3.2	3.1	210.6	205.1	97.4	166.1	156.2	99.7	141.2	154.4	120.4	134.8	214.6	163.6	615.4	407.1	124.6	233.4	45.7	83.1	50.0	64.7	42.7	94.4	60.8	58.0	262.9	144.4	100.6	145.3	73.0	28.3	31.7	343.6	7.9	223.7	12.1	140.4	80.3	426.4	83.1	21.5	231.3	121.9	42.0	271.6	139.7	115.7	35.4	68.2	228.5	184.6	14.2	141.3	195.4	135.5	77.3	17.7	47.0	31.5	503.2	16.6	147.7	294.2	9.7	131.9	36.0	154.8	283.1	243.3	109.9	663.5	76.3	75.6	142.8	44.1	187.3	93.6	164.3	340.3	171.9	54.7	53.3	79.7	68.2	11.1	49.2	56.6	151.9	88.1
SREBF2	"bHLHd2, SREBP2"	ENSG00000198911	"Sterol regulatory element binding transcription factor 2"	Q12772	22	41833079-41907307	"Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Transcription factors"	"Cholesterol metabolism, Lipid metabolism, Steroid metabolism, Sterol metabolism, Transcription, Transcription regulation"	"Activator, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA031962, HPA031963"	Approved		Supported	"Nucleoplasm,Endoplasmic reticulum,Vesicles"		NA	NA			"Cluster 39: Non-specific - mRNA processing"	"Cluster 27: Brain & Skin - Unknown function"	"Cluster 25: RPMI-8226 - Immune response"	"Cluster 44: Endometrium - Transcription"	"Nucleoplasm, Vesicles"	"Endoplasmic reticulum"	"HPA031962: AB_10601266, HPA031963: AB_2674090"	"unprognostic (6.53e-2)"	"unprognostic (6.07e-2)"	"unprognostic (1.75e-2)"	"unprognostic (1.50e-3)"	"unprognostic (3.41e-3)"	"unprognostic (9.08e-2)"	"unprognostic (5.04e-2)"	"unprognostic (1.31e-1)"	"unprognostic (4.78e-1)"	"unprognostic (1.04e-2)"	"unprognostic (2.30e-1)"	"unprognostic (9.85e-2)"	"prognostic favorable (1.37e-4)"	"unprognostic (4.68e-2)"	"unprognostic (1.92e-2)"	"unprognostic (3.22e-1)"	"unprognostic (7.93e-3)"	22.8	80.7	50.1	31.1	58.7	32.3	24.5	22.3	60.5	26.5	2.5	47.1	40.8	34.4	60.5	82.0	27.4	25.3	53.8	51.8	32.3	33.3	36.2	43.2	35.2	38.5	37.8	35.8	45.8	51.4	30.5	24.5	38.3	33.5	31.6	21.0	49.1	22.9	34.1	58.4	35.9	30.1	16.1	26.1	53.8	20.4	37.8	25.0	23.3	33.5	36.2	29.7	39.0	45.1	65.5	45.8	119.4	111.6	68.4	90.9	66.7	21.4	71.1	24.8	50.5	54.3	84.2	115.8	29.7	52.6	91.1	109.6	68.7	141.8	17.5	32.9	75.0	58.0	79.7	54.6	113.8	85.7	37.9	85.8	78.7	65.1	80.6	56.7	49.2	64.2	60.6	135.9	26.4	83.1	62.5	64.5	75.7	81.2	34.9	71.3	68.1	189.0	103.3	67.6	48.2	36.3	49.1	89.3	91.7	69.5	56.3	150.2	53.0	33.2	61.0	15.9	25.8	98.3	54.3	91.7	32.4	64.0	51.9	0.0	4.7	1.6	4.6	3.6	3.1	7.0	2.5	3.3	5.0	4.8	2.2	2.6	0.7	1.4	3.1	6.3	1.5	4.8	50.1	58.7	22.3	60.5	51.8	32.3	38.5	37.8	38.3	16.1	37.8	45.1	14.5	44.8	43.3	100.6	35.4	16.3	13.5	52.2	30.7	41.0	36.3	23.1	30.3	37.1	38.0	58.8	10.4	25.4	23.5	67.0	3.9	20.3	15.9	25.2	10.5	16.8	49.1	14.1	72.6	44.3	22.6	16.3	42.8	59.2	12.7	43.2	8.2	34.3	14.8	57.2	75.1	39.4	52.9	10.3	14.8	7.0	31.4	16.3	7.2	67.5	18.1	18.6	20.6	90.5	129.5	38.4	30.5	27.4	29.2	27.9	26.3	4.8	30.0	18.7	19.7	13.7	20.5	8.4	13.8	55.7	28.1	36.5	19.0	43.0	40.3	30.2
SRSF2	"PR264, SC-35, SC35, SFRS2, SFRS2A"	ENSG00000161547	"Serine and arginine rich splicing factor 2"	Q01130	17	76734115-76737333	"Cancer-related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"	"mRNA processing, mRNA splicing"	RNA-binding	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							HPA049905	Supported		Approved	Nucleoplasm,Cytosol		NA	NA		180000	"Cluster 39: Non-specific - mRNA processing"	"Cluster 18: Non-specific - Mitochondria"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 7: Non-specific - Mitochondria"	Nucleoplasm	Cytosol	"HPA049905: AB_2680945"	"unprognostic (2.50e-1)"	"unprognostic (2.16e-3)"	"unprognostic (2.73e-3)"	"prognostic unfavorable (8.73e-4)"	"unprognostic (1.75e-2)"	"unprognostic (4.19e-2)"	"prognostic unfavorable (3.53e-8)"	"unprognostic (1.19e-1)"	"unprognostic (7.79e-3)"	"unprognostic (7.03e-3)"	"unprognostic (1.92e-1)"	"unprognostic (1.07e-3)"	"prognostic unfavorable (1.05e-7)"	"unprognostic (3.85e-2)"	"unprognostic (8.05e-2)"	"unprognostic (1.95e-1)"	"prognostic favorable (9.87e-4)"	106.0	106.8	27.8	95.5	29.6	184.7	92.1	29.9	34.0	83.6	37.7	100.3	86.2	88.9	64.0	129.5	89.5	42.1	78.5	29.2	32.9	83.0	115.2	95.4	111.6	30.8	28.5	85.6	88.3	48.4	81.9	66.0	30.3	78.0	71.6	53.4	90.6	52.3	91.7	96.5	113.2	49.0	31.3	121.6	94.4	49.5	30.0	94.2	102.1	36.0	100.2	80.0	94.3	36.0	318.7	239.8	289.5	207.5	70.9	58.5	300.5	197.3	146.8	225.4	207.0	257.2	216.8	478.0	143.3	188.7	164.3	279.9	293.3	229.0	230.2	202.3	489.3	357.9	246.6	311.9	79.3	404.4	210.6	65.2	51.1	186.2	54.0	91.1	179.9	212.0	373.4	209.6	183.7	251.0	460.0	440.9	339.5	186.4	340.2	455.0	310.6	360.5	156.5	225.2	247.7	350.8	227.1	196.3	120.4	154.0	238.8	301.6	187.9	206.9	271.3	139.4	330.0	278.2	219.2	552.9	187.3	318.9	177.1	2.5	40.9	10.0	26.0	53.3	26.0	23.5	17.7	26.7	67.0	19.6	20.1	19.4	4.4	35.6	33.6	49.2	24.0	33.0	27.8	29.6	29.9	34.0	29.2	32.9	30.8	28.5	30.3	31.3	30.0	36.0	271.3	118.6	105.6	57.5	396.7	460.8	439.7	205.9	540.1	151.9	291.7	277.9	86.2	148.7	141.5	88.3	91.8	339.4	548.0	233.1	156.5	199.1	203.6	176.8	181.9	204.3	266.3	366.6	51.1	157.3	579.7	233.9	196.7	257.4	218.4	241.7	116.7	125.1	251.3	99.3	55.4	246.9	132.2	143.7	480.4	162.0	159.1	273.5	282.8	63.7	226.9	153.3	196.7	55.8	87.9	189.0	288.7	127.5	492.0	384.8	250.5	128.7	97.4	188.9	118.3	286.8	242.1	272.3	296.8	489.5	443.4	316.0	469.1	185.4	329.4	459.4
SRSF6	"B52, SFRS6, SRP55"	ENSG00000124193	"Serine and arginine rich splicing factor 6"	Q13247	20	43457893-43466046	"Predicted intracellular proteins"	"mRNA processing, mRNA splicing"	"Repressor, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA029005, CAB034889"	Supported		Supported	"Nuclear speckles"		NA	NA		50000	"Cluster 39: Non-specific - mRNA processing"	"Cluster 50: Non-specific - Ribosome"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 65: Plasmacytoid DCs - Unknown function"	"Nuclear speckles"		"CAB034889: AB_785899, HPA029005: AB_10610424"	"unprognostic (1.51e-1)"	"unprognostic (1.26e-1)"	"unprognostic (1.98e-1)"	"unprognostic (3.25e-2)"	"unprognostic (6.41e-2)"	"unprognostic (3.91e-2)"	"prognostic unfavorable (3.86e-4)"	"unprognostic (3.99e-3)"	"unprognostic (4.39e-2)"	"unprognostic (2.07e-1)"	"unprognostic (1.27e-3)"	"unprognostic (6.03e-3)"	"prognostic unfavorable (2.82e-4)"	"unprognostic (1.73e-1)"	"unprognostic (2.70e-1)"	"unprognostic (4.31e-1)"	"unprognostic (1.18e-2)"	43.3	53.7	34.0	34.5	37.5	115.9	56.2	41.4	43.8	44.2	52.7	37.8	36.3	52.7	59.7	32.8	47.4	31.4	31.4	33.3	39.6	47.4	50.3	40.3	48.4	34.5	34.7	58.5	66.3	41.8	48.0	39.3	35.6	48.7	43.4	38.7	45.3	30.0	30.5	48.7	45.4	39.7	35.6	55.9	47.4	30.3	35.7	53.7	50.8	18.1	40.8	29.7	30.4	47.3	52.7	79.1	88.7	57.3	50.7	67.7	86.3	79.6	38.3	55.4	47.1	112.9	55.9	95.9	73.9	73.3	45.1	77.6	91.7	116.9	71.7	40.2	85.7	74.6	83.3	94.1	62.3	94.9	78.9	115.7	61.9	51.0	46.2	85.1	52.7	83.8	63.3	54.5	52.6	112.3	144.5	107.6	57.8	87.4	107.4	100.2	54.4	76.9	63.1	93.7	69.0	90.9	89.5	108.7	105.0	61.7	70.4	103.3	54.9	57.9	61.6	49.9	67.3	98.2	67.3	131.4	69.9	67.2	42.8	26.0	19.9	9.7	19.7	33.4	22.4	16.0	20.8	19.1	24.5	15.9	27.3	25.7	10.8	21.2	29.6	20.4	18.7	22.9	34.0	37.5	41.4	43.8	33.3	39.6	34.5	34.7	35.6	35.6	35.7	47.3	78.9	64.1	80.0	49.6	75.8	94.4	61.0	58.5	50.7	48.9	110.7	78.7	28.7	75.8	61.3	46.0	39.6	97.8	103.3	67.8	88.0	60.2	12.3	60.1	87.7	62.3	101.4	71.1	32.1	43.7	108.2	80.0	70.8	79.1	97.0	103.2	60.7	94.7	56.5	32.0	37.2	97.2	46.8	73.2	93.7	14.7	55.0	77.3	101.4	26.2	61.2	45.0	37.0	89.0	79.6	46.2	74.3	44.8	49.3	68.9	66.7	67.7	47.6	46.4	59.2	166.1	99.8	53.8	61.0	51.5	98.3	139.1	76.4	90.7	105.5	55.3
SYCE1	"bA108K14.6, C10orf94, CT76"	ENSG00000171772	"Synaptonemal complex central element protein 1"	Q8N0S2	10	133553901-133569835	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	"Cell cycle, Cell division, Meiosis"		"Premature ovarian failure"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	6	"testis: 70.9"	"Group enriched"	"Detected in many"	6	"Early spermatids: 141.2;Late spermatids: 112.6;Spermatocytes: 362.8;Spermatogonia: 170.9"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	8	"K-562: 18.5;U-2 OS: 15.5"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA040208	Enhanced		Approved	Nucleoplasm,Vesicles,Cytosol		No	No			"Cluster 39: Non-specific - mRNA processing"	"Cluster 78: Testis - Spermatogenesis"	"Cluster 1: K-562 - Erythropoiesis"	"Cluster 13: Spermatocytes & Spermatogonia - Spermatogenesis"	Nucleoplasm	"Vesicles, Cytosol"	"HPA040208: AB_10796450"	"unprognostic (5.04e-2)"	"unprognostic (1.96e-1)"	"unprognostic (1.03e-2)"		"unprognostic (1.85e-1)"	"unprognostic (9.05e-2)"	"unprognostic (1.61e-1)"	"unprognostic (3.20e-1)"	"unprognostic (5.75e-1)"	"unprognostic (5.38e-2)"	"unprognostic (3.36e-1)"	"unprognostic (2.22e-2)"	"unprognostic (7.17e-3)"	"unprognostic (2.95e-2)"	"unprognostic (1.27e-1)"	"unprognostic (1.69e-1)"	"unprognostic (2.42e-1)"	1.9	1.6	8.5	0.6	8.5	0.0	1.4	9.1	11.6	1.3	2.0	0.9	0.1	0.9	0.3	0.7	1.2	1.2	0.7	9.0	6.3	1.2	4.0	0.4	0.2	6.6	5.4	2.0	3.8	0.0	1.2	9.4	6.4	1.7	0.4	2.3	0.2	0.4	0.9	0.5	0.5	0.6	3.7	0.9	0.6	70.9	6.7	0.2	1.4	1.7	0.5	0.4	0.4	8.1	0.1	0.0	0.0	0.1	0.0	0.0	0.3	2.0	0.0	0.0	0.0	0.1	0.1	0.1	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.3	0.8	0.0	0.5	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	18.5	0.0	0.0	0.1	0.1	0.5	0.3	0.0	0.3	1.0	0.1	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.5	0.0	0.2	0.1	0.1	0.1	15.5	0.2	0.4	0.2	0.3	0.4	0.0	0.1	0.0	0.0	0.5	0.1	0.9	0.6	0.8	0.2	0.6	0.2	0.3	0.3	0.3	0.8	0.0	0.0	0.8	0.6	0.7	0.4	8.5	8.5	9.1	11.6	9.0	6.3	6.6	5.4	6.4	3.7	6.7	8.1	0.7	0.0	1.5	0.7	0.3	1.0	1.2	0.0	0.0	2.7	1.0	2.4	0.3	1.5	1.3	0.0	0.0	0.3	0.0	0.0	0.0	0.0	141.2	1.2	3.2	1.3	0.0	0.0	29.8	1.1	0.2	5.6	0.5	0.6	0.0	0.0	0.0	7.8	0.7	10.1	19.1	0.0	0.0	0.3	0.9	112.6	5.3	0.9	0.0	0.0	0.0	0.3	0.0	7.1	0.8	0.4	0.3	3.8	0.1	0.6	0.0	0.5	1.5	2.1	26.3	0.5	0.9	362.8	170.9	0.0	1.0	0.3	0.5	7.0	0.0	0.6
SYNJ2BP	Arip2	ENSG00000213463	"Synaptojanin 2 binding protein"	P57105	14	70366499-70417090	"Predicted membrane proteins, Transporters"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Distal tubular cells: 140.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"							"Low region specificity"	"Detected in all"			HPA000866	Approved	Supported	Approved	Mitochondria		NA	NA			"Cluster 39: Non-specific - mRNA processing"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 13: SH-SY5Y - Nervous system development"	"Cluster 44: Endometrium - Transcription"	Mitochondria		"HPA000866: AB_2276678"	"unprognostic (2.68e-1)"	"unprognostic (1.76e-1)"	"unprognostic (2.67e-1)"	"unprognostic (3.31e-1)"	"unprognostic (1.28e-1)"	"unprognostic (1.04e-1)"	"unprognostic (1.65e-1)"	"unprognostic (1.60e-2)"	"unprognostic (5.70e-2)"	"unprognostic (6.14e-2)"	"unprognostic (6.35e-3)"	"unprognostic (1.44e-2)"	"prognostic favorable (1.11e-16)"	"unprognostic (2.81e-1)"	"unprognostic (1.38e-1)"	"unprognostic (5.35e-3)"	"unprognostic (1.14e-2)"	10.2	10.1	10.3	7.3	10.1	1.3	9.9	9.3	10.0	8.1	13.3	13.7	19.6	9.0	7.9	8.2	7.2	8.4	14.9	8.4	9.3	21.7	20.3	9.5	6.6	10.0	9.8	7.2	7.4	24.9	6.6	9.3	9.8	12.9	15.1	16.4	9.5	11.9	28.7	5.7	16.0	10.7	10.8	9.1	15.5	3.9	10.6	5.1	11.2	29.3	6.4	8.6	6.1	9.7	14.0	9.1	15.3	10.3	11.7	13.4	10.6	10.8	11.1	7.4	8.3	8.7	12.8	0.0	10.0	12.7	7.5	11.6	15.7	11.6	17.5	1.9	8.0	5.2	13.9	11.4	10.3	0.0	1.7	10.5	9.2	9.4	5.3	13.1	16.6	5.8	3.1	2.7	13.4	10.2	7.2	2.1	11.1	13.9	10.9	9.0	22.4	3.9	16.0	20.7	11.1	19.4	14.6	12.0	8.8	9.9	22.7	3.6	18.5	17.7	12.1	6.9	8.7	3.7	15.0	0.0	15.6	1.8	14.9	0.3	3.0	0.1	2.3	3.1	2.7	2.5	2.8	2.7	3.0	2.0	3.8	3.1	0.3	2.3	2.1	1.9	2.3	1.1	10.3	10.1	9.3	10.0	8.4	9.3	10.0	9.8	9.8	10.8	10.6	9.7	36.6	38.5	46.6	0.0	17.8	6.0	28.7	49.4	9.1	44.9	25.9	15.4	89.4	48.6	43.3	75.4	81.3	38.3	13.1	50.1	140.8	49.0	36.9	56.0	26.5	38.4	19.8	5.7	0.0	39.2	31.5	21.7	21.9	85.7	9.5	33.5	37.1	50.4	24.7	30.3	0.0	41.2	44.7	23.6	9.1	9.8	30.4	16.9	14.2	0.0	28.8	37.1	28.8	0.0	0.0	35.7	43.5	41.3	4.2	25.8	87.3	77.0	31.5	88.0	26.3	37.6	27.8	68.9	12.9	12.5	4.8	10.9	17.4	25.0	62.6	30.3
TAF1C	"MGC:39976, SL1, TAFI110, TAFI95"	ENSG00000103168	"TATA-box binding protein associated factor, RNA polymerase I subunit C"	Q15572	16	84177847-84187070	"Predicted intracellular proteins"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA072229			Supported	"Nucleoplasm,Nucleoli fibrillar center"		NA	NA			"Cluster 39: Non-specific - mRNA processing"	"Cluster 72: Non-specific - Transcription"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 52: Non-specific - Transcription"	"Nucleoplasm, Nucleoli fibrillar center"		"HPA072229: AB_2686499"	"unprognostic (9.39e-2)"	"unprognostic (1.13e-1)"	"unprognostic (6.86e-3)"	"unprognostic (8.20e-3)"	"unprognostic (4.45e-2)"	"unprognostic (3.47e-2)"	"unprognostic (6.21e-2)"	"unprognostic (1.26e-1)"	"unprognostic (2.52e-1)"	"unprognostic (3.53e-1)"	"prognostic favorable (1.76e-4)"	"unprognostic (1.06e-2)"	"prognostic unfavorable (8.08e-6)"	"unprognostic (5.60e-2)"	"unprognostic (2.22e-1)"	"unprognostic (1.82e-1)"	"prognostic favorable (3.22e-4)"	19.4	15.8	9.8	7.2	9.9	13.5	20.6	8.1	12.9	25.9	5.4	16.0	7.9	23.5	2.2	15.9	21.4	10.1	18.3	10.9	7.7	20.6	14.8	17.0	11.1	10.5	8.7	31.7	17.9	4.2	20.6	6.2	8.6	21.7	2.9	1.8	15.3	8.3	12.3	17.8	19.3	5.3	7.3	32.2	18.7	13.8	8.9	7.4	23.7	6.7	3.6	18.5	19.1	8.9	11.8	12.7	7.5	23.6	5.7	5.9	34.3	13.8	5.3	11.5	3.7	15.0	8.3	12.7	17.3	5.0	6.1	21.2	4.3	5.4	2.6	11.4	18.2	6.8	21.0	9.7	4.8	7.6	21.8	8.9	6.9	9.1	3.7	5.0	20.4	20.7	17.9	4.1	5.6	25.4	11.3	24.9	27.8	5.1	12.2	29.2	6.1	10.5	4.7	9.5	34.0	16.8	26.3	7.8	43.0	4.6	28.9	8.1	8.9	19.2	16.5	19.2	12.0	19.6	16.9	26.7	9.8	9.2	12.4	0.0	1.3	0.4	1.5	1.3	1.8	0.9	0.6	0.9	1.5	1.1	0.7	1.3	0.0	1.5	0.5	0.6	0.9	1.2	9.8	9.9	8.1	12.9	10.9	7.7	10.5	8.7	8.6	7.3	8.9	8.9	24.9	19.2	15.8	22.5	9.2	6.5	5.1	5.2	5.2	9.3	10.2	10.2	3.0	2.8	8.2	3.7	20.9	9.4	6.5	9.9	5.9	5.1	0.5	6.9	7.4	18.7	7.2	7.4	16.5	7.1	6.7	8.4	20.9	8.8	6.3	24.6	22.9	12.9	6.6	1.7	13.0	8.2	0.0	9.8	6.3	2.5	11.8	7.3	7.2	15.9	6.3	7.8	5.2	13.6	12.5	5.2	5.1	9.1	12.1	3.9	7.6	4.0	6.1	10.4	6.6	8.3	7.8	9.9	10.6	8.7	5.3	7.4	8.0	16.8	10.2	4.4
TANGO6	"FLJ12688, KIAA1746, TMCO7"	ENSG00000103047	"Transport and golgi organization 6 homolog"	Q9C0B7	16	68843531-69085182	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Early spermatids: 110.2;Excitatory neurons: 45.4;Inhibitory neurons: 57.4;Late spermatids: 50.5;Oligodendrocyte precursor cells: 38.7;Oligodendrocytes: 51.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA041312	Approved		Approved	"Golgi apparatus,Cytosol"		NA	NA			"Cluster 39: Non-specific - mRNA processing"	"Cluster 55: Non-specific - Mitochondria & Proteasome"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 29: Early spermatids - Spermatogenesis"	"Golgi apparatus"	Cytosol	"HPA041312: AB_10796342"	"unprognostic (8.55e-2)"	"unprognostic (6.64e-2)"	"unprognostic (4.66e-2)"	"unprognostic (1.94e-2)"	"unprognostic (3.07e-1)"	"unprognostic (2.52e-2)"	"unprognostic (1.50e-1)"	"unprognostic (1.86e-1)"	"unprognostic (2.22e-1)"	"unprognostic (9.82e-3)"	"unprognostic (1.49e-1)"	"unprognostic (1.62e-1)"	"prognostic favorable (3.20e-4)"	"unprognostic (1.55e-2)"	"unprognostic (1.73e-1)"	"unprognostic (1.45e-3)"	"unprognostic (6.02e-2)"	5.1	3.0	2.8	4.5	3.8	3.4	4.6	3.5	3.4	4.8	4.9	3.9	2.4	4.3	1.9	3.6	3.8	2.8	3.2	2.6	3.6	5.7	12.9	3.6	4.9	2.7	3.1	4.2	3.2	6.0	2.5	3.4	2.8	4.0	3.1	4.2	3.2	4.2	8.8	4.2	3.1	4.8	2.4	4.5	4.1	4.3	3.5	4.7	3.3	5.7	4.6	5.5	4.2	3.9	7.1	14.3	4.6	9.9	7.6	8.6	3.3	9.5	7.7	11.5	9.3	9.1	5.7	15.8	5.1	13.2	6.0	5.8	10.6	12.8	14.0	3.8	6.3	3.0	5.4	8.5	6.3	8.0	7.2	6.6	6.7	16.3	14.7	4.7	11.2	7.6	10.6	2.7	10.7	7.1	8.3	6.4	10.2	6.9	7.6	8.9	6.8	17.8	8.4	3.9	4.8	5.6	23.3	1.3	6.3	5.5	4.6	8.9	6.5	10.9	3.9	11.2	6.8	4.9	4.5	10.7	6.9	3.0	7.4	0.0	3.8	2.0	3.4	6.6	3.5	2.7	3.3	3.5	4.8	2.4	2.0	3.3	0.2	2.0	6.2	1.3	4.9	3.1	2.8	3.8	3.5	3.4	2.6	3.6	2.7	3.1	2.8	2.4	3.5	3.9	5.1	0.0	4.2	23.5	5.4	5.2	9.5	5.0	2.8	8.8	1.5	1.8	3.8	5.7	2.2	7.3	10.4	5.6	3.1	2.1	0.0	2.2	110.2	1.5	3.5	4.8	0.0	7.8	45.4	3.3	2.7	4.0	6.1	3.0	1.3	3.7	3.9	12.3	4.7	5.0	57.4	1.8	4.1	7.6	3.5	50.5	5.6	4.2	5.4	25.3	3.5	3.3	4.1	38.7	51.3	2.7	4.4	3.4	2.9	3.7	1.1	6.0	0.5	10.5	0.0	3.9	3.4	5.7	4.7	4.0	3.0	2.5	7.0	3.2	2.2	9.2
TASOR	"C3orf63, FAM208A, KIAA1105, RAP140, se89-1, TASOR1"	ENSG00000163946	"Transcription activation suppressor"	Q9UK61	3	56620133-56683237	"Predicted intracellular proteins"	"Transcription, Transcription regulation"	Repressor		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"Adipocytes: 25.0;Cardiomyocytes: 31.4;Cytotrophoblasts: 14.5;dendritic cells: 12.1;Extravillous trophoblasts: 9.9;Fibroblasts: 10.7;Hofbauer cells: 20.7;Syncytiotrophoblasts: 9.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA006735, HPA017142"	Uncertain		Enhanced	Nucleoplasm		NA	NA			"Cluster 39: Non-specific - mRNA processing"	"Cluster 34: Non-specific - Transcription"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 24: Non-specific - Transcription regulation"	Nucleoplasm		"HPA006735: AB_1852384, HPA017142: AB_1852382"	"unprognostic (1.46e-1)"	"unprognostic (7.97e-2)"	"unprognostic (1.07e-2)"	"unprognostic (1.79e-1)"	"unprognostic (1.92e-1)"	"unprognostic (2.51e-2)"	"unprognostic (2.30e-3)"	"unprognostic (9.31e-2)"	"unprognostic (3.91e-2)"	"unprognostic (5.93e-2)"	"unprognostic (1.51e-1)"	"unprognostic (8.84e-2)"	"unprognostic (1.73e-1)"	"unprognostic (1.90e-1)"	"unprognostic (2.04e-1)"	"unprognostic (1.67e-1)"	"unprognostic (2.74e-1)"	9.5	8.4	4.0	15.4	8.4	11.8	11.4	8.7	5.3	12.0	1.7	11.7	10.0	12.3	7.4	11.1	13.1	11.7	6.2	2.2	3.6	10.2	7.9	11.3	20.7	5.1	5.6	14.2	12.4	21.1	4.4	9.4	6.0	9.3	12.4	9.9	8.9	9.4	2.6	7.1	11.3	12.3	5.9	14.7	12.8	29.2	4.5	21.3	18.8	6.9	19.3	12.5	3.8	12.0	49.2	19.2	29.2	23.0	15.5	26.7	14.6	21.4	22.0	20.1	21.1	15.8	35.8	77.3	7.9	21.6	33.9	19.1	29.3	25.1	29.2	38.3	14.8	30.4	27.3	7.1	10.9	32.2	46.1	12.9	20.6	19.6	35.1	23.7	26.5	28.8	29.8	43.3	26.0	17.3	39.8	6.4	16.3	25.9	29.0	20.9	28.9	25.9	19.0	35.5	19.3	23.9	46.9	18.5	23.2	16.6	30.6	36.7	28.6	25.9	23.7	23.8	33.1	39.2	58.5	38.6	30.1	46.7	35.0	0.6	0.8	1.1	1.2	0.6	0.7	0.7	1.0	1.2	1.0	1.1	1.1	1.2	0.2	0.9	0.7	0.7	1.0	0.6	4.0	8.4	8.7	5.3	2.2	3.6	5.1	5.6	6.0	5.9	4.5	12.0	25.0	0.0	0.0	0.0	4.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	31.4	0.0	0.0	0.0	0.0	14.5	12.1	0.0	0.0	0.0	0.0	0.0	0.0	4.7	0.0	0.0	0.0	0.0	9.9	10.7	0.0	0.0	0.0	0.0	0.0	0.0	20.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.6	0.0	0.0	0.0	0.0	9.2	2.1	0.0	0.0	0.0
TBC1D24	"DFNA65, DFNB86, KIAA1171, TLDC6"	ENSG00000162065	"TBC1 domain family member 24"	Q9ULP9	16	2475051-2509560	"Disease related genes, Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins"		"GTPase activation"	"Deafness, Disease variant, Epilepsy, Mental retardation, Non-syndromic deafness"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"salivary gland: 16.5"	"Cell type enhanced"	"Detected in many"		"Cone photoreceptor cells: 43.8;Inhibitory neurons: 34.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in all"		"SCLC-21H: 34.7"									"HPA044712, HPA068080"	Uncertain		Supported	"Plasma membrane,Cell Junctions"		NA	NA			"Cluster 39: Non-specific - mRNA processing"	"Cluster 22: Non-specific - Unknown function"	"Cluster 7: SCLC-21H - Neuronal signaling"	"Cluster 30: Mammary glandular cells - Lactation"	"Plasma membrane, Cell Junctions"		"HPA044712: AB_10795619, HPA068080: AB_2685948"	"prognostic unfavorable (3.22e-4)"	"unprognostic (5.23e-2)"	"unprognostic (4.02e-2)"	"unprognostic (6.41e-2)"	"unprognostic (3.52e-1)"	"unprognostic (1.52e-2)"	"unprognostic (1.40e-1)"	"unprognostic (2.03e-2)"	"unprognostic (1.68e-1)"	"unprognostic (7.37e-2)"	"unprognostic (4.37e-2)"	"unprognostic (1.28e-1)"	"unprognostic (4.66e-3)"	"unprognostic (2.02e-2)"	"unprognostic (8.19e-2)"	"unprognostic (7.78e-3)"	"unprognostic (1.61e-1)"	3.8	3.3	7.5	1.8	8.1	2.5	2.8	3.6	10.5	2.1	0.0	2.0	2.2	1.4	2.8	1.0	2.3	1.9	3.0	8.3	3.7	4.3	3.7	3.9	1.8	2.9	2.9	1.0	10.6	1.9	2.6	2.1	3.1	2.5	0.9	4.2	16.5	3.5	3.4	1.2	1.6	1.7	1.9	2.0	2.2	1.2	4.4	0.9	3.1	1.7	1.2	1.8	0.9	2.8	3.4	6.7	4.5	9.2	5.1	5.1	3.8	6.2	3.3	4.0	3.5	6.2	2.9	8.6	5.2	4.9	1.9	6.3	7.1	2.0	2.9	9.3	8.0	8.0	9.5	5.5	3.1	5.9	3.2	1.9	2.8	3.5	1.4	2.8	5.1	3.3	9.9	4.8	3.8	6.4	4.1	11.9	4.0	3.2	4.3	20.9	8.5	6.1	2.9	2.3	34.7	8.5	3.8	15.3	2.6	1.6	4.8	5.2	5.4	7.8	8.4	7.9	6.2	3.2	3.0	11.0	3.4	8.5	7.2	0.0	0.1	0.0	0.3	0.1	0.1	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.2	7.5	8.1	3.6	10.5	8.3	3.7	2.9	2.9	3.1	1.9	4.4	2.8	4.7	28.9	26.7	15.7	1.9	0.5	3.0	1.4	1.8	19.0	17.8	10.8	6.9	10.0	6.9	5.5	43.8	1.5	5.6	2.4	33.2	5.0	0.2	2.8	10.0	5.4	11.4	6.5	29.6	6.1	1.0	5.8	5.6	4.0	3.8	6.0	10.4	17.3	3.5	26.9	34.0	2.6	6.1	5.1	3.3	1.0	9.0	3.0	1.8	6.5	3.6	13.8	6.2	25.1	9.7	5.0	2.8	6.0	1.7	3.1	1.8	3.9	3.6	25.5	0.0	11.2	3.7	8.8	5.9	1.4	1.4	0.3	2.9	3.4	4.7	1.6
TBC1D9B	"GRAMD9B, KIAA0676"	ENSG00000197226	"TBC1 domain family member 9B"	Q66K14	5	179862066-179907897	"Predicted intracellular proteins"		"GTPase activation"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA038350	Approved		Approved	"Nucleoplasm,Nucleoli fibrillar center,Plasma membrane"		NA	NA			"Cluster 39: Non-specific - mRNA processing"	"Cluster 15: Liver - Metabolism"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 52: Non-specific - Transcription"	"Plasma membrane"	"Nucleoplasm, Nucleoli fibrillar center"	"HPA038350: AB_10673170"	"unprognostic (5.06e-2)"	"unprognostic (1.37e-1)"	"unprognostic (1.60e-2)"	"unprognostic (9.53e-2)"	"unprognostic (9.45e-3)"	"unprognostic (4.25e-1)"	"unprognostic (1.06e-1)"	"unprognostic (2.84e-1)"	"unprognostic (1.10e-1)"	"unprognostic (5.08e-2)"	"unprognostic (2.01e-1)"	"unprognostic (2.28e-2)"	"unprognostic (3.95e-2)"	"unprognostic (1.86e-1)"	"unprognostic (4.01e-2)"	"prognostic unfavorable (3.99e-4)"	"unprognostic (8.22e-2)"	54.9	61.8	53.9	20.8	62.2	22.8	46.3	58.1	51.1	39.3	38.6	34.1	22.8	38.9	12.0	43.9	34.2	23.8	30.9	51.4	50.1	44.8	55.0	31.7	23.9	60.5	59.8	39.0	46.4	27.0	29.2	17.2	61.6	33.6	12.1	9.1	37.0	25.0	45.9	44.4	34.4	21.1	63.4	39.5	35.5	20.5	57.2	13.1	36.3	18.7	15.3	35.1	35.7	65.9	42.7	64.0	27.4	62.4	69.9	49.0	66.8	51.0	47.2	50.1	48.4	43.8	41.9	29.3	60.2	57.8	56.6	39.6	28.3	115.9	9.8	98.0	39.1	26.0	47.3	27.9	41.5	35.1	85.0	50.6	42.6	39.2	18.9	22.6	48.4	55.3	17.7	28.1	39.5	104.2	22.7	24.5	20.3	17.4	36.5	38.7	22.1	27.8	35.1	66.8	40.1	30.4	48.2	54.5	54.9	11.0	45.0	48.8	57.2	71.2	31.9	34.8	45.2	16.8	23.3	22.7	68.0	41.7	51.7	5.0	7.8	5.5	6.1	9.2	4.8	6.3	4.2	4.9	9.3	5.1	3.9	3.5	0.9	4.2	9.2	9.5	4.0	7.1	53.9	62.2	58.1	51.1	51.4	50.1	60.5	59.8	61.6	63.4	57.2	65.9	24.9	22.4	19.2	20.2	19.7	16.6	10.2	14.6	15.4	27.8	23.9	21.6	9.5	12.8	14.0	27.6	8.4	19.8	20.4	28.4	13.7	21.1	2.4	18.2	20.2	21.0	18.0	17.5	32.1	18.0	23.6	21.1	21.9	27.0	11.4	30.0	24.3	35.2	30.7	62.2	23.6	23.9	10.2	33.5	15.7	8.2	32.3	28.6	16.0	15.9	21.4	17.8	24.7	14.6	27.0	25.2	24.3	28.6	16.4	15.3	24.4	22.6	13.3	18.0	26.3	26.7	16.4	11.1	18.5	25.0	15.6	14.1	17.9	57.1	20.5	13.7
TMC6	"EVER1, EVIN1, LAK-4P, TNRC6C-AS1"	ENSG00000141524	"Transmembrane channel like 6"	Q7Z403	17	78107397-78132407	"Disease related genes, Human disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Ion transport, Transport"	"Ion channel"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 110.5"	"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"K-562: 108.7;SK-BR-3: 121.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA051430	Uncertain					NA	NA			"Cluster 39: Non-specific - mRNA processing"	"Cluster 32: Brain & Lymphoid tissue - Unknown function"	"Cluster 8: SK-BR-3 - Unknown function"	"Cluster 63: NK-cells & T-cells - Immune response"			"HPA051430: AB_2681483"	"unprognostic (6.34e-2)"	"unprognostic (5.14e-2)"	"unprognostic (5.55e-2)"	"unprognostic (2.81e-3)"	"unprognostic (3.99e-2)"	"unprognostic (1.06e-2)"	"unprognostic (5.36e-2)"	"unprognostic (6.27e-2)"	"unprognostic (1.47e-1)"	"unprognostic (9.94e-2)"	"unprognostic (1.74e-1)"	"unprognostic (6.61e-2)"	"unprognostic (1.16e-2)"	"prognostic favorable (1.82e-4)"	"unprognostic (2.70e-2)"	"unprognostic (1.10e-2)"	"prognostic favorable (3.20e-4)"	29.5	6.8	19.2	45.4	50.5	72.7	25.2	43.4	33.5	11.3	5.2	23.5	21.7	7.6	1.0	25.4	14.1	9.7	35.9	19.3	26.4	20.6	9.1	40.3	69.7	59.3	49.7	3.8	14.6	3.1	5.6	8.8	55.9	20.2	6.6	0.6	29.3	7.9	3.5	17.9	50.6	3.5	35.8	110.5	14.6	2.6	48.4	26.3	12.9	1.8	32.4	14.6	18.4	81.9	17.9	14.0	7.5	6.0	0.0	0.0	15.2	0.0	0.0	0.2	0.2	25.2	19.2	19.7	23.7	0.0	6.3	31.0	1.0	5.9	0.0	2.0	11.3	41.3	4.2	31.0	1.9	38.3	67.0	1.1	16.2	0.0	1.3	0.2	14.7	9.2	108.7	73.3	0.0	36.1	18.9	65.4	5.9	32.9	4.9	8.4	0.6	58.9	11.4	65.1	1.9	4.9	5.7	121.0	33.2	9.7	68.7	57.6	5.2	0.0	8.7	0.1	0.3	57.6	27.3	13.2	0.0	60.4	1.0	17.7	11.6	23.2	56.2	38.3	49.0	28.5	41.7	46.2	18.6	21.7	36.5	39.6	15.3	35.8	63.5	5.7	38.0	33.5	19.2	50.5	43.4	33.5	19.3	26.4	59.3	49.7	55.9	35.8	48.4	81.9	43.8	41.7	29.6	8.1	69.5	11.1	21.0	22.3	7.4	3.2	17.4	6.5	14.7	10.0	41.5	16.5	0.0	1.2	79.8	25.0	0.0	41.2	0.3	5.1	1.6	19.7	9.1	28.4	0.2	23.1	26.4	4.6	10.2	8.0	40.5	0.7	23.6	2.2	67.0	1.7	0.2	14.0	40.7	66.2	29.9	1.2	9.6	44.7	14.2	20.6	62.0	7.5	85.5	1.5	50.8	40.5	53.7	1.2	62.6	31.5	20.3	2.0	20.3	1.8	13.1	4.6	13.5	0.5	2.2	8.4	10.2	3.7	83.7	2.5	30.3	37.4
TMC8	"EVER2, EVIN2"	ENSG00000167895	"Transmembrane channel like 8"	Q8IU68	17	78130770-78142968	"Disease related genes, Human disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Ion transport, Transport"	"Ion channel"	"Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"bone marrow: 91.8;intestine: 54.6;lymphoid tissue: 117.0"	"Cell type enhanced"	"Detected in many"		"B-cells: 44.9;dendritic cells: 52.3;granulocytes: 41.2;Langerhans cells: 44.6;NK-cells: 85.5;T-cells: 68.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"Daudi: 46.3;HL-60: 63.0;HMC-1: 119.9;Karpas-707: 103.9;RPMI-8226: 66.6;U-266/70: 49.3;U-937: 51.9"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA047387, HPA054429"	Uncertain		Uncertain	"Golgi apparatus"		NA	NA			"Cluster 39: Non-specific - mRNA processing"	"Cluster 2: Immune cells - Immune response"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 63: NK-cells & T-cells - Immune response"	"Golgi apparatus"		"HPA047387: , HPA054429: AB_2682485"	"unprognostic (8.54e-3)"	"prognostic favorable (8.45e-6)"	"unprognostic (1.32e-1)"	"unprognostic (2.33e-3)"	"unprognostic (3.59e-1)"	"prognostic favorable (4.19e-5)"	"unprognostic (6.38e-3)"	"unprognostic (6.47e-2)"	"unprognostic (2.13e-1)"	"unprognostic (1.39e-1)"	"unprognostic (6.06e-2)"	"unprognostic (4.27e-1)"	"prognostic unfavorable (1.96e-7)"	"unprognostic (6.24e-2)"	"unprognostic (1.01e-2)"	"unprognostic (1.25e-1)"	"unprognostic (2.89e-2)"	7.8	3.0	3.6	56.0	4.4	91.8	3.7	3.7	5.1	3.7	3.5	8.2	10.3	2.5	0.7	4.8	4.0	7.4	2.7	3.6	4.8	5.2	7.1	18.4	100.5	5.8	4.7	1.3	2.0	0.5	2.2	3.9	5.6	4.9	4.5	0.1	5.8	1.3	1.8	3.6	54.6	2.4	5.0	117.0	10.4	1.2	7.8	60.1	6.4	0.9	46.7	6.4	5.0	7.2	0.5	0.8	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	1.3	46.3	2.0	0.0	0.1	3.4	0.0	0.1	0.0	0.0	0.1	16.4	0.1	0.8	0.0	63.0	119.9	0.0	0.0	0.0	0.0	0.0	0.0	22.1	4.0	103.9	0.0	1.3	20.9	2.8	0.2	3.5	0.5	1.4	0.3	66.6	0.0	0.2	0.0	0.1	0.0	2.2	0.6	0.1	6.9	12.7	0.1	0.0	0.1	0.1	0.0	49.3	2.0	4.6	0.1	51.9	0.1	2.6	2.0	6.6	13.4	3.4	9.7	5.5	10.8	13.3	2.3	4.8	9.4	8.6	3.3	7.5	7.9	2.1	6.5	5.5	3.6	4.4	3.7	5.1	3.6	4.8	5.8	4.7	5.6	5.0	7.8	7.2	3.6	3.2	10.2	1.0	44.9	5.4	10.4	4.9	4.6	0.2	1.2	1.5	1.9	1.5	6.5	0.0	0.0	0.4	52.3	3.7	0.0	1.0	0.7	1.0	0.6	3.2	1.2	17.1	0.4	1.3	1.4	2.3	2.0	1.8	41.2	0.1	5.7	0.5	30.5	0.0	0.4	1.4	14.2	28.2	44.6	0.5	0.0	22.0	7.2	24.4	30.2	0.2	85.5	1.0	2.7	0.6	3.6	0.4	20.2	2.9	0.9	0.4	2.1	0.2	0.0	0.3	2.0	0.4	0.6	8.4	4.5	0.5	68.6	2.7	7.0	10.7
TMEM259	"ASBABP1, C19orf6, MBRL, MGC4022"	ENSG00000182087	"Transmembrane protein 259"	Q4ZIN3	19	1009648-1021179	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA042669, HPA054801"	Approved		Approved	"Nuclear speckles,Endoplasmic reticulum"		NA	NA			"Cluster 39: Non-specific - mRNA processing"	"Cluster 18: Non-specific - Mitochondria"	"Cluster 29: U-266 - Adaptive immune response"	"Cluster 52: Non-specific - Transcription"	"Endoplasmic reticulum"	"Nuclear speckles"	"HPA042669: AB_10794916, HPA054801: AB_2682604"	"unprognostic (1.35e-1)"	"unprognostic (1.28e-1)"	"unprognostic (1.41e-1)"	"prognostic favorable (1.01e-4)"	"unprognostic (4.12e-2)"	"unprognostic (6.87e-3)"	"unprognostic (2.77e-2)"	"unprognostic (1.23e-1)"	"unprognostic (2.20e-1)"	"unprognostic (2.74e-1)"	"unprognostic (4.85e-3)"	"unprognostic (4.07e-2)"	"unprognostic (4.81e-2)"	"prognostic favorable (8.92e-6)"	"unprognostic (2.47e-1)"	"unprognostic (2.57e-1)"	"unprognostic (4.10e-3)"	114.9	119.8	59.6	68.7	62.3	82.4	112.4	59.9	74.5	111.8	71.3	117.4	66.8	108.0	22.3	114.7	110.9	48.0	129.9	57.0	61.3	119.3	162.6	128.5	75.2	72.1	65.6	106.5	127.3	83.2	154.2	50.3	63.7	126.3	33.9	39.1	109.2	45.6	112.7	128.6	135.7	35.2	58.9	191.5	115.5	101.2	66.1	71.9	133.2	48.2	47.8	103.3	113.1	75.5	125.0	78.3	53.6	61.3	64.7	62.2	94.4	101.1	89.5	83.7	89.9	73.2	68.6	84.8	98.5	78.9	39.4	138.9	54.4	102.0	36.9	108.5	88.0	50.4	102.9	81.2	114.6	98.1	122.5	83.7	102.2	67.5	83.6	79.5	73.7	85.6	85.5	168.2	56.8	54.9	106.5	89.9	78.3	63.1	60.2	120.8	40.6	110.1	66.3	115.1	73.7	77.8	64.9	82.2	73.9	43.0	80.9	125.3	87.0	83.0	47.2	118.5	108.2	240.2	95.7	96.2	98.3	79.3	84.6	0.6	1.7	1.0	2.2	1.4	1.6	1.6	1.3	2.2	2.5	1.3	1.3	1.6	1.1	1.2	2.3	2.9	1.4	1.6	59.6	62.3	59.9	74.5	57.0	61.3	72.1	65.6	63.7	58.9	66.1	75.5	73.6	32.1	49.9	64.6	70.1	62.3	54.5	26.0	51.2	118.5	50.3	44.7	14.1	30.0	27.6	66.2	98.0	59.2	90.0	114.1	11.7	28.4	18.3	46.5	56.4	50.4	40.2	21.0	36.3	34.3	51.4	49.6	122.3	63.5	15.2	89.4	40.7	52.0	51.1	104.3	40.8	78.4	18.3	30.0	58.1	11.4	42.6	55.2	44.4	36.5	28.7	65.9	26.8	35.2	58.4	42.9	75.8	34.3	89.1	63.7	56.2	20.7	26.3	170.2	32.9	48.5	51.2	45.4	38.5	53.8	64.9	82.4	69.3	126.4	62.6	66.3
TMSB4Y	TB4Y	ENSG00000154620	"Thymosin beta 4 Y-linked"	O14604	Y	13703899-13706024	"Predicted intracellular proteins"		Actin-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 6.4"	"Cell type enhanced"	"Detected in many"		"Langerhans cells: 9.2"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"BEWO: 17.8;HEL: 14.7;RPTEC TERT1: 23.4;RT4: 7.9;U-698: 8.2"					"Low region specificity"	"Detected in all"									NA	NA		2400000	"Cluster 39: Non-specific - mRNA processing"	"Cluster 37: Intestine - Unknown function"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 51: Myeloid cells - Hemostasis"					"unprognostic (7.27e-2)"	"unprognostic (1.31e-1)"		"unprognostic (5.79e-2)"	"unprognostic (1.39e-5)"	"unprognostic (1.46e-2)"	"unprognostic (2.84e-1)"	"unprognostic (3.39e-2)"	"unprognostic (1.89e-1)"	"unprognostic (3.30e-2)"	"unprognostic (8.53e-2)"	"unprognostic (1.42e-1)"	"unprognostic (6.64e-3)"	"unprognostic (1.84e-1)"	"unprognostic (1.27e-1)"	"unprognostic (1.09e-1)"	0.9	0.8	0.6	0.5	0.9	2.8	0.8	0.6	1.4	0.0	0.3	2.8	1.0	0.0	3.1	2.0	0.0	0.9	0.5	0.6	1.0	2.0	1.1	0.5	0.4	1.4	0.7	0.0	1.2	1.0	1.2	0.4	1.5	3.8	6.4	0.5	1.2	2.2	0.2	1.0	2.7	0.0	0.9	0.8	1.0	3.8	0.8	0.0	1.2	0.4	1.1	1.7	0.0	1.2	0.0	1.0	0.0	0.0	0.0	0.0	17.8	0.6	1.2	0.0	0.0	0.0	0.0	0.9	0.0	1.4	0.0	0.0	0.0	0.0	0.0	1.3	0.0	14.7	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.2	0.0	4.2	0.0	1.2	0.0	0.0	0.0	0.0	2.8	23.4	7.9	5.6	0.0	0.0	0.0	1.1	1.5	0.0	0.9	0.4	0.8	0.0	0.0	0.1	1.7	3.9	8.2	0.0	0.0	0.0	0.0	1.3	0.5	1.3	1.3	0.7	1.0	1.4	0.2	2.9	0.7	0.9	0.4	0.6	0.8	0.4	0.7	0.5	1.4	0.6	0.9	0.6	1.4	0.6	1.0	1.4	0.7	1.5	0.9	0.8	1.2	0.0	0.0	2.6	0.0	1.9	2.5	4.5	4.5	3.4	3.4	0.0	0.0	1.2	1.5	1.7	1.8	4.2	5.7	2.7	1.7	3.9	1.6	0.5	0.0	0.0	1.4	0.0	5.7	0.4	0.0	1.0	1.4	2.6	0.0	2.5	0.0	1.1	0.2	3.2	3.3	0.4	3.4	0.0	7.2	9.2	2.3	1.5	5.2	0.0	0.0	2.5	5.5	3.1	1.0	0.6	0.2	4.4	1.9	0.9	3.0	2.2	6.2	1.4	1.1	0.0	1.1	1.2	1.1	3.5	3.4	2.8	1.1	2.1	0.0	4.6	6.8
TNFSF9	"4-1BB-L, 4-1BBL"	ENSG00000125657	"TNF superfamily member 9"	P41273	19	6531026-6535924	"Plasma proteins, Predicted intracellular proteins"		Cytokine		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"cervix: 9.8;esophagus: 9.8;vagina: 9.5"	"Cell type enhanced"	"Detected in many"		"B-cells: 57.5;dendritic cells: 51.6;Gastric mucus-secreting cells: 23.0;Macrophages: 22.5;T-cells: 31.5"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"HMC-1: 85.8"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			HPA059857			Approved	"Golgi apparatus"		NA	NA			"Cluster 39: Non-specific - mRNA processing"	"Cluster 27: Brain & Skin - Unknown function"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 65: Plasmacytoid DCs - Unknown function"	"Golgi apparatus"		"HPA059857: AB_2684144"	"unprognostic (2.21e-1)"	"unprognostic (1.84e-1)"	"unprognostic (1.26e-1)"	"unprognostic (7.67e-3)"	"unprognostic (2.33e-1)"	"unprognostic (1.35e-1)"	"unprognostic (2.19e-2)"	"unprognostic (2.78e-2)"	"unprognostic (1.36e-1)"	"unprognostic (2.93e-2)"	"unprognostic (2.41e-3)"	"unprognostic (4.88e-1)"	"prognostic unfavorable (1.04e-4)"	"unprognostic (5.10e-2)"	"unprognostic (1.16e-1)"	"unprognostic (1.62e-1)"	"unprognostic (8.07e-3)"	1.8	0.6	3.5	1.0	3.0	3.7	0.8	3.7	7.6	9.8	2.3	1.2	0.3	0.3	0.3	9.8	1.1	1.0	0.6	3.9	3.3	0.9	0.4	4.9	1.1	3.6	2.9	0.5	0.3	0.5	0.3	0.9	3.4	0.3	1.8	0.3	1.5	0.1	0.7	1.4	1.2	0.4	3.1	2.2	0.6	3.3	3.1	0.5	0.4	0.3	0.7	0.7	9.5	6.3	10.7	13.4	0.2	4.8	2.5	6.0	0.4	1.5	4.8	3.6	17.1	0.3	18.0	11.3	6.8	3.0	0.0	19.2	5.4	2.3	0.9	0.0	2.6	1.8	18.4	4.4	0.4	0.3	85.8	1.0	10.1	20.1	5.5	2.6	0.6	1.6	10.9	0.2	1.3	1.5	0.9	1.8	1.8	0.7	9.5	1.2	0.0	2.8	22.9	0.4	0.0	0.0	29.8	1.7	5.0	0.6	1.2	16.4	6.2	0.0	9.6	26.0	0.0	26.9	10.2	20.9	10.2	5.9	5.9	0.0	0.0	0.0	0.1	0.0	0.0	0.4	0.0	0.8	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	3.5	3.0	3.7	7.6	3.9	3.3	3.6	2.9	3.4	3.1	3.1	6.3	11.3	0.0	4.5	0.0	57.5	2.7	0.3	4.3	6.2	0.2	4.0	3.8	8.1	0.0	1.6	0.0	0.0	0.1	51.6	4.3	0.0	0.3	0.1	5.7	3.9	6.8	14.2	0.0	2.2	0.2	0.0	12.6	23.0	9.2	8.9	0.6	1.8	0.0	4.5	0.0	2.5	3.4	2.0	1.9	15.9	0.0	0.0	22.5	3.6	0.0	1.6	0.8	0.0	1.5	2.9	0.8	4.9	0.0	17.2	0.9	0.2	0.1	0.9	0.2	0.0	2.5	7.5	0.1	0.4	12.7	1.3	0.1	31.5	0.9	5.7	0.3
TOP3B		ENSG00000100038	"DNA topoisomerase III beta"	O95985	22	21957025-21982813	"Enzymes, Plasma proteins, Predicted intracellular proteins"		"DNA-binding, Isomerase, Topoisomerase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"K-562: 112.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA072114			Approved	Nucleoplasm		NA	NA			"Cluster 39: Non-specific - mRNA processing"	"Cluster 18: Non-specific - Mitochondria"	"Cluster 1: K-562 - Erythropoiesis"	"Cluster 10: Non-specific - Unknown function"	Nucleoplasm		"HPA072114: "	"unprognostic (1.03e-1)"	"unprognostic (2.05e-2)"	"unprognostic (1.44e-1)"	"unprognostic (1.68e-2)"	"unprognostic (3.37e-1)"	"unprognostic (5.04e-2)"	"unprognostic (2.27e-1)"	"unprognostic (3.93e-1)"	"unprognostic (2.15e-2)"	"unprognostic (2.89e-2)"	"unprognostic (1.95e-1)"	"unprognostic (1.29e-2)"	"unprognostic (1.96e-2)"	"unprognostic (1.69e-2)"	"unprognostic (1.21e-1)"	"unprognostic (3.53e-2)"	"unprognostic (1.11e-4)"	10.6	12.0	5.5	10.1	6.9	16.2	11.2	7.5	8.3	17.9	12.2	13.7	11.1	13.5	7.1	14.8	13.5	7.4	11.8	6.0	5.7	13.9	17.0	13.7	12.7	5.9	5.0	20.3	12.7	7.4	12.9	8.4	6.1	16.7	9.9	6.9	13.9	6.8	10.4	14.7	17.7	9.7	4.0	25.0	13.5	11.1	6.3	13.6	14.3	5.7	13.4	11.4	15.5	8.1	22.1	21.1	40.9	16.8	14.8	12.3	25.7	14.2	17.6	32.1	28.3	22.2	9.3	29.9	10.5	14.9	13.4	39.6	18.6	25.2	25.9	15.3	45.4	23.5	31.4	24.1	20.1	32.3	14.9	6.1	37.5	26.8	12.7	18.6	27.1	17.2	112.5	15.7	15.2	22.3	20.6	25.0	17.0	15.8	19.9	31.6	27.1	4.6	15.8	28.9	26.7	19.3	17.4	15.4	13.7	16.4	11.9	20.7	19.9	13.2	27.6	13.0	17.6	23.2	20.8	28.2	10.2	19.4	14.0	1.9	4.3	1.8	5.5	4.4	3.8	4.5	3.6	3.9	4.7	4.9	3.3	3.5	1.5	4.3	2.6	5.4	4.2	3.7	5.5	6.9	7.5	8.3	6.0	5.7	5.9	5.0	6.1	4.0	6.3	8.1	7.2	0.0	2.6	12.1	7.2	1.8	2.6	6.2	2.8	4.6	3.7	3.9	0.2	8.6	5.0	3.7	10.4	5.2	7.2	7.0	1.9	4.8	1.3	5.3	6.7	5.7	4.8	2.1	8.9	4.3	3.6	4.3	12.2	5.0	1.3	15.0	7.9	7.1	4.0	1.7	7.7	5.3	4.1	3.4	3.8	1.8	10.5	5.1	5.4	6.5	4.3	3.1	5.2	4.5	9.2	6.4	4.6	7.5	6.1	3.4	4.5	2.8	8.2	6.1	6.6	4.9	9.6	6.6	4.9	3.6	1.6	4.0	5.9	7.6	5.8	2.9
TP53	"LFS1, p53"	ENSG00000141510	"Tumor protein p53"	P04637	17	7661779-7687538	"Cancer-related genes, Disease related genes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Transcription factors, Transporters"	"Apoptosis, Biological rhythms, Cell cycle, Host-virus interaction, Necrosis, Transcription, Transcription regulation"	"Activator, DNA-binding, Repressor"	"Cancer-related genes, Disease variant, Li-Fraumeni syndrome, Tumor suppressor"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB002973, CAB039238, CAB039239, HPA051244, HPA063532, CAB072876, CAB079965"	Enhanced		Supported	Nucleoplasm,Mitochondria,Cytosol		Yes	No			"Cluster 39: Non-specific - mRNA processing"	"Cluster 3: T-cells - Adaptive immune response"	"Cluster 14: REH - Unknown function"	"Cluster 32: Non-specific - Translation"	Nucleoplasm	"Mitochondria, Cytosol"	"CAB002973: AB_2206626, CAB039238: , CAB039239: , CAB072876: AB_2665731, CAB079965: , HPA051244: AB_2681403, HPA063532: "	"unprognostic (2.29e-2)"	"unprognostic (8.83e-3)"	"unprognostic (1.26e-2)"	"prognostic favorable (1.35e-4)"	"unprognostic (9.95e-2)"	"unprognostic (4.00e-2)"	"unprognostic (2.79e-3)"	"unprognostic (4.99e-2)"	"unprognostic (2.75e-2)"	"unprognostic (2.55e-1)"	"unprognostic (1.30e-1)"	"prognostic unfavorable (5.01e-4)"	"unprognostic (1.86e-3)"	"unprognostic (7.89e-3)"	"unprognostic (8.05e-2)"	"unprognostic (2.74e-1)"	"unprognostic (1.08e-1)"	19.3	13.8	10.4	27.1	12.6	19.6	22.5	10.4	16.5	19.9	10.3	29.0	18.9	24.5	12.8	28.8	31.3	13.2	11.1	10.1	11.4	14.9	16.5	15.1	34.6	18.7	13.6	27.3	18.3	9.4	7.3	23.5	12.5	17.7	27.5	4.1	18.9	15.3	12.3	37.4	20.4	24.6	12.6	31.1	22.6	10.4	12.3	47.2	17.4	6.1	45.4	20.8	19.9	13.3	81.5	145.3	81.1	57.3	37.3	43.9	82.8	28.4	66.1	78.5	100.2	4.2	40.6	190.5	126.9	58.7	77.6	174.9	119.7	80.4	72.8	42.7	76.5	77.6	76.8	70.9	111.5	1.6	37.0	55.7	93.0	38.9	106.5	45.6	79.4	24.7	3.8	6.9	41.5	145.1	130.0	96.3	80.2	10.4	2.4	252.2	56.1	66.2	59.4	87.3	46.0	80.5	94.1	62.6	24.3	39.4	109.2	7.4	100.7	91.6	30.2	1.0	48.3	47.6	37.9	82.5	23.6	9.7	80.1	1.2	21.2	3.4	13.0	21.7	15.9	21.5	13.3	14.6	30.3	19.1	13.7	15.4	2.4	17.5	19.3	27.3	17.3	14.7	10.4	12.6	10.4	16.5	10.1	11.4	18.7	13.6	12.5	12.6	12.3	13.3	21.1	9.6	12.8	16.3	26.0	28.7	14.5	24.6	24.5	2.6	36.1	30.4	2.5	18.6	15.4	20.2	0.0	36.9	24.7	16.9	9.8	24.8	12.8	11.5	29.0	24.5	30.7	21.7	2.1	18.1	39.6	17.0	11.2	19.5	1.3	31.7	22.1	18.0	24.2	0.0	3.2	43.0	18.3	27.8	20.1	3.8	23.0	19.3	12.4	7.5	31.9	4.9	25.7	9.0	8.0	15.8	16.4	17.0	7.8	15.7	10.3	10.1	8.8	2.6	13.1	25.9	20.6	0.5	4.9	28.7	32.8	22.4	16.5	27.4	54.1	11.5
TPP2	TPPII	ENSG00000134900	"Tripeptidyl peptidase 2"	P29144	13	102596986-102679958	"Enzymes, Plasma proteins, Predicted intracellular proteins"		"Aminopeptidase, Hydrolase, Protease, Serine protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in all"	9	"Early spermatids: 796.3;Late spermatids: 892.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA021069, HPA049630"	Approved		Supported	"Nuclear bodies,Cytosol"		NA	NA		280000	"Cluster 39: Non-specific - mRNA processing"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 32: U-937 - Innate immune response"	"Cluster 25: Spermatids - Spermatogenesis"	"Nuclear bodies, Cytosol"		"HPA021069: AB_1858344, HPA049630: AB_2680836"	"unprognostic (4.75e-2)"	"unprognostic (4.78e-2)"	"unprognostic (9.97e-2)"	"unprognostic (1.08e-1)"	"unprognostic (2.01e-2)"	"unprognostic (4.43e-2)"	"unprognostic (2.45e-2)"	"unprognostic (8.33e-3)"	"unprognostic (5.02e-2)"	"unprognostic (1.51e-1)"	"unprognostic (3.12e-1)"	"unprognostic (2.75e-3)"	"unprognostic (6.26e-2)"	"unprognostic (3.12e-1)"	"unprognostic (7.53e-2)"	"unprognostic (3.95e-2)"	"unprognostic (3.43e-3)"	12.6	8.1	3.5	15.6	5.5	48.0	16.4	9.7	5.3	12.9	5.7	13.9	12.3	16.3	19.7	11.6	11.5	12.5	13.8	3.0	2.3	10.0	20.4	14.6	19.9	3.7	3.1	14.1	10.9	11.3	8.3	17.7	4.4	11.3	19.2	17.4	10.6	16.7	27.7	12.1	12.5	13.1	3.3	18.6	12.2	51.8	4.9	16.1	19.9	22.1	17.1	12.8	11.4	9.8	33.8	13.7	38.0	28.7	28.9	37.5	25.5	34.9	26.6	23.8	28.0	30.7	41.0	37.3	11.9	30.3	25.7	30.0	30.5	23.7	39.3	26.4	24.9	71.2	34.0	22.8	22.9	89.3	44.6	31.5	11.2	26.4	35.6	23.6	32.7	34.8	43.4	42.9	32.0	11.3	37.2	53.4	28.5	43.7	17.6	43.5	30.3	31.8	25.7	29.7	35.8	26.7	23.2	35.0	13.7	31.9	20.0	79.9	28.5	20.9	15.1	12.9	29.0	40.7	56.2	37.0	31.1	56.6	26.8	7.4	5.5	3.7	7.1	5.9	8.4	4.8	8.2	8.4	5.2	4.5	9.7	9.8	1.0	8.9	4.9	3.3	9.6	4.5	3.5	5.5	9.7	5.3	3.0	2.3	3.7	3.1	4.4	3.3	4.9	9.8	20.9	38.5	41.6	41.8	24.5	15.4	16.4	10.6	22.8	27.5	18.5	12.7	41.8	11.5	18.5	14.7	73.0	28.5	38.7	13.3	9.8	19.8	796.3	23.0	28.9	19.3	19.8	26.1	64.1	8.8	30.7	25.8	14.3	22.7	38.6	24.8	20.3	22.4	32.1	8.4	69.8	18.5	8.2	25.7	19.9	892.8	32.0	29.5	17.8	65.6	29.3	13.8	42.2	66.4	67.3	13.3	16.3	18.8	58.9	16.5	10.2	13.2	36.4	46.5	26.3	24.3	28.8	92.7	30.0	22.9	13.4	33.1	35.6	31.6	21.8	19.6
TRIM11	"BIA1, RNF92"	ENSG00000154370	"Tripartite motif containing 11"	Q96F44	1	228393673-228406835	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	"Antiviral defense, Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Early spermatids: 154.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA028541, HPA043879"	Approved		Enhanced	Nucleoplasm,Cytosol		NA	NA			"Cluster 39: Non-specific - mRNA processing"	"Cluster 18: Non-specific - Mitochondria"	"Cluster 28: BEWO - Transcription regulation"	"Cluster 29: Early spermatids - Spermatogenesis"	"Nucleoplasm, Cytosol"		"HPA028541: AB_10600833, HPA043879: AB_2678711"	"unprognostic (1.73e-1)"	"unprognostic (9.73e-3)"	"unprognostic (5.48e-3)"	"unprognostic (7.73e-2)"	"unprognostic (3.27e-1)"	"unprognostic (2.33e-1)"	"prognostic unfavorable (7.42e-5)"	"unprognostic (1.08e-1)"	"unprognostic (9.74e-2)"	"unprognostic (2.04e-1)"	"unprognostic (1.40e-1)"	"unprognostic (3.15e-1)"	"prognostic unfavorable (1.62e-4)"	"unprognostic (3.40e-2)"	"unprognostic (4.89e-2)"	"unprognostic (2.04e-1)"	"unprognostic (1.22e-2)"	10.2	12.1	12.7	8.9	16.0	30.7	10.4	23.9	15.2	14.7	10.1	13.6	7.7	11.5	4.5	20.7	12.7	6.1	8.7	14.4	11.6	12.2	10.2	11.8	12.2	11.6	9.9	11.9	11.9	6.7	9.8	5.6	10.8	15.4	7.1	2.0	17.1	7.0	5.0	17.1	14.6	4.6	8.6	24.1	12.9	14.9	13.2	10.1	11.0	3.1	8.7	11.7	15.6	11.0	28.3	26.3	13.8	19.1	10.2	8.4	65.1	18.1	12.1	20.5	16.4	32.2	24.0	21.1	19.7	12.2	13.5	45.1	16.8	17.4	8.6	23.6	40.5	17.5	26.7	17.6	27.6	22.2	25.6	11.3	27.2	21.3	10.6	10.5	10.2	33.9	40.7	26.4	10.7	18.2	27.1	35.1	35.3	23.9	22.9	26.3	12.5	25.8	13.4	34.0	22.9	42.0	15.1	42.2	24.7	5.6	29.9	36.8	11.6	13.0	18.3	30.6	37.9	26.9	19.3	18.9	16.1	17.7	20.9	5.2	4.5	5.6	5.5	5.3	5.9	3.7	6.4	7.1	4.4	3.5	3.6	5.1	6.2	6.2	7.5	3.5	6.4	3.9	12.7	16.0	23.9	15.2	14.4	11.6	11.6	9.9	10.8	8.6	13.2	11.0	7.8	3.2	5.8	1.6	12.1	15.8	16.3	7.4	10.8	12.1	13.3	10.7	3.6	12.8	10.4	1.8	2.1	15.7	21.6	28.1	17.6	14.8	154.2	11.2	10.2	10.1	14.4	12.6	9.8	11.0	15.5	8.5	23.4	17.1	5.7	13.4	8.9	5.7	11.8	5.0	4.7	21.7	4.1	12.6	9.3	16.5	9.6	11.0	5.4	2.8	22.0	10.3	30.9	3.0	3.2	18.3	21.1	7.5	12.8	17.4	17.8	9.9	7.3	1.6	6.6	8.4	9.1	7.3	12.4	15.8	19.5	57.3	18.9	14.9	17.6	30.1
TRIM26	"RNF95, ZNF173"	ENSG00000234127	"Tripartite motif containing 26"	Q12899	6	30184455-30213427	"Enzymes, Predicted intracellular proteins"	"Immunity, Innate immunity"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"Daudi: 38.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA044975, HPA050456"	Approved		Supported	Nucleoplasm,Cytosol		NA	NA			"Cluster 39: Non-specific - mRNA processing"	"Cluster 18: Non-specific - Mitochondria"	"Cluster 16: U-266 - Nucleosome"	"Cluster 44: Endometrium - Transcription"	"Nucleoplasm, Cytosol"		"HPA044975: AB_2679162, HPA050456: AB_2681133"	"unprognostic (1.93e-1)"	"unprognostic (5.41e-2)"	"unprognostic (8.53e-2)"	"unprognostic (1.96e-3)"	"unprognostic (1.52e-1)"	"unprognostic (5.50e-2)"	"unprognostic (2.02e-1)"	"unprognostic (1.40e-2)"	"unprognostic (2.85e-1)"	"unprognostic (3.08e-2)"	"unprognostic (1.97e-1)"	"unprognostic (7.00e-3)"	"unprognostic (1.37e-2)"	"unprognostic (1.63e-3)"	"unprognostic (5.21e-2)"	"unprognostic (8.82e-2)"	"prognostic favorable (3.25e-5)"	15.6	16.5	3.6	6.9	4.4	4.5	16.3	4.5	7.1	15.8	3.7	17.9	5.6	16.8	2.9	28.9	16.4	4.9	12.5	3.3	4.9	18.1	26.1	16.8	6.6	4.7	4.0	12.5	15.5	4.2	14.1	2.9	4.3	18.2	2.3	4.2	21.0	3.2	14.5	20.8	19.8	1.1	3.6	18.0	17.6	11.5	4.8	3.9	17.6	1.3	6.6	17.8	17.4	4.9	15.7	8.3	0.0	23.8	8.1	4.6	7.8	9.7	5.4	11.4	11.6	0.0	0.9	38.2	13.0	12.4	17.0	17.6	0.0	16.8	3.5	0.0	13.0	6.1	2.5	16.7	7.1	13.3	5.4	4.6	5.7	11.9	7.1	0.0	7.6	18.4	2.8	0.0	0.0	0.0	19.1	17.8	0.0	0.0	6.7	16.9	15.1	5.3	9.8	14.5	0.5	11.0	18.5	0.9	5.2	5.0	8.0	2.3	16.5	8.7	5.8	0.0	0.2	15.1	31.2	18.1	0.0	21.3	15.0	0.5	1.5	0.1	1.8	1.9	1.2	1.0	1.2	1.5	1.2	1.4	0.7	1.0	0.5	0.7	1.6	0.5	1.6	1.3	3.6	4.4	4.5	7.1	3.3	4.9	4.7	4.0	4.3	3.6	4.8	4.9	13.5	28.9	21.7	18.3	23.8	30.1	22.4	13.1	34.7	20.1	22.0	18.0	13.5	18.6	15.7	12.9	16.7	18.6	31.1	21.8	11.7	16.1	0.5	25.7	15.1	16.2	22.3	1.7	16.5	15.9	14.4	12.7	17.9	34.7	5.1	12.2	9.3	52.9	13.8	13.5	25.1	15.4	6.1	17.3	25.7	1.6	7.5	21.0	17.8	18.7	24.0	12.1	21.6	18.1	26.9	13.6	15.7	12.0	26.3	20.2	17.1	15.8	24.4	19.7	6.6	10.7	12.1	5.0	13.4	42.0	34.0	17.6	28.7	9.4	17.2	22.3
TRIM27	"RFP, RNF76"	ENSG00000204713	"Tripartite motif containing 27"	P14373	6	28903002-28923988	"Cancer-related genes, Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Transcription, Transcription regulation, Transport, Ubl conjugation pathway"	"DNA-binding, Repressor, Transferase"	"Cancer-related genes, Proto-oncogene"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"RPMI-8226: 49.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA048684, HPA053408"	Approved		Approved	Nucleoplasm,Nucleoli		NA	NA			"Cluster 39: Non-specific - mRNA processing"	"Cluster 18: Non-specific - Mitochondria"	"Cluster 25: RPMI-8226 - Immune response"	"Cluster 39: Non-specific - Basic cellular processes"	Nucleoli	Nucleoplasm	"HPA048684: AB_2680493, HPA053408: AB_2682139"	"unprognostic (1.57e-1)"	"unprognostic (1.48e-2)"	"unprognostic (2.36e-1)"	"unprognostic (1.14e-2)"	"unprognostic (1.70e-2)"	"unprognostic (2.56e-1)"	"unprognostic (2.00e-3)"	"unprognostic (1.17e-2)"	"unprognostic (1.01e-2)"	"unprognostic (1.12e-3)"	"unprognostic (4.76e-3)"	"unprognostic (1.16e-2)"	"prognostic unfavorable (3.50e-6)"	"unprognostic (1.27e-1)"	"unprognostic (1.41e-1)"	"unprognostic (1.47e-1)"	"prognostic favorable (2.71e-4)"	23.8	28.1	1.8	7.2	1.7	1.1	23.3	1.1	2.6	33.0	2.2	23.0	8.7	24.5	0.0	20.5	31.0	0.5	24.3	1.6	1.3	32.7	59.5	26.8	2.2	2.2	2.1	30.8	53.0	0.6	33.8	4.5	1.8	35.1	0.6	0.1	25.8	6.5	21.2	17.6	26.8	2.3	1.5	45.8	27.3	14.4	2.0	0.9	26.3	0.0	1.0	28.7	22.6	2.0	2.4	8.2	1.2	21.7	2.8	6.2	0.3	16.1	0.8	5.1	6.2	6.1	1.7	1.6	1.1	4.8	1.3	17.5	4.0	9.2	0.5	1.3	2.6	20.3	2.5	9.3	4.3	2.0	5.7	0.1	1.0	4.1	1.3	0.6	4.5	5.8	2.1	12.1	1.3	4.9	11.1	0.9	0.0	3.4	13.5	20.1	4.6	49.7	3.9	2.3	4.9	18.7	19.9	11.6	4.1	0.6	11.6	12.2	13.1	6.3	9.3	14.7	5.1	31.7	2.7	17.9	6.8	24.8	20.0	5.2	4.4	2.5	7.0	12.5	11.3	7.0	10.6	5.5	8.5	1.8	4.1	7.6	2.7	6.4	7.0	5.6	5.2	9.9	1.8	1.7	1.1	2.6	1.6	1.3	2.2	2.1	1.8	1.5	2.0	2.0	21.4	16.0	24.8	11.8	32.2	28.4	41.9	27.4	33.6	11.7	32.2	24.6	18.3	24.3	24.0	29.5	16.7	46.4	25.4	15.9	21.5	39.5	12.9	27.1	27.0	32.0	27.6	24.6	13.5	43.4	55.5	25.5	26.5	27.2	21.5	36.9	27.8	42.1	41.1	8.4	13.4	38.5	26.4	28.3	23.5	6.8	23.9	29.0	8.8	16.9	46.5	10.4	29.9	19.1	19.7	48.9	18.7	18.4	51.2	53.3	19.3	27.6	23.9	13.6	19.7	14.8	31.0	8.0	16.1	25.8	19.6	45.6	28.9	43.7	28.3	30.9
TRIM3	"BERP, HAC1, RNF22, RNF97"	ENSG00000110171	"Tripartite motif containing 3"	O75382	11	6448613-6474459	"Predicted intracellular proteins"	"Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Proximal enterocytes: 28.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"SK-BR-3: 54.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA043396, HPA048233"	Enhanced		Approved	Mitochondria		NA	NA			"Cluster 39: Non-specific - mRNA processing"	"Cluster 12: Smooth muscle tissue - Mixed function"	"Cluster 8: SK-BR-3 - Unknown function"	"Cluster 45: Enterocytes - Digestion"	Mitochondria		"HPA043396: AB_2678460, HPA048233: AB_2680321"	"unprognostic (1.24e-1)"	"unprognostic (1.98e-1)"	"unprognostic (2.31e-1)"	"prognostic favorable (2.20e-4)"	"unprognostic (4.01e-2)"	"unprognostic (3.88e-2)"	"unprognostic (1.61e-3)"	"unprognostic (2.84e-1)"	"unprognostic (2.24e-1)"	"unprognostic (3.91e-1)"	"prognostic favorable (5.49e-5)"	"unprognostic (2.01e-1)"	"prognostic unfavorable (1.07e-5)"	"unprognostic (2.51e-1)"	"unprognostic (1.66e-1)"	"unprognostic (1.54e-1)"	"unprognostic (1.93e-1)"	9.5	4.6	6.4	4.6	6.2	1.3	10.3	11.6	7.5	11.2	0.0	13.0	17.8	13.5	1.8	4.8	10.1	4.1	8.0	5.8	3.4	6.3	6.3	9.7	2.4	8.5	3.1	8.7	6.4	2.7	5.9	3.9	9.4	9.5	4.8	4.8	9.0	5.4	11.5	8.4	15.7	5.6	2.2	5.7	10.1	3.8	5.9	1.5	6.8	4.8	1.6	11.2	9.3	6.1	7.2	12.4	4.9	8.3	8.1	7.8	6.7	10.3	6.1	7.8	8.6	7.6	5.0	3.9	3.6	7.9	9.1	5.0	5.1	7.7	3.0	4.8	7.6	1.2	13.5	5.3	5.2	0.4	4.1	6.7	3.7	6.1	3.2	3.3	8.0	2.9	1.7	4.7	7.8	15.2	0.3	1.0	3.5	15.2	10.7	2.4	4.2	4.9	1.9	3.8	5.1	7.8	5.7	54.9	6.6	2.5	20.8	1.3	13.4	20.3	9.5	15.0	6.9	5.5	3.6	0.8	11.0	1.7	7.6	0.0	1.0	0.6	0.5	1.0	0.4	0.1	0.4	0.4	1.2	0.1	0.1	0.6	0.0	0.6	0.2	0.2	0.5	0.5	6.4	6.2	11.6	7.5	5.8	3.4	8.5	3.1	9.4	2.2	5.9	6.1	8.5	6.4	0.0	9.8	2.4	4.8	2.8	2.8	3.4	8.8	8.5	6.0	2.2	2.8	2.7	0.0	10.4	1.8	3.5	16.0	0.0	3.1	3.9	2.8	4.4	6.5	4.8	0.4	13.2	3.5	2.2	6.9	5.6	7.3	1.3	3.6	4.6	2.5	4.7	8.4	12.2	11.4	4.1	0.8	6.5	5.6	5.9	3.5	7.2	11.2	3.4	2.2	3.1	5.0	10.2	3.1	5.4	5.3	2.5	3.2	28.7	3.1	8.4	9.6	13.1	5.0	11.3	3.1	6.0	3.7	5.4	0.8	3.4	3.3	6.6	2.3
TRMT1	"FLJ20244, TRM1"	ENSG00000104907	"TRNA methyltransferase 1"	Q9NXH9	19	13104902-13117567	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"tRNA processing"	"Methyltransferase, RNA-binding, Transferase, tRNA-binding"	"Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Kupffer cells: 80.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041130, HPA041380"	Approved		Approved	"Nucleoplasm,Plasma membrane,Cytosol"		NA	NA			"Cluster 39: Non-specific - mRNA processing"	"Cluster 72: Non-specific - Transcription"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 57: B-cells - Immune response"	"Plasma membrane, Cytosol"	Nucleoplasm	"HPA041130: AB_10803995, HPA041380: AB_10793873"	"unprognostic (2.10e-2)"	"unprognostic (2.40e-3)"	"unprognostic (2.23e-2)"	"unprognostic (1.01e-1)"	"unprognostic (1.12e-2)"	"unprognostic (5.54e-2)"	"unprognostic (1.08e-3)"	"unprognostic (2.19e-2)"	"unprognostic (1.59e-1)"	"unprognostic (7.62e-2)"	"unprognostic (1.91e-2)"	"unprognostic (8.74e-3)"	"prognostic unfavorable (9.87e-7)"	"unprognostic (1.19e-3)"	"unprognostic (3.47e-2)"	"unprognostic (2.22e-1)"	"unprognostic (2.49e-2)"	22.0	19.8	16.5	16.2	15.3	21.1	21.0	14.7	22.1	24.3	14.8	20.0	11.8	22.9	6.3	22.3	23.6	8.9	17.3	15.5	14.7	18.0	22.1	17.3	23.2	16.0	14.8	28.7	25.4	10.0	17.2	11.3	16.8	23.0	10.9	6.5	17.0	11.4	28.8	23.4	21.7	12.5	14.2	30.6	18.9	16.8	16.2	11.6	19.2	10.5	15.9	22.3	22.2	17.6	38.6	25.3	26.9	46.0	26.7	34.1	38.7	42.1	20.9	45.3	39.1	27.4	30.8	47.7	53.6	22.9	23.7	34.8	45.2	37.3	20.9	31.3	62.8	38.0	68.7	46.5	48.7	77.2	43.1	48.4	48.4	47.3	44.1	28.9	33.8	35.2	83.7	14.9	28.6	42.6	31.7	83.3	64.0	24.2	57.5	52.5	34.6	65.8	28.3	38.2	63.5	28.9	26.2	53.7	44.8	19.4	21.0	42.8	38.2	65.1	25.5	39.8	75.1	25.6	53.4	44.1	30.3	80.7	34.7	1.8	18.9	0.6	8.9	15.0	8.6	12.4	9.6	8.6	18.2	12.9	11.1	8.5	3.7	5.6	9.9	10.6	6.9	10.7	16.5	15.3	14.7	22.1	15.5	14.7	16.0	14.8	16.8	14.2	16.2	17.6	15.5	12.8	13.1	8.5	47.5	24.0	27.0	16.8	22.8	8.9	16.6	20.2	8.3	11.5	9.6	12.9	2.1	21.7	19.6	16.6	5.9	17.3	22.4	7.9	11.7	17.6	7.2	13.0	12.0	14.9	22.6	14.3	17.9	9.8	29.8	19.7	6.1	10.8	47.7	8.4	9.1	14.1	4.1	80.0	51.0	47.9	14.0	57.4	17.8	10.3	64.8	6.1	12.3	2.5	7.5	12.8	6.8	12.8	24.2	29.0	7.8	14.2	9.2	12.6	13.1	17.5	16.1	21.1	20.0	20.7	20.6	15.5	24.4	14.6	22.5	20.3
TSC2	"LAM, PPP1R160, TSC4, tuberin"	ENSG00000103197	"TSC complex subunit 2"	P49815	16	2047967-2089491	"Cancer-related genes, Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Host-virus interaction"	"GTPase activation"	"Cancer-related genes, Disease variant, Epilepsy, Tumor suppressor"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB002225, HPA030409, HPA049679"	Approved		Enhanced	Cytosol		NA	NA			"Cluster 39: Non-specific - mRNA processing"	"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 52: Non-specific - Transcription"	Cytosol		"CAB002225: AB_564043, HPA030409: AB_10602483, HPA049679: AB_2680848"	"unprognostic (2.80e-1)"	"unprognostic (1.01e-1)"	"unprognostic (1.60e-2)"	"unprognostic (2.24e-1)"	"unprognostic (1.02e-1)"	"unprognostic (1.03e-3)"	"unprognostic (2.04e-2)"	"unprognostic (6.05e-3)"	"unprognostic (3.43e-1)"	"unprognostic (8.94e-2)"	"prognostic favorable (5.06e-4)"	"unprognostic (4.32e-2)"	"unprognostic (3.91e-2)"	"unprognostic (2.14e-2)"	"unprognostic (2.54e-1)"	"unprognostic (1.51e-2)"	"unprognostic (8.96e-2)"	12.6	10.0	3.8	10.2	4.6	10.9	12.6	4.5	6.1	16.7	0.9	15.3	12.4	17.4	7.3	12.0	16.0	10.9	12.6	5.9	1.3	9.6	9.0	12.0	7.7	3.1	1.5	18.4	14.8	14.7	16.5	9.2	2.7	12.4	9.1	17.7	21.3	15.6	31.1	14.4	12.8	11.4	0.1	11.4	15.7	16.2	2.6	11.7	18.6	14.5	7.8	14.0	12.8	12.5	13.5	21.4	28.9	32.5	33.7	28.1	24.3	31.7	21.7	23.4	19.7	25.7	25.4	20.5	27.6	26.2	11.0	22.0	17.5	23.1	17.3	15.5	28.5	19.2	39.6	10.7	23.0	24.0	22.4	33.5	14.3	18.9	13.9	27.9	22.3	14.4	19.0	17.7	21.0	27.0	28.9	7.1	29.8	10.1	21.2	45.3	31.6	25.7	9.4	12.1	22.1	41.3	45.2	29.4	15.3	28.2	26.8	17.5	35.5	24.5	16.5	22.0	16.5	39.0	42.7	40.8	10.2	9.7	29.6	3.2	2.7	2.8	3.1	2.1	2.8	1.8	1.9	1.7	2.5	1.8	1.3	2.1	3.5	1.6	1.7	0.6	1.4	2.2	3.8	4.6	4.5	6.1	5.9	1.3	3.1	1.5	2.7	0.1	2.6	12.5	23.8	25.6	18.9	43.8	16.8	9.2	8.1	10.1	14.8	53.8	23.7	20.2	41.8	21.5	15.3	20.2	93.8	13.0	17.3	34.5	3.9	15.2	13.1	47.8	26.3	25.6	32.5	17.4	22.8	14.1	8.0	19.7	44.9	62.1	8.8	49.0	32.2	38.7	11.4	45.4	22.4	26.6	8.2	17.6	9.9	29.3	28.3	13.8	8.8	15.9	12.1	19.0	36.0	18.6	25.7	21.4	17.5	25.9	14.4	9.4	25.4	8.9	17.8	64.7	13.1	17.2	20.4	18.3	37.7	12.9	9.8	9.3	18.8	31.6	28.9	10.6
TSC22D2	"KIAA0669, TILZ4a, TILZ4b, TILZ4c"	ENSG00000196428	"TSC22 domain family member 2"	O75157	3	150408335-150466431	"Predicted intracellular proteins, Transcription factors"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA004926	Approved		Approved	Cytosol		NA	NA		100000	"Cluster 39: Non-specific - mRNA processing"	"Cluster 55: Non-specific - Mitochondria & Proteasome"	"Cluster 4: Mesenchymal cell lines - Antiviral immune response"	"Cluster 44: Endometrium - Transcription"	Cytosol		"HPA004926: AB_1080401"	"unprognostic (4.65e-2)"	"unprognostic (1.54e-1)"	"unprognostic (2.19e-1)"	"prognostic unfavorable (2.74e-4)"	"unprognostic (2.49e-1)"	"unprognostic (2.65e-2)"	"unprognostic (1.89e-1)"	"unprognostic (1.09e-2)"	"unprognostic (7.63e-2)"	"unprognostic (2.59e-1)"	"unprognostic (2.28e-3)"	"unprognostic (8.32e-2)"	"prognostic unfavorable (5.80e-4)"	"unprognostic (1.10e-2)"	"unprognostic (4.86e-1)"	"unprognostic (1.10e-2)"	"unprognostic (3.49e-1)"	20.9	11.8	8.1	10.7	8.9	34.9	13.2	9.9	15.2	18.9	3.3	14.9	6.0	23.4	14.4	23.8	15.4	22.6	21.5	9.1	9.0	15.9	29.6	15.0	10.3	8.5	8.8	15.2	11.4	10.8	9.8	16.9	9.0	11.4	12.4	16.7	10.6	7.3	17.0	11.1	11.9	26.3	6.1	13.8	16.3	17.8	6.6	11.8	12.9	14.4	9.9	20.6	23.3	11.1	45.7	6.2	19.6	18.8	25.1	12.2	56.4	44.6	16.9	32.1	39.5	25.0	22.4	14.9	25.1	33.7	65.7	18.9	19.8	16.2	63.7	11.8	11.1	16.0	11.6	12.7	28.5	9.8	10.6	22.6	12.4	20.9	31.4	19.4	20.4	7.1	27.7	23.9	22.6	16.1	10.5	12.1	25.1	13.6	12.3	11.0	35.8	17.7	20.7	26.6	11.3	10.1	20.5	10.8	45.8	23.5	10.3	13.0	33.0	21.1	21.9	25.3	41.6	31.9	6.6	20.6	14.3	29.2	12.7	0.5	1.7	2.0	1.1	1.6	1.8	1.1	1.4	1.2	1.1	1.4	1.1	1.1	2.2	2.0	2.9	1.2	0.6	1.5	8.1	8.9	9.9	15.2	9.1	9.0	8.5	8.8	9.0	6.1	6.6	11.1	97.4	64.1	30.8	160.3	52.5	148.9	81.5	12.6	111.0	18.6	65.1	28.4	46.9	20.0	18.2	12.9	29.2	28.6	53.7	77.6	17.6	13.8	23.2	85.5	107.6	48.3	31.6	10.3	78.7	13.8	33.0	59.6	50.0	166.6	65.4	10.9	29.3	40.1	18.4	16.8	70.9	45.4	22.4	24.1	94.9	29.6	18.6	58.9	42.7	86.2	20.2	31.8	16.5	59.3	86.5	26.0	82.2	15.1	37.3	42.6	16.0	10.6	10.8	21.3	13.1	79.0	48.9	51.6	29.3	77.0	108.3	54.9	48.7	17.9	34.8	83.5
TSPYL4	"dJ486I3.2, KIAA0721"	ENSG00000187189	"TSPY like 4"	Q9UJ04	6	116249964-116254075	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 109.7"	"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"							HPA044863	Approved					NA	Yes			"Cluster 39: Non-specific - mRNA processing"	"Cluster 10: Brain - Neuronal signaling"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 36: Stromal cells - Cell proliferation"			"HPA044863: AB_10962578"	"unprognostic (5.10e-2)"	"unprognostic (2.05e-1)"	"unprognostic (1.79e-1)"	"unprognostic (1.65e-3)"	"unprognostic (1.67e-1)"	"unprognostic (1.77e-1)"	"unprognostic (1.13e-1)"	"unprognostic (1.80e-2)"	"unprognostic (3.34e-1)"	"unprognostic (7.41e-3)"	"prognostic favorable (8.46e-5)"	"unprognostic (1.30e-1)"	"prognostic favorable (5.13e-7)"	"unprognostic (3.34e-3)"	"unprognostic (2.57e-1)"	"unprognostic (3.61e-1)"	"unprognostic (5.38e-2)"	8.2	35.4	57.5	7.5	61.8	10.4	14.0	56.2	109.7	17.1	15.5	12.3	5.8	21.5	18.0	11.6	21.0	10.6	20.4	62.8	72.8	14.9	9.0	10.2	10.3	44.9	55.9	25.4	12.2	28.7	28.4	10.7	60.0	22.4	8.1	30.1	9.6	18.5	5.1	10.5	9.3	15.4	43.1	11.0	15.3	14.8	69.5	17.7	14.3	7.8	9.2	11.8	11.9	48.5	6.2	3.4	47.6	39.7	19.2	16.4	8.9	24.3	16.4	30.6	18.2	9.6	5.9	5.0	9.0	37.5	16.1	13.6	20.7	21.6	45.8	20.7	7.0	10.1	18.8	22.7	15.1	19.1	6.4	16.0	10.0	23.7	12.0	23.9	21.0	28.0	15.7	16.4	25.7	19.2	36.9	11.7	11.5	2.1	8.1	20.9	2.6	4.9	9.2	9.0	55.9	37.6	21.6	9.0	4.3	16.9	16.3	10.5	24.4	25.4	21.3	14.6	14.1	6.6	8.2	0.8	11.7	12.5	16.2	0.5	2.1	2.5	3.2	1.8	3.8	2.4	3.9	3.3	1.9	3.0	4.1	3.1	2.8	3.8	2.8	3.1	3.6	4.0	57.5	61.8	56.2	109.7	62.8	72.8	44.9	55.9	60.0	43.1	69.5	48.5	7.0	3.2	7.7	11.8	9.2	4.8	11.9	4.9	30.1	21.4	11.8	13.2	44.2	11.5	7.2	11.0	20.9	3.3	13.0	3.2	19.6	5.4	20.3	30.8	31.9	11.5	31.7	6.1	16.2	7.4	2.0	13.3	8.6	25.8	11.4	27.5	11.7	3.7	3.6	40.4	16.8	5.8	6.1	6.8	3.5	6.7	10.2	8.8	5.4	7.5	5.9	20.7	6.2	4.5	8.5	7.1	2.5	10.9	7.3	7.0	0.7	6.4	27.5	28.7	0.0	14.8	16.8	20.1	3.6	14.1	5.3	3.4	11.9	18.9	4.5	8.0
TTLL12	KIAA0153	ENSG00000100304	"Tubulin tyrosine ligase like 12"	Q14166	22	43166622-43187134	"Plasma proteins, Predicted intracellular proteins"	"Immunity, Innate immunity"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"esophagus: 104.5"	"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 56.3;Paneth cells: 56.9;Squamous epithelial cells: 60.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA003054, CAB046029"	Approved		Approved	"Plasma membrane,Cytosol"		NA	NA		140000	"Cluster 39: Non-specific - mRNA processing"	"Cluster 37: Intestine - Unknown function"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 61: Squamous epithelial cells - Keratinization"	Cytosol	"Plasma membrane"	"CAB046029: AB_11128395, HPA003054: AB_2666770"	"unprognostic (2.45e-2)"	"unprognostic (3.47e-2)"	"unprognostic (7.37e-3)"	"unprognostic (5.40e-2)"	"unprognostic (2.65e-1)"	"unprognostic (3.50e-1)"	"prognostic unfavorable (2.84e-4)"	"unprognostic (5.81e-3)"	"unprognostic (2.24e-1)"	"unprognostic (6.08e-2)"	"unprognostic (4.75e-2)"	"unprognostic (1.73e-1)"	"unprognostic (1.15e-1)"	"unprognostic (1.17e-3)"	"unprognostic (1.40e-1)"	"unprognostic (6.66e-2)"	"unprognostic (2.81e-2)"	13.9	28.1	8.7	16.6	8.5	26.2	13.0	10.0	15.1	25.8	1.8	35.6	24.4	13.9	3.6	104.5	13.9	18.5	10.2	9.5	9.7	9.0	21.0	9.3	11.2	16.2	8.7	23.7	19.2	9.4	14.7	7.2	15.8	15.2	19.5	4.7	21.9	6.8	12.6	36.8	22.9	7.1	6.5	10.7	33.4	25.7	8.1	8.0	9.1	7.9	12.9	15.5	37.0	9.1	113.2	46.7	18.5	45.9	27.8	19.0	59.7	36.3	12.8	34.1	17.8	76.2	62.7	107.9	43.0	30.3	16.7	78.8	77.3	66.5	8.7	13.6	123.3	26.5	73.6	66.4	43.5	120.2	26.4	30.2	79.3	40.8	43.4	18.3	36.5	52.1	166.1	24.8	16.1	104.4	84.1	65.2	67.4	78.9	46.1	84.4	63.5	155.6	28.7	36.6	56.2	23.2	77.1	111.2	41.6	8.4	44.0	52.9	35.2	22.7	31.7	44.1	51.4	41.6	55.4	81.0	25.7	60.8	31.4	0.0	2.3	0.3	2.6	1.2	2.5	1.8	2.5	1.9	1.8	1.1	2.4	1.7	0.6	2.3	1.7	1.6	1.8	1.9	8.7	8.5	10.0	15.1	9.5	9.7	16.2	8.7	15.8	6.5	8.1	9.1	3.7	6.4	6.7	3.6	6.4	11.2	11.4	11.0	17.1	8.5	13.5	9.9	4.5	17.2	7.6	7.3	4.2	8.8	3.2	56.3	5.9	14.2	1.0	5.0	9.5	5.8	9.1	39.1	8.0	8.6	19.0	6.0	34.1	14.7	0.0	14.3	8.2	35.0	9.8	0.0	8.5	30.6	10.2	14.2	2.9	2.6	8.7	7.5	10.6	1.9	7.7	4.2	4.1	3.0	2.2	25.8	56.9	17.0	9.4	28.7	32.1	8.3	5.0	5.6	0.0	5.2	7.2	2.0	12.2	60.2	18.2	4.1	5.9	13.4	39.9	13.7
TUBB	"M40, MGC16435, OK/SW-cl.56, Tubb5"	ENSG00000196230	"Tubulin beta class I"	P07437	6	30717435-30725538	"Disease related genes, FDA approved drug targets, Human disease related genes, Plasma proteins, Predicted intracellular proteins"			"Disease variant, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Extravillous trophoblasts: 2296.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB005417, CAB012406, HPA043640, HPA046280"	Enhanced		Supported	"Microtubules,Cytokinetic bridge,Mitotic spindle"		Yes	Yes		170000000	"Cluster 39: Non-specific - mRNA processing"	"Cluster 66: Lymphoid tissue - Immune response regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 10: Non-specific - Unknown function"	Microtubules	"Cytokinetic bridge, Mitotic spindle"	"CAB005417: AB_2241191, CAB012406: AB_2210370, HPA043640: AB_2678594, HPA046280: AB_2679612"	"unprognostic (1.01e-1)"	"unprognostic (2.33e-1)"	"unprognostic (2.17e-3)"	"unprognostic (1.92e-2)"	"unprognostic (1.56e-1)"	"unprognostic (2.16e-2)"	"prognostic unfavorable (5.97e-4)"	"unprognostic (2.57e-2)"	"unprognostic (2.52e-1)"	"unprognostic (2.18e-3)"	"unprognostic (1.27e-2)"	"unprognostic (2.47e-1)"	"prognostic unfavorable (2.62e-8)"	"unprognostic (8.63e-2)"	"unprognostic (1.47e-1)"	"unprognostic (2.49e-1)"	"unprognostic (2.50e-1)"	229.5	164.8	74.6	243.5	81.8	541.0	186.9	46.2	367.7	228.7	87.0	250.3	87.6	333.0	174.5	246.3	227.0	158.5	245.3	73.5	119.7	137.8	236.6	205.3	369.2	80.5	74.8	467.5	138.1	74.4	97.0	194.4	99.2	145.2	194.4	82.4	160.2	194.6	185.7	211.9	159.4	371.0	57.5	195.0	172.8	77.8	94.0	620.4	142.4	98.6	487.6	222.3	213.8	63.5	2281.7	1027.3	2650.0	1458.4	733.2	1265.2	568.2	396.9	469.5	943.3	863.5	1329.2	703.9	1494.1	1105.1	1408.1	1877.8	805.3	2160.6	1968.0	160.3	892.5	1321.1	461.4	207.3	1306.7	345.8	2550.0	1223.9	943.6	455.9	416.0	443.6	967.1	1493.3	2058.1	1270.4	294.1	1844.8	1398.2	2719.0	249.3	377.3	604.1	948.6	102.6	708.5	911.6	1564.5	1071.4	940.8	1516.7	969.0	911.2	354.7	1625.5	1148.3	422.4	880.6	2712.0	1526.0	614.5	917.7	835.3	1735.4	2101.3	538.8	2494.6	3548.7	119.8	115.6	122.8	187.3	182.5	218.8	166.1	152.3	188.8	111.7	113.0	143.2	163.3	46.8	165.1	222.4	227.7	180.8	342.5	74.6	81.8	46.2	367.7	73.5	119.7	80.5	74.8	99.2	57.5	94.0	63.5	215.8	131.4	47.3	21.5	214.9	576.2	358.4	698.6	434.2	72.7	234.2	312.8	114.9	244.5	238.7	171.0	39.6	811.9	198.7	133.4	311.0	1091.0	9.1	69.1	261.6	370.8	163.6	1322.1	28.2	1061.1	2296.1	471.5	95.3	140.2	207.3	643.6	298.4	267.8	955.2	109.4	25.0	185.3	376.4	454.5	689.6	24.4	402.6	295.8	321.9	30.9	774.0	192.6	246.1	20.1	23.0	1087.0	90.7	237.3	304.6	199.5	117.9	245.9	66.6	65.4	118.3	124.0	838.6	58.0	126.5	447.0	430.6	220.4	244.0	224.9	253.2	229.0
UBE2E1	UbcH6	ENSG00000170142	"Ubiquitin conjugating enzyme E2 E1"	P51965	3	23805955-23891640	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	"Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA030445, CAB073413"	Approved		Approved	Nucleoplasm		NA	NA			"Cluster 39: Non-specific - mRNA processing"	"Cluster 76: Brain & Bone marrow - Chromatin organization"	"Cluster 25: RPMI-8226 - Immune response"	"Cluster 26: Respiratory epithelial cells - Mucosal defense"	Nucleoplasm		"CAB073413: , HPA030445: AB_10669599"	"unprognostic (7.50e-2)"	"unprognostic (2.78e-2)"	"unprognostic (7.91e-3)"	"unprognostic (7.13e-2)"	"unprognostic (6.74e-3)"	"unprognostic (1.74e-1)"	"prognostic unfavorable (9.97e-7)"	"unprognostic (3.69e-2)"	"unprognostic (3.53e-2)"	"unprognostic (1.34e-2)"	"unprognostic (5.36e-3)"	"unprognostic (2.70e-2)"	"unprognostic (2.40e-2)"	"unprognostic (1.94e-1)"	"unprognostic (2.94e-1)"	"unprognostic (2.75e-1)"	"unprognostic (1.93e-1)"	68.6	54.9	84.5	67.1	91.0	123.2	89.5	91.5	121.1	74.7	83.9	76.9	50.6	66.6	68.3	80.9	63.5	61.8	62.6	82.4	94.1	69.3	71.2	71.2	102.4	92.5	88.7	79.3	53.9	103.7	34.4	96.1	93.8	71.3	79.0	73.1	64.6	73.6	89.4	63.8	51.4	77.5	93.2	73.8	60.9	51.7	87.2	98.5	61.4	94.9	108.1	92.5	65.1	101.8	199.3	101.7	202.1	99.1	129.2	170.3	151.5	141.0	256.8	172.7	234.0	80.1	235.8	182.6	121.2	166.3	146.8	65.6	232.5	208.6	228.2	202.2	201.4	235.5	75.8	97.3	177.0	260.2	138.8	172.6	162.8	230.4	324.9	207.1	278.6	118.9	177.2	210.8	136.0	86.7	188.6	235.8	268.0	117.8	255.3	201.6	80.7	531.0	262.0	129.3	54.3	176.0	146.7	131.5	215.5	202.5	146.4	329.1	183.1	132.2	144.2	85.9	109.5	154.9	99.8	363.6	152.2	231.9	110.9	1.7	4.2	3.7	1.8	4.7	2.9	3.0	2.4	1.8	3.8	2.8	3.2	2.0	1.5	4.3	2.8	4.0	2.0	2.1	84.5	91.0	91.5	121.1	82.4	94.1	92.5	88.7	93.8	93.2	87.2	101.8	30.7	44.8	28.9	66.3	52.7	72.3	62.6	89.0	59.2	31.3	37.9	24.9	68.2	31.5	59.5	18.4	4.2	97.3	27.9	56.7	56.7	90.4	25.6	37.0	28.7	58.4	46.3	41.0	47.1	78.0	99.4	43.2	25.5	32.7	40.6	40.2	43.5	22.5	98.8	20.2	50.6	37.9	150.5	69.4	156.5	55.3	40.7	61.5	97.8	127.4	98.9	81.6	36.0	90.5	102.8	71.8	61.9	48.5	40.8	78.0	21.5	43.4	60.1	27.7	52.6	47.1	63.0	35.4	59.5	61.7	90.2	72.1	35.7	27.6	52.2	72.6
UBE2Z	"FLJ13855, USE1"	ENSG00000159202	"Ubiquitin conjugating enzyme E2 Z"	Q9H832	17	48908407-48929056	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	"Apoptosis, Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA007922	Approved		Supported	Nucleoplasm,Cytosol		NA	NA			"Cluster 39: Non-specific - mRNA processing"	"Cluster 30: Epididymis - Antimicrobial activity"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 22: Epithelial cell types - Mixed function"	"Nucleoplasm, Cytosol"		"HPA007922: AB_1858551"	"unprognostic (6.85e-2)"	"unprognostic (5.72e-3)"	"prognostic favorable (4.62e-4)"	"unprognostic (9.11e-2)"	"unprognostic (3.71e-3)"	"unprognostic (1.76e-1)"	"prognostic unfavorable (5.57e-4)"	"unprognostic (2.32e-2)"	"unprognostic (5.26e-2)"	"unprognostic (8.66e-2)"	"unprognostic (9.17e-3)"	"unprognostic (3.48e-2)"	"prognostic unfavorable (1.05e-4)"	"unprognostic (2.63e-2)"	"unprognostic (2.11e-2)"	"unprognostic (1.91e-2)"	"unprognostic (1.52e-1)"	33.5	45.9	37.4	37.8	40.6	33.4	36.0	37.7	44.5	41.2	32.8	37.6	34.6	39.8	60.3	45.3	44.4	34.6	33.8	40.0	40.7	40.2	33.1	34.9	44.9	39.2	37.9	36.2	34.5	46.8	31.4	42.6	42.6	39.1	40.4	38.4	38.5	47.0	29.9	43.9	35.7	49.3	35.7	41.9	35.8	28.0	40.7	45.2	50.2	28.8	59.3	45.8	39.1	57.8	101.2	122.4	45.1	43.0	111.8	107.7	61.6	107.6	131.1	126.1	120.7	153.8	84.8	81.6	150.5	133.1	158.0	64.0	57.1	100.7	159.7	271.7	61.8	73.9	80.3	96.8	128.8	53.0	76.3	92.4	109.5	103.1	132.3	134.7	94.0	38.1	55.2	103.0	137.4	160.8	57.5	52.4	42.1	122.4	105.7	45.7	114.6	46.6	98.7	97.6	46.4	70.1	73.2	38.8	76.5	100.7	107.7	41.4	111.2	187.2	89.9	62.0	89.4	77.8	79.5	47.6	91.8	38.2	83.2	5.2	7.7	5.7	8.3	9.9	6.8	6.2	7.3	8.4	5.4	8.6	6.9	7.6	7.3	5.4	9.5	6.8	8.2	6.4	37.4	40.6	37.7	44.5	40.0	40.7	39.2	37.9	42.6	35.7	40.7	57.8	36.6	25.6	19.2	17.9	32.7	52.8	50.3	47.1	27.3	56.4	40.6	32.9	37.9	21.5	25.8	36.8	41.7	34.2	40.0	42.1	21.5	44.2	1.6	48.8	40.8	44.0	48.6	23.4	22.5	54.7	32.7	35.1	20.9	59.5	6.3	37.6	37.5	25.8	24.8	43.7	20.8	35.9	20.3	28.1	54.0	5.1	28.0	35.6	30.2	12.2	48.6	31.6	26.8	13.6	52.7	75.8	25.6	29.0	23.7	89.5	34.7	27.5	42.1	34.4	32.9	25.8	39.3	21.6	26.0	35.9	57.0	42.8	30.7	50.4	30.8	66.7
URB2	"KIAA0133, NET10, NPA2"	ENSG00000135763	"URB2 ribosome biogenesis homolog"	Q14146	1	229626247-229660200	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Cone photoreceptor cells: 29.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA008902, HPA046788"	Uncertain		Enhanced	Nucleoli		NA	NA			"Cluster 39: Non-specific - mRNA processing"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 9: Photoreceptor cells - Phototransduction"	Nucleoli		"HPA008902: AB_2213805, HPA046788: AB_2679807"	"unprognostic (1.26e-1)"	"unprognostic (4.03e-3)"	"unprognostic (2.16e-2)"	"unprognostic (3.63e-2)"	"unprognostic (1.79e-1)"	"unprognostic (2.48e-1)"	"unprognostic (5.53e-3)"	"unprognostic (1.67e-1)"	"unprognostic (1.02e-1)"	"unprognostic (1.17e-1)"	"unprognostic (1.59e-1)"	"unprognostic (2.61e-2)"	"unprognostic (1.62e-3)"	"unprognostic (7.81e-2)"	"unprognostic (2.72e-1)"	"unprognostic (1.69e-2)"	"unprognostic (1.45e-1)"	4.9	2.8	2.2	3.9	2.6	4.5	3.2	2.6	2.4	2.1	1.9	2.6	2.2	3.2	1.8	3.7	2.8	2.6	2.6	2.0	2.3	2.2	2.8	2.1	4.5	2.6	2.7	2.9	4.7	2.5	4.3	3.3	2.5	2.0	2.4	2.6	2.3	1.8	6.9	3.0	2.5	3.3	2.6	3.0	2.7	5.7	2.5	4.6	2.2	4.5	4.7	4.9	2.2	3.1	13.6	20.1	12.8	17.2	7.9	6.5	39.1	10.6	6.6	16.1	12.1	20.1	10.4	28.0	11.9	7.6	8.6	18.3	32.0	13.0	14.6	13.8	30.4	17.5	16.8	11.9	7.5	25.8	14.5	6.4	9.3	16.0	12.4	4.1	7.8	16.2	37.7	12.7	10.1	10.7	29.0	12.6	43.1	24.1	13.2	32.0	18.2	27.9	7.1	17.0	19.1	23.4	12.5	12.9	10.6	4.4	14.6	14.6	8.6	13.1	16.6	16.8	30.8	13.9	14.4	41.6	7.0	19.0	24.4	0.1	0.9	0.2	1.2	1.7	2.2	0.8	1.1	1.4	1.1	1.0	1.6	1.3	0.1	0.8	0.6	0.7	1.4	1.4	2.2	2.6	2.6	2.4	2.0	2.3	2.6	2.7	2.5	2.6	2.5	3.1	5.4	0.0	1.1	3.6	6.0	10.1	8.6	1.8	4.0	6.4	5.1	4.3	2.7	1.5	2.6	5.5	29.2	5.3	4.5	2.0	0.0	2.4	0.4	2.8	5.0	4.6	6.6	6.9	7.1	2.7	11.7	3.6	4.1	3.2	0.0	3.5	3.9	3.7	2.8	3.3	7.2	2.5	4.1	1.3	2.7	0.9	2.1	2.8	5.4	6.5	2.7	2.6	2.1	10.1	7.0	2.7	0.8	3.4	4.4	8.7	0.6	2.3	1.3	16.7	0.0	11.6	4.0	8.0	4.0	5.5	9.1	3.3	4.2	3.1	3.1	5.5
USP20	KIAA1003	ENSG00000136878	"Ubiquitin specific peptidase 20"	Q9Y2K6	9	129834698-129881828	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	"Endocytosis, Ubl conjugation pathway"	"Hydrolase, Protease, Thiol protease"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"JURKAT: 95.9;K-562: 60.2;MOLT-4: 56.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA006287, HPA007008"	Uncertain	Supported	Approved	"Nucleoplasm,Plasma membrane,Cytosol"		NA	NA			"Cluster 39: Non-specific - mRNA processing"	"Cluster 66: Lymphoid tissue - Immune response regulation"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 58: T-cells - T-cell receptor"	"Nucleoplasm, Plasma membrane, Cytosol"		"HPA006287: AB_1080510, HPA007008: "	"unprognostic (2.64e-2)"	"prognostic favorable (8.01e-4)"	"prognostic unfavorable (2.48e-4)"	"prognostic favorable (4.01e-4)"	"unprognostic (4.69e-1)"	"unprognostic (1.89e-2)"	"unprognostic (2.25e-1)"	"unprognostic (2.55e-3)"	"unprognostic (1.24e-1)"	"unprognostic (7.89e-2)"	"prognostic favorable (1.54e-7)"	"unprognostic (2.09e-1)"	"prognostic favorable (5.65e-5)"	"unprognostic (1.76e-2)"	"unprognostic (1.20e-1)"	"unprognostic (1.19e-2)"	"unprognostic (1.24e-2)"	8.1	12.0	8.7	13.5	8.0	22.6	8.3	4.8	8.7	12.5	2.5	13.6	8.2	12.5	4.2	7.9	12.1	7.7	7.5	7.8	10.6	7.6	7.4	8.4	18.3	10.2	9.1	13.5	10.9	8.4	18.4	6.7	10.0	14.8	4.9	6.7	11.4	13.2	10.9	12.1	12.5	8.2	5.4	13.9	9.9	10.0	8.9	32.3	18.7	7.5	11.8	14.9	10.1	6.5	6.0	5.8	10.0	13.4	12.8	10.8	14.1	9.5	7.9	7.1	4.9	4.7	6.5	8.1	8.0	9.3	8.0	14.7	6.0	6.7	2.9	43.4	7.9	14.9	17.0	3.3	8.8	14.2	10.6	9.6	9.8	9.3	7.0	12.4	7.7	95.9	60.2	9.9	4.4	15.9	56.4	33.6	7.9	12.7	13.6	9.4	11.2	14.0	5.5	6.5	2.2	11.0	11.0	13.9	9.1	5.9	14.4	19.9	11.5	7.8	3.5	10.5	6.3	9.7	15.3	5.7	15.5	18.6	7.4	1.0	1.9	5.4	8.6	1.5	9.1	3.7	8.7	8.3	2.6	3.4	9.8	8.9	2.8	10.0	1.5	2.1	11.5	6.3	8.7	8.0	4.8	8.7	7.8	10.6	10.2	9.1	10.0	5.4	8.9	6.5	3.0	9.6	6.9	16.3	9.2	2.8	2.2	2.5	4.0	7.8	6.4	8.0	7.7	4.3	3.0	1.8	4.2	5.9	9.4	6.2	3.9	2.4	2.1	4.1	6.3	4.3	8.4	12.8	17.0	4.0	2.5	4.6	8.2	5.7	1.3	6.8	6.4	6.1	3.3	10.1	21.1	4.6	4.1	1.6	3.8	3.3	6.2	6.0	3.6	11.2	3.1	5.3	11.3	9.5	14.3	2.7	5.0	4.9	6.7	3.0	4.1	2.9	5.0	6.3	0.0	4.3	5.7	12.1	6.0	4.8	2.0	6.2	19.3	2.9	5.2	1.6
USP9Y	"AZFA, DFFRY"	ENSG00000114374	"Ubiquitin specific peptidase 9 Y-linked"	O00507	Y	12537650-12860839	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"	"Ubl conjugation pathway"	"Hydrolase, Protease, Thiol protease"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Cone photoreceptor cells: 64.6;Excitatory neurons: 89.5;Inhibitory neurons: 69.5"	"Cancer enhanced"	"Detected in many"		"prostate cancer: 5.7"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"RPTEC TERT1: 21.5;RT4: 17.4"	"Not detected"	"Not detected"							HPA057687			Uncertain	Vesicles		NA	NA			"Cluster 39: Non-specific - mRNA processing"	"Cluster 54: Non-specific - Microtubule organization"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	Vesicles		"HPA057687: "			"unprognostic (2.63e-1)"		"unprognostic (8.97e-2)"	"unprognostic (1.10e-5)"	"unprognostic (8.46e-3)"	"unprognostic (4.93e-2)"	"unprognostic (2.53e-2)"	"unprognostic (2.77e-1)"	"unprognostic (3.17e-2)"	"unprognostic (1.71e-1)"	"unprognostic (4.05e-2)"	"unprognostic (1.41e-4)"	"unprognostic (2.28e-1)"	"unprognostic (1.19e-2)"	"unprognostic (1.42e-1)"	3.6	5.2	1.3	1.7	1.4	2.6	3.3	2.8	5.2	0.0	2.5	4.5	1.7	0.0	7.2	5.2	0.0	4.6	5.5	1.3	1.4	7.1	3.0	5.2	2.2	1.2	1.1	0.0	6.0	3.5	8.8	2.3	1.3	9.7	4.9	12.9	4.9	7.0	5.2	3.2	4.4	0.0	1.0	5.1	3.9	4.2	1.4	0.0	5.7	9.7	5.6	4.5	0.0	2.4	0.0	4.7	0.0	0.0	0.0	0.0	5.3	14.2	14.6	7.2	8.5	0.0	0.0	7.7	0.0	12.2	0.0	0.0	0.0	0.0	8.6	8.1	0.0	7.3	0.0	9.5	5.8	0.0	0.0	9.7	8.9	0.0	0.0	0.0	0.0	3.0	0.0	0.0	12.2	0.0	9.8	0.0	4.6	0.0	0.0	0.0	3.5	2.1	21.5	17.4	7.2	0.0	0.0	0.0	4.4	12.5	0.0	0.2	10.6	9.5	0.0	0.0	7.0	0.0	9.7	15.1	0.5	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.9	0.4	0.7	0.5	0.1	0.7	0.8	0.5	0.0	0.1	0.0	0.6	0.6	0.0	1.3	1.4	2.8	5.2	1.3	1.4	1.2	1.1	1.3	1.0	1.4	2.4	0.0	25.6	23.5	29.4	11.0	11.7	8.5	9.5	18.2	23.6	0.0	0.0	26.5	7.2	12.6	20.2	64.6	6.3	5.3	0.3	1.9	6.9	0.5	0.0	0.0	5.8	0.0	5.9	89.5	0.0	1.7	8.1	6.6	0.0	2.5	0.0	6.1	2.3	3.1	26.9	69.5	1.1	8.2	5.6	9.3	1.1	12.5	3.6	3.6	31.9	3.6	8.8	14.4	28.6	17.4	2.3	0.0	15.4	4.1	13.2	0.7	6.3	19.9	23.1	0.0	5.2	4.4	2.8	2.6	20.6	11.6	3.4	14.7	0.0	1.5	11.9
UTY	"KDM6AL, KDM6C"	ENSG00000183878	"Ubiquitously transcribed tetratricopeptide repeat containing, Y-linked"	O14607	Y	13248379-13480673	"Enzymes, Predicted intracellular proteins"		"Chromatin regulator, Dioxygenase, Oxidoreductase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Cone photoreceptor cells: 64.6;Excitatory neurons: 66.7;Inhibitory neurons: 65.2;Oligodendrocytes: 65.8"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HEL: 20.6;SK-MEL-30: 14.9;U-266/84: 16.4;U-698: 20.2"	"Low region specificity"	"Detected in all"							"HPA000568, HPA001165"	Supported		Approved	"Nucleoplasm,Nucleoli,Nucleoli rim"	"Intracellular and membrane"	NA	NA			"Cluster 39: Non-specific - mRNA processing"	"Cluster 29: Non-specific - Vesicular transport"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 59: Non-specific - Transcription"	Nucleoplasm	"Nucleoli, Nucleoli rim"	"HPA000568: AB_1858705, HPA001165: AB_1080541"			"unprognostic (7.52e-2)"		"unprognostic (6.60e-2)"	"unprognostic (4.04e-6)"	"unprognostic (6.47e-2)"	"unprognostic (9.34e-2)"	"unprognostic (2.00e-2)"		"unprognostic (9.17e-2)"	"unprognostic (1.53e-2)"	"unprognostic (1.29e-1)"	"unprognostic (1.41e-2)"	"unprognostic (2.82e-1)"	"unprognostic (2.67e-2)"	"unprognostic (1.46e-2)"	3.6	3.5	0.9	2.4	1.5	6.8	3.5	2.0	2.2	0.0	1.6	2.9	2.5	0.0	9.4	4.1	0.0	3.5	2.9	0.9	1.2	3.1	4.1	4.2	2.1	2.1	1.1	0.0	3.4	2.9	4.0	3.4	2.1	8.1	6.2	4.5	4.3	6.2	5.7	5.1	6.3	0.0	1.3	3.4	2.9	3.8	1.4	0.0	3.8	5.2	6.0	3.6	0.0	3.2	0.0	2.5	0.0	0.0	0.0	0.0	8.7	4.5	7.7	5.0	7.5	0.0	0.0	12.4	0.0	5.1	0.0	0.0	0.0	0.0	6.9	6.9	0.0	20.6	0.0	0.0	6.4	0.0	0.0	7.8	7.8	0.0	0.0	0.0	0.0	4.2	0.0	0.0	5.5	0.0	7.1	0.1	0.0	0.0	0.0	0.0	3.1	5.6	5.4	8.3	4.9	0.0	0.0	0.0	14.9	8.5	0.0	4.4	5.9	8.7	0.0	0.0	3.1	13.5	16.4	20.2	0.8	0.0	0.0	1.8	1.7	3.8	2.6	1.9	3.7	2.9	2.6	2.1	1.8	3.2	3.6	2.7	3.9	5.8	2.2	2.9	3.2	1.1	0.9	1.5	2.0	2.2	0.9	1.2	2.1	1.1	2.1	1.3	1.4	3.2	0.0	16.0	25.3	58.4	35.4	11.3	18.4	8.2	44.3	35.2	0.0	0.0	6.1	5.7	10.7	18.4	64.6	10.0	8.0	3.0	0.0	4.8	0.4	0.0	0.0	9.0	1.8	19.6	66.7	0.0	3.7	9.3	37.8	0.0	16.4	0.0	12.5	2.1	3.0	37.0	65.2	3.3	2.0	14.2	14.5	2.0	10.8	12.7	8.8	54.4	18.1	12.8	25.7	57.8	65.8	1.5	2.2	11.7	23.2	14.0	2.9	2.6	10.7	37.4	0.0	4.7	5.0	4.0	6.8	33.2	15.3	13.3	25.1	0.0	2.9	21.3
VARS1	"VARS, VARS2"	ENSG00000204394	"Valyl-tRNA synthetase 1"	P26640	6	31777518-31795752	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Protein biosynthesis"	"Aminoacyl-tRNA synthetase, Ligase"	"Disease variant, Epilepsy, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"		"Cardiomyocytes: 10.1;Cytotrophoblasts: 23.2;Extravillous trophoblasts: 48.3;Hofbauer cells: 30.7;Syncytiotrophoblasts: 16.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in all"		"U-266/84: 140.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA046710	Approved		Enhanced	Cytosol		NA	NA		110000	"Cluster 39: Non-specific - mRNA processing"	"Cluster 71: Testis - DNA repair"	"Cluster 16: U-266 - Nucleosome"	"Cluster 24: Non-specific - Transcription regulation"	Cytosol		"HPA046710: AB_2679765"	"unprognostic (1.86e-2)"	"prognostic unfavorable (7.25e-4)"	"unprognostic (2.19e-1)"	"unprognostic (2.07e-1)"	"unprognostic (2.49e-2)"	"unprognostic (3.43e-2)"	"prognostic unfavorable (1.86e-4)"	"prognostic unfavorable (6.90e-4)"	"unprognostic (3.20e-1)"	"unprognostic (2.76e-1)"	"unprognostic (4.72e-1)"	"unprognostic (1.28e-1)"	"unprognostic (1.09e-2)"	"unprognostic (1.98e-1)"	"unprognostic (1.69e-1)"	"unprognostic (3.85e-2)"	"unprognostic (2.59e-1)"	22.2	24.6	2.0	6.6	1.6	3.2	21.9	0.4	2.4	20.1	0.0	21.0	5.6	29.4	0.9	32.5	22.1	1.1	20.0	0.7	2.3	19.2	29.3	19.8	3.0	2.4	1.9	19.7	37.3	2.5	33.6	2.2	2.2	17.6	1.7	1.3	20.6	1.2	58.2	34.3	21.9	3.5	0.8	30.0	23.3	63.6	2.6	3.0	18.5	3.1	2.8	23.5	20.7	1.5	36.2	11.6	12.4	36.9	9.1	8.5	84.0	52.2	10.8	25.2	13.3	11.5	9.9	58.3	60.2	18.4	18.9	22.0	33.5	32.4	8.8	46.0	74.0	31.7	18.4	21.3	18.3	75.7	60.6	12.5	8.2	14.8	16.5	6.2	13.5	22.9	92.2	48.8	12.7	13.2	51.0	16.2	35.0	11.9	32.5	55.5	20.5	132.7	13.0	12.4	42.1	26.2	12.0	31.0	19.5	5.8	23.2	34.0	31.2	24.2	37.8	28.2	72.5	87.9	140.4	44.1	14.6	31.1	29.0	0.0	0.3	0.1	0.2	0.3	0.3	0.5	0.3	0.3	0.5	0.3	0.3	0.1	0.1	0.5	0.3	0.6	0.1	0.5	2.0	1.6	0.4	2.4	0.7	2.3	2.4	1.9	2.2	0.8	2.6	1.5	4.2	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	10.1	0.0	0.0	0.0	0.0	23.2	1.9	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.0	48.3	3.6	0.0	0.0	0.0	0.0	0.0	0.0	30.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.0	16.6	0.4	0.0	0.0	0.0
VARS2	"DKFZP434L1435, G7a, KIAA1885, VARS2L, VARSL"	ENSG00000137411	"Valyl-tRNA synthetase 2, mitochondrial"	Q5ST30	6	30914205-30926459	"Disease related genes, Enzymes, Human disease related genes, Potential drug targets, Predicted intracellular proteins"	"Protein biosynthesis"	"Aminoacyl-tRNA synthetase, Ligase"	"Disease variant, Primary mitochondrial disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA062449, HPA070267"	Approved		Approved	Mitochondria		NA	NA			"Cluster 39: Non-specific - mRNA processing"	"Cluster 72: Non-specific - Transcription"	"Cluster 23: AN3-CA - Transcription regulation"	"Cluster 53: Intestinal epithelial cells - Unknown function"	Mitochondria		"HPA062449: AB_2684766, HPA070267: AB_2686245"	"unprognostic (1.74e-1)"	"unprognostic (8.24e-2)"	"unprognostic (1.96e-3)"	"unprognostic (2.50e-1)"	"unprognostic (5.80e-2)"	"unprognostic (3.05e-2)"	"unprognostic (2.43e-2)"	"unprognostic (1.66e-2)"	"unprognostic (3.14e-1)"	"unprognostic (8.98e-2)"	"unprognostic (4.23e-2)"	"unprognostic (2.60e-2)"	"unprognostic (2.15e-3)"	"unprognostic (1.04e-2)"	"unprognostic (7.23e-2)"	"unprognostic (1.19e-2)"	"unprognostic (2.43e-2)"	10.2	14.4	1.3	2.1	1.5	1.9	9.7	1.5	1.6	12.5	0.4	10.5	1.2	10.4	1.5	22.5	10.1	0.2	11.1	1.4	1.3	12.5	18.9	10.5	3.1	1.3	1.6	15.3	14.0	2.3	17.1	0.9	1.4	10.2	2.2	1.4	10.9	1.1	20.9	10.1	12.8	0.7	1.2	13.4	11.7	11.8	1.3	4.1	15.0	0.2	2.3	10.5	13.2	1.3	13.8	9.6	5.5	23.1	4.9	4.4	0.7	2.2	1.9	2.5	1.6	12.6	8.9	11.9	7.5	3.0	9.4	0.0	21.3	0.0	2.4	4.6	15.7	13.2	10.2	0.9	6.7	2.3	0.3	6.2	8.1	5.9	1.3	0.9	1.3	19.5	0.1	10.5	5.4	0.0	4.6	0.0	1.7	0.0	1.2	9.1	0.0	10.3	18.3	0.0	8.5	0.2	0.2	6.6	5.4	5.0	16.3	7.4	2.2	14.2	1.4	1.0	0.1	10.0	17.1	18.8	0.0	0.6	8.7	0.0	0.0	0.0	0.3	0.1	0.4	0.3	0.1	0.3	0.2	0.1	0.1	0.1	0.0	0.0	0.2	0.3	0.2	0.1	1.3	1.5	1.5	1.6	1.4	1.3	1.3	1.6	1.4	1.2	1.3	1.3	3.0	6.4	12.5	14.7	8.0	4.0	4.9	4.7	4.0	6.6	6.4	3.7	11.6	8.6	5.5	9.2	0.0	8.7	4.1	10.1	1.9	6.7	1.5	7.7	5.2	3.9	13.1	3.4	8.3	7.1	9.6	4.8	11.7	8.6	12.7	12.9	7.5	22.5	9.2	8.4	9.1	8.4	2.0	6.9	3.5	1.6	4.1	5.1	1.8	3.7	7.9	2.8	4.1	8.0	7.2	8.9	4.7	4.1	12.3	2.3	12.4	12.5	8.9	6.0	0.0	2.9	3.7	10.4	8.0	9.0	4.1	3.4	4.8	6.9	10.9	3.8
VSIG2	"CTH, CTXL"	ENSG00000019102	"V-set and immunoglobulin domain containing 2"	Q96IQ7	11	124747474-124752255	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	4	"stomach 1: 619.2"	"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 514.3;Gastric mucus-secreting cells: 623.4;Intestinal goblet cells: 285.6;Pancreatic endocrine cells: 260.2;Paneth cells: 509.9;Undifferentiated cells: 207.0;Urothelial cells: 285.3"	"Cancer enhanced"	"Detected in many"		"urothelial cancer: 87.4"	"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in single"			"Low lineage specificity"	"Detected in single"			"Cell line enriched"	"Detected in some"	6	"OE19: 429.0"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"HPA035919, HPA050147"	Enhanced		Approved	Nucleoplasm		NA	NA		78000	"Cluster 39: Non-specific - mRNA processing"	"Cluster 4: Stomach - Digestion"	"Cluster 21: OE19 - Mitochondria"	"Cluster 53: Intestinal epithelial cells - Unknown function"	Nucleoplasm		"HPA035919: AB_10669981, HPA050147: AB_2681032"	"unprognostic (1.64e-3)"	"unprognostic (1.21e-1)"	"unprognostic (1.10e-2)"	"unprognostic (1.90e-1)"	"unprognostic (2.00e-1)"	"unprognostic (2.18e-3)"	"unprognostic (2.16e-1)"	"unprognostic (2.22e-2)"	"unprognostic (3.47e-3)"	"unprognostic (2.02e-1)"	"unprognostic (6.01e-2)"	"unprognostic (2.78e-2)"	"unprognostic (2.99e-2)"	"unprognostic (2.61e-1)"	"unprognostic (1.95e-1)"	"unprognostic (1.87e-1)"	"unprognostic (1.36e-2)"	6.5	0.8	3.1	7.0	6.4	3.4	9.5	0.8	7.1	29.7	0.2	136.2	6.2	4.9	0.4	26.4	17.5	26.5	5.3	2.8	1.5	6.3	3.0	45.7	0.9	1.7	3.6	1.1	2.0	1.9	1.7	6.0	2.0	58.2	137.8	0.6	31.8	4.3	2.3	1.5	2.8	4.7	1.1	1.6	619.2	0.9	3.1	0.2	43.7	2.5	2.5	84.5	9.3	3.6	0.4	0.1	4.8	3.4	0.0	0.0	0.5	0.1	0.0	0.0	0.0	0.9	1.5	2.4	0.1	0.0	0.4	0.2	0.0	0.0	0.0	0.0	0.3	16.6	0.0	7.9	0.7	0.5	3.0	0.1	0.0	0.0	0.0	0.3	2.8	0.3	0.3	0.6	0.0	1.6	0.1	0.1	0.6	429.0	3.7	0.4	3.6	0.1	0.1	69.2	0.3	0.9	0.1	4.6	0.0	0.7	0.4	2.4	4.1	1.8	1.1	0.3	0.8	0.3	0.0	0.0	0.6	1.7	0.9	0.0	1.2	0.0	0.0	0.1	0.5	0.0	0.5	0.1	0.4	0.0	0.6	0.4	0.1	0.3	0.2	0.0	0.7	0.9	3.1	6.4	0.8	7.1	2.8	1.5	1.7	3.6	2.0	1.1	3.1	3.6	4.6	125.0	51.6	0.0	1.5	0.8	19.2	25.3	2.8	1.5	31.5	18.4	0.7	82.9	99.3	3.7	0.0	0.0	0.6	514.3	1.9	14.6	0.0	12.1	1.8	5.0	66.8	0.0	0.2	90.9	0.1	0.9	623.4	18.3	1.3	0.1	3.9	0.2	0.1	0.0	0.1	285.6	20.3	0.3	2.7	0.0	1.5	2.4	3.6	1.0	0.0	0.0	0.0	0.0	0.1	260.2	509.9	0.0	0.7	61.6	1.3	0.1	36.7	0.0	0.0	0.3	6.2	0.2	0.7	0.7	0.4	0.0	2.2	0.3	207.0	285.3
WASHC2A	"bA56A21.1, bA98I6.1, FAM21A, FAM21B, FLJ10824"	ENSG00000099290	"WASH complex subunit 2A"	Q641Q2	10	50067888-50133509	"Predicted intracellular proteins, Transporters"	"Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Alveolar cells type 1: 38.5;Alveolar cells type 2: 28.5;Endometrial ciliated cells: 45.7;Respiratory ciliated cells: 41.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											"HPA047844, HPA060975, HPA061022"	Supported		Supported	Nucleoli,Vesicles,Cytosol		NA	NA			"Cluster 39: Non-specific - mRNA processing"	"Cluster 44: Heart - Cardiac muscle contraction"	"Cluster 18: U-2197 - ECM organization"	"Cluster 7: Non-specific - Mitochondria"	Vesicles	"Nucleoli, Cytosol"	"HPA047844: AB_2680177, HPA060975: AB_2684401, HPA061022: AB_2732656"	"unprognostic (2.46e-1)"	"unprognostic (1.11e-3)"	"unprognostic (8.82e-2)"	"unprognostic (3.28e-1)"	"unprognostic (2.75e-1)"	"unprognostic (6.51e-3)"	"prognostic unfavorable (6.75e-5)"	"unprognostic (4.60e-2)"	"unprognostic (2.85e-2)"	"unprognostic (2.37e-2)"	"unprognostic (9.04e-2)"	"unprognostic (2.73e-2)"	"unprognostic (1.18e-1)"	"unprognostic (2.57e-1)"	"unprognostic (2.95e-1)"	"unprognostic (1.85e-2)"	"unprognostic (4.40e-2)"	25.3	25.9	19.9	22.1	20.7	37.5	24.0	23.4	24.8	24.7	18.3	28.9	25.2	22.5	19.2	20.2	19.7	18.0	58.6	19.9	19.9	22.9	15.5	26.0	28.8	21.1	21.2	26.7	17.7	23.3	21.5	22.9	21.1	20.6	28.9	19.9	21.9	20.0	22.3	25.7	28.9	21.2	18.6	26.6	21.5	12.5	22.6	24.2	23.3	15.6	26.9	23.8	22.1	23.9	26.1	12.5	21.1	24.3	83.2	46.0	16.9	29.8	64.0	43.7	46.6	28.8	37.8	22.5	18.1	44.8	41.3	28.0	31.2	25.3	43.2	22.2	22.0	15.9	25.6	29.7	58.6	28.0	27.2	47.8	31.2	47.6	30.5	46.2	33.1	19.2	26.6	22.2	53.9	19.1	15.5	48.0	17.1	16.7	58.4	23.1	30.1	13.7	30.5	29.3	7.3	22.4	27.8	25.9	40.9	30.9	31.6	19.2	49.4	22.0	18.5	62.7	25.0	23.4	48.3	19.1	48.9	51.4	9.0	1.0	9.1	9.9	9.1	11.6	10.1	5.1	8.0	8.8	7.3	4.9	7.7	6.0	4.1	8.2	6.9	4.6	9.2	7.9	19.9	20.7	23.4	24.8	19.9	19.9	21.1	21.2	21.1	18.6	22.6	23.9	16.2	38.5	28.5	0.0	3.3	0.0	0.0	0.0	0.0	0.0	10.6	11.0	0.0	0.0	22.9	14.7	0.0	7.4	10.0	0.0	0.0	16.7	0.0	45.7	19.9	7.9	0.0	0.0	0.0	15.6	6.9	8.9	0.0	20.3	15.2	13.5	0.0	0.0	18.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	15.2	0.0	0.0	5.7	0.0	0.0	0.0	0.0	15.1	0.0	0.0	2.6	0.0	0.0	11.7	41.5	0.0	0.0	0.0	6.9	0.0	0.0	0.0	0.0	7.7	7.8	9.4	0.0	0.0
WDR5	"CFAP89, SWD3"	ENSG00000196363	"WD repeat domain 5"	P61964	9	134135365-134159968	"Predicted intracellular proteins"	"Transcription, Transcription regulation"	"Chromatin regulator"	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Early spermatids: 152.7;Spermatocytes: 99.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA047182			Supported	Nucleoplasm		NA	NA			"Cluster 39: Non-specific - mRNA processing"	"Cluster 55: Non-specific - Mitochondria & Proteasome"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 66: Spermatocytes - Spermatogenesis"	Nucleoplasm		"HPA047182: AB_2679971"	"unprognostic (9.28e-2)"	"unprognostic (1.89e-2)"	"unprognostic (1.52e-2)"	"unprognostic (1.73e-1)"	"unprognostic (1.72e-1)"	"unprognostic (2.20e-1)"	"unprognostic (1.05e-3)"	"unprognostic (2.26e-3)"	"unprognostic (1.22e-1)"	"unprognostic (1.05e-1)"	"unprognostic (4.31e-3)"	"unprognostic (4.63e-2)"	"unprognostic (7.06e-2)"	"unprognostic (5.91e-3)"	"unprognostic (1.47e-1)"	"unprognostic (3.22e-2)"	"unprognostic (2.88e-2)"	17.5	18.4	17.4	13.9	18.2	20.3	16.7	20.1	21.0	17.1	17.3	19.3	17.6	18.7	8.9	24.9	18.9	8.3	19.5	17.8	18.0	18.6	34.0	15.4	16.2	15.9	16.9	21.9	27.7	13.5	25.4	14.7	16.5	18.9	13.7	9.1	18.1	12.7	33.9	22.2	19.4	13.5	15.0	20.0	20.6	38.7	18.4	17.8	17.7	18.2	18.0	18.4	16.3	17.9	43.6	52.4	49.0	56.1	26.1	28.7	77.4	43.0	28.3	57.5	39.1	61.3	34.9	68.8	26.7	35.2	50.5	105.9	66.9	44.1	46.6	46.4	45.6	39.7	85.6	49.9	27.9	90.0	40.2	27.7	41.0	43.1	52.6	23.7	38.7	67.5	75.3	37.6	40.5	116.1	77.4	73.6	62.3	98.3	65.2	83.4	99.2	65.2	28.3	42.0	81.7	42.5	64.8	50.2	29.7	32.5	69.1	78.3	33.9	58.7	53.8	54.5	70.5	19.6	40.0	74.0	34.1	60.4	48.2	0.9	9.3	1.6	6.7	6.0	6.6	4.6	6.6	6.9	10.0	5.8	6.8	5.4	0.8	4.9	5.1	8.3	6.4	7.1	17.4	18.2	20.1	21.0	17.8	18.0	15.9	16.9	16.5	15.0	18.4	17.9	8.2	9.6	8.6	10.7	11.8	11.9	14.9	7.0	16.5	9.6	13.6	12.8	9.5	11.5	5.0	5.5	22.9	27.4	8.9	9.1	9.8	14.7	152.7	8.6	14.4	9.6	6.6	17.5	16.4	20.9	42.5	12.2	15.3	10.0	8.9	17.6	5.3	21.9	19.1	8.4	16.6	13.7	8.2	6.3	9.8	41.4	11.5	10.9	5.4	11.2	10.0	6.8	10.3	10.1	14.3	16.7	9.7	11.7	26.6	30.4	17.6	10.2	3.9	7.4	6.6	9.7	10.9	99.9	42.3	25.6	16.3	17.8	9.7	32.5	22.2	18.0
WDR55	"FLJ20195, FLJ21702"	ENSG00000120314	"WD repeat domain 55"	Q9H6Y2	5	140664676-140674124	"Predicted intracellular proteins"	"rRNA processing"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA043470, HPA048143, HPA075133"	Uncertain		Enhanced	Nucleoplasm,Nucleoli		NA	NA			"Cluster 39: Non-specific - mRNA processing"	"Cluster 29: Non-specific - Vesicular transport"	"Cluster 8: SK-BR-3 - Unknown function"	"Cluster 53: Intestinal epithelial cells - Unknown function"	Nucleoplasm	Nucleoli	"HPA043470: AB_2678495, HPA048143: AB_2680282, HPA075133: "	"prognostic unfavorable (1.51e-4)"	"unprognostic (1.35e-1)"	"unprognostic (7.77e-2)"	"unprognostic (1.11e-1)"	"unprognostic (1.44e-1)"	"unprognostic (2.35e-1)"	"prognostic unfavorable (8.88e-6)"	"unprognostic (9.96e-2)"	"unprognostic (2.78e-1)"	"unprognostic (3.05e-1)"	"unprognostic (4.00e-2)"	"unprognostic (1.02e-2)"	"unprognostic (1.19e-3)"	"unprognostic (1.37e-1)"	"unprognostic (2.14e-1)"	"unprognostic (3.70e-1)"	"unprognostic (2.51e-2)"	9.9	9.2	5.2	9.5	5.4	12.9	9.2	6.2	5.6	7.6	6.8	10.6	9.3	7.8	4.3	13.4	7.4	6.1	7.7	5.4	5.8	9.4	12.3	8.8	10.1	6.4	5.6	7.5	11.1	6.1	9.0	7.6	6.0	8.8	10.3	4.0	10.5	5.4	9.1	11.0	11.0	6.4	5.4	12.6	10.5	4.9	5.7	7.8	7.4	6.0	10.6	8.9	7.9	5.9	13.2	18.0	8.5	34.4	12.8	10.1	23.7	12.9	15.5	13.3	15.2	31.1	17.7	12.3	16.8	16.6	24.3	16.1	11.5	22.4	10.2	11.6	9.6	14.1	15.9	12.7	12.2	14.8	25.5	12.2	12.7	18.3	9.6	9.2	14.4	13.7	9.9	9.3	14.9	19.2	14.0	13.3	8.9	18.9	15.2	11.6	12.2	11.6	15.9	19.7	8.3	11.1	17.7	51.3	20.2	10.4	36.3	15.8	13.0	17.5	9.0	20.3	17.6	15.6	12.9	9.6	22.7	19.5	10.6	6.4	10.2	7.8	11.3	16.6	11.7	8.5	10.5	9.8	9.9	7.3	8.3	8.5	9.0	10.3	14.2	7.2	12.6	10.0	5.2	5.4	6.2	5.6	5.4	5.8	6.4	5.6	6.0	5.4	5.7	5.9	17.1	9.6	16.7	5.9	16.9	14.5	10.9	9.1	9.6	13.5	15.5	10.3	5.3	5.7	16.2	18.4	12.5	21.6	28.9	31.9	21.5	20.2	29.3	20.6	13.1	12.9	14.9	13.9	7.2	28.2	42.8	12.6	25.0	13.9	19.7	16.4	12.5	14.9	20.8	23.5	7.0	22.6	8.2	16.1	13.9	9.7	9.6	18.3	8.8	1.0	20.5	5.7	23.7	4.5	6.5	27.2	39.3	7.5	23.0	15.6	24.9	20.8	17.2	8.3	13.1	13.0	14.1	7.9	9.8	15.1	13.4	23.3	21.0	14.2	26.0	16.4
WDR6		ENSG00000178252	"WD repeat domain 6"	Q9NNW5	3	49007062-49015953	"Predicted intracellular proteins"	"Cell cycle"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA042622	Approved		Supported	"Plasma membrane,Cytosol"		NA	NA			"Cluster 39: Non-specific - mRNA processing"	"Cluster 35: Non-specific - Unknown function"	"Cluster 20: HeLa - Mitochondria"	"Cluster 52: Non-specific - Transcription"	Cytosol	"Plasma membrane"	"HPA042622: AB_10966784"	"unprognostic (2.41e-2)"	"unprognostic (2.03e-1)"	"unprognostic (2.14e-1)"	"unprognostic (1.26e-2)"	"unprognostic (4.80e-2)"	"unprognostic (1.05e-1)"	"prognostic unfavorable (2.97e-6)"	"unprognostic (1.79e-2)"	"unprognostic (1.90e-1)"	"unprognostic (1.20e-1)"	"unprognostic (1.01e-3)"	"unprognostic (1.94e-2)"	"prognostic favorable (4.52e-5)"	"unprognostic (1.13e-1)"	"unprognostic (1.51e-1)"	"unprognostic (1.87e-1)"	"unprognostic (1.61e-2)"	67.5	148.8	108.7	51.9	106.3	41.8	69.8	104.9	124.5	153.1	120.1	130.1	66.5	122.8	83.1	65.1	129.8	59.7	82.7	105.8	116.3	113.7	97.7	77.8	61.2	105.1	112.8	205.9	136.7	91.0	207.4	46.1	108.1	159.3	50.9	49.4	99.2	74.1	71.4	63.7	105.4	68.1	102.0	112.9	93.3	61.2	120.9	54.7	178.2	37.8	53.5	118.8	90.5	107.2	61.4	82.4	133.7	113.7	87.8	71.1	90.1	89.4	73.1	98.7	79.4	73.9	86.2	98.3	55.5	143.2	75.8	68.1	107.8	125.0	70.0	78.3	71.8	93.1	223.0	98.8	88.8	97.3	40.3	128.5	87.3	91.1	68.4	136.2	73.0	101.8	54.0	102.4	90.6	121.7	113.5	109.8	119.1	55.7	75.9	65.5	57.3	61.8	117.6	179.3	64.9	121.0	66.8	54.1	40.6	96.9	94.8	76.7	98.4	72.7	116.1	71.3	121.1	177.3	82.7	84.3	98.7	122.2	53.4	6.4	11.5	12.8	19.0	15.5	21.1	13.0	13.9	14.4	13.5	12.8	15.8	12.2	3.9	14.6	8.0	17.0	12.6	16.8	108.7	106.3	104.9	124.5	105.8	116.3	105.1	112.8	108.1	102.0	120.9	107.2	16.0	22.4	48.5	67.9	28.0	17.8	24.3	32.0	27.9	26.0	48.1	43.1	3.1	42.9	38.5	47.8	47.9	46.5	21.4	18.4	9.8	30.7	4.3	34.6	32.3	20.8	72.3	16.6	9.3	26.0	21.0	24.1	36.7	39.2	29.1	66.7	26.0	44.7	26.8	37.0	17.5	32.3	28.5	19.2	20.2	7.0	38.2	18.7	12.4	22.5	24.7	39.0	12.3	27.2	23.3	28.0	23.5	28.2	29.9	26.2	30.8	31.3	26.2	46.4	26.3	20.0	21.0	43.0	34.9	15.5	11.4	56.5	25.9	44.7	36.4	19.9
WDR74	"FLJ10439, Nsa1"	ENSG00000133316	"WD repeat domain 74"	Q6RFH5	11	62832342-62841809	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in all"	5	"brain: 565.6;choroid plexus: 711.0"	"Cell type enriched"	"Detected in all"	5	"Early spermatids: 616.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA037795, HPA038419"	Uncertain		Supported	Nucleoplasm,Nucleoli		NA	NA			"Cluster 39: Non-specific - mRNA processing"	"Cluster 88: Choroid plexus - Transmembrane transport"	"Cluster 25: RPMI-8226 - Immune response"	"Cluster 29: Early spermatids - Spermatogenesis"	"Nucleoplasm, Nucleoli"		"HPA037795: AB_10671380, HPA038419: AB_2676006"	"unprognostic (5.52e-2)"	"unprognostic (3.10e-1)"	"unprognostic (1.06e-1)"	"unprognostic (1.17e-2)"	"unprognostic (4.35e-2)"	"unprognostic (3.47e-2)"	"unprognostic (3.97e-3)"	"unprognostic (6.58e-2)"	"unprognostic (1.67e-2)"	"unprognostic (1.62e-2)"	"unprognostic (2.46e-2)"	"unprognostic (8.20e-3)"	"unprognostic (1.29e-3)"	"unprognostic (2.77e-2)"	"unprognostic (6.82e-2)"	"unprognostic (1.29e-1)"	"unprognostic (1.35e-1)"	21.3	21.8	352.4	20.5	274.3	127.1	21.2	485.9	291.6	19.5	711.0	19.6	17.1	20.8	14.6	25.8	22.3	11.4	23.1	251.8	208.5	21.5	28.5	14.9	30.6	220.8	221.4	25.6	30.9	15.1	11.4	18.3	292.3	19.5	16.4	33.7	25.0	13.7	59.3	31.2	17.7	17.0	305.3	30.1	22.0	15.4	244.7	62.3	28.4	25.3	23.9	24.8	18.9	565.6	64.2	76.2	28.8	49.4	22.9	31.4	85.9	35.8	37.5	73.6	49.1	108.8	77.0	111.6	97.6	28.5	59.0	84.1	88.8	69.0	56.8	72.7	64.2	55.5	84.1	97.5	65.9	112.3	36.0	30.9	75.7	47.8	153.9	24.8	36.1	80.5	126.1	32.5	33.7	120.6	106.7	178.7	117.1	70.9	96.7	108.9	49.9	193.6	52.7	35.6	65.7	72.1	40.8	84.1	115.4	27.8	58.8	83.1	28.0	44.4	52.4	98.3	88.2	81.0	120.3	137.1	47.5	68.3	57.2	40.1	140.9	11.7	40.2	61.4	49.7	66.0	42.1	38.6	105.0	121.5	56.8	52.0	51.0	93.2	44.9	154.3	52.4	47.8	352.4	274.3	485.9	291.6	251.8	208.5	220.8	221.4	292.3	305.3	244.7	565.6	36.8	38.5	67.9	1.6	112.5	104.5	47.2	45.7	60.9	15.2	37.6	57.0	2.0	40.0	108.7	16.5	16.7	55.2	57.9	32.0	43.0	42.8	616.0	22.4	34.0	41.7	41.0	26.5	3.6	40.5	53.8	39.1	65.2	32.4	43.6	23.5	20.7	34.0	37.9	3.3	3.0	32.1	20.3	33.1	69.2	97.1	32.9	45.0	30.2	1.0	22.4	15.4	45.3	2.0	2.8	39.8	24.2	21.4	74.3	50.3	44.8	54.0	32.0	11.4	19.7	53.0	89.3	19.4	31.4	50.3	109.3	34.8	66.3	30.4	41.5	39.8
WDR75	"FLJ12519, NET16, UTP17"	ENSG00000115368	"WD repeat domain 75"	Q8IWA0	2	189441446-189475552	"Predicted intracellular proteins"	"Ribosome biogenesis, rRNA processing, Transcription, Transcription regulation"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"									NA	NA			"Cluster 39: Non-specific - mRNA processing"	"Cluster 50: Non-specific - Ribosome"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 59: Non-specific - Transcription"				"unprognostic (1.23e-1)"	"unprognostic (7.34e-2)"	"unprognostic (3.31e-1)"	"unprognostic (1.54e-1)"	"unprognostic (4.22e-2)"	"unprognostic (1.29e-2)"	"prognostic unfavorable (6.50e-8)"	"unprognostic (1.49e-1)"	"unprognostic (2.46e-3)"	"unprognostic (1.93e-2)"	"unprognostic (3.25e-2)"	"unprognostic (1.09e-1)"	"prognostic unfavorable (3.15e-11)"	"unprognostic (1.34e-1)"	"unprognostic (7.56e-2)"	"unprognostic (1.10e-1)"	"unprognostic (1.38e-2)"	18.0	21.1	16.5	18.7	16.6	20.5	24.3	17.9	20.5	23.5	14.7	16.3	13.8	23.4	23.8	18.0	21.2	14.9	13.7	16.3	17.3	15.5	17.7	12.3	26.3	17.5	16.1	23.4	19.8	17.3	13.5	16.9	17.5	15.1	18.2	15.8	13.6	13.1	15.9	21.9	16.0	19.5	17.9	21.6	16.3	16.1	17.6	20.6	14.7	13.8	24.1	23.1	17.9	19.4	36.0	34.3	43.7	55.2	46.7	49.5	49.2	73.3	34.1	82.0	62.7	71.5	39.7	76.1	41.0	24.1	31.6	48.3	81.9	49.0	79.7	49.9	39.1	99.5	60.3	55.4	44.4	111.2	48.7	41.1	41.3	59.4	80.6	34.7	55.9	43.5	99.9	45.3	56.3	35.7	54.8	77.4	101.6	41.5	92.6	51.0	65.4	64.0	41.3	42.5	41.2	41.9	46.1	44.1	38.1	70.2	40.7	45.9	48.3	48.7	52.4	37.4	55.3	48.7	81.2	95.1	34.5	47.5	40.3	0.7	4.3	2.5	5.7	7.4	11.3	5.9	6.3	7.4	8.0	4.3	7.7	7.5	0.0	7.6	4.6	4.5	8.4	4.7	16.5	16.6	17.9	20.5	16.3	17.3	17.5	16.1	17.5	17.9	17.6	19.4	19.8	28.9	16.4	20.5	20.4	17.0	21.0	16.6	26.7	6.4	8.3	9.7	18.3	2.8	13.1	1.8	8.4	19.0	13.3	4.2	11.7	15.0	2.1	10.6	27.3	18.0	9.0	15.8	32.8	16.9	16.0	17.8	15.3	12.0	5.1	13.7	9.7	8.5	10.7	16.8	41.2	12.1	20.3	44.5	8.5	3.8	18.0	11.9	14.2	12.2	11.4	4.8	9.2	28.6	29.7	16.3	6.7	15.8	14.9	16.6	6.1	14.6	11.3	9.6	19.7	20.4	19.6	30.5	31.4	18.1	11.2	17.2	19.5	17.0	11.4	15.2
XRCC3		ENSG00000126215	"X-ray repair cross complementing 3"	O43542	14	103697609-103715504	"Cancer-related genes, Disease related genes, Predicted intracellular proteins"	"DNA damage, DNA recombination, DNA repair"	DNA-binding	"Cancer-related genes, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Cytotrophoblasts: 10.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"HPA062422, HPA068953"			Enhanced	Nucleoplasm		NA	NA			"Cluster 39: Non-specific - mRNA processing"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 12: Non-specific - Cell cycle regulation"	Nucleoplasm		"HPA062422: AB_2684757, HPA068953: AB_2686062"	"unprognostic (2.52e-2)"	"unprognostic (1.81e-3)"	"unprognostic (6.75e-2)"	"unprognostic (4.01e-2)"	"unprognostic (4.29e-1)"	"unprognostic (1.83e-1)"	"unprognostic (2.53e-4)"	"unprognostic (2.93e-2)"	"unprognostic (4.67e-2)"	"unprognostic (1.58e-2)"	"unprognostic (4.46e-2)"	"unprognostic (2.53e-2)"	"unprognostic (3.52e-7)"	"unprognostic (1.27e-1)"	"unprognostic (1.57e-1)"	"unprognostic (8.84e-2)"	"unprognostic (3.72e-2)"	9.8	6.0	8.7	8.7	12.5	31.9	9.3	7.2	10.3	13.7	11.9	11.1	6.9	10.4	1.7	13.9	10.9	6.6	8.3	6.6	5.8	7.9	7.7	12.1	15.4	13.6	9.7	12.7	9.8	1.7	8.6	5.2	9.7	13.4	7.5	4.5	12.7	3.3	12.4	39.0	12.6	2.8	7.7	21.3	9.1	13.8	9.7	10.0	10.5	2.5	11.0	9.6	12.4	14.3	32.4	58.4	31.5	38.5	2.8	7.9	57.0	35.5	11.6	48.9	52.3	32.4	50.3	51.8	29.5	7.5	38.4	50.3	34.6	52.4	29.9	31.3	36.1	50.6	31.6	30.4	4.9	45.3	30.8	6.0	5.2	43.2	26.7	10.4	20.2	51.3	31.8	30.4	25.2	70.7	79.6	35.8	26.4	47.1	42.0	63.7	45.7	19.8	10.5	44.2	31.1	25.7	41.3	21.7	14.3	17.4	34.6	35.0	17.5	25.1	28.9	80.0	38.8	26.2	25.8	63.7	15.6	36.9	38.4	0.7	0.5	0.9	1.0	0.9	1.0	1.1	0.8	0.8	0.5	0.9	0.8	0.5	0.3	0.7	0.7	0.4	0.6	1.3	8.7	12.5	7.2	10.3	6.6	5.8	13.6	9.7	9.7	7.7	9.7	14.3	2.2	0.0	0.0	2.6	2.5	1.5	1.9	2.1	1.8	1.7	3.2	3.6	0.2	2.8	2.5	0.0	2.1	10.2	1.8	6.9	1.9	1.5	0.7	1.9	2.2	2.0	1.2	7.4	2.6	1.8	6.1	1.2	0.5	2.0	0.0	4.7	0.4	0.3	4.4	3.3	1.0	7.4	0.0	0.0	2.0	1.8	0.3	1.5	0.0	1.0	1.5	1.7	2.1	1.5	1.4	1.7	2.6	1.2	4.4	1.6	0.7	0.2	1.7	2.3	0.0	2.6	1.2	3.1	5.8	2.8	1.3	3.1	2.0	4.2	8.3	1.2
XYLT2	"PXYLT2, XT-II"	ENSG00000015532	"Xylosyltransferase 2"	Q9H1B5	17	50346126-50363138	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins, Predicted secreted proteins"		"Glycosyltransferase, Transferase"	"Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	6	"stomach 1: 86.7"	"Group enriched"	"Detected in many"	6	"Early spermatids: 316.4;Late spermatids: 91.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"								"Secreted to blood"	NA	NA		1100000	"Cluster 39: Non-specific - mRNA processing"	"Cluster 4: Stomach - Digestion"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 29: Early spermatids - Spermatogenesis"				"unprognostic (1.52e-1)"	"unprognostic (2.84e-1)"	"unprognostic (1.65e-1)"	"unprognostic (8.07e-2)"	"unprognostic (1.90e-3)"	"unprognostic (1.90e-1)"	"unprognostic (7.29e-3)"	"unprognostic (2.52e-2)"	"unprognostic (1.92e-1)"	"unprognostic (2.30e-1)"	"unprognostic (1.54e-2)"	"unprognostic (2.81e-1)"	"unprognostic (7.63e-2)"	"unprognostic (5.15e-2)"	"unprognostic (7.38e-2)"	"unprognostic (1.52e-2)"	"unprognostic (2.68e-2)"	7.4	9.7	4.9	6.6	5.2	4.5	8.1	8.0	8.2	12.3	8.7	10.0	9.6	11.4	5.3	8.4	11.8	6.6	9.1	5.6	3.0	8.9	7.5	7.3	9.3	4.1	5.6	13.6	12.9	9.4	6.4	8.6	3.8	13.6	3.6	4.5	12.2	10.1	5.8	15.3	8.7	5.2	2.5	10.1	86.7	6.7	7.0	8.6	9.3	2.4	4.0	12.0	10.9	5.3	21.1	26.2	7.0	5.9	9.7	9.4	18.4	19.3	17.4	17.2	19.1	28.3	15.5	10.9	47.6	17.3	14.9	15.8	2.4	27.0	3.7	54.3	18.5	24.6	8.6	12.4	13.3	7.8	12.5	12.8	16.4	13.6	6.3	16.9	14.9	9.4	4.4	8.8	11.3	27.5	14.4	10.7	6.5	14.0	18.0	7.2	20.4	9.0	9.5	10.8	3.6	9.0	12.9	11.9	20.3	8.0	57.4	7.5	17.4	38.4	19.2	20.9	17.3	48.0	23.6	3.9	40.4	12.3	10.6	3.7	2.0	1.5	2.7	1.2	2.7	1.3	2.7	3.6	2.4	2.2	2.7	2.5	1.9	3.6	1.1	1.6	2.5	2.9	4.9	5.2	8.0	8.2	5.6	3.0	4.1	5.6	3.8	2.5	7.0	5.3	7.5	9.6	6.1	13.1	3.9	5.7	3.2	7.3	5.7	8.3	3.9	5.7	8.4	10.0	4.4	1.8	29.2	7.0	3.8	7.5	0.0	7.1	316.4	4.6	6.7	6.8	10.8	0.8	4.9	6.2	5.4	9.1	17.3	6.8	1.3	9.6	10.4	8.0	3.6	6.7	7.2	9.4	2.0	6.0	1.4	91.4	12.5	3.8	7.2	6.5	2.7	5.9	5.2	6.6	4.7	6.8	3.5	17.3	4.7	2.0	4.6	2.8	3.2	6.1	26.3	6.9	6.7	2.4	4.3	3.4	3.1	1.5	4.8	5.3	11.1	1.4
ZBED6CL	C7orf29	ENSG00000188707	"ZBED6 C-terminal like"	Q96FA7	7	150322639-150332721	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"adrenal gland: 72.3;parathyroid gland: 25.6"	"Cell type enhanced"	"Detected in many"		"Cone photoreceptor cells: 8.4;Exocrine glandular cells: 13.3;Pancreatic endocrine cells: 13.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"HDLM-2: 85.2;K-562: 34.5"					"Low region specificity"	"Detected in all"			"HPA019724, HPA055805"	Approved		Approved	"Nuclear membrane,Vesicles"		NA	NA			"Cluster 39: Non-specific - mRNA processing"	"Cluster 17: Adrenal gland - Steroid metabolism"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 1: Pancreatic cells - Digestion"	"Nuclear membrane"	Vesicles	"HPA019724: AB_1845756, HPA055805: AB_2682929"	"prognostic favorable (9.48e-5)"	"unprognostic (6.77e-2)"	"unprognostic (2.06e-2)"	"unprognostic (7.41e-2)"	"prognostic unfavorable (3.12e-5)"	"unprognostic (3.35e-2)"	"unprognostic (2.49e-3)"	"unprognostic (2.78e-2)"	"unprognostic (3.12e-2)"	"unprognostic (3.44e-1)"	"prognostic favorable (2.44e-5)"	"unprognostic (2.78e-1)"	"prognostic unfavorable (1.38e-5)"	"unprognostic (1.86e-2)"	"unprognostic (7.82e-2)"	"unprognostic (8.52e-3)"	"unprognostic (1.50e-3)"	1.3	72.3	1.0	5.2	0.8	3.8	2.1	0.6	0.8	3.0	3.1	4.0	3.3	4.3	1.2	3.0	4.1	1.6	1.2	1.1	1.1	5.3	12.1	3.1	6.9	1.1	1.0	6.0	7.2	25.6	5.4	0.8	0.8	3.5	3.1	1.7	2.7	2.1	0.5	3.6	5.0	1.8	0.6	4.9	4.2	1.1	1.2	5.6	4.0	0.2	6.7	2.7	2.1	0.6	8.1	0.2	0.0	0.0	0.0	0.0	1.3	0.1	0.0	0.3	0.9	10.9	8.4	4.8	4.0	0.1	0.0	3.5	0.0	0.0	0.7	85.2	5.4	6.3	13.3	17.6	2.1	0.0	8.4	1.4	3.9	0.0	0.0	0.3	0.4	16.2	34.5	11.8	0.0	3.3	14.5	2.8	5.3	3.4	0.0	0.0	0.5	10.2	3.2	16.4	15.1	8.4	14.9	3.2	0.5	2.4	1.0	3.6	0.2	0.0	0.0	0.0	0.1	10.0	3.0	0.0	0.0	0.0	0.0	0.0	0.3	0.3	0.7	0.2	0.8	0.5	0.6	0.9	0.2	0.8	0.8	0.8	0.8	0.7	0.0	0.2	0.6	0.7	1.0	0.8	0.6	0.8	1.1	1.1	1.1	1.0	0.8	0.6	1.2	0.6	0.0	0.0	1.5	0.0	0.6	0.3	0.5	1.0	0.0	1.0	1.2	0.9	0.9	2.8	1.6	1.8	8.4	1.5	2.2	2.2	5.9	2.8	0.0	3.1	0.4	0.9	4.8	0.8	0.0	13.3	0.8	0.6	1.5	3.3	1.3	1.3	0.4	3.7	0.6	0.0	0.0	2.4	4.1	1.2	0.0	0.4	2.8	0.7	0.0	0.0	3.4	1.2	3.1	0.0	0.0	13.4	1.2	1.2	0.2	0.4	1.3	0.9	0.6	0.6	0.0	0.9	0.2	0.4	0.9	0.9	0.1	1.9	1.4	1.1	2.3	0.4
ZCCHC8	DKFZp434E2220	ENSG00000033030	"Zinc finger CCHC-type containing 8"	Q6NZY4	12	122471599-122501073	"Disease related genes, Predicted intracellular proteins"	"mRNA processing, mRNA splicing"		"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 43.7"	"Cell type enhanced"	"Detected in all"		"Cone photoreceptor cells: 125.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA037483, HPA037484"	Supported		Enhanced	Nucleoplasm		NA	NA			"Cluster 39: Non-specific - mRNA processing"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 9: Photoreceptor cells - Phototransduction"	Nucleoplasm		"HPA037483: AB_10671502, HPA037484: AB_10672485"	"unprognostic (1.96e-3)"	"unprognostic (8.48e-2)"	"unprognostic (5.55e-2)"	"unprognostic (5.24e-2)"	"unprognostic (2.44e-1)"	"unprognostic (6.30e-3)"	"unprognostic (1.33e-2)"	"unprognostic (2.08e-1)"	"prognostic unfavorable (7.40e-4)"	"unprognostic (1.03e-1)"	"unprognostic (6.95e-2)"	"unprognostic (4.78e-2)"	"prognostic unfavorable (5.36e-4)"	"unprognostic (8.86e-2)"	"unprognostic (2.88e-1)"	"unprognostic (2.55e-2)"	"unprognostic (1.48e-2)"	10.2	8.2	3.6	8.9	4.0	43.7	9.9	7.5	4.8	10.8	5.5	9.3	9.0	9.8	8.8	9.8	10.2	6.5	6.3	3.4	3.5	7.9	10.3	8.5	10.5	4.2	3.6	11.5	9.4	8.9	8.9	8.1	3.9	7.9	8.1	10.8	9.7	6.6	16.8	11.8	10.4	7.5	3.0	11.0	10.7	12.1	3.9	10.7	10.8	8.7	11.8	8.9	9.6	5.5	14.8	14.4	21.7	21.0	8.4	10.8	25.2	18.0	11.3	21.5	16.1	13.9	13.0	26.6	10.9	7.6	12.5	17.4	23.1	9.8	19.6	20.9	14.0	17.5	21.0	11.5	19.8	30.5	16.9	9.4	15.7	12.9	18.2	19.2	10.9	26.8	24.3	17.0	11.3	8.4	20.7	23.9	18.5	10.0	15.3	24.2	17.8	21.4	10.5	9.3	15.6	17.2	20.5	9.5	23.0	21.1	20.0	20.3	12.2	14.3	15.3	14.2	17.7	18.2	11.6	36.6	7.8	19.6	8.6	5.5	3.4	2.2	3.5	3.6	3.6	4.5	4.1	4.3	2.8	4.0	4.6	3.8	2.9	4.3	4.3	2.9	5.7	2.5	3.6	4.0	7.5	4.8	3.4	3.5	4.2	3.6	3.9	3.0	3.9	5.5	21.6	32.1	22.6	20.5	26.8	20.5	27.2	13.5	27.3	30.5	23.1	21.5	9.4	21.5	27.0	9.2	125.1	17.4	32.6	13.3	1.9	11.8	78.5	30.7	40.6	21.0	19.6	48.2	21.7	9.5	17.6	22.8	26.0	41.4	19.0	22.5	10.4	17.9	12.8	15.2	24.6	15.5	14.2	15.6	20.2	48.1	14.9	22.4	16.0	26.2	23.5	12.4	21.6	27.6	25.3	14.1	12.2	14.7	29.6	21.3	18.8	6.6	20.4	72.7	6.6	33.6	21.0	34.4	17.1	24.0	25.7	32.3	26.2	19.0	17.3	22.9
ZFAND1	FLJ14007	ENSG00000104231	"Zinc finger AN1-type containing 1"	Q8TCF1	8	81701334-81732903	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"hTERT-HME1: 239.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA023383	Approved		Approved	Centrosome,Cytosol		NA	NA			"Cluster 39: Non-specific - mRNA processing"	"Cluster 29: Non-specific - Vesicular transport"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 32: Non-specific - Translation"	"Centrosome, Cytosol"		"HPA023383: AB_1859008"	"unprognostic (6.45e-2)"	"unprognostic (1.48e-2)"	"unprognostic (7.74e-2)"	"unprognostic (8.90e-2)"	"unprognostic (1.23e-1)"	"unprognostic (8.04e-3)"	"unprognostic (8.13e-2)"	"unprognostic (1.82e-1)"	"unprognostic (2.07e-2)"	"unprognostic (3.88e-2)"	"unprognostic (1.30e-2)"	"unprognostic (3.77e-2)"	"unprognostic (1.38e-1)"	"unprognostic (1.09e-1)"	"unprognostic (3.22e-1)"	"unprognostic (8.35e-2)"	"unprognostic (2.36e-2)"	30.3	26.8	15.2	14.8	15.9	28.6	41.8	19.1	21.4	30.8	11.8	27.6	25.8	35.3	26.9	28.3	32.0	24.2	22.2	15.6	17.4	30.7	35.5	24.5	26.8	15.4	15.7	55.7	53.8	32.3	21.7	18.9	16.7	28.1	29.9	21.0	39.9	26.5	21.6	20.7	23.6	32.5	14.0	25.2	30.0	9.2	16.0	31.8	58.1	27.9	29.6	32.1	23.5	16.4	74.1	23.5	31.3	29.4	40.5	86.0	31.0	42.5	57.8	38.3	48.0	26.4	56.8	72.5	49.1	32.5	41.4	47.2	35.9	61.7	57.4	60.1	36.8	41.1	35.1	29.5	78.7	53.9	26.6	70.8	138.4	26.0	239.0	64.6	46.9	70.6	61.1	96.7	38.6	46.0	65.4	35.6	9.6	147.5	70.1	43.8	26.2	32.5	48.1	67.1	30.8	21.6	30.1	19.3	71.6	35.2	62.6	38.7	29.7	27.2	39.4	38.5	60.5	38.2	26.2	45.3	30.9	4.6	21.9	16.8	29.5	8.4	21.8	21.3	36.7	36.4	35.2	28.8	40.8	27.2	46.6	36.1	2.9	37.0	25.8	24.3	44.1	36.0	15.2	15.9	19.1	21.4	15.6	17.4	15.4	15.7	16.7	14.0	16.0	16.4	44.1	25.6	38.3	14.4	47.9	95.8	73.0	73.0	88.2	27.3	49.7	63.6	18.8	41.5	41.4	25.8	4.2	33.8	32.8	10.0	103.7	27.4	3.4	20.1	25.3	42.8	23.4	31.5	49.2	49.4	45.6	36.3	32.1	21.4	34.9	28.9	41.7	22.5	29.1	23.5	45.3	33.6	36.7	47.7	75.0	3.7	39.7	29.1	49.8	20.6	35.2	15.3	23.7	26.7	29.0	33.6	24.4	29.7	44.4	72.2	28.4	80.1	20.9	15.2	32.9	42.6	48.1	18.5	17.3	53.0	78.4	32.7	42.6	49.1	33.3	61.5
ZFY	ZNF911	ENSG00000067646	"Zinc finger protein Y-linked"	P08048	Y	2935281-2982506	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Early spermatids: 35.7;Late spermatids: 88.9"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"							"Low region specificity"	"Detected in all"			"HPA001748, HPA071863"	Uncertain		Approved	Nucleoplasm,Nucleoli		NA	NA			"Cluster 39: Non-specific - mRNA processing"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 59: Non-specific - Transcription"	Nucleoplasm	Nucleoli	"HPA001748: AB_1080650, HPA071863: AB_2686463"			"unprognostic (1.07e-1)"		"unprognostic (7.43e-2)"	"prognostic favorable (3.58e-5)"	"unprognostic (1.07e-1)"	"unprognostic (7.52e-2)"	"unprognostic (2.75e-2)"		"unprognostic (2.94e-2)"	"unprognostic (1.04e-1)"	"unprognostic (8.32e-2)"	"unprognostic (1.20e-2)"	"unprognostic (1.91e-1)"		"unprognostic (2.54e-2)"	2.6	1.7	0.6	2.5	0.8	8.0	2.1	3.3	2.1	0.0	1.0	2.3	2.7	0.0	3.0	4.6	0.0	3.1	1.9	0.6	1.0	1.7	4.4	1.7	1.3	0.8	0.9	0.0	2.6	1.9	1.6	3.8	0.9	5.0	5.0	2.3	2.7	4.0	3.4	1.8	4.2	0.0	0.7	2.2	2.5	7.2	0.6	0.0	2.8	7.4	3.7	3.2	0.0	1.2	0.0	5.9	0.0	0.0	0.0	0.0	9.3	13.6	13.5	11.5	10.7	0.0	0.0	10.0	0.0	14.6	0.0	0.0	0.0	0.0	14.7	15.5	0.0	19.2	0.2	7.6	9.6	0.0	0.0	10.6	9.0	0.0	0.0	0.0	0.0	3.1	0.0	0.0	12.8	0.0	8.5	0.0	4.9	0.0	0.0	0.0	8.1	5.2	7.6	17.7	9.8	0.0	0.0	0.0	13.4	6.4	0.0	6.5	11.7	11.3	0.0	0.1	7.3	6.7	0.0	17.5	1.8	0.0	0.0	0.0	2.7	2.2	2.3	1.8	3.1	2.0	2.5	1.3	2.8	2.4	2.7	1.4	1.5	2.9	1.5	2.0	1.6	1.8	0.6	0.8	3.3	2.1	0.6	1.0	0.8	0.9	0.9	0.7	0.6	1.2	0.0	9.6	10.5	7.2	14.7	11.1	10.6	6.8	10.2	12.4	0.0	0.0	7.6	7.2	10.3	1.8	8.4	5.0	8.0	1.0	0.0	4.4	35.7	0.0	0.0	5.8	1.8	11.1	14.1	0.0	2.8	7.8	11.7	0.0	7.0	0.0	10.0	3.7	3.4	13.5	11.3	1.9	2.0	11.3	12.6	88.9	9.9	10.5	3.6	6.5	8.0	12.1	18.6	7.5	6.7	1.3	0.0	10.9	12.2	11.7	1.9	3.3	7.5	8.6	13.1	6.5	5.9	20.3	7.7	12.8	9.5	3.7	12.7	0.1	2.4	12.0
ZNF121	"D19S204, ZHC32, ZNF20"	ENSG00000197961	"Zinc finger protein 121"	P58317	19	9560329-9584504	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"NB-4: 68.2;RT4: 72.3"	"Low region specificity"	"Detected in all"							HPA054961	Uncertain		Approved	Nucleoplasm,Nucleoli,Centrosome		NA	NA			"Cluster 39: Non-specific - mRNA processing"	"Cluster 55: Non-specific - Mitochondria & Proteasome"	"Cluster 24: NB-4 - Immune response"	"Cluster 22: Epithelial cell types - Mixed function"	"Nucleoplasm, Centrosome"	Nucleoli	"HPA054961: AB_2682651"	"unprognostic (3.06e-1)"	"unprognostic (9.38e-3)"	"unprognostic (9.51e-2)"	"unprognostic (7.49e-2)"	"unprognostic (3.07e-2)"	"unprognostic (3.91e-3)"	"unprognostic (3.68e-2)"	"unprognostic (1.76e-1)"	"unprognostic (6.80e-3)"	"prognostic favorable (6.59e-5)"	"unprognostic (9.36e-2)"	"unprognostic (1.76e-3)"	"prognostic unfavorable (1.01e-4)"	"unprognostic (8.75e-3)"	"unprognostic (2.83e-1)"	"unprognostic (1.06e-1)"	"prognostic favorable (5.75e-5)"	7.0	4.8	5.5	5.2	5.9	14.3	7.2	8.8	6.4	5.3	8.2	5.5	3.6	4.7	5.6	9.3	5.4	4.0	6.1	5.7	6.7	8.0	8.5	7.5	6.2	6.0	5.1	4.6	6.3	8.7	6.7	4.2	6.3	7.1	5.8	7.2	6.7	3.5	4.4	10.8	6.4	4.8	5.3	7.4	5.7	3.6	6.3	6.0	5.6	3.2	6.8	5.3	7.0	9.5	14.9	8.7	10.3	23.7	4.6	5.4	16.4	5.3	5.3	7.3	10.0	17.7	6.6	16.1	13.3	4.6	4.1	13.6	18.8	15.0	9.2	8.4	32.4	43.2	29.2	15.7	6.1	26.0	25.6	7.2	11.2	7.2	16.3	6.1	5.4	17.4	16.9	27.7	5.4	11.8	17.9	68.2	27.1	5.2	13.9	10.9	13.0	11.8	8.0	72.3	19.6	10.2	7.6	10.6	6.2	20.7	7.8	8.2	6.1	21.7	12.0	7.6	12.1	26.6	17.6	18.4	6.0	14.4	9.1	1.6	1.5	0.9	2.1	1.9	2.8	1.5	2.0	1.9	1.6	2.3	2.3	2.6	1.2	3.1	2.0	2.0	2.0	0.9	5.5	5.9	8.8	6.4	5.7	6.7	6.0	5.1	6.3	5.3	6.3	9.5	16.0	6.4	10.5	3.9	14.7	22.6	36.9	15.6	10.8	7.3	12.7	11.7	11.2	5.7	15.7	9.2	12.5	12.3	25.8	5.6	7.9	11.4	1.5	12.3	16.9	11.8	13.7	11.6	6.2	5.3	11.3	11.7	11.7	18.3	15.2	16.7	10.8	9.9	5.3	6.7	5.3	10.2	8.2	10.4	13.8	0.6	6.2	9.7	8.8	1.0	6.9	3.1	12.3	7.5	6.7	11.4	5.6	8.2	12.6	26.2	4.1	5.3	11.0	7.8	6.6	17.0	10.3	11.0	12.5	21.3	31.7	10.5	14.5	11.9	14.6	35.9
ZNF132	pHZ-12	ENSG00000131849	"Zinc finger protein 132"	P52740	19	58432814-58440153	"Cancer-related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding	"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"		"Cardiomyocytes: 4.0;Cone photoreceptor cells: 4.2;Early spermatids: 3.7"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"											HPA008726	Uncertain		Approved	"Vesicles,Intermediate filaments"		NA	NA			"Cluster 39: Non-specific - mRNA processing"	"Cluster 42: Ciliated cells - Cilium & Cell projection"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 43: Cardiomyocytes - Nuclear processes"	Vesicles	"Intermediate filaments"	"HPA008726: AB_1080664"	"unprognostic (4.86e-2)"	"unprognostic (2.03e-1)"	"unprognostic (6.79e-3)"	"unprognostic (3.06e-2)"	"unprognostic (8.16e-2)"	"unprognostic (4.78e-2)"	"unprognostic (4.02e-2)"	"unprognostic (2.32e-3)"	"unprognostic (5.00e-2)"	"unprognostic (1.29e-1)"	"prognostic favorable (1.92e-4)"	"unprognostic (4.51e-1)"	"prognostic favorable (7.26e-13)"	"unprognostic (2.70e-1)"	"unprognostic (7.65e-2)"	"unprognostic (6.09e-2)"	"unprognostic (3.72e-1)"	1.4	2.3	1.8	1.3	1.9	0.3	2.6	4.7	2.7	2.7	4.6	1.7	1.2	1.8	3.5	1.6	3.8	1.3	3.0	1.8	1.9	3.0	0.8	1.8	1.8	1.5	2.3	3.7	1.6	8.9	3.4	1.8	1.6	2.9	1.1	5.0	3.0	3.1	1.9	2.3	1.1	2.1	1.4	2.3	1.5	3.1	1.7	1.6	5.4	1.7	2.2	1.9	1.5	2.7	1.2	1.3	3.4	1.2	3.9	3.3	0.1	2.6	3.2	2.1	2.0	0.1	1.0	3.3	0.2	3.2	2.1	1.3	0.0	3.9	1.5	0.5	5.9	0.6	1.1	0.7	3.4	1.3	2.1	3.5	1.3	3.6	2.3	2.5	2.0	0.5	0.4	0.3	4.1	0.5	0.7	0.1	3.5	0.4	1.2	0.4	0.7	0.9	1.3	1.4	3.0	3.1	1.0	0.9	1.1	3.6	0.2	3.2	2.4	2.1	0.2	0.5	0.5	4.1	0.8	0.0	1.0	0.1	1.4	0.0	0.8	0.8	0.9	1.0	2.2	1.1	1.1	0.5	1.2	1.4	1.7	1.4	0.0	1.2	1.2	1.0	1.1	0.8	1.8	1.9	4.7	2.7	1.8	1.9	1.5	2.3	1.6	1.4	1.7	2.7	0.4	0.0	0.5	1.6	0.6	0.0	0.6	0.5	0.0	1.2	0.4	0.4	4.0	1.5	0.2	0.0	4.2	0.5	0.2	0.1	0.0	0.6	3.7	1.2	1.0	0.8	0.0	1.7	2.0	0.4	0.2	0.7	2.0	0.4	1.3	1.6	0.4	0.9	0.5	3.3	2.3	0.8	0.0	0.3	0.0	0.7	0.6	0.7	0.0	0.0	0.2	1.4	0.0	1.0	2.5	0.1	0.0	0.7	0.5	0.9	0.3	1.5	0.7	1.7	0.0	0.7	0.8	2.5	0.8	0.8	0.3	0.4	0.5	0.8	0.2	0.3
ZNF251		ENSG00000198169	"Zinc finger protein 251"	Q9BRH9	8	144720907-144756417	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Astrocytes: 31.6;Excitatory neurons: 49.1;Inhibitory neurons: 50.2;Oligodendrocyte precursor cells: 37.7;Oligodendrocytes: 40.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA018290	Approved		Approved	Nucleoplasm		NA	NA			"Cluster 39: Non-specific - mRNA processing"	"Cluster 21: Non-specific - Transcription"	"Cluster 11: RPE1 & U-87MG - Synaptic function"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	Nucleoplasm		"HPA018290: AB_1859153"	"unprognostic (1.16e-3)"	"unprognostic (1.50e-1)"	"unprognostic (1.47e-1)"	"unprognostic (1.77e-1)"	"unprognostic (6.87e-2)"	"unprognostic (1.20e-1)"	"unprognostic (4.26e-3)"	"unprognostic (3.04e-2)"	"unprognostic (2.53e-1)"	"unprognostic (2.30e-1)"	"unprognostic (5.75e-2)"	"unprognostic (2.07e-1)"	"prognostic unfavorable (1.42e-9)"	"unprognostic (5.29e-2)"	"unprognostic (1.60e-1)"	"unprognostic (1.77e-1)"	"unprognostic (2.33e-3)"	16.6	10.4	12.5	6.2	12.3	3.5	16.6	17.4	12.9	21.3	10.4	17.5	6.8	17.5	24.4	9.8	18.1	10.5	23.4	12.7	12.4	15.8	11.4	10.5	12.2	11.8	12.0	20.0	14.5	12.2	22.6	8.8	11.6	17.8	11.4	17.5	12.2	13.5	10.1	13.1	15.7	12.6	10.9	14.9	13.2	14.1	12.9	11.2	28.0	8.6	11.1	16.6	15.5	12.6	9.9	6.0	23.0	10.8	13.5	17.7	8.7	9.9	14.9	11.3	15.8	2.5	11.6	14.6	9.0	12.9	6.3	13.5	6.8	6.1	15.3	4.1	5.0	11.1	25.1	6.8	7.8	4.1	5.9	13.4	9.1	6.9	13.2	22.0	9.2	10.3	7.4	4.1	13.3	4.7	12.3	2.4	6.9	7.3	10.5	12.7	3.3	5.9	7.6	5.5	10.7	13.9	9.5	4.8	11.0	10.4	12.2	9.6	7.4	9.4	14.4	16.4	8.7	4.4	1.3	8.5	10.5	6.0	7.5	0.0	0.3	1.0	0.9	0.5	1.5	1.3	1.4	1.4	0.7	1.0	1.9	1.4	0.0	1.2	0.5	0.7	1.6	0.8	12.5	12.3	17.4	12.9	12.7	12.4	11.8	12.0	11.6	10.9	12.9	12.6	9.3	0.0	5.3	31.6	4.8	2.2	3.8	1.7	5.7	5.5	4.0	4.1	3.9	1.5	8.9	1.8	6.2	2.0	3.1	1.0	5.9	1.6	20.2	4.5	7.1	7.7	1.2	3.8	49.1	1.5	1.4	5.6	6.6	5.0	1.3	6.8	1.8	0.9	1.6	5.0	50.2	2.1	0.0	3.0	3.0	9.5	7.8	2.0	1.8	22.5	2.9	2.8	3.1	37.7	40.7	2.0	1.8	4.5	5.7	3.0	2.0	3.2	5.3	5.9	13.1	5.2	6.1	11.9	10.3	3.9	3.1	1.4	5.0	5.4	1.9	2.0
ZNF619	FLJ90764	ENSG00000177873	"Zinc finger protein 619"	Q8N2I2	3	40477113-40491053	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"							"Low region specificity"	"Detected in all"			HPA045094	Uncertain		Approved	"Nucleoplasm,Intermediate filaments"		NA	NA			"Cluster 39: Non-specific - mRNA processing"	"Cluster 69: Cerebellum - Gene expression regulation"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 52: Non-specific - Transcription"	Nucleoplasm	"Intermediate filaments"	"HPA045094: AB_10959900"	"unprognostic (7.16e-2)"	"unprognostic (5.94e-1)"	"unprognostic (8.38e-3)"	"unprognostic (5.42e-2)"	"unprognostic (8.16e-3)"	"unprognostic (1.32e-2)"	"unprognostic (5.59e-2)"	"unprognostic (1.85e-1)"	"unprognostic (5.46e-2)"	"unprognostic (2.65e-1)"	"unprognostic (7.99e-2)"	"unprognostic (6.15e-3)"	"unprognostic (8.28e-6)"	"unprognostic (1.94e-1)"	"unprognostic (1.69e-1)"	"unprognostic (6.56e-2)"	"unprognostic (1.38e-2)"	1.7	1.6	2.3	2.0	3.5	3.1	2.9	3.0	2.8	2.0	2.5	2.0	2.3	2.0	2.1	1.4	2.5	1.3	1.8	2.2	2.6	2.2	2.4	2.0	2.4	3.0	3.0	2.6	2.5	3.1	1.2	2.0	3.0	2.1	2.6	4.1	2.7	2.2	2.5	2.4	2.0	2.3	2.2	2.9	2.4	1.1	3.0	1.5	3.0	2.2	2.9	1.7	1.5	4.6	1.9	2.5	2.9	2.8	4.5	4.3	1.3	2.7	3.1	4.5	3.9	0.9	2.6	0.2	1.4	2.2	2.2	2.1	3.2	5.0	4.8	3.6	1.1	6.1	2.2	1.4	4.6	4.2	5.0	3.4	3.9	4.7	6.6	3.9	3.8	0.2	3.9	2.9	2.9	2.3	0.1	2.1	1.6	2.2	2.8	1.2	3.0	3.3	2.1	4.2	2.1	2.2	2.4	4.1	2.0	2.9	3.4	2.7	3.6	3.3	2.7	2.0	2.8	1.6	2.2	0.2	2.1	2.6	3.7	0.8	0.7	1.1	0.7	0.9	0.7	0.7	0.6	0.8	1.0	0.8	0.6	0.9	0.8	1.3	1.0	0.6	1.2	0.7	2.3	3.5	3.0	2.8	2.2	2.6	3.0	3.0	3.0	2.2	3.0	4.6	1.5	0.0	1.1	1.0	2.3	0.3	0.8	0.6	1.2	3.6	1.0	1.0	1.3	0.0	0.3	3.7	2.1	1.4	1.0	0.7	0.0	1.4	0.1	1.4	1.6	1.6	0.0	2.1	0.5	1.5	0.9	1.2	1.5	1.1	0.0	2.4	1.8	0.9	1.1	0.0	1.0	1.3	0.0	1.6	0.4	0.0	1.2	1.2	0.0	2.8	1.6	2.5	2.1	1.0	2.3	0.6	0.2	0.4	1.7	0.5	1.6	1.3	1.0	3.6	0.0	2.0	1.1	1.2	1.4	1.7	0.1	0.4	1.5	2.5	0.8	0.6
ZNF625		ENSG00000257591	"Zinc finger protein 625"	Q96I27	19	12142090-12156734	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Cone photoreceptor cells: 10.4;Rod photoreceptor cells: 9.5"	"Low cancer specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in many"											HPA074014			Approved	Nucleoplasm,Mitochondria		NA	NA			"Cluster 39: Non-specific - mRNA processing"	"Cluster 77: Retina - Visual perception"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 9: Photoreceptor cells - Phototransduction"	Mitochondria	Nucleoplasm	"HPA074014: AB_2686652"	"unprognostic (7.88e-3)"	"unprognostic (6.74e-2)"	"unprognostic (9.56e-2)"	"unprognostic (8.75e-2)"	"unprognostic (7.21e-3)"	"unprognostic (6.11e-3)"	"unprognostic (4.72e-2)"	"unprognostic (3.31e-2)"	"unprognostic (6.23e-2)"	"unprognostic (2.73e-1)"	"unprognostic (5.49e-2)"	"unprognostic (3.70e-2)"	"unprognostic (8.29e-2)"	"unprognostic (4.41e-2)"	"unprognostic (1.50e-1)"	"unprognostic (6.98e-2)"	"unprognostic (1.62e-1)"	1.2	2.2	2.2	0.8	2.1	1.2	2.4	5.0	6.3	2.2	1.8	2.1	0.8	2.2	2.9	1.3	2.0	0.9	1.9	2.1	3.0	4.0	1.0	1.4	1.2	2.4	2.4	2.1	1.8	1.4	3.5	1.7	2.4	2.8	0.8	8.8	1.8	1.5	0.5	2.1	1.4	1.6	2.4	2.4	1.4	1.6	3.2	0.9	2.8	0.8	1.1	2.1	1.6	2.6	0.7	0.0	5.5	8.7	2.2	1.5	0.9	2.2	2.8	3.2	3.6	0.1	0.1	0.0	4.1	1.6	2.3	0.4	0.0	2.9	2.9	0.0	1.6	2.7	0.0	2.6	0.9	0.1	3.5	1.1	1.2	3.1	1.1	2.3	2.7	0.2	0.0	0.0	4.9	1.9	0.0	1.2	6.6	0.0	1.8	0.2	4.5	0.0	2.7	7.5	3.5	2.4	0.0	0.1	2.0	6.4	3.6	0.2	1.6	7.3	3.5	5.9	3.1	6.1	5.1	0.0	2.0	0.0	2.7	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.2	0.2	0.1	0.2	0.2	0.2	0.2	0.5	0.0	0.0	0.4	0.1	2.2	2.1	5.0	6.3	2.1	3.0	2.4	2.4	2.4	2.4	3.2	2.6	2.1	3.2	1.5	0.0	0.5	0.4	0.5	1.0	1.2	5.0	2.0	2.2	0.1	2.8	0.4	1.8	10.4	4.1	0.5	0.5	3.9	3.4	0.1	1.9	3.5	2.5	1.2	0.0	0.0	3.1	3.9	1.3	0.0	1.5	0.0	4.9	6.4	0.8	1.5	5.0	0.0	0.6	2.0	4.1	2.0	1.3	0.6	0.5	0.0	0.0	1.7	5.1	7.2	0.0	0.0	3.6	1.9	1.5	1.6	0.7	0.3	2.7	2.5	9.5	0.0	1.8	1.7	2.9	6.6	0.3	0.9	1.2	0.4	2.0	1.0	0.3
ZNF629	"KIAA0326, ZNF65"	ENSG00000102870	"Zinc finger protein 629"	Q9UEG4	16	30778456-30787205	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Cardiomyocytes: 28.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA019550, HPA056051"	Uncertain		Supported	"Nucleoplasm,Golgi apparatus"		NA	NA			"Cluster 39: Non-specific - mRNA processing"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 62: Horizontal cells - Visual perception"	Nucleoplasm	"Golgi apparatus"	"HPA019550: AB_1859386, HPA056051: AB_2683020"	"unprognostic (1.03e-2)"	"unprognostic (2.15e-2)"	"unprognostic (1.24e-1)"	"unprognostic (2.67e-1)"	"unprognostic (3.17e-1)"	"unprognostic (6.38e-2)"	"unprognostic (6.14e-2)"	"unprognostic (2.98e-2)"	"unprognostic (3.15e-1)"	"unprognostic (6.24e-2)"	"unprognostic (4.87e-3)"	"unprognostic (2.66e-2)"	"prognostic favorable (4.57e-10)"	"unprognostic (8.41e-2)"	"unprognostic (1.96e-1)"	"unprognostic (5.71e-2)"	"unprognostic (9.70e-2)"	5.6	9.0	5.6	3.0	6.0	4.1	5.7	7.1	5.9	6.5	4.3	6.8	5.5	8.0	4.3	5.1	6.6	3.6	12.6	5.9	6.1	7.8	4.3	5.3	1.9	6.2	6.7	6.8	5.9	15.0	6.6	3.6	5.6	6.3	4.5	7.8	6.5	6.0	9.7	8.6	5.3	6.8	5.0	4.0	7.3	4.1	7.0	3.9	5.9	9.6	2.3	6.5	5.1	5.5	9.8	15.8	23.9	18.5	11.5	10.6	3.6	10.8	15.6	16.6	14.0	9.7	8.8	1.8	10.2	17.6	5.2	11.4	11.7	14.3	11.0	0.4	17.6	13.6	14.0	10.2	12.3	4.8	8.0	17.7	10.5	10.3	8.6	13.0	8.9	0.8	20.2	0.4	14.6	20.8	7.2	6.3	12.6	4.7	6.4	24.3	18.4	0.8	13.9	15.9	22.6	25.3	10.5	19.4	2.6	7.8	14.6	17.4	10.8	15.5	10.1	10.6	8.3	0.3	0.1	0.5	10.2	11.9	5.3	0.0	0.3	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.2	0.2	0.0	0.3	0.1	0.6	0.0	0.1	5.6	6.0	7.1	5.9	5.9	6.1	6.2	6.7	5.6	5.0	7.0	5.5	4.9	19.2	9.4	5.9	2.6	1.9	3.4	4.3	5.7	16.7	4.2	3.4	28.3	4.3	6.5	9.2	4.2	1.3	1.6	5.4	1.9	8.7	1.7	5.1	9.5	8.0	11.5	4.6	2.4	8.0	0.6	5.3	7.1	5.3	2.5	10.7	8.2	4.7	4.4	16.8	3.7	7.9	6.1	5.2	3.0	4.7	9.3	2.6	1.8	1.0	7.7	13.4	1.0	4.5	3.4	10.9	5.0	4.5	3.0	4.8	5.1	4.3	5.9	12.4	0.0	6.7	5.6	4.6	1.5	3.8	1.8	0.5	1.4	8.3	9.0	3.8
ZNF75D	"D8C6, ZKSCAN24, ZNF75, ZNF82, ZSCAN28"	ENSG00000186376	"Zinc finger protein 75D"	P51815	X	135248920-135344109	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in many"	10	"Early spermatids: 202.9;Late spermatids: 378.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"							"Low region specificity"	"Detected in all"			HPA004705	Supported		Approved	"Nucleoplasm,Golgi apparatus"		NA	NA			"Cluster 39: Non-specific - mRNA processing"	"Cluster 17: Adrenal gland - Steroid metabolism"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 31: Spermatids - Spermatogenesis"	"Nucleoplasm, Golgi apparatus"		"HPA004705: AB_1080749"	"unprognostic (1.56e-3)"	"unprognostic (7.96e-3)"	"unprognostic (3.07e-1)"	"unprognostic (5.12e-2)"	"unprognostic (1.30e-1)"	"unprognostic (3.00e-2)"	"unprognostic (7.92e-2)"	"unprognostic (1.32e-3)"	"unprognostic (9.17e-2)"	"unprognostic (1.81e-1)"	"unprognostic (1.15e-2)"	"unprognostic (2.13e-2)"	"prognostic favorable (1.31e-4)"	"unprognostic (1.09e-2)"	"unprognostic (1.96e-1)"	"unprognostic (1.15e-1)"	"prognostic favorable (7.42e-5)"	6.3	14.5	4.8	5.6	4.9	6.9	6.3	4.7	5.3	7.1	5.6	6.7	4.8	6.2	7.5	5.2	7.0	4.7	5.5	4.6	5.6	8.4	11.0	6.7	8.4	5.2	4.9	6.8	9.8	7.1	6.9	5.0	5.4	10.2	5.5	6.7	6.4	5.9	5.1	6.8	8.2	4.9	4.9	13.9	7.5	2.2	5.2	8.6	9.3	3.9	7.2	6.0	5.8	5.3	3.3	4.3	4.6	7.4	7.7	9.3	7.0	5.5	7.5	4.4	9.4	2.6	4.1	3.5	7.9	4.7	8.5	4.5	15.2	2.5	4.2	3.3	4.0	2.4	8.6	3.5	3.3	4.1	6.6	4.6	5.9	2.7	3.4	5.5	4.6	4.4	2.1	5.4	3.9	8.0	5.0	7.5	2.2	6.7	5.8	4.7	4.6	3.1	5.0	4.5	1.5	5.2	3.1	5.2	0.9	4.9	1.8	5.9	4.8	4.2	1.0	7.1	5.3	2.7	4.1	2.5	2.6	4.5	2.7	2.7	1.0	2.0	2.3	0.8	2.1	1.4	2.5	2.7	0.9	1.6	3.1	2.8	1.1	2.8	0.8	0.8	3.4	1.5	4.8	4.9	4.7	5.3	4.6	5.6	5.2	4.9	5.4	4.9	5.2	5.3	6.4	6.4	12.9	23.5	7.5	1.8	1.3	1.4	2.8	4.9	3.9	2.0	4.7	1.5	5.0	0.0	6.2	2.4	8.4	3.7	1.9	2.0	202.9	9.2	4.8	7.1	1.8	0.8	18.5	4.0	1.5	4.2	6.1	4.9	6.3	4.9	5.7	5.3	2.4	5.0	21.8	5.0	6.1	2.9	1.6	378.3	6.5	3.8	0.0	28.1	3.9	4.1	6.2	18.6	21.4	3.1	2.8	3.4	5.0	2.3	3.3	3.7	5.1	5.1	0.0	3.4	3.5	7.6	3.1	3.4	1.4	1.8	7.1	10.2	3.6	2.3
ZNF845		ENSG00000213799	"Zinc finger protein 845"	Q96IR2	19	53333749-53356906	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"							"Low region specificity"	"Detected in all"									NA	NA			"Cluster 39: Non-specific - mRNA processing"	"Cluster 34: Non-specific - Transcription"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 43: Cardiomyocytes - Nuclear processes"				"unprognostic (4.85e-3)"	"unprognostic (1.35e-1)"	"unprognostic (1.12e-1)"	"unprognostic (1.96e-1)"	"unprognostic (2.50e-2)"	"unprognostic (5.78e-2)"	"unprognostic (1.07e-3)"	"unprognostic (9.79e-2)"	"unprognostic (3.12e-3)"	"unprognostic (1.05e-1)"	"unprognostic (7.52e-2)"	"unprognostic (2.46e-2)"	"prognostic favorable (3.98e-4)"	"unprognostic (3.13e-1)"	"unprognostic (1.58e-1)"	"unprognostic (1.05e-1)"	"unprognostic (1.65e-1)"	2.6	1.7	1.0	2.7	1.5	5.0	4.1	2.1	1.4	2.9	1.3	2.9	2.5	2.2	2.4	2.5	2.9	2.0	2.1	1.0	1.4	2.5	1.5	2.9	4.3	1.4	1.3	4.2	2.0	3.6	0.9	3.0	1.3	2.9	3.1	1.3	2.1	2.4	0.6	3.1	2.6	2.0	1.0	3.6	3.6	2.3	1.3	4.2	3.7	2.0	3.8	2.7	2.3	2.0	4.7	5.6	3.3	5.1	4.5	4.6	9.0	3.8	5.4	4.1	6.0	4.4	3.5	7.8	3.3	4.1	5.0	5.2	6.1	6.0	6.5	2.3	9.5	9.1	3.6	3.7	4.6	0.0	6.2	4.6	5.9	4.6	6.4	3.6	5.1	6.2	6.6	0.0	5.8	4.8	10.1	3.3	6.1	7.4	5.8	6.9	9.2	5.5	3.0	15.2	4.9	3.0	12.0	6.0	2.9	7.7	4.4	6.2	4.8	6.8	4.4	3.5	4.5	5.4	8.1	12.7	1.3	5.1	6.7	1.3	1.6	2.3	2.2	2.3	3.3	3.3	2.5	3.4	1.8	2.0	3.3	3.1	1.3	2.3	1.4	1.3	3.8	1.9	1.0	1.5	2.1	1.4	1.0	1.4	1.4	1.3	1.3	1.0	1.3	2.0	3.6	0.0	6.1	1.6	3.5	0.4	1.7	1.0	3.4	1.4	3.0	2.8	3.1	2.8	3.8	1.8	4.2	2.7	6.5	4.5	1.9	2.8	0.4	2.1	2.4	2.8	0.0	3.6	1.0	3.6	1.9	3.5	1.5	2.8	1.3	5.7	4.2	1.2	2.4	3.3	1.3	2.7	0.0	3.8	1.7	0.1	2.1	2.6	3.6	4.7	3.4	1.4	2.1	1.0	3.6	2.5	2.1	1.2	2.3	1.9	3.1	2.2	3.5	0.6	0.0	2.0	2.8	0.9	2.8	1.3	1.8	7.7	3.0	2.4	2.0	1.8
ZSCAN20	"KOX29, ZNF31, ZNF360"	ENSG00000121903	"Zinc finger and SCAN domain containing 20"	P17040	1	33472645-33496507	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Early spermatids: 15.9"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA017933	Uncertain		Approved	Nucleoplasm		NA	NA			"Cluster 39: Non-specific - mRNA processing"	"Cluster 21: Non-specific - Transcription"	"Cluster 12: NES - Nervous system development"	"Cluster 29: Early spermatids - Spermatogenesis"	Nucleoplasm		"HPA017933: AB_1859028"	"unprognostic (1.52e-1)"	"unprognostic (1.10e-2)"	"unprognostic (1.27e-1)"	"unprognostic (6.75e-3)"	"unprognostic (9.28e-2)"	"unprognostic (3.03e-3)"	"unprognostic (1.77e-6)"	"unprognostic (3.13e-1)"	"unprognostic (6.94e-2)"	"unprognostic (4.05e-2)"	"unprognostic (2.96e-1)"	"unprognostic (1.25e-1)"	"unprognostic (1.53e-1)"	"unprognostic (2.03e-1)"	"unprognostic (2.92e-2)"	"unprognostic (4.43e-2)"	"unprognostic (1.74e-2)"	0.8	0.8	1.4	0.7	1.7	0.2	1.3	2.3	1.4	1.2	1.6	1.1	2.7	1.4	0.9	0.9	1.2	0.7	1.9	1.1	1.2	1.1	0.5	0.9	0.6	1.7	1.6	2.3	0.9	2.5	0.9	1.2	1.9	1.2	1.3	1.5	1.0	1.5	1.1	0.8	1.2	1.5	1.1	0.9	1.2	1.7	1.8	1.2	1.3	2.0	1.0	1.0	0.7	2.4	2.4	1.7	4.0	2.7	3.1	3.1	2.6	2.9	2.9	3.8	3.1	1.8	3.0	1.7	1.5	3.0	2.2	2.9	3.3	1.5	3.9	0.0	3.7	3.6	4.2	1.5	2.9	2.0	1.2	2.2	2.7	4.0	3.3	3.5	3.0	2.9	2.4	2.2	3.4	0.8	1.6	1.2	3.3	2.2	1.0	1.7	4.6	0.7	2.1	2.0	1.5	2.3	2.2	2.4	3.2	5.2	1.6	2.2	2.7	3.3	2.3	3.1	4.2	2.9	2.0	0.8	3.5	0.6	2.2	0.0	0.5	0.0	0.2	0.2	0.4	0.0	0.0	0.1	0.4	0.1	0.4	0.6	0.1	0.2	0.2	0.2	0.2	0.1	1.4	1.7	2.3	1.4	1.1	1.2	1.7	1.6	1.9	1.1	1.8	2.4	0.8	0.0	1.3	1.3	0.2	0.0	0.6	0.7	1.8	1.8	0.5	0.4	2.2	2.8	0.4	0.0	4.2	0.9	0.1	1.0	0.0	0.8	15.9	0.4	1.2	0.9	1.2	2.7	2.6	0.2	0.8	1.7	2.6	0.4	1.3	2.8	1.8	0.4	0.6	0.0	2.7	0.7	0.0	1.2	0.0	2.6	1.2	0.3	0.0	4.7	2.0	1.0	1.0	4.0	3.7	0.9	1.6	1.9	0.4	0.5	0.4	0.5	0.9	1.9	0.0	1.4	1.2	3.2	1.5	1.0	0.0	0.3	0.8	0.9	0.4	0.5